Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,maintenance of blood-brain barrier (GO:0035633),-0.6606500791333559,-2.236388871470106,0.0,0.011449993997987016,0.008,15/30,7.61%,TJP1;CDH5;GJB6;OCLN;PECAM1;DMD;CLDN5;LAMA2;ESAM;SLC12A2;F11R;LSR;TJP2;ACTB;GJA1
prerank,superoxide anion generation (GO:0042554),0.8971669905174063,1.925664283168218,0.0,0.07854705134773585,0.069,3/13,0.87%,NOX4;DUOX1;NCF4
prerank,dopaminergic neuron differentiation (GO:0071542),0.8363500280043938,1.8914741346137982,0.0,0.1052142601386338,0.165,5/19,3.91%,LMX1A;LRP6;WNT2;VEGFA;LMX1B
prerank,collagen fibril organization (GO:0030199),0.6827181647451753,1.8780939720559007,0.0,0.10117377395819473,0.224,35/88,10.87%,COL14A1;PLOD2;COL3A1;P4HA3;COL5A2;COL6A3;COL1A2;DDR2;COL1A1;LOXL2;COL17A1;COL5A1;BMP1;COL8A1;COL11A1;COL5A3;ADAMTS2;COL6A2;TGFB2;COL8A2;P4HA1;ADAMTS3;DPT;DST;COL12A1;COL6A1;P4HA2;TLL1;COL15A1;PLOD3;COL9A3;LOXL1;COL2A1;COLGALT1;SERPINH1
prerank,regulation of bicellular tight junction assembly (GO:2000810),-0.6189756304124537,-1.8731119335759263,0.008583690987124463,1.0,0.805,6/19,4.00%,TJP1;PRKCH;OCLN;CLDN5;F11R;NPHP1
prerank,protein localization to cell-cell junction (GO:0150105),-0.6657632286922598,-1.8728911523623306,0.00392156862745098,0.7621879337993358,0.806,7/15,5.82%,TJP1;CGNL1;CDH5;F11R;LSR;TJP2;ACTB
prerank,ethanol metabolic process (GO:0006067),-0.7133170501864768,-1.8566065108643717,0.003787878787878788,0.6726871473817373,0.861,5/12,15.32%,ALDH1A1;ACSS1;ACSS2;ADH1A;SULT1A1
prerank,regulation of cell junction assembly (GO:1901888),-0.5559096172096487,-1.824564423883506,0.0,0.7279906183920145,0.932,8/27,3.21%,TJP1;RAPGEF2;PRKCH;OCLN;PDLIM5;CLDN5;MEF2C;F11R
prerank,protein homotrimerization (GO:0070207),0.8357518017950095,1.805998238399832,0.0,0.30003034181468474,0.681,5/14,4.28%,SCARA5;SLC1A5;DISP1;MIF;P2RX3
prerank,protein trimerization (GO:0070206),0.8357518017950095,1.805998238399832,0.0,0.30003034181468474,0.681,5/14,4.28%,SCARA5;SLC1A5;DISP1;MIF;P2RX3
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.7938686044026233,1.8054194054158934,0.0,0.25196471821218147,0.683,9/19,11.48%,GFPT2;UAP1;UGDH;UGP2;GFPT1;GNPNAT1;NAGK;GMPPB;SLC35D1
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),-0.6775007305190893,-1.8046187679239885,0.011764705882352941,0.7320362829379701,0.952,9/12,21.82%,ATP1B3;DMD;WNK4;FXYD1;NOS1;ATP1B1;GLRX;ANK3;ATP1B2
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.8689463916401814,1.788583996523182,0.0013831258644536654,0.306846064788774,0.808,3/11,1.22%,LMX1A;LRP6;WNT2
prerank,regulation of transmembrane transport (GO:0034762),-0.5124158732563006,-1.7852720449821802,0.0,0.7457217519546115,0.966,8/31,5.82%,NEDD4L;OCLN;SLC2A1;BCL2;CTTNBP2NL;SNCA;WWP2;ACTB
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.8365700667438274,1.7836527904700177,0.001349527665317139,0.29503630089566213,0.838,5/13,6.60%,GFPT2;UAP1;GFPT1;GNPNAT1;NAGK
prerank,amino sugar biosynthetic process (GO:0046349),0.8426320450383035,1.771743164019677,0.0,0.32668677597576823,0.891,5/12,6.60%,GFPT2;UAP1;GFPT1;GNPNAT1;NAGK
prerank,smooth muscle cell differentiation (GO:0051145),-0.6516735574000064,-1.771689380776386,0.011857707509881422,0.7329427407961439,0.978,9/12,23.48%,MEF2C;TBX18;MRTFB;TMEM204;EDNRB;MYOCD;APLNR;HEY1;HEY2
prerank,regulation of multicellular organismal development (GO:2000026),-0.553276488079152,-1.769951179687281,0.006172839506172839,0.6602829872172513,0.98,10/25,18.82%,PTN;INSR;TRIP12;MYSM1;SOX17;OAS2;SPAAR;TDG;DUSP6;RACGAP1
prerank,positive regulation of protein processing (GO:0010954),0.7738343151333569,1.7625067601443747,0.0,0.34531611092504605,0.923,6/19,7.12%,GSN;CCBE1;HPN;CLEC3B;KLKB1;MELTF
prerank,B cell homeostasis (GO:0001782),-0.6760395780524366,-1.7584098781689694,0.016778523489932886,0.6605501537438709,0.989,2/10,2.00%,LYN;MEF2C
prerank,transport across blood-brain barrier (GO:0150104),-0.4000921693889572,-1.7537277048873503,0.0,0.6235042186176567,0.993,22/83,5.75%,ATP1A2;SLC24A3;SLC7A2;SLC6A13;SLC1A3;SLC16A12;ABCC4;SLC13A3;SLC22A8;SLC16A2;INSR;ABCG2;SLCO2B1;SLC2A1;SLCO1C1;SLC12A2;SLC6A1;SLC5A3;SLC7A5;ABCC9;SLC6A9;SLC5A5
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.85047307190631,1.7536808292527033,0.0,0.3729882988240969,0.952,5/11,6.60%,GFPT2;UAP1;GFPT1;GNPNAT1;NAGK
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),-0.49486168227351546,-1.7522986232401572,0.0,0.5792742796814931,0.993,13/35,7.48%,PDE7B;IRAG1;RAPGEF2;ADCY1;RAPGEF3;PDE3A;ADGRG6;APOE;NUDT4;KSR1;GUCY1B1;AHR;CAP2
prerank,amino acid import (GO:0043090),-0.5618252233193549,-1.7496442262082899,0.019417475728155338,0.5470454824730567,0.996,6/21,4.70%,SLC6A13;SLC1A3;SLC16A2;SLC6A1;SLC7A5;SLC22A4
prerank,skin development (GO:0043588),0.651727648435646,1.7494967587178696,0.0,0.3676034326963481,0.963,13/65,4.91%,COL3A1;COL5A2;COL1A2;COL1A1;LORICRIN;COL5A1;ANXA1;COL5A3;SCEL;ADAM9;PKD1;KRT10;DACT2
prerank,cGMP-mediated signaling (GO:0019934),-0.6383700281043128,-1.7463125175664969,0.014814814814814815,0.5222015119796222,0.996,5/13,9.63%,IRAG1;PDE3A;APOE;GUCY1B1;PDE2A
prerank,macrophage activation involved in immune response (GO:0002281),0.8193792113018719,1.7454407661351004,0.0026954177897574125,0.3631216011023533,0.97,2/13,0.28%,SYK;LBP
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),-0.49583354047984657,-1.7428122601707992,0.0,0.5012807372318716,0.996,12/35,13.23%,TJP1;RAPGEF3;ESAM;F11R;IQGAP2;NRP1;NTRK3;MDK;TEK;CDK5;ABL1;ABI3
prerank,vascular transport (GO:0010232),-0.40596357101196273,-1.738377599537196,0.0,0.4874119320018098,0.999,22/81,5.75%,ATP1A2;SLC24A3;SLC7A2;SLC6A13;SLC1A3;SLC16A12;ABCC4;SLC13A3;SLC22A8;SLC16A2;INSR;ABCG2;SLCO2B1;SLC2A1;SLCO1C1;SLC12A2;SLC6A1;SLC5A3;SLC7A5;ABCC9;SLC6A9;SLC5A5
prerank,bicellular tight junction assembly (GO:0070830),-0.46114596851674167,-1.7358078637227363,0.0,0.46749651964722283,0.999,10/46,3.97%,CDH5;PARD6G;OCLN;PECAM1;CLDN5;PATJ;ESAM;F11R;DLG1;STRN
prerank,establishment of endothelial intestinal barrier (GO:0090557),-0.6921603494532473,-1.7307982396955064,0.00964630225080386,0.45717281590851494,1.0,4/11,4.28%,TJP1;RAPGEF2;F11R;TJP2
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.8001841428719526,1.7294885182251398,0.002717391304347826,0.4376885515576215,0.982,4/14,8.09%,SYK;CD55;TGFBR2;CD81
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.7843980551836988,1.7282488341208557,0.007741935483870968,0.41717211715797475,0.983,2/15,0.49%,SYK;CD55
prerank,cation transmembrane transport (GO:0098655),-0.4648705564118822,-1.7280667901359934,0.0,0.4423916102064352,1.0,10/44,9.21%,ATP1A2;TRPM3;SLC7A2;TRPM6;SLC7A5;ABCC9;SLC6A9;SLC3A2;SLC25A20;SLC38A5
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),0.7656397357787657,1.7264597521605343,0.003870967741935484,0.4029778892060923,0.986,5/17,7.27%,SFRP4;FSTL1;PCSK6;SLIT2;SULF1
prerank,muscle tissue morphogenesis (GO:0060415),-0.5994206014312672,-1.7232296992216352,0.012448132780082987,0.4382485202729531,1.0,5/16,10.58%,MYLK;NOTCH1;TGFBR3;TBX1;BMP2
prerank,fructose 6-phosphate metabolic process (GO:0006002),0.8572942894050625,1.7232165253461293,0.0014144271570014145,0.4000366529423903,0.99,3/10,3.12%,GFPT2;PFKP;GFPT1
prerank,superoxide metabolic process (GO:0006801),0.7080088843025691,1.7217043206619753,0.0011933174224343676,0.38783280017307975,0.991,3/29,0.87%,NOX4;DUOX1;NCF4
prerank,heart process (GO:0003015),0.8101497334562876,1.7213060870653802,0.0039946737683089215,0.369513094059524,0.993,3/14,3.15%,NOX4;FYN;TNNI3
prerank,eye morphogenesis (GO:0048592),0.748466037405,1.7209069361929292,0.0025673940949935813,0.3535587027331418,0.993,7/19,5.31%,MFAP5;COL5A2;FBN1;COL5A1;VEGFA;SKI;TENM3
prerank,regulation of interleukin-2 production (GO:0032663),0.6637760507692165,1.7205012162993816,0.0,0.33921613121720606,0.993,7/43,3.72%,CD34;CD80;IRF4;ANXA1;GLMN;RUNX1;HDAC7
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.7661367595629175,1.7187648156629058,0.0037926675094816687,0.3326128223737456,0.994,3/17,2.88%,SFRP4;TMEM100;FGF2
prerank,positive regulation of vascular permeability (GO:0043117),-0.6623869352572862,-1.7141589775739035,0.01838235294117647,0.4485126220354343,1.0,8/12,12.49%,TJP1;BMP6;OCLN;PDE3A;TJP2;PDE2A;TGFB1;TRPV4
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.7279684641836303,1.710890625092643,0.0024813895781637717,0.35820491049402237,0.996,6/21,8.56%,DCN;UGDH;CSGALNACT2;VCAN;CHST12;CHSY3
prerank,response to iron ion (GO:0010039),-0.6438683220278929,-1.7107552327079742,0.02197802197802198,0.43895113354101134,1.0,5/12,6.86%,BMP6;BCL2;SNCA;ACO1;B2M
prerank,extracellular matrix disassembly (GO:0022617),0.6442912355816113,1.7063379851768894,0.0,0.3661084528095856,0.997,13/53,8.22%,ADAMTS5;TIMP2;GSN;BMP1;HPN;CD44;CAPN2;MMP2;KLKB1;SCUBE3;TLL1;MMP11;CAPN1
prerank,C21-steroid hormone metabolic process (GO:0008207),0.7460264251140747,1.703193200806456,0.005031446540880503,0.36915174700069237,0.998,2/20,0.74%,AKR1B1;DHRS9
prerank,tight junction assembly (GO:0120192),-0.4473455387122324,-1.7004882445389269,0.0,0.45272280616388666,1.0,11/49,3.97%,CDH5;PARD6G;OCLN;PECAM1;CLDN5;PATJ;ESAM;F11R;DLG1;LSR;STRN
prerank,actin filament bundle assembly (GO:0051017),-0.4899212328989424,-1.6974550966081705,0.013333333333333334,0.4442597671218963,1.0,5/33,2.04%,PAWR;MYO1B;SHROOM2;CALD1;EPS8
prerank,regulation of fatty acid oxidation (GO:0046320),-0.5723053613670381,-1.6949694574890997,0.01904761904761905,0.434779172091563,1.0,5/16,8.39%,PRKAG2;LONP2;PPARA;ACADL;APPL2
prerank,extracellular matrix organization (GO:0030198),0.5904928544043668,1.6947126456804225,0.0,0.4033648434595266,0.998,75/276,10.15%,COL14A1;PLOD2;MFAP5;COMP;COL3A1;P4HA3;DCN;ADAMTS5;COL5A2;COL6A3;COL1A2;TIMP2;DDR2;FBN1;HAS2;GSN;COL1A1;HAS1;LOXL2;COL17A1;COL5A1;BMP1;COL8A1;FLRT2;COL11A1;POSTN;VIT;COL5A3;ITGA11;ADAMTS2;SPARC;COL6A2;CD44;ITGB3;CAPN2;MMP2;FGF2;TGFB2;COL8A2;P4HA1;KLKB1;ELN;SMOC2;ADAMTS3;ACAN;SCUBE3;ITGA2;ADAMTSL1;ADAM19;ITGA5;ITGB5;DPT;DST;VCAN;ADAMTSL4;COL12A1;CREB3L1;JAM3;COL6A1;TGFBI;P4HA2;TLL1;GAS6;MMP11;CAPN1;COL15A1;PLOD3;ADAMTSL5;ADAMTSL3;ADAMTS18;ITGAV;COL9A3;LOXL1;COL2A1;CD47
prerank,myeloid cell activation involved in immune response (GO:0002275),0.7493057228496538,1.6929318565277278,0.007712082262210797,0.39848172597308146,0.999,2/18,0.28%,SYK;LBP
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.7555693569574408,1.6907051994615252,0.008928571428571428,0.3947093228439794,1.0,6/17,8.77%,SYK;LIF;TGFB2;ADAM9;RET;FOXC2
prerank,negative regulation of protein autophosphorylation (GO:0031953),-0.6758474255580393,-1.6844358350392878,0.033112582781456956,0.44980861036707465,1.0,4/10,6.08%,ENG;ENPP1;ERRFI1;CAV1
prerank,transition metal ion transport (GO:0000041),-0.4802110169640644,-1.6775992117516911,0.014598540145985401,0.4552008724977505,1.0,15/35,14.72%,CP;IREB2;ATP2C1;SLC30A10;SLC39A8;FTH1;TRPC5;SLC30A1;TRPC6;TRPC4;CUTC;TFRC;TRPC7;TRPC3;COX17
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.69039181464273,1.6760926495821489,0.00245398773006135,0.46643372466988803,1.0,8/27,9.12%,DCN;UGDH;CSGALNACT2;VCAN;CHST12;CHSY3;B3GAT3;XYLT1
prerank,response to interleukin-4 (GO:0070670),-0.6629505596771583,-1.671253762202152,0.013468013468013467,0.46024886588337105,1.0,2/10,4.64%,LEF1;TCF7
prerank,embryonic eye morphogenesis (GO:0048048),0.8195607062225899,1.6695081165950676,0.005673758865248227,0.4922605123352547,1.0,3/11,0.47%,MFAP5;FBN1;LRP6
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.7703950538463228,1.6678328855900901,0.002638522427440633,0.48820542826926056,1.0,6/15,8.70%,DCN;CSGALNACT2;VCAN;CHST12;CHST14;B3GAT3
prerank,modified amino acid transport (GO:0072337),-0.5773351607317174,-1.6656506645458484,0.01968503937007874,0.4634088950150814,1.0,5/15,10.50%,SLC6A13;SLC16A12;PDPN;CTNS;MGST1
prerank,response to glucagon (GO:0033762),-0.5472601249026603,-1.6624670593429975,0.017937219730941704,0.4583432597394203,1.0,9/19,15.92%,ADCY5;ADCY1;PRKAR1B;CRY1;ADCY4;ADCY9;PRKAR2B;CYSLTR2;PRKACB
prerank,cellular component disassembly (GO:0022411),0.6253162747277811,1.658913514923367,0.0010893246187363835,0.5320411190247678,1.0,12/53,8.22%,ADAMTS5;TIMP2;GSN;BMP1;CD44;CAPN2;MMP2;KLKB1;SCUBE3;TLL1;MMP11;CAPN1
prerank,positive regulation of interleukin-10 production (GO:0032733),0.6671175046754975,1.655177369906481,0.005952380952380952,0.5410431385763234,1.0,3/30,1.14%,CD34;SYK;IRF4
prerank,positive regulation of biomineral tissue development (GO:0070169),-0.43586261839549995,-1.6546187986443965,0.0,0.4688218510208039,1.0,15/40,12.16%,PTN;BMP6;WNT4;ADGRV1;BMP7;MEF2C;WNT6;OSR1;KL;NELL1;ATRAID;BMPR2;BMP2;PKDCC;TGFB1
prerank,regulation of interleukin-1 production (GO:0032652),0.7393680342422376,1.6488008782234205,0.011889035667107,0.5706782681252166,1.0,6/15,10.20%,ANXA1;FOXP1;F2R;GAS6;TLR4;SIRPA
prerank,diol biosynthetic process (GO:0034312),-0.5744803753374934,-1.647255040607027,0.031007751937984496,0.477035374941134,1.0,8/15,22.80%,ACER2;GCH1;QDPR;SPR;SPHK1;SPTLC2;SPHK2;ABCA2
prerank,actin filament bundle organization (GO:0061572),-0.4836621445533671,-1.6471587659551683,0.02054794520547945,0.46306551483980224,1.0,5/33,2.04%,PAWR;MYO1B;SHROOM2;CALD1;EPS8
prerank,vasoconstriction (GO:0042310),-0.6367423299636692,-1.6420846526323722,0.0353356890459364,0.46480240341240237,1.0,5/11,15.59%,EDNRA;ACTA2;EDNRB;EDN1;EDN3
prerank,smooth muscle tissue development (GO:0048745),-0.6706607478921591,-1.6406914550183533,0.05263157894736842,0.4562986179540655,1.0,4/10,8.06%,MYLK;ENG;PTCH1;STRA6
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.6258321282923817,-1.6389333831893638,0.03529411764705882,0.4488715702599744,1.0,6/13,8.64%,PLXNA2;NRP2;PLXNA4;PLXND1;NRP1;PLXNB1
prerank,myoblast fusion (GO:0007520),0.787897801050707,1.6385079419244037,0.007142857142857143,0.6285980603094994,1.0,4/12,8.09%,ADAMTS5;CD9;PTGFRN;CD81
prerank,carbohydrate catabolic process (GO:0016052),-0.4571747591499522,-1.635780670678933,0.007042253521126761,0.44636409034314795,1.0,18/38,20.36%,ENO1;HK2;PGAM1;PGAM4;DERA;MAN2B1;PGK1;PFKM;ALDOC;GAPDH;PFKL;MANBA;TPI1;MAN2B2;GAPDHS;NEU3;ENO3;GPI
prerank,heart trabecula morphogenesis (GO:0061384),-0.5407754172387145,-1.6337512753299872,0.03684210526315789,0.4402221376594482,1.0,8/18,6.54%,BMP5;ENG;ADGRG6;BMP7;RBP4;NOTCH1;TGFBR3;S1PR1
prerank,negative regulation of hormone secretion (GO:0046888),0.7991271120849148,1.63359731564663,0.01,0.6480131736188206,1.0,2/10,1.02%,LIF;RAB11FIP5
prerank,establishment of endothelial barrier (GO:0061028),-0.4787844437546944,-1.6324215953223113,0.01744186046511628,0.43266297832906325,1.0,10/29,10.96%,TJP1;RAPGEF2;RAPGEF3;PECAM1;PPP1R16B;F11R;TJP2;PDE2A;ROBO4;ICAM1
prerank,smooth muscle contraction (GO:0006939),-0.5933185387755355,-1.6317000588146895,0.023622047244094488,0.42382152783548943,1.0,5/14,11.49%,MYLK;EDNRA;MYH11;SMTN;ACTA2
prerank,peptide cross-linking (GO:0018149),0.6815047083350815,1.6303689657771725,0.00975609756097561,0.6551091409703053,1.0,4/25,4.62%,COL3A1;LORICRIN;ANXA1;KRT10
prerank,positive regulation of actin filament depolymerization (GO:0030836),-0.6659406474089582,-1.6294737167164368,0.03367003367003367,0.41915356077021254,1.0,3/10,13.42%,ACTN2;SEMA5A;WDR1
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.7036346766347548,1.6250379025603001,0.011180124223602485,0.6808687059808123,1.0,7/20,7.85%,NPTN;SULF2;FGF2;SMOC2;CREB3L1;SULF1;PRKD2
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.6424338693352376,-1.62414008418331,0.03103448275862069,0.424085968173062,1.0,5/11,9.38%,MLLT3;WNT5B;RSPO3;NKD1;SFRP1
prerank,cellular response to interleukin-4 (GO:0071353),-0.6413541298332095,-1.621403419037839,0.02622950819672131,0.4219455927723309,1.0,2/10,4.64%,LEF1;TCF7
prerank,regulation of protein neddylation (GO:2000434),-0.6323981457767871,-1.6202183680187734,0.030927835051546393,0.4157648956950877,1.0,7/10,25.13%,EPAS1;DCUN1D4;RPL5;DCUN1D3;DCUN1D5;HIF1A;DCUN1D2
prerank,homocysteine metabolic process (GO:0050667),0.7792314611127102,1.6200413159422504,0.010057471264367816,0.704561331747212,1.0,1/11,0.01%,NOX4
prerank,regulation of mast cell activation (GO:0033003),-0.6496907958195385,-1.6188103908994775,0.02877697841726619,0.4098334518346153,1.0,4/10,12.01%,LYN;PLSCR1;NECTIN2;CD84
prerank,sulfur amino acid metabolic process (GO:0000096),0.671233677399277,1.6161272960847262,0.010830324909747292,0.7195540219296751,1.0,2/24,0.79%,NOX4;GCLC
prerank,positive regulation of protein depolymerization (GO:1901881),-0.6384110990594876,-1.6149917825361126,0.02857142857142857,0.41170195810153315,1.0,5/11,19.05%,SEMA5A;NES;TRPV4;WDR1;KATNB1
prerank,presynaptic endocytosis (GO:0140238),0.677851860760181,1.614737267677324,0.014652014652014652,0.7123869878331236,1.0,5/24,3.29%,STON2;SNCB;SYT2;CEL;STX1A
prerank,synaptic vesicle membrane organization (GO:0048499),0.7193429670454802,1.614399705168619,0.013020833333333334,0.6980343925326565,1.0,11/17,17.98%,STX2;STX1A;STX11;AP3D1;STX1B;TOR1A;STX4;SNAP23;SNAP25;SNAP47;STX3
prerank,angiogenesis involved in wound healing (GO:0060055),0.7699096428843749,1.6119397414440846,0.015602836879432624,0.7005864763619757,1.0,4/11,6.11%,CD34;ITGB3;VEGFA;PRCP
prerank,cardiac muscle tissue morphogenesis (GO:0055008),-0.4787311661007227,-1.609206303165655,0.006134969325153374,0.41826584457753,1.0,8/29,12.16%,TPM1;ENG;NOTCH1;TGFBR3;S1PR1;FGFR2;BMP2;TGFB1
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.6270459306812938,1.6089446131066207,0.007918552036199095,0.7073201644091566,1.0,12/41,17.16%,CD34;LBP;IRAK3;SYT11;GAS6;TLR4;SIRPA;ZC3H12A;IL4;SELENOS;ILRUN;CHRNA7
prerank,renal absorption (GO:0070293),0.7899957403127251,1.6086136910657558,0.02142857142857143,0.6942093989485075,1.0,2/10,0.45%,HAS2;GSN
prerank,positive regulation of bone mineralization (GO:0030501),-0.4607973733636577,-1.608285929006556,0.007751937984496124,0.41212822146504524,1.0,14/35,12.16%,PTN;BMP6;WNT4;ADGRV1;BMP7;MEF2C;OSR1;KL;NELL1;ATRAID;BMPR2;BMP2;PKDCC;TGFB1
prerank,cell junction maintenance (GO:0034331),0.7358845482245489,1.6081666630907043,0.01078167115902965,0.68242757547743,1.0,5/14,8.24%,DCTN1;CD177;F2R;MYADM;PARD6A
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.619926580156987,1.6056203657428452,0.008958566629339306,0.6870339539869335,1.0,12/43,17.16%,CD34;LBP;IRAK3;SYT11;GAS6;TLR4;SIRPA;ZC3H12A;IL4;SELENOS;ILRUN;CHRNA7
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),-0.5459725741588908,-1.6055427021488957,0.018691588785046728,0.41028366248297155,1.0,11/17,12.05%,MAML3;CREBBP;NOTCH3;NOTCH1;PLXND1;WWC1;HEYL;MAML2;NOTCH4;STAT1;EP300
prerank,external encapsulating structure organization (GO:0045229),0.5615073420321872,1.6033802614414154,0.0,0.6892059302283972,1.0,52/205,10.15%,COL14A1;MFAP5;COMP;COL3A1;DCN;ADAMTS5;COL5A2;COL6A3;COL1A2;DDR2;FBN1;COL1A1;COL17A1;COL5A1;COL8A1;COL11A1;POSTN;VIT;COL5A3;ITGA11;ADAMTS2;SPARC;COL6A2;CD44;ITGB3;MMP2;FGF2;COL8A2;ELN;SMOC2;ADAMTS3;ACAN;ITGA2;ADAMTSL1;ADAM19;ITGA5;ITGB5;VCAN;ADAMTSL4;JAM3;COL6A1;TGFBI;MMP11;COL15A1;ADAMTSL5;ADAMTSL3;ADAMTS18;ITGAV;COL9A3;LOXL1;COL2A1;CD47
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.6706232165782922,1.602641168448242,0.01079136690647482,0.6806025807256193,1.0,8/25,10.59%,HAS2;HAS1;B3GALNT1;CSGALNACT2;EXT1;HS2ST1;FUT9;B3GNT8
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),-0.5421894507754838,-1.6020427597933902,0.024096385542168676,0.41240588381949644,1.0,10/16,21.83%,APOE;SCARB1;PIK3CB;NPR3;GCH1;TERT;S100A1;HIF1A;NOS1AP;TERF2
prerank,extracellular structure organization (GO:0043062),0.560096916903911,1.600202916733705,0.0,0.6863460741098824,1.0,52/204,10.15%,COL14A1;MFAP5;COMP;COL3A1;DCN;ADAMTS5;COL5A2;COL6A3;COL1A2;DDR2;FBN1;COL1A1;COL17A1;COL5A1;COL8A1;COL11A1;POSTN;VIT;COL5A3;ITGA11;ADAMTS2;SPARC;COL6A2;CD44;ITGB3;MMP2;FGF2;COL8A2;ELN;SMOC2;ADAMTS3;ACAN;ITGA2;ADAMTSL1;ADAM19;ITGA5;ITGB5;VCAN;ADAMTSL4;JAM3;COL6A1;TGFBI;MMP11;COL15A1;ADAMTSL5;ADAMTSL3;ADAMTS18;ITGAV;COL9A3;LOXL1;COL2A1;CD47
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.7501572776889419,1.598873649875835,0.0203527815468114,0.683593219572452,1.0,4/13,8.09%,SYK;CD9;ABCA1;CD81
prerank,renal water homeostasis (GO:0003091),-0.5020284635518044,-1.596445211275609,0.0273224043715847,0.4190248783890778,1.0,9/23,15.92%,ADCY5;ADCY1;PRKAR1B;ADCY4;ADCY9;RAB11A;MYO5B;PRKAR2B;PRKACB
prerank,positive regulation of immune system process (GO:0002684),0.7078859483135261,1.595580805618135,0.021850899742930592,0.694391738837676,1.0,5/16,8.14%,ANXA1;VEGFA;TGFB2;MIA3;TNFRSF18
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.7148203557209925,1.5940140500998536,0.010443864229765013,0.6936950628460417,1.0,5/17,4.94%,MID1;STK25;TGFB2;TAOK3;KLHDC10
prerank,regulation of interleukin-12 production (GO:0032655),0.5958511194191304,1.5901520563127305,0.01002227171492205,0.7091143035252383,1.0,11/47,11.89%,SYK;IL16;IRAK3;FOXP1;MAPK14;C1QBP;TIRAP;TLR4;MAPK11;CD47;PIBF1
prerank,bone morphogenesis (GO:0060349),0.7403996870124552,1.5899361995430954,0.016107382550335572,0.6978962813686707,1.0,3/14,4.06%,SFRP4;LRP6;SKI
prerank,positive regulation of cell adhesion (GO:0045785),0.5815006774984166,1.5881811053868162,0.0010695187165775401,0.6999449652836928,1.0,19/74,10.15%,SYK;LIF;FBLN2;PRKCA;VIT;VEGFA;TGFB2;ADAM9;PTPRJ;ZFHX3;C1QBP;RET;FLCN;PRKD2;TNFRSF18;FOXC2;STX4;ITGAV;CD47
prerank,regulation of sensory perception of pain (GO:0051930),0.7671430324945221,1.5867170623545808,0.009735744089012517,0.698025886245961,1.0,4/11,8.27%,MGLL;TMEM100;F2R;SPX
prerank,positive regulation of interleukin-2 production (GO:0032743),0.6707569824471794,1.5864757013099613,0.023894862604540025,0.6875291284635149,1.0,7/25,11.84%,CD80;IRF4;ANXA1;GLMN;RUNX1;PRKD2;PDE4D
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),-0.619536184748471,-1.5861130241434234,0.043795620437956206,0.4388210199728525,1.0,6/11,15.14%,EFNB2;SOX6;MEF2C;BMP2;TGFB1;MYOCD
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.7166799163318884,1.5830597995073414,0.017310252996005325,0.701450315425543,1.0,7/16,14.08%,ZFP36L1;TRIM71;TARDBP;RC3H1;ZFP36L2;ZFP36;ZC3H12A
prerank,regulation of coagulation (GO:0050818),0.7611780097442977,1.5830510425202777,0.022315202231520222,0.6898241246140043,1.0,4/11,11.66%,EPHB2;F2R;PROCR;HS3ST5
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.5701278502175282,1.582186172393661,0.0010460251046025104,0.6849538153045728,1.0,20/86,8.09%,GHR;LIF;CD80;FGF7;EGFR;EFNA5;ANGPT4;CD44;FYN;ITGB3;DGKQ;VEGFA;MIF;ACVR1;ITGA5;PTPRJ;THBS4;SRC;BANK1;CD81
prerank,spinal cord development (GO:0021510),0.7467696924718648,1.578541598478608,0.025245441795231416,0.6990875257048484,1.0,5/12,7.86%,VIT;ZPR1;PKD1;GLI2;PKD2
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.7645857016155023,1.578028264361764,0.0196078431372549,0.6916542724496394,1.0,4/12,7.69%,DCN;VCAN;CHST12;CHST14
prerank,cellular defense response (GO:0006968),0.6078135401815549,1.57695955051064,0.013921113689095127,0.6881048977442276,1.0,4/40,4.69%,LBP;LSP1;KIR3DL2;RAB23
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.6591056582617157,1.5739875468943338,0.018137847642079808,0.6993895094362499,1.0,6/24,11.92%,GFPT2;GFPT1;COQ10B;PID1;ACADVL;NDUFS1
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.7521204617406719,1.573894499020787,0.017857142857142856,0.6895567178922444,1.0,9/12,17.98%,STX2;STX1A;STX11;STX1B;STX4;SNAP23;SNAP25;SNAP47;STX3
prerank,endothelial cell proliferation (GO:0001935),0.7093954916690819,1.5732910065256274,0.020434227330779056,0.6833029005303034,1.0,3/17,1.55%,CD34;LOXL2;ANGPT4
prerank,negative regulation of actin filament bundle assembly (GO:0032232),-0.4852483141019422,-1.5728044047569647,0.03508771929824561,0.4680887168950654,1.0,8/27,3.53%,TJP1;CGNL1;PHLDB2;ARHGAP28;ARHGAP6;F11R;SHANK3;RHPN2
prerank,gas transport (GO:0015669),0.7706483305987801,1.572518001784346,0.017759562841530054,0.6785592491429401,1.0,1/10,0.41%,CYGB
prerank,cellular response to glucagon stimulus (GO:0071377),-0.5352696198946109,-1.5709528823257428,0.025423728813559324,0.4649545710886283,1.0,8/17,15.92%,ADCY5;ADCY1;PRKAR1B;ADCY4;ADCY9;PRKAR2B;CYSLTR2;PRKACB
prerank,gliogenesis (GO:0042063),0.7139475170817945,1.5706921279088066,0.01706036745406824,0.6813454278743212,1.0,4/15,5.95%,CD9;ANXA1;TGFB2;NFIB
prerank,negative regulation of actin filament polymerization (GO:0030837),0.6634702036645701,1.569775560581701,0.022304832713754646,0.6784553509268717,1.0,8/22,11.00%,GSN;SCIN;SLIT2;MYADM;PFN2;TWF1;KANK1;SSH1
prerank,amino sugar metabolic process (GO:0006040),0.7625955002159157,1.569715415391453,0.032448377581120944,0.6692957232210828,1.0,2/10,3.12%,GFPT2;GFPT1
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.5427009055814884,-1.569506958280377,0.031818181818181815,0.4603105768899835,1.0,10/18,30.06%,SLC39A8;ITGA4;VCAM1;GCNT1;ROCK1;JAM2;SELPLG;PODXL2;SELP;ITGB7
prerank,regulation of protein localization to membrane (GO:1905475),0.6471242223184434,1.568439041126096,0.01979045401629802,0.6683502873936974,1.0,6/28,5.39%,AR;GSN;GPC6;GPC3;FYN;ZDHHC7
prerank,apical junction assembly (GO:0043297),-0.4099428241318359,-1.5662139828994794,0.020833333333333332,0.46202770423662964,1.0,10/53,3.97%,CDH5;PARD6G;OCLN;PECAM1;CLDN5;PATJ;ESAM;F11R;DLG1;STRN
prerank,response to glucocorticoid (GO:0051384),0.6514961682234347,1.5652291083088685,0.024600246002460024,0.6811529091760274,1.0,10/26,20.59%,ANXA1;SLIT3;SLIT2;ADAM9;ZFP36L1;ZFP36L2;ZFP36;IL6;PDCD7;GOT1
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.7167254384630302,1.5632481524102946,0.021248339973439574,0.6853669223453339,1.0,3/15,2.91%,TGFB3;IRAK3;TGFB2
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.5490175545808887,1.5615463325735388,0.001017293997965412,0.6882402540312722,1.0,25/121,8.88%,NOX4;GHR;LIF;CD80;FGF7;EFNA5;ANGPT4;CTF1;CD44;ITGB3;DGKQ;VEGFA;MIF;DLG4;ACVR1;ITGA5;CLCF1;PTPRJ;THBS4;SRC;BANK1;GAS6;CD81;TNFRSF18;SRCIN1
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.6918839088083545,1.5609661639364423,0.016476552598225603,0.6831143656684667,1.0,7/19,14.83%,SYK;AXL;ZMIZ1;GAS6;ZBTB1;CD27;IL4
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),0.7023730864755396,1.5588529992654483,0.022813688212927757,0.6892292810900894,1.0,8/16,17.22%,AR;ESR1;TRIP4;EGLN2;RBFOX2;DDX17;DDX5;PADI2
prerank,negative regulation of gluconeogenesis (GO:0045721),-0.5965473107940723,-1.5561283427380899,0.037037037037037035,0.48210501044155857,1.0,4/11,12.05%,CRY1;C1QTNF3;SIK1;EP300
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.7085956719212012,1.5557710455737697,0.022020725388601035,0.701801368879343,1.0,6/15,7.85%,FGF18;FGFR1;VEGFA;FGF2;SMOC2;PRKD2
prerank,regulation of B cell differentiation (GO:0045577),0.6925243357016633,1.5538776136599581,0.017105263157894738,0.7062115182355502,1.0,5/17,12.21%,SYK;ZFP36L1;INHA;ZFP36L2;CD27
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.600117446386513,1.5474712079867698,0.017758046614872364,0.7446090767345779,1.0,8/41,8.88%,NOX4;AREG;BTC;FYN;DLG4;SRC;GAS6;SRCIN1
prerank,negative regulation of small molecule metabolic process (GO:0062014),-0.5018419005672421,-1.5469454485497172,0.035555555555555556,0.49979223801213324,1.0,5/20,12.05%,WNT4;CRY1;C1QTNF3;SIK1;EP300
prerank,regulation of actin nucleation (GO:0051125),0.7403197890226866,1.5464325053420418,0.023842917251051893,0.7431022746845467,1.0,3/12,9.95%,GSN;SCIN;ARF1
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.6450401798781329,-1.5461040979406548,0.048327137546468404,0.49374702931658593,1.0,5/10,25.34%,LYN;KIT;CD40;BTLA;FGR
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),-0.5030591594636822,-1.5456271687889247,0.04519774011299435,0.4871972446143476,1.0,5/22,7.78%,LYN;EPHA4;SP1;ABCG1;CASP3
prerank,hematopoietic progenitor cell differentiation (GO:0002244),-0.44605303839060656,-1.5451245763458532,0.018292682926829267,0.48061819068599604,1.0,8/30,12.56%,FLT1;MLLT3;KDR;KIT;SFRP1;INHBA;TGFB1;FLT4
prerank,response to laminar fluid shear stress (GO:0034616),0.7594270058103938,1.544580887525937,0.023977433004231313,0.7477225177077148,1.0,6/10,14.33%,MAPK7;NFE2L2;KLF2;ABCA1;SMAD6;KLF4
prerank,cardiac muscle cell contraction (GO:0086003),0.6784341946785983,1.5425857526224074,0.023989898989898988,0.7533179795923415,1.0,5/19,8.49%,GSN;ATP1A1;KCNJ2;CAMK2D;PIK3CA
prerank,regulation of epithelial cell migration (GO:0010632),-0.40495897976919426,-1.5410845935889537,0.0,0.4846117620986731,1.0,18/51,14.14%,PTN;PTPRG;SASH1;DOCK5;GLUL;PLCG1;DAB2IP;DUSP10;PRKCE;BMPR2;EMP2;RAB11A;MACF1;EVL;CEACAM1;PPM1F;PTK2;PFN1
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.5529034444058646,1.5407104127994296,0.002079002079002079,0.758029840189062,1.0,26/95,12.54%,DCN;HAS2;HAS1;ST3GAL2;GPC6;UGDH;B4GALT3;GPC3;B4GALT1;OGN;CHST1;CSGALNACT2;EXT1;ACAN;VCAN;CHST12;CHST14;CHSY3;B3GAT3;XYLT1;HS2ST1;HS3ST6;HS3ST5;ST3GAL4;HSPG2;GLCE
prerank,iron ion transmembrane transport (GO:0034755),0.756714770697323,1.5404456492639382,0.025174825174825177,0.7509029658254137,1.0,4/10,12.18%,SCARA5;SLC39A14;SLC11A2;SLC25A28
prerank,central nervous system neuron differentiation (GO:0021953),0.6152467733054197,1.540283702299757,0.024305555555555556,0.7433554924058979,1.0,3/33,1.22%,LMX1A;LRP6;WNT2
prerank,extracellular matrix assembly (GO:0085029),0.6503608617356154,1.538674521296713,0.027744270205066344,0.7462917302380663,1.0,5/23,7.58%,HAS2;TNXB;HAS1;NTN4;GAS6
prerank,regulation of spindle organization (GO:0090224),0.6854364429869643,1.5382870171852918,0.03300733496332518,0.7407423314598977,1.0,6/18,7.43%,PARP3;GPSM2;DCTN1;PSRC1;FSD1;CLTC
prerank,regulation of neutrophil chemotaxis (GO:0090022),0.6504866395994551,1.5382046980225845,0.02669902912621359,0.7330186470343011,1.0,8/23,11.70%,DPP4;SLIT2;JAM3;THBS4;C1QBP;MCU;TIRAP;MPP1
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.7527406033381614,1.5376450988846422,0.02616279069767442,0.7290976502878723,1.0,3/10,8.09%,CD55;TGFBR2;CD81
prerank,positive regulation of dendrite development (GO:1900006),-0.6222928780613894,-1.5361973217502538,0.05673758865248227,0.4904050603931488,1.0,4/10,3.60%,PTN;BMP5;BMP7;DAB2IP
prerank,positive regulation of leukocyte proliferation (GO:0070665),-0.5795449304052089,-1.5357606504928931,0.0703125,0.4838695901086826,1.0,4/12,13.28%,LYN;IL34;MAPK3;PTK2
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.41012930455682556,-1.5350445798122383,0.010869565217391304,0.4783983646112791,1.0,14/46,17.58%,ATP1A2;MEF2C;GRM3;SHANK3;DGKZ;CACNG4;OPHN1;GRM7;CACNG8;CDK5;UNC13A;GRM8;CDH2;CLN3
prerank,regulation of immune response (GO:0050776),0.5426801629431873,1.53356112426111,0.0020387359836901123,0.7496123086496375,1.0,19/135,11.15%,CD34;COL3A1;SYK;COL1A2;COL1A1;COL17A1;IRF4;KIR3DL2;NPDC1;TGFB2;FOXP1;CD160;CSK;CD81;TIRAP;SAMHD1;COL2A1;SPPL2B;BCL6
prerank,renal filtration (GO:0097205),0.7430575229264781,1.5326882673356124,0.037142857142857144,0.7474091336576222,1.0,4/10,10.07%,CD34;SULF2;SULF1;XPNPEP3
prerank,regulation of leukocyte migration (GO:0002685),0.6834290324230147,1.5324199878187603,0.04302477183833116,0.7413119096730756,1.0,6/16,14.43%,ANXA1;VEGFA;MIA3;CD81;TNFRSF18;HOXA7
prerank,positive regulation of actin nucleation (GO:0051127),0.7433039513960472,1.530897866068634,0.04395604395604396,0.7438036445000134,1.0,3/11,5.88%,GSN;SCIN;WASF1
prerank,synaptic vesicle endocytosis (GO:0048488),0.6056015558639548,1.5306686491816475,0.027939464493597205,0.7374133961615508,1.0,6/33,3.29%,STON2;SNCB;SYT2;DNM1;CEL;STX1A
prerank,embryonic skeletal system development (GO:0048706),0.6070553791289882,1.5299355123119545,0.0199764982373678,0.7343987681566083,1.0,14/35,14.58%,HOXA3;COL1A1;PCSK5;SULF2;WNT9A;HOXA4;UCMA;SULF1;XYLT1;SLC2A10;SIX1;PDGFRA;HOXC4;HOXA9
prerank,positive regulation of interleukin-12 production (GO:0032735),0.6064686903566444,1.5292034171823121,0.020047169811320754,0.7320461221826784,1.0,6/31,9.77%,SYK;IL16;MAPK14;TIRAP;TLR4;MAPK11
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.7491928620461413,1.528955175950096,0.04055944055944056,0.7264068514095031,1.0,2/10,1.22%,LRP6;WNT2
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.7054810486053148,1.5283326253954894,0.026281208935611037,0.7233498750377348,1.0,6/15,7.12%,DDR2;DPP4;LRP1;FAP;FSCN1;MELTF
prerank,negative regulation of interleukin-2 production (GO:0032703),0.6702796452795923,1.5270491145082292,0.03631647211413749,0.7246207915999457,1.0,2/18,3.72%,CD34;HDAC7
prerank,positive regulation of ossification (GO:0045778),-0.422984322299031,-1.526013312882463,0.02586206896551724,0.49672155780358224,1.0,15/39,12.16%,PTN;BMP6;WNT4;ADGRV1;BMP7;MEF2C;OSR1;KL;WNT5A;NELL1;ATRAID;BMPR2;BMP2;PKDCC;TGFB1
prerank,regulation of cellular component biogenesis (GO:0044087),-0.42842196249909525,-1.5256888097691903,0.008403361344537815,0.4902477280899307,1.0,10/39,9.90%,TJP1;RAPGEF2;SNCAIP;APOE;NOTCH1;DAB2IP;TIE1;PINK1;GFAP;PARP10
prerank,androgen receptor signaling pathway (GO:0030521),0.7338231072527224,1.5242293595086291,0.033426183844011144,0.7371959047282549,1.0,7/11,16.59%,AR;ZMIZ1;PMEPA1;PLPP1;DDX17;RNF14;DDX5
prerank,regulation of hemopoiesis (GO:1903706),-0.5968259748069549,-1.5237606054065809,0.08450704225352113,0.4883422440141463,1.0,4/10,5.37%,PTN;CREBBP;PURB;MYSM1
prerank,regulation of protein processing (GO:0070613),0.6471023659474546,1.5234482773037823,0.03132832080200501,0.7353399637609931,1.0,3/21,3.49%,CCBE1;GAS1;RUNX1
prerank,embryonic appendage morphogenesis (GO:0035113),0.734365967926172,1.5229889242387205,0.033287101248266296,0.7313829178891117,1.0,5/12,9.48%,LRP6;MBNL1;TGFB2;SKI;FBXW4
prerank,urogenital system development (GO:0001655),0.7311281527108475,1.5220992010477035,0.03744798890429958,0.7304017949042662,1.0,3/11,1.34%,EPHB2;AMH;ANXA1
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.6098677471503329,1.5219935681998826,0.02127659574468085,0.7242305960773776,1.0,9/33,8.77%,SYK;LIF;DPP4;TGFB2;ADAM9;JAM3;MUC1;RET;FOXC2
prerank,positive regulation of muscle cell differentiation (GO:0051149),0.6463029741609407,1.5214801954822266,0.034229828850855744,0.7208928713315783,1.0,6/24,9.77%,CDON;MAPK12;MAPK14;RBM4;BOC;MAPK11
prerank,synaptic vesicle recycling (GO:0036465),0.6177806967122306,1.5194267327978603,0.0330188679245283,0.7280125342983294,1.0,5/31,3.29%,STON2;SNCB;SYT2;CEL;STX1A
prerank,chondroitin sulfate metabolic process (GO:0030204),0.6177975248786457,1.519047355259843,0.014184397163120567,0.7239114618038243,1.0,6/30,8.56%,DCN;UGDH;CSGALNACT2;VCAN;CHST12;CHSY3
prerank,regulation of dendrite morphogenesis (GO:0048814),-0.43973697440248966,-1.518843023620395,0.04,0.495602203976638,1.0,7/32,3.17%,NEDD4L;RAPGEF2;TNIK;CUX1;PTPRD;CDKL5;YWHAH
prerank,regulation of epidermal cell differentiation (GO:0045604),0.6517344739556216,1.517351781870304,0.03426395939086294,0.7287020533289946,1.0,6/21,12.64%,SFRP4;RUNX1;ZFP36L1;MAFF;SFN;ZFP36
prerank,phosphate ion homeostasis (GO:0055062),0.7518588132735953,1.516581923916519,0.027142857142857142,0.7272610656603999,1.0,1/10,0.14%,SFRP4
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.7064070689619101,1.5157832274226384,0.040927694406548434,0.7260382378329754,1.0,3/13,10.05%,GNAI3;RAB23;RHOQ
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.6036841197635165,1.5156944578472982,0.024277456647398842,0.7200492700929347,1.0,20/33,24.81%,AR;ESR1;RUNX1;AXIN1;PRMT2;HDAC6;RNF14;TRIM68;DDX5;UFL1;GPAM;UFM1;KCTD6;CARM1;RNF6;NCOA2;KDM4C;LATS1;UFSP2;CALR
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.5516552287656784,1.5151708709885192,0.00522466039707419,0.7169724730690084,1.0,24/90,17.74%,EBF2;IL4R;SYK;UCP1;GNAS;IRF4;GADD45G;GRB10;VEGFA;PRKAB2;ADCYAP1;ALMS1;HDAC3;CEBPB;TSHR;HCRT;CNOT3;IL4;DYNC1H1;DIO2;OGT;CXCR4;FABP5;IL18
prerank,high-density lipoprotein particle remodeling (GO:0034375),-0.5509716422408588,-1.5147453629730425,0.06329113924050633,0.4997922380121333,1.0,4/15,5.81%,PLTP;APOE;SCARB1;ABCG1
prerank,negative regulation of epithelial cell differentiation (GO:0030857),-0.5523358200274631,-1.513886340334156,0.057034220532319393,0.49507516302000487,1.0,6/14,17.74%,OSR1;CAV1;NOTCH4;SPRED3;SPRED2;SPRY1
prerank,bone development (GO:0060348),0.598707736062328,1.5138018646984608,0.024475524475524476,0.7194787412924186,1.0,9/39,7.35%,SFRP4;MYOC;LRP6;GNAS;AKAP13;SULF2;SKI;SULF1;LRRC17
prerank,regulation of synapse organization (GO:0050807),-0.46081235106536045,-1.5127525696244155,0.029069767441860465,0.49106161758866823,1.0,8/26,12.12%,EPHA4;PDLIM5;MEF2C;CDKL5;WNT5A;ABHD17C;CAMK2B;ABL1
prerank,early endosome to Golgi transport (GO:0034498),0.739492246792808,1.5122654681514465,0.040927694406548434,0.7230123267535066,1.0,5/11,8.79%,RAB6A;STX5;SNX1;SURF4;LMAN1
prerank,dermatan sulfate metabolic process (GO:0030205),0.7202439559738589,1.5122135952054656,0.03561643835616438,0.7171138469309092,1.0,4/13,7.69%,DCN;VCAN;CHST12;CHST14
prerank,nucleotide-sugar metabolic process (GO:0009225),0.7145872734380452,1.510875105419928,0.04495912806539509,0.7198944587909296,1.0,3/12,3.12%,GFPT2;UGP2;GFPT1
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.6588927939317933,1.5101080588273574,0.046954314720812185,0.7188148184071046,1.0,8/18,16.59%,ESR1;EGFR;NCOR2;NCOR1;ZC3H12A;MAP2K2;IL6;DDX5
prerank,actin filament capping (GO:0051693),0.6608883386771591,1.5091834874314787,0.03389830508474576,0.7128710577872288,1.0,7/18,14.36%,GSN;SCIN;SVIL;ADD3;TWF1;AVIL;TRIOBP
prerank,barbed-end actin filament capping (GO:0051016),0.6608883386771591,1.5091834874314787,0.03389830508474576,0.7128710577872288,1.0,7/18,14.36%,GSN;SCIN;SVIL;ADD3;TWF1;AVIL;TRIOBP
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.6605523393391135,1.5070294084018254,0.048223350253807105,0.7212368009427086,1.0,7/17,13.40%,EGFR;PKD1;PSRC1;MAPRE3;PKD2;AKT1;CCND1
prerank,limb morphogenesis (GO:0035108),0.6557867494281303,1.505603636016613,0.04315659679408138,0.7246406628434561,1.0,7/20,11.60%,LRP6;MBNL1;PCSK5;TGFB2;SKI;FBXW4;GLI3
prerank,osteoclast differentiation (GO:0030316),0.6405885072899106,1.5037453779163148,0.03278688524590164,0.7309692823254064,1.0,6/22,7.43%,ANXA2;FOXP1;MAPK14;FARP2;SRC;OSTM1
prerank,regulation of mitochondrial depolarization (GO:0051900),0.7399582879109196,1.5031435889624327,0.03862660944206009,0.7290314384498187,1.0,3/10,6.81%,DCN;MYOC;SRC
prerank,regulation of glucose transmembrane transport (GO:0010827),-0.5196546887132866,-1.502504337120644,0.05194805194805195,0.5129911009563882,1.0,3/18,1.84%,PRKAG2;OCLN;SLC2A1
prerank,embryonic digit morphogenesis (GO:0042733),-0.5012863045491047,-1.5025041071196314,0.05116279069767442,0.5060587887813018,1.0,7/18,9.71%,MAP3K20;CREBBP;OSR1;TBX3;SALL1;TBX2;INTU
prerank,hippo signaling (GO:0035329),-0.4582606033402957,-1.5022466599251327,0.03409090909090909,0.5000136045627611,1.0,14/26,17.82%,TJP1;FAT4;TEAD4;TEAD1;TJP2;AMOT;WWC1;TEAD2;CASP3;YAP1;AMOTL1;TEAD3;SAV1;NPHP4
prerank,response to fatty acid (GO:0070542),0.6737400363432275,1.5016766726620834,0.056461731493099125,0.7323610701660893,1.0,5/17,8.43%,UCP1;IRS1;FOXO1;PID1;PPP5C
prerank,positive regulation of bone resorption (GO:0045780),0.72898379247309,1.5000503395640403,0.043356643356643354,0.7369538946554764,1.0,2/11,1.26%,SYK;PRKCA
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.5887977600692416,1.4987922071437618,0.03896103896103896,0.7399930916996666,1.0,9/35,10.38%,MYOC;EPHB2;ARHGAP44;HEG1;TGFB2;ABL2;FLCN;CUL3;KANK1
prerank,cyclooxygenase pathway (GO:0019371),-0.6075657715918334,-1.4980877905407368,0.0657439446366782,0.505276182505906,1.0,7/10,23.95%,PTGDS;PTGS2;PTGIS;PTGES3;TBXAS1;CBR1;PTGS1
prerank,skeletal system development (GO:0001501),0.5245542888680012,1.497051823181128,0.0030303030303030303,0.7453787893519516,1.0,30/148,9.28%,COMP;COL1A2;FBN1;MYOC;COL1A1;TRPS1;GNAS;BMP1;AKAP13;FGFR1;PAPSS2;PCSK5;EIF2AK3;CD44;SULF2;TGFB2;EXT1;PKD1;PAX1;ACAN;VCAN;TNFRSF11B;INHA;TLL1;UCMA;SULF1;GLI2;BPNT2;XYLT1;SOX5
prerank,B cell proliferation (GO:0042100),-0.5145656323785895,-1.4962078942812473,0.06224066390041494,0.5042755798178387,1.0,3/17,2.75%,MEF2C;BCL2;CTPS1
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.5436191276301783,-1.4950367261543507,0.08076923076923077,0.5011721090836856,1.0,6/13,17.35%,NAMPT;PTGS2;PTGIS;PARP10;NUDT12;PARP9
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.6112948823890522,1.4947145451507804,0.03933253873659118,0.7551988151543292,1.0,5/30,4.05%,SFRP4;FSTL1;PCSK6;SMAD4;SMURF2
prerank,toxin transport (GO:1901998),0.7419868348554921,1.494487942384505,0.0446685878962536,0.7509709776289938,1.0,2/10,1.15%,ANTXR1;ANTXR2
prerank,transition metal ion homeostasis (GO:0055076),-0.43516102058916095,-1.4939819358245274,0.044585987261146494,0.4981761945554554,1.0,10/28,19.01%,CP;IREB2;XIAP;SLC40A1;B2M;CUTC;HFE;FTL;MT3;CYBRD1
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.6251915785953325,1.4934948527207264,0.039950062421972535,0.7517154899974154,1.0,9/21,12.54%,UGDH;SULF2;EXT1;SULF1;B3GAT3;XYLT1;HS2ST1;HS3ST5;GLCE
prerank,cellular modified amino acid biosynthetic process (GO:0042398),0.6442751464115787,1.4919149011430093,0.050387596899224806,0.7571136468291858,1.0,5/20,11.63%,PLOD2;GCLC;HAGH;CNDP2;GAMT
prerank,anion transport (GO:0006820),-0.4170865660979262,-1.4918894636250941,0.03333333333333333,0.49723030185508366,1.0,7/33,7.50%,SLC13A4;SLC13A3;ABCG2;SLCO2B1;SLC26A7;SLC22A6;LRRC8B
prerank,cytoplasmic sequestering of protein (GO:0051220),0.685699665057086,1.4918018224810277,0.05962059620596206,0.7521210088951117,1.0,9/13,24.04%,DBN1;PKD1;GET4;PKD2;KEAP1;GOPC;FLNA;YWHAB;LATS1
prerank,ganglioside metabolic process (GO:0001573),-0.4985265287171573,-1.4914100111763204,0.06217616580310881,0.4924910998640342,1.0,12/20,31.87%,ST8SIA4;ST6GALNAC3;ST6GALNAC5;ST8SIA2;ST8SIA6;NEU3;ST6GALNAC6;ABCA2;ST3GAL5;GM2A;NEU2;B4GALNT1
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.5519364895511747,1.4897853223175117,0.012806830309498399,0.7601999861780868,1.0,16/65,13.18%,ASPN;FBN1;HTRA3;LDLRAD4;SKIL;TGFBR2;PMEPA1;SMURF2;SKI;STUB1;SMAD6;PEG10;SLC2A10;VASN;UBA52;PIN1
prerank,limb development (GO:0060173),0.6185974467689555,1.4884696442908467,0.03909952606635071,0.7634615363095979,1.0,7/28,11.94%,RSPO2;COMP;PCSK5;KREMEN1;KAT2B;GLI3;LNPK
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.5193852948131306,1.4881702888308121,0.002012072434607646,0.7596731975935432,1.0,56/173,18.09%,AREG;CD55;SEC16B;DCTN1;COPA;SEC24D;BET1L;ANK2;CNIH3;DYNC1LI2;TMED1;STX5;SPTAN1;SEC31A;SPTA1;ZW10;PREB;MIA3;KDELR3;SEC24A;KDELR1;SEC22B;ARF4;GAS6;COPB1;TFG;SEC23A;USO1;DYNC1LI1;DYNC1I1;ARFGAP3;ARFGAP1;LMAN1;CUL3;NRBP2;SCFD1;RAB2A;COPB2;NAPA;MPPE1;STX17;GOSR1;CNIH1;TRAPPC2L;KDELR2;COG6;DYNC1H1;NSF;ANK1;SPTBN1;COPZ2;GOPC;SEC24B;RAB1B;BCAP31;ARCN1
prerank,nitric oxide mediated signal transduction (GO:0007263),-0.5118898583362663,-1.4861351146699355,0.058365758754863814,0.5012304689655389,1.0,6/16,12.97%,APOE;NOS3;GUCY1B1;NDNF;NOS1;GUCY1A1
prerank,regulation of blood coagulation (GO:0030193),0.6098481698798535,1.4858096469136812,0.03515151515151515,0.7697639344973976,1.0,4/27,3.19%,CD34;EPHB2;FAP;F2R
prerank,negative regulation of cell communication (GO:0010648),0.6426886757925365,1.4854372027784715,0.04455445544554455,0.7665961728153421,1.0,3/21,4.40%,LIF;SRMS;ACVR1
prerank,regulation of interleukin-10 production (GO:0032653),0.5721421359174602,1.485203135233685,0.017977528089887642,0.7627623997783727,1.0,3/44,1.14%,CD34;SYK;IRF4
prerank,regulation of Wnt signaling pathway (GO:0030111),0.5258741981926565,1.4847495820241867,0.009297520661157025,0.7601747611385637,1.0,26/108,10.38%,RSPO2;SFRP4;ESR1;LRP1;GPC3;GRB10;SULF2;DACT3;CDK14;AMER3;RUNX1;SKI;KREMEN1;AXIN1;DACT1;ZRANB1;NFATC1;DAAM2;SULF1;FOXL1;MDFIC;FZD7;PSEN1;GSKIP;TSKU;KANK1
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),-0.541539010519289,-1.4841716878527187,0.08260869565217391,0.5004337135794904,1.0,6/15,18.72%,SORT1;ZFYVE27;CASP3;NTRK2;BDNF;GRB2
prerank,positive regulation of superoxide anion generation (GO:0032930),0.6910705319683651,1.4839854254426503,0.06666666666666667,0.7601547183621307,1.0,2/13,2.49%,SYK;CD177
prerank,negative regulation of stress fiber assembly (GO:0051497),-0.473693270222049,-1.4837193156195754,0.059782608695652176,0.4955121212081239,1.0,7/24,3.53%,TJP1;CGNL1;PHLDB2;ARHGAP28;ARHGAP6;F11R;RHPN2
prerank,glycine transport (GO:0015816),-0.5923869142960547,-1.4833679057876332,0.08391608391608392,0.49066591926667896,1.0,3/10,10.88%,SLC6A9;SLC38A5;SLC6A17
prerank,potassium ion export across plasma membrane (GO:0097623),0.6957623985772874,1.4825186618733812,0.06351351351351352,0.764286984240645,1.0,2/13,1.19%,KCNK5;KCNT2
prerank,ERBB2 signaling pathway (GO:0038128),0.593475544908126,1.4824857694817954,0.0340632603406326,0.7591661007882565,1.0,10/31,16.31%,MYOC;PRKCA;EGFR;BTC;SRC;STUB1;PIK3CA;EGF;HSP90AA1;SOS1
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.681034456264189,1.4821899166005525,0.06640106241699867,0.7559278253547145,1.0,2/14,1.34%,CD80;ANXA1
prerank,vesicle coating (GO:0006901),0.5518106887407654,1.4798714425366433,0.02074235807860262,0.7550332837034058,1.0,22/61,17.28%,AREG;SEC16B;SEC24D;CNIH3;STX5;SEC31A;PREB;SEC24A;SEC22B;TFG;SEC23A;USO1;LMAN1;CUL3;SCFD1;SEC23IP;NAPA;CNIH1;TRAPPC2L;NSF;SEC24B;RAB1B
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.5518106887407654,1.4798714425366433,0.02074235807860262,0.7550332837034058,1.0,22/61,17.28%,AREG;SEC16B;SEC24D;CNIH3;STX5;SEC31A;PREB;SEC24A;SEC22B;TFG;SEC23A;USO1;LMAN1;CUL3;SCFD1;SEC23IP;NAPA;CNIH1;TRAPPC2L;NSF;SEC24B;RAB1B
prerank,COPII vesicle coating (GO:0048208),0.5518106887407654,1.4798714425366433,0.02074235807860262,0.7550332837034058,1.0,22/61,17.28%,AREG;SEC16B;SEC24D;CNIH3;STX5;SEC31A;PREB;SEC24A;SEC22B;TFG;SEC23A;USO1;LMAN1;CUL3;SCFD1;SEC23IP;NAPA;CNIH1;TRAPPC2L;NSF;SEC24B;RAB1B
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.5000730443647867,-1.4785546152765048,0.06132075471698113,0.49768863446366596,1.0,8/18,12.76%,ACSL1;ELOVL7;ACSL4;HACD1;ACSL3;HACD2;ACSL6;ELOVL1
prerank,COPII-coated vesicle cargo loading (GO:0090110),0.6913000688962971,1.47820691518711,0.06648575305291723,0.7605723824195175,1.0,5/14,8.23%,SEC24D;SEC31A;MIA3;SEC24A;SEC23A
prerank,peptidyl-proline hydroxylation (GO:0019511),0.7126292676714072,1.4759972421360716,0.05337078651685393,0.7695580484392265,1.0,4/11,7.08%,P4HA3;P4HA1;EGLN2;P4HA2
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),0.699532597417705,1.4753737083270178,0.053497942386831275,0.7683711759617401,1.0,3/12,7.43%,AR;TMEFF2;CLTC
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),-0.5681756029776089,-1.4749560906305823,0.09090909090909091,0.5012860015969282,1.0,7/12,21.62%,INSR;IGF1R;UVRAG;JMJD4;ADRB2;IRGM;BNIP3
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.6025553898836855,-1.4743646891441289,0.08653846153846154,0.49718996664895443,1.0,4/10,4.66%,ATP1A2;NEDD4L;OSR1;PRKCE
prerank,regulation of tumor necrosis factor production (GO:0032680),0.5233227919610636,1.4739136579460734,0.007164790174002047,0.7726972255098458,1.0,26/112,17.16%,CD34;SYK;LBP;EPHB2;IRAK3;FOXP1;MIF;TMEM106A;SYT11;PTPRJ;IL33;GAS6;PSEN1;TIRAP;TLR4;CD47;SIRPA;ZFP36;TWIST1;ZC3H12A;IL4;CD14;SELENOS;ILRUN;IL6;CHRNA7
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.7271980360601553,1.473803558262897,0.06573426573426573,0.7632430859717899,1.0,4/10,18.61%,MAPK7;MYADM;KLF4;MBP
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.7271980360601553,1.473803558262897,0.06573426573426573,0.7632430859717899,1.0,4/10,18.61%,MAPK7;MYADM;KLF4;MBP
prerank,actin filament-based transport (GO:0099515),-0.4737911560097162,-1.4720974529835569,0.047619047619047616,0.497019795645205,1.0,5/21,5.81%,SYNE2;MYO1B;FNBP1L;SUN2;MYO1D
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.7220771970459918,1.4715639448296003,0.04492753623188406,0.7721778386821788,1.0,3/10,6.71%,ESR1;PSMC4;PSMC6
prerank,regulation of cell communication (GO:0010646),0.5925441069489715,1.4713345020623174,0.04142692750287687,0.7687851302878393,1.0,9/35,7.00%,MGLL;ANXA1;ANK2;SRI;MTCH1;SOCS2;CAMK2D;SCG5;YWHAG
prerank,skeletal system morphogenesis (GO:0048705),0.5713800138921291,1.4710731008727447,0.03211009174311927,0.7654794310830628,1.0,14/42,19.26%,SFRP4;LRP6;HOXA3;FGFR1;SKI;HOXA4;SIX1;PDGFRA;HOXC4;HOXA9;RAB33B;DYNC2I1;TGFBR1;RFLNA
prerank,focal adhesion assembly (GO:0048041),-0.46406861852050735,-1.4703063825683118,0.041916167664670656,0.49593740669947767,1.0,5/21,5.86%,PTPRK;SORBS1;ACTN2;THSD1;PIP5K1A
prerank,positive regulation of interleukin-4 production (GO:0032753),0.6498700632446208,1.4701533788239602,0.04967320261437908,0.766422066016761,1.0,2/17,1.14%,SYK;IRF4
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.7299188872843887,1.4688679554957647,0.055636896046852125,0.7647161369157973,1.0,1/10,0.11%,MPG
prerank,DNA dealkylation (GO:0035510),0.7299188872843887,1.4688679554957647,0.055636896046852125,0.7647161369157973,1.0,1/10,0.11%,MPG
prerank,mesonephros development (GO:0001823),-0.5694081141620893,-1.4686970406410402,0.09824561403508772,0.49460199348007877,1.0,4/11,13.55%,BMP7;OSR1;FGF1;PAX8
prerank,regulation of muscle cell differentiation (GO:0051147),0.6004981166860819,1.4684817708127251,0.04659498207885305,0.7623185276634424,1.0,8/31,9.77%,CDON;MAPK12;HDAC9;MAPK14;RBM4;BOC;CDK9;MAPK11
prerank,granulocyte chemotaxis (GO:0071621),0.556457460670277,1.4673273712369295,0.026030368763557483,0.7649137244082822,1.0,8/55,9.03%,SYK;CCL8;ANXA1;TGFB2;S100A8;S100A9;CXCL10;CCL25
prerank,protein heterooligomerization (GO:0051291),0.6505671547507007,1.4666292213884877,0.05078125,0.7645018866772426,1.0,8/17,15.11%,PKD1;KRT10;PKD2;CPSF6;MAT2A;TMEM120A;KCNC2;HSD17B8
prerank,secretion (GO:0046903),-0.5519884436348592,-1.4661715667585984,0.08185053380782918,0.4951749034759885,1.0,5/14,16.67%,SLC22A6;SLC22A4;FBLN5;NPR1;SLC22A2
prerank,chordate embryonic development (GO:0043009),0.5453420448384051,1.465600214905206,0.032329988851727984,0.7662487060923296,1.0,18/55,9.12%,COL1A1;TGFB3;FGFR1;MBNL1;PCSK5;SIX4;SULF2;VEGFA;LMX1B;PKD1;DACT1;TRIM71;UCMA;SULF1;FLCN;PKD2;SOX8;XYLT1
prerank,regulation of hormone secretion (GO:0046883),0.6726209447280229,1.4652554971079574,0.057640750670241284,0.7639297947134468,1.0,3/15,6.71%,LIF;ANXA1;SCG5
prerank,COPII-coated vesicle budding (GO:0090114),0.5384036209611649,1.4630240452965413,0.029978586723768737,0.7735106743832587,1.0,23/68,17.28%,AREG;SEC16B;SEC24D;CNIH3;STX5;SEC31A;PREB;MIA3;SEC24A;SEC22B;TFG;SEC23A;USO1;LMAN1;CUL3;SCFD1;SEC23IP;NAPA;CNIH1;TRAPPC2L;NSF;SEC24B;RAB1B
prerank,chondroitin sulfate catabolic process (GO:0030207),0.6927520340224184,1.4629524154813136,0.06648936170212766,0.7692365215321436,1.0,2/13,5.07%,DCN;VCAN
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.7070323868512586,1.4628030757666581,0.05131761442441054,0.7656232582465932,1.0,5/11,21.60%,ANXA1;RC3H1;ZC3H12A;IL4;RC3H2
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.6314576636324022,1.462520638466927,0.04580152671755725,0.7628957399749338,1.0,8/19,18.66%,HNRNPA1;CTC1;GNL3L;SRC;ACD;TERF1;TENT4B;TINF2
prerank,positive regulation of T cell proliferation (GO:0042102),0.5484190264370611,1.460293698954685,0.02717391304347826,0.7724338489538682,1.0,4/55,1.34%,TNFSF9;SYK;CD80;ANXA1
prerank,regulation of translational initiation (GO:0006446),0.5374929732860659,1.4598339676957393,0.020496224379719527,0.7709589885224826,1.0,31/63,26.92%,EIF3B;EIF2AK3;DAZL;RBM4;PAIP2B;CTIF;AGO2;EIF1;NPM1;CEBPB;LARP1;POLR2D;POLR2G;CDC123;EIF3E;NCK1;YTHDF1;YTHDF2;PAIP2;MTIF2;ATF4;YTHDF3;TPR;EIF4G3;NCK2;EIF4H;DNAJC3;EIF2B2;EIF4EBP2;EIF4G1;DDX1
prerank,ribosomal small subunit assembly (GO:0000028),0.65756530027576,1.4590484720544452,0.04621309370988447,0.7712196478332273,1.0,8/16,17.34%,RPSA;MRPS11;ABT1;XRCC5;RPS27L;RPS5;RRP7A;PWP2
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.5590648395416414,1.4582887550713444,0.040313549832026875,0.7714547246709794,1.0,15/47,18.13%,MID1;EGFR;STK25;TGFB2;TAOK3;COPS5;KLHDC10;FOXO1;TAOK2;MAP2K2;PER1;NBR1;PPIA;QARS1;EPHB1
prerank,regulation of superoxide anion generation (GO:0032928),0.6704830031063908,1.458164455841872,0.07017543859649122,0.7677017164480054,1.0,2/14,2.49%,SYK;CD177
prerank,cellular sodium ion homeostasis (GO:0006883),-0.5058350993128601,-1.4572122567236805,0.09333333333333334,0.5131320966108633,1.0,4/15,2.85%,ATP1A2;NEDD4L;ATP1B3;SLC12A2
prerank,gastrulation (GO:0007369),0.6674082377417536,1.456195599564071,0.06275579809004093,0.7760241354417111,1.0,2/15,2.21%,UGDH;GPC3
prerank,negative regulation of translational initiation (GO:0045947),0.6773107447663752,1.4556139357542959,0.07085561497326204,0.7753023413981277,1.0,8/13,26.07%,RBM4;PAIP2B;AGO2;LARP1;EIF3E;PAIP2;TPR;EIF4EBP2
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.5900231927046189,1.454808467242928,0.046019900497512436,0.7760102660612485,1.0,5/24,6.34%,ACKR3;TRIAP1;CD44;MIF;MUC1
prerank,sequestering of extracellular ligand from receptor (GO:0035581),0.6841025920281394,1.4543324552459629,0.07381615598885793,0.774491348317223,1.0,2/13,0.36%,FSTL1;FBN1
prerank,Notch signaling pathway (GO:0007219),-0.36981426235624276,-1.4539117006916251,0.016129032258064516,0.516833239717648,1.0,19/59,12.05%,SORBS2;ADAM10;GMDS;MAML3;CREBBP;NOTCH3;NOTCH1;PLXND1;WWC1;HEYL;DTX3L;JAG2;MAML2;NOTCH4;STAT1;BMP2;MDK;GALNT11;EP300
prerank,positive regulation of interleukin-6 production (GO:0032755),0.5387711353805159,1.4533074133311803,0.02771855010660981,0.7763126834513115,1.0,10/68,9.08%,SYK;LBP;IL16;RAB7B;F2R;TMEM106A;IL33;IL17RA;TIRAP;TLR4
prerank,histone H4 deacetylation (GO:0070933),0.7088282413580225,1.4530497658966768,0.08057553956834532,0.7734059377582462,1.0,4/10,13.86%,HDAC9;SIRT2;HDAC3;HDAC4
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.5888316861086951,1.450228397854928,0.06172839506172839,0.7861493151556721,1.0,11/26,16.60%,EGFR;PDE8A;ZPR1;ZFP36L1;ZFP36L2;SYAP1;IQGAP1;INPP5K;ZFP36;STAT5B;SNAI2
prerank,positive regulation of metabolic process (GO:0009893),0.5222476826483936,1.448930997675737,0.013457556935817806,0.7900297891541146,1.0,25/103,17.74%,EBF2;IL4R;SYK;UCP1;GNAS;IRF4;GADD45G;GRB10;VEGFA;ACLY;PRKAB2;ADCYAP1;ALMS1;HDAC3;CEBPB;TSHR;HCRT;CNOT3;IL4;DYNC1H1;DIO2;OGT;CXCR4;FABP5;IL18
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.6726200185925968,1.4481661418424407,0.06914893617021277,0.790574846348823,1.0,6/13,17.66%,SEC16B;EDEM1;CD81;EDEM2;TMEM30A;BCAP31
prerank,positive regulation of vasculogenesis (GO:2001214),0.7130946440385549,1.4481605548520013,0.0703448275862069,0.7862918582091198,1.0,2/10,0.95%,CD34;TMEM100
prerank,endoplasmic reticulum organization (GO:0007029),0.5400326244546919,1.4480679755029748,0.028272251308900525,0.782540282629979,1.0,31/72,24.68%,SEC16B;TLE6;MOSPD3;EIF2AK3;STX1A;STX5;UBE2J2;SEC31A;GET4;REEP3;TOR1AIP2;MIA3;ALDH3A2;WDR83OS;LMAN1;TRAM2;LNPK;SGTA;RTN3;TRAM1;SEC61A1;REEP5;SHTN1;VAMP2;RAB10;TMEM33;BNIP1;EMD;RAB18;RTN4;SEC61B
prerank,leukocyte tethering or rolling (GO:0050901),-0.5111016969061285,-1.4478715300142015,0.06726457399103139,0.527675986553547,1.0,9/17,30.06%,ITGA4;VCAM1;GCNT1;ROCK1;JAM2;SELPLG;PODXL2;SELP;ITGB7
prerank,miRNA metabolic process (GO:0010586),0.6163772669191181,1.446700888473649,0.06407035175879397,0.7868333585457876,1.0,6/20,13.12%,DIS3L2;TARBP2;TRIM71;DGCR8;AGO2;DDX17
prerank,neurogenesis (GO:0022008),0.5568414509306479,1.4442496434571028,0.046223224351747465,0.7979412785658878,1.0,16/43,19.88%,WNT2;ANXA1;SIX4;TGFB2;LPAR1;TRAK2;DAGLA;MAPT;SIX1;THOC2;DAGLB;CDK5RAP2;CXCR4;EPHB1;CIT;WDR62
prerank,cellular response to estradiol stimulus (GO:0071392),0.6293862191297738,1.4442150864702872,0.06719367588932806,0.7938816389336222,1.0,3/18,6.23%,ESR1;EGFR;NCOA3
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.5988860029362383,1.4425139891648042,0.05853658536585366,0.8001710057508709,1.0,9/24,18.66%,HNRNPA1;CTC1;GNL3L;SRC;ACD;ERCC4;TERF1;TENT4B;TINF2
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.6603824221619782,1.4414299831379696,0.07346938775510205,0.8029356753290595,1.0,3/14,5.38%,DDX18;URB1;ZNHIT6
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.6834613184262591,1.441181138551912,0.08380681818181818,0.8003326975920179,1.0,4/11,6.34%,TRIAP1;CD44;MIF;MUC1
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.6328193625522485,1.4400138950444672,0.07323232323232323,0.8036514320266598,1.0,5/19,7.91%,AR;ZC3H8;MTOR;MAF1;BRF2
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),0.6947462558019621,1.4394061009069539,0.07203389830508475,0.8030314765390918,1.0,3/11,1.94%,GHR;IRS1;EIF2AK3
prerank,organelle transport along microtubule (GO:0072384),0.5849743761562852,1.4390670543154525,0.05778301886792453,0.8010965180632639,1.0,15/31,25.67%,ARHGAP21;RAB6A;NDEL1;TRAK2;BICD1;DYNC1I1;MAPT;UXT;PAFAH1B1;COPG1;TMEM201;FBXW11;MAP1S;RHOT2;RAB1A
prerank,mammary gland development (GO:0030879),0.6069514557966545,1.4376711813704448,0.06463878326996197,0.8052647303118392,1.0,5/21,7.50%,WNT2;TGFB3;GPAT4;VEGFA;GLI2
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.6911638071424339,1.4374352029450332,0.06811594202898551,0.8026519039431024,1.0,3/10,11.34%,LBP;TIRAP;WDFY1
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.5268245426593393,1.4371037378822236,0.01791359325605901,0.8005357548072813,1.0,37/80,23.55%,COPA;RAB6A;KLC1;PLPP3;RAB6B;ZW10;KDELR3;ATP9A;RINT1;KDELR1;SEC22B;ARF4;COPB1;SURF4;ARFGAP3;ARFGAP1;KIF2A;RER1;ATP9B;SCFD1;COPB2;NAPA;KIF3A;SCYL1;KIF3B;KDELR2;NSF;COPZ2;RAB1B;ARCN1;CENPE;TMED2;COPG1;USE1;GOLPH3L;BNIP1;PICK1
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.5043441346545909,-1.4353615661113641,0.0794979079497908,0.5573523120061805,1.0,11/17,26.61%,NRP1;NTRK3;TEK;CDK5;ABL1;BAIAP2L1;FES;HRAS;NTF3;HCK;HCLS1
prerank,hyaluronan metabolic process (GO:0030212),0.6188879755460206,1.434543887977163,0.0546583850931677,0.8124995201171038,1.0,4/23,2.88%,HAS2;HAS1;CD44;FGF2
prerank,glutathione biosynthetic process (GO:0006750),0.6877459329498316,1.4340113187520074,0.08073654390934844,0.8116234785725641,1.0,3/11,9.78%,GCLC;HAGH;CNDP2
prerank,PERK-mediated unfolded protein response (GO:0036499),0.706284606618107,1.4331721909443322,0.08559201141226819,0.8127395313656847,1.0,5/10,13.68%,EIF2AK3;NFE2L2;HERPUD1;QRICH1;EIF2S1
prerank,glycolytic process (GO:0006096),-0.43875438901989405,-1.4329515528684869,0.05521472392638037,0.5586416659265295,1.0,13/28,20.36%,ENO1;HK2;PGAM1;PGAM4;PGK1;PFKM;ALDOC;GAPDH;PFKL;TPI1;GAPDHS;ENO3;GPI
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),-0.48390354389988016,-1.430747842382469,0.07659574468085106,0.5590401151180437,1.0,9/18,10.67%,FLT1;COL4A3;MEF2C;PLCG1;SP1;HMGB1;ITGA4;IGF2;MDK
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.6850734429433207,1.429947706869166,0.07608695652173914,0.8289817010572709,1.0,3/12,5.50%,UMPS;TK1;TK2
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.6046872644613996,1.4298350532242992,0.06801007556675064,0.8254845939317604,1.0,8/23,13.72%,LIF;SIX4;VEGFA;FGF2;SOX8;EGF;GDNF;SIX1
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.5415406745116361,1.4283924508455585,0.05,0.8303751167230937,1.0,17/48,11.31%,FGF18;PRKCA;ANXA1;FGFR1;ANGPT4;VEGFA;FGF2;HDAC9;HDAC7;MAPK14;MAP2K3;PRKD2;STAT5A;FOXC2;AKT3;RHOJ;AKT1
prerank,neutrophil activation (GO:0042119),0.6864107399483411,1.4274640026001446,0.06896551724137931,0.8320694605002352,1.0,1/12,0.24%,SYK
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.5415437304054468,1.4265330675701027,0.039647577092511016,0.8338945519716326,1.0,8/51,6.85%,FSTL1;FBN1;HTRA3;SKIL;SMAD4;SMURF2;SKI;SMAD5
prerank,cAMP biosynthetic process (GO:0006171),-0.5756279594392589,-1.42641014478753,0.11,0.565872582161122,1.0,4/10,9.13%,ADCY5;ADCY1;ADCY4;ADCY9
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),-0.556890474731538,-1.426092974600609,0.11406844106463879,0.5611184058653518,1.0,7/11,32.92%,ALG10B;LRRC38;AKAP6;NOS1AP;LRRC55;TREM2;RNF207
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),-0.5466237690460632,-1.425788033782237,0.12589928057553956,0.5563109955140781,1.0,6/11,10.54%,LYN;RAPGEF2;MEF2C;PIK3CB;PIK3CD;SIRT1
prerank,response to hydrogen peroxide (GO:0042542),0.5426549933701073,1.4252816727940643,0.05022321428571429,0.8379156299056839,1.0,14/45,16.30%,ANXA1;STK25;FYN;MAPK7;ADAM9;NFE2L2;HDAC6;ANKZF1;SIRPA;GPX1;PLEKHA1;OSER1;STK24;IL6
prerank,regulation of vasculogenesis (GO:2001212),0.6648845681870492,1.4250826588412513,0.07275132275132275,0.8351331882777068,1.0,2/14,0.95%,CD34;TMEM100
prerank,atrial septum development (GO:0003283),0.66961456583018,1.4242751631098007,0.08984375,0.83632208158016,1.0,3/13,6.76%,ANK2;TGFB2;MDM4
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.5104582073783055,-1.4234148748614404,0.1198501872659176,0.5575249038274738,1.0,8/14,24.02%,WNT5A;SEMA7A;KIT;MAVS;SIRT1;CD74;NR4A3;GPRC5B
prerank,telomere maintenance via recombination (GO:0000722),0.6754956170894308,1.4230481680035516,0.07967032967032966,0.8401942366919668,1.0,9/11,26.42%,XRCC3;SMC5;ERCC4;SMC6;RAD50;TEP1;ERCC1;NSMCE2;RAD51D
prerank,RNA catabolic process (GO:0006401),0.549739555238779,1.4230104016593503,0.047244094488188976,0.8364200775892071,1.0,17/46,19.45%,DIS3L2;ZPR1;ZFP36L2;HNRNPD;NUDT16L1;EXOSC7;SIDT2;ERN1;NUDT16;RNASE6;ZFP36;DNA2;CNOT10;AGO4;YTHDF2;SUPV3L1;AGO3
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.6044422693835356,1.4220105044918123,0.08322981366459627,0.8386710178028884,1.0,7/20,13.40%,EGFR;PKD1;PSRC1;MAPRE3;PKD2;AKT1;CCND1
prerank,regulation of mitotic spindle organization (GO:0060236),0.5730743729612697,1.4215050532718383,0.05034324942791762,0.8381477297050659,1.0,10/35,15.35%,PARP3;GPSM2;DCTN1;PSRC1;VPS4B;FSD1;CLTC;CCSAP;CEP97;DYNC1H1
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.6708943933064874,1.4214404932869564,0.07628294036061026,0.8345738559079398,1.0,3/12,17.74%,CD80;PAEP;IL18
prerank,GTP metabolic process (GO:0046039),0.6449449225630471,1.420076753496151,0.08552631578947369,0.8390280114229194,1.0,3/15,10.05%,GNAI3;RAB23;RHOQ
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.6247410479840698,1.4200496314270077,0.07001321003963012,0.8352795124628386,1.0,6/18,10.38%,MYOC;HEG1;ABL2;FLCN;CUL3;KANK1
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),0.7131068238404886,1.4197547309078382,0.08177905308464849,0.8331219402639692,1.0,5/10,16.38%,DGKQ;USP7;ZNF692;SELENOS;OGT
prerank,positive regulation of cholesterol efflux (GO:0010875),-0.45674605230951243,-1.419282200354864,0.06944444444444445,0.5632730057067983,1.0,9/21,15.06%,PLTP;PTCH1;APOE;NR1H3;CAV1;SIRT1;ABCA3;NFKBIA;EEPD1
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.6034138967057564,1.4182405757212304,0.07343941248470012,0.838742079051903,1.0,18/23,31.46%,SYVN1;PREB;SURF4;LMAN1;HERPUD1;SELENOS;AUP1;DERL1;SEL1L;TECPR2;SEC61B;HSP90B1;UFD1;NPLOC4;RANGRF;SEC13;TMEM129;DERL2
prerank,proteoglycan metabolic process (GO:0006029),0.5869961918086581,1.418128573045212,0.05961070559610705,0.8354891256259166,1.0,9/26,9.12%,SULF2;CSGALNACT2;CHST10;GAL3ST3;SULF1;CHST12;CHST14;FOXL1;XYLT1
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.43024134006294545,-1.4176338368001424,0.05747126436781609,0.5628222530491291,1.0,11/25,19.64%,EPHA4;RPS7;PSMF1;OPHN1;PDCL3;PSME3IP1;RPL5;HIPK2;HFE;CSNK2A1;TAF1
prerank,positive regulation of viral life cycle (GO:1903902),0.6093726694870159,1.4175581708697356,0.07384230287859825,0.8352685789342562,1.0,7/22,20.75%,AXL;KPNA2;LGALS1;TRIM11;DDB1;VPS37B;TYRO3
prerank,regulation of BMP signaling pathway (GO:0030510),0.5171791509902158,1.4162287155650415,0.03571428571428571,0.8394646926382068,1.0,10/73,7.27%,SFRP4;FSTL1;HTRA3;PCSK6;SKIL;SMAD4;SMURF2;SKI;SMAD5;SULF1
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.6161333830550872,1.4159516157996581,0.07944514501891552,0.8373944340652556,1.0,3/20,3.89%,SFRP4;GSN;CD160
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.6128307428675754,1.4154832667414305,0.06545454545454546,0.8365890626199272,1.0,5/22,13.20%,ESR1;PSMC4;PSMC6;MED24;MED13
prerank,DNA modification (GO:0006304),0.606604625666815,1.4152276743501249,0.08395061728395062,0.834436837891112,1.0,2/22,0.89%,MPG;PARP3
prerank,protein import into peroxisome membrane (GO:0045046),0.6117267772499266,1.4149037025575795,0.06699751861042183,0.8326300535242053,1.0,13/22,24.14%,PXMP2;PEX16;GDAP1;ALDH3A2;PXMP4;PEX12;SLC25A17;PEX3;PEX5;ATAD1;ABCD3;PEX2;FIS1
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.6560338028572535,1.4135915611880716,0.09917355371900827,0.8371945087100936,1.0,4/12,6.34%,TRIAP1;CD44;MIF;MUC1
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.6701778507934036,1.4132888993261123,0.09090909090909091,0.8355165140397676,1.0,6/12,25.21%,TIPIN;NBN;GMNN;BLM;WDR18;KAT7
prerank,atrioventricular valve morphogenesis (GO:0003181),0.6293113689615893,1.4122078150783133,0.07970112079701121,0.8386032643152811,1.0,7/19,10.09%,TGFB2;SLIT3;TGFBR2;SMAD4;ACVR1;MDM4;SMAD6
prerank,regulation of cell killing (GO:0031341),0.6344897435141004,1.411983067438712,0.07881136950904392,0.8363101533364655,1.0,4/16,8.19%,CD55;CFH;TGFB2;FZD7
prerank,regulation of glucose import (GO:0046324),-0.41428953133350765,-1.4111996615427866,0.0759493670886076,0.5757711267559186,1.0,7/30,3.34%,PRKAG2;SORBS1;OCLN;INSR;IGF1;ENPP1;OSBPL8
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),-0.44018023824124436,-1.4108521702288939,0.07894736842105263,0.571408709905203,1.0,3/21,3.34%,OSBPL10;PLA1A;OSBPL8
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.5835234239095688,1.4105885932209399,0.08812729498164015,0.8411058816103307,1.0,12/26,23.83%,FYN;MAPK7;PDE8A;NFE2L2;AKT1;GPR37L1;GPR37;HTRA2;PPIA;PYCR1;ATF4;BAG5
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.6512635016676005,1.4099476356756984,0.09733333333333333,0.841421895732878,1.0,4/14,7.27%,SULF2;FGF2;CREB3L1;SULF1
prerank,cellular response to fatty acid (GO:0071398),0.681137435131368,1.4092241091050355,0.10136986301369863,0.8422453172051421,1.0,4/12,14.08%,UCP1;IRS1;PID1;ZC3H12A
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.6915294913070424,1.4089539976013197,0.06258692628650904,0.8402951882997319,1.0,2/11,1.26%,SYK;PRKCA
prerank,regulation of plasminogen activation (GO:0010755),0.6743599508751009,1.4087499633874325,0.09517426273458444,0.8378477538157192,1.0,4/12,7.12%,HPN;CLEC3B;RUNX1;MELTF
prerank,positive regulation of embryonic development (GO:0040019),-0.469606907722503,-1.4087060998212295,0.07281553398058252,0.5717613358004152,1.0,5/19,4.85%,WNT4;TENM4;NIBAN2;OSR1;PLCB1
prerank,negative regulation of T cell activation (GO:0050868),0.5592521580360041,1.4083174951302737,0.06941176470588235,0.8369695445469755,1.0,3/35,1.78%,CD80;LAX1;GLMN
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.5791884363755282,1.4080884475794708,0.07384987893462469,0.8348804793536406,1.0,8/27,14.13%,DDR2;WNT2;MIF;CDK4;GAS6;S100A6;CDKN1A;PDGFRA
prerank,vasculogenesis (GO:0001570),0.5667931190936528,1.4072531881428068,0.07272727272727272,0.836345564492133,1.0,6/32,3.19%,HAS2;WT1;GLMN;VEGFA;TNNI3;TGFBR2
prerank,aggrephagy (GO:0035973),0.5796312517269953,1.406204191034359,0.07484662576687116,0.8391131037339337,1.0,9/27,15.35%,DYNC1LI2;HDAC6;UBE2N;ARL13B;DYNC1LI1;DYNC1I1;SQSTM1;UBA52;DYNC1H1
prerank,supramolecular fiber organization (GO:0097435),0.48593751840473054,1.4056591502126943,0.0,0.8390136042694859,1.0,75/333,13.67%,COL14A1;PLOD2;COL3A1;P4HA3;COL5A2;COL6A3;COL1A2;DDR2;DBN1;TNXB;GSN;KRT20;COL1A1;LOXL2;COL17A1;COL5A1;BMP1;COL8A1;TLE6;DCTN1;COL11A1;COL5A3;ADAMTS2;CCDC88C;COL6A2;FGF13;TGFB2;CDC42EP2;COL8A2;P4HA1;HOOK2;CLIP1;ADAMTS3;SPTA1;DPT;DST;MARCKS;VPS4B;COL12A1;FSD1;MYO1A;NEFL;COL6A1;TGFBI;P4HA2;TLL1;MYO5A;SLK;CLIP2;COL15A1;PLOD3;SIAH1;KIF2A;GGA1;COL9A3;LOXL1;COL2A1;CALCA;COLGALT1;SERPINH1;CLIP4;CAMSAP1;AVIL;MAPT;COL20A1;TPPP3;NAT8;UBA52;HSPG2;PIN1;SLAIN2;P3H1;CRIPT;RHOA;WDR73
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.6575754361031246,1.404745859484466,0.09838274932614555,0.8411884783689595,1.0,6/13,19.81%,PDE8A;NFE2L2;GPR37L1;GPR37;HGF;PYCR1
prerank,regulation of cholesterol storage (GO:0010885),-0.5008493456333438,-1.4044063991853208,0.08823529411764706,0.5787971965982437,1.0,5/15,5.81%,SCARB1;TTC39B;PPARA;NR1H3;ABCG1
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.6609324296166746,1.4039650900489093,0.10178817056396149,0.8425742482089061,1.0,6/13,21.14%,SYK;CD177;STX4;IL4;ITGAM;GAB2
prerank,negative regulation of epithelial cell proliferation (GO:0050680),-0.3461432454442547,-1.4039368040956668,0.02564102564102564,0.5747476803723501,1.0,23/66,12.16%,PTPRK;NR2F2;ROBO1;MTSS1;APOE;THBS1;DAB2IP;CDK6;DUSP10;PTPRM;TGFBR3;CAV1;RGCC;FGFR2;B2M;BRCA2;AQP11;SFRP1;CAV2;STAT1;CEACAM1;CDKN1C;TGFB1
prerank,integrated stress response signaling (GO:0140467),0.6462250149815664,1.4037145744606891,0.09742895805142084,0.8405867854647279,1.0,5/14,13.68%,EIF2AK3;NFE2L2;HERPUD1;QRICH1;EIF2S1
prerank,positive regulation of heart rate (GO:0010460),-0.47398695567907784,-1.4035548570844043,0.08016877637130802,0.5704178828088078,1.0,7/17,15.59%,TPM1;ADRA1B;KCNQ1;RYR2;EDN1;ADM;EDN3
prerank,actin filament polymerization (GO:0030041),0.5826150967132715,1.403380642033855,0.056422569027611044,0.8391268287133636,1.0,7/29,5.88%,GSN;PSTPIP1;ANG;DIAPH3;COBL;MSRB1;WASF1
prerank,cellular response to hormone stimulus (GO:0032870),0.5147006979490585,1.4023929704531537,0.04075235109717868,0.8418342939210506,1.0,14/69,7.16%,GHR;AR;UCP1;WT1;SLIT3;SLIT2;SFR1;ATP1A3;ATP1A1;ZFP36L1;SOCS2;NCOA3;SRC;GAS2L1
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),0.6148021178845443,1.4020319565193287,0.0926892950391645,0.8406406087312551,1.0,7/18,14.97%,NXF1;DDX19B;NUP93;MCM3AP;POLDIP3;THOC2;ZC3H11A
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.5592641410502637,1.4020113441687314,0.06666666666666667,0.8373145877958776,1.0,12/38,14.60%,CD34;KLF2;ATP2B4;PKD2;TLR4;CD47;SIRPA;AKT1;GLA;ZC3H12A;KLF4;HSP90AA1
prerank,melanocyte differentiation (GO:0030318),-0.5598151101343684,-1.4012700183981321,0.11072664359861592,0.5719323578544055,1.0,6/11,13.99%,LRMDA;ENPP1;MEF2C;KIT;SLC24A5;MREG
prerank,positive regulation of protein maturation (GO:1903319),0.676051359636688,1.4005589558506284,0.085383502170767,0.8425413088103392,1.0,1/11,0.71%,CCBE1
prerank,sphingosine biosynthetic process (GO:0046512),-0.5516217465352077,-1.4002710515208066,0.11186440677966102,0.564292182077785,1.0,5/11,22.80%,ACER2;SPHK1;SPTLC2;SPHK2;ABCA2
prerank,sphingoid biosynthetic process (GO:0046520),-0.5516217465352077,-1.4002710515208066,0.11186440677966102,0.564292182077785,1.0,5/11,22.80%,ACER2;SPHK1;SPTLC2;SPHK2;ABCA2
prerank,positive regulation of translational initiation (GO:0045948),0.6101869657893332,1.4002132112994217,0.08651399491094147,0.8411503840126775,1.0,9/18,22.31%,DAZL;MTOR;LARP1;POLR2D;POLR2G;CDC123;YTHDF1;YTHDF2;YTHDF3
prerank,regulation of lymphocyte proliferation (GO:0050670),0.632543442830811,1.3993455438713713,0.09740259740259741,0.8427976511681485,1.0,1/16,0.18%,TNFSF9
prerank,regulation of Rho protein signal transduction (GO:0035023),0.5027142639655872,1.3993359367737488,0.03723404255319149,0.839465746057052,1.0,16/72,10.38%,COL3A1;MYOC;ARHGEF28;AKAP13;HEG1;F2R;LPAR1;RIT2;ABCA1;ARHGEF3;ABL2;MYO9B;FLCN;CUL3;GPR20;KANK1
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.616291073392116,1.3989313619875983,0.0759493670886076,0.838419381052539,1.0,8/18,9.73%,ANXA1;VEGFA;FGF2;HDAC9;HDAC7;FOXC2;AKT3;RHOJ
prerank,adipose tissue development (GO:0060612),-0.5428874042036086,-1.39873150585628,0.11827956989247312,0.5635606694974136,1.0,6/11,17.21%,ARID5B;NAMPT;SH3PXD2B;SPTLC2;DYRK1B;PGRMC2
prerank,positive regulation of transforming growth factor beta production (GO:0071636),0.6741916005340711,1.398007535860523,0.0954356846473029,0.8406823025580336,1.0,1/11,0.11%,CD34
prerank,negative regulation of macroautophagy (GO:0016242),0.5758828155869471,1.3979373380475655,0.07099143206854346,0.8377579461142309,1.0,19/26,31.64%,USP36;MTOR;SEC22B;PIK3CA;NRBP2;SCFD1;AKT1;SMCR8;NUPR1;QSOX1;UBQLN4;TSC2;MTM1;TMEM39A;TSC1;LZTS1;RUBCN;CHMP4A;CHMP4B
prerank,negative regulation of signaling (GO:0023057),0.5893339648329204,1.3977347571336156,0.08706166868198308,0.8358226674497826,1.0,3/25,4.40%,LIF;SRMS;ACVR1
prerank,keratinocyte differentiation (GO:0030216),0.5675203291424925,1.39740572580676,0.08520710059171598,0.834569607205192,1.0,6/29,8.93%,LORICRIN;ANXA1;SCEL;ADAM9;KRT10;JAG1
prerank,regulation of T cell activation (GO:0050863),0.5380703741919339,1.3962040567007004,0.07069555302166476,0.8383315260641548,1.0,9/42,20.96%,TNFSF9;LAX1;CD47;SIRPA;GPNMB;TNFRSF1B;VTCN1;PRELID1;PYCARD
prerank,regulation of transforming growth factor beta production (GO:0071634),0.6205525968745744,1.3960412855199522,0.09290322580645162,0.8360326821880578,1.0,3/18,3.68%,CD34;TGFB2;SMAD4
prerank,regulation of cholesterol efflux (GO:0010874),-0.41303594370497876,-1.3956652388818906,0.04242424242424243,0.5669539201977172,1.0,11/30,16.89%,PLTP;PTCH1;APOE;TTC39B;NR1H3;CAV1;SIRT1;ABCA3;NFKBIA;EEPD1;ABCA5
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.6689407055551782,1.3952461789943316,0.09164420485175202,0.837229141448783,1.0,8/13,25.23%,DESI1;DESI2;UBA6;UBA2;SENP6;SAE1;ATG10;UBA7
prerank,negative regulation of interleukin-8 production (GO:0032717),0.6304358060648713,1.3948910173891207,0.08256880733944955,0.836307061625893,1.0,7/17,23.23%,ANXA1;OTUD7B;BCL3;KLF4;ANXA4;ARRB1;SSC5D
prerank,positive regulation of vasoconstriction (GO:0045907),0.6633649916500541,1.3941094562806193,0.08551724137931034,0.8379554893133132,1.0,2/13,3.19%,AVPR1A;F2R
prerank,activation of protein kinase A activity (GO:0034199),-0.48647810428668564,-1.3933248603721793,0.0931174089068826,0.5683441417328401,1.0,7/16,15.92%,ADCY5;ADCY1;PRKAR1B;ADCY4;ADCY9;PRKAR2B;PRKACB
prerank,regulation of T cell proliferation (GO:0042129),0.516119848204878,1.3913003832710753,0.04310344827586207,0.851385039383116,1.0,11/61,18.08%,TNFSF9;CD80;ANXA1;GLMN;CEBPB;GPNMB;TNFRSF1B;IL4;IL6;NCK1;VTCN1
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.6064987461404032,1.3894675195136197,0.10776942355889724,0.859568057120543,1.0,4/19,4.22%,DCN;CCBE1;SMOC2;ADAMTS3
prerank,circulatory system development (GO:0072359),0.49484735479380215,1.3886143071603363,0.03160040774719674,0.8614130767216572,1.0,32/118,13.17%,COL3A1;FBN1;WT1;AKAP13;PCSK5;PLCE1;ZDHHC16;HEG1;TGFB2;TNNI3;TGFBR2;BORCS8;HDAC9;CRIP1;PKD1;ACVR1;TCF25;PDLIM7;GLI2;ZFPM2;FOXL1;PKD2;PIK3CA;FOXC2;ECE1;KAT2B;EEF1AKMT4-ECE2;MICAL2;PDLIM1;FLRT3;HSPG2;CDKN1A
prerank,nuclear membrane disassembly (GO:0051081),0.647149530722906,1.3884272912264457,0.1009421265141319,0.8592689140438698,1.0,2/14,1.72%,PRKCA;DCTN1
prerank,regulation of platelet aggregation (GO:0090330),0.6203724171735892,1.38801927300184,0.10371318822023047,0.8584647384940757,1.0,4/17,1.27%,SYK;C1QTNF1;PRKCA;CD9
prerank,regulation of cellular pH (GO:0030641),0.5702828221003999,1.3870939321134281,0.08066429418742586,0.8609614880049802,1.0,12/29,15.89%,SLC4A10;SLC4A8;ATP1A4;SLC4A3;SLC9A9;SLC4A4;SLC26A6;SLC9A1;ATP6AP1;CHP1;SLC9A7;SLC9A6
prerank,negative regulation of T cell mediated immunity (GO:0002710),-0.5321209348754785,-1.3865415942899257,0.1223021582733813,0.5812878149507973,1.0,6/11,31.89%,AHR;CEACAM1;HFE;PTPRC;LILRB1;IL4I1
prerank,neutrophil chemotaxis (GO:0030593),0.5257192439347469,1.3860840791762061,0.055853920515574654,0.8637138422412665,1.0,7/53,9.03%,SYK;CCL8;TGFB2;S100A8;S100A9;CXCL10;CCL25
prerank,response to cAMP (GO:0051591),0.5518163913827391,1.385971461953731,0.06643757159221077,0.8611448702895881,1.0,10/37,11.33%,IGFBP5;DUOX1;WT1;DGKQ;ZFP36L1;RAP1B;PKD2;INPP5K;HCN4;SLC26A6
prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.40135853869359206,-1.3849948486559251,0.07142857142857142,0.5810871953978411,1.0,11/35,10.42%,FLT1;NR2F2;COL4A3;MEF2C;APOE;THBS1;PTPRM;CAV1;RGCC;CAV2;STAT1
prerank,neutrophil migration (GO:1990266),0.5228287836418053,1.384973493366071,0.05561497326203209,0.8639303992805274,1.0,10/58,12.91%,SYK;CCL8;CD177;TGFB2;S100A8;S100A9;CXCL10;CCL25;IRAK4;CCL13
prerank,peroxisomal membrane transport (GO:0015919),0.57702550181997,1.3848148231953896,0.07904191616766468,0.8615968914626639,1.0,13/27,21.44%,PXMP2;PEX16;GDAP1;ALDH3A2;PXMP4;PEX12;PEX1;SLC25A17;PEX3;PEX5;ATAD1;ABCD3;PEX2
prerank,positive regulation of epidermal cell differentiation (GO:0045606),0.6274182197706802,1.384577194491613,0.11543450064850844,0.8597241351975228,1.0,6/15,14.02%,SFRP4;NCOA3;CYP27B1;VDR;SFN;NME2
prerank,positive regulation of collagen biosynthetic process (GO:0032967),0.6247891437480867,1.3839157288945303,0.09921671018276762,0.8603829230343348,1.0,4/16,5.67%,TGFB3;F2R;RUNX1;CREB3L1
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.6101068197989719,1.3838674659246342,0.10978835978835978,0.8575659073343208,1.0,6/17,17.74%,CD55;JAG1;TLR4;BACH2;BTN3A3;IL18
prerank,muscle cell differentiation (GO:0042692),-0.4005117956005554,-1.3838632774097614,0.07534246575342465,0.5795428894846673,1.0,9/32,11.66%,NEBL;DMD;WNT5B;MEF2C;SPEG;TBX18;TBX1;MRTFB;TMEM204
prerank,positive regulation of multicellular organismal process (GO:0051240),0.476472373402626,1.383701421502006,0.002002002002002002,0.8554362852048146,1.0,59/308,14.02%,EBF2;IL4R;GHR;SYK;LBP;AVPR1A;UCP1;COL1A1;LOXL2;GNAS;IRF4;BMP1;LRP1;TGFB3;TLE6;TMEM119;GLMN;GADD45G;SIX4;GRB10;VEGFA;FGF2;TGFB2;F2R;TGFBR2;MIF;SMAD4;WWTR1;SMURF2;ACVR1;MTOR;PRKAB2;IL33;NCOA3;C1QBP;ABCA1;SCAMP5;ADCYAP1;GAS6;HMCES;SOX8;CYP27B1;VDR;AGO2;SOX5;ALMS1;INPP5K;TSKU;HDAC3;CEBPB;FBXO5;TSHR;HCRT;EGF;GDNF;CNOT3;TWIST1;SIX1;NME2
prerank,cAMP-mediated signaling (GO:0019933),-0.4409832829039402,-1.3831974018916204,0.09782608695652174,0.5765358227836413,1.0,10/24,9.63%,PDE7B;RAPGEF2;ADCY1;RAPGEF3;PDE3A;ADGRG6;KSR1;AHR;CAP2;PDE2A
prerank,negative regulation of neurogenesis (GO:0050768),-0.4004691872731577,-1.3821261602161212,0.06382978723404255,0.574590979794851,1.0,7/34,10.51%,PTN;RAPGEF2;YWHAH;NOTCH1;B2M;APPL2;SORL1
prerank,heart development (GO:0007507),0.4863339705403541,1.3818204612662908,0.015090543259557344,0.8637618153701565,1.0,37/150,13.17%,COL3A1;FBN1;WT1;AKAP13;FLRT2;PCSK5;PLCE1;GPC3;ZDHHC16;HEG1;VEGFA;TGFB2;TNNI3;TGFBR2;BORCS8;HDAC9;CRIP1;MEF2D;PKD1;ACVR1;TCF25;PDLIM7;GLI2;ZFPM2;FOXL1;PKD2;NDRG4;FOXC2;ECE1;KAT2B;EEF1AKMT4-ECE2;ALPK2;MICAL2;PDLIM1;FLRT3;SGCZ;CDKN1A
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.6863364214655918,1.3817428467448303,0.10674157303370786,0.8610942583272466,1.0,3/10,14.33%,MAPK7;IRAK3;KLF4
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.5283001683986864,1.381604900371812,0.05997818974918211,0.8588974607372418,1.0,18/52,17.07%,DCTN1;GFPT1;LMNA;CXXC1;SEC31A;SYVN1;PREB;EDEM1;KDELR3;TPP1;ARFGAP1;CTDSP2;ACADVL;ERN1;DDX11;DNAJB11;KLHDC3;PPP2R5B
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.6321461033450315,1.3811925390351747,0.11621621621621622,0.8583081821788215,1.0,4/15,6.68%,SFRP4;GPC3;DACT1;DAAM2
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),0.5636257576033541,1.3809525884711298,0.07692307692307693,0.8566904275754258,1.0,9/29,16.39%,GHR;PKD1;CLCF1;SOCS2;PKD2;STAT5A;FER;SOCS6;STAT5B
prerank,peptidyl-amino acid modification (GO:0018193),0.6801790993357151,1.3806413446638777,0.10754189944134078,0.8553215083809204,1.0,5/10,21.79%,FKBP10;METAP2;METAP1;FKBP7;METAP1D
prerank,protein insertion into ER membrane (GO:0045048),0.5458038511344614,1.3803843589987197,0.07249712313003452,0.8538372774939061,1.0,18/37,24.68%,STX1A;STX5;UBE2J2;GET4;ALDH3A2;WDR83OS;EMC1;TRAM2;EMC10;EMC8;SGTA;TRAM1;EMC3;VAMP2;EMC2;EMD;EMC6;SEC61B
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.5549473378898679,1.3803033836182068,0.08018867924528301,0.8512865700828421,1.0,20/35,26.82%,AR;ESR1;ZMIZ1;PMEPA1;TRIP4;SRC;EGLN2;PLPP1;RBFOX2;DDX17;RNF14;DDX5;PADI2;TMF1;UBE3A;NCOA4;NR3C1;KDM3A;SAFB;ARID1A
prerank,regulation of interleukin-6 production (GO:0032675),0.4972672661163197,1.379625907441918,0.03329864724245578,0.8520358697203387,1.0,20/96,16.30%,SYK;LBP;IL16;RAB7B;IRAK3;F2R;TMEM106A;SYT11;IL33;IL17RA;GAS6;TIRAP;TLR4;CD47;SIRPA;TWIST1;CD200R1;ZC3H12A;SELENOS;IL6
prerank,aminoglycan metabolic process (GO:0006022),0.6715628871024749,1.3794101372979013,0.09117647058823529,0.8503314924862452,1.0,5/10,21.55%,GAL3ST3;B3GAT3;XYLT1;XYLT2;B3GAT2
prerank,positive regulation of collagen metabolic process (GO:0010714),0.6173629595944384,1.379121780579482,0.09752925877763328,0.8490195085606855,1.0,4/17,5.67%,TGFB3;F2R;RUNX1;CREB3L1
prerank,regulation of lymphocyte activation (GO:0051249),-0.5345996598119588,-1.3790909084490004,0.10714285714285714,0.578083918283615,1.0,8/12,38.31%,PAG1;DCAF15;LAT;IKZF3;THEMIS2;CCL5;CRTAM;LCK
prerank,protein insertion into membrane (GO:0051205),0.5629298162920385,1.37849169182809,0.08391608391608392,0.8497961916350699,1.0,10/32,14.23%,EGFR;STX1A;STX5;UBE2J2;GET4;ALDH3A2;WDR83OS;TRAM2;SGTA;TRAM1
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.4923214549585475,-1.3783412397768646,0.10276679841897234,0.5757485193345521,1.0,6/14,12.02%,KMT5B;SHLD1;KMT5C;NECTIN2;TFRC;RIF1
prerank,receptor internalization (GO:0031623),0.5376174454084957,1.3783323207022438,0.07300884955752213,0.8477059094574941,1.0,8/44,8.09%,ACKR3;SYK;CD9;LRP1;DNM1;CLTC;SNX1;CD81
prerank,natural killer cell activation (GO:0030101),0.5944231780707296,1.3779607981584459,0.10790464240903387,0.8467728828275727,1.0,3/23,2.92%,AXL;ELF4;PBX1
prerank,secretory granule organization (GO:0033363),0.6787874010850843,1.3777702354161343,0.10384068278805121,0.8448631262269821,1.0,6/10,21.09%,F2R;DTNBP1;ABCA1;BLOC1S2;VPS33B;LYST
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),0.6527443270618183,1.3773811572229728,0.09362279511533243,0.8440946008837124,1.0,3/13,11.60%,TGFBR2;RUNX1;GLI3
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.6529168782977506,1.377242428850391,0.10164835164835165,0.8420294906877235,1.0,6/12,13.76%,GPAA1;KDELR3;KDELR1;INSIG2;RER1;KDELR2
prerank,embryonic organ morphogenesis (GO:0048562),0.5279894200285393,1.3771600108210702,0.06696428571428571,0.8395807044057986,1.0,13/42,18.95%,MFAP5;FBN1;HOXA3;ACVR1;HOXA4;ALDH1A3;SIX1;PDGFRA;HOXC4;HOXA9;EFEMP1;DYNC2I1;NIPBL
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.5664847707170033,1.3770201969740261,0.10576923076923077,0.8374819842437858,1.0,13/26,26.46%,CUL3;HECW2;CDC23;ANAPC5;FBXO5;CDC27;CDK5RAP2;ANAPC4;CENPE;RIOK2;ANAPC15;NSMCE2;DUSP1
prerank,endodermal cell differentiation (GO:0035987),0.5472900390897087,1.3768965044083736,0.08930669800235018,0.8352747638182173,1.0,9/31,11.81%,COL8A1;COL11A1;MMP2;ITGA5;ITGB5;COL12A1;COL6A1;ITGAV;SETD2
prerank,axonal transport (GO:0098930),0.5480640983634237,1.3768609890822634,0.0657439446366782,0.8325960965953969,1.0,15/36,22.51%,DCTN1;DST;DTNBP1;NEFL;AP3D1;SYBU;MAPT;KIF3A;KIF3B;BLOC1S2;DYNC1H1;SNAPIN;PAFAH1B1;AP3B2;FBXW11
prerank,camera-type eye morphogenesis (GO:0048593),0.6805793452696659,1.376727376691906,0.10601719197707736,0.830549145826796,1.0,4/10,5.31%,LRP6;VEGFA;SKI;TENM3
prerank,central nervous system neuron axonogenesis (GO:0021955),0.6530202479686215,1.3761819896075016,0.12376933895921238,0.8309387208111889,1.0,6/12,22.27%,EPHB2;MYCBP2;HSP90AA1;EPHB1;PTEN;SPTBN4
prerank,protein ADP-ribosylation (GO:0006471),0.5653585163977728,1.375453025628817,0.1018957345971564,0.8322921041456033,1.0,8/28,11.05%,PARP3;ART4;PARP11;ARF4;PARP6;SIRT2;ZC3HAV1;PARP14
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.4572049186981036,-1.3746252126988672,0.09782608695652174,0.58119800179137,1.0,7/20,16.43%,IGF1;NIBAN2;FOXC1;LAMTOR5;EP300;TGFB1;GTF2B
prerank,aminoglycan biosynthetic process (GO:0006023),0.5190416043675159,1.3740994267179751,0.06971677559912855,0.8372115918623427,1.0,13/49,12.33%,HAS1;GPC6;UGDH;GPC3;B3GALNT1;EXT1;B3GAT3;XYLT1;HS2ST1;B3GNT8;HS3ST6;HS3ST5;HSPG2
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.6651126994548545,1.3737304984167826,0.1078167115902965,0.8364489750903185,1.0,1/12,0.38%,AKR1B1
prerank,receptor signaling pathway via STAT (GO:0097696),0.5742658066863012,1.3736312784693334,0.09587378640776699,0.8342287764098436,1.0,10/25,19.87%,GHR;PKD1;CLCF1;SOCS2;PKD2;STAT5A;SOCS6;STAT5B;THPO;IL31RA
prerank,response to UV-A (GO:0070141),0.6317645861845252,1.3734961905906147,0.11351351351351352,0.8321041887775141,1.0,4/14,13.40%,EGFR;MMP2;AKT1;CCND1
prerank,negative regulation of cell-substrate junction organization (GO:0150118),-0.4734067018566254,-1.3734464053749256,0.11203319502074689,0.5753803729924953,1.0,4/16,3.43%,PHLDB2;ARHGAP6;THBS1;APOD
prerank,negative regulation of focal adhesion assembly (GO:0051895),-0.4734067018566254,-1.3734464053749256,0.11203319502074689,0.5753803729924953,1.0,4/16,3.43%,PHLDB2;ARHGAP6;THBS1;APOD
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.5026202692805629,1.3728411949850572,0.046858359957401494,0.8329318629074411,1.0,10/69,9.08%,SYK;LBP;EPHB2;MIF;TMEM106A;PTPRJ;IL33;PSEN1;TIRAP;TLR4
prerank,positive regulation of glial cell differentiation (GO:0045687),-0.473984849369095,-1.3724828188438265,0.10416666666666667,0.573419305716512,1.0,8/17,12.16%,PTN;IL34;TENM4;NOTCH1;PTPRZ1;BMP2;MDK;TGFB1
prerank,intracellular lipid transport (GO:0032365),-0.4389610143250473,-1.3709642990792688,0.07368421052631578,0.5729916918289518,1.0,6/21,11.32%,PRKAG2;PLEKHA8;CERT1;PRKAA2;SLC25A20;ACACB
prerank,catecholamine metabolic process (GO:0006584),-0.4857857033456918,-1.3708690866768916,0.11811023622047244,0.5688072987341085,1.0,3/14,11.47%,SNCAIP;DDC;RNF180
prerank,membrane depolarization during action potential (GO:0086010),-0.40559383636568647,-1.37085769551711,0.04678362573099415,0.5644406656623061,1.0,4/26,4.94%,ATP1A2;YWHAH;CACNA1D;SCN3A
prerank,membrane repolarization (GO:0086009),-0.4903498218841531,-1.3708314556807728,0.0958904109589041,0.560175660558006,1.0,3/15,2.68%,ATP1A2;ATP1B3;KCND3
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.6316077065089173,1.3706509997565237,0.1043360433604336,0.842821870035363,1.0,4/15,5.33%,PIEZO2;HPN;COL11A1;PDZD7
prerank,cell junction assembly (GO:0034329),-0.30597216408183386,-1.3704930861973594,0.043478260869565216,0.5567819808657505,1.0,25/100,13.24%,TJP1;PKP4;CDH5;ITGA6;CLDN5;SPOCK2;CDH1;SHANK3;PLXND1;DNM3;CDH6;ACTB;TLN2;RYK;CDH7;OPHN1;SDK2;LIMS1;SDK1;CDK5;FBLIM1;BDNF;TRPV4;PCDHB14;SLITRK1
prerank,negative regulation of peptidase activity (GO:0010466),0.5194633643834737,1.370270863951594,0.05754614549402823,0.8423637592830341,1.0,10/47,12.90%,TIMP2;LRP1;SERPINB8;ECM1;SERPINE3;SERPINF1;CSTB;SERPINH1;AKT1;SERPING1
prerank,polyol metabolic process (GO:0019751),-0.3556559081536419,-1.3699766761148167,0.04,0.5541366644123537,1.0,14/46,11.72%,ITPKB;INPP4B;PLCG1;ISYNA1;SLC5A3;NUDT4;PLCB1;INPPL1;ITPK1;INPP5D;MINPP1;NUDT3;ITPKC;PLCD3
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.6290761035508122,1.3697097856012737,0.1215323645970938,0.8428145819503217,1.0,12/15,31.46%,SYVN1;HERPUD1;SELENOS;AUP1;DERL1;SEL1L;SEC61B;HSP90B1;UFD1;NPLOC4;TMEM129;DERL2
prerank,regulation of chondrocyte differentiation (GO:0032330),0.5792955633253797,1.3691714228329976,0.11327649208282582,0.8429063557196919,1.0,9/24,18.40%,LOXL2;TRPS1;SCIN;WNT9A;CHADL;SOX5;SNAI2;EFEMP1;TGFBR1
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.5609931203971118,1.3690595475511207,0.0955794504181601,0.8408204206362203,1.0,4/29,3.66%,DBN1;EPHB2;SLC4A10;DLG4
prerank,regulation of cardiac muscle cell contraction (GO:0086004),0.567544364355295,1.3689192580245995,0.09186046511627907,0.8387986136866247,1.0,11/27,17.31%,ANK2;FGF13;SRI;DSC2;CAMK2D;HCN4;PDE4D;JUP;ATP2A2;STC1;AKAP9
prerank,cardiac ventricle development (GO:0003231),-0.44521242452144455,-1.3677393833942697,0.07142857142857142,0.5557775817993056,1.0,7/20,9.63%,ENG;NOTCH1;SALL1;HEYL;STRA6;HECTD1;PDE2A
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.5150153844634805,1.3666405527382752,0.06570155902004454,0.8488169409712034,1.0,12/49,17.74%,GHR;LIF;CTF1;VEGFA;CLCF1;TNFRSF18;PARP14;PIBF1;FLT3;IL4;IL6;IL18
prerank,skeletal muscle organ development (GO:0060538),0.5603573654711189,1.3665814905510905,0.11085180863477247,0.8464308583744684,1.0,7/26,13.72%,WT1;DISP1;SIX4;SVIL;MYH14;LARGE1;SIX1
prerank,cellular response to interleukin-7 (GO:0098761),0.6056565776416377,1.3661838974578155,0.09323116219667944,0.8431421526233916,1.0,6/17,16.39%,IRS1;SOCS2;STAT5A;IRS2;SMARCA4;STAT5B
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.6056565776416377,1.3661838974578155,0.09323116219667944,0.8431421526233916,1.0,6/17,16.39%,IRS1;SOCS2;STAT5A;IRS2;SMARCA4;STAT5B
prerank,fatty acid transmembrane transport (GO:1902001),-0.4419239493685124,-1.3659634414152013,0.09047619047619047,0.5565036342103112,1.0,5/19,11.32%,PRKAG2;SLC2A1;PRKAA2;SLC25A20;ACACB
prerank,long-chain fatty acid transport (GO:0015909),-0.3895214121739904,-1.3659025308531791,0.08982035928143713,0.5525716588749131,1.0,7/30,11.32%,PRKAG2;ACSL1;APOE;PRKAA2;ACSL3;SLC25A20;ACACB
prerank,plasma membrane repair (GO:0001778),0.6447933066090568,1.3656125120601172,0.11700680272108843,0.8436162176801696,1.0,2/13,4.28%,AHNAK2;SYT11
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.6775314041017536,1.3655561494542048,0.11174785100286533,0.8412617531992858,1.0,6/10,20.09%,PDE8A;NFE2L2;GPR37L1;GPR37;PYCR1;STK26
prerank,JNK cascade (GO:0007254),-0.364425152662388,-1.3654859711838812,0.056451612903225805,0.549449274026031,1.0,21/40,26.53%,MAP4K3;TNFRSF19;CRKL;IRAK2;MAP3K13;IKBKG;MAPK8;MAPK10;NOD1;MAPK9;TAB1;UBE2V1;MAP3K5;MINK1;MAP2K7;MAP3K10;NOD2;TAB3;RIPK2;ARHGEF6;SH2D3C
prerank,positive regulation of behavior (GO:0048520),-0.5425041479211701,-1.364458332707994,0.11858974358974358,0.5481809082992785,1.0,5/10,21.72%,MEF2C;STRA6;SGIP1;CFAP20;NR4A3
prerank,regulation of cholesterol esterification (GO:0010872),-0.559449694737792,-1.3644412215692767,0.16376306620209058,0.5442701103805728,1.0,3/10,6.36%,APOE;ABCG1;AGTR1
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.6596709300823608,1.364043271176552,0.1361760660247593,0.8471463474973958,1.0,4/10,7.85%,GRB10;ITGB3;ITGA5;PRKD2
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.6653480013062213,1.3635581410954785,0.12430939226519337,0.8445127571064581,1.0,2/11,8.10%,SYK;STAT5A
prerank,cellular response to interleukin-2 (GO:0071352),0.6653480013062213,1.3635581410954785,0.12430939226519337,0.8445127571064581,1.0,2/11,8.10%,SYK;STAT5A
prerank,response to ketone (GO:1901654),0.5700852407018593,1.362952144317309,0.10281517747858017,0.8452228036193268,1.0,5/24,3.64%,TGFB3;TGFB2;SLIT3;SLIT2;CATSPERB
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.6678631110050173,1.3626190093043917,0.10885341074020319,0.8444250186293801,1.0,4/10,12.43%,GAP43;F2R;PLPP1;PRKD3
prerank,positive regulation of phospholipase C activity (GO:0010863),0.5285818895333892,1.3625245721876462,0.09111617312072894,0.842361572186011,1.0,7/40,3.92%,AVPR1A;ESR1;EGFR;FGFR1;ANG;FGF2;LPAR1
prerank,actin polymerization or depolymerization (GO:0008154),0.5201522385446904,1.3619445325330308,0.08134490238611713,0.843071684465698,1.0,13/50,11.23%,GSN;PSTPIP1;SCIN;ANG;DIAPH3;COBL;SVIL;MSRB1;WASF1;ABI1;TWF1;AVIL;MICAL2
prerank,vasculature development (GO:0001944),-0.47003877373700237,-1.360971622909214,0.13793103448275862,0.5494197834262655,1.0,8/16,16.14%,CDH5;ERRFI1;BMPR2;STRA6;PDGFRB;NOTCH4;FLT4;SOX18
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.49215843968917444,1.360941531805622,0.06,0.8461125468127859,1.0,22/79,17.20%,DCTN1;SEC24D;DYNC1LI2;ACTR1B;KLC1;SEC31A;AP1M1;SEC24A;AP2A2;CLTC;SEC23A;DYNC1LI1;DYNC1I1;KIF2A;ARF1;AP1S2;KIF3A;KIF3B;DYNC1H1;MFSD6;SEC24B;CTSD
prerank,response to peptide hormone (GO:0043434),0.5229682106500066,1.3608873789894802,0.08333333333333333,0.8438402301103549,1.0,12/43,16.39%,IGFBP5;ANXA1;IRS1;ZFP36L1;MEAK7;SRC;STAT5A;EPM2AIP1;AKT1;EIF6;OGT;STAT5B
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.549935237651588,1.360671309835173,0.08955223880597014,0.8425517001636902,1.0,11/33,14.33%,CDK2AP2;FHL1;CDK4;DACT1;PRMT2;PKD2;BRD7;GPNMB;CDKN1A;NACC2;KLF4
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.5730728866253421,1.3600195389431917,0.10184049079754601,0.8436116131375136,1.0,10/25,12.38%,AR;EGFR;GLMN;ANG;MIF;SRC;FZD7;PSEN1;DSCAM;EGF
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.6082020850926145,1.3596926476824551,0.13458950201884254,0.842776293845245,1.0,4/15,6.34%,TRIAP1;CD44;MIF;MUC1
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.5033045871438722,1.359292251096016,0.05456453305351522,0.8425915854697303,1.0,16/72,15.09%,FGF18;FGF7;POLR2H;FGFR1;FLRT2;HNRNPA1;FGF2;TRIM71;HNRNPH1;RBFOX2;FLRT3;SHOC2;POLR2D;POLR2G;CBL;GTF2F1
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.6681544320347363,1.3590337591305226,0.11484593837535013,0.841429393642412,1.0,1/10,0.19%,DCN
prerank,regulation of integrin activation (GO:0033623),0.6171122100609183,1.3589717562383437,0.1453104359313078,0.839215878068238,1.0,4/15,6.81%,RAP1B;JAM3;FARP2;SRC
prerank,negative regulation of interleukin-6 production (GO:0032715),0.5630357899467954,1.3588224684905494,0.10669975186104218,0.8374756233869028,1.0,8/27,15.83%,IRAK3;SYT11;GAS6;TLR4;SIRPA;CD200R1;ZC3H12A;SELENOS
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.6003007228940069,1.3586720142245885,0.10318471337579618,0.8358017478763116,1.0,8/18,18.62%,RAB23;FLCN;MDFIC;OTUD7B;CABP1;CHP1;ILRUN;UFM1
prerank,regulation of wound healing (GO:0061041),0.5270401651163346,1.3582425995333218,0.07945516458569807,0.8357258608653357,1.0,6/42,3.19%,EPHB2;DUOX1;ANXA1;SRSF6;FGF2;F2R
prerank,positive regulation of macrophage differentiation (GO:0045651),0.6580148121549918,1.3577274174005418,0.10027855153203342,0.8359483560101403,1.0,2/11,1.26%,LIF;PRKCA
prerank,lipid translocation (GO:0034204),0.5845545600813111,1.357250101177571,0.10656753407682776,0.8360908891707441,1.0,7/21,12.71%,ATP8B1;ATP9A;ABCA1;ATP11A;ATP9B;TMEM30A;ABCC1
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.5464248611267077,1.3567507912219552,0.09501187648456057,0.8364154794712491,1.0,6/30,8.98%,COL3A1;AKAP13;F2R;LPAR1;ARHGEF3;GPR20
prerank,regulation of leukocyte chemotaxis (GO:0002688),-0.45825631767852426,-1.3564604432131524,0.11016949152542373,0.5568432542056494,1.0,3/18,4.62%,PTN;LYN;IL6R
prerank,calcium-ion regulated exocytosis (GO:0017156),0.5615843208325485,1.3563392746732759,0.1136094674556213,0.8361389338492312,1.0,10/27,21.37%,SCIN;SYT2;SYT12;SYT11;SYT13;SYT1;VAMP2;RIMS2;PPP3CB;ARHGAP17
prerank,regulation of cardiac muscle contraction (GO:0055117),0.552637652492363,1.3561721554856854,0.094211123723042,0.8346461163548595,1.0,11/34,15.37%,ANK2;TNNI3;SRI;TNNI3K;HCN4;PDE4D;SLC9A1;CALM2;ATP2A2;ZC3H12A;STC1
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.5576761433753235,1.356093460872187,0.10494571773220748,0.8326470862452863,1.0,12/29,17.05%,COPA;RAB6A;RAB6B;COPB1;COPB2;NAPA;GOSR1;COG6;RAB33B;NSF;COPZ2;NAPG
prerank,sulfur compound biosynthetic process (GO:0044272),0.4860621071523985,1.3560678045991443,0.0364963503649635,0.8303127376195568,1.0,28/104,18.15%,DCN;GCLC;ST3GAL2;UGDH;B4GALT3;PAPSS2;B4GALT1;OGN;CHST1;CSGALNACT2;ACAN;VCAN;CHST12;CHST14;CHSY3;HAGH;CNDP2;GSTM2;ST3GAL4;MAT2A;MAT2B;GLCE;GGT7;SLC26A1;MPST;GSTO2;ST3GAL1;ST3GAL3
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.6192927186146092,1.3559734798700651,0.11901504787961696,0.8283297024625045,1.0,5/15,13.72%,SIX4;VEGFA;SOX8;GDNF;SIX1
prerank,negative regulation of cation channel activity (GO:2001258),0.5552455669181672,1.355010875683491,0.10545023696682465,0.8313637815687316,1.0,6/26,12.63%,EPHB2;SRI;PKD2;CRHR1;GSTM2;CALM2
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.6357050136654501,1.3549631722309532,0.13730929264909847,0.8291845453124619,1.0,5/12,13.72%,SIX4;VEGFA;SOX8;GDNF;SIX1
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.5523249819300935,1.3542276472396704,0.09313154831199069,0.8308260341386241,1.0,10/31,14.33%,CDK2AP2;FHL1;CDK4;DACT1;PRMT2;PKD2;BRD7;GPNMB;CDKN1A;KLF4
prerank,RNA transport (GO:0050658),0.49622061712061044,1.3541205772730938,0.039014373716632446,0.8290059863817887,1.0,24/71,19.22%,SRSF2;HNRNPA1;SRSF6;NXF1;TGFBR2;RFTN1;ZFP36L1;RTRAF;U2AF1;SRSF3;ATXN2;SIDT2;SRSF11;THOC7;ZFP36;POLDIP3;THOC2;THOC1;ZC3H11A;DDX39A;CKAP5;SRRM1;SLBP;U2AF2
prerank,regulation of hydrolase activity (GO:0051336),-0.318013977142836,-1.3538833612948513,0.017241379310344827,0.5600740373987185,1.0,14/71,6.08%,PLXNA2;PRKG1;EPHA4;CHN2;SCARB2;PLXNA4;FGD4;CHN1;FGD5;DAB2IP;PLXND1;SIPA1L1;RASIP1;CAV1
prerank,"base-excision repair, AP site formation (GO:0006285)",0.6056060075211329,1.353652618447802,0.10682110682110682,0.8292909955761437,1.0,7/17,22.09%,MPG;ACD;TERF1;ERCC5;TINF2;OGG1;TERF2IP
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),-0.4218779802712087,-1.3535601036422678,0.07602339181286549,0.5570862464405222,1.0,9/23,16.37%,EFNB2;IGF1;MEF2C;NIBAN2;TGFB1;AKAP6;EDN1;MYOCD;MAML1
prerank,establishment of spindle orientation (GO:0051294),0.5443371698648928,1.3531769731094991,0.09529411764705882,0.8294647323964768,1.0,5/28,4.97%,GPSM2;DCTN1;LLGL1;NDEL1;ZW10
prerank,regulation of muscle contraction (GO:0006937),-0.4066125784105913,-1.3531013738972235,0.1130952380952381,0.5543625913511506,1.0,7/26,10.28%,ATP1A2;TPM1;KCNB2;CAV1;ENO1;MYL9;KCNA1
prerank,negative regulation of calcium ion transport (GO:0051926),-0.48299138447902573,-1.3530654710387697,0.11764705882352941,0.5506104699942337,1.0,4/15,11.92%,ATP1A2;SLC30A1;ADRA2A;NOS1
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.6246514728979637,1.3524798655779189,0.10786802030456853,0.8308594200846724,1.0,3/15,2.91%,FGFR1;SCEL;TGFB2
prerank,carbohydrate transport (GO:0008643),0.6583980575133296,1.3522383755928833,0.12638888888888888,0.8298371476680103,1.0,4/11,13.02%,SLC50A1;SLC26A6;SLC23A1;SLC23A2
prerank,positive regulation of glucose import (GO:0046326),-0.4346596687708333,-1.3518433571015351,0.06467661691542288,0.550117314371779,1.0,5/21,3.34%,SORBS1;OCLN;INSR;IGF1;OSBPL8
prerank,acylglycerol catabolic process (GO:0046464),0.5537893909329605,1.351727532765915,0.11771700356718193,0.8302195945612696,1.0,6/30,18.64%,MGLL;FABP12;DAGLA;FABP5;LIPC;LIPH
prerank,cellular response to pH (GO:0071467),0.5887856029074878,1.3514414746381704,0.13548387096774195,0.8294800909755645,1.0,6/17,20.32%,RAB11FIP5;SLC9A1;GPR68;CHP1;GPLD1;ASIC1
prerank,lipoprotein transport (GO:0042953),0.6570779435331046,1.351366612635306,0.13304721030042918,0.8274564752453862,1.0,2/10,5.30%,LRP1;MIA3
prerank,protein import (GO:0017038),0.48511469287007963,1.3511054823181274,0.05687693898655636,0.8263726658885725,1.0,39/84,27.68%,SYK;PXMP2;PEX16;SPRN;NUP93;GDAP1;ALDH3A2;NUP107;PXMP4;AKT1;IPO9;TNPO2;PEX12;HSP90AA1;SLC25A17;E2F3;PEX3;IPO5;PEX5;NUP50;NXT2;ATAD1;ABCD3;PEX2;RANBP6;TPR;IPO11;FIS1;IPO13;TSC2;NUP133;NUP85;TNPO1;FAM53C;NUP188;KPNB1;SNX33;NUP88;RAB8B
prerank,pyroptosis (GO:0070269),-0.47992585339027327,-1.3509259491860233,0.11811023622047244,0.5488831136395572,1.0,7/15,30.71%,CASP4;AIM2;GSDMD;ZBP1;CASP1;TREM2;NLRC4
prerank,nonribosomal peptide biosynthetic process (GO:0019184),0.6384225078073948,1.3503382147019398,0.13630041724617525,0.8282262036049137,1.0,4/12,16.57%,GCLC;HAGH;CNDP2;BDH2
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.491444929960517,1.3502982658441356,0.05985552115583075,0.8261271902844962,1.0,20/87,15.09%,FGF18;FGF7;POLR2H;FGFR1;FLRT2;HNRNPA1;CD44;FGF2;ZFP36L1;TRIM71;ZFP36L2;HNRNPH1;RBFOX2;FLRT3;SHOC2;ZFP36;POLR2D;POLR2G;CBL;GTF2F1
prerank,integrin-mediated signaling pathway (GO:0007229),0.49744557066248185,1.3501485884982178,0.06396588486140725,0.8245413300140382,1.0,19/73,14.02%,COL3A1;SYK;ITGA11;PRAM1;ITGBL1;ITGB3;ADAM9;PLPP3;ITGA2;ITGA5;ITGB5;DST;SRC;CUL3;ITGAV;CD47;FYB2;ADAM15;NME2
prerank,stress granule assembly (GO:0034063),0.5855175221345833,1.3500945531838726,0.12148337595907928,0.82253008035737,1.0,12/20,24.44%,UBAP2L;BICD1;ATXN2;MAPT;EIF2S1;ATXN2L;DYNC1H1;YTHDF1;YTHDF2;YTHDF3;OGFOD1;G3BP1
prerank,positive regulation of amyloid-beta formation (GO:1902004),-0.45252927048330016,-1.350092473981705,0.0979381443298969,0.5471859293848823,1.0,4/18,7.78%,EPHA4;SP1;ABCG1;CASP3
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.495225135458207,-1.3498933826126622,0.11857707509881422,0.5439899833003362,1.0,10/14,38.74%,WDR48;ARID2;MRNIP;FANCB;TIMELESS;WRAP53;RAD51AP1;ERCC6;WAS;PARP1
prerank,ion homeostasis (GO:0050801),0.5536446690798361,1.3497677729505806,0.1111111111111111,0.8219901527275698,1.0,9/30,12.93%,SLC4A10;FHL1;SLC4A8;SLC4A3;CAMK2D;AP3D1;HCN4;SLC4A4;SLC12A5
prerank,positive regulation of natural killer cell activation (GO:0032816),0.6424090664633862,1.3497619309613578,0.1251700680272109,0.819714822234868,1.0,3/13,8.30%,AXL;GAS6;ZBTB1
prerank,response to estradiol (GO:0032355),0.5388332816537539,1.3496239673706738,0.11473429951690821,0.8181645927161739,1.0,5/31,6.23%,ESR1;EGFR;ANXA1;SOCS2;NCOA3
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.5949708447276162,1.348555947946845,0.12532637075718014,0.8214715829901553,1.0,4/18,12.64%,ANXA1;ZFP36L1;ZFP36L2;ZFP36
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.47609371656105975,1.348264350086612,0.02332657200811359,0.8206685354238901,1.0,23/150,8.49%,AREG;MYOC;CD80;ESR1;FGF18;AXL;FGF7;EGFR;IRS1;FGFR1;BTC;FYN;FGF2;MST1R;PIK3R2;TCF7L2;PTPRJ;C1QBP;RET;SRC;GAS6;FLT3LG;PIK3CA
prerank,renal system development (GO:0072001),0.5130179008001274,1.348104246647658,0.08232711306256861,0.8192682290157193,1.0,10/52,7.50%,HAS2;WT1;PCSK5;SULF2;VEGFA;TGFB2;C1GALT1;PKD1;SULF1;GLI2
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.46522416217836315,-1.3479830706009879,0.09387755102040816,0.545080780938838,1.0,5/15,9.08%,GGACT;GGT5;PRODH;ALDH4A1;SARDH
prerank,hematopoietic stem cell proliferation (GO:0071425),0.668337746844836,1.347391818555147,0.11127167630057803,0.8206749793668592,1.0,3/11,3.49%,CD34;WNT10B;RUNX1
prerank,wound healing (GO:0042060),0.5009205607964943,1.3473536434546538,0.07104984093319194,0.8186145214381569,1.0,13/62,10.19%,COL3A1;AHNAK2;DCBLD2;ITGB3;FGF2;TGFB2;SYT11;DST;MIA3;PPL;PRCP;FZD7;TSKU
prerank,positive regulation of DNA recombination (GO:0045911),-0.40534275054709745,-1.346833861903434,0.06976744186046512,0.5444510059930238,1.0,11/27,19.43%,WDR48;KMT5B;SHLD1;KMT5C;ARID2;MRNIP;TFRC;RIF1;FANCB;TIMELESS;MAD2L2
prerank,positive regulation of cell killing (GO:0031343),0.6320435957285259,1.3452091827995225,0.1502086230876217,0.8276665094852538,1.0,2/13,8.19%,SYK;FZD7
prerank,regulation of cartilage development (GO:0061035),0.5922874169420568,1.3450448949123837,0.11630847029077118,0.826331452078007,1.0,3/18,1.35%,TRPS1;SCIN;BMP1
prerank,protein localization to endoplasmic reticulum (GO:0070972),0.6109192509939504,1.3449820045304373,0.12321660181582361,0.8243890062671746,1.0,3/16,5.30%,SEC16B;ANK2;MIA3
prerank,protein auto-ADP-ribosylation (GO:0070213),0.6371139406341448,1.3448174476729342,0.14246947082767977,0.823025236147166,1.0,3/12,7.36%,PARP3;PARP11;PARP6
prerank,cellular response to fluid shear stress (GO:0071498),0.6429397860656609,1.3447823475441685,0.12827586206896552,0.8209389552091257,1.0,7/12,14.33%,HAS2;MAPK7;NFE2L2;KLF2;PKD2;HDAC3;KLF4
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.4866087305505321,1.3436953841276442,0.07180570221752904,0.8224140982553926,1.0,21/78,17.20%,DCTN1;SEC24D;DYNC1LI2;ACTR1B;KLC1;SEC31A;AP1M1;SEC24A;AP2A2;CLTC;SEC23A;DYNC1LI1;DYNC1I1;KIF2A;ARF1;AP1S2;KIF3A;KIF3B;DYNC1H1;SEC24B;CTSD
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.4866087305505321,1.3436953841276442,0.07180570221752904,0.8224140982553926,1.0,21/78,17.20%,DCTN1;SEC24D;DYNC1LI2;ACTR1B;KLC1;SEC31A;AP1M1;SEC24A;AP2A2;CLTC;SEC23A;DYNC1LI1;DYNC1I1;KIF2A;ARF1;AP1S2;KIF3A;KIF3B;DYNC1H1;SEC24B;CTSD
prerank,regulation of RNA metabolic process (GO:0051252),0.5037220052216279,1.343595080174957,0.08643326039387308,0.8207880655658282,1.0,19/59,21.98%,AHNAK2;AHNAK;AFF2;MBNL1;USP36;CLK1;RC3H1;MBNL2;SON;HNRNPH1;MITF;IGF2BP1;TNFRSF1B;YTHDF2;NOVA1;PTBP1;RASA1;RC3H2;PTBP2
prerank,chemokine-mediated signaling pathway (GO:0070098),0.5170272001524288,1.342589043515361,0.08930540242557883,0.8238916269054175,1.0,6/42,12.91%,ACKR3;CCL8;CXCL10;CCL25;STK39;CCL13
prerank,activation of phospholipase C activity (GO:0007202),0.5453270881748301,1.3421956992162014,0.11515863689776733,0.823731426153512,1.0,4/29,3.92%,AVPR1A;EGFR;ANG;LPAR1
prerank,regulation of lipase activity (GO:0060191),0.6294028863662083,1.34092190676435,0.14112903225806453,0.8283247309684582,1.0,5/13,18.77%,PCSK6;PCSK5;RHOA;LIPC;ANGPTL3
prerank,regulation of dendrite development (GO:0050773),-0.3699631718510292,-1.3406420727825283,0.07086614173228346,0.5561533268890667,1.0,8/37,3.60%,PTN;NEDD4L;BMP5;MARK1;TNIK;BMP7;CDKL5;DAB2IP
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),-0.38408906868655335,-1.3398958824505818,0.06923076923076923,0.5542695133770656,1.0,13/35,25.09%,CDH5;ATP2C1;CDH6;CDH7;CDH13;PCDHB14;PCDHGC3;CDH11;DCHS1;CDH19;CDH24;CDH20;PCDHGB4
prerank,female gamete generation (GO:0007292),-0.3954540732861186,-1.339537853320799,0.09032258064516129,0.5513320811251502,1.0,4/29,3.90%,PTN;MCM9;DIAPH2;TOB2
prerank,protein targeting to membrane (GO:0006612),0.4889820195149306,1.3391624391433006,0.05246589716684155,0.8354044578896967,1.0,48/83,33.06%,PXMP2;PEX16;GDAP1;ZDHHC7;ALDH3A2;VPS37D;SRP19;PXMP4;TAOK2;ZDHHC2;VPS37C;SGTA;PEX12;TRAM1;SEC63;SLC25A17;SEC61A1;ZDHHC4;PEX3;ZDHHC24;VPS37B;ZDHHC21;ZDHHC20;NACA;PEX5;ATAD1;ABCD3;ZDHHC18;ICMT;PEX2;ATG3;SDCBP;FIS1;MICALL1;SSR1;RAB8B;PRKCI;ZDHHC15;PARD3;MYO1C;GOLGA7B;PIKFYVE;CHMP4A;CHMP4B;ARL6;CHM;PEX19;ZDHHC3
prerank,positive regulation of signaling receptor activity (GO:2000273),0.5352024117362877,1.3390201408749098,0.11425206124852769,0.8339744008787529,1.0,5/36,7.11%,AREG;EPHB2;BTC;NCOA3;HDAC6
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.5397708238748343,1.338885205373118,0.10247349823321555,0.8324464704726002,1.0,4/33,4.40%,LIF;PRKCA;RUNX1;ZFP36L1
prerank,regulation of extracellular matrix organization (GO:1903053),0.6183283031770795,1.3386588329830953,0.1394422310756972,0.8313653057110443,1.0,4/15,3.49%,DDR2;LRP1;FAP;RUNX1
prerank,response to organophosphorus (GO:0046683),0.5985041423186346,1.3385618108626032,0.13821138211382114,0.8296808949307454,1.0,2/16,2.74%,DUOX1;DGKQ
prerank,pentose-phosphate shunt (GO:0006098),-0.5192184625272753,-1.33807939388749,0.14925373134328357,0.551505581872074,1.0,7/11,29.42%,DERA;PGLS;TALDO1;RBKS;RPE;RPIA;H6PD
prerank,muscle tissue development (GO:0060537),-0.5088828062774795,-1.3380357950050419,0.1583011583011583,0.5480730460369785,1.0,4/13,8.06%,PGM5;ENG;PTCH1;STRA6
prerank,membrane raft organization (GO:0031579),0.6142890050868225,1.334979218056699,0.13157894736842105,0.8466545324219106,1.0,6/15,16.98%,ANXA2;S100A10;RFTN1;MYADM;FA2H;FLOT2
prerank,negative regulation of immune effector process (GO:0002698),0.6257232150876318,1.3349719225205188,0.12777777777777777,0.8444730650584222,1.0,4/13,14.21%,CD55;RC3H1;CD47;FER
prerank,import into nucleus (GO:0051170),0.4856887301086125,1.3337182494300386,0.07052631578947369,0.8489387242522304,1.0,31/73,27.02%,SYK;GEMIN6;HNRNPA1;SPRN;NUP93;NUP107;AKT1;BACH2;IPO9;TNPO2;DDX20;E2F3;SNRPG;SNRPD3;IPO5;NUP50;NXT2;RANBP6;TPR;HTATIP2;SMN1;IPO11;IPO13;TSC2;NUP133;NUP85;TNPO1;FAM53C;NUP188;KPNB1;NUP88
prerank,response to interleukin-1 (GO:0070555),0.49034611768445957,1.3334694984493232,0.08429926238145416,0.8478995063239924,1.0,17/73,14.08%,HAS2;CCL8;PRKCA;ANXA1;IRAK3;USP10;NR1D1;SRC;RC3H1;CCL25;MAPK11;CD47;SIRPA;IRAK1;CCL13;HDAC4;ZC3H12A
prerank,cellular glucan metabolic process (GO:0006073),-0.5263179332931691,-1.3333161420725916,0.1314878892733564,0.5563457274754392,1.0,4/11,5.32%,PRKAG2;PHKB;PYGM;GBE1
prerank,protein polymerization (GO:0051258),0.5068550735177052,1.3332714258980545,0.08485499462943072,0.8467268092766776,1.0,17/55,17.83%,GSN;PSTPIP1;ANG;DIAPH3;FGF13;COBL;MSRB1;WASF1;MAPT;TPPP3;PIN1;CASQ1;DIAPH1;WASHC3;CORO7;MAP7D3;CKAP5
prerank,t-circle formation (GO:0090656),0.6566331644743544,1.333256601957813,0.15351506456241032,0.840250736036589,1.0,7/10,22.85%,XRCC3;TERF1;DNA2;NBN;BLM;SMARCAL1;ERCC1
prerank,telomere maintenance via telomere trimming (GO:0090737),0.6566331644743544,1.333256601957813,0.15351506456241032,0.840250736036589,1.0,7/10,22.85%,XRCC3;TERF1;DNA2;NBN;BLM;SMARCAL1;ERCC1
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.6566331644743544,1.333256601957813,0.15351506456241032,0.840250736036589,1.0,7/10,22.85%,XRCC3;TERF1;DNA2;NBN;BLM;SMARCAL1;ERCC1
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.48817543238924493,1.3331793917725414,0.053304904051172705,0.8384525340170252,1.0,10/73,9.08%,SYK;LBP;EPHB2;MIF;TMEM106A;PTPRJ;IL33;PSEN1;TIRAP;TLR4
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.5155578253748268,1.332748278046432,0.1113662456946039,0.8386478818276678,1.0,16/41,22.29%,MGLL;DAGLA;SCP2;PTGR1;GPX1;GSTM2;PNPLA8;ELOVL5;FADS1;DAGLB;ACOX1;EPHX1;FADS3;SCD5;HSD17B4;CYP1B1
prerank,signal peptide processing (GO:0006465),0.6486179319407424,1.332541051786452,0.14705882352941177,0.8375492722769255,1.0,3/11,9.04%,PCSK5;SPCS1;SEC11C
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.5082861088916564,1.3315917067643865,0.11368653421633554,0.8402433854742876,1.0,15/49,18.04%,LDLRAD4;PMEPA1;DACT1;AIDA;JAM3;SRC;HDAC6;TFIP11;SMAD6;ULK1;NOP53;NLRP2B;ANKRD27;PEX5;IAPP
prerank,lipoprotein localization (GO:0044872),0.6344867827782741,1.3305043198232775,0.1477900552486188,0.8437203061860109,1.0,2/11,5.30%,LRP1;MIA3
prerank,regulation of cilium movement (GO:0003352),-0.5208749096250906,-1.3298389587495048,0.15384615384615385,0.561593218274686,1.0,8/10,35.93%,DNAH11;CFAP43;CFAP298;ODAD2;DRC1;CCDC65;CFAP206;CCDC40
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.6446790848102602,1.3297256912490916,0.15718157181571815,0.8455139887230406,1.0,4/11,5.78%,SMAD4;LMNA;ATP2B4;FOXO1
prerank,B cell activation involved in immune response (GO:0002312),-0.480503715997156,-1.3294712922406038,0.15018315018315018,0.5589685434702832,1.0,7/13,25.77%,MSH2;BATF;RNF8;CD180;GPR183;LIG4;FCGR2B
prerank,amino acid import across plasma membrane (GO:0089718),-0.42552176288451826,-1.3287085663394838,0.09302325581395349,0.5574572702844954,1.0,8/24,6.69%,SLC7A2;SLC6A13;SLC1A3;SLC16A2;SLC7A5;SLC22A4;SLC6A9;SLC3A2
prerank,eye development (GO:0001654),0.508060527871765,1.3282233515891042,0.10428100987925357,0.851472778188527,1.0,9/54,5.70%,COL5A2;FBN1;COL5A1;WT1;ZDHHC16;TGFB2;PBX1;SKI;MEIS2
prerank,long-term synaptic potentiation (GO:0060291),0.5720001775916687,1.3282227721123219,0.13135068153655513,0.8493171509019737,1.0,8/21,18.56%,NPTN;NFATC4;MPP2;GRIN2D;STX4;SLC8A2;GRIN2A;VAMP2
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.5220678801199784,1.3281892752399194,0.10376282782212087,0.8473511715256588,1.0,9/39,7.86%,LRP6;WT1;VEGFA;FGF2;SLIT2;TGFBR2;PKD1;GLI2;PKD2
prerank,regulation of tissue remodeling (GO:0034103),0.5761789752943581,1.3280802589361107,0.13881748071979436,0.8458152254699515,1.0,4/18,11.79%,DDR2;RUNX1;THBS4;GPNMB
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.542712201075984,1.327907843188908,0.1267605633802817,0.8446305405812226,1.0,6/31,7.34%,SYT2;STX1A;SYT12;SYT11;SYT13;SCAMP5
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.4851930895604634,1.32787068751265,0.08764519535374868,0.8426789370571212,1.0,27/69,22.79%,IRS1;FGFR1;PLCE1;PIK3C2B;PIK3R2;CD160;ZFP36L1;PLCB4;C1QBP;INPP5F;PIK3CA;SIRT2;AKT1;IRS2;PLEKHA1;RHOA;PI4KB;PDGFRA;PI4KA;OGT;PLCD4;TYRO3;PTEN;GAB2;PIK3CG;NF1;HTR2A
prerank,regulation of fibroblast migration (GO:0010762),0.5787542250738358,1.3274998195548446,0.14949748743718594,0.8424825815805901,1.0,3/20,2.88%,DDR2;HAS1;FGF2
prerank,response to molecule of bacterial origin (GO:0002237),0.48741720952246476,1.326931097831113,0.08280254777070063,0.8434092716202851,1.0,18/69,16.30%,LBP;IRAK3;FOXP1;F2R;S100A8;S100A9;CYP27B1;TIRAP;SIRT2;TLR4;SMAD6;C4B;SLPI;IRAK1;FER;GGT7;CD14;IL6
prerank,regulation of oligodendrocyte differentiation (GO:0048713),-0.44523820429300187,-1.326730556256955,0.11160714285714286,0.5588521604694521,1.0,8/18,11.90%,PTN;IL34;TENM4;NOTCH1;PTPRZ1;TNFRSF21;MDK;SLC45A3
prerank,miRNA mediated inhibition of translation (GO:0035278),0.642098474520388,1.3263100452347973,0.14676258992805755,0.8423517360000777,1.0,9/11,27.67%,RBM4;TRIM71;AGO2;EIF6;ZFP36;AGO4;AGO3;TNRC6A;AGO1
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",0.642098474520388,1.3263100452347973,0.14676258992805755,0.8423517360000777,1.0,9/11,27.67%,RBM4;TRIM71;AGO2;EIF6;ZFP36;AGO4;AGO3;TNRC6A;AGO1
prerank,dendritic spine morphogenesis (GO:0060997),0.596979099077357,1.3257789711536514,0.15106951871657753,0.8427774090563582,1.0,7/15,21.11%,EPHB2;DLG4;EPHB3;CTNND2;DIP2A;EPHB1;PTEN
prerank,epidermal cell differentiation (GO:0009913),0.5152210306728651,1.325707834669017,0.10666666666666667,0.8411250680125442,1.0,7/41,11.87%,LORICRIN;ANXA1;SCEL;ADAM9;KRT10;JAG1;ERCC3
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.612308359432796,1.3251397547329982,0.13443072702331962,0.8419792006949003,1.0,3/14,17.74%,CD80;PAEP;IL18
prerank,membrane assembly (GO:0071709),0.5324568395518273,1.3249604143925724,0.11123986095017381,0.8408658768357125,1.0,8/34,9.18%,CEL;STX2;ANXA2;S100A10;RFTN1;CHMP7;TLCD2;STX4
prerank,negative chemotaxis (GO:0050919),0.5288047332089562,1.324795433884466,0.10446009389671361,0.8397128520714648,1.0,10/33,13.49%,SEMA3C;ITGB3;SLIT3;SLIT2;SLIT1;NTN1;SEMA3A;ITGAV;SEMA3D;RHOA
prerank,regulation of vesicle-mediated transport (GO:0060627),0.47985859321447044,1.3247283233396143,0.057291666666666664,0.8379845839383141,1.0,34/91,24.55%,SYK;STON2;BET1L;CD177;GAS1;ATP9A;RINT1;SRC;RIT2;ABL2;INPP5F;ARFGAP1;STX4;SCFD1;ITGAV;RAB3D;RUFY1;USP7;MAP2K2;RAB33B;NSF;SYT1;RAB5B;RAB5C;VAMP2;RIMS2;RALA;RAB10;MAPK1;PACSIN2;PACSIN3;STXBP5L;RAB12;TSC2
prerank,atrioventricular valve development (GO:0003171),0.6216767244262218,1.3244968004363828,0.1482444733420026,0.8371351262337552,1.0,5/14,6.76%,TGFB2;SLIT3;TGFBR2;ACVR1;MDM4
prerank,polyamine metabolic process (GO:0006595),0.6193084008946719,1.3244035878726794,0.13896457765667575,0.8355701827068145,1.0,6/13,22.17%,SRM;HDAC6;ODC1;SMS;SAT1;AMD1
prerank,positive regulation of macrophage activation (GO:0043032),0.5925827974265793,1.3242856969066468,0.1432258064516129,0.8341611179131312,1.0,3/17,9.08%,LBP;IL33;TLR4
prerank,positive regulation of calcium-mediated signaling (GO:0050850),0.6491928908233249,1.324180020497749,0.13019390581717452,0.8326555654572735,1.0,2/11,4.28%,NEUROD2;P2RX3
prerank,regulation of neurotransmitter transport (GO:0051588),-0.4587812316937766,-1.3239805622845475,0.1409090909090909,0.5623148595591662,1.0,4/16,14.37%,SNCAIP;MEF2C;MCTP1;KCNMB4
prerank,negative regulation of T cell proliferation (GO:0042130),0.5500604697161138,1.3236980771306166,0.12363636363636364,0.8330686118383455,1.0,5/28,11.79%,CD80;GLMN;RC3H1;CEBPB;GPNMB
prerank,ncRNA metabolic process (GO:0034660),0.5191403144467341,1.322793866143875,0.11252900232018562,0.83569249100575,1.0,10/37,18.37%,TARBP2;TRIM71;DGCR8;MEPCE;AGO2;MAPT;DDX17;DDX4;ZCCHC8;TENT4B
prerank,positive regulation of cell projection organization (GO:0031346),-0.3024913023660957,-1.3225282504494287,0.07407407407407407,0.5625318830385265,1.0,32/115,12.46%,PLXNA2;PTN;ROBO1;LYN;RAPGEF2;PTK7;CUX1;ITGA6;SCARB2;APOE;PLXNA4;PTPRD;CDKL5;PRKD1;WNT5A;DAB2IP;PLXND1;SNX3;ROBO2;NDNF;PLPPR5;DVL3;NTRK3;MAP3K13;PLXNB1;CX3CL1;CAMK2B;MDK;EP300;SS18L1;NTRK2;BDNF
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.6066380669822206,1.3224720661732232,0.13896457765667575,0.8352407560380631,1.0,4/15,12.64%,ANXA1;ZFP36L1;ZFP36L2;ZFP36
prerank,negative regulation of extracellular matrix organization (GO:1903054),0.6544400142698825,1.322190900987604,0.13623595505617977,0.834616778189531,1.0,4/10,13.72%,DPP4;FAP;CHADL;TNFRSF1B
prerank,intestinal absorption (GO:0050892),-0.48482424694330745,-1.32204490965058,0.13618677042801555,0.5604283342758632,1.0,4/13,10.39%,F11R;TJP2;ADRA2A;KCNQ1
prerank,monosaccharide transmembrane transport (GO:0015749),0.5996268908660163,1.3218833980759976,0.1371280724450194,0.834172098005181,1.0,5/16,13.02%,SLC5A9;SLC50A1;SLC2A10;SLC23A1;SLC23A2
prerank,positive regulation of JUN kinase activity (GO:0043507),-0.3999923544327893,-1.321666644318473,0.11046511627906977,0.5579894347782656,1.0,9/23,20.40%,SASH1;DAB2IP;DVL3;TNFRSF11A;EDN1;MAP3K5;ARHGEF5;DUSP19;MAP3K10
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.5959150422569699,1.3213406693437804,0.1503267973856209,0.8348404330197697,1.0,13/17,31.46%,SYVN1;HERPUD1;SELENOS;AUP1;DERL1;SEL1L;SEC61B;HSP90B1;UFD1;NPLOC4;HM13;TMEM129;DERL2
prerank,nucleosome organization (GO:0034728),0.5038855174026216,1.3213275176791408,0.09684439608269858,0.8329104389342052,1.0,25/55,22.51%,CHAF1B;SMARCD2;MCM3AP;SMARCD1;SPTY2D1;POLE3;NPM1;SMARCC2;SETD2;ANP32B;DMAP1;INO80;SMARCA4;SRCAP;GRWD1;NAP1L2;SET;CTCF;PRDM9;ZNHIT1;PAF1;BRD2;KAT6B;VPS72;NAP1L3
prerank,endoderm formation (GO:0001706),0.5224493852410833,1.3213205325962634,0.11392405063291139,0.830968883181233,1.0,9/35,11.81%,COL8A1;COL11A1;MMP2;ITGA5;ITGB5;COL12A1;COL6A1;ITGAV;SETD2
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.5721452854163239,1.3211946691617522,0.14955640050697086,0.8296546660522301,1.0,4/19,5.35%,MYOC;VEGFA;S100A10;PTPRJ
prerank,glycosaminoglycan catabolic process (GO:0006027),0.5003185271679195,1.3209799231145982,0.08922742110990206,0.8287982801782372,1.0,14/55,16.73%,DCN;GPC6;GPC3;CD44;OGN;FGF2;ACAN;VCAN;SLC9A1;HSPG2;CHP1;NAGLU;IDUA;SDC2
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.4896048162597013,1.3205651720802423,0.0744336569579288,0.8289270858818053,1.0,18/67,14.83%,GHR;SYK;DDR2;EPHB2;SRMS;EGFR;FGFR1;EPHA3;FYN;SRC;ABL2;ABI1;PIBF1;FLT3;PDGFRA;FER;DDR1;IL4
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.5522539309944876,1.3199953017927522,0.14007308160779536,0.8298264954149034,1.0,15/24,29.97%,MAPK7;VEGFA;NFE2L2;KLF2;CREB3L1;MUC1;CEBPB;ATF6;SESN2;ATF4;CHD6;DDIT3;RBPJ;TP53;HSF1
prerank,lysosome organization (GO:0007040),0.5180850275162512,1.3197827564929885,0.12585812356979406,0.8289529737696105,1.0,13/36,20.11%,HOOK2;ACP2;MTOR;ABCA1;TPP1;CLVS2;HPS4;VPS33A;GAA;SNAPIN;TMEM165;CLVS1;ACP3
prerank,negative regulation of proteolysis (GO:0045861),0.5180366378470138,1.3197027513699724,0.12829324169530354,0.8274453927690055,1.0,7/34,11.31%,TIMP2;GAS1;ECM1;CAMK2N1;HDAC6;CSTB;AKT1
prerank,blood vessel morphogenesis (GO:0048514),0.4944821718094702,1.3196890528999499,0.10991379310344827,0.8255732828570436,1.0,8/54,3.19%,SYK;HAS2;CCBE1;WT1;GLMN;VEGFA;TNNI3;TGFBR2
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.45013870162575526,-1.3192713933486215,0.1,0.5609117541664483,1.0,7/19,14.84%,TJP1;BMP6;NOTCH1;RGCC;NOTCH4;PPM1F;AFDN
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.5171694044771469,1.3180173494346221,0.12629161882893225,0.832021435099715,1.0,10/37,13.14%,PHLDB1;CDK2AP2;EFNA5;EPHA3;MAPRE3;BICD1;GAS2L1;MAPRE1;MAPT;MAP6
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.4731344929038485,1.3179151990534925,0.071875,0.8305871459569105,1.0,21/95,16.30%,LBP;CD80;AXL;ADAM9;MAPK14;NR1D1;CXCL10;CARD16;TIRAP;SIRT2;TLR4;SIRPA;IRAK1;ZFP36;RHOA;TNFRSF1B;ZC3H12A;CD14;SELENOS;PDCD4;IL6
prerank,establishment of mitotic spindle orientation (GO:0000132),0.5468579578564203,1.3177215953396775,0.11459589867310012,0.8296769946689689,1.0,4/23,4.97%,GPSM2;DCTN1;NDEL1;ZW10
prerank,negative regulation of interleukin-10 production (GO:0032693),-0.4525278621786456,-1.3174871009694165,0.1506849315068493,0.5620712921922022,1.0,13/16,45.24%,TRIB2;TNFRSF21;JAK3;FCGR2B;DLL1;AGER;LILRB1;TYROBP;PDCD1LG2;IL23A;FOXP3;IL23R;IL12B
prerank,cytoplasmic microtubule organization (GO:0031122),0.5043057795021874,1.3169853764130524,0.09586056644880174,0.8314871616434703,1.0,27/54,26.59%,DCTN1;CCDC88C;HOOK2;CLIP1;DST;VPS4B;FSD1;SLK;CLIP2;CLIP4;CAMSAP1;MAPT;SLAIN2;CRIPT;RHOA;WDR73;CHP1;DYNC1H1;CLIP3;NUMA1;TUBGCP5;PCM1;CCDC88A;KATNA1;CEP126;CCDC88B;KPNB1
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.4783486317248091,1.3168998504707001,0.09157894736842105,0.8300080554655663,1.0,29/71,27.81%,FAP;CAPN2;ZRANB1;VPS4B;NR1D1;HDAC6;STUB1;UBE2W;CLPX;OTUD7B;UBA52;RSPRY1;DDB1;CLPP;NGLY1;SOCS6;ZER1;IDE;NEDD8;RNF41;PDCD6IP;RNF123;ZYG11B;CTSK;MDM2;PRPF19;CTSB;CTSL;CASP8
prerank,negative regulation of protein localization to cell surface (GO:2000009),-0.5362292683583832,-1.316650585071511,0.17582417582417584,0.5608111643597392,1.0,2/11,1.20%,NEDD4L;ACTN2
prerank,regulation of receptor internalization (GO:0002090),0.5349746225416318,1.3157828926245216,0.12121212121212122,0.8338356916497739,1.0,15/35,24.51%,SFRP4;VEGFA;DLG4;ATXN2;ARF1;MAGI2;EGF;AHI1;ATAD1;MKLN1;ARRB1;SDCBP;FLOT1;PICK1;RSPO1
prerank,negative regulation of response to stimulus (GO:0048585),0.4948402102529929,1.3150060204198324,0.09935205183585313,0.8359091564117664,1.0,6/60,4.40%,CD34;COL3A1;SRMS;MAPK7;SLIT2;ACVR1
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.5863328711323446,1.3148391452425083,0.14285714285714285,0.8348815819092673,1.0,3/17,3.71%,PCSK6;PCSK5;HDAC9
prerank,lymphocyte mediated immunity (GO:0002449),0.6196956909752449,1.314304090247767,0.15268225584594222,0.8357404488174044,1.0,3/12,15.15%,CD55;JAG1;BTN3A3
prerank,regulation of platelet activation (GO:0010543),0.5642657937257045,1.3141893313429327,0.13466334164588528,0.8344168523689459,1.0,3/21,1.26%,SYK;C1QTNF1;PRKCA
prerank,cell proliferation in forebrain (GO:0021846),0.6542115838624437,1.3131393198439905,0.15691868758915833,0.8378440500631684,1.0,3/10,5.71%,NUMBL;AKNA;DOCK7
prerank,protein localization to nucleus (GO:0034504),0.46694300226510826,1.3125348982899092,0.05458290422245108,0.8388622324995315,1.0,42/102,27.02%,SYK;COL1A1;SIX4;SPRN;LMNA;TOR1AIP2;TAF8;NUP93;NUP107;YWHAE;TOR1A;TAF3;AKT1;BCL3;IPO9;SIX1;TNPO2;BBS4;NOP53;E2F3;PML;IPO5;RPF2;TBRG1;NUP50;NXT2;PAF1;RANBP6;TPR;IPO11;IPO13;DVL1;TSC2;NUP133;MDM2;CALR;NUP85;TNPO1;FAM53C;NUP188;KPNB1;NUP88
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.6228321978733236,1.3125255909816107,0.15862068965517243,0.8370018297432577,1.0,5/12,16.30%,ESR1;NCOR2;NCOR1;ZC3H12A;IL6
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.4693086193659224,1.3122456092725827,0.06646216768916155,0.8365407961786767,1.0,36/104,23.82%,ASPN;HTRA3;LDLRAD4;SKIL;TGFBR2;PMEPA1;SMAD4;SMURF2;SKI;ACVR1;IGSF1;SMAD5;STUB1;SMAD6;PEG10;SLC2A10;MAGI2;VASN;UBA52;PIN1;SNX6;HTRA4;TGFBR1;STRAP;NBL1;UBE2D3;BMPER;PPM1A;ACVR2A;BMPR1A;SMURF1;CILP;CD109;FKBP1A;SKOR2;CCN3
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.6426339872722485,1.312228289490975,0.14484679665738162,0.8347443792588576,1.0,4/11,16.31%,HPN;MST1R;SIRT2;HGF
prerank,neuron differentiation (GO:0030182),0.4557687094997832,1.3121802364302286,0.032160804020100506,0.8330608885431787,1.0,16/165,5.31%,LMX1A;LRP6;LHX8;WNT10B;WNT2;UGDH;CTF1;NEUROD2;VEGFA;WNT9A;TGFB2;PBX1;RUNX1;LMX1B;IRX5;TENM3
prerank,negative regulation of defense response to virus (GO:0050687),0.6568767079501043,1.3117069402094719,0.15886524822695036,0.833705746701998,1.0,5/10,20.73%,TARBP2;ITCH;C1QBP;ILRUN;TSPAN6
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.4765215982320038,-1.3114232662983494,0.15555555555555556,0.5709075409706367,1.0,7/14,17.69%,RAPGEF2;PKIG;PRKAR1B;SIRT1;HTT;PRKAR2B;ADRB2
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.48581626920004894,1.3107613191291778,0.08128342245989305,0.8365502310578367,1.0,27/69,25.51%,UBE2J2;SYVN1;EDEM1;RNF121;PSMC6;STUB1;ANKZF1;FBXO2;EDEM2;FBXO17;ECPAS;UBE2G2;HERPUD1;DNAJB2;TMUB2;SGTA;AMFR;SELENOS;AUP1;JKAMP;DERL1;SEL1L;USP19;RHBDD2;SEC61B;HSP90B1;UFD1
prerank,protein targeting to peroxisome (GO:0006625),0.5382783731209194,1.3107277303650173,0.12128418549346016,0.8348241030639296,1.0,13/29,21.44%,PXMP2;PEX16;GDAP1;ALDH3A2;PXMP4;PEX12;PEX1;SLC25A17;PEX3;PEX5;ATAD1;ABCD3;PEX2
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.5078033498363727,1.3104117553720882,0.11503416856492027,0.8344412059842802,1.0,13/45,16.68%,AREG;EGFR;PLCE1;BTC;SRC;PIK3CA;IQGAP1;AKT1;EGF;AAMP;CBL;SOS1;EFEMP1
prerank,odontogenesis (GO:0042476),0.5266740997952185,1.3100924042668614,0.12702078521939955,0.8341226464947755,1.0,5/35,7.50%,COL1A2;LRP6;TGFB3;TGFB2;GLI2
prerank,visual perception (GO:0007601),0.47966415408235796,1.3097842093564867,0.0804953560371517,0.8339197139012581,1.0,20/84,20.30%,COL1A1;SLC4A10;ROM1;RABGGTA;COL11A1;ABLIM1;MYO9A;CNGB1;COL2A1;CRYBB1;RPGR;CABP1;CRYZ;OPA3;EFEMP1;TYR;RP2;SFRP5;KIFC3;ATF6
prerank,regulation of collagen biosynthetic process (GO:0032965),0.5711742048447707,1.309368927587008,0.1476846057571965,0.8342724193775407,1.0,4/19,5.67%,TGFB3;F2R;RUNX1;CREB3L1
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.6257157491505229,1.309113925344404,0.14733969986357434,0.8317771609238529,1.0,7/12,24.32%,EFNA5;MELTF;KANK1;RCC2;CORO1C;FBLN1;DMTN
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.6257157491505229,1.309113925344404,0.14733969986357434,0.8317771609238529,1.0,7/12,24.32%,EFNA5;MELTF;KANK1;RCC2;CORO1C;FBLN1;DMTN
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.5476345108551087,1.3090430092770116,0.13414634146341464,0.8303316577493032,1.0,4/24,7.27%,CCBE1;EIF2AK3;SULF2;SULF1
prerank,regulation of osteoblast differentiation (GO:0045667),-0.3139703255083635,-1.3089244377586962,0.058823529411764705,0.5739477873755668,1.0,24/82,10.58%,BMP6;RANBP3L;SMOC1;WNT4;TMEM64;PTCH1;IGF1;BMP7;MEF2C;PRKD1;NOTCH1;CDK6;ZHX3;IL6R;NELL1;ATRAID;FGFR2;NOCT;BMPR2;YAP1;NPNT;RUNX2;LRP3;BMP2
prerank,negative regulation of lymphocyte activation (GO:0051250),0.5531439133258842,1.3087355876580307,0.14968553459119496,0.829983706109262,1.0,4/21,11.89%,LAX1;BANK1;GPNMB;PIBF1
prerank,cardiac right ventricle morphogenesis (GO:0003215),0.6422361309674547,1.3086877599890259,0.16642958748221906,0.8283762235702737,1.0,3/11,8.93%,TGFB2;ZFPM2;JAG1
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.4751876106248737,1.3079334668149654,0.07845188284518828,0.8302536001319756,1.0,13/79,7.27%,HTRA3;TNMD;SULF2;SKIL;FGF2;SLIT2;SMAD4;SMURF2;SKI;ATP2B4;CREB3L1;SMAD5;SULF1
prerank,reticulophagy (GO:0061709),0.6257904153401113,1.3078677431181078,0.15447154471544716,0.8288049924232344,1.0,7/12,18.62%,ATG2B;ULK2;ATG2A;ULK1;UFC1;UFL1;UFM1
prerank,cellular response to virus (GO:0098586),0.5345000758637761,1.3072445240936752,0.12382075471698113,0.8300964949620198,1.0,15/30,30.22%,MAPK14;CXCL10;CHUK;MAPK11;ARF1;ZC3H12A;HSP90AA1;VWCE;IL6;RRP1B;LGALS8;RIOK3;GBF1;BAX;LGALS9
prerank,cartilage development (GO:0051216),0.4937007530673174,1.3071057969490545,0.11491712707182321,0.8289707390425899,1.0,11/49,10.14%,WNT10B;CD44;SULF2;FGF2;RUNX1;PKD1;SLC39A14;NFIB;SULF1;SOX5;COL2A1
prerank,calcium-mediated signaling (GO:0019722),0.4744362921911148,1.3070771274405066,0.07716049382716049,0.8272882307530871,1.0,21/93,17.66%,ACKR3;EGFR;EIF2AK3;PLCE1;ANK2;TNNI3;PTPRJ;RCAN3;STIMATE;MCU;ACKR4;RCAN1;PPP3CC;CAMKK2;SLC9A1;ATP2A2;PPP3CA;CXCR4;PPP1R9B;CXCR2;BCAP31
prerank,energy reserve metabolic process (GO:0006112),0.5685038835760278,1.3067059506330228,0.1618798955613577,0.8274181063688261,1.0,4/19,7.26%,GFPT2;UGP2;GFPT1;PID1
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.6381834307290629,1.3062230697429704,0.16066481994459833,0.8279935325295164,1.0,3/11,5.61%,SESTD1;BIN1;CAMK2D
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.6214919068129447,1.3061052334082275,0.15688949522510232,0.8268381256095712,1.0,7/12,21.34%,DCTN1;BICD1;KIF3A;BBS4;NIN;CCDC120;PCM1
prerank,regulation of GTPase activity (GO:0043087),-0.2657412690948734,-1.3054362492872338,0.0,0.5794366553273711,1.0,43/177,10.64%,PLXNA2;PKP4;PRKG1;EPHA4;RAPGEF2;RAPGEF3;CHN2;ITGA6;RAP1GDS1;NET1;PLXNA4;FGD4;CHN1;CDKL5;F11R;FGD5;DAB2IP;DOCK8;TGM2;PLXND1;RASGRP2;SIPA1L1;RASIP1;LRCH1;MAP4K4;RGS6;DVL3;DOCK9;CPEB2;BCAR3;PLXNB1;ERBB2;CX3CL1;SFRP1;CAV2;STMN3;ZC3H15;USP6NL;LIMS1;AGRN;TBC1D30;ARL2;RGP1
prerank,positive regulation of cell cycle (GO:0045787),0.489555292827383,1.3054116937960156,0.10032715376226826,0.8284800551472298,1.0,17/62,17.07%,LRP6;PRKCA;EGFR;TGFB2;SMOC2;PKD1;CDK4;PSRC1;MEIS2;MAPRE3;PKD2;AKT1;NUDT16;CCND1;NUPR1;USP22;TTL
prerank,positive regulation of vacuole organization (GO:0044090),0.6479963821610154,1.3051485903752722,0.14620689655172414,0.8280735384930472,1.0,4/10,20.47%,ANXA2;PIP4K2C;LRSAM1;PIP4K2B
prerank,atrial septum morphogenesis (GO:0060413),0.6567556106381787,1.3038899946411255,0.16879432624113475,0.8325007343771091,1.0,2/10,4.40%,TGFB2;ACVR1
prerank,N-glycan processing (GO:0006491),-0.4420799565497062,-1.3036588270237877,0.16,0.5805280096444511,1.0,8/18,21.58%,FUT8;ST8SIA4;MAN2A1;MGAT4A;ST8SIA2;ST8SIA6;MAN2A2;MAN1A2
prerank,insulin secretion (GO:0030073),0.5739478113725694,1.303505065915865,0.15274151436031333,0.8326468157113261,1.0,3/19,7.34%,RAB11FIP5;ANXA1;ADCYAP1
prerank,positive regulation of keratinocyte migration (GO:0051549),0.6385890316908776,1.3034801426558906,0.17302452316076294,0.8309934393117604,1.0,3/10,5.16%,FGF7;ADAM9;MTOR
prerank,snRNA metabolic process (GO:0016073),0.5867810344118126,1.303400548918421,0.14561855670103094,0.8296194445185681,1.0,7/17,18.59%,INTS3;MEPCE;INTS10;INTS6;ZCCHC8;INTS2;INTS12
prerank,positive regulation of organelle organization (GO:0010638),0.5234372351245016,1.3033799870418157,0.14763552479815456,0.8279692221329626,1.0,8/32,16.64%,ANXA1;ANXA2;SORBS3;SURF4;LMAN1;LNPK;SMCR8;HTRA2
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.47915451263499637,1.3031763541229981,0.08731808731808732,0.8272155840029559,1.0,46/80,32.02%,SGSM2;DCTN1;RAB7B;BET1L;RAB6A;STX5;HEATR5A;RAB6B;VPS52;CLTC;SNX1;SURF4;MAGEL2;LMAN1;TBC1D17;GGA1;TBC1D10A;TBC1D23;GOSR1;ARFRP1;TMEM87A;EVI5;PHETA2;PREPL;SNX6;DENND2A;STX16;ANKFY1;VTI1A;BAIAP3;RAB29;RNF126;GOSR2;GBF1;RBSN;VAMP3;YKT6;RHOBTB3;TBC1D5;SPAG9;RAB9B;PIKFYVE;TRAPPC10;TMEM87B;SNX5;ARL1
prerank,keratan sulfate biosynthetic process (GO:0018146),0.5407597838359394,1.3031136298531922,0.14512195121951219,0.8257680845704886,1.0,6/26,4.27%,ST3GAL2;B4GALT3;B4GALT1;OGN;CHST1;ACAN
prerank,regulation of vasculature development (GO:1901342),-0.39642479626291105,-1.3029278018619102,0.08854166666666667,0.5790189161351991,1.0,11/26,15.57%,ETS1;SP100;PLXND1;EMP2;ERBB2;TSPAN12;SFRP1;EGLN1;CTNNB1;ADGRA2;EPHA2
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.4976190012135742,1.3027679492066127,0.11784140969162996,0.8256871602292933,1.0,10/47,14.08%,SYK;CD177;TGFBR2;MAPK14;PID1;DHRS4;TLR4;MAPT;CDKN1A;ZC3H12A
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),-0.39080718908407985,-1.3024979221468236,0.1111111111111111,0.5768296401583598,1.0,10/25,17.10%,ATP1B3;ACTN2;DMD;WNK4;SLC6A9;TRPC6;NDUFA4;COX17;ATP1B1;GLRX
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.48324783098607865,1.3023864660272308,0.10295728368017525,0.8258821803111057,1.0,13/57,17.74%,GHR;LIF;CTF1;VEGFA;CLCF1;TNFRSF18;INPP5F;PARP14;PIBF1;FLT3;IL4;IL6;IL18
prerank,regulation of interleukin-4 production (GO:0032673),0.5551068004804048,1.3020487098636764,0.14556962025316456,0.8258115423908314,1.0,2/21,1.14%,SYK;IRF4
prerank,import into cell (GO:0098657),-0.36500647538965697,-1.3014634818491668,0.11904761904761904,0.5763010979066825,1.0,9/41,4.70%,ATP1A2;SLC6A13;SLC1A3;SLC16A2;SLC12A7;GLUL;SLC5A3;SLC7A5;SLC22A4
prerank,water transport (GO:0006833),-0.4921617720460317,-1.3013858089158454,0.1557377049180328,0.5731958074890011,1.0,2/12,8.86%,PDPN;AQP11
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.6421766629003525,1.3011810387190528,0.17746478873239438,0.8282112337075729,1.0,3/10,13.76%,CNGB1;SAG;GNB1
prerank,alpha-amino acid metabolic process (GO:1901605),0.5032204128587208,1.3009301549799088,0.11173184357541899,0.8276836196409951,1.0,2/45,2.65%,NOX4;ALDH18A1
prerank,carnitine shuttle (GO:0006853),-0.5064052070478882,-1.300542561255944,0.15498154981549817,0.5720274685084734,1.0,4/11,11.32%,PRKAG2;PRKAA2;SLC25A20;ACACB
prerank,regulation of catecholamine secretion (GO:0050433),0.5389602324404669,1.300126764946482,0.14066193853427897,0.829836570084117,1.0,7/29,10.51%,SYT2;STX1A;SYT12;SYT11;SYT13;DTNBP1;KCNA2
prerank,regulation of microtubule-based process (GO:0032886),0.5058936547386572,1.299736427827152,0.14935822637106183,0.8299481853516318,1.0,10/36,15.01%,PHLDB1;CDK2AP2;EFNA5;EPHA3;ATF5;BICD1;HDAC6;MAPT;MAP6;DIAPH1
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.5614497942869405,1.2993987913179192,0.16951379763469118,0.8298597482653374,1.0,4/18,11.79%,LAX1;MIA3;AKT1;GPNMB
prerank,coenzyme A metabolic process (GO:0015936),0.6040193112112324,1.2990128066463762,0.17391304347826086,0.8300372437026298,1.0,9/14,26.31%,ACLY;NUDT7;SLC25A16;PANK1;PANK3;DCAKD;ACAT1;CROT;ACOT7
prerank,receptor metabolic process (GO:0043112),0.4956664773810389,1.2988327665842956,0.1019522776572668,0.8291037488361075,1.0,9/53,8.09%,ACKR3;SYK;CD9;LRP1;DNM1;MVB12A;CLTC;SNX1;CD81
prerank,lytic vacuole organization (GO:0080171),0.5162397283157965,1.2988190862620916,0.13934426229508196,0.8274688628894399,1.0,11/32,20.11%,HOOK2;ACP2;MTOR;ABCA1;TPP1;CLVS2;HPS4;GAA;SNAPIN;CLVS1;ACP3
prerank,axonal transport of mitochondrion (GO:0019896),0.6355776477232591,1.2987952348925875,0.1617440225035162,0.8258627123147507,1.0,4/11,11.38%,NEFL;TRAK2;SYBU;MAPT
prerank,intracellular protein transport (GO:0006886),0.4479555421268335,1.2976832997859153,0.012012012012012012,0.8294768950623381,1.0,123/304,25.82%,SYK;SGSM2;COPA;DESI1;STX2;RAB32;RABGAP1L;RAB6A;AP4B1;STX1A;TMED1;SPRN;STX5;STX11;PKD1;SEC31A;RAB23;RAB19;RAB6B;NUP93;PREB;SCFD2;ARF4;TRAK2;SCG5;TBCK;AP3D1;HDAC6;NUP107;STX1B;CLTC;SNX1;STRADA;ACD;SURF4;USO1;HPS4;TBC1D2B;ARFGAP3;LMAN1;STX4;TBC1D17;GGA1;SCFD1;ARF1;STX12;AP4E1;NPM1;SEC23IP;COPB2;VPS33A;AKT1;TBC1D10A;NAPA;STX17;RAB43;RPGR;IPO9;TNPO2;ARFRP1;SYNDIG1;ARF6;GGA2;GIPC1;CHP1;E2F3;NSF;EVI5;SGSM1;COPZ2;EVI5L;AP4M1;NAPG;TBC1D13;RAB1B;RAB5B;RAB5C;IPO5;BCS1L;STX3;SNX6;ARCN1;ADPRH;NUP50;NXT2;TBC1D22B;TBC1D15;CLIP3;RAB24;TMED2;VPS33B;VPS36;AP1S3;COX18;RUNDC1;CTTN;SMURF1;RANBP6;NAPB;STX16;BAG3;TPR;TBC1D8B;IPO11;TBC1D12;FUT10;TECPR2;XPO7;PICK1;RABL3;STAM;IPO13;RAB18;TSC2;NUP133;CALR;NUP85;STX7;TNPO1;RAB29;KIF13B;RAB1A;FAM53C
prerank,phospholipid translocation (GO:0045332),0.5409994196001221,1.297663699228274,0.13080684596577016,0.8278811821379771,1.0,8/28,12.71%,ATP8B1;PLSCR4;ATP9A;ABCA1;ATP11A;ATP9B;TMEM30A;ABCC1
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.5247662484894282,1.2974135586702589,0.12142857142857143,0.8274326183981776,1.0,6/32,12.91%,ANG;S100A9;CXCL14;CXCL10;RNASE6;CCL13
prerank,negative regulation of hemostasis (GO:1900047),0.6123936469082341,1.2972940035496692,0.17671232876712328,0.8263017333326912,1.0,1/12,0.11%,CD34
prerank,engulfment of apoptotic cell (GO:0043652),-0.4659538339665661,-1.2972567799084396,0.1864406779661017,0.5772726749254781,1.0,5/15,16.68%,RHOBTB1;THBS1;XKR6;RHOH;MEGF10
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.595563525388425,1.297243788216922,0.1644021739130435,0.8248311157513598,1.0,8/15,24.70%,SKI;ACVR1;DACT1;IGSF1;MAGI2;ACVR2A;FKBP1A;ACVR1B
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.45091708425492655,1.2971381569082632,0.05141129032258065,0.8236923606708595,1.0,28/152,12.38%,RSPO2;SFRP4;COL1A1;DKK2;EGFR;SCEL;GPC3;PSMC4;SULF2;UBE2B;SMURF2;SKI;AXIN1;DACT1;ZRANB1;DAAM2;PSMC6;SULF1;PSMD8;GSKIP;PLEKHA4;KANK1;TMEM9;CSNK1G1;CSNK1G3;PRDM15;JUP;EGF
prerank,muscle cell migration (GO:0014812),0.6383973862802986,1.2971194451814023,0.17827298050139276,0.8221049118362955,1.0,5/10,14.53%,ITGB3;THBS4;SIX1;AAMP;DDR1
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.6021504864800946,1.2968143351735584,0.1519674355495251,0.8218575092673508,1.0,3/15,3.63%,FANCD2;EME1;TIPIN
prerank,regulation of intracellular pH (GO:0051453),0.5234943693911804,1.2965454123807088,0.12369942196531791,0.8214226613614435,1.0,12/34,16.48%,SLC4A10;SLC4A8;SLC4A3;SLC9A9;VPS33A;SLC4A4;SLC26A6;SLC9A1;CHP1;SLC9A7;SLC9A6;TMEM165
prerank,nuclear membrane organization (GO:0071763),0.5720087392453194,1.296339438094353,0.15829145728643215,0.8207544875844558,1.0,5/19,9.04%,DCTN1;TMEM43;CHMP7;TARDBP;TOR1A
prerank,myotube differentiation (GO:0014902),0.5802707380104908,1.2961931035145318,0.16036505867014342,0.8198309382940764,1.0,3/17,4.06%,ADAMTS5;SIX4;SKI
prerank,positive regulation of B cell activation (GO:0050871),0.4906073220798703,1.2958154761423892,0.11123348017621146,0.8200115485770669,1.0,12/50,16.30%,SYK;EPHB2;MIF;CLCF1;HMCES;CD81;TIRAP;TNFSF13B;IRS2;CD27;IL4;IL6
prerank,protein hydroxylation (GO:0018126),0.595023597917493,1.2956493432532192,0.16150740242261102,0.8191730362778594,1.0,7/15,22.69%,PLOD2;PLOD3;P3H1;VPS33B;PLOD1;OGFOD1;JMJD7
prerank,phosphatidylserine metabolic process (GO:0006658),-0.3743081973382634,-1.2952455909713254,0.06201550387596899,0.5792289701149276,1.0,6/32,13.11%,OSBPL10;PLA1A;OSBPL8;PLSCR1;PLAAT3;PLA2G15
prerank,ribosome assembly (GO:0042255),0.5017183304025747,1.295160513695305,0.11648351648351649,0.8197739982342854,1.0,20/47,26.66%,RPSA;MRPS11;C1QBP;NPM1;EIF6;SBDS;RPS27L;RPS5;RRP7A;RPL6;NOP53;PWP2;RPF2;MPV17L2;EIF2A;NOP2;RSL24D1;BRIX1;ERAL1;DHX29
prerank,regulation of osteoblast proliferation (GO:0033688),0.5813979702618304,1.295159111204379,0.155467720685112,0.8181441474046498,1.0,4/17,8.13%,MN1;TMEM119;TNN;SOX8
prerank,positive regulation of immune effector process (GO:0002699),0.5236000339976118,1.294541695996321,0.14494518879415347,0.8195093110673952,1.0,3/27,8.09%,LBP;PTPRJ;CD81
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.47290269068045365,1.2945179243518519,0.09584664536741214,0.8179811345531145,1.0,12/74,5.16%,COL1A1;PHLDB1;LOXL2;TGFB3;HPN;LDLRAD4;EPHA3;TGFB2;TGFBR2;SMAD4;WWTR1;MTOR
prerank,plasma membrane organization (GO:0007009),0.4906774317628051,1.2937123870970815,0.10289389067524116,0.8201508980021704,1.0,12/61,11.28%,AHNAK2;COL5A1;STX2;ANK2;PLSCR4;BIN1;SYT11;TLCD2;OSBPL2;STX4;EHD2;FA2H
prerank,macrophage activation (GO:0042116),0.5250328781505608,1.293238612157837,0.14514285714285713,0.8207170212580555,1.0,6/34,11.38%,SYK;LBP;FOXP1;TMEM106A;TLR4;MAPT
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.6378738469890117,1.2932227824238285,0.17705382436260622,0.8191590471247041,1.0,7/10,29.59%,CSGALNACT2;B3GAT3;XYLT1;XYLT2;B3GAT2;DSEL;CSGALNACT1
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.5546487679873767,1.2927858873925895,0.15736040609137056,0.8195160013803624,1.0,8/21,17.29%,CDK4;RAD51B;VPS4B;DTL;NPM1;FBXO5;CCND1;RCC2
prerank,cell projection assembly (GO:0030031),0.5593129960146953,1.2927334780371695,0.1577639751552795,0.8181788468130692,1.0,4/22,10.05%,GSN;SCIN;RHOJ;RHOQ
prerank,regulation of dopamine secretion (GO:0014059),0.5443014136302788,1.292490189050035,0.1473053892215569,0.8176792331573026,1.0,8/25,17.26%,SYT2;SYT12;SYT11;SYT13;DTNBP1;KCNA2;GDNF;SYT1
prerank,intestinal lipid absorption (GO:0098856),0.6261887831262216,1.2924360559457049,0.17959183673469387,0.8163204589641248,1.0,1/11,1.78%,CEL
prerank,establishment of protein localization to extracellular region (GO:0035592),0.5082475458757448,1.2913477188803786,0.1350407450523865,0.8199391880557112,1.0,19/39,30.70%,NECAB3;STEAP3;PREB;MIA3;RCN3;ABCA1;ARFGAP3;RAB3D;MON1A;RAB10;COPG1;SEL1L;RAB12;AFM;RAB3C;RAB8B;PDIA4;COPG2;TMEM167A
prerank,regulation of RNA splicing (GO:0043484),0.47342943910885854,1.290675085764984,0.11254019292604502,0.8215796505613795,1.0,12/69,10.63%,AHNAK2;AHNAK;AFF2;MBNL1;ZPR1;CLK1;SRSF3;RBM22;ERN1;MBNL2;SON;HNRNPH1
prerank,regulation of establishment of cell polarity (GO:2000114),0.5827542606392245,1.2905376495751777,0.17040951122853368,0.8206530468935318,1.0,7/16,19.86%,GSN;RAP1B;KANK1;KIF20B;BCAS3;SHTN1;ARFGEF1
prerank,positive regulation of DNA replication (GO:0045740),0.5829916103040126,1.290392994509199,0.15414012738853503,0.8197489585749409,1.0,5/16,13.52%,EGFR;CTC1;GLI2;EGF;DNA2
prerank,proteoglycan biosynthetic process (GO:0030166),0.5118586962485709,1.2903781493727235,0.14622641509433962,0.8182314671847473,1.0,10/31,12.54%,UGDH;CSGALNACT2;CHST10;EXT1;GAL3ST3;CHST12;FOXL1;B3GAT3;XYLT1;GLCE
prerank,regulation of axonogenesis (GO:0050770),-0.34771463971424177,-1.289448895529747,0.10185185185185185,0.591156829008293,1.0,8/51,5.19%,PLXNA2;ROBO1;EPHA4;PLXNA4;CHN1;PLXND1;SIPA1L1;ROBO2
prerank,icosanoid metabolic process (GO:0006690),0.5041828325582834,1.2891837723474628,0.1449771689497717,0.8222538443673985,1.0,12/40,17.78%,MGLL;CYP2S1;DPEP1;DAGLA;PON3;PTGR1;GPX1;PNPLA8;ABCC1;FADS1;DAGLB;EPHX1
prerank,ESCRT complex disassembly (GO:1904896),0.6414535708548184,1.2889781217065988,0.1710914454277286,0.8200727056893847,1.0,2/10,5.32%,CHMP7;VPS4B
prerank,ESCRT III complex disassembly (GO:1904903),0.6414535708548184,1.2889781217065988,0.1710914454277286,0.8200727056893847,1.0,2/10,5.32%,CHMP7;VPS4B
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.5965963022602747,1.288828375286276,0.17391304347826086,0.8192028009609099,1.0,6/14,22.15%,EHHADH;CRAT;SCP2;ACOX1;HSD17B4;CROT
prerank,mitochondrion distribution (GO:0048311),0.6050332793964359,1.2888043637424966,0.1792452830188679,0.8177532973967232,1.0,4/12,14.51%,CLUH;TRAK2;MAPT;ATCAY
prerank,steroid hormone mediated signaling pathway (GO:0043401),0.6108002447546982,1.288449682039308,0.167574931880109,0.8177695383905299,1.0,3/13,7.05%,AR;ESR1;PLPP1
prerank,regulation of trophoblast cell migration (GO:1901163),0.5982968329990608,1.2881627856609295,0.1592442645074224,0.8174823315890076,1.0,4/14,8.90%,VEGFA;SMURF2;C1QBP;AGO2
prerank,positive regulation of receptor internalization (GO:0002092),0.5531238584907923,1.2876413428803442,0.19283065512978986,0.8183015536000711,1.0,8/22,23.55%,SFRP4;VEGFA;MAGI2;EGF;AHI1;ATAD1;ARRB1;PICK1
prerank,iron ion transport (GO:0006826),0.49112401959783125,1.2875066554062915,0.13296703296703297,0.8173246867454014,1.0,13/47,16.13%,SCARA5;STEAP3;ATP6V0A2;SLC39A14;MELTF;SLC11A2;CLTC;ATP6V1E1;ATP6AP1;REP15;ATP6V0A1;ATP6V1D;ATP6V1B2
prerank,mRNA metabolic process (GO:0016071),0.4680153761203222,1.287335831770359,0.08958333333333333,0.8165736209130712,1.0,32/90,21.68%,SRSF2;DIS3L2;RNASE4;U2AF1;ZFP36L2;PRPF3;AURKAIP1;CPSF6;USP39;NUDT16L1;ERN1;SON;TCERG1;NUDT16;SRSF11;ZFP36;CNOT10;SF3B4;SF3A1;DDX5;SNRPG;SNRPD3;AGO4;YTHDF2;SLBP;U2AF2;AGO3;PTBP1;HIPK3;SF3B2;AKAP8L;KIN
prerank,cellular response to reactive oxygen species (GO:0034614),0.4733664553792841,1.2871382508480975,0.13478260869565217,0.8159436293653053,1.0,17/59,14.21%,UCP1;EGFR;ANXA1;MAPK7;NFE2L2;HDAC6;PKD2;ANKZF1;CHUK;SIRPA;CAMKK2;AKT1;MAPT;PLEKHA1;OSER1;PDGFRA;FER
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.5652531343516662,1.286601169370682,0.15288220551378445,0.8168867530214783,1.0,4/21,4.00%,IGFBP5;MMP2;FGF2;MEF2D
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.5265382112326809,-1.2865462622958281,0.156794425087108,0.5956084446919732,1.0,5/10,12.23%,BMP6;NOTCH1;RGCC;NOTCH4;PPM1F
prerank,keratan sulfate metabolic process (GO:0042339),0.5201280185459486,1.2863185749979311,0.1542111506524318,0.8166008111019513,1.0,6/31,4.27%,ST3GAL2;B4GALT3;B4GALT1;OGN;CHST1;ACAN
prerank,epithelial cell morphogenesis (GO:0003382),0.5818337819692978,1.28615854501201,0.1747448979591837,0.8158568061388877,1.0,4/17,8.29%,TNMD;CCDC88C;DACT2;COL15A1
prerank,selective autophagy (GO:0061912),0.48501555629118337,1.2860378592468908,0.11563876651982379,0.8148571451410042,1.0,20/56,18.78%,DYNC1LI2;HDAC6;UBE2N;ATG2B;ARL13B;DYNC1LI1;DYNC1I1;SQSTM1;UBA52;ULK2;ATG2A;ULK1;UFC1;DYNC1H1;NBR1;UFL1;PEX5;AUP1;UFM1;ATG13
prerank,T cell activation involved in immune response (GO:0002286),-0.49495297631529855,-1.2857213591580476,0.1543859649122807,0.5944937543042754,1.0,6/12,31.71%,MDK;ICAM1;CD74;LCP1;SLC11A1;LILRB1
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.5407938682286554,1.2856950950810477,0.15903307888040713,0.8148675662144669,1.0,6/23,14.77%,CCDC88C;HOOK2;MYO10;DYNC1I1;MAP6;CCDC186
prerank,oogenesis (GO:0048477),-0.45841100697246095,-1.2855816527195443,0.16806722689075632,0.5915892800566506,1.0,1/15,0.09%,PTN
prerank,arachidonic acid secretion (GO:0050482),0.6258439063930298,1.285410701164625,0.17988668555240794,0.8131274894844872,1.0,2/10,11.43%,ANXA1;PNPLA8
prerank,arachidonate transport (GO:1903963),0.6258439063930298,1.285410701164625,0.17988668555240794,0.8131274894844872,1.0,2/10,11.43%,ANXA1;PNPLA8
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.4621807187740077,1.2852478286290492,0.065775950668037,0.8123569546516303,1.0,30/113,17.52%,SYK;ESR1;PSMC4;GTF2H3;VEGFA;CDC42EP2;MPP7;RAP1B;GNL3L;PSMC6;SRC;FSCN1;ABCA1;STUB1;DHX33;TIRAP;TLR4;BMF;USP50;TPPP3;ERCC3;BAK1;ERCC4;DDB1;IL5;TERF1;HSP90AA1;HRK;SPIDR;ERCC5
prerank,positive regulation of T cell migration (GO:2000406),-0.4116897551629516,-1.2842352010578697,0.165,0.5918837929992039,1.0,5/20,4.18%,ADAM10;APP;WNT5A;DOCK8;CXCL12
prerank,regulation of macrophage differentiation (GO:0045649),0.5877448232128468,1.2842102247123939,0.1529255319148936,0.8156570311301398,1.0,3/15,6.75%,LIF;PRKCA;INHA
prerank,basement membrane organization (GO:0071711),0.589229212298066,1.2841822541649741,0.16237113402061856,0.8142575048124165,1.0,3/14,3.04%,HPN;FLRT2;NTN4
prerank,protein mono-ADP-ribosylation (GO:0140289),0.6257814227695988,1.2832640304578742,0.17154811715481172,0.8169645956097839,1.0,4/11,11.05%,PARP3;PARP11;PARP6;PARP14
prerank,myelination in peripheral nervous system (GO:0022011),0.6006598976808991,1.283227240724845,0.1829436038514443,0.8156003512072473,1.0,4/13,9.55%,MYOC;SKI;SIRT2;ARHGEF10
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.6245373450077507,1.2825290214637026,0.17955801104972377,0.8172746972634615,1.0,3/11,4.40%,TGFB2;TGFBR2;ACVR1
prerank,cell differentiation in spinal cord (GO:0021515),-0.5045176287464176,-1.2820708466066066,0.18374558303886926,0.5942299317517468,1.0,2/10,2.51%,SOX6;SOX13
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.5668351405819033,1.2820027293751284,0.16205533596837945,0.818102649287735,1.0,8/17,24.13%,GET4;EMC1;EMC10;EMC8;SGTA;EMC3;EMC2;EMC6
prerank,regulation of urine volume (GO:0035809),0.6271840025697688,1.2819925785868576,0.1793103448275862,0.8166181724994543,1.0,2/10,9.97%,HAS2;INPP5K
prerank,embryonic skeletal system morphogenesis (GO:0048704),0.5185750066642946,1.2818158567391003,0.13706793802145412,0.8159224852567949,1.0,12/31,18.40%,HOXA3;TGFBR2;IRX5;HOXA4;COL2A1;TWIST1;SIX1;PDGFRA;HOXC4;HOXA9;DYNC2I1;TGFBR1
prerank,positive regulation of microtubule polymerization (GO:0031116),0.5389981959733632,1.2813792602901308,0.14965197215777262,0.8164155683748673,1.0,12/28,20.65%,DCTN1;CLIP1;PSRC1;TOGARAM1;MAPRE1;MAPT;SLAIN2;CDK5RAP2;AKAP9;CKAP5;NAV3;NUMA1
prerank,negative regulation of cellular protein catabolic process (GO:1903363),-0.5225903296406056,-1.2811952452717363,0.1986062717770035,0.593134312738734,1.0,6/10,13.64%,EPHA4;DAB2IP;NELL1;ATRAID;RGP1;RIC1
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),-0.47477462844762575,-1.2805388981765113,0.18149466192170818,0.5918422298670732,1.0,1/12,0.65%,IL1R1
prerank,negative regulation of epithelial cell migration (GO:0010633),-0.37742203673442254,-1.2805031439921921,0.06870229007633588,0.5887915796571249,1.0,9/33,4.18%,NR2F2;PTPRG;SP100;ADAMTS9;APOE;THBS1;DAB2IP;DUSP10;PTPRM
prerank,cardiac muscle cell differentiation (GO:0055007),0.5531853090166989,1.2803337885945807,0.16293532338308458,0.8197391938382184,1.0,4/21,4.40%,WT1;AKAP13;VEGFA;ACVR1
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.6080500248848419,1.280133103566729,0.1760752688172043,0.8190950829574859,1.0,2/12,5.24%,DCN;ATP2B4
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.5708430279907243,1.2799738662979265,0.18050065876152832,0.8183287850197445,1.0,4/16,12.39%,PRKCA;SLC39A14;GRP;KLK6
prerank,positive regulation of leukocyte activation (GO:0002696),0.5678232634463013,1.278942803298248,0.16393442622950818,0.8217780558891019,1.0,3/18,9.08%,LBP;IL33;TLR4
prerank,ERAD pathway (GO:0036503),0.4660227466975792,1.278779017259742,0.100418410041841,0.820954698364087,1.0,32/83,25.51%,UBE2J2;GET4;SYVN1;EDEM1;RNF121;RCN3;PSMC6;STUB1;ANKZF1;FBXO2;FBXO17;TOR1A;ECPAS;UBE2G2;HERPUD1;DNAJB2;TMUB2;SGTA;AMFR;SELENOS;AUP1;UGGT1;JKAMP;USP13;DERL1;SEL1L;USP19;UBXN6;RHBDD2;SEC61B;HSP90B1;UFD1
prerank,peripheral nervous system development (GO:0007422),0.5409564137638134,1.2786826435162173,0.16625,0.8199485424144423,1.0,7/23,14.31%,PMP22;SOX10;ALDH3A2;SOX8;GDNF;ASIC2;ARTN
prerank,protein heterotetramerization (GO:0051290),0.5919492567789878,1.2784773491730088,0.17871759890859482,0.8194317933861244,1.0,5/13,15.11%,PKD1;KRT10;PKD2;CPSF6;HSD17B8
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),0.6335061662465229,1.2782514126474471,0.18428571428571427,0.8175468406460042,1.0,3/10,8.76%,AP2A2;CLTC;MYLIP
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),0.6335061662465229,1.2782514126474471,0.18428571428571427,0.8175468406460042,1.0,3/10,8.76%,AP2A2;CLTC;MYLIP
prerank,"wound healing, spreading of cells (GO:0044319)",0.5407781318636102,1.2781972908297048,0.17509247842170161,0.8162994230341086,1.0,7/24,14.53%,COL5A1;TMEFF2;CD44;ITGA5;TOR1A;RHOA;DDR1
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),0.6101834567239824,1.2779818852065097,0.18926553672316385,0.815819313907677,1.0,5/11,17.52%,TIMM10B;TIMM9;AGK;TIMM22;TIMM8B
prerank,regulation of interleukin-8 production (GO:0032677),0.4694012733379379,1.2773528440053439,0.11336898395721925,0.8173363839098033,1.0,14/69,16.44%,SYK;LBP;ANXA1;F2R;TLR5;PRKD2;TIRAP;TLR4;OTUD7B;BCL3;KLF4;CD14;IL6;ANXA4
prerank,proteolysis (GO:0006508),0.44164666703017497,1.2770650045753524,0.02702702702702703,0.817270231740706,1.0,60/252,19.06%,CAPN5;HTRA3;PCSK6;PRSS48;DPP4;BMP1;HPN;FAP;PCSK5;DESI1;DESI2;PSMC4;ANPEP;CAPN2;MMP2;KLKB1;ADAMTS3;ACAN;ADAM19;ADAM33;PCSK4;SPCS1;PRCP;RET;LNPEP;TPP1;FBXO2;CAPN1;CLPX;PSEN1;ECE1;FBXL2;CNDP2;XPNPEP3;ECE2;EEF1AKMT4-ECE2;CAPN11;SPPL2B;NAPSA;THOP1;RSPRY1;NPEPPS;TASP1;FAM111A;CLPP;HGF;OGT;HTRA2;SENP6;IDE;SPG7;LAP3;CTSD;PGPEP1;HTRA4;MMP16;METAP2;CAPN10;NEDD8;PCSK7
prerank,cellular response to hydrogen peroxide (GO:0070301),0.5065682131212514,1.2769587479549107,0.16666666666666666,0.8163130851096827,1.0,9/33,16.30%,ANXA1;MAPK7;NFE2L2;HDAC6;ANKZF1;SIRPA;PLEKHA1;OSER1;IL6
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.6102079103931849,1.2768309333294534,0.17735334242837653,0.8154185680307141,1.0,8/12,22.27%,EPHB2;NFIB;GLI2;MYCBP2;TSKU;EPHB1;PAFAH1B1;SPTBN4
prerank,ribosomal subunit export from nucleus (GO:0000054),0.6036615631785326,1.276750214345009,0.17842876165113183,0.8143204537274527,1.0,5/13,12.35%,SDAD1;ABCE1;NOP9;NPM1;EIF6
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.5633314181210161,1.276048253920511,0.17834394904458598,0.8161545004081375,1.0,5/18,17.44%,FBN1;LRRC17;TLR4;IL4;GPR137B
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.6176756307604683,1.2752414569557486,0.1950207468879668,0.8183473723152798,1.0,4/12,12.63%,SRI;CAMK2D;PDE4D;CALM2
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.5406378849958579,1.2745496585792082,0.1468005018820577,0.8200363325790655,1.0,5/22,11.34%,LBP;RAB7B;NR1D1;TIRAP;WDFY1
prerank,positive regulation of B cell proliferation (GO:0030890),0.5203886768900525,1.2744193124715744,0.163855421686747,0.8191811092811612,1.0,8/29,14.83%,EPHB2;MIF;CLCF1;CD81;TIRAP;TNFSF13B;IRS2;IL4
prerank,positive regulation of stem cell differentiation (GO:2000738),-0.44499333249364065,-1.2740332631970048,0.11374407582938388,0.6028209803014276,1.0,3/16,3.59%,PTN;SOX6;FOXC1
prerank,glycosphingolipid biosynthetic process (GO:0006688),-0.4411239068766091,-1.2726058461874357,0.17757009345794392,0.6033664731928716,1.0,8/16,25.95%,ST8SIA4;ST6GALNAC3;ST6GALNAC5;ST8SIA2;ST8SIA6;ST6GALNAC6;ST3GAL5;A4GALT
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),0.5904838720554668,1.2723233430263654,0.199203187250996,0.8274301371398849,1.0,3/13,12.19%,SEC16B;CD81;TMEM30A
prerank,establishment of spindle localization (GO:0051293),0.5888199098711627,1.2721156540349983,0.205607476635514,0.8269448146026994,1.0,7/14,26.59%,TLE6;LLGL1;DYNC1H1;MAP4;CLASP2;NLRP5;KPNB1
prerank,canonical Wnt signaling pathway (GO:0060070),0.46209551162945167,1.2721142244807824,0.12927350427350429,0.825489777025379,1.0,8/68,5.14%,SFRP4;LRP6;WNT10B;WNT2;WNT9A;PLPP3;AXIN1;TCF7L2
prerank,negative regulation of immune system process (GO:0002683),0.5732362902142372,1.2714655882122978,0.17546174142480211,0.8269952895432109,1.0,1/16,0.16%,COL3A1
prerank,peptidyl-tyrosine modification (GO:0018212),0.4785218590121708,1.2706020294745404,0.13157894736842105,0.8294429749314406,1.0,11/56,8.00%,SYK;DDR2;EPHB2;SRMS;EGFR;FGFR1;EPHA3;FYN;SRC;ABL2;ABI1
prerank,artery development (GO:0060840),-0.40364790967853803,-1.2701412989551355,0.15025906735751296,0.6068436871320565,1.0,9/23,9.63%,ROBO1;ENG;ROBO2;NRP1;TBX1;BMPR2;STRA6;HECTD1;PDE2A
prerank,positive regulation of interleukin-8 production (GO:0032757),0.48177528927581365,1.2695558625651513,0.14237668161434977,0.8326264016984463,1.0,7/49,9.08%,SYK;LBP;F2R;TLR5;PRKD2;TIRAP;TLR4
prerank,response to estrogen (GO:0043627),0.5150742150083969,1.2693073728963056,0.17070217917675545,0.8322538046432917,1.0,4/31,8.44%,AR;ESR1;SFR1;CYP27B1
prerank,regulation of immune effector process (GO:0002697),0.4991983063959768,1.2691853973236409,0.15759637188208617,0.8313568264284332,1.0,9/41,13.59%,CD55;IRF4;CFH;C7;C1QBP;CD81;C4B;SERPING1;CR2
prerank,regulation of protein kinase activity (GO:0045859),0.4504485421492754,1.2691722507691712,0.07975460122699386,0.829958601456111,1.0,25/106,13.17%,DDR2;LRP6;PLCE1;TARBP2;CAMKK1;CAMK2N1;WWTR1;MAP2K3;DTNBP1;RTRAF;MAPRE3;RASSF2;YWHAG;ADCYAP1;GAS6;IQGAP1;GSKIP;INPP5K;CAMKK2;AKT1;XRCC5;SFN;DEPTOR;SMCR8;CDKN1A
prerank,positive regulation of lipid transport (GO:0032370),0.6012118798305415,1.2691599470820507,0.19288645690834474,0.8285567888378588,1.0,2/12,1.66%,LRP1;TRIAP1
prerank,neuron apoptotic process (GO:0051402),-0.4188400433221715,-1.2690390754246288,0.13402061855670103,0.6066707757370934,1.0,8/19,13.10%,APP;BCL2;TRPC5;FAM162A;TNFRSF21;FAS;CDK5;GAPDH
prerank,positive regulation of glucose transmembrane transport (GO:0010828),-0.3860935825254673,-1.2689491789359564,0.14201183431952663,0.6037469114990388,1.0,5/26,3.34%,SORBS1;OCLN;INSR;IGF1;OSBPL8
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.5266133229710507,1.2687716781247662,0.16906474820143885,0.8287726788800369,1.0,4/26,7.27%,CCBE1;EIF2AK3;SULF2;SULF1
prerank,microtubule bundle formation (GO:0001578),0.4977799399148011,1.268283799687891,0.1414027149321267,0.8295199782865997,1.0,14/42,22.56%,NAV1;CLIP1;PSRC1;GAS2L1;TOGARAM1;RSPH1;TPPP3;TTLL3;CHP1;CDK5RAP2;SPAG16;NUMA1;DCX;MAP1S
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.6201928962593046,1.2681728540497765,0.17613636363636365,0.8271110906386002,1.0,1/10,1.06%,SMPD3
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.6201928962593046,1.2681728540497765,0.17613636363636365,0.8271110906386002,1.0,1/10,1.06%,SMPD3
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.6330386953423648,1.2681574337527302,0.20906432748538012,0.8257364441798083,1.0,2/10,2.27%,AREG;BTC
prerank,sensory perception of light stimulus (GO:0050953),0.46640187511356207,1.2679880563259218,0.09573361082206035,0.8250762258351267,1.0,20/87,20.30%,COL1A1;SLC4A10;ROM1;RABGGTA;COL11A1;ABLIM1;MYO9A;CNGB1;COL2A1;CRYBB1;RPGR;CABP1;CRYZ;OPA3;EFEMP1;TYR;RP2;SFRP5;KIFC3;ATF6
prerank,response to peptide (GO:1901652),0.5048759295754499,1.2677174865041105,0.16402714932126697,0.8248202431392925,1.0,5/33,8.10%,ANXA1;IRS1;FYN;MMP2;STAT5A
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.5011514267733241,1.2672326105700253,0.16458569807037457,0.8255147967219225,1.0,4/38,8.88%,NOX4;DLG4;GAS6;SRCIN1
prerank,cellular response to oxygen levels (GO:0071453),0.6312439145492281,1.2671366703351952,0.1875,0.8245162141473171,1.0,5/10,23.55%,ATP6V0A2;ATP6AP1;CCDC115;TMEM199;PICK1
prerank,cellular response to chemokine (GO:1990869),0.4842037631070594,1.266942768952683,0.13463626492942454,0.823999256750131,1.0,8/46,14.08%,ACKR3;CCL8;CXCL10;CCL25;STK39;CCL13;RHOA;ZC3H12A
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.4948435410712578,1.266911379522336,0.15085714285714286,0.8227222713492405,1.0,9/40,5.16%,COL1A1;LOXL2;TGFB3;TGFB2;TGFBR2;SMAD4;WWTR1;TCF7L2;MTOR
prerank,positive regulation of histone acetylation (GO:0035066),0.5392866435366827,1.2667770081314518,0.18679950186799502,0.8219278756325861,1.0,4/23,10.15%,LIF;SMAD4;MUC1;BRD7
prerank,regulation of defense response to virus (GO:0050688),0.5981602715824472,1.2663561653892013,0.17965653896961692,0.8224904838846389,1.0,5/14,16.06%,ITCH;C1QBP;RNF216;ILRUN;TRAF3
prerank,negative regulation of ATP metabolic process (GO:1903579),0.5692471913162284,1.2656861175208356,0.1821656050955414,0.8241152126330419,1.0,7/17,15.12%,MLXIPL;PID1;FLCN;TIGAR;NCOR1;HDAC4;NUPR1
prerank,recombinational repair (GO:0000725),0.466111747376251,1.2655298617610666,0.11204188481675392,0.8233869313908594,1.0,25/77,18.43%,REV3L;XRCC3;SFR1;RAD51B;RFWD3;UBE2N;RHNO1;HELQ;AP5S1;SAMHD1;SMC5;RMI1;ERCC4;FAN1;SEM1;SMC6;NBN;INO80;RECQL;SPIDR;RNF138;RAD50;ERCC5;BLM;MORF4L1
prerank,detection of mechanical stimulus (GO:0050982),0.557912266556561,1.2652795485275237,0.20175438596491227,0.8231459856374118,1.0,4/19,12.09%,PIEZO2;PKD1;PKD2;JUP
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.530270675270901,1.2648797917582864,0.18081180811808117,0.823633557142925,1.0,6/23,16.30%,GHR;F2R;IL10RA;PIBF1;IL4;IL6
prerank,acylglycerol biosynthetic process (GO:0046463),0.5423518284159711,1.2647745755955146,0.1855921855921856,0.8226501085503262,1.0,8/23,20.28%,PLCE1;GPAT4;ANG;MOGAT1;MOGAT2;GPAT3;GPAM;LPIN3
prerank,regulation of protein-containing complex assembly (GO:0043254),0.44608341972520227,1.2646728311465494,0.10802469135802469,0.821696240946083,1.0,26/110,18.04%,SYK;GSN;VEGFA;CDC42EP2;MPP7;AIDA;GNL3L;PREB;FARP2;SRC;ABCA1;HDAC6;STX1B;TFIP11;HJURP;TIRAP;BMF;NAPA;BAK1;ULK1;HSP90AA1;NOP53;HRK;SPIDR;PEX5;IAPP
prerank,monocarboxylic acid transport (GO:0015718),-0.3245540998083736,-1.263858573045868,0.07777777777777778,0.6134304774127736,1.0,9/51,2.26%,SLC6A13;SLC16A12;ABCC4;SLC16A2;ABCG2;SLCO2B1;SLCO1C1;SLC16A6;SLC6A12
prerank,dicarboxylic acid catabolic process (GO:0043649),-0.4763591844530556,-1.263576475178974,0.183206106870229,0.6111595770699901,1.0,3/13,4.21%,DDO;GLUL;MTHFS
prerank,regulation of regulated secretory pathway (GO:1903305),0.5069383749829937,1.2635674573985727,0.16666666666666666,0.8254025291963086,1.0,10/34,18.84%,SYT2;SYT12;SYT11;SYT13;DTNBP1;RAB3D;SNAPIN;SYT1;PREPL;RIMS2
prerank,ERBB signaling pathway (GO:0038127),0.4702956056589253,1.2634186625052608,0.13062568605927552,0.8246761753361214,1.0,16/64,16.68%,AREG;PRKCA;EGFR;PLCE1;BTC;SRC;STUB1;PIK3CA;IQGAP1;AKT1;EGF;AAMP;CBL;HSP90AA1;SOS1;EFEMP1
prerank,negative regulation of T cell differentiation (GO:0045581),0.6192112307120828,1.2634062897671434,0.18387553041018387,0.8233743551490491,1.0,2/10,11.60%,ZC3H8;GLI3
prerank,peptidyl-proline modification (GO:0018208),0.53475791752323,1.2632567646313977,0.17804878048780487,0.8226636301659501,1.0,14/25,25.77%,FKBP10;PPIL6;NTMT1;NKTR;PPIC;PIN1;PPIA;FKBP4;FKBP7;OGFOD1;FKBP1A;PPIG;CWC27;PPIH
prerank,positive regulation of heart contraction (GO:0045823),-0.4206525462253298,-1.2632241476473967,0.145,0.6090578950214951,1.0,6/19,15.59%,ATP1A2;KCNQ1;RYR2;EDN1;ADM;EDN3
prerank,eosinophil chemotaxis (GO:0048245),0.5869235202308722,1.2626987524939686,0.19363395225464192,0.8223733498726933,1.0,2/14,12.91%,CCL8;CCL13
prerank,eosinophil migration (GO:0072677),0.5869235202308722,1.2626987524939686,0.19363395225464192,0.8223733498726933,1.0,2/14,12.91%,CCL8;CCL13
prerank,pyrimidine-containing compound metabolic process (GO:0072527),-0.5052168372374218,-1.2614491917227673,0.19844357976653695,0.6107322179291776,1.0,3/11,12.88%,ENPP3;CTPS2;SLC19A3
prerank,sulfur compound transport (GO:0072348),-0.39810415239200286,-1.2597183251797277,0.125,0.6121872296004544,1.0,9/27,12.51%,SLC6A13;SLC13A4;ABCG2;SLC26A7;SLC25A26;SLC35F3;SLC25A11;MGST1;SLC6A6
prerank,neurotransmitter uptake (GO:0001504),-0.4881449144690887,-1.2595825512662093,0.20503597122302158,0.6093870926235191,1.0,3/12,1.65%,ATP1A2;SLC1A3;GLUL
prerank,alpha-amino acid catabolic process (GO:1901606),-0.3660859742133449,-1.2593085717157009,0.1390728476821192,0.6069699068302908,1.0,14/29,33.11%,DDO;PRODH;ALDH4A1;SARDH;BLMH;CBS;THNSL2;KYNU;HSD17B10;HOGA1;FAH;HGD;IL4I1;HAAO
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.5429473627828296,1.2587942885487415,0.196405648267009,0.8389411454427624,1.0,5/19,14.88%,LBP;TIRAP;TLR4;IRAK1;CD14
prerank,regulation of actomyosin structure organization (GO:0110020),0.5942414981629542,1.2587074839153136,0.20885200553250347,0.8379372046113219,1.0,5/13,15.99%,AKAP13;ASAP3;ALMS1;SLC9A1;ACTG1
prerank,long-chain fatty acid import into cell (GO:0044539),-0.5096721556980972,-1.258705215071984,0.18874172185430463,0.6056363243203909,1.0,3/10,5.97%,ACSL1;SLC2A1;ACSL3
prerank,response to chemokine (GO:1990868),-0.46933998427252305,-1.2585419712765828,0.20078740157480315,0.6029612185850847,1.0,5/13,5.61%,SLC12A2;FOXC1;DOCK8;CXCL12;LRCH1
prerank,body fluid secretion (GO:0007589),0.5640337016746964,1.2577053547898862,0.1871584699453552,0.8410902300428107,1.0,2/15,2.76%,GPAT4;VEGFA
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.5347500028347116,1.2570643302701519,0.187422934648582,0.842556330873938,1.0,10/24,17.66%,SEC24D;SEC31A;SEC24A;SEC23A;PDIA3;MFSD6;IDE;SEC24B;ABCB9;BCAP31
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.4611664355867649,1.2569501325735533,0.1555793991416309,0.8416577022321341,1.0,13/63,17.74%,EPHB2;CD80;ANXA1;MIF;CLCF1;CD81;TIRAP;TNFSF13B;IRS2;IL4;IL6;NCK1;IL18
prerank,establishment of protein localization to membrane (GO:0090150),0.4666546937865601,1.2565714208885976,0.15263157894736842,0.8419311818590641,1.0,35/66,33.06%,EGFR;RFTN1;NECTIN3;ZDHHC7;VPS37D;TAOK2;ZDHHC2;VPS37C;SEC63;FRMPD1;ZDHHC4;ZDHHC24;VPS37B;ZDHHC21;ZDHHC20;NACA;RAB10;COX18;ZDHHC18;ICMT;ATG3;SDCBP;SYNE3;MICALL1;GORASP1;PRKCI;ZDHHC15;PARD3;MYO1C;GOLGA7B;PIKFYVE;ARL6;CHM;RAB3GAP1;ZDHHC3
prerank,regulation of lipid biosynthetic process (GO:0046890),-0.3579021370729337,-1.256373757917408,0.12857142857142856,0.6059415789210578,1.0,5/32,4.40%,PRKAG2;SORBS1;APOE;PRKAA2;PPARA
prerank,cellular response to estrogen stimulus (GO:0071391),0.5874567947509031,1.2553205863121635,0.1994572591587517,0.8462062454797468,1.0,2/14,3.41%,AR;SFR1
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.5566055353928298,1.25471806210635,0.20539152759948653,0.8475772606587086,1.0,4/17,11.42%,SLC4A8;STX1A;SCAMP5;RAB3D
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.5459171315459588,1.2546635018043972,0.20178799489144317,0.8464410498920475,1.0,2/21,4.35%,LRP6;AXIN1
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.44608220413001154,1.2546489774987797,0.09528688524590163,0.8451248638419485,1.0,38/122,17.46%,AR;NIBAN1;EGFR;IRS1;CTC1;FGF2;TGFB2;SMOC2;TMEM106A;MTOR;IL33;GLI2;PRKD2;LARP4;EPM2AIP1;TLR4;HNRNPD;DYRK2;NPM1;AKT1;PASK;IRS2;EIF6;EGF;RPS27L;BCL3;ZCCHC4;DNA2;POLDIP3;RBM3;KLF4;EIF3E;IL4;IL6;HGF;EIF3D;FXR2;YTHDF1
prerank,cardiocyte differentiation (GO:0035051),0.6157174262609759,1.2546461220001839,0.20055325034578148,0.8437492102010073,1.0,3/10,10.66%,AKAP13;TGFB2;EEF1AKMT4-ECE2
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.47259532807503557,1.2544789059524775,0.1501632208922742,0.8430802829387518,1.0,15/54,12.09%,FGF18;PRKCA;FGFR1;ANGPT4;VEGFA;FGF2;MAPK14;MAP2K3;ATP2B4;PRCP;PRKD2;STAT5A;AKT3;AKT1;JUP
prerank,sulfur compound catabolic process (GO:0044273),0.4965932897203592,1.2542675531982816,0.1619156214367161,0.8426790286939334,1.0,6/38,7.88%,DCN;OGN;ACAN;VCAN;NUDT7;DPEP1
prerank,regulation of macrophage cytokine production (GO:0010935),0.5847707277044505,1.2541265498524277,0.1928374655647383,0.8420061070824391,1.0,3/13,2.91%,TGFB3;IRAK3;TGFB2
prerank,cell-matrix adhesion (GO:0007160),0.4538113872252819,1.2538459478075341,0.11838006230529595,0.8418725315475191,1.0,24/95,14.67%,CD34;COL3A1;THBS3;COL17A1;ITGA11;CD44;ITGBL1;ITGB3;ADAM9;TNN;PPFIA2;PKD1;ITGA2;ITGB5;TIMM10B;SRC;TESK2;ITGAV;L1CAM;TAOK2;ADAM15;SGCE;DDR1;PPFIA1
prerank,regulation of fibrinolysis (GO:0051917),0.5855014377683919,1.2536662637606624,0.19444444444444445,0.8413012001068801,1.0,2/13,3.63%,FAP;KLKB1
prerank,mRNA transport (GO:0051028),0.4500009909408527,1.2535652540978706,0.10670731707317073,0.8404095436816923,1.0,44/101,28.07%,SRSF2;SRSF6;NXF1;DDX19B;ZFP36L1;NUP93;MCM3AP;NUP107;U2AF1;SRSF3;NUP98;CPSF4;SRSF11;THOC7;ZFP36;POLDIP3;SMG7;THOC2;THOC1;ZC3H11A;SMG6;FYTTD1;NUP37;CPSF2;DDX39A;SRRM1;NUP50;SLBP;U2AF2;TPR;CPSF1;AGFG1;WDR33;NUP133;NUP85;ALYREF;UPF3B;NUP188;UPF1;NUP88;SMG5;CDC40;THOC5;CPSF3
prerank,positive regulation of chemotaxis (GO:0050921),-0.3322366297687772,-1.2524903435245325,0.10526315789473684,0.6131527913343607,1.0,14/43,12.23%,PTN;F3;THBS1;PRKD1;SEMA5A;KDR;IL6R;NRP1;NTRK3;PDGFRB;CDH13;MDK;TGFB1;PPM1F
prerank,ribosomal small subunit biogenesis (GO:0042274),0.49121415107580535,1.2518945092403058,0.15885714285714286,0.846573701951261,1.0,14/39,20.91%,RPSA;MRPS11;RIOK1;RRP36;NPM1;RPS27L;RPS5;SNU13;RRP7A;DDX52;PWP2;SRFBP1;RIOK2;RPS25
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.6048831059885893,1.2513188771077663,0.19854014598540146,0.8476835058868206,1.0,6/10,24.13%,EMC1;EMC10;EMC8;EMC3;EMC2;EMC6
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.5259674802303069,1.251174040656564,0.1885245901639344,0.8469775838195885,1.0,11/26,20.65%,DCTN1;CLIP1;PSRC1;TOGARAM1;MAPRE1;MAPT;SLAIN2;CDK5RAP2;AKAP9;NAV3;NUMA1
prerank,negative regulation of sprouting angiogenesis (GO:1903671),-0.48890620742912516,-1.2511709354619813,0.21875,0.6134627515975152,1.0,5/11,6.26%,ADAMTS9;EPN2;THBS1;PIK3CB;SEMA6A
prerank,ribonucleoprotein complex assembly (GO:0022618),0.44302175669304167,1.2509800453653814,0.0911854103343465,0.8464842084832588,1.0,53/132,27.22%,RPSA;GEMIN6;TARBP2;MRPS11;SRSF6;ABT1;LSM4;WDR77;CPSF6;USP39;KHDC4;CELF2;EIF6;EIF3A;XRCC5;TGS1;POLR2D;RPS27L;RPS5;RRP7A;HSP90AA1;DDX20;RPL6;NOP53;SNRPG;SNRPD3;PWP2;LUC7L3;RPF2;EIF2S2;PUF60;GCFC2;STRAP;LUC7L2;SF3B1;SRPK1;NOP2;RSL24D1;RBM5;SMN1;COIL;BRIX1;EIF4H;CPSF7;CELF3;RAMAC;ERAL1;PRPF19;CRNKL1;PRPF6;DHX29;DDX1;PRKDC
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.5002759451663686,1.2508350448132182,0.18909512761020883,0.8458169696285807,1.0,15/33,22.79%,IRS1;PIK3C2B;PIK3R2;CD160;ZFP36L1;C1QBP;PIK3CA;SIRT2;AKT1;PLEKHA1;TYRO3;PTEN;PIK3CG;NF1;HTR2A
prerank,regulation of protein import into nucleus (GO:0042306),0.487127080909195,1.2507744491860653,0.19907940161104717,0.8447139465906507,1.0,17/36,22.69%,ZPR1;PIK3R2;RAB23;MDFIC;PSEN1;RBM22;HDAC3;JUP;CABP1;ZC3H12A;DMAP1;CHP1;IPO5;UFM1;FLNA;BAG3;TPR
prerank,negative regulation of interferon-gamma production (GO:0032689),0.5296975016072618,1.2504992579635494,0.2143727161997564,0.8446513388889375,1.0,6/23,14.08%,AXL;C1QBP;INHA;GAS6;TLR4;ZC3H12A
prerank,organelle fission (GO:0048285),0.5287485438752771,1.2502796796989013,0.18610421836228289,0.8442942758210807,1.0,3/24,5.15%,SEC16B;DNM1;GDAP1
prerank,positive regulation of response to external stimulus (GO:0032103),-0.280738053931296,-1.2493582729674726,0.058823529411764705,0.6153260124015305,1.0,38/128,17.79%,PTN;BMP6;ETS1;SASH1;APP;THBS1;SNCA;WNT5A;GPR4;PLSCR1;POLR3C;OPTN;NAPEPLD;AGTR1;POLR3B;DDX60;PUM2;PDGFRB;TLR3;FEM1A;CX3CL1;PDE2A;GBP5;MDK;RIPK1;TGFB1;PPM1F;USF1;NFKBIA;LY86;NMI;SERPINE1;USP15;LY96;LPL;DHX58;CYBA;RARRES2
prerank,chromatin assembly (GO:0031497),0.4905515568585071,1.249305896182417,0.1775486827033219,0.8473954067817263,1.0,21/38,29.87%,CHAF1B;NOC2L;SPTY2D1;POLE3;NPM1;ANP32B;EZH1;BAHD1;GRWD1;NAP1L2;CTCF;PRDM9;PAF1;BRD2;KAT6B;NAP1L3;H1-0;LIN54;ATRX;TP53;SOX9
prerank,regulation of keratinocyte migration (GO:0051547),0.598312097564894,1.2485621534589912,0.20619946091644206,0.8494329637468555,1.0,8/12,28.75%,FGF7;ADAM9;MTOR;ARF6;PTEN;IQSEC1;FGF10;MAPRE2
prerank,organic acid transport (GO:0015849),-0.2922222659967196,-1.2484510484721538,0.05263157894736842,0.6148591462938362,1.0,12/94,2.99%,SLC7A11;SLC7A2;SLC6A13;ABCC4;SLC13A3;ACSL1;ABCG2;SLCO2B1;SLC26A7;SLCO1C1;SLC6A12;PDPN
prerank,glycosaminoglycan metabolic process (GO:0030203),0.46795905084531736,1.2483804127454723,0.14455231930960086,0.8488496443515049,1.0,15/54,17.64%,HAS1;GPC6;UGDH;GPC3;EXT1;B3GAT3;XYLT1;HS2ST1;HS3ST6;HS3ST5;HSPG2;NAGLU;IDUA;SDC2;NDST2
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.5474017383755472,1.2482344576626052,0.17945544554455445,0.8481597538235013,1.0,6/18,18.84%,SLC4A8;RAP1B;DTNBP1;SNAPIN;PREPL;RIMS2
prerank,regulation of fatty acid metabolic process (GO:0019217),-0.42033112936559036,-1.2480400653343304,0.1891891891891892,0.6129214815951292,1.0,4/17,6.08%,PRKAG2;PRKAA2;PPARA;CAV1
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.5252664074342334,1.2477706378318976,0.18280871670702178,0.8488748279092362,1.0,12/28,22.56%,MAP1B;MAPRE3;GAS2L1;MAPRE1;CAMSAP1;MAPT;GBA2;FKBP4;STMN4;CLASP2;MAP1A;MAP1S
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.5415552839579778,1.2473902842393432,0.217005076142132,0.8491892378986904,1.0,7/18,17.29%,CDK4;RAD51B;VPS4B;DTL;FBXO5;CCND1;RCC2
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.42923518218315565,1.247170279530123,0.011,0.8488690177183237,1.0,91/390,16.35%,ANGPTL1;GHR;SYK;DDR2;EPHB2;FGF18;COL1A1;AXL;ARHGEF28;NCF4;FGF7;SRMS;EGFR;TNK1;POLR2H;IRS1;HPN;FGFR1;EFNA5;DNM1;FLRT2;EIF2AK3;HNRNPA1;GRB10;EPHA3;SULF2;FYN;ITGB3;VEGFA;MMP2;FGF2;MST1R;PIK3R2;MAPK14;ATP6V0A2;SLC39A14;ANKS1B;NFATC4;TRIM71;PTPRJ;SOCS2;FOXO1;AP2A2;RET;SRC;ACTR3;SULF1;POLR1G;PRKD2;ABI1;PIK3CA;PSEN1;FOXC2;SIRT2;MAPK11;ITGAV;RHOQ;EFS;EPHB3;MUSK;HNRNPH1;AKT1;ATP6V1E1;RBFOX2;EPHA10;IRS2;FLRT3;NGEF;SHOC2;ATP6AP1;POLR2D;POLR2G;FLT3;RHOA;AAMP;CBL;PDGFRA;FER;DDR1;HSP90AA1;RAPGEF1;GTF2F1;ATP6V0A1;ATP6V1D;AHI1;ACTG1;ATP6V1B2;ARPC1A;SOS1;HGF;NCK1
prerank,negative regulation of biomineral tissue development (GO:0070168),0.5379038442730588,1.246958957300854,0.20198265179677818,0.8484713132355952,1.0,3/21,7.58%,ASPN;ECM1;GAS6
prerank,negative regulation of viral entry into host cell (GO:0046597),0.5886553448867281,1.2466696394945171,0.22371967654986524,0.8484544572944547,1.0,3/12,10.83%,GSN;MID2;TRIM11
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.46612936221630913,1.246664502584249,0.16830601092896175,0.8471380502158496,1.0,16/57,15.55%,CDC14B;FANCD2;EME1;TIPIN;TAOK3;RFWD3;RINT1;DTL;FBXO31;TAOK2;RPS27L;CDKN1A;ABRAXAS1;CCND1;NBN;NOP53
prerank,response to cholesterol (GO:0070723),0.5516128580914988,1.2463350963618416,0.19745222929936307,0.847248972699564,1.0,3/17,3.19%,LRP6;GRAMD1A;TGFBR2
prerank,protein localization to cell junction (GO:1902414),-0.3941994876342759,-1.245897607330601,0.16923076923076924,0.6159055862371744,1.0,4/22,4.53%,TJP1;CGNL1;TJP2;PCLO
prerank,regulation of biosynthetic process (GO:0009889),0.6081713522403949,1.2457503674264376,0.19696969696969696,0.8484623303310631,1.0,1/11,0.56%,UCP1
prerank,regulation of long-term synaptic potentiation (GO:1900271),-0.3818345738809774,-1.2457362302341455,0.1590909090909091,0.6134361546312016,1.0,6/28,3.46%,PTN;EPHA4;ADCY1;APP;APOE;SHANK3
prerank,protein glycosylation (GO:0006486),0.44530647624066866,1.2455894893116022,0.0821501014198783,0.8478210055445637,1.0,26/125,16.48%,GFPT2;PLOD2;ST3GAL2;B4GALT1;B3GALNT1;GFPT1;FUT2;MGAT1;POMGNT2;GALNT10;GALNT18;OGA;PLOD3;ALG1;LARGE1;FUT9;B3GNT8;GALNT1;ST3GAL4;MGAT5;MGAT2;MGAT4B;TUSC3;B3GALNT2;OGT;TMEM165
prerank,intracellular cholesterol transport (GO:0032367),0.576957922197597,1.2446527015093212,0.22121604139715395,0.850674812159048,1.0,3/15,7.01%,LRP6;OSBPL2;ABCA1
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.5153355887964127,1.2444576895312687,0.20221948212083848,0.8501888264402495,1.0,4/24,5.35%,MYOC;VEGFA;S100A10;PTPRJ
prerank,positive regulation of osteoblast differentiation (GO:0045669),-0.3330796194845259,-1.2443703907936332,0.09433962264150944,0.6140615501508118,1.0,16/43,10.58%,BMP6;WNT4;IGF1;BMP7;MEF2C;PRKD1;ZHX3;IL6R;NELL1;ATRAID;BMPR2;YAP1;NPNT;RUNX2;LRP3;BMP2
prerank,cellular response to cytokine stimulus (GO:0071345),0.42526446074489116,1.2439059995243158,0.012,0.8513899688926474,1.0,92/416,17.98%,IL4R;GHR;SYK;LBP;LIF;COL1A2;HAS2;CD80;DUOX1;AXL;CCL8;IRF4;ANXA1;NUMBL;IL16;CTF1;GRB10;FYN;VEGFA;IRAK3;MMP2;FGF2;STX1A;NFE2L2;ZFP36L1;CLCF1;PTPRJ;SOCS2;USP10;FOXO1;NR1D1;CSK;CXCL10;MUC1;FSCN1;RC3H1;PID1;ABL2;GAS6;IL10RA;FLT3LG;ZFP36L2;STAT5A;CHUK;PIK3CA;CDK9;CCL25;TLR4;STX4;UBE2G2;MAPK11;INPP5K;CD47;SIRPA;IRAK4;BCL6;AKT1;SLC26A6;CSF2RA;IRAK1;STK39;UBA52;CDC34;ZFP36;CCL13;FLT3;CDKN1A;CCND1;IL5;RHOA;TWIST1;TNFRSF1B;CBL;ZC3H12A;FER;CNTFR;HSP90AA1;IL4;RAPGEF1;BAG4;SOCS6;IL6;SOS1;HGF;STAT5B;HTRA2;ZEB1;CXCR4;PTPN5;IL18;EPRS1;STX3
prerank,regulation of protein kinase B signaling (GO:0051896),0.43557072083753046,1.2428675437778525,0.059356136820925554,0.8548454715013106,1.0,35/193,13.15%,AREG;MYOC;CD80;ESR1;FGF18;AXL;FGF7;EGFR;IRS1;FGFR1;BTC;FYN;FGF2;MST1R;PIK3R2;OTUD3;TCF7L2;PTPRJ;RCN3;C1QBP;RET;SRC;BANK1;GAS6;FLCN;FLT3LG;PIK3CA;PHLPP2;INPP5K;AKT1;MAGI2;IRS2;EGF;FLT3;PLEKHA1
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),-0.4058987112059783,-1.2423285341639982,0.20297029702970298,0.6165713749104706,1.0,5/20,8.53%,GRK3;MGRN1;SNCA;CRY1;APLP1
prerank,regulation of neuroinflammatory response (GO:0150077),0.541152049068664,1.2423084734958818,0.2,0.8560446754695428,1.0,9/19,17.74%,IL33;NR1D1;DAGLA;CD200R1;TNFRSF1B;IL4;NUPR1;IL6;IL18
prerank,regulation of cell communication by electrical coupling (GO:0010649),0.589895390252023,1.2419857091347954,0.2005420054200542,0.8561115751418589,1.0,4/13,12.63%,SRI;CAMK2D;PDE4D;CALM2
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),0.5637499949116576,1.2416934680308007,0.21391076115485563,0.8560453457371101,1.0,8/15,21.77%,TGFBR2;IRX5;TWIST1;SIX1;PDGFRA;TGFBR1;NIPBL;LHX1
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.5906730829735067,1.2416857802206862,0.19808743169398907,0.8547607669990779,1.0,4/12,14.08%,ESR1;NCOR2;NCOR1;ZC3H12A
prerank,protein import into nucleus (GO:0006606),0.45729304594075304,1.2411523424117619,0.13978494623655913,0.8559300674554775,1.0,28/66,27.02%,SYK;SPRN;NUP93;KPNA2;NUP107;AKT1;IPO9;TNPO2;E2F3;IPO5;NUP50;NXT2;KPNA1;RPL23;RANBP6;TPR;IPO11;CBLB;IPO13;TSC2;NUP133;NUP85;TNPO1;KPNA6;FAM53C;NUP188;KPNB1;NUP88
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.5266046457787081,1.2410192255507522,0.23649459783913565,0.8552059222191208,1.0,9/23,21.11%,MTMR11;OCRL;INPP5F;INPP5K;MTMR6;MTMR1;PIP4P1;INPP5B;PTEN
prerank,regulation of cell differentiation (GO:0045595),0.43505429930657685,1.240386774551676,0.09053916581892167,0.8566321064940376,1.0,36/148,16.98%,LIF;AR;PHLDB1;TRPS1;SCIN;FGFR1;EPHA3;RUNX1;BIN1;ZFP36L1;HOPX;HEMGN;TAF8;NR1D2;NR1D1;ZFHX3;TRIP4;YWHAG;CDK9;PDCD2;PLEKHB2;BCL6;CEBPB;ANP32B;KLK6;ST7;GDNF;DDX17;SIX1;FADS1;KLF4;KLHL41;CDK5RAP2;DDX5;SNAI2;FLOT2
prerank,regulation of smooth muscle cell migration (GO:0014910),0.5432715764483528,1.239849899437103,0.21019900497512436,0.8576881775706914,1.0,4/20,8.17%,IGFBP5;LRP1;SLIT2;NDRG4
prerank,glycolipid metabolic process (GO:0006664),0.4734125967429667,1.2398014932315091,0.17997750281214847,0.8565995314930808,1.0,11/47,13.75%,SMPD3;ST3GAL2;ARSA;B3GALNT1;FUT2;GBA2;ST3GAL4;GLA;CERK;GLTP;PIGW
prerank,protein targeting (GO:0006605),0.4407470013130439,1.2397322189686764,0.10010111223458039,0.8556233147067434,1.0,60/118,33.06%,AP4B1;PEX16;GDAP1;EDEM1;ZDHHC7;SPCS1;VPS37D;TIMM10B;TRAK2;TIMM9;HPS4;AP4E1;TAOK2;ZDHHC2;VPS37C;PEX12;PEX1;SEC63;GIPC1;TIMM22;SEC61A1;ZDHHC4;AP4M1;ZDHHC24;VPS37B;ZDHHC21;TIMM8B;ZDHHC20;NACA;BCAP31;TOMM5;AP1S3;ZDHHC18;ICMT;TIMM17A;ATG3;SDCBP;FUT10;SRPRB;FIS1;TOMM40;KIF13B;MICALL1;PITRM1;NLGN1;PRKCI;SPCS3;ZDHHC15;PARD3;MYO1C;GOLGA7B;PIKFYVE;MFN2;CDC37;TOMM34;ARL6;CHM;AP4S1;PEX19;ZDHHC3
prerank,camera-type eye development (GO:0043010),0.5180488115780193,1.2396445225204475,0.20634920634920634,0.8547202196399264,1.0,7/25,12.56%,FBN1;WT1;VEGFA;SKI;TENM3;TSKU;ALDH1A3
prerank,regulation of filopodium assembly (GO:0051489),0.47909644349959113,1.2392417227097825,0.18820861678004536,0.8551873336443964,1.0,16/38,24.32%,ARHGAP44;TGFB3;GAP43;MYO10;FSCN1;PALM;RHOQ;BCAS3;ARF6;FXR2;ARAP1;GPM6A;RALA;ABITRAM;DOCK11;DMTN
prerank,synaptic vesicle exocytosis (GO:0016079),0.4872527537790443,1.2382553999005612,0.1707865168539326,0.8583375832092304,1.0,15/40,18.84%,SYT2;STX2;STX1A;STX11;STX1B;STX4;SNAP23;SNAP25;SNAP47;SNAPIN;SNPH;SYT1;STX3;VAMP2;RIMS2
prerank,relaxation of cardiac muscle (GO:0055119),0.5694405398997211,1.2381442729124226,0.204,0.8575072463877117,1.0,6/13,11.18%,GSN;ATP1A1;KCNJ2;CAMK2D;PIK3CA;GSTM2
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.5286970188213139,1.2377490273176248,0.20330368487928843,0.8580243005530448,1.0,6/22,9.54%,ABT1;URB1;KRI1;ERI3;NOP9;EXOSC7
prerank,positive regulation of double-strand break repair (GO:2000781),-0.33692479836576184,-1.2376833955313515,0.09774436090225563,0.6258039912064115,1.0,18/39,19.43%,WDR48;SPIRE1;KMT5B;SHLD1;DTX3L;SLF2;KMT5C;ARID2;MGMT;MRNIP;PNKP;RIF1;SMCHD1;SETMAR;PARP9;FANCB;TIMELESS;MAD2L2
prerank,negative regulation of coagulation (GO:0050819),0.5689798079793332,1.237566578859786,0.2136181575433912,0.8575508129584104,1.0,2/14,4.72%,CD34;PROCR
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.5771333726721399,1.2370116620639213,0.20572916666666666,0.8587018617867311,1.0,7/15,26.92%,TSEN54;RTRAF;ERN1;CPSF4;TRPT1;CPSF1;DDX1
prerank,L-amino acid transport (GO:0015807),-0.37287107994064106,-1.236967896025929,0.17105263157894737,0.6248111911695934,1.0,6/28,9.21%,SLC7A2;SLC1A3;SLC7A5;SLC3A2;CTNS;SLC38A5
prerank,antibacterial humoral response (GO:0019731),0.5661822690373244,1.2368999079520802,0.2073669849931787,0.8578848816909483,1.0,4/16,12.32%,ANG;DMBT1;SLPI;RNASE6
prerank,response to purine-containing compound (GO:0014074),0.5427204962407385,1.2368356086799106,0.22786458333333334,0.856855219717398,1.0,2/17,2.74%,DUOX1;DGKQ
prerank,relaxation of muscle (GO:0090075),0.564623545643337,1.2367174257373663,0.20448548812664907,0.8560714797115144,1.0,6/13,11.18%,GSN;ATP1A1;KCNJ2;CAMK2D;PIK3CA;GSTM2
prerank,regulation of cell morphogenesis (GO:0022604),0.4972661207387271,1.23647354731584,0.20734597156398105,0.8558836988269448,1.0,7/30,11.11%,EFNA5;SPARC;CD44;ZRANB1;MYO9A;LARP4;CAMSAP1
prerank,cellular response to lipid (GO:0071396),0.4297179003710277,1.2363730742769405,0.08617234468937876,0.8550055079634529,1.0,40/191,16.64%,LBP;AR;CD80;UCP1;ESR1;AXL;WNT10B;WNT2;EGFR;IRS1;EPHA3;WNT9A;ADAM9;ATP1A3;ATP1A1;MAPK14;NR1D1;CXCL10;NCOA3;CARD16;RET;PID1;ABL2;FZD7;TLR4;SIRPA;URI1;IRAK1;ADCY8;ZFP36;ADAM15;RHOA;TNFRSF1B;ZC3H12A;CD14;FZD4;SELENOS;PDCD4;IL6;HTRA2
prerank,regulation of centrosome cycle (GO:0046605),0.5289601628245447,1.236350861196603,0.2144638403990025,0.85381649687564,1.0,4/21,10.70%,XRCC3;ATF5;VPS4B;NPM1
prerank,phospholipid dephosphorylation (GO:0046839),0.4921051514860229,1.2353050370664758,0.19930875576036866,0.8570832860987732,1.0,16/37,24.98%,MTMR11;PLPP3;PLPP5;PLPP1;OCRL;INPP5F;INPP5K;PLPPR3;MTMR6;MTMR1;PIP4P1;PLPP2;INPP5B;PTEN;SGPP1;MTM1
prerank,cytokine-mediated signaling pathway (GO:0019221),0.42113475128542943,1.2352675606671628,0.014,0.8559516834366971,1.0,104/532,17.98%,MID1;IL4R;TNFSF9;GHR;ACKR3;SYK;LBP;LIF;COL1A2;CD80;DUOX1;CCL8;IL1RL1;IRF4;ANXA1;IRS1;NUMBL;IL16;CTF1;PSMC4;CD44;GRB10;FYN;ANXA2;VEGFA;IRAK3;MMP2;FGF2;STX1A;MIF;SMAD4;RAP1B;CLCF1;PTPRJ;SOCS2;CAMK2D;FOXO1;IL33;CSK;CXCL10;MUC1;TNFRSF11B;PSMC6;SRC;FSCN1;PELI3;IL17RA;ABL2;IL10RA;UBE2N;FLT3LG;STAT5A;TNFRSF18;CHUK;PIK3CA;PSMD8;TNFSF13B;CCL25;STX4;SAMHD1;ARF1;SQSTM1;IRAK4;BCL6;AKT1;CSF2RA;IRAK1;UBA52;PLVAP;IRS2;CD27;CCL13;FLT3;CDKN1A;TRAF3IP2;CCND1;IL5;TWIST1;TNFRSF1B;CBL;FER;CNTFR;HSP90AA1;IL4;RAPGEF1;SMARCA4;EDA;BAG4;TRIM68;TRAF3;SOCS6;PDCD4;IL6;SOS1;HGF;STAT5B;ZEB1;PML;MAP3K14;PPIA;CXCR2;IL18;ILK;STX3
prerank,tRNA 5'-leader removal (GO:0001682),0.5659332538359239,1.23475939282327,0.23351648351648352,0.8570778931020111,1.0,5/13,15.94%,RPP25;RPP21;PRORP;RPP25L;POP4
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.47384853946165223,1.234565794620159,0.18171557562076748,0.8565728780356943,1.0,14/44,16.31%,TRIAP1;CD44;VEGFA;CARD16;SRC;GAS6;CAST;DPEP1;YWHAE;GPX1;AKT1;SFN;KLF4;HGF
prerank,RNA export from nucleus (GO:0006405),0.4438051002008394,1.2337937234324938,0.1353001017293998,0.858562726750489,1.0,43/100,28.07%,SRSF2;HNRNPA1;SRSF6;NXF1;DDX19B;NUP93;MCM3AP;NUP107;U2AF1;SRSF3;NUP98;CPSF4;SRSF11;THOC7;POLDIP3;SMG7;THOC2;THOC1;ZC3H11A;SMG6;FYTTD1;NUP37;CPSF2;DDX39A;SRRM1;NUP50;SLBP;U2AF2;TPR;CPSF1;AGFG1;WDR33;NUP133;NUP85;ALYREF;UPF3B;NUP188;UPF1;NUP88;SMG5;CDC40;THOC5;CPSF3
prerank,regulation of intracellular transport (GO:0032386),0.4895720034876754,1.233482965344674,0.1853546910755149,0.8586812197235515,1.0,14/38,23.19%,GAS1;NDEL1;RBM4;ATP9A;RINT1;INPP5F;SCFD1;ANTKMT;DYNC1H1;REEP5;CAPN10;NUMA1;GRIPAP1;CRYAB
prerank,ureteric bud morphogenesis (GO:0060675),0.5521977532470699,1.2334690473976213,0.22864651773981604,0.8574585693214218,1.0,5/16,13.72%,WT1;FGF2;PKD2;GDNF;SIX1
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.34746676807823024,-1.233313302200535,0.11764705882352941,0.6318479478591496,1.0,8/37,6.12%,ALCAM;TENM4;PTPRD;FAT4;CADM1;HMCN1;CXADR;VCAM1
prerank,embryonic limb morphogenesis (GO:0030326),0.4966980366324155,1.233292234392587,0.18663594470046083,0.8569791585102972,1.0,9/34,13.57%,LRP6;AFF3;MBNL1;TGFB2;SKI;ECE1;FBXW4;GLI3;TWIST1
prerank,Golgi inheritance (GO:0048313),0.6000984873690582,1.2328647528648198,0.23529411764705882,0.8576240825494712,1.0,2/11,3.58%,STK25;STX5
prerank,regulation of peptidase activity (GO:0052547),0.5408003387462179,1.2326104449242965,0.22179487179487178,0.8574849644897915,1.0,4/19,10.48%,MAPK12;ECM1;RCN3;CSTB
prerank,regulation of lymphocyte migration (GO:2000401),0.5995365629232813,1.2323360739724296,0.2297872340425532,0.8575119618159949,1.0,5/10,27.25%,MIA3;AKT1;SLC8B1;STK10;WASL
prerank,regulation of phospholipase activity (GO:0010517),0.6090639771861359,1.2322628634439348,0.23587570621468926,0.8565360711260023,1.0,2/10,1.44%,LRP1;FGFR1
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.33905340001178197,-1.2321395598255844,0.14285714285714285,0.6319548539185278,1.0,14/39,12.92%,ROBO1;TSPAN14;EPN2;MAML3;CREBBP;NOS3;NOTCH1;ROBO2;JAG2;YAP1;MAML2;NOTCH4;EP300;PDCD10
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.43311072189521227,1.2319269157654396,0.1079429735234216,0.856663520822368,1.0,24/128,10.84%,COL3A1;COL1A2;AMH;TMEM100;TGFB3;ZMIZ1;TGFB2;TGFBR2;ADAM9;SMAD4;SMURF2;SKI;ACVR1;BMP15;ITGB5;FAM83G;RNF111;SRC;SMAD5;STUB1;PARD6A;BMP8A;SMAD6;AMHR2
prerank,telomere capping (GO:0016233),0.5467379236320717,1.2315608968816942,0.23552123552123552,0.8570545400014784,1.0,11/16,27.64%,CTC1;ACD;TFIP11;TERF1;NBN;RAD50;TINF2;DCLRE1A;TERF2IP;PRKDC;STN1
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.4747007514389939,1.231558587624042,0.18543799772468714,0.8558057690416528,1.0,22/42,31.04%,MARS2;TARS1;SARS2;VARS1;HARS1;GARS1;VARS2;EEF1E1;EPRS1;QARS1;AIMP1;EARS2;AIMP2;NARS1;PPA1;YARS1;SARS1;PPA2;DARS1;WARS2;AARS1;LARS2
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.5947350179088056,1.2312262262070708,0.2253922967189729,0.8559795002820615,1.0,4/11,16.59%,EGFR;MAP2K2;IL6;DDX5
prerank,response to alcohol (GO:0097305),0.511613072497585,1.2310916095141797,0.20141342756183744,0.8553600942298111,1.0,7/27,18.40%,SLIT3;SLIT2;TGFBR2;GRIN3A;PMVK;GRIN2A;TGFBR1
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.5315449086042854,1.230896992006851,0.199252801992528,0.8549407314585667,1.0,6/21,16.35%,EIF2AK3;SYVN1;CREB3L1;HERPUD1;SELENOS;NCK1
prerank,positive regulation of response to biotic stimulus (GO:0002833),-0.33957897155145284,-1.2308420947030771,0.11194029850746269,0.6324934472528588,1.0,14/38,17.72%,BMP6;SASH1;PLSCR1;POLR3C;POLR3B;DDX60;PUM2;GBP5;LY86;NMI;USP15;LY96;DHX58;CYBA
prerank,response to lipopolysaccharide (GO:0032496),0.4322353123830418,1.2306230179459552,0.10446247464503043,0.8548757423481184,1.0,30/138,16.30%,LBP;CD80;AXL;IRAK3;FOXP1;F2R;S100A8;S100A9;ADAM9;MAPK14;NR1D1;CXCL10;CARD16;CYP27B1;TIRAP;TLR4;SMAD6;SIRPA;SLPI;IRAK1;ZFP36;RHOA;TNFRSF1B;ZC3H12A;FER;GGT7;CD14;SELENOS;PDCD4;IL6
prerank,regulation of exosomal secretion (GO:1903541),0.547642795672016,1.2299790739574323,0.2121982210927573,0.856454627818494,1.0,3/19,5.88%,SMPD3;VPS4B;ATP9A
prerank,chondrocyte differentiation (GO:0002062),0.4904188803410547,1.2297929460257704,0.19437939110070257,0.8560482826239331,1.0,8/32,9.28%,WNT10B;EIF2AK3;SULF2;RUNX1;SLC39A14;NFIB;SULF1;SOX5
prerank,sensory perception of chemical stimulus (GO:0007606),0.5603379891713192,1.2296516898622765,0.2261904761904762,0.8554531518370126,1.0,2/15,14.12%,GNAS;BBS4
prerank,primary neural tube formation (GO:0014020),0.5049466158647568,1.2296231155140642,0.2016706443914081,0.8543288918607992,1.0,4/30,4.06%,LRP6;TGFB2;COBL;SKI
prerank,tube closure (GO:0060606),0.5018665973231665,1.2294700375895613,0.20734597156398105,0.8537592062671538,1.0,4/31,4.06%,LRP6;TGFB2;COBL;SKI
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.44074499718353954,1.2292929819614382,0.14434060228452752,0.8533055125549275,1.0,19/87,14.03%,COL3A1;COL1A2;TGFB3;ZMIZ1;TGFB2;TGFBR2;ADAM9;SMAD4;SKI;ACVR1;ITGB5;SRC;SMAD5;PARD6A;SMAD6;AMHR2;UBA52;RHOA;CBL
prerank,Golgi localization (GO:0051645),0.6057009569010269,1.229261641805863,0.24005486968449932,0.852227332185778,1.0,2/11,1.49%,ARHGAP21;STK25
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.47374295809913075,1.22898590493635,0.17420066152149946,0.852162813557342,1.0,20/51,24.31%,DBN1;DCLK1;TAOK3;TRIO;DTNBP1;WASF1;SNX1;KIF20B;TAOK2;SLC9A6;ANKRD27;SRGAP2;SHTN1;GPM6A;NBL1;GAS7;CTTN;MAP1S;CNTNAP1;ALS2
prerank,respiratory tube development (GO:0030323),0.5097197880783899,1.2289844413023028,0.20329024676850763,0.8509306057599642,1.0,5/28,7.50%,FGF7;PCSK5;VEGFA;FGF2;GLI2
prerank,regulation of cellular protein localization (GO:1903827),0.47143039940677023,1.2289753552156428,0.18638392857142858,0.8497356448742999,1.0,12/45,16.66%,RAB11FIP5;GPC6;GPC3;NDEL1;TRIM46;TOR1A;MAPT;SETD2;EGF;PIN1;HSP90AA1;SPIDR
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.546663285483878,1.2288774857704394,0.2204928664072633,0.8488930674798414,1.0,5/17,12.63%,DGKQ;SIRT2;INPP5K;PPEF2;CALM2
prerank,protein secretion (GO:0009306),0.46779702391538874,1.228214027868514,0.18020022246941045,0.8505170935977777,1.0,11/56,11.42%,ANXA1;NECAB3;PCSK5;STEAP3;PREB;MIA3;RCN3;ABCA1;ADCYAP1;ARFGAP3;RAB3D
prerank,regulation of signal transduction (GO:0009966),0.4309178794037332,1.228197305546339,0.07931726907630522,0.8493544425273901,1.0,35/190,10.07%,IGFBP5;CD80;CD55;ESR1;MGLL;SRMS;PLCE1;FYN;CD177;GAS1;DGKQ;IGFBP6;CDKN2AIP;RUNX1;LLGL1;WWTR1;AXIN1;ACVR1;GNG4;IGFBP4;ZDHHC7;MTCH1;SOCS2;TSPEAR;DTNBP1;CSK;SRC;YWHAG;SULF1;ADCYAP1;FOXL1;MDFIC;RFNG;GSKIP;USP33
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.4331600648078042,1.227886698641168,0.13641025641025642,0.8495122775738098,1.0,22/112,10.84%,COL3A1;COL1A2;WNT2;TGFB3;CLEC3B;MAPK7;ZMIZ1;TGFB2;TGFBR2;ADAM9;SMAD4;SKI;ACVR1;ZFP36L1;ITGB5;SRC;SMAD5;ZFP36L2;PARD6A;SOX5;SMAD6;AMHR2
prerank,regulation of protein sumoylation (GO:0033233),0.546972820981652,1.2278537191184966,0.20707732634338138,0.8484031756443422,1.0,5/17,13.86%,ZMIZ1;GNL3L;PIAS3;UBA2;HDAC4
prerank,cellular response to drug (GO:0035690),-0.3784565731634974,-1.2277513966439884,0.17543859649122806,0.6378749637951969,1.0,8/25,12.23%,PPM1E;MEF2C;ACER2;AIM2;TFRC;KCNQ1;CERS1;PPM1F
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.5753577059626847,1.2277437859471545,0.24081632653061225,0.8476728996952928,1.0,4/12,17.74%,IL33;NUPR1;IL6;IL18
prerank,mRNA destabilization (GO:0061157),0.479824220070584,1.2268110881782919,0.18369690011481057,0.8504304170274917,1.0,12/38,17.50%,DIS3L2;ZFP36L1;TRIM71;TARDBP;RC3H1;ZFP36L2;PUM1;ZFP36;POLR2D;ZC3H12A;YTHDF1;YTHDF2
prerank,growth hormone receptor signaling pathway (GO:0060396),0.564069929265224,1.22659511039379,0.23302263648468707,0.8501446509008398,1.0,3/14,8.10%,GHR;SOCS2;STAT5A
prerank,in utero embryonic development (GO:0001701),0.5079943906449584,1.226474325042659,0.2109181141439206,0.8494302552890861,1.0,7/25,8.13%,TGFB3;MBNL1;VEGFA;LMX1B;PKD1;FLCN;SOX8
prerank,epithelial structure maintenance (GO:0010669),-0.46699928117126743,-1.2264533116481018,0.26153846153846155,0.6383293229261336,1.0,2/11,6.09%,RBP4;CXADR
prerank,epithelial cell differentiation (GO:0030855),0.446721656860594,1.2264525049148234,0.14730290456431536,0.8483056645555043,1.0,17/88,16.57%,FSTL1;DHRS9;ANXA1;WT1;VEGFA;ZDHHC7;TPP1;FZD7;JAG1;TDRD7;ACADVL;AKT1;DMBT1;SIX1;VDAC1;ANXA4;BDH2
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),0.5412150577622369,1.226268871572619,0.22761194029850745,0.8478570014661346,1.0,7/19,17.16%,HPN;MAPK7;TMEM106A;KLF2;EGF;KLF4;CHRNA7
prerank,positive regulation of axon extension (GO:0045773),0.5265283964385665,1.2262397899173623,0.22194199243379573,0.8467847475782463,1.0,9/22,17.87%,DBN1;VEGFA;NTN1;ISLR2;DSCAM;L1CAM;MAPT;GOLGA4;SHTN1
prerank,positive regulation of T cell differentiation (GO:0045582),0.4830142902750311,1.2262002839455999,0.18649885583524028,0.8457678825280587,1.0,7/36,14.83%,TNFSF9;ZMIZ1;GLI2;ZBTB1;BCL6;GLI3;IL4
prerank,regulation of histone modification (GO:0031056),0.5732967889459939,1.2261881891261304,0.24836601307189543,0.8446287330976152,1.0,6/13,14.66%,FLCN;UBE2N;CDK9;PARG;AKAP8;SETD5
prerank,amino acid transport (GO:0006865),-0.3205242215916122,-1.2247944625582878,0.10204081632653061,0.6397059601248082,1.0,13/49,13.35%,SLC7A11;SLC7A2;SLC6A12;PDPN;SLC38A11;SLC7A5;SLC3A2;SLC38A5;SLC25A44;SLC6A17;SLC6A6;SLC43A1;SLC7A14
prerank,actomyosin structure organization (GO:0031032),-0.29957656232852325,-1.2244856491025573,0.10344827586206896,0.6375833309413024,1.0,10/75,3.56%,TJP1;SORBS1;TPM1;ACTN2;PGM5;FRMD5;PHACTR1;EPB41;F11R;MYO18A
prerank,secondary palate development (GO:0062009),0.5709677345131159,1.2243814617828228,0.2449528936742934,0.8512120851672245,1.0,4/14,3.68%,TGFB3;TGFB2;TGFBR2;SMAD4
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.6049416226502229,1.2240429046187364,0.25,0.8515113742757612,1.0,5/11,16.99%,MTOR;DDX11;SMARCA4;NOP53;IPPK
prerank,semaphorin-plexin signaling pathway (GO:0071526),-0.3467765155057948,-1.2239896058972344,0.14705882352941177,0.6360007476935924,1.0,10/35,8.64%,PLXNA2;NRP2;PLXNA4;SEMA5A;SEMA7A;PLXND1;SEMA6A;NRP1;SEMA3B;PLXNB1
prerank,positive regulation of interleukin-13 production (GO:0032736),0.6053098670510648,1.2239329169714581,0.2237960339943343,0.8507743577475806,1.0,5/10,24.85%,IRF4;IL4;IL18;PRKCZ;RARA
prerank,protein localization to chromosome (GO:0034502),0.4824478284759502,1.2235095902273074,0.18979833926453143,0.851382525727245,1.0,9/34,18.67%,ESR1;PARP3;CHMP7;ACD;TPP1;XRCC5;IFFO1;TINF2;CTCF
prerank,epithelium development (GO:0060429),0.43617297558458057,1.2233372360021806,0.12487205731832139,0.850897707839416,1.0,23/107,16.60%,CD34;DHRS9;WNT2;WT1;MEOX2;VEGFA;PKD1;SOX10;DACT1;TRIM71;RCN3;PKD2;TPP1;SOX8;NDRG4;ACADVL;DMBT1;SIX1;VDAC1;AHI1;ANXA4;BDH2;SNAI2
prerank,regulation of osteoclast differentiation (GO:0045670),0.4933887850898472,1.2230696941548245,0.21845794392523366,0.8508643331882488,1.0,7/33,17.44%,FBN1;MTOR;LRRC17;TLR4;CEBPB;IL4;GPR137B
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.5107573390152881,1.222813620569463,0.22580645161290322,0.8507561443962396,1.0,5/24,7.85%,TNMD;GRB10;ITGB3;ITGA5;PRKD2
prerank,positive regulation of mitochondrial fission (GO:0090141),0.5321227216645517,1.2227622057998657,0.231055900621118,0.8497669457399977,1.0,3/18,8.59%,DCN;MIEF2;MCU
prerank,negative regulation of axonogenesis (GO:0050771),0.5102080081554904,1.2226329026670497,0.20673076923076922,0.849136352361541,1.0,8/27,14.33%,FGF13;PTPRS;TRIM46;GDI1;ULK2;RHOA;ULK1;DCC
prerank,cellular biogenic amine metabolic process (GO:0006576),0.5828402553376456,1.2223732447772777,0.22602739726027396,0.8490825716550818,1.0,4/12,13.66%,SRM;ODC1;TRH;SMS
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.4280109118642814,1.2222692710645946,0.11178861788617886,0.8482989449557615,1.0,22/138,10.44%,ANGPTL1;SYK;LIF;DDR2;EPHB2;AXL;SRMS;EGFR;TNK1;FGFR1;EPHA3;FYN;MST1R;TRIO;RET;PTPRF;SRC;POLR1G;ABI1;EFS;EPHB3;MUSK
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.38313963021091335,-1.2219536077268796,0.1797752808988764,0.6385245756034382,1.0,8/23,12.76%,ACSL1;ELOVL7;ACSL4;HACD1;ACSL3;HACD2;ACSL6;ELOVL1
prerank,positive regulation of translation (GO:0045727),0.437031368284206,1.2216729060864635,0.14984391259105098,0.8496030035828784,1.0,33/94,22.31%,NIBAN1;DAZL;MTOR;C1QBP;LARP4;AGO2;HNRNPD;MRPS27;NPM1;PASK;EIF6;LARP1;POLR2D;RPS27L;POLR2G;BCL3;ZCCHC4;POLDIP3;CDC123;RBM3;EIF3E;PKM;IL6;EIF3D;FXR2;YTHDF1;YTHDF2;RCC1L;RMND1;PCIF1;EIF5A2;MPV17L2;YTHDF3
prerank,regulation of keratinocyte proliferation (GO:0010837),0.5237916747731356,1.2216641914369604,0.21625,0.848453477000009,1.0,5/22,8.44%,AREG;FGF7;SRSF6;ZFP36L1;VDR
prerank,negative regulation of cellular component organization (GO:0051129),0.45027938010839824,1.2214985786183985,0.16,0.8479734067380278,1.0,12/74,7.93%,AR;TMEFF2;FAP;EPHA3;VEGFA;IRAK3;SYT11;AIDA;SRC;HDAC6;SCAMP5;TFIP11
prerank,acute-phase response (GO:0006953),0.583612194059894,1.2210323082936125,0.2445054945054945,0.8488253367866433,1.0,4/12,18.60%,LBP;CEBPB;IL6;MBL2
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.44087071427285035,1.2208081124927659,0.14504596527068436,0.8485666560070467,1.0,42/96,28.07%,SRSF2;SRSF6;NXF1;DDX19B;NUP93;MCM3AP;NUP107;U2AF1;SRSF3;NUP98;CPSF4;SRSF11;THOC7;POLDIP3;SMG7;THOC2;THOC1;ZC3H11A;SMG6;FYTTD1;NUP37;CPSF2;DDX39A;SRRM1;NUP50;SLBP;U2AF2;TPR;CPSF1;AGFG1;WDR33;NUP133;NUP85;ALYREF;UPF3B;NUP188;UPF1;NUP88;SMG5;CDC40;THOC5;CPSF3
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.45251816891884344,1.2207130547527012,0.16596194503171247,0.8478050300824637,1.0,13/75,8.12%,DCN;TNMD;ANGPT4;ISM1;SPARC;TGFB2;CD160;ATP2B4;HOXA5;CXCL10;THBS4;SULF1;SERPINF1
prerank,cellular response to oxygen-containing compound (GO:1901701),0.4192411031328957,1.2203143784495343,0.056056056056056056,0.8483626089087174,1.0,66/291,17.31%,IGFBP5;LBP;CD80;UCP1;ESR1;AXL;WNT10B;WNT2;EGFR;WT1;IRS1;EPHA3;CAPN2;WNT9A;SLIT2;ADAM9;MAPK14;P2RX3;ZFP36L1;RAP1B;MTOR;ATP2B4;FOXO1;NR1D1;CXCL10;NCOA3;CARD16;RET;PID1;ABL2;PKD2;DPEP1;CHUK;FZD7;TIRAP;TLR4;INPP5K;HCN4;SIRPA;CAMKK2;SSH1;AKT1;SLC26A6;MAPT;IRAK1;TSHR;MTR;ZFP36;RHOA;NSMF;RRAGD;TNFRSF1B;GNB1;ZC3H12A;PDGFRA;FER;KCNC2;CD14;RAPGEF1;FZD4;SELENOS;PDCD4;IL6;HTRA2;CPEB1;AKAP9
prerank,retinoid metabolic process (GO:0001523),0.44738138321244203,1.2201714458011081,0.19491525423728814,0.8477962405826751,1.0,6/71,2.21%,AKR1B1;DHRS9;LRP1;CYP2S1;GPC6;GPC3
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.49283381923484343,1.2200926978219995,0.2116279069767442,0.8469518887391724,1.0,4/33,2.55%,IGFBP5;TGFB3;ANG;OGN
prerank,aorta development (GO:0035904),-0.44376063769052987,-1.2198753988285196,0.196,0.6412763379542238,1.0,8/14,9.63%,ROBO1;ADAMTS9;ROBO2;TBX1;PDGFRB;HECTD1;TBX2;PDE2A
prerank,placenta development (GO:0001890),0.5777793811683829,1.2197519334485782,0.2472375690607735,0.8472719201162794,1.0,2/12,4.55%,ANG;ADAM19
prerank,intermediate filament organization (GO:0045109),0.5458152222280963,1.2197285745928304,0.23076923076923078,0.8462171946205408,1.0,2/17,6.69%,KRT20;NEFL
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.5150745646678939,1.2194493594975775,0.22276621787025705,0.8462562979910367,1.0,5/22,16.30%,GHR;F2R;IL10RA;MGAT5;IL6
prerank,regulation of spindle assembly (GO:0090169),0.5157326340125464,1.2189623856572527,0.21798029556650247,0.8471785476865993,1.0,9/25,22.69%,GPSM2;VPS4B;CCSAP;CEP97;DYNC1H1;SENP6;NUMA1;PDCD6IP;TPR
prerank,cardiac muscle tissue development (GO:0048738),-0.3188314119094584,-1.2187131384835521,0.0851063829787234,0.6416169525574218,1.0,12/50,10.58%,GJB6;BMP5;ADAMTS9;BMP7;RBP4;NOTCH1;TBX18;GJA1;BMPR2;TBX2;SIK1;BMP2
prerank,peptidyl-lysine modification (GO:0018205),0.4374670030689662,1.2186105161812788,0.15615305067218202,0.8474407230566451,1.0,17/99,10.04%,PLOD2;LOXL2;LIPT2;STX1A;HDAC9;RNF212B;NUP93;PIAS3;HDAC6;NUP107;UBA2;PLOD3;NUP98;SIRT2;KAT2B;LOXL1;NDUFAB1
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.4514467942182209,1.2185583213845013,0.17634635691657866,0.8464751114461198,1.0,16/66,14.55%,CDK2AP2;EGFR;ANXA1;FHL1;PKD1;CDK4;DACT1;PRMT2;PKD2;BRD7;AKT1;GPNMB;CDKN1A;CCND1;KLF4;INO80
prerank,negative regulation of blood coagulation (GO:0030195),0.47811244394799784,1.218335274957788,0.19112627986348124,0.8462314771337581,1.0,3/38,3.63%,CD34;C1QTNF1;KLKB1
prerank,response to progesterone (GO:0032570),0.5309532115003075,1.2181329836548704,0.22,0.8458694427765495,1.0,4/18,6.81%,TGFB3;TGFB2;CATSPERB;SRC
prerank,negative regulation of B cell proliferation (GO:0030889),-0.4701127268748637,-1.2176003405202969,0.2127659574468085,0.6418886900747625,1.0,4/11,13.50%,LYN;TNFRSF21;ATM;CD300A
prerank,protein localization to phagophore assembly site (GO:0034497),0.5872493618793644,1.2174915381501918,0.24583333333333332,0.8474200843177843,1.0,5/11,18.78%,PACS2;WIPI2;WDR45B;STX17;ATG13
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.5096566150604085,1.2174429137519776,0.22546728971962618,0.8464703105557587,1.0,8/27,15.07%,AHNAK;JSRP1;ANK2;CAMK2D;YWHAE;PDE4D;CALM2;CACNB1
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.5934256199807842,1.217410875212312,0.24737631184407796,0.8454532875590985,1.0,6/10,25.88%,DLGAP4;DLGAP3;DLGAP1;AKAP9;NPTX1;BEGAIN
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.5293072409006772,1.217304903349094,0.23429951690821257,0.8447692807544369,1.0,8/22,17.41%,VEGFA;RASSF2;GPNMB;CALM2;TAOK2;NBN;TNKS1BP1;RAD50
prerank,negative regulation of phosphorylation (GO:0042326),0.4369609235886823,1.2171540737075373,0.1671858774662513,0.8442316653437766,1.0,33/85,24.14%,EPHB2;LRP6;NIBAN1;SLIT2;WWTR1;PLPP3;TARDBP;MYADM;INHA;PID1;PIP5KL1;TIGAR;INPP5K;SIRPA;MAPT;IRS2;CDKN1A;NCOR1;HDAC4;ZC3H12A;NUPR1;CHP1;PPIA;IBTK;FKBP8;CORO1C;PTEN;CDKN2C;TERF2IP;FBLN1;ANKLE2;ATG14;DYNLL1
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.46495593090161225,1.2171437821744453,0.2,0.8431207607904011,1.0,16/46,20.75%,ANTXR1;TMEFF2;ITGB3;NTN4;RADIL;MEGF9;SRCIN1;ITGAV;EPHB3;ATRN;RHOA;FER;SRGAP2;ILK;LAMC1;TYRO3
prerank,regulation of T cell migration (GO:2000404),-0.4037469767780173,-1.2163043943072105,0.1926605504587156,0.6426725265513311,1.0,5/18,5.61%,APP;APOD;DOCK8;CXCL12;LRCH1
prerank,heart morphogenesis (GO:0003007),-0.3040445073583939,-1.2160313216235088,0.14814814814814814,0.6405518352794921,1.0,14/50,11.15%,CHD7;INSR;ENG;EPHB4;NOS3;NOTCH1;TBX3;TGFBR3;HEYL;TBX1;SOX17;TBX2;BMP2;RYR2
prerank,cell-substrate junction assembly (GO:0007044),-0.33432921849838704,-1.2159339299801242,0.18796992481203006,0.6380346655463447,1.0,7/33,5.86%,PTPRK;SORBS1;ACTN2;ITGA6;THSD1;ITGB4;PIP5K1A
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.5937235962156429,1.2154996512436185,0.24119241192411925,0.8478386075299466,1.0,4/11,12.63%,SRI;PKD2;GSTM2;CALM2
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.5937235962156429,1.2154996512436185,0.24119241192411925,0.8478386075299466,1.0,4/11,12.63%,SRI;PKD2;GSTM2;CALM2
prerank,respiratory system development (GO:0060541),0.4945808957368584,1.2150436987527755,0.20833333333333334,0.8485582944115911,1.0,6/32,7.50%,FGF7;WT1;DISP1;VEGFA;FGF2;GLI2
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.42572024860264196,1.2148727484415371,0.10030395136778116,0.8481471006676333,1.0,16/140,10.17%,ACKR3;CD55;ESR1;C1QTNF1;LPAR3;NPTN;PLCE1;F2R;DLG4;LPAR1;P2RX3;ADCYAP1;ABL2;GPR20;ACKR4;CALCA
prerank,myelin assembly (GO:0032288),0.5878499367216719,1.21458317999459,0.25673758865248225,0.8482518484255487,1.0,2/10,1.65%,CD9;PMP22
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),-0.38254005295644006,-1.2140043918441121,0.19653179190751446,0.6404827946978338,1.0,10/26,22.93%,ACER2;NOS3;GCH1;NOS1;SPR;SPHK1;SPTLC2;SPHK2;ABCA2;NQO1
prerank,cellular response to cAMP (GO:0071320),0.5010927381388057,1.2139863203416894,0.22288438617401668,0.84956943706041,1.0,8/30,11.33%,IGFBP5;WT1;ZFP36L1;RAP1B;PKD2;INPP5K;HCN4;SLC26A6
prerank,cGMP metabolic process (GO:0046068),-0.47244778652293884,-1.2139674191300363,0.23381294964028776,0.6378241461761781,1.0,4/12,12.97%,GUCY1B1;NPR1;PDE2A;GUCY1A1
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.5709708093497405,1.213843191225011,0.2554945054945055,0.8467739797921465,1.0,6/12,23.88%,CUL3;CDC23;ANAPC5;CDC27;ANAPC4;NSMCE2
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.5709708093497405,1.213843191225011,0.2554945054945055,0.8467739797921465,1.0,6/12,23.88%,CUL3;CDC23;ANAPC5;CDC27;ANAPC4;NSMCE2
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.5709708093497405,1.213843191225011,0.2554945054945055,0.8467739797921465,1.0,6/12,23.88%,CUL3;CDC23;ANAPC5;CDC27;ANAPC4;NSMCE2
prerank,regulation of supramolecular fiber organization (GO:1902903),0.5191549069616201,1.2137328691229898,0.24938875305623473,0.8461159992976397,1.0,8/22,11.50%,MAP1B;AKAP13;MAPRE3;PIK3CA;GPX1;CAMSAP1;MAPT;GBA2
prerank,establishment of mitotic spindle localization (GO:0040001),0.49153797423890044,1.2137077152665667,0.19596199524940616,0.8450783515223512,1.0,9/28,22.51%,GPSM2;DCTN1;NDEL1;ZW10;CDK5RAP2;PAFAH1B1;CLASP2;NUMA1;FBXW11
prerank,regulation of bone mineralization (GO:0030500),-0.3178027535289836,-1.2135186101777626,0.10810810810810811,0.636145873432989,1.0,15/55,7.95%,PTN;BMP6;WNT4;ADGRV1;ENPP1;BMP7;MEF2C;OSR1;ANKH;KL;NELL1;ATRAID;S1PR1;NOTUM;BMPR2
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.5265897061396866,1.2132260891380682,0.2258485639686684,0.8459829004899062,1.0,9/19,20.19%,UGDH;EXT1;B3GAT3;XYLT1;HS2ST1;HS3ST5;GLCE;NDST2;XYLT2
prerank,peptide catabolic process (GO:0043171),0.5140493313696133,1.213140072322345,0.22545454545454546,0.8452112508499271,1.0,8/23,16.89%,ANPEP;LNPEP;DPEP1;TPP1;ECE1;NPEPPS;GGT7;IDE
prerank,tRNA aminoacylation (GO:0043039),0.47727023887832987,1.2126218449035575,0.21814006888633755,0.8463257085233024,1.0,21/37,31.04%,MARS2;TARS1;SARS2;VARS1;HARS1;GARS1;EEF1E1;EPRS1;QARS1;AIMP1;QRSL1;AIMP2;NARS1;PPA1;YARS1;SARS1;PPA2;DARS1;WARS2;AARS1;LARS2
prerank,regulation of biomineral tissue development (GO:0070167),0.5128117142382007,1.2122164361821215,0.2191780821917808,0.8469150549383635,1.0,10/26,16.45%,DDR2;ECM1;GAS6;CYP27B1;BMP2K;SGMS2;CEBPB;FBXO5;TWIST1;NBR1
prerank,anion transmembrane transport (GO:0098656),-0.30105001863748765,-1.2121833766249779,0.08695652173913043,0.6367670911035029,1.0,14/67,9.55%,SLC7A2;SLC6A13;SLC1A3;SLC16A12;SLC13A4;SLC13A3;SLC39A8;SLC7A5;SLC6A9;SLC25A42;SLC3A2;LRRC8B;SLC38A5;SLC25A11
prerank,regulation of stress fiber assembly (GO:0051492),-0.300310190728558,-1.211667589298576,0.15517241379310345,0.6354550942489666,1.0,15/74,6.55%,TJP1;CGNL1;PHLDB2;ARHGAP28;TPM1;ARHGAP6;PPM1E;RAPGEF3;CCN2;F11R;RHPN2;LIMCH1;FHOD1;NRP1;RGCC
prerank,RNA metabolic process (GO:0016070),0.43075011762133114,1.2114327601483796,0.12677484787018256,0.8489875984303399,1.0,40/127,19.99%,POLR2H;ADARB1;HNRNPA1;RNASE4;RBM4;BICD1;PRPF4;ATXN2;TFIP11;AGO2;DUSP11;HNRNPD;EXOSC7;SIDT2;HNRNPH1;DHX8;CELF2;RBFOX2;RNASE6;POLR2D;POLR2G;MPHOSPH10;DDX17;HNRNPA3;ZC3H12A;RBM3;THOC1;GTF2F1;DDX20;AGO4;NUFIP1;TENT2;RBM6;RBM39;SUPV3L1;DDX24;HNRNPUL1;AGO3;NOVA1;PTBP1
prerank,regulation of immunoglobulin production (GO:0002637),0.5115510823521522,1.2105400574158636,0.23247232472324722,0.8515472135088311,1.0,5/23,16.30%,EPHB2;CLCF1;STX4;IL4;IL6
prerank,catecholamine biosynthetic process (GO:0042423),-0.48860684439038515,-1.2104300753841613,0.26119402985074625,0.6357767518363114,1.0,4/11,10.24%,MOXD1;SNCA;GCH1;DDC
prerank,establishment of protein localization to organelle (GO:0072594),0.4393640175770372,1.210394427432391,0.17560462670872765,0.8510128570722326,1.0,27/72,27.02%,SYK;TSPAN17;SPRN;NUP93;NUP107;IL10RA;AKT1;IPO9;TNPO2;E2F3;IPO5;NUP50;NXT2;LRSAM1;RALA;RANBP6;TPR;IPO11;IPO13;TSC2;NUP133;NUP85;TNPO1;FAM53C;NUP188;KPNB1;NUP88
prerank,regulation of telomere maintenance (GO:0032204),0.5024176683482424,1.210274813265162,0.22057001239157373,0.8503903588744756,1.0,15/26,29.30%,HNRNPD;ERCC4;XRCC5;NBN;USP7;SMG6;PML;RAD50;TINF2;TERF2IP;ERCC1;UPF1;SMG5;HDAC8;ATRX
prerank,regulation of keratinocyte differentiation (GO:0045616),0.5026930362970385,1.2102171704180833,0.23902439024390243,0.8495356957799473,1.0,9/24,14.43%,SRSF6;RUNX1;ZFP36L1;NCOA3;CYP27B1;VDR;ZFP36;NME2;HOXA7
prerank,regulation of trans-synaptic signaling (GO:0099177),0.48174506006440665,1.2100980967139856,0.22336769759450173,0.8489091237105956,1.0,20/33,32.58%,CEL;SLC4A8;NRG3;PXK;BTBD9;GRID1;FABP5;GRIK5;GRIK2;BCR;GRIK4;EIF4EBP2;GRID2;NLGN1;NLGN3;IQSEC2;PSMC5;NLGN2;NGF;LRRC4C
prerank,production of siRNA involved in RNA interference (GO:0030422),0.6052663103919702,1.2100870160652502,0.2352092352092352,0.8478292852656836,1.0,2/10,8.90%,TARBP2;AGO2
prerank,mRNA export from nucleus (GO:0006406),0.43460277368062605,1.2095351463429005,0.15,0.849007317739022,1.0,44/102,28.07%,SRSF2;SRSF6;NXF1;DDX19B;NUP93;MCM3AP;NUP107;U2AF1;SRSF3;NUP98;CPSF4;SRSF11;THOC7;POLR2D;POLDIP3;SMG7;THOC2;THOC1;ZC3H11A;SMG6;FYTTD1;NUP37;CPSF2;DDX39A;SRRM1;NUP50;SLBP;U2AF2;TPR;CPSF1;AGFG1;WDR33;PABPN1;NUP133;NUP85;ALYREF;UPF3B;NUP188;UPF1;NUP88;SMG5;CDC40;THOC5;CPSF3
prerank,nucleoside salvage (GO:0043174),0.5939562552144695,1.2092061800231306,0.24578651685393257,0.8492888012040901,1.0,2/10,5.50%,TK1;TK2
prerank,regulation of amyloid-beta formation (GO:1902003),-0.34780834730283966,-1.2084583752183375,0.19672131147540983,0.638312906925916,1.0,9/34,12.26%,EPHA4;IGF1;SP1;APOE;GGA3;ABCG1;CASP3;SORL1;NTRK2
prerank,myoblast differentiation (GO:0045445),0.564398515191618,1.2079792073897562,0.23648648648648649,0.8532199472532631,1.0,6/14,16.59%,MAPK12;MBNL1;TCF7L2;JAG1;DDX17;DDX5
prerank,phospholipid homeostasis (GO:0055091),0.5890556822757698,1.2070294674886477,0.2541208791208791,0.856143211835953,1.0,3/11,7.01%,TLCD2;RCN3;ABCA1
prerank,endosome organization (GO:0007032),0.4685682708378378,1.2068713865828902,0.2240566037735849,0.8556686333284899,1.0,17/41,27.53%,DNM1;HOOK2;PLEKHF1;PI4K2B;TMEM9;SQSTM1;USP50;PHETA2;VPS11;ANXA8;ANXA8L1;VPS33B;CORO1C;PI4K2A;ALS2;SNX33;ARFGEF2
prerank,protein O-linked glycosylation via serine (GO:0018242),0.5975839363465382,1.2065924988676757,0.25936599423631124,0.8557174474510397,1.0,5/10,23.98%,GALNT16;GALNT1;MGAT5B;POGLUT2;GALNT4
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.4899754689126815,1.2065792647518623,0.22093023255813954,0.8546474248422697,1.0,11/32,14.33%,ANXA1;MEOX2;VEGFA;FGF2;HDAC9;HDAC7;FOXC2;AKT3;RHOJ;RHOA;KLF4
prerank,regulation of leukocyte activation (GO:0002694),-0.4305172077611293,-1.206378245192366,0.1940928270042194,0.6410160774856175,1.0,6/14,15.79%,LYN;MYO18A;PLSCR1;CD200;GPER1;CD74
prerank,positive regulation of glycolytic process (GO:0045821),-0.3891151029486897,-1.2063014391797149,0.21782178217821782,0.6358435579082983,1.0,4/20,4.23%,INSR;IGF1;APP;PRKAA2
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),-0.3891151029486897,-1.2063014391797149,0.21782178217821782,0.6358435579082983,1.0,4/20,4.23%,INSR;IGF1;APP;PRKAA2
prerank,endothelial cell migration (GO:0043542),0.4732752734960177,1.2061949672048835,0.2339930151338766,0.8551766237761292,1.0,5/37,2.76%,FSTL1;LOXL2;DPP4;FAP;VEGFA
prerank,positive regulation of protein secretion (GO:0050714),-0.3003236362175585,-1.2057775472674015,0.041666666666666664,0.634544354875943,1.0,10/69,3.64%,BMP6;WLS;UNC13B;FRMD4A;MYRIP;IGF1;RBP4;CD2AP;MYO18A;ACSL4
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),-0.30631792061245083,-1.2051237872759255,0.12987012987012986,0.6336550205392217,1.0,7/51,4.62%,PTN;IL34;VEGFC;HMGB1;THBS1;CXCL12;IL6R
prerank,positive regulation of synaptic transmission (GO:0050806),0.44559981819935357,1.20499341684218,0.19072708113804004,0.8590014848905418,1.0,26/72,24.63%,EPHB2;NPTN;DLG4;NFATC4;DTNBP1;MPP2;GRIN2D;STX1B;STX4;SQSTM1;CACNG2;LGI1;ADCY8;ZDHHC2;SLC8A2;GRIN2A;CHRNA7;SYT1;VAMP2;RIMS2;CLSTN3;NMU;FLOT1;GRIK2;PRKCZ;BAIAP3
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.47268784358120036,1.2049471498452051,0.20842824601366744,0.8580910991808206,1.0,18/38,26.43%,UBE2J2;USP36;HPS4;LMAN1;NPEPPS;BAG4;HTRA2;VPS11;ARIH2;ATG13;SREBF1;UBE2D3;SAE1;CSNK2A2;PARL;LEPROT;FBXW7;RNF31
prerank,androgen metabolic process (GO:0008209),0.5286887699423896,1.204772042369322,0.2421185372005044,0.8576729547637271,1.0,5/18,23.87%,DHRS9;SRD5A1;HSD17B4;HSD17B11;SRD5A3
prerank,kidney development (GO:0001822),0.44703701274238233,1.204525449051808,0.2108050847457627,0.8576334921196078,1.0,10/65,7.50%,HAS2;WT1;PCSK5;SULF2;VEGFA;TGFB2;C1GALT1;PKD1;SULF1;GLI2
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.4991242240711448,1.204441573216053,0.24158653846153846,0.8568825047328149,1.0,13/27,28.67%,RNASE4;NYNRIN;ERN1;NUDT16;RNASE6;ZC3H12A;RPP30;KHNYN;RNASE1;TRIR;NHP2;CPSF3;PDE12
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.5503442088561994,1.2044052438851474,0.24146981627296588,0.8548152534129023,1.0,4/15,12.64%,ZFP36L1;ZFP36L2;AGO2;ZFP36
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.5503442088561994,1.2044052438851474,0.24146981627296588,0.8548152534129023,1.0,4/15,12.64%,ZFP36L1;ZFP36L2;AGO2;ZFP36
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.5048402907782592,1.2041259264727429,0.21744471744471744,0.8548083764002418,1.0,14/25,27.32%,HDAC6;STUB1;UBE2W;CUL3;TOR1A;CLPP;NGLY1;ZER1;AUP1;UGGT1;DERL1;ZYG11B;UFD1;UGGT2
prerank,cellular response to chemical stress (GO:0062197),0.4269023364151614,1.2040670181493502,0.18453608247422681,0.8539327606032128,1.0,19/96,17.22%,NOX4;NCF4;LRRC8D;STX2;NFE2L2;FOXO1;PKD2;BRF2;PIK3CA;SIRT2;STX4;GPX1;EIF2S1;ZC3H12A;SOD3;SELENOS;HTRA2;KEAP1;PPIA
prerank,hepaticobiliary system development (GO:0061008),-0.3875805340057524,-1.20400144242116,0.23039215686274508,0.6338849156555011,1.0,6/20,9.21%,ARID5B;WNT4;LSR;TGFBR3;PHF2;CITED2
prerank,positive regulation of protein kinase activity (GO:0045860),0.4217283354545472,1.2039098135271367,0.1301715438950555,0.853481387665278,1.0,30/148,14.60%,NOX4;DDR2;CAMKK1;ITGB3;VEGFA;TGFB2;TGFBR2;DLG4;TAOK3;AXIN1;MAP2K3;MAPRE3;ETAA1;RASSF2;SRC;ADCYAP1;GAS6;STRADA;SYAP1;SRCIN1;IQGAP1;CALCA;XRCC5;CALM2;TAOK2;CDKN1A;RHOA;SLC8A2;STK3;HSP90AA1
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),0.5995232212412621,1.2037749778811715,0.2556818181818182,0.8529018765360771,1.0,3/10,9.84%,C1QTNF1;CD9;ADAMTS18
prerank,dopamine metabolic process (GO:0042417),-0.41963464558751185,-1.2037561418946106,0.20689655172413793,0.6320208209621377,1.0,4/18,8.05%,SNCAIP;MOXD1;SNCA;GCH1
prerank,heart contraction (GO:0060047),-0.32951836800461987,-1.2036430209775126,0.12037037037037036,0.629740284648304,1.0,3/41,1.52%,ATP1A2;TPM1;DMD
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.4990087536469355,1.203359079537976,0.23233532934131737,0.8534847778539295,1.0,9/27,14.88%,IRAK3;TLR5;TIRAP;TLR4;IRAK4;IRAK1;TNIP1;UBA52;CD14
prerank,negative regulation of angiogenesis (GO:0016525),0.4424858633325499,1.2027654637083591,0.1845672575599583,0.854755654457309,1.0,15/84,8.12%,DCN;TNMD;ANGPT4;ISM1;SPARC;TGFB2;CD160;KLF2;ATP2B4;HOXA5;CREB3L1;CXCL10;THBS4;SULF1;SERPINF1
prerank,negative regulation of microtubule polymerization (GO:0031115),-0.4481068594936969,-1.2027334686547213,0.22556390977443608,0.6293010170632424,1.0,3/12,3.36%,CDH5;SNCA;DYRK1A
prerank,global genome nucleotide-excision repair (GO:0070911),0.5046739535236984,1.2023512584151081,0.2422062350119904,0.8553619455407759,1.0,7/26,13.25%,GTF2H3;RAD23B;RNF111;ERCC3;UBA52;ERCC4;DDB1
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.5715946543726835,1.2008087621693186,0.2629370629370629,0.8606779793086089,1.0,6/11,20.60%,TIPIN;FBXO5;GMNN;BLM;SMARCAL1;DONSON
prerank,glucose transmembrane transport (GO:1904659),-0.39799502767191486,-1.2006745797571143,0.17592592592592593,0.6321513759474003,1.0,3/18,3.66%,SORT1;SLC2A1;SLC5A3
prerank,glucan biosynthetic process (GO:0009250),0.5796096477236663,1.2003537492399903,0.25862068965517243,0.8603829778670564,1.0,4/12,12.80%,UGP2;NR1D1;PGM2L1;PPP1R3C
prerank,glycogen biosynthetic process (GO:0005978),0.5796096477236663,1.2003537492399903,0.25862068965517243,0.8603829778670564,1.0,4/12,12.80%,UGP2;NR1D1;PGM2L1;PPP1R3C
prerank,carboxylic acid transport (GO:0046942),-0.2963150133106809,-1.2002300844947305,0.14666666666666667,0.6307046086599682,1.0,18/55,15.87%,SLC6A13;SLC16A12;SLC13A3;SLC16A2;SLC16A6;SLC6A12;SLC7A5;SLC16A11;SLC6A9;SLC3A2;SLC16A4;SLC38A5;SLC6A17;SLC6A6;SLC6A7;SLC16A13;LLGL2;SLC38A6
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",-0.47004551888903423,-1.2001293187811755,0.24092409240924093,0.6284892471628947,1.0,4/10,29.56%,APPL2;CD300A;C3;TREM2
prerank,negative regulation of cell junction assembly (GO:1901889),-0.3773593825162894,-1.1997577934276928,0.2391304347826087,0.6270274223202867,1.0,5/25,5.19%,PHLDB2;ARHGAP6;THBS1;APOD;ROBO2
prerank,muscle cell development (GO:0055001),-0.35575737764331666,-1.1994157742294385,0.15328467153284672,0.6253437121988606,1.0,8/30,8.78%,NEBL;ENG;DMD;IGF1;DYSF;CXADR;MYOF;MYH11
prerank,regulation of exit from mitosis (GO:0007096),0.4692748512820459,1.1992467024756577,0.21387940841865757,0.8638746332682156,1.0,14/38,26.29%,CDC14B;ZW10;SIRT2;CDC23;ANAPC5;UBA52;CDC27;CDC26;PPP1R9B;ANAPC4;ANAPC10;ANAPC15;CDC14A;ANAPC2
prerank,regulation of macrophage activation (GO:0043030),0.49250537662779825,1.199084357109733,0.22650602409638554,0.863447794743406,1.0,10/30,19.87%,LBP;MIF;IL33;TLR4;ZC3H12A;IL4;LRFN5;IL6;GPR137B;IL31RA
prerank,dendritic cell differentiation (GO:0097028),0.5069201932945302,1.1986274853622012,0.26805385556915545,0.8641982344733147,1.0,5/22,14.83%,AXL;TGFBR2;GAS6;FLT3;IL4
prerank,tRNA 5'-end processing (GO:0099116),0.532197448704571,1.1985961648018186,0.26693227091633465,0.8632331990521421,1.0,5/15,15.94%,RPP25;RPP21;PRORP;RPP25L;POP4
prerank,response to nutrient levels (GO:0031667),0.5358917522623149,1.1979322232664973,0.25680933852140075,0.8649284365010688,1.0,3/17,6.05%,UCP1;MTOR;MEAK7
prerank,homologous chromosome segregation (GO:0045143),0.5228356464621012,1.1977641835944348,0.25380710659898476,0.8645489499773096,1.0,6/20,21.29%,FANCD2;RNF212B;TERB1;CENPC;PRDM9;FMN2
prerank,C4-dicarboxylate transport (GO:0015740),0.5475748426490725,1.1975979433401336,0.25906040268456376,0.8641129467939438,1.0,2/14,4.54%,LRRC8D;SLC1A6
prerank,nucleus organization (GO:0006997),0.4543217160897633,1.1975087147220345,0.23730684326710816,0.8634350020317232,1.0,9/47,9.04%,BIN1;USP36;REEP3;NUP93;CHMP7;VPS4B;SYNE1;NUP98;TOR1A
prerank,heterotypic cell-cell adhesion (GO:0034113),0.49963400491911425,1.1974154325436044,0.24477244772447723,0.8627441255579611,1.0,7/25,13.62%,ITGB3;ITGA5;DSC2;JAM3;ITGAV;JUP;CD200R1
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.530537800854472,1.1973487723135208,0.23544631306597671,0.8619477800952753,1.0,5/18,10.79%,DDR2;RUNX1;FSCN1;MELTF;COLGALT1
prerank,epidermis development (GO:0008544),0.4461508767831195,1.1972608713170771,0.20065430752453653,0.8612021013305288,1.0,10/56,17.19%,COL17A1;FGF7;SCEL;EMP1;ALDH3A2;SVEP1;ATP2A2;EVPL;FLOT2;FABP5
prerank,protein localization to organelle (GO:0033365),0.42586777381483326,1.1972586939407575,0.15736040609137056,0.860133837356618,1.0,48/133,29.03%,COL1A1;TSPAN17;SIX4;RAB6A;ANK2;STX1A;STX5;LMNA;UBE2J2;GET4;ALDH3A2;BICD1;BBS9;WDR83OS;YWHAE;TOR1A;TRAM2;TMEM30A;SGTA;SIX1;ARFRP1;BBS4;TRAM1;MTCH2;ARF6;ATP6V1D;RAB33B;RAB35;AUP1;VAMP2;TOLLIP;PAF1;CROCC;PACSIN2;EMD;DVL1;SEC61B;MDM2;CALR;DCP1A;GBF1;DDX1;MICALL1;DNAJA1;TOPORS;CNTLN;ZBTB7A;PRNP
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.43005050290263974,1.196978108847905,0.18020833333333333,0.8602248681601012,1.0,18/93,14.08%,MID1;SH3RF3;STK25;GADD45G;VEGFA;TGFB2;TAOK3;AXIN1;KLHDC10;RASSF2;FZD7;SEMA3A;TIRAP;EMC10;ANKRD6;CD27;TAOK2;ZC3H12A
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.47747153014191074,1.196741912958481,0.23930635838150288,0.8601096065913736,1.0,15/37,26.91%,ENTPD2;NUDT1;HNRNPD;EXOSC7;SIDT2;NUDT16;RNASE6;DNASE1L2;NUDT5;ENTPD6;SUPV3L1;DFFB;RNASEH2C;DNASE1L1;ADPRM
prerank,response to thyroid hormone (GO:0097066),0.5654876185719969,1.1965365410458275,0.2663115845539281,0.8598554100720307,1.0,2/13,7.16%,HPN;GAS2L1
prerank,regulation of rRNA processing (GO:2000232),0.5366257863170979,1.196299757252233,0.2545454545454545,0.8598122348693135,1.0,7/16,19.78%,DIMT1;USP36;RIOK1;KAT2B;NUDT16;YTHDF2;RIOK2
prerank,cytoplasmic translational initiation (GO:0002183),0.5354303503132323,1.1951071116768155,0.24780976220275344,0.8634451542299675,1.0,9/17,27.14%,RBM4;EIF4A1;EIF3A;EIF3D;EIF2S2;EIF4H;EIF4G1;DHX29;EIF3M
prerank,positive regulation of lipid metabolic process (GO:0045834),-0.37212836285463513,-1.1950879654245614,0.20994475138121546,0.6339145481841713,1.0,3/22,4.40%,SORBS1;APOE;PPARA
prerank,inflammatory response (GO:0006954),0.41707069406302855,1.194958107765675,0.1214859437751004,0.8629875423779017,1.0,34/195,17.74%,NOX4;MGLL;CCL8;ANXA1;CD44;F2R;S100A8;S100A9;HDAC9;NFATC4;ITCH;CXCL10;TLR5;CHUK;CCL25;TLR4;LTB4R2;CEBPB;GPR68;HSPG2;PXK;ADCY8;ACKR1;CCL13;TRAF3IP2;HDAC4;TUSC2;IL4;CD14;IL6;CXCR4;ABCF1;CXCR2;IL18
prerank,autophagy of nucleus (GO:0044804),0.5464122940124632,1.194917396814826,0.2506393861892583,0.8621130653514225,1.0,8/16,21.77%,ATG2B;WIPI2;WDR45B;ULK2;ATG2A;ULK1;ATG13;ATG3
prerank,protein K63-linked deubiquitination (GO:0070536),0.4742158819424778,1.1947935589128182,0.24154025670945156,0.8615523669540115,1.0,9/31,14.80%,ZRANB1;SPATA2;OTUD1;USP33;OTUD7B;USP50;ABRAXAS1;STAMBPL1;USP7
prerank,epithelial cell-cell adhesion (GO:0090136),0.5775090437952328,1.194462145615188,0.27459016393442626,0.8618065627218948,1.0,6/11,23.82%,SERPINB8;ITGB5;THBS4;JUP;KIFC3;CCN3
prerank,RNA processing (GO:0006396),0.4189126624038372,1.194251224106783,0.12424849699398798,0.8616232767270815,1.0,57/176,21.68%,SRSF2;WT1;MBNL1;ADARB1;TSEN54;DHX16;RBM4;ZCRB1;TENT4A;TARDBP;BICD1;LSM4;PRPF4;U2AF1;TFIP11;PRPF3;AURKAIP1;CPSF6;USP39;DUSP11;HNRNPD;SON;HNRNPH1;TCERG1;DHX8;CELF2;SRSF11;MPHOSPH10;DDX17;RBM3;THOC1;SF3B4;DDX20;ZCCHC8;BCAS2;SF3A1;SNRPG;SNRPD3;NUFIP1;TENT2;PPP1R9B;LUC7L3;PDCD7;SRRM1;RBM6;RBM39;TENT4B;HNRNPUL1;U2AF2;ZMAT5;NOVA1;PTBP1;SF3B2;SF3B1;SRPK1;AKAP8L;KIN
prerank,response to steroid hormone (GO:0048545),0.4809315937241997,1.1939935617283823,0.21922626025791325,0.8615818858381021,1.0,6/31,3.99%,AR;TGFB3;TGFB2;CATSPERB;ATP1A3;ATP1A1
prerank,negative regulation of viral life cycle (GO:1903901),0.5393858819279438,1.1938739450985563,0.24518613607188702,0.861010245925757,1.0,3/15,10.83%,GSN;MID2;TRIM11
prerank,regulation of DNA metabolic process (GO:0051052),0.47129633741509674,1.1938531153871088,0.23068309070548712,0.8600418459940334,1.0,20/44,27.95%,KPNA2;UBE2N;CDK9;HNRNPD;PARG;MPHOSPH8;XRCC5;NBN;THOC1;SMG6;KPNA1;KDM1B;TERF2IP;WDR18;POLH;KAT7;ALYREF;UPF1;SMG5;HDAC8
prerank,prostanoid metabolic process (GO:0006692),0.5595649156315436,1.1938303703350388,0.279291553133515,0.8590722485867105,1.0,4/13,23.16%,CYP2S1;PTGR1;ACOX1;GSTM1
prerank,protein transport (GO:0015031),0.4111823742895043,1.193797339037062,0.063,0.8581443976066494,1.0,112/332,23.64%,SGSM2;LRP1;COPA;NECAB3;STX2;RAB32;RABGAP1L;RAB6A;STEAP3;STX1A;TMED1;STX5;STX11;ATP6V0A2;SEC31A;RAB23;ARRDC2;RAB19;RAB6B;PREB;MIA3;TOM1;SCFD2;SCAMP3;RCN3;ARF4;SCG5;TBCK;AP3D1;ABCA1;HDAC6;STX1B;SCAMP5;CLTC;SNX1;IL10RA;ACD;USO1;TBC1D2B;ARFGAP3;STX4;TBC1D17;GGA1;SCFD1;ARF1;STX12;NPM1;SEC23IP;COPB2;VPS33A;RAB3D;ATP6V1E1;TBC1D10A;NAPA;LRP1B;STX17;ATP6AP1;RUFY1;KIF3A;RAB43;RPGR;KIF3B;CMTM6;ARFRP1;SYNDIG1;ARF6;GGA2;REP15;ATP6V0A1;ATP6V1D;GOLGA4;NSF;EVI5;SGSM1;ATP6V1B2;SPTBN1;COPZ2;BLZF1;EVI5L;AP4M1;NAPG;TBC1D13;RAB1B;RAB5B;RAB5C;PREPL;STX3;SNX6;ARCN1;ADPRH;VAMP2;TBC1D22B;TBC1D15;RAB24;LRSAM1;MON1A;TMED2;VPS33B;RAB10;COPG1;RUNDC1;CTTN;VAMP4;NAPB;STX16;SEL1L;GOLPH3L;TBC1D8B;ATP6V0B;TBC1D12;PICK1;RABL3
prerank,epithelial cell migration (GO:0010631),0.4664477798439949,1.1936398569974254,0.21814006888633755,0.8577406149426174,1.0,4/37,1.79%,FSTL1;LOXL2;DPP4;FAP
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.46282869322822723,1.1935305141883685,0.2323008849557522,0.8571296017825729,1.0,9/46,12.46%,IGFBP5;ANG;OGN;FOXP1;ELN;TCF7L2;NDRG4;AKT1;XRCC5
prerank,protein N-linked glycosylation (GO:0006487),0.4404589872170999,1.1933706694449009,0.22032085561497325,0.8566721986247137,1.0,19/66,24.68%,GFPT2;B4GALT1;GFPT1;MGAT1;LMAN1;ALG1;MGAT5;MGAT2;MGAT4B;TUSC3;TMEM165;ST3GAL1;DDOST;UGGT1;MGAT5B;KRTCAP2;SRD5A3;DPM2;PGM3
prerank,RNA splicing (GO:0008380),0.43063727735065843,1.1931560434024877,0.19361483007209063,0.856471103781697,1.0,29/95,21.09%,SRSF2;WT1;MBNL1;DHX16;ZCRB1;TARDBP;LSM4;PRPF4;U2AF1;PRPF3;USP39;TCERG1;DHX8;SRSF11;MPHOSPH10;SF3B4;BCAS2;SNRPG;SNRPD3;PPP1R9B;LUC7L3;PDCD7;SRRM1;ZMAT5;NOVA1;PTBP1;SF3B2;SF3B1;SRPK1
prerank,spliceosomal snRNP assembly (GO:0000387),0.47298116039385774,1.1921041499060918,0.23006833712984054,0.8597285245314527,1.0,11/38,18.71%,GEMIN6;CD2BP2;USP4;LSM4;WDR77;PRPF3;TGS1;DDX20;SNRPG;SNRPD3;STRAP
prerank,neuron cell-cell adhesion (GO:0007158),0.5530307510977425,1.1916925879979587,0.24432576769025366,0.8604169440266429,1.0,10/14,32.87%,CEL;RET;NRXN3;CNTN4;NLGN1;NLGN3;NRXN1;NLGN2;NCAM2;NRXN2
prerank,positive regulation of actin filament polymerization (GO:0030838),0.4588335096402033,1.1916656943918953,0.2345679012345679,0.8594776351333754,1.0,9/44,16.35%,GSN;SCIN;CDC42EP2;BIN1;PFN2;FCHSD1;FER;ARF6;NCK1
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.4271656917061503,1.1914857396175829,0.19072164948453607,0.8591866985221477,1.0,33/95,24.12%,ASPN;HTRA3;LDLRAD4;SKIL;TGFBR2;PMEPA1;SMAD4;SMURF2;SKI;RNF111;STUB1;FLCN;SMAD6;PEG10;SLC2A10;VASN;UBA52;PIN1;BCL9;GIPC1;DKK3;SNX6;HTRA4;TGFBR1;STRAP;PPM1A;SMURF1;CD109;SDCBP;FKBP1A;SKOR2;LATS1;ZEB2
prerank,defense response to fungus (GO:0050832),0.533238703519155,1.1914208904109318,0.27483870967741936,0.8584210490761883,1.0,2/17,3.54%,S100A8;S100A9
prerank,protein import into peroxisome matrix (GO:0016558),0.5650769850339756,1.191061325191648,0.27595628415300544,0.8589415751875735,1.0,6/12,21.44%,PEX16;PEX12;PEX1;PEX5L;PEX5;PEX2
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.48181560515079636,1.1909310202845969,0.23662306777645659,0.8583710834579835,1.0,10/30,18.66%,HNRNPA1;CTC1;GNL3L;SRC;ACD;ERCC4;CDKN1A;TERF1;TENT4B;TINF2
prerank,metal ion export (GO:0070839),0.48276824758552944,1.1909028443669367,0.24161849710982658,0.8574317192777487,1.0,8/31,12.04%,KCNK5;KCNT2;ATP1A4;ATP1A3;ATP1A1;ATP2B4;SLC4A4;SLC9A1
prerank,positive regulation of cellular protein localization (GO:1903829),0.4329097043814815,1.190624762258161,0.21308016877637131,0.8575324377565967,1.0,21/69,23.07%,LIF;EIF2AK3;FYN;WWTR1;SYT11;GNL3L;MEAK7;BICD1;PARD6A;STX4;AKT1;MAPT;GPR137B;STX3;ENTR1;NUMA1;MAP1A;SESN2;CROCC;CCDC88A;TRAPPC12
prerank,regulation of fat cell differentiation (GO:0045598),0.43046058580706037,1.190590227597961,0.20715036803364878,0.856624501115009,1.0,17/74,14.40%,MEDAG;WNT10B;WWTR1;TRIO;ZFP36L1;TAF8;FOXO1;NR1D1;ZFPM2;ZFP36L2;SYAP1;SIRT2;CEBPB;AKT1;ZFP36;ZC3H12A;WDFY2
prerank,purine nucleotide biosynthetic process (GO:0006164),0.5568998153953693,1.190148063288852,0.25651577503429357,0.8573771136241988,1.0,5/12,16.62%,AMPD2;GART;PRPSAP1;PRPS1;PRPS1L1
prerank,T cell differentiation in thymus (GO:0033077),0.5406114673443894,1.1896311980542318,0.27137042062415195,0.8585104162786507,1.0,3/14,11.60%,ZFP36L1;ZFP36L2;GLI3
prerank,regulation of fibroblast proliferation (GO:0048145),0.4508702365718923,1.1896243090260399,0.23719376391982183,0.8575041063800009,1.0,7/45,7.92%,DDR2;WNT2;MIF;SKI;CDK4;GAS6;S100A6
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),-0.3600704246088619,-1.1888216726499499,0.1746987951807229,0.6475380534218729,1.0,6/28,8.54%,SORT1;BCL2;DAB2IP;CASP8AP2;DELE1;GABARAP
prerank,cAMP metabolic process (GO:0046058),-0.4412886086664832,-1.18798673661039,0.2585551330798479,0.6472550362071571,1.0,4/13,9.13%,ADCY5;ADCY1;ADCY4;ADCY9
prerank,modulation by symbiont of entry into host (GO:0052372),-0.4202080298840267,-1.1879855028023223,0.20087336244541484,0.6447067880331131,1.0,8/16,22.96%,TRIM25;CAV1;NECTIN2;TRIM62;TRIM21;EXOC2;TRIM5;TRIM6
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),-0.4018943689950091,-1.1878576887931698,0.21338912133891214,0.6424793690988128,1.0,3/17,2.00%,PRKG1;TPM1;MEF2C
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.5366254229376761,1.1875418471213557,0.26,0.8649534406133144,1.0,5/16,13.72%,WT1;FGF2;PKD2;GDNF;SIX1
prerank,amino acid transmembrane transport (GO:0003333),-0.3137988706898664,-1.1866436964765112,0.13636363636363635,0.6430513426041349,1.0,7/45,6.69%,SLC7A11;SLC6A13;SLC16A2;SLC38A11;SLC7A5;SLC22A4;SLC3A2
prerank,thyroid hormone generation (GO:0006590),0.5917095746917139,1.1865626009115615,0.29902642559109877,0.8678428174147675,1.0,1/10,0.50%,DUOX1
prerank,response to muscle stretch (GO:0035994),0.5424308613483715,1.186294792991522,0.27140974967061926,0.8678743131705813,1.0,3/15,12.04%,GSN;PIK3CA;SLC9A1
prerank,ovarian follicle development (GO:0001541),0.5593857533537976,1.1862794988085255,0.2697274031563845,0.8668906702500914,1.0,5/13,14.19%,ANG;VEGFA;INHA;CEBPB;LHCGR
prerank,negative regulation by host of viral process (GO:0044793),0.5933364025879732,1.1860833133417095,0.2741477272727273,0.8666468325747989,1.0,2/10,14.08%,CCL8;ZC3H12A
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.4347578096475381,1.1860027552947494,0.206163655685441,0.8659546782953335,1.0,12/73,7.85%,LIF;EGFR;CD44;VEGFA;MIF;AXIN1;ATP2B4;DOCK7;PFN2;HDAC6;GAS6;PRKD2
prerank,microtubule anchoring at centrosome (GO:0034454),0.593970850568004,1.1859360032135815,0.27074235807860264,0.8651703343590116,1.0,6/10,21.34%,DCTN1;KIF3A;BBS4;NIN;CCDC120;PCM1
prerank,negative regulation of kinase activity (GO:0033673),0.4364595433743082,1.1858214304322292,0.20488322717622082,0.8645834257536578,1.0,19/62,17.86%,LRP6;TARBP2;CAMK2N1;WWTR1;DTNBP1;RTRAF;YWHAG;GSKIP;INPP5K;AKT1;MAPT;IRS2;SFN;DEPTOR;SMCR8;CHP1;CEP85;PPIA;QARS1
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.5521102121534198,1.1853911264557506,0.2752659574468085,0.865345579686975,1.0,4/14,15.94%,CARD16;PELI3;GAS6;NLRP2B
prerank,cellular response to oxidative stress (GO:0034599),0.41571276541365504,1.1852885925048477,0.18472652218782248,0.8647194549958677,1.0,25/118,17.22%,NOX4;UCP1;NCF4;EGFR;STX2;NFE2L2;FOXO1;PKD2;BRF2;CHUK;SIRT2;STX4;GPX1;CAMKK2;AKT1;MAPT;EIF2S1;ZC3H12A;PDGFRA;FER;SOD3;SELENOS;HTRA2;KEAP1;PPIA
prerank,vesicle organization (GO:0016050),0.4521828009453775,1.1851490726222342,0.2276330690826727,0.8643000625509085,1.0,11/46,18.19%,CD34;DNM1;HOOK2;PLEKHF1;PI4K2B;SQSTM1;USP50;PHETA2;VPS11;ANXA8;ANXA8L1
prerank,regulation of peptide hormone secretion (GO:0090276),-0.28770786996873476,-1.1850606169477476,0.16417910447761194,0.6446569383395834,1.0,11/67,5.33%,ITPR1;RAPGEF4;CHD7;RAPGEF3;SLC2A1;CACNA1E;KCNB1;CACNA1D;HADH;ITPR3;KCNS3
prerank,positive regulation of wound healing (GO:0090303),0.4691257810583752,1.1849319285254685,0.23642533936651583,0.8641465532675291,1.0,9/36,11.72%,DUOX1;ANXA1;F2R;SMOC2;PLPP3;MTOR;FOXC2;KANK1;ST3GAL4
prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.47149513914231134,1.184455426028869,0.23908045977011494,0.8650332941624116,1.0,12/38,18.74%,ANK2;BIN1;DSC2;KCNJ2;CAMK2D;YWHAE;HCN4;JUP;KCNJ3;SCN4B;AKAP9;KCNH2
prerank,positive regulation of signaling (GO:0023056),0.47080407930122126,1.1842786637143738,0.24022988505747125,0.8647402565239084,1.0,15/37,23.03%,CD80;ANXA2;CDKN2AIP;DLG4;INPP5F;ECE1;HCRT;LGI1;NSF;SYT1;ILK;RIMS2;CLSTN3;NMU;GRIK2
prerank,negative regulation of lipid biosynthetic process (GO:0051055),-0.37853896593129366,-1.1842510567369409,0.2112676056338028,0.6443195653526158,1.0,13/20,29.45%,WNT4;BMP5;ACADL;SIK1;BMP2;CEACAM1;GPER1;ABCA2;BRCA1;ERLIN2;TRIB3;ASXL3;APOC1
prerank,regulation of ossification (GO:0030278),0.4746670342964631,1.1839827204567237,0.24387397899649943,0.864866784169054,1.0,9/36,10.09%,DDR2;LRP6;TGFB2;ECM1;ACVR1;CYP27B1;BMP2K;SGMS2;SMAD6
prerank,mitochondrial genome maintenance (GO:0000002),0.5765011556149289,1.1837103948212297,0.27785419532324623,0.864888705107969,1.0,5/11,22.35%,SLC25A4;AKT3;SLC25A36;SLC25A33;MGME1
prerank,mitochondrial transport (GO:0006839),0.45281014656869245,1.183667936378871,0.2185792349726776,0.8640496215749555,1.0,21/53,25.09%,SLC25A31;GDAP1;TIMM10B;TIMM9;SLC25A4;SLC25A16;BAK1;HSP90AA1;TIMM22;SPG7;FLVCR1;TIMM8B;BCAP31;BCS1L;TOMM5;ABCB10;COX18;TIMM17A;FIS1;TMEM14A;TOMM40
prerank,blood circulation (GO:0008015),0.4540419024825081,1.1835456291569504,0.23937360178970918,0.8635269888143182,1.0,10/49,12.90%,AVPR1A;GCLC;MEOX2;TNNI3;ELN;CXCL10;HCN4;GPX1;SGCZ;SERPING1
prerank,modulation by host of viral genome replication (GO:0044827),0.5569387911916089,1.1833830118978896,0.27212681638044917,0.8631152371692505,1.0,3/13,14.08%,CCL8;FBXL2;ZC3H12A
prerank,transepithelial transport (GO:0070633),-0.42077518508232414,-1.1831356735332272,0.22267206477732793,0.6445904536156343,1.0,4/15,6.09%,SLC1A3;ABCG2;SLC12A2;CXADR
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),0.5843011767313355,1.1829395517226933,0.2672292545710267,0.8638304665473742,1.0,4/10,21.60%,RC3H1;ZC3H12A;IL4;RC3H2
prerank,interstrand cross-link repair (GO:0036297),0.4411472834676025,1.1818924491180078,0.24141749723145073,0.8670133170699942,1.0,12/53,14.22%,FANCD2;XRCC3;EME1;RFWD3;FANCL;FAAP100;FANCE;EXO5;UBA52;ERCC4;FAN1;FANCG
prerank,nucleoside catabolic process (GO:0009164),-0.4525155018490581,-1.1818024299199794,0.27402135231316727,0.6455330462311264,1.0,4/11,8.10%,DPYD;UPB1;NT5E;DERA
prerank,positive regulation of protein export from nucleus (GO:0046827),0.5306568369940976,1.1817113123585203,0.2727272727272727,0.8667753389138841,1.0,8/15,23.97%,TCF7L2;GAS6;YWHAE;RBM22;ANP32B;BAG3;TPR;EMD
prerank,T cell homeostasis (GO:0043029),0.5844380435943988,1.1817051202519062,0.2824858757062147,0.8657898840622257,1.0,2/10,11.31%,ZC3H8;AKT1
prerank,cell projection organization (GO:0030030),0.48406707485398404,1.1814937463643749,0.2532239155920281,0.8656027223074061,1.0,4/30,10.05%,GSN;SCIN;RHOJ;RHOQ
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.5512993611371342,1.1813888121995677,0.2790091264667536,0.8649861473368401,1.0,5/14,12.64%,MAPK14;DAZL;TARDBP;TIRAP;ZFP36
prerank,oligodendrocyte development (GO:0014003),0.5303178564640575,1.181326134632747,0.2597402597402597,0.8642056173594735,1.0,8/15,28.08%,PRDM8;SOX10;PLP1;EIF2B1;CNTNAP1;EIF2B2;B4GALT5;MYRF
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.5725510715388642,1.180897064761807,0.289875173370319,0.8639090650563327,1.0,5/11,27.87%,OCRL;INPP5K;INPP5B;PTEN;SYNJ2
prerank,inositol phosphate dephosphorylation (GO:0046855),0.5725510715388642,1.180897064761807,0.289875173370319,0.8639090650563327,1.0,5/11,27.87%,OCRL;INPP5K;INPP5B;PTEN;SYNJ2
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.5464600574224301,1.1805965911436622,0.26045883940620784,0.8640852982371994,1.0,6/13,26.46%,XRCC3;DYNC1LI1;CDK5RAP2;ANAPC15;TPR;DUSP1
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.5656515470322543,1.1803261660451103,0.266016713091922,0.8641979772312904,1.0,1/11,0.45%,GSN
prerank,inositol lipid-mediated signaling (GO:0048017),0.44513039538399607,1.1802919665022755,0.2222222222222222,0.8633350464626285,1.0,15/50,17.17%,IRS1;FGFR1;PLCE1;PIK3C2B;PIK3R2;PLCB4;INPP5F;PIK3CA;IRS2;RHOA;PI4KB;PDGFRA;PI4KA;OGT;PLCD4
prerank,response to acidic pH (GO:0010447),0.5505779549435823,1.1797263633201183,0.28940217391304346,0.8645462966593791,1.0,3/13,15.25%,RAB11FIP5;SLC9A1;CHP1
prerank,regulation of postsynapse organization (GO:0099175),-0.3430728897174288,-1.1796519360668216,0.14754098360655737,0.6486004837626002,1.0,7/28,5.39%,EPHA4;PDLIM5;CDKL5;WNT5A;SHANK3;SIPA1L1;ABHD17C
prerank,regulation of actin filament-based movement (GO:1903115),0.5943987136868558,1.1794342738689871,0.29427792915531337,0.8647468187387272,1.0,4/10,15.37%,ANK2;SRI;PDE4D;STC1
prerank,negative regulation of multicellular organismal process (GO:0051241),0.4108841646948802,1.179280004321513,0.14228456913827656,0.8643890650822402,1.0,35/199,11.91%,ADAMTS5;LOXL2;PARP3;WNT10B;RAB11FIP5;EGFR;HPN;NPTN;LDLRAD4;SRSF6;F2R;HDAC9;SYT11;PROCR;TRPV3;ATP2B4;DOCK7;NR1D1;NFIB;PFN2;LNPEP;GAS6;FLCN;SPX;WDR77;FOXC2;TLR4;PAEP;SMAD6;ALPK2;HS3ST5;SLC6A4;GPNMB;VASN;PGAM5
prerank,regulation of viral transcription (GO:0046782),0.4654847142823977,1.178647825473735,0.2491544532130778,0.8658908556664853,1.0,12/39,16.12%,POLR2H;TARBP2;MID2;MDFIC;CDK9;TRIM11;ZFP36;POLR2D;POLR2G;CTDP1;GTF2F1;UBP1
prerank,positive regulation of cytokine production (GO:0001819),0.40681379649886695,1.1782914915988154,0.0732196589769308,0.8663578741416164,1.0,38/292,11.89%,CD34;SYK;LBP;CD80;CCBE1;IRF4;POLR2H;ANXA1;IL16;GLMN;EIF2AK3;RAB7B;SULF2;FOXP1;F2R;RFTN1;RUNX1;MIF;TMEM106A;MAPK14;IL33;CGAS;TLR5;SULF1;SCAMP5;IL17RA;DHX33;POLR3E;PRKD2;TIRAP;TLR4;PAEP;MAPK11;POLR3D;CEBPB;IRAK1;PDE4D;PIBF1
prerank,positive regulation of cellular component organization (GO:0051130),0.4202872723955009,1.1768249685533176,0.18499486125385406,0.8710684229237761,1.0,20/107,12.19%,SYK;AR;LRP1;TGFB3;DCTN1;GPC3;NEUROD2;VEGFA;TGFB2;CDC42EP2;RUNX1;MPP7;GNL3L;SURF4;LMAN1;TIRAP;GPX1;BMF;BAK1;TMEM30A
prerank,negative regulation of catabolic process (GO:0009895),0.4530508333450551,1.1765620616176502,0.23905723905723905,0.8711910104742921,1.0,14/47,21.70%,EGFR;IRAK3;ZDHHC7;MDM4;TIGAR;SIRT2;PIN1;NCOR1;PDE3B;HDAC4;NUPR1;FLNA;FMN2;AZIN2
prerank,regulation of cellular ketone metabolic process (GO:0010565),-0.2944749007548056,-1.176175818443365,0.13333333333333333,0.6552586832351829,1.0,27/61,24.29%,PRKAG2;PPARA;PSMC1;CAV1;PSMA5;PSMD12;SIRT5;PSMF1;PSMA2;SIRT1;PSME2;PSMA3;FGFR4;PSME1;PSMB10;PSMA1;PSMB8;PSMB9;NR1H4;PSMB4;PSMA8;PDK4;PSMD6;NQO1;PSMD11;PSMD10;PSMD9
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.5788289993434396,1.1753969748497244,0.2887323943661972,0.87490428054699,1.0,3/10,8.17%,LRP1;PTPRJ;NDRG4
prerank,positive regulation of protein polymerization (GO:0032273),0.4381064362942299,1.1753706714692675,0.23779193205944799,0.8740156782150359,1.0,22/65,21.98%,DCTN1;CDC42EP2;BIN1;CLIP1;PSRC1;PFN2;TOGARAM1;MAPRE1;MAPT;FCHSD1;TPPP3;SLAIN2;FER;HSP90AA1;ARF6;CDK5RAP2;NCK1;AKAP9;NAV3;NUMA1;PYCARD;CTTN
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),0.5450051972260893,1.1752820210130752,0.2872200263504611,0.8733417637030306,1.0,5/14,18.58%,ENTPD2;NUDT1;NUDT16;NUDT5;ENTPD6
prerank,cellular response to sterol (GO:0036315),0.5464781795271165,1.1751521910340805,0.2868525896414343,0.8728617813185893,1.0,3/13,8.51%,LRP6;GRAMD1A;INSIG2
prerank,negative regulation of endopeptidase activity (GO:0010951),0.4476453930024038,1.1749858925733532,0.2513842746400886,0.8724917556348728,1.0,9/47,12.90%,TIMP2;SERPINB8;BIN1;SERPINE3;SERPINF1;SERPINH1;AKT1;RECK;SERPING1
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.48447079552250955,1.1749512888244737,0.2693682955899881,0.8716410468971666,1.0,4/29,11.82%,FANCD2;RNF212B;SYCP2;TERB1
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.4494929039601139,1.1743652704412388,0.25027808676307006,0.8730387005989294,1.0,4/45,5.61%,MID1;IRF4;CD44;CAMK2D
prerank,TOR signaling (GO:0031929),0.4842105379932869,1.1739660532184908,0.2636138613861386,0.8736261730569329,1.0,14/26,29.14%,MTOR;MEAK7;FLCN;SYAP1;AKT1;LARP1;CARD11;CCDC88A;TIPRL;MAPKAP1;EIF4EBP2;PRR5;RHEBL1;FNIP1
prerank,response to insulin (GO:0032868),0.4241467903048568,1.1738037324823238,0.226215644820296,0.8732779721485635,1.0,31/80,21.66%,IRS1;HDAC9;PIK3R2;ZFP36L1;SLC39A14;FOXO1;MEAK7;MYO5A;INSIG2;SYAP1;EPM2AIP1;KAT2B;INPP5K;RHOQ;AKT1;IRS2;EIF6;PDE3B;FER;PKM;SELENOS;OGT;CPEB1;EPRS1;VAMP2;CAPN10;GPLD1;LPIN3;GOT1;RAB10;SLC25A33
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.5516457558064232,1.1735974617785698,0.2998661311914324,0.8731105915376833,1.0,4/13,15.37%,CD2BP2;USP4;PRPF3;DDX20
prerank,monoacylglycerol metabolic process (GO:0046462),0.5556040166363433,1.173518480366671,0.2827586206896552,0.8724427369643472,1.0,1/13,0.62%,MGLL
prerank,mitotic recombination (GO:0006312),0.5219804588130958,1.1727448951934492,0.2766233766233766,0.8746524917689354,1.0,8/15,26.42%,XRCC3;SMC5;SMC6;RAD50;TEP1;ERCC1;NSMCE2;RAD51D
prerank,cardiac ventricle morphogenesis (GO:0003208),-0.3201859072039907,-1.1723549130784667,0.21666666666666667,0.6627979225275823,1.0,8/41,6.77%,TPM1;ENG;CPE;MEF2C;NOTCH1;TGFBR3;FGFR2;HEYL
prerank,regulation of myotube differentiation (GO:0010830),0.5014412918260847,1.1719433691414145,0.24452554744525548,0.8769551924023604,1.0,6/24,13.86%,TMEM119;HDAC9;MAPK14;ATP11A;HDAC3;HDAC4
prerank,ventricular septum morphogenesis (GO:0060412),0.49154027578378345,1.171231921312346,0.26570048309178745,0.878778807670965,1.0,7/27,7.56%,TGFB2;SLIT3;SLIT2;TGFBR2;SMAD4;ACVR1;ZFPM2
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.5286989403720804,1.1708441408582229,0.28846153846153844,0.8793726935521335,1.0,3/16,4.58%,IGFBP5;IGFBP6;IGFBP4
prerank,amide transport (GO:0042886),-0.3636683050630849,-1.1704787834245476,0.19230769230769232,0.665487529943609,1.0,7/26,9.21%,PLTP;ABCG2;PDPN;PLEKHA8;CERT1;AQP11;SLC38A5
prerank,glutamine family amino acid catabolic process (GO:0009065),-0.4388808289096341,-1.1703409091221717,0.26556016597510373,0.6633219164418742,1.0,5/13,11.92%,GLUL;NOS3;PRODH;ALDH4A1;NOS1
prerank,protein homooligomerization (GO:0051260),0.41644597127332694,1.169915186146701,0.18979591836734694,0.8820659229590574,1.0,20/114,14.87%,SCARA5;SLC1A5;DISP1;MIF;P2RX3;TK1;KCNJ2;MPP2;OSBPL2;PKD2;ZBTB1;SAMHD1;VSTM5;ADCY8;ALDH1A3;TMEM120A;GLS;NACC2;KCNC2;CRYZ
prerank,N-terminal protein amino acid modification (GO:0031365),0.5358026453586591,1.1698902984676856,0.27140974967061926,0.8811842894322642,1.0,6/14,21.79%,NTMT1;NAA15;METAP2;NAA50;METAP1;METAP1D
prerank,skeletal muscle contraction (GO:0003009),0.5221949731679358,1.1698598302757903,0.28797083839611176,0.8803123074673634,1.0,3/19,9.11%,JSRP1;TNNI3;MYH14
prerank,anterior/posterior pattern specification (GO:0009952),0.43937517102133156,1.1697988253939653,0.253551912568306,0.8795483373200618,1.0,10/53,14.58%,HOXA3;WT1;PCSK5;BHLHE40;SKI;HOXA5;HOXA4;HOXA7;HOXC4;HOXA9
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.4096594123876005,1.169579996999524,0.20182555780933062,0.8794653263138756,1.0,24/129,13.18%,SFRP4;COL1A1;DKK2;EGFR;SCEL;GPC3;PSMC4;UBE2B;SMURF2;AXIN1;DACT1;DAAM2;PSMC6;PSMD8;GSKIP;PLEKHA4;KANK1;TMEM9;CSNK1G1;CSNK1G3;PRDM15;JUP;EGF;PIN1
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.4678400455846779,1.1694591100312322,0.2633495145631068,0.8790029054271746,1.0,7/30,16.60%,ACKR3;CD44;MIF;FBXO5;TWIST1;THOC1;SNAI2
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.5560739470830943,1.1691706398086472,0.2883845126835781,0.8790786813569261,1.0,6/14,26.92%,TSEN54;RTRAF;CPSF4;TRPT1;CPSF1;DDX1
prerank,protein palmitoylation (GO:0018345),0.47479703084686287,1.1689669232013435,0.27078384798099764,0.8788560802686247,1.0,13/30,23.21%,ZDHHC16;ZDHHC7;HHAT;SELENOK;ZDHHC2;ZDHHC4;ZDHHC24;ZDHHC21;ZDHHC20;CLIP3;ZDHHC18;ZDHHC8;ZDHHC5
prerank,endochondral bone morphogenesis (GO:0060350),-0.4491162657557187,-1.1675041396084214,0.24427480916030533,0.668417074432112,1.0,7/11,16.52%,MEF2C;FOXC1;COL13A1;INPPL1;BMPR2;TRPV4;FGFR3
prerank,neuron remodeling (GO:0016322),-0.4722227304702121,-1.1673929441904922,0.28975265017667845,0.6662009616431771,1.0,7/10,22.66%,APP;EPHA8;ANKS1A;CX3CL1;C1QA;C3;SCARF1
prerank,generation of neurons (GO:0048699),0.4022514493017684,1.1672281172405474,0.15577889447236182,0.8846914461775812,1.0,33/190,15.34%,LMX1A;LHX8;NAV1;WNT10B;WNT2;MAP1B;FGFR1;CTF1;SIX4;NEUROD2;WNT9A;FGF13;TGFB2;BHLHE40;RUNX1;LMX1B;IRX5;POMGNT2;DOCK7;LRP12;FZD7;SEMA3A;NRBP2;FUT9;MAPT;PIN1;SIX1;TAFA1;ARTN;THOC2;POU3F2;MDGA1;FZD4
prerank,negative regulation of secretion by cell (GO:1903531),0.4549169396451716,1.1667521774808711,0.2747126436781609,0.8855826304620052,1.0,4/38,5.42%,LIF;ANXA1;SYT11;RHBDF1
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.4283327289272084,1.1667404289474814,0.25109170305676853,0.8846408571066211,1.0,16/62,19.36%,ACKR3;MAPK7;NFE2L2;SYVN1;CREB3L1;SRC;NOC2L;HERPUD1;URI1;AKT1;SELENOS;SNAI2;HTRA2;PPIA;PLAUR;MCL1
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.47114887425580687,1.1666540416264521,0.26913875598086123,0.883990478054202,1.0,10/30,16.59%,AR;FOXP1;PRMT2;HDAC6;NCOR2;NCOR1;SMARCA4;RNF14;TRIM68;DDX5
prerank,positive regulation of ATP metabolic process (GO:1903580),-0.3304870486296611,-1.1665192037924192,0.2108843537414966,0.6660948560612544,1.0,7/32,7.51%,INSR;IGF1;APP;PRKAA2;PPARA;PINK1;ENO1
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.517072489308538,1.1664296694281053,0.2963446475195822,0.8839010859251908,1.0,1/16,0.24%,ACKR3
prerank,cellular response to increased oxygen levels (GO:0036295),0.57387191389921,1.1664248073239303,0.2923076923076923,0.8829448777474026,1.0,5/11,19.70%,ATP6V0A2;FOXO1;ATP6AP1;CCDC115;TMEM199
prerank,negative regulation of fat cell differentiation (GO:0045599),0.4659502801493309,1.165838697338373,0.2628434886499403,0.8843384206674557,1.0,8/34,9.06%,WNT10B;WWTR1;TRIO;FOXO1;ZFPM2;FLCN;ZFP36L2;SIRT2
prerank,positive regulation of macrophage migration (GO:1905523),-0.3741170293521844,-1.1657358574194177,0.24778761061946902,0.6657213796576831,1.0,6/19,13.28%,IL34;THBS1;CX3CL1;MDK;MAPK3;PTK2
prerank,positive regulation of developmental process (GO:0051094),0.4107234500075913,1.1652038560170808,0.16851664984863773,0.8859068425273369,1.0,26/164,9.28%,DCN;AR;PHLDB1;BMP1;WT1;FGFR1;TLE6;TMEM119;NEUROD2;VEGFA;COBL;DLG4;LMNA;SMURF2;ACVR1;KRT10;NCOA3;C1QBP;SRC;MIEF2;HMCES;SOX8;MCU;PSEN1;AGO2;SOX5
prerank,regulation of protein catabolic process (GO:0042176),0.41701449252951395,1.164842901837764,0.2134020618556701,0.8864395694690775,1.0,24/99,16.89%,EGFR;GPC3;IRAK3;STX5;SMURF2;AXIN1;DACT1;ITCH;FOXO1;SEC22B;MDM4;EGLN2;WDR91;DTL;SIRT2;ODC1;HECW2;TMEM9;PIN1;ZDHHC2;DDB1;NSF;HACE1;IDE
prerank,regulation of endocytosis (GO:0030100),0.43410794370985084,1.1648254972820797,0.25026968716289105,0.8855256871327244,1.0,18/61,19.46%,STON2;LRP1;GPC3;EPHA3;CD177;SYT11;SRC;RIT2;SCAMP5;ABL2;ARFGAP1;RUFY1;CALY;RAB5B;RAB5C;SMPD1;CLIP3;LRSAM1
prerank,response to reactive oxygen species (GO:0000302),0.4329539429791517,1.1643605468071168,0.27071823204419887,0.8863533007589662,1.0,14/54,14.38%,UCP1;EGFR;STK25;FYN;ADAM9;PKD2;CHUK;GPX1;CAMKK2;AKT1;MAPT;PDGFRA;FER;STK24
prerank,regulation of apoptotic signaling pathway (GO:2001233),-0.3256450051510832,-1.1642340710401708,0.1953125,0.6672886872486122,1.0,9/36,12.46%,SGMS1;BCL2;DAB2IP;TPD52L1;DAPK2;ING5;CX3CL1;FAS;BDNF
prerank,cellular protein localization (GO:0034613),0.4032840414757507,1.1640218587098288,0.11311311311311312,0.8867334197552811,1.0,100/285,23.64%,FGF7;SGSM2;EGFR;COPA;STX2;RAB32;RABGAP1L;CD177;RAB6A;ANK2;STX1A;TMED1;STX5;STX11;SEC31A;RAB23;RAB19;RAB6B;SCFD2;JAM3;USP4;ARF4;SCG5;TBCK;BICD1;AP3D1;HDAC6;STX1B;CLTC;SNX1;ACD;PACS2;USO1;TBC1D2B;ARFGAP3;STX4;TBC1D17;GGA1;SCFD1;WIPI2;ARF1;STX12;WDR45B;NPM1;SEC23IP;COPB2;VPS33A;TBC1D10A;NAPA;DUOXA1;STX17;RAB43;RPGR;HPS6;RRAGD;ARFRP1;BBS4;SYNDIG1;PIGK;ARF6;GGA2;AHI1;NSF;EVI5;SGSM1;COPZ2;EVI5L;AP4M1;NAPG;TBC1D13;RAB1B;RAB5B;RAB5C;STX3;SNX6;ARCN1;ADPRH;TBC1D22B;ATG13;TBC1D15;NIPBL;RAB24;TMED2;VPS33B;FLNA;COX18;CNTN2;ABHD17A;RUNDC1;CTTN;SMURF1;CROCC;SEPTIN9;NAPB;STX16;CNTNAP1;TBC1D8B;TBC1D12;PICK1;RABL3
prerank,negative regulation of RNA metabolic process (GO:0051253),0.5172945230200771,1.163829793839659,0.292713567839196,0.8864551354718848,1.0,8/18,21.98%,ESR1;KAT2B;NUDT16;NCOR2;NCOR1;ZC3H12A;PTBP1;PTBP2
prerank,7-methylguanosine mRNA capping (GO:0006370),0.476531572500842,1.1636048803044485,0.29534883720930233,0.8854198328155737,1.0,8/31,15.40%,POLR2H;GTF2H3;ERCC3;POLR2D;POLR2G;CCNH;GTF2F1;CMTR2
prerank,7-methylguanosine RNA capping (GO:0009452),0.476531572500842,1.1636048803044485,0.29534883720930233,0.8854198328155737,1.0,8/31,15.40%,POLR2H;GTF2H3;ERCC3;POLR2D;POLR2G;CCNH;GTF2F1;CMTR2
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.4744507319663264,1.163527252265673,0.28361858190709044,0.8847515401716668,1.0,11/27,24.63%,IRS1;GRB10;TNS2;PID1;INPP5K;KANK1;NCK1;PIP4K2C;PIP4K2B;TSC2;PRKCZ
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.5754145037008187,1.1635235943792346,0.28368794326241137,0.8837878239014701,1.0,3/10,11.31%,MIA3;TLR4;AKT1
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.5365585034696846,1.1630042076030702,0.29654255319148937,0.8848467378080839,1.0,6/14,19.26%,WNT9A;CHADL;SNAI2;EFEMP1;TGFBR1;RFLNA
prerank,transport along microtubule (GO:0010970),0.5497144990166922,1.162852908363425,0.2953020134228188,0.8844626025019041,1.0,6/13,22.58%,ARHGAP21;APBA1;DYNC1I1;CLIP3;COPG1;BAG3
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.40865993813801565,1.1628477468530232,0.1762917933130699,0.8835151504322342,1.0,24/152,14.19%,ADGRD1;GNAS;VIPR2;LPAR3;GPR12;GNAI3;LPAR1;GLP2R;CXCL10;S1PR2;ABCA1;HTR1F;ADCYAP1;ADGRG2;CRHR1;GNAZ;CALCA;AKAP12;GPR161;GPR37L1;TSHR;ADCY8;GPR37;LHCGR
prerank,regulation of neuron migration (GO:2001222),0.48136222263320916,1.162215119661848,0.291970802919708,0.8850472321084427,1.0,9/26,18.95%,COL3A1;IGSF10;TNN;SEMA3A;KIF20B;NSMF;SRGAP2;SHTN1;NIPBL
prerank,male gonad development (GO:0008584),0.4754754954038407,1.1619155171028948,0.27102803738317754,0.8852429954923174,1.0,6/34,9.99%,AR;WT1;SIX4;TGFB2;SOX8;COL9A3
prerank,regulation of gastrulation (GO:0010470),-0.423316892452078,-1.1616958834237656,0.2727272727272727,0.6717808655689814,1.0,3/14,2.28%,PHLDB2;TENM4;OSR1
prerank,regulation of programmed necrotic cell death (GO:0062098),0.5099844190750692,1.1611580270433097,0.2964824120603015,0.8872875823469071,1.0,10/20,22.93%,SPATA2;STUB1;HSP90AA1;NUPR1;OGT;FLOT2;PDCD6IP;SDCBP;CYLD;FLOT1
prerank,maturation of LSU-rRNA (GO:0000470),0.48146809089042986,1.1606005981837997,0.2935444579780755,0.8884851594343525,1.0,10/26,22.24%,DDX18;URB1;ZNHIT6;RPL10A;EIF6;SNU13;RSL1D1;RPF2;MAK16;NOP2
prerank,regulation of phosphate metabolic process (GO:0019220),0.5258453648872023,1.1598324317232849,0.2955145118733509,0.8905407982132307,1.0,6/16,15.17%,TIGAR;PSEN1;SIRT2;SMG7;IL4;SMG6
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.49226536337631277,1.1595032938503473,0.2917166866746699,0.8908640178666142,1.0,8/22,22.45%,EDEM3;SYVN1;EDEM1;EDEM2;UBA52;AMFR;UGGT1;SEL1L
prerank,muscle contraction (GO:0006936),-0.27185450227847435,-1.1592835924681992,0.06666666666666667,0.6757559141554624,1.0,29/126,18.87%,SORBS1;TPM1;MYLK;CALD1;ACTN2;ITGA1;DMD;DTNA;DYSF;TMOD3;MYOF;EDNRA;MYL9;MYH11;SMTN;FXYD1;KCNJ12;ACTA2;NOS1;DES;MYOM1;MYL12A;CLCN1;MYBPC1;GJC1;UTRN;MYL6;ROCK1;TNNT3
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),-0.42774908140231005,-1.1589616500562263,0.27137546468401486,0.6740397565628181,1.0,7/14,17.24%,PLCG1;THBS1;ITGA4;RGCC;ECSCR;GPER1;CD40
prerank,regulation of endothelial cell proliferation (GO:0001936),0.41985324335156166,1.1588070022017054,0.23277661795407098,0.8926379393539352,1.0,19/88,12.38%,TNMD;FGF18;PRKCA;SPARC;ANG;ITGB3;VEGFA;FGF2;ECM1;FUT2;THBS4;SULF1;PRKD2;STAT5A;AKT3;EMC10;NRAS;AKT1;EGF
prerank,histone ubiquitination (GO:0016574),0.49390483133490215,1.1586431286028072,0.28877679697351827,0.892335613388605,1.0,9/21,25.69%,UBE2B;UBE2N;ATXN7L3;PHC1;UBE2A;USP22;PAF1;UBR2;RNF20
prerank,muscle organ development (GO:0007517),0.4370869155527255,1.158621192570492,0.27410617551462624,0.8914489525240318,1.0,10/54,10.55%,COL6A3;MAPK12;CTF1;FHL1;ITGA11;SRI;MEF2D;CXCL10;LARGE1;CHD2
prerank,positive regulation of myoblast differentiation (GO:0045663),-0.4133426863892101,-1.1584780055505275,0.24774774774774774,0.6728626582386407,1.0,4/16,4.85%,RANBP3L;MEF2C;IGFBP3;PLCB1
prerank,response to tumor necrosis factor (GO:0034612),0.41158945599207514,1.1584233179210535,0.23711340206185566,0.8912422817417361,1.0,18/91,15.58%,HAS2;CCL8;AFF3;ADAM9;NFE2L2;ZFP36L1;NR1D1;PID1;ZFP36L2;CHUK;CCL25;INPP5K;AKT1;ZFP36;CCL13;ZC3H12A;GGT7;BAG4
prerank,non-motile cilium assembly (GO:1905515),0.4694542372937053,1.1583244430042334,0.2818713450292398,0.8906784630952764,1.0,11/30,21.35%,DCTN1;ARL13B;TOGARAM1;PIBF1;VANGL2;BBS4;TTC8;RPGRIP1;CEP89;PCM1;IFT57
prerank,glutamate metabolic process (GO:0006536),0.5121253572381252,1.158253412099175,0.28337531486146095,0.8899813875710595,1.0,6/19,15.42%,GCLC;ALDH18A1;GLS2;GLS;ALDH5A1;GLUD1
prerank,BMP signaling pathway (GO:0030509),0.4286237201926423,1.1581867083440027,0.2558886509635974,0.8892763755759535,1.0,12/62,10.84%,AMH;TMEM100;TGFB3;TGFB2;SMAD4;ACVR1;BMP15;FAM83G;SMAD5;BMP8A;SMAD6;AMHR2
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.3937865797486527,-1.1580167881865275,0.28054298642533937,0.6716857933611861,1.0,2/16,1.52%,ATP1A2;DMD
prerank,vasodilation (GO:0042311),0.5357736902210058,1.157989236463833,0.2923497267759563,0.8891054458501548,1.0,2/13,4.86%,KCNMA1;KLF2
prerank,leukocyte cell-cell adhesion (GO:0007159),0.486443228815575,1.1579495774221573,0.2898203592814371,0.8882960870559278,1.0,2/24,2.49%,SYK;CD177
prerank,calcineurin-mediated signaling (GO:0097720),0.5758246005988948,1.1577722501722414,0.3328631875881523,0.8870838644665628,1.0,5/10,19.14%,NFATC4;NFATC1;PPP3CC;PPP3CA;PPP3CB
prerank,calcineurin-NFAT signaling cascade (GO:0033173),0.5758246005988948,1.1577722501722414,0.3328631875881523,0.8870838644665628,1.0,5/10,19.14%,NFATC4;NFATC1;PPP3CC;PPP3CA;PPP3CB
prerank,mesenchymal to epithelial transition (GO:0060231),0.5639913470118287,1.1576653821841338,0.30886426592797783,0.8865433840131782,1.0,2/10,8.19%,WT1;FZD7
prerank,dendrite self-avoidance (GO:0070593),0.5228660473334638,1.1575225162878227,0.30299089726918077,0.8861813259222331,1.0,7/16,21.46%,NPTN;TNN;DSCAM;IGSF9;PALLD;CNTN4;CNTN2
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.43084903814957803,-1.1572699516195617,0.26153846153846155,0.671189521355189,1.0,5/13,11.92%,NOS3;PPARA;PINK1;ENO1;NOS1
prerank,toll-like receptor signaling pathway (GO:0002224),0.4223486002549872,1.1572119543858996,0.24025289778714437,0.8864272903259699,1.0,36/84,30.46%,LBP;IRAK3;RFTN1;S100A8;S100A9;TLR5;SCARA3;CHUK;TIRAP;TLR4;IRAK4;IRAK1;TNIP1;UBA52;EPG5;CD14;TRAF3;ITGAM;UBE2D3;TAB2;MAP3K7;TNIP2;CTSK;TICAM1;HSP90B1;CTSB;CTSL;BCL10;CASP8;MAPKAPK3;SFTPA1;SFTPA2;MYD88;TRIL;LGALS9;TRAF6
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.5532837894948409,1.1571941829579404,0.3147632311977716,0.8855427780699674,1.0,1/12,1.26%,PRKCA
prerank,regulation of lysosomal lumen pH (GO:0035751),0.5545179027123819,1.157108358238843,0.2907608695652174,0.8849314331010544,1.0,5/12,19.70%,TMEM9;VPS33A;CCDC115;TMEM165;TMEM199
prerank,positive regulation of secretion (GO:0051047),0.5482774022670808,1.1570249219690123,0.3090128755364807,0.8843162060192095,1.0,3/11,19.54%,SCIN;TRH;GPLD1
prerank,vesicle transport along microtubule (GO:0047496),0.48822340846170353,1.156822630026136,0.28217821782178215,0.8841773005364205,1.0,10/23,26.54%,NDEL1;TRAK2;DYNC1I1;KIF3A;KIF3B;DYNC1H1;PAFAH1B1;FBXW11;RAB1A;KIFAP3
prerank,positive regulation of endothelial cell migration (GO:0010595),0.42321196659669924,1.156476326790288,0.2264736297828335,0.8845131899808959,1.0,23/84,14.56%,FGF18;PRKCA;FGFR1;ANGPT4;SPARC;ITGB3;VEGFA;FGF2;FOXP1;SMOC2;MAPK14;PLPP3;MAP2K3;PRKD2;STAT5A;FOXC2;AKT3;EMC10;AKT1;EGF;AAMP;ZC3H12A;BCAS3
prerank,negative regulation of cell migration (GO:0030336),0.4071643658079219,1.1563729629502473,0.20263424518743667,0.8840142198462538,1.0,31/137,15.37%,COL3A1;IGFBP5;HAS1;LRP1;TMEFF2;ADARB1;LDLRAD4;FGF2;SLIT2;MIF;TNN;GTPBP4;MIA3;PTPRJ;SRGAP1;PFN2;SULF1;PIP5KL1;FLCN;DPEP1;NDRG4;JAG1;KANK1;MITF;MAGI2;RECK;ADAM15;STK24;HOXA7;IL4;STC1
prerank,negative regulation of smooth muscle cell migration (GO:0014912),0.5461753718033301,1.1561370497954895,0.3032345013477089,0.8839649884971382,1.0,4/14,8.17%,IGFBP5;LRP1;SLIT2;NDRG4
prerank,cardiac myofibril assembly (GO:0055003),-0.4138536591044182,-1.1558927830197903,0.27125506072874495,0.6724618677164338,1.0,1/15,0.08%,NEBL
prerank,response to organic cyclic compound (GO:0014070),0.4339547191121722,1.1558061021658124,0.2836484983314794,0.8842783439622276,1.0,5/52,8.44%,IGFBP5;ESR1;ANXA1;SOCS2;CYP27B1
prerank,response to lipid (GO:0033993),0.4073639816041651,1.155626967394636,0.22760041194644695,0.8840566569242507,1.0,17/105,11.74%,LBP;ESR1;ANXA1;IRAK3;FOXP1;F2R;S100A8;S100A9;VPS4B;SOCS2;FOXO1;CYP27B1;TIRAP;TLR4;SMAD6;SLPI;IRAK1
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),-0.3501479178718277,-1.1555791499267745,0.25806451612903225,0.67084608719573,1.0,10/29,12.76%,ACSL1;ELOVL7;ACSL4;HACD1;ACSL3;CBR4;HACD2;ACSL6;SCD;ELOVL1
prerank,protein deubiquitination (GO:0016579),0.39846418363223884,1.1551244695492147,0.157,0.8850019865276951,1.0,87/242,27.59%,AR;ESR1;UCHL1;DESI2;PSMC4;JOSD2;SMAD4;SMURF2;USP36;COPS5;OTUD3;ZRANB1;SPATA2;FOXK2;USP32;USP10;RAD23B;IL33;USP29;USP4;PSMC6;MDM4;OTUD1;UCHL5;ADRM1;PSMD8;SENP8;ATXN7L3;KAT2B;POLB;USP26;USP33;OTUD7B;ACTR5;USP48;USP50;TNIP1;UBA52;USP5;ABRAXAS1;RHOA;NFRKB;ZC3H12A;RCE1;INO80;STAMBPL1;RNF128;USP7;TRAF3;USP22;OGT;KEAP1;CCP110;WDR20;TGFBR1;NEDD8;SKP2;SUDS3;KDM1B;FOXO4;USP35;TRRAP;PTEN;USP13;CLSPN;USP19;CYLD;MAP3K7;RNF123;TNIP2;TFPT;PSMD3;STAM;PSMD4;MDM2;ASXL1;UFD1;OTUD4;USP49;PSMB3;INO80C;CFTR;OTULIN;USP38;VCPIP1;USP9Y;PSMB2
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.5597458070717062,1.1550773860827177,0.301521438450899,0.884271466888824,1.0,7/11,28.38%,ZMIZ1;SMARCD1;PADI2;ELOF1;SERTAD2;ARID1A;ARID1B
prerank,DNA geometric change (GO:0032392),0.4837525159002076,1.1549990757314526,0.2822085889570552,0.8836175648079155,1.0,10/24,18.63%,ANXA1;ASCC3;DNA2;DDX11;NBN;HMGB3;RECQL;RAD50;BLM;SUPV3L1
prerank,outflow tract septum morphogenesis (GO:0003148),0.4901468685497566,1.1548079975066452,0.2973621103117506,0.8834201164291959,1.0,7/24,10.09%,SEMA3C;TGFB2;TGFBR2;SMAD4;ACVR1;ZFPM2;SMAD6
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.49251669968837064,1.1545634882682678,0.30049261083743845,0.8834724416492072,1.0,2/22,8.30%,CD55;ZBTB1
prerank,regulation of T cell cytokine production (GO:0002724),0.534205194251065,1.1544771528577025,0.3157199471598415,0.8828911626824079,1.0,1/15,0.49%,CD55
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.5567988009498896,1.1541668092396795,0.3103448275862069,0.8831405416579644,1.0,6/11,27.55%,MOSPD3;BNIP1;RTN4;ATL1;LPCAT3;VCPIP1
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.4914475691058944,1.15411229441651,0.3077858880778589,0.8824176320184456,1.0,8/23,20.50%,SCNN1B;SLC12A8;SLC12A4;SLC9A1;SLC12A5;SLC9A7;KCNH2;SLC12A6
prerank,regulation of monooxygenase activity (GO:0032768),0.4941701812259183,1.1540904102158913,0.3001230012300123,0.8815746481259932,1.0,8/23,17.32%,CYGB;EGFR;VDR;AKT1;POR;GDNF;HSP90AA1;ZDHHC21
prerank,spindle assembly (GO:0051225),0.4282724073951604,1.1539284967532075,0.24498416050686378,0.8812417746294048,1.0,22/67,21.06%,KIFC2;MAPRE3;STARD9;TOGARAM1;KIF2A;ARHGEF10;SMC1A;HDAC3;MAPRE1;HAUS3;PIBF1;NCOR1;ABRAXAS1;RHOA;KIF3B;INO80;NEK7;STAG2;FLNA;CLASP2;NUMA1;TUBGCP5
prerank,regulation of mitochondrion organization (GO:0010821),0.4410819291668452,1.1538545733158594,0.2737556561085973,0.8806444841079307,1.0,20/47,26.67%,USP36;MIEF2;HDAC6;PID1;FLCN;SQSTM1;MAPT;VDAC1;HTRA2;IAPP;SREBF1;STAT2;CSNK2A2;PARL;FIS1;RHOT2;FBXW7;MUL1;INF2;PLSCR3
prerank,regulation of response to stress (GO:0080134),0.5768677619078614,1.153734866054017,0.32848837209302323,0.8801961468428877,1.0,2/10,12.54%,CORO2B;ADCY8
prerank,anterograde axonal transport (GO:0008089),0.4606314223704896,1.153706185757529,0.29118329466357307,0.8793844707550815,1.0,12/37,21.23%,DTNBP1;DLG2;NEFL;TRAK2;AP3D1;KIF3A;KIF3B;BLOC1S2;RAB27B;SNAPIN;MAP1A;AP3B2
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.5668500197866864,1.1536871874169512,0.31636863823933975,0.8785307878903291,1.0,2/10,8.10%,GHR;STAT5A
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),0.4958403376852893,1.1536479678709808,0.2844611528822055,0.877744894502168,1.0,7/22,16.99%,EIF2AK3;MTOR;DHX33;UBTF;DDX11;SMARCA4;IPPK
prerank,leukotriene biosynthetic process (GO:0019370),-0.4260305960956625,-1.1534417639576764,0.2637795275590551,0.67392448544281,1.0,9/14,33.13%,GGT5;GGTA1;MGST3;GGT1;PLA2G4A;PLA2G5;ALOX5AP;MGST2;ALOX5
prerank,regulation of complement activation (GO:0030449),0.45469668568790006,1.1532345384316538,0.2767653758542141,0.8783594311276619,1.0,8/40,13.59%,CD55;CFH;C7;C1QBP;CD81;C4B;SERPING1;CR2
prerank,regulation of cytoskeleton organization (GO:0051493),0.4092176577339134,1.153210404886038,0.2329896907216495,0.8775267213787278,1.0,23/108,16.21%,PHLDB1;CDK2AP2;CORO2B;ARHGAP44;LRP1;EFNA5;EPHA3;CAPN2;S100A8;S100A9;SORBS3;MTOR;FSCN1;BICD1;IQGAP1;RHOQ;MAPT;TAOK2;MAP6;RHOA;DIAPH1;RND3;RAC3
prerank,gonad development (GO:0008406),0.45615865125287036,1.1528119108257366,0.28698553948832034,0.8781300804812985,1.0,8/41,9.99%,AR;WT1;SIX4;TGFB2;IRX5;NUP107;SOX8;COL9A3
prerank,steroid hormone biosynthetic process (GO:0120178),0.470182616559518,1.1526595008155638,0.2977461447212337,0.8777816769138875,1.0,6/29,23.87%,AKR1B1;SRD5A1;HSD17B8;FDX1;HSD17B11;SRD5A3
prerank,ceramide transport (GO:0035627),-0.43721341568993943,-1.151971020327559,0.28771929824561404,0.6754637709262491,1.0,3/12,3.81%,PLTP;PLEKHA8;CERT1
prerank,positive regulation of cardiocyte differentiation (GO:1905209),-0.45794523665059855,-1.1519116600414494,0.3,0.6732026008481946,1.0,5/11,15.14%,EFNB2;MEF2C;TGFB1;GPER1;MYOCD
prerank,negative regulation of interleukin-12 production (GO:0032695),0.531774863749898,1.1515487921605978,0.30398899587345257,0.8810421533463743,1.0,3/14,11.89%,IRAK3;C1QBP;PIBF1
prerank,replicative senescence (GO:0090399),-0.46002277417259596,-1.1515195776567189,0.2644927536231884,0.6718832116329425,1.0,7/12,31.66%,ATM;TERT;SERPINE1;PLA2R1;CHEK1;ATR;WNT16
prerank,positive regulation of viral process (GO:0048524),0.43322504825036057,1.1514451136224308,0.2678375411635565,0.8805259570611774,1.0,14/60,15.32%,AXL;POLR2H;TARBP2;ADARB1;KPNA2;MDFIC;CDK9;LARP1;POLR2D;POLR2G;DDB1;CTDP1;GTF2F1;HACD3
prerank,negative regulation of cell growth (GO:0030308),0.4087175502132146,1.1513113816538336,0.20901639344262296,0.8801307885076687,1.0,25/121,15.05%,WT1;DCBLD2;FHL1;DACT3;FGF13;TGFB2;SLIT3;SLIT2;PTPRS;CDKN2AIP;SMAD4;GNG4;PSRC1;PTPRJ;TRIM46;FLCN;CYP27B1;BCL6;DNAJB2;ULK2;ADAM15;CDKN1A;ULK1;DCC;SMARCA4
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),-0.3911217460183291,-1.1511357306914372,0.2796610169491525,0.6705124577089747,1.0,15/16,46.94%,CEACAM1;CYRIB;PTPRC;AGER;LILRB1;FADD;IL12A;IL12RB1;IL23A;KLRD1;IL23R;IL12B;RIPK3;XCL1;KLRC1
prerank,positive regulation of integrin activation (GO:0033625),0.5528218128529119,1.1509916028886698,0.3245492371705964,0.8804231974361133,1.0,2/11,6.81%,RAP1B;SRC
prerank,regulation of cytoplasmic transport (GO:1903649),0.5559716803832955,1.1508864314531015,0.3125,0.8799052259206598,1.0,5/11,21.04%,ATP9A;SRC;USP7;MAP2K2;MAPK1
prerank,regulation of multicellular organism growth (GO:0040014),0.5314686808807667,1.1508008143099142,0.31151832460732987,0.8793230102172437,1.0,2/15,8.10%,GHR;STAT5A
prerank,cellular response to lipopolysaccharide (GO:0071222),0.4103817648567702,1.1504523254096737,0.24407826982492276,0.879772951310061,1.0,19/101,16.30%,LBP;CD80;AXL;ADAM9;MAPK14;NR1D1;CXCL10;CARD16;TLR4;SIRPA;IRAK1;ZFP36;RHOA;TNFRSF1B;ZC3H12A;CD14;SELENOS;PDCD4;IL6
prerank,histone H3-K36 demethylation (GO:0070544),-0.46290588872337063,-1.1503517396765712,0.2895622895622896,0.6702036275568217,1.0,2/10,2.52%,KDM7A;KDM4A
prerank,defense response to Gram-positive bacterium (GO:0050830),0.44802325615747435,1.149800727995492,0.28018223234624146,0.8813671701382962,1.0,7/40,18.60%,LBP;ANG;TIRAP;DMBT1;RNASE6;IL6;MBL2
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.5059036587665443,1.149721366254216,0.2809278350515464,0.8807491847058448,1.0,10/20,25.77%,PPIL6;NKTR;PPIC;PIN1;PPIA;FKBP4;FKBP1A;PPIG;CWC27;PPIH
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.447482572845861,1.1489402489425118,0.28929384965831434,0.882798445109503,1.0,15/39,23.58%,TTC7A;PIK3C2B;PIK3R2;SOCS2;PI4K2B;PIK3CA;PI4KB;PI4KA;SOCS6;PIP4K2C;IP6K1;PIP4K2B;PIK3CG;PI4K2A;TTC7B
prerank,regulation of axon regeneration (GO:0048679),-0.42640376429636523,-1.148673272037811,0.3079710144927536,0.6721508055576211,1.0,2/12,0.51%,PTN;EPHA4
prerank,actin nucleation (GO:0045010),0.48907411712657345,1.1485448270255536,0.3008631319358816,0.883365911926839,1.0,6/21,17.42%,SCIN;ACTR3;MAGEL2;ARPC5L;ARPC1A;ARPC2
prerank,carboxylic acid metabolic process (GO:0019752),0.4558392208052041,1.148499358896199,0.29350348027842227,0.8826299333387526,1.0,11/33,18.68%,CYP2S1;LIPT2;MIF;PON3;SLC23A1;SLC23A2;SLC2A3;GLUD1;GSTO2;ST3GAL1;GNE
prerank,protein modification by small protein removal (GO:0070646),0.396467756691868,1.1484168915475643,0.16,0.88204012849167,1.0,85/252,25.98%,AR;ESR1;UCHL1;DESI1;DESI2;PSMC4;JOSD2;SMAD4;SMURF2;USP36;COPS5;OTUD3;ZRANB1;FOXK2;USP32;USP10;RAD23B;IL33;USP29;USP4;PSMC6;MDM4;OTUD1;UCHL5;ADRM1;PSMD8;SENP8;TOR1A;KAT2B;POLB;USP26;USP33;OTUD7B;ACTR5;USP48;USP50;TNIP1;UBA52;USP5;ABRAXAS1;RHOA;NFRKB;ZC3H12A;RCE1;INO80;STAMBPL1;RNF128;USP7;TRAF3;USP22;OGT;KEAP1;SENP6;CCP110;WDR20;TGFBR1;COPS4;NEDD8;SKP2;SUDS3;KDM1B;FOXO4;USP35;TRRAP;PTEN;USP13;CLSPN;USP19;CYLD;MAP3K7;RNF123;TNIP2;TFPT;PSMD3;STAM;GPS1;SENP5;PSMD4;MDM2;ASXL1;UFD1;OTUD4;USP49;PSMB3;INO80C
prerank,lung development (GO:0030324),0.4627833493113555,1.1473556939229492,0.29466357308584684,0.8851769223823981,1.0,6/33,7.50%,FGF7;VEGFA;FGF2;PKD1;RCN3;GLI2
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.4998225883173731,1.146967717216416,0.30892143808255657,0.885698797075958,1.0,5/17,17.22%,MAPK7;NFE2L2;AKT1;HTRA2;PPIA
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.4228341120728536,1.1469450624217634,0.2613882863340564,0.8848699545504077,1.0,14/66,14.30%,LIF;EIF2AK3;ZPR1;PIK3R2;WWTR1;MEPCE;PSEN1;RBM22;HDAC3;AKT1;CCT7;JUP;ZC3H12A;DMAP1
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.450730197954681,1.1464587406718219,0.2842227378190255,0.8858809004973636,1.0,14/39,20.71%,MYOC;CORO2B;EFNA5;MELTF;FZD7;JAG1;KANK1;ADAM15;RHOA;HOXA7;FZD4;RCC2;RASA1;CORO1C
prerank,ephrin receptor signaling pathway (GO:0048013),0.41713850374296135,1.1464191348646087,0.2630480167014614,0.8851270166373141,1.0,31/82,25.16%,EPHB2;ARHGEF28;EFNA5;DNM1;EPHA3;FYN;MMP2;ANKS1B;AP2A2;SRC;ACTR3;PSEN1;EPHB3;EPHA10;NGEF;RHOA;ACTG1;ARPC1A;SDC2;ARPC2;EPHB1;RASA1;TIAM1;YES1;SDCBP;AP2M1;VAV2;NCK2;EPHA5;ITSN1;RAC1
prerank,protein dephosphorylation (GO:0006470),-0.24165954249164362,-1.1461867214442283,0.0,0.6766225823817447,1.0,34/135,14.45%,PTPRK;PTPN14;EYA1;PTPRG;PTPRB;PPM1E;PPM1H;CTTNBP2NL;PTPRD;PPM1D;DUSP10;PTPN9;PTPRM;PTPRN2;PTPRZ1;SSU72;RPRD1B;PTPRO;PTPN1;UBLCP1;PPP2R2C;PPP1R15B;PPP2R5A;PPM1L;PTPRT;PTPN2;PPM1F;PTPN4;PTPN21;UBASH3B;DUSP7;PPP1CB;PPP4R1;CTDNEP1
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.5032042683058503,1.1461445470672564,0.3057324840764331,0.8852710178993793,1.0,4/17,8.92%,THBS4;C1QBP;MCU;TIRAP
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),0.5548327519834781,1.1460778044405897,0.31456043956043955,0.8846213204220659,1.0,6/11,26.46%,SLIT2;MIF;PADI2;NBL1;CCN3;DUSP1
prerank,positive regulation of developmental growth (GO:0048639),0.43855837877503157,1.145811217554164,0.3026607538802661,0.8847200265068444,1.0,11/49,18.84%,GHR;DBN1;SYT2;NTN1;ISLR2;L1CAM;MAPT;GOLGA4;SYT1;SHTN1;RIMS2
prerank,proton transmembrane transport (GO:1902600),0.452484488691676,1.145629315779343,0.2932242990654206,0.884520004915244,1.0,7/36,12.04%,UCP1;ATP1A4;ATP1A3;ATP1A1;SLC25A27;ATP5PO;SLC9A1
prerank,negative regulation of protein secretion (GO:0050709),0.44060647156980104,1.1455760993254362,0.30439814814814814,0.8838345448664102,1.0,6/38,9.60%,RAB11FIP5;IRS1;F2R;MIDN;RHBDF1;BMP8A
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.49072871145156105,1.1454579003290328,0.3067484662576687,0.8825348173447162,1.0,9/22,22.79%,ZDHHC7;ZDHHC2;ZDHHC4;ZDHHC24;ZDHHC21;ZDHHC20;CLIP3;ZDHHC18;ZDHHC8
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.49072871145156105,1.1454579003290328,0.3067484662576687,0.8825348173447162,1.0,9/22,22.79%,ZDHHC7;ZDHHC2;ZDHHC4;ZDHHC24;ZDHHC21;ZDHHC20;CLIP3;ZDHHC18;ZDHHC8
prerank,regulation of mononuclear cell migration (GO:0071675),-0.3653629400096486,-1.145048018303061,0.25882352941176473,0.6773768574669755,1.0,4/23,2.72%,LYN;IL34;BMP5;THBS1
prerank,regulation of ERBB signaling pathway (GO:1901184),0.5113361247472513,1.145026871360344,0.2878179384203481,0.883214017218771,1.0,5/15,14.21%,EGFR;RHBDF1;MVB12A;EGF;FER
prerank,neurotrophin signaling pathway (GO:0038179),-0.3865985395454006,-1.1449248715025104,0.2513089005235602,0.675366764032655,1.0,6/21,12.46%,RAPGEF2;SORT1;ZFYVE27;CASP3;NTRK2;BDNF
prerank,Golgi organization (GO:0007030),0.4079046620453077,1.1448950507747706,0.23721881390593047,0.8828041044645459,1.0,46/112,28.31%,SEC16B;ATP8B1;ARHGAP21;STK25;TMED1;STX5;FBXW8;FHDC1;ZW10;LYSMD3;RAB30;PI4K2B;SEC22B;SYNE1;SURF4;LMAN1;RAB2A;SEC23IP;STX17;RAB43;BCAS3;BLZF1;HACE1;DYNC2H1;ARFGEF1;TMED2;CLASP2;ATP8B2;VAMP4;TJAP1;PI4K2A;STX16;GOLPH3L;TRAPPC12;VTI1A;BAG5;RAB29;RAB1A;GOSR2;GBF1;ARHGEF7;GORASP1;CUL7;VCPIP1;NPLOC4;TMED3
prerank,protein localization to cell surface (GO:0034394),0.48040307330006804,1.1448479334724402,0.31204819277108437,0.8821012581107264,1.0,9/26,14.78%,FGF7;CD177;ANK2;JAM3;USP4;GGA1;PIGK;ARF6;GGA2
prerank,protein-DNA complex disassembly (GO:0032986),0.5229504458694257,1.1447320801319407,0.309462915601023,0.8816118373604507,1.0,7/16,19.50%,SMARCD2;SMARCD1;SMARCC2;SMARCA4;GRWD1;SET;RPL23
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.4791910422106199,1.144334694722981,0.30685920577617326,0.882149992150035,1.0,5/26,9.06%,IRAK3;ITCH;CARD16;C1QBP;SIRT2
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.5191144747970704,1.143722144543785,0.31704095112285335,0.883476546270089,1.0,5/16,18.23%,SRSF6;RBM17;DDX17;DDX5;PUF60
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.49039295322152154,1.1433883839587191,0.29818181818181816,0.8838590836821913,1.0,7/24,12.63%,JSRP1;SRI;CAMK2D;PKD2;GSTM2;PDE4D;CALM2
prerank,nucleosome disassembly (GO:0006337),0.5362069253282745,1.1432252295126097,0.3194805194805195,0.8826775309727269,1.0,6/14,17.70%,SMARCD2;SMARCD1;SMARCC2;SMARCA4;GRWD1;SET
prerank,chromatin disassembly (GO:0031498),0.5362069253282745,1.1432252295126097,0.3194805194805195,0.8826775309727269,1.0,6/14,17.70%,SMARCD2;SMARCD1;SMARCC2;SMARCA4;GRWD1;SET
prerank,regulation of mitochondrial fission (GO:0090140),0.4801036059525187,1.1431070695299625,0.3014705882352941,0.8822441410767988,1.0,10/24,26.56%,DCN;MIEF2;MCU;MAPT;DDHD1;RALA;STAT2;FIS1;MUL1;INF2
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.3980821142715123,1.1429288725054527,0.23529411764705882,0.8820572189034686,1.0,31/136,16.86%,SFRP4;ESR1;IRAK3;BHLHE40;GLIS2;PKD1;TCF7L2;ITCH;PRMT2;TBX6;GAS6;RNF2;PKD2;CHUK;TAF3;IRAK1;NWD1;COMMD6;HDAC4;ZC3H12A;KLF4;USP7;NUPR1;CHP1;NLRP2B;TRAF3;RBCK1;ANXA4;KEAP1;UFL1;TAX1BP1
prerank,peptidyl-methionine modification (GO:0018206),0.5455886926010582,1.142902793059246,0.31994459833795014,0.8812796901212834,1.0,6/12,23.22%,NAA15;METAP2;NAA20;METAP1;METAP1D;NAA30
prerank,histone H3 deacetylation (GO:0070932),0.5153673120330851,1.1428627569674232,0.28272251308900526,0.8805533254398132,1.0,5/15,16.20%,HDAC9;SIRT2;HDAC3;HDAC4;PER1
prerank,cellular response to growth factor stimulus (GO:0071363),0.3989782344055121,1.1427418328934984,0.22548028311425683,0.8800936795798914,1.0,41/151,16.75%,HAS2;HAS1;TMEM100;WNT2;EGFR;ANXA1;CLEC3B;CD44;MAPK7;GAS1;VEGFA;PDE8A;TGFBR2;ZPR1;SMAD4;MAPK14;ACVR1;ZFP36L1;MAP2K3;PRKD2;ZFP36L2;SYAP1;SIRT2;IQGAP1;SOX5;INPP5K;ERN1;URI1;AMHR2;AKT1;MAPT;MAGI2;KIDINS220;ZFP36;KLF4;RAPGEF1;HGF;STAT5B;SNAI2;HTRA2;RAB35
prerank,positive regulation of lyase activity (GO:0051349),-0.41766063264145353,-1.142689640829598,0.29435483870967744,0.6788737098827258,1.0,4/14,13.06%,NOS3;CACNA1D;NOS1;ISCU
prerank,positive regulation of DNA metabolic process (GO:0051054),0.4299933136039467,1.1426025925892536,0.27645788336933047,0.8797359054184515,1.0,16/61,17.41%,PARP3;EGFR;WT1;FGF2;SMOC2;STPG4;EYA2;UBE2N;PRKD2;TIGAR;ABRAXAS1;NBN;USP7;HGF;PML;RAD50
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.49628364023233323,1.1425016174207143,0.31738035264483627,0.8792314498694723,1.0,7/20,19.45%,TARBP2;TRIM71;AGO2;PUM1;AGO4;SNIP1;AGO3
prerank,actin-myosin filament sliding (GO:0033275),-0.3169652574511691,-1.1422081412428102,0.22,0.6753529105891724,1.0,3/38,1.52%,TPM1;ACTN2;DMD
prerank,muscle filament sliding (GO:0030049),-0.3169652574511691,-1.1422081412428102,0.22,0.6753529105891724,1.0,3/38,1.52%,TPM1;ACTN2;DMD
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.453834232300984,1.1421852210876031,0.3071512309495897,0.8795892191382317,1.0,12/32,21.72%,CDC14B;TAOK3;RINT1;DTL;TAOK2;CDKN1A;ABRAXAS1;NBN;NOP53;BLM;DONSON;CLSPN
prerank,mitochondrion transport along microtubule (GO:0047497),0.5374911172899371,1.1421304631342282,0.33060109289617484,0.878916555183863,1.0,6/13,25.60%,NEFL;SYBU;MAPT;UXT;MAP1S;RHOT2
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.4842343717226052,1.1418516976993325,0.30798004987531175,0.8791124666959287,1.0,5/24,12.28%,SEMA3C;VEGFA;SEMA3A;DSCAM;SEMA3D
prerank,fatty acid beta-oxidation (GO:0006635),0.43558982246091205,1.1415593015252479,0.28289473684210525,0.8793273050114225,1.0,18/51,22.15%,EHHADH;ETFA;CRAT;AUH;SCP2;ACADVL;SLC25A17;ACOX1;ETFB;ETFDH;BDH2;ABCD3;MCAT;HSD17B4;ACAT1;CPT2;PEX2;CROT
prerank,negative regulation of protein phosphorylation (GO:0001933),0.399864148118125,1.1415422454526634,0.21435793731041455,0.8785198949246761,1.0,38/150,16.35%,EPHB2;LRP6;NIBAN1;TARBP2;LDLRAD4;DGKQ;SLIT2;CAMK2N1;PMEPA1;WWTR1;PLPP3;DTNBP1;RTRAF;RASSF2;TARDBP;MYADM;MLXIPL;YWHAG;PID1;PIP5KL1;SIRT2;GSKIP;INPP5K;SMAD6;SIRPA;AKT1;PPEF2;PDE4D;SFN;CALM2;DEPTOR;SMCR8;TWIST1;ZC3H12A;CHP1;NLRP2B;CEP85;NCK1
prerank,positive regulation of lipid biosynthetic process (GO:0046889),-0.3288331353784817,-1.1412035314761737,0.21476510067114093,0.6757143375757256,1.0,5/29,5.24%,SORBS1;APOE;SCARB1;PPARA;NR1H3
prerank,positive regulation of activated T cell proliferation (GO:0042104),0.5002388367039737,1.1411098079315662,0.3060179257362356,0.8793026517507139,1.0,1/18,0.18%,TNFSF9
prerank,cellular response to acid chemical (GO:0071229),0.46648892699650835,1.1409356971982643,0.2929171668667467,0.879122804044884,1.0,10/27,22.92%,CAPN2;VEGFA;KLF2;MTOR;NSMF;RRAGD;CPEB1;IPO5;SESN2;SLC38A9
prerank,positive regulation of lipid catabolic process (GO:0050996),0.5053268287901436,1.1407658205341475,0.3075933075933076,0.8789057943794931,1.0,5/19,18.77%,IRS1;IRS2;TWIST1;DAGLB;ANGPTL3
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.41636670106593593,1.140714062651501,0.2730125523012552,0.8782480850725698,1.0,19/78,16.15%,AR;EPHB2;EGFR;LRP1;EPHA3;TMBIM1;ATP2B4;ZDHHC7;PID1;CLTC;STX4;RHOQ;SQSTM1;AKT1;ZDHHC2;PPFIA1;ARF6;PLS1;SPTBN1
prerank,high-density lipoprotein particle assembly (GO:0034380),0.5766141285050712,1.1404941342049693,0.33102493074792244,0.8781917503653293,1.0,2/10,7.01%,BMP1;ABCA1
prerank,negative regulation of metabolic process (GO:0009892),0.4349472401428949,1.1404601139412205,0.2629310344827586,0.877427662697787,1.0,9/54,9.08%,ADAMTS5;WNT10B;ZDHHC7;DOCK7;NR1D1;LNPEP;FLCN;FOXC2;TLR4
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.5330707207124572,1.1403493904705868,0.3016304347826087,0.8769688402120067,1.0,5/12,18.61%,FOXP1;TIRAP;TLR4;KLF4;MBP
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.4698507584584921,1.140073842621795,0.3150851581508516,0.8771254923122617,1.0,8/25,18.49%,ARHGAP44;SLIT2;PFN2;KANK1;CEP97;EVI5L;CCP110;ODF2L
prerank,double-strand break repair via homologous recombination (GO:0000724),0.4148652951336509,1.140000979678031,0.2515527950310559,0.8765205982743395,1.0,26/95,18.95%,REV3L;XRCC3;SFR1;RAD51B;RFWD3;UBE2N;HELQ;AP5S1;SAMHD1;MCM3;SMC5;RMI1;ERCC4;FAN1;SEM1;SMC6;NBN;INO80;RECQL;SPIDR;RNF138;RAD50;ERCC5;BLM;MORF4L1;NIPBL
prerank,negative regulation of osteoblast differentiation (GO:0045668),-0.32475429747108975,-1.1399911701904906,0.20134228187919462,0.6767259080632798,1.0,5/31,3.70%,RANBP3L;TMEM64;PTCH1;NOTCH1;CDK6
prerank,dendritic spine organization (GO:0097061),0.4662270421357847,1.1398596775571783,0.29328621908127206,0.8762216642463189,1.0,9/26,18.13%,EPHB2;FYN;DLG4;ARF1;EPHB3;CTNND2;DIP2A;CHRNA7;EPHB1
prerank,retinol metabolic process (GO:0042572),0.5214814048194377,1.1398412572151067,0.3062330623306233,0.8754184169728135,1.0,1/14,0.74%,DHRS9
prerank,T cell proliferation (GO:0042098),-0.41842910742527417,-1.1396151812460447,0.2902097902097902,0.6754328092077853,1.0,3/13,4.78%,CTPS1;DOCK8;CADM1
prerank,negative regulation of cytokine production (GO:0001818),0.399493680827632,1.139481116682689,0.2217741935483871,0.8759287750589692,1.0,31/163,16.86%,CD34;AXL;ANXA1;NPTN;IRAK3;HDAC9;HDAC7;SYT11;ITCH;C1QBP;INHA;GAS6;TLR4;SIRPA;OTUD7B;SLC2A10;GPNMB;PIBF1;ZFP36;PIN1;BCL3;CD200R1;ZC3H12A;KLF4;RNF216;SELENOS;ILRUN;PDCD4;IL6;ANXA4;TAX1BP1
prerank,inositol phosphate metabolic process (GO:0043647),-0.2994861086557059,-1.1393471410049565,0.23157894736842105,0.6738729009974611,1.0,13/46,11.72%,ITPKB;INPP4B;PLCG1;ISYNA1;NUDT4;PLCB1;INPPL1;ITPK1;INPP5D;MINPP1;NUDT3;ITPKC;PLCD3
prerank,organelle assembly (GO:0070925),0.3920714702458283,1.1393258102377672,0.114,0.8756398764685215,1.0,121/384,24.54%,CD34;GSN;NME8;CDC14B;RAB32;ABLIM1;PKD1;RAB23;RAB19;FHDC1;CHMP7;VPS4B;CENPT;MAPRE3;MVB12A;UBAP2L;VPS37D;FARP2;STARD9;ARF4;BICD1;RC3H1;ACTR3;HDAC6;LSM4;BBS9;ATAT1;ATXN2;ATG2B;PACS2;ARL13B;TMEM138;OCRL;CPLANE1;HPS4;CNGB1;EHD2;WIPI2;NUDCD3;STX12;WDR45B;DZIP1;HDAC3;NPM1;MAPRE1;TTC39C;HAUS3;AVIL;TEKT5;MAPT;PIBF1;ULK2;DYNC2I2;KIF3A;RAB43;ATG2A;NCOR1;RPGR;ATP2A2;VPS37C;KIF3B;IFT46;EIF2S1;ATXN2L;TTLL3;ULK1;BBS4;INO80;TMOD2;TTC8;DYNC1H1;KLHL41;ATP6V1D;AHI1;CENPC;RAB1B;VPS37B;CEP164;YTHDF1;YTHDF2;DYNC2H1;ATG16L2;CEP89;AUP1;DYNC2I1;CEP83;CCDC28B;RP2;ATG13;CENPE;BBS5;NEK7;BBIP1;IFT52;EXOC4;CC2D2A;SPAG16;FLNA;VPS36;TUBGCP5;ATG16L1;PCM1;DNAH5;ATG3;FBF1;EIF2A;PDCD6IP;TMEM231;YTHDF3;OGFOD1;TCTN2;ATG14;IST1;EDC3;RAB11FIP3;PDE6D;STAM;EMC6;DYNLL1;G3BP1;TCTN1
prerank,regulation of neuron death (GO:1901214),0.4169500072728364,1.1392260195543022,0.28645294725956566,0.8751450399751334,1.0,21/82,19.92%,CD34;SNCB;FYN;KIR3DL2;EGLN2;AKT1;MAPT;GPNMB;NSMF;CD200R1;EIF2S1;TNFRSF1B;DCC;CHP1;HTRA2;SARM1;CHRNA7;FAIM2;EPHB1;RRAS2;ITGAM
prerank,neural tube closure (GO:0001843),0.4581545159456186,1.1389105100013914,0.29732868757259,0.8754545174723136,1.0,4/34,4.06%,LRP6;TGFB2;COBL;SKI
prerank,mRNA catabolic process (GO:0006402),0.4424228443606638,1.138822454148976,0.2819634703196347,0.8749076446397657,1.0,19/44,28.67%,DIS3L2;RC3H1;ZFP36L2;NUDT16L1;ERN1;NUDT16;ZFP36;CNOT10;DDX5;AGO4;YTHDF2;SUPV3L1;AGO3;THRAP3;EXOSC10;UPF1;LSM5;AGO1;PDE12
prerank,regulation of humoral immune response (GO:0002920),0.4433554188665145,1.138735138847737,0.30846325167037864,0.8744064375897818,1.0,8/44,13.59%,CD55;CFH;C7;C1QBP;CD81;C4B;SERPING1;CR2
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.4964421347506014,1.1385830178133483,0.31155778894472363,0.8741507723955091,1.0,10/20,17.66%,CAMK2D;PACS2;PSEN1;HERPUD1;SELENOK;BAK1;THADA;ATP2A2;PML;BCAP31
prerank,negative regulation of translation (GO:0017148),0.4131440272705292,1.1383486219212648,0.2640918580375783,0.8741569754971166,1.0,21/87,19.66%,IGFBP5;EIF2AK3;RBM4;PAIP2B;TRIM71;SAMD4B;MRPL13;AGO2;PUM1;IGF2BP1;UNK;LARP1;CNOT10;EIF3E;FXR2;CPEB1;YTHDF1;YTHDF2;EPRS1;PAIP2;PCIF1
prerank,negative regulation of complement activation (GO:0045916),0.5683893877295658,1.1382427828316184,0.3314285714285714,0.8736854036413847,1.0,3/10,13.59%,CD55;SERPING1;CR2
prerank,base conversion or substitution editing (GO:0016553),0.5488394266015699,1.138061521754769,0.3333333333333333,0.8735427156383024,1.0,2/11,11.59%,ADARB1;NUDT16
prerank,axon development (GO:0061564),0.4114063118585502,1.1378125362092752,0.27157894736842103,0.8736146440550026,1.0,29/78,26.09%,EPHB2;MAP1B;GAP43;ZPR1;LLGL1;DOCK7;S100A6;EPHB3;PLP1;L1CAM;MAPT;MTR;TAOK2;RTN4RL1;DCC;SHTN1;CNTN4;SLITRK4;RAB10;MAP1A;SPTBN4;MAP1S;NTNG2;RTN4;MARK2;PAX2;ATL1;NRCAM;SLITRK5
prerank,negative regulation of ossification (GO:0030279),-0.3583626683679097,-1.137805620267431,0.24855491329479767,0.6757585309068731,1.0,7/23,14.48%,ENPP1;MEF2C;NOTCH1;SFRP1;MDK;SRGN;BCOR
prerank,inner ear morphogenesis (GO:0042472),0.4843319166267055,1.1377217952706893,0.3076923076923077,0.8730657383915,1.0,5/22,13.72%,EPHB2;HPN;MYO3B;TTC39C;SIX1
prerank,regulation of phospholipase C activity (GO:1900274),0.519877572937179,1.137002925723367,0.31923601637107774,0.8748493661447365,1.0,5/15,7.45%,ESR1;FGFR1;FGF2;BICD1;ABL2
prerank,regulation of dendritic spine development (GO:0060998),0.4959744447162043,1.1361526442417345,0.3172839506172839,0.8771143888847653,1.0,7/19,14.70%,PTPRS;PPFIA2;GRIN3A;PSEN1;TANC2;LLPH;ARF6
prerank,NAD biosynthetic process (GO:0009435),-0.3648749081422887,-1.1357728546813237,0.2931937172774869,0.6787533310705699,1.0,7/20,17.35%,NAMPT;PTGS2;PTGIS;PARP10;NUDT12;NMNAT3;PARP9
prerank,endomembrane system organization (GO:0010256),0.3956174337740754,1.1357000222686038,0.21953675730110775,0.8779293780770533,1.0,43/178,18.19%,SEC16B;ATP8B1;ARHGAP21;DNM1;EIF2AK3;TMED1;HOOK2;SEC31A;FBXW8;REEP3;TOR1AIP2;ZW10;NUP93;MIA3;TLCD2;PLEKHF1;LYSMD3;RAB30;PI4K2B;SYNE1;OSBPL2;AP3D1;SURF4;LMAN1;TOR1A;SQSTM1;RAB2A;SEC23IP;USP50;LNPK;STX17;RAB43;BCAS3;SEC61A1;SPTBN1;PHETA2;BLZF1;HACE1;REEP5;DYNC2H1;VPS11;ANXA8;ANXA8L1
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.5269577271288699,1.1355315089473699,0.33067729083665337,0.8776819252985699,1.0,4/14,15.83%,SYVN1;CREB3L1;HERPUD1;SELENOS
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.47873540144332494,1.1355162852172898,0.3130434782608696,0.8768998707737872,1.0,3/21,2.97%,EPHB2;TGFB2;SLIT2
prerank,positive regulation of histone deacetylation (GO:0031065),0.5384112834454547,1.1344158990088846,0.32072829131652664,0.8802401559158258,1.0,6/12,21.50%,VEGFA;PRKD2;AKAP8;NIPBL;CTBP1;AKAP8L
prerank,autophagosome assembly (GO:0000045),0.4318953251231323,1.134225932065034,0.28524590163934427,0.8801092402219733,1.0,21/52,24.13%,RAB23;RAB19;ATG2B;PACS2;WIPI2;STX12;WDR45B;ULK2;STX17;RAB43;ATG2A;ATP2A2;ULK1;RAB1B;ATG16L2;ATG13;ATG16L1;ATG3;SMURF1;ATG14;EMC6
prerank,ventricular septum development (GO:0003281),0.45255425338217137,1.1340964512924212,0.30498866213151926,0.8797380201302234,1.0,8/37,7.56%,TGFB2;SLIT3;SLIT2;TGFBR2;SMAD4;ACVR1;MDM4;ZFPM2
prerank,anterior/posterior axis specification (GO:0009948),-0.400529272745342,-1.1339784192528586,0.275,0.6812208509621163,1.0,2/15,3.49%,WLS;TBX3
prerank,positive regulation of ERAD pathway (GO:1904294),0.5258161452190551,1.1336486616271728,0.327027027027027,0.8805429584869773,1.0,6/13,21.67%,NFE2L2;TMEM259;HERPUD1;SGTA;BCAP31;USP13
prerank,cyclic purine nucleotide metabolic process (GO:0052652),-0.3687531613176569,-1.1333517104220128,0.2676767676767677,0.6806963990361822,1.0,7/21,12.97%,ADCY5;ADCY1;GUCY1B1;ADCY4;ADCY9;NPR1;GUCY1A1
prerank,mRNA stabilization (GO:0048255),0.4476108556572297,1.1333298747386191,0.3291284403669725,0.8808745665915318,1.0,9/40,13.08%,TENT5B;MAPK14;DAZL;TARDBP;TIRAP;IGF2BP1;LARP1;ZFP36;GDNF
prerank,striated muscle tissue development (GO:0014706),-0.34402788004552254,-1.1331851139491604,0.2465753424657534,0.6788968607933124,1.0,9/29,11.33%,BMP5;PGM5;BMP7;MEF2C;RBP4;CAV1;BMPR2;TBX2;CFLAR
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.3969191066767695,-1.1326572917019717,0.2981651376146789,0.677988000084792,1.0,6/17,17.81%,ATP1A2;GJA1;RYR2;ATP1B1;GJC1;GJD3
prerank,regulation of epithelial cell proliferation (GO:0050678),0.4122933839044235,1.132454269703314,0.28229166666666666,0.883280300750734,1.0,13/85,5.89%,FGF18;FGF7;EGFR;HPN;SIX4;SRSF6;VEGFA;FGF2;TGFB2;FUT2;ZFP36L1;TCF7L2;NR1D1
prerank,cellular response to organic substance (GO:0071310),0.4002971163632434,1.1321847605536564,0.25944841675178754,0.8834352089883966,1.0,26/116,18.40%,GHR;IGFBP5;UCP1;CLEC3B;MAPK7;SLIT3;SLIT2;TGFBR2;ACVR1;SOCS2;NCOA3;HDAC6;PID1;CDK9;INPP5K;URI1;AMHR2;FLT3;RHOA;KLF4;STAT5B;HTRA2;CXCR4;PTPN5;IL18;TGFBR1
prerank,blood vessel endothelial cell migration (GO:0043534),-0.3616093432669233,-1.1320733857349135,0.2300469483568075,0.6772368138710037,1.0,8/22,8.35%,ROBO1;CDH5;EFNB2;EPHB4;KDR;NRP1;ID1;EMP2
prerank,triglyceride biosynthetic process (GO:0019432),0.504958228197395,1.1317749747585335,0.3311772315653299,0.8840686230461781,1.0,6/18,20.28%,GPAT4;MOGAT1;MOGAT2;GPAT3;GPAM;LPIN3
prerank,positive regulation of cartilage development (GO:0061036),0.5084884978822216,1.1315249015494089,0.33248081841432225,0.8841647783345743,1.0,3/17,9.28%,LOXL2;BMP1;SOX5
prerank,T cell mediated immunity (GO:0002456),0.5259736214970278,1.1313115974112695,0.3240223463687151,0.8841017640511373,1.0,3/13,15.15%,CD55;JAG1;BTN3A3
prerank,translesion synthesis (GO:0019985),0.4385104150215545,1.1311807874579303,0.30821147356580425,0.8837778643659359,1.0,17/42,28.18%,REV3L;POLDIP2;USP10;ZBTB1;DTL;POLI;UBA52;PCLAF;RFC4;POLD1;FAAP20;REV1;POLH;UFD1;POLE2;NPLOC4;RFC3
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.42811842714699866,1.131001866425781,0.3091517857142857,0.8835928504081821,1.0,18/46,23.97%,ZPR1;PIK3R2;TCF7L2;GAS6;YWHAE;PSEN1;CPSF6;RBM22;HDAC3;JUP;ANP32B;ZC3H12A;DMAP1;IPO5;FLNA;BAG3;TPR;EMD
prerank,glycoprotein biosynthetic process (GO:0009101),0.4162871198220601,1.1306832455206666,0.27510460251046026,0.8838754341906786,1.0,17/79,12.00%,ST3GAL2;B3GALNT1;CSGALNACT2;FUT2;CHST10;TMEM106A;MGAT1;GAL3ST3;CHST12;FOXL1;XYLT1;ALG1;LARGE1;FUT9;B3GNT8;ST3GAL4;TNIP1
prerank,positive regulation of signal transduction (GO:0009967),0.3912709506669723,1.1301226822750152,0.1921921921921922,0.8850595832854715,1.0,44/238,12.88%,RSPO2;MN1;CD80;CCBE1;AXL;PRKCA;IRS1;NPTN;GRB10;SULF2;ITGB3;ZMIZ1;TGFB2;CDKN2AIP;DLG4;TEDC1;SMOC2;SKI;ADAMTS3;SLC39A14;DACT1;ITGA5;ZRANB1;KLF2;SRC;UCHL5;STX1B;SULF1;ESM1;GAS6;PRKD2;PKD2;CYP27B1;JAG1;KAT2B;BMP2K;ITGAV;ERN1;KANK1;ENHO;BAK1;KLK6;TUBD1;MGAT5
prerank,response to copper ion (GO:0046688),0.5004908010069041,1.129787811064389,0.3374536464771323,0.8853809415275319,1.0,1/20,0.82%,LOXL2
prerank,regulation of exocytosis (GO:0017157),0.435460278534788,1.129682654845596,0.30439560439560437,0.8849103834708377,1.0,19/46,27.68%,ANXA1;STX4;RAB3D;ATP6AP1;RAB27B;NSF;SYT1;VAMP2;RIMS2;RAB2B;RALA;CLASP2;RAB10;STXBP5L;RAB12;RAB3C;CFTR;IL1RAPL1;RAB8B
prerank,membrane organization (GO:0061024),0.39199907339874274,1.1292599514093322,0.2072072072072072,0.885550816432664,1.0,66/227,24.22%,STON2;AREG;TRIP10;EGFR;TIMM50;SYT2;DNM1;MOSPD3;BTC;ANK2;BIN1;TMEM43;STX11;REEP3;TOR1AIP2;NUP93;CHMP7;VPS4B;TLCD2;MTCH1;AP2A2;MYADM;OSBPL2;SLC18A3;AP3D1;ACTR3;CLTC;USO1;OCRL;TOR1A;SNAP23;NAPA;UBA52;EGF;SGCZ;GLTP;CBL;CHP1;FZD4;ACTG1;ARPC1A;SPTBN1;IGF2R;HACE1;NAPG;SYT1;ARPC2;VAMP2;VPS33B;CORO1C;COX18;CNTN2;ARRB1;AZIN2;CTTN;VAMP4;PDCD6IP;LDLR;CCDC88A;PACSIN2;TMEM33;AP2M1;PICK1;STAM;EMD;AGFG1
prerank,positive chemotaxis (GO:0050918),0.507074679109802,1.1292535414399363,0.3135483870967742,0.8847313036835203,1.0,4/17,11.79%,FGF7;VEGFA;PTPRJ;GPNMB
prerank,negative regulation of wound healing (GO:0061045),0.45892008040540827,1.12862274096188,0.31654676258992803,0.8861901552245501,1.0,2/28,2.88%,CD34;FGF2
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.4604004469768297,1.128438652937117,0.3177914110429448,0.8860143860002437,1.0,5/26,14.59%,LBP;TLR5;TIRAP;WDFY1;SLC15A4
prerank,ventricular cardiac muscle tissue development (GO:0003229),-0.3498950848779802,-1.1282586856519634,0.25555555555555554,0.6851744428161756,1.0,4/23,6.76%,TPM1;ADAMTS9;TGFBR3;FGFR2
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.4249738532103041,1.1280829831883592,0.2788671023965142,0.8864986152582697,1.0,20/54,28.10%,SYK;SPATA2;CARD16;PELI3;GAS6;CHUK;SPPL2B;MADD;NLRP2B;RBCK1;TAX1BP1;CLIP3;PYCARD;CPNE1;CYLD;UBE2K;RNF31;OTULIN;CASP8;LAPTM5
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.3136237016695701,-1.1277278913633273,0.24,0.6842087038422117,1.0,11/38,12.44%,SP100;BMP5;BCL2L1;NOS3;THBS1;SFRP1;FAS;ICAM1;CFLAR;RIPK1;TNFSF10
prerank,mRNA processing (GO:0006397),0.3928232246657073,1.1276669695238093,0.17617617617617617,0.8872815735970935,1.0,111/287,28.90%,GEMIN6;POLR2H;SRSF2;CD2BP2;HNRNPA1;GTF2H3;SRSF6;DHX16;RBM4;ZCRB1;DDX42;LSM4;PRPF4;U2AF1;SRSF3;TFIP11;PRPF3;GPATCH1;AURKAIP1;CPSF6;USP39;HNRNPD;RBM22;DNAJC8;ERN1;SNRPB2;SON;CPSF4;HNRNPH1;TCERG1;DHX8;RBM17;ERCC3;PRPF40A;SRSF11;THOC7;POLR2D;POLR2G;SNU13;HNRNPA3;AQR;POLDIP3;CCNH;THOC2;THOC1;SF3B4;ZC3H11A;GTF2F1;ZCCHC8;CMTR2;BCAS2;SF3A1;CPSF2;PHF5A;DDX5;SNRPA;SNRPG;SNRPD3;PNN;SNIP1;PDCD7;DDX39A;SRRM1;RBM6;PUF60;GCFC2;PRCC;HNRNPUL1;U2AF2;ELAVL2;ZMAT5;NOVA1;LSM7;PTBP1;SF3B2;SF3B1;AKAP8L;KIN;PRPF38A;GPKOW;RBM5;RNMT;SNRPA1;CSTF2T;CPSF1;RALY;CPSF7;WDR33;PABPN1;POLR2C;CWC27;RAMAC;ALYREF;UPF3B;PPIH;USP49;RBMX;PRPF19;CRNKL1;PRPF6;LSM5;CDC40;THOC5;WDR83;CELF1;CPSF3;RBM15;HNRNPC;SNRPC;WBP11;SRSF5
prerank,positive regulation of neurogenesis (GO:0050769),-0.27583064821068887,-1.12765271381423,0.3225806451612903,0.6821455932433531,1.0,22/68,15.57%,PLXNA2;ROBO1;CUX1;PLXNA4;PTPRD;CDKL5;SHANK3;TGM2;PLXND1;ROBO2;NUMB;PLXNB1;CX3CL1;SS18L1;SMARCD3;NTRK2;SLITRK1;CTNNB1;TRIM32;CUX2;GPER1;SOX11
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.5587175342100446,1.1270494989331425,0.35602836879432626,0.8886975890490671,1.0,2/10,3.49%,IRF4;RUNX1
prerank,error-free translesion synthesis (GO:0070987),0.47583494915765123,1.1269291450426946,0.34875,0.8883045182377179,1.0,12/22,33.17%,POLDIP2;UBA52;RFC4;POLD1;REV1;POLH;UFD1;NPLOC4;RFC3;SPRTN;RPA3;RCHY1
prerank,negative regulation of locomotion (GO:0040013),-0.4321418991270272,-1.1268152660565665,0.305019305019305,0.6820492012977384,1.0,4/12,16.73%,FRMD5;CCDC125;PTPN2;SPINT2
prerank,regulation of glucose metabolic process (GO:0010906),0.4574944547423346,1.126680877783144,0.3178114086146682,0.8882852289308377,1.0,10/34,19.54%,IRS1;DGKQ;FOXK2;AKT1;IRS2;USP7;ZNF692;SELENOS;OGT;GPLD1
prerank,positive regulation of MAPK cascade (GO:0043410),0.38901920457176087,1.126629622130589,0.191,0.8876158355006967,1.0,40/245,13.11%,MID1;ACKR3;LIF;FGF18;CCL8;PRKCA;EGFR;FGFR1;STK25;CD44;VEGFA;PDE8A;FGF2;TGFB2;MST1R;F2R;MIF;LPAR1;TAOK3;TMEM106A;KLHDC10;PTPRJ;RET;RIT2;ADCYAP1;GAS6;DHX33;PRKD2;NDRG4;TIRAP;CCL25;IQGAP1;GPR37L1;IRAK1;GPNMB;EGF;ATP6AP1;TAOK2;CCL13;FLT3
prerank,positive regulation of growth (GO:0045927),0.4131553733505033,1.1265703922134243,0.2983957219251337,0.8869980205653123,1.0,9/64,4.22%,EGFR;HPN;TGFB2;RFTN1;CDKN2AIP;S100A8;S100A9;ZPR1;DDX49
prerank,nuclear pore complex assembly (GO:0051292),0.5557667840743152,1.1261899401972482,0.349002849002849,0.8875411915875012,1.0,4/10,8.69%,NUP93;AHCTF1;NUP107;NUP98
prerank,cellular response to misfolded protein (GO:0071218),0.4879550974295907,1.1260113532715479,0.3175591531755915,0.8873629004579272,1.0,10/20,27.32%,STUB1;UBE2W;CUL3;TOR1A;AUP1;UGGT1;DERL1;UFD1;RNF126;UGGT2
prerank,development of primary male sexual characteristics (GO:0046546),0.458406667830323,1.1256334121877376,0.3267670915411356,0.887880075645322,1.0,6/34,9.99%,AR;WT1;SIX4;TGFB2;SOX8;COL9A3
prerank,neuron projection organization (GO:0106027),0.5074627359567842,1.1256189988716367,0.34908136482939633,0.8870957282223301,1.0,8/15,23.55%,DCTN1;ATP1A3;PSEN1;ARF1;PLS1;CHRNA7;MAP1A;PICK1
prerank,regulation of DNA recombination at telomere (GO:0072695),0.4885095246125449,1.1251067892948008,0.31880448318804483,0.887324423308178,1.0,8/19,24.66%,POLR2H;ACD;POLR2D;POLR2G;TERF1;TINF2;TERF2IP;POLR2C
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.4885095246125449,1.1251067892948008,0.31880448318804483,0.887324423308178,1.0,8/19,24.66%,POLR2H;ACD;POLR2D;POLR2G;TERF1;TINF2;TERF2IP;POLR2C
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.47014735475240543,1.1250507458380417,0.3180169286577993,0.886697302249542,1.0,7/26,17.44%,FBN1;INHA;LRRC17;TLR4;HOXA7;IL4;GPR137B
prerank,positive regulation of cell communication (GO:0010647),0.46224969738244454,1.124910658875589,0.31971153846153844,0.8863510116970627,1.0,11/28,23.03%,CD80;CDKN2AIP;DLG4;HCRT;LGI1;SYT1;ILK;RIMS2;CLSTN3;NMU;GRIK2
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.3906297725275011,1.1247633826084291,0.164,0.8860697749010099,1.0,51/348,12.38%,CD34;SFRP4;AR;GSN;EPHB2;AMH;FGF18;SEC16B;FGF7;C1QTNF1;WT1;HPN;TMEM119;PKP3;EIF2AK3;ANXA2;MAPK7;ANK2;DGKQ;VEGFA;FGF2;CAMK2N1;ZPR1;NFE2L2;RBMS3;MAPK14;ADAM19;KLF2;MTOR;ITCH;HOXA5;DTNBP1;IL33;PID1;GAS6;INPP5F;VDR;PSEN1;AGO2;ECE1;TLR4;MAPK11;MUSK;MPHOSPH8;MITF;KRAS;AKT1;SLC2A10;MAGI2;NAT8;EGF
prerank,cellular response to nitrogen compound (GO:1901699),0.49339805401335385,1.1246265511156237,0.3371647509578544,0.8857500938584242,1.0,10/20,29.97%,ATP2B4;EPG5;DDX11;SPIDR;BLM;NSMCE3;RIOK3;PDE12;ATRX;HSF1
prerank,glycogen metabolic process (GO:0005977),-0.338168146699089,-1.1243458707577048,0.24561403508771928,0.6862537119314694,1.0,6/27,5.34%,PRKAG2;PHKB;PYGM;GYS1;GBE1;AGL
prerank,negative regulation of developmental process (GO:0051093),0.4126943399702536,1.123917953083548,0.28722280887011614,0.8874981089410219,1.0,15/69,12.34%,LOXL2;PARP3;NEUROD2;PTPRS;MIF;HOPX;GRIN3A;NFIB;RC3H1;GAS6;WDR77;KANK1;ALPK2;MAPT;ANP32B
prerank,diterpenoid metabolic process (GO:0016101),0.4231682474285469,1.1236910308388195,0.3172866520787746,0.8874852513129594,1.0,5/55,5.80%,AKR1B1;LRP1;GPC6;GPC3;ALDH3A2
prerank,purine ribonucleotide metabolic process (GO:0009150),0.4164113564147859,1.1230780989952198,0.30319148936170215,0.888903947218552,1.0,16/68,22.48%,GNAI3;GPAT4;AMPD2;RAB23;ACLY;ACOT6;BPNT2;RHOQ;ACOT9;ACOT1;SULT4A1;ABHD14B;ACAT1;TPST2;CROT;ADSS2
prerank,protein depolymerization (GO:0051261),0.4671574004125517,1.1229325329379616,0.33657351154313486,0.8885954585273809,1.0,8/27,20.39%,GSN;VPS4B;KIF2A;TWF1;MICAL2;CKAP5;MICAL1;STMN4
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.4530201332152419,1.1225690859119877,0.3099078341013825,0.8891300697055952,1.0,3/33,5.24%,MN1;PKD1;ATP2B4
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.45280867255911283,1.1224631219942565,0.3212121212121212,0.8886894643810126,1.0,11/28,24.63%,IRS1;GRB10;TNS2;PID1;INPP5K;KANK1;NCK1;PIP4K2C;PIP4K2B;TSC2;PRKCZ
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.40862441895543705,1.1222265814818373,0.284527518172378,0.8887061734195544,1.0,29/82,26.73%,DCTN1;ODF2;ATF5;YWHAG;SSNA1;YWHAE;ALMS1;NPM1;MAPRE1;HAUS3;SFI1;HSP90AA1;TUBB4A;TUBA4A;DYNC1H1;CDK5RAP2;CCP110;AKAP9;CEP164;CKAP5;PAFAH1B1;PCM1;DCTN2;NEDD1;DYNLL1;CEP78;CSNK1E;ACTR1A;CETN2
prerank,positive regulation of brown fat cell differentiation (GO:0090336),-0.40705517762120574,-1.122123177213922,0.3111111111111111,0.6899476415806508,1.0,4/13,6.40%,BMP7;SOX13;NAPEPLD;PTGS2
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.3813259037843456,-1.1219196689208684,0.2825112107623318,0.6882446877702643,1.0,3/17,4.69%,ATP1A2;CACNB2;CACNA1D
prerank,regulation of steroid biosynthetic process (GO:0050810),-0.44434700821560824,-1.121736747778513,0.3111888111888112,0.6864677691902822,1.0,5/11,12.14%,WNT4;BMP5;SIRT1;BMP2;FGFR4
prerank,endothelial cell differentiation (GO:0045446),0.5322955222276954,1.1217014112882198,0.35149863760217986,0.8897582354120919,1.0,2/12,8.93%,FSTL1;JAG1
prerank,glycosphingolipid metabolic process (GO:0006687),0.4387991027305569,1.121472524836418,0.3062857142857143,0.8897703280874812,1.0,8/42,13.64%,SMPD3;ARSA;B3GALNT1;LARGE1;GBA2;GLA;CERK;GLTP
prerank,divalent inorganic cation homeostasis (GO:0072507),-0.3491457713999542,-1.1214499607168538,0.2617801047120419,0.6849342229554684,1.0,10/25,23.80%,TMTC2;SNCA;CAV1;CNNM2;KCNA1;JPH2;MT3;ANK3;GRIN1;CIB2
prerank,inositol phosphate-mediated signaling (GO:0048016),0.4960330555981412,1.1213704115488372,0.34513274336283184,0.8893128040862787,1.0,6/19,19.14%,PLCE1;NFATC4;NFATC1;PPP3CC;PPP3CA;PPP3CB
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.5248167561218102,1.1213403552291858,0.32972972972972975,0.8885995687775617,1.0,4/14,13.57%,IRS1;AKT1;IRS2;TWIST1
prerank,connective tissue development (GO:0061448),0.4441681614345916,1.1213317499844664,0.33951332560834296,0.88780878393325,1.0,8/35,10.14%,CD44;SULF2;SLC39A13;PKD1;SULF1;SOX8;SOX5;COL2A1
prerank,negative regulation of bone remodeling (GO:0046851),0.5462118969221614,1.1204731573886326,0.34265734265734266,0.890063814687209,1.0,4/11,17.44%,TMEM119;CALCA;IL6;GPR137B
prerank,glycerol metabolic process (GO:0006071),0.552536703452987,1.120399298482178,0.329004329004329,0.8895200401089224,1.0,6/10,28.42%,GK5;COQ3;ANGPTL3;GOT1;COQ2;PGP
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.4353344222186249,1.1203018633420654,0.3277216610549944,0.8890317865138969,1.0,18/47,25.16%,MYOC;EFNA5;S100A10;MYADM;C1QBP;MELTF;KANK1;TRIOBP;LIMS2;RAC3;RCC2;ILK;FLNA;CORO1C;FBLN1;DMTN;CALR;RAC1
prerank,protein O-linked glycosylation (GO:0006493),0.40399476034671744,1.1201271850788772,0.2787564766839378,0.8888444549380067,1.0,29/96,24.68%,PLOD2;ST3GAL2;GALNT16;C1GALT1;POFUT2;POMGNT2;GALNT10;MUC1;GALNT18;OGA;PLOD3;LARGE1;B3GNT8;GALNT1;ST3GAL4;B3GALNT2;OGT;ST3GAL1;ST3GAL3;GALNTL6;PLOD1;MGAT5B;CRPPA;TMTC3;GXYLT1;POGLUT2;GALNT4;DPM2;PGM3
prerank,regulation of protein localization to nucleus (GO:1900180),0.428473420114729,1.1194805394790526,0.3125,0.8902694993601701,1.0,8/43,15.97%,LIF;EIF2AK3;WWTR1;FLCN;OTUD7B;AKT1;PIN1;ILRUN
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.41787603788386185,1.119285628787098,0.3096774193548387,0.8901446556839305,1.0,13/56,13.54%,EGFR;ANXA1;CDK4;RAD51B;VPS4B;CUL3;DTL;CDC23;AKT1;ANAPC5;FBXO5;CCND1;CDC27
prerank,error-prone translesion synthesis (GO:0042276),0.46920694979900673,1.1192144962604191,0.3275217932752179,0.8895881656311523,1.0,8/21,28.18%,REV3L;POLI;UBA52;RFC4;REV1;POLH;POLE2;RFC3
prerank,regulation of endothelial cell apoptotic process (GO:2000351),-0.30083212063844866,-1.1191530540323806,0.23387096774193547,0.6888786132532497,1.0,11/39,11.50%,CDH5;PLCG1;THBS1;SEMA5A;KDR;ITGA4;NDNF;RGCC;ICAM1;ECSCR;TEK
prerank,modification-dependent protein catabolic process (GO:0019941),0.3920006113934402,1.1187378437374402,0.24072216649949849,0.8904748166093315,1.0,74/193,26.29%,UBE2B;SPSB1;SPSB4;UBA6;SMURF2;SYVN1;ITCH;RBBP6;RNF111;SPSB2;RC3H1;STUB1;WDR91;ADRM1;SIAH1;MYLIP;CUL3;DTL;UBE2G2;FBXW4;USP33;HERPUD1;SQSTM1;CDC23;ANAPC5;RNF7;UBE2A;UBA52;CDC34;NDFIP1;DDB1;CDC27;CBL;UBR4;AMFR;RNF128;TRPC4AP;RNF14;HACE1;KEAP1;CDC26;UBE2G1;FBXO11;ANAPC4;NTAN1;ARIH2;UBE2R2;NEDD8;RNF19A;UBE3C;TOLLIP;KCTD6;ARIH1;KCTD10;ANAPC10;KCTD21;ARRB1;RC3H2;SMURF1;ANAPC15;RNF6;RNF114;RNF13;PSMD3;UBQLN4;MDM2;RNF166;UFD1;FBXO22;RNF20;RNF126;UBE2K;RNF167;ANAPC2
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.34737183709967545,-1.1185151483719762,0.2727272727272727,0.688290965080911,1.0,6/26,4.69%,NEDD4L;ATP1B3;ACTN2;DLG1;WWP2;CACNA1D
prerank,regulation of microtubule polymerization (GO:0031113),0.4437888552787294,1.1182688643937169,0.2945128779395297,0.8913776188539726,1.0,16/40,20.65%,DCTN1;CLIP1;PSRC1;MAPRE3;TOGARAM1;MAPRE1;CAMSAP1;MAPT;GBA2;SLAIN2;TUBB4A;CDK5RAP2;AKAP9;NAV3;CLIP3;NUMA1
prerank,neural crest cell migration (GO:0001755),0.43929228067208903,1.1179816334732262,0.3401826484018265,0.8915772326514518,1.0,7/36,13.08%,SEMA3C;RADIL;SOX10;SOX8;SEMA3A;SEMA3D;GDNF
prerank,positive regulation of neutrophil migration (GO:1902624),0.48410639780833287,1.1179666149666436,0.342534504391468,0.8908209598107657,1.0,4/18,8.92%,THBS4;C1QBP;MCU;TIRAP
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.4457574309234612,-1.117958053563841,0.31125827814569534,0.6876231905077738,1.0,5/10,16.30%,ATP5F1C;ATP5F1D;ATP5PD;ATP5MG;ATP5MC2
prerank,macromolecule catabolic process (GO:0009057),0.46940865796370124,1.1179224823846234,0.3249701314217443,0.8901671186406261,1.0,10/26,23.83%,MTOR;MVB12A;TPP1;CLPX;SIAH1;IDE;LRSAM1;SMURF1;USE1;TRIM24
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.46752757740442785,1.1176648097273207,0.31868131868131866,0.8902707621553115,1.0,5/26,12.00%,ST3GAL2;GK5;LARGE1;ST3GAL4;TNIP1
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.5174173472987069,1.1176634202847229,0.34274193548387094,0.8894602408699204,1.0,7/13,28.38%,ZMIZ1;SMARCD1;PADI2;ELOF1;SERTAD2;ARID1A;ARID1B
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.5330823278046116,1.1164907934294328,0.34579439252336447,0.8928465258028868,1.0,3/13,10.59%,B3GALNT1;GAL3ST3;B3GNT8
prerank,regulation of cardiac muscle cell action potential (GO:0098901),0.46716900345495604,1.1163965927542123,0.3380447585394582,0.8923778035630746,1.0,8/25,17.31%,ANK2;FGF13;DSC2;CAMK2D;HCN4;JUP;ATP2A2;AKAP9
prerank,positive regulation of response to stimulus (GO:0048584),0.4391070299685833,1.116322234051145,0.33183856502242154,0.8918384629366671,1.0,9/40,19.02%,CD80;TGFB2;CDKN2AIP;CGAS;YPEL3;FXR2;EEF1E1;ILK;SELENON
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.4252686009814725,1.1161656492260217,0.3008658008658009,0.8916060044651323,1.0,19/52,23.21%,EPHB2;GPSM2;EGFR;LRP1;EPHA3;ATP2B4;STX4;SQSTM1;AKT1;ARF6;PLS1;SPTBN1;STX3;CLIP3;NUMA1;STAC3;ZDHHC8;EPB41L2;ZDHHC5
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.552630586634261,1.1161260446477754,0.3640416047548291,0.8909309460165225,1.0,3/10,18.92%,DIS3L2;UBA52;NEDD8
prerank,microtubule polymerization (GO:0046785),0.4594098139236632,1.1159122544981188,0.3357142857142857,0.8908986040643073,1.0,12/28,23.11%,FGF13;NDEL1;MAPT;TPPP3;PIN1;SLAIN2;MAP7D3;AKAP9;CKAP5;CLASP2;TUBGCP5;TUBG2
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.46519849515668843,1.1157437858708774,0.3190984578884935,0.8898995139104895,1.0,7/29,22.15%,GPAT4;ACLY;ACOT6;ACOT9;ACOT1;ACAT1;CROT
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.46519849515668843,1.1157437858708774,0.3190984578884935,0.8898995139104895,1.0,7/29,22.15%,GPAT4;ACLY;ACOT6;ACOT9;ACOT1;ACAT1;CROT
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.5003716390975926,1.1153024873651025,0.355584082156611,0.8907176825532084,1.0,6/15,23.78%,TENT4A;AGO2;ZFP36;POLR2G;TENT4B;TNRC6A
prerank,acetyl-CoA metabolic process (GO:0006084),0.5180103896951643,1.1152356159036905,0.3521505376344086,0.8901639673683579,1.0,7/15,25.38%,ACLY;MVK;NUDT7;PMVK;DIP2A;ACAT1;MVD
prerank,myelination (GO:0042552),0.427470386250184,1.1151140195294758,0.3325942350332594,0.8897663021232679,1.0,12/46,18.61%,MYOC;PMP22;SKI;SOX10;MAL2;SIRT2;ARHGEF10;PLP1;KLK6;MARVELD1;CXCR4;MBP
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.40863767841428833,1.1149760530670858,0.29179978700745474,0.8894131144636072,1.0,18/70,17.94%,ANTXR1;TMEFF2;ITGB3;NTN4;RADIL;DACT2;MEGF9;ARL13B;SRCIN1;ITGAV;EPHB3;ATRN;UNK;RHOA;FER;SRGAP2;YTHDF2;ILK
prerank,negative regulation of transferase activity (GO:0051348),0.45579402888110715,1.1145060846099024,0.3409090909090909,0.8902488820320177,1.0,8/28,13.44%,SRC;INPP5K;MAPT;FBXO5;IRS2;ERCC4;ZFP36;TERF1
prerank,positive regulation of lipid localization (GO:1905954),0.5346189134404701,1.1141024516674254,0.35080645161290325,0.8908743488594852,1.0,2/11,14.08%,LRP1;ZC3H12A
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.4022548985942108,1.1140516465209163,0.28258602711157454,0.8902514123799335,1.0,23/93,17.31%,LIF;EGFR;CD44;VEGFA;MIF;AXIN1;ATP2B4;DOCK7;RASSF2;MLXIPL;PFN2;HDAC6;GAS6;PRKD2;INPP5K;AKT1;PDE4D;HSP90AA1;TNKS1BP1;NLRP2B;IL6;NCK1;AKAP9
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),-0.40794518460474194,-1.1138358467386489,0.3203125,0.6965231269505625,1.0,5/13,10.54%,SORBS1;IGF2;ECHDC3;SORL1;SIRT1
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.4048046084288243,1.1138287595815497,0.3094736842105263,0.8902112518902414,1.0,30/84,24.93%,MBNL1;HNRNPA1;SRSF6;RBM4;C1QBP;SRSF3;NSRP1;NUP98;MBNL2;SON;CELF2;RBFOX2;DDX17;RBM3;SF3B4;DDX5;FXR2;SAP18;RBM39;PUF60;U2AF2;NOVA1;PTBP1;SRPK1;THRAP3;LARP7;RBM5;DAZAP1;RBM24;CELF3
prerank,fat cell differentiation (GO:0045444),0.4177984784908994,1.1135303735263813,0.3154435925520263,0.8904647794897256,1.0,12/57,14.33%,UCP1;ATF5;METRNL;TCF7L2;FOXO1;PID1;BBS9;SOX8;SMAD6;TMEM120A;BBS4;KLF4
prerank,GPI anchor biosynthetic process (GO:0006506),0.457024673239516,1.1130768651381537,0.33294255568581477,0.8912836650685184,1.0,9/30,14.92%,PIGT;GPAA1;PIGZ;PIGC;MPPE1;PIGS;PIGW;PIGK;PIGM
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.43038954516625466,1.112833114844624,0.31838074398249455,0.8913687935006734,1.0,8/46,9.08%,ADAMTS5;WNT10B;DOCK7;NR1D1;LNPEP;FLCN;FOXC2;TLR4
prerank,negative regulation of protein localization to membrane (GO:1905476),0.4610318018675048,1.11275648855682,0.32756489493201485,0.8908185875669143,1.0,10/24,24.39%,TMBIM1;PID1;CLTC;INPP5K;RHOQ;GDI1;PPFIA1;AP2M1;DMTN;MRAP2
prerank,bicarbonate transport (GO:0015701),0.4633863553849939,1.1126072277369656,0.3439024390243902,0.8905645356924131,1.0,5/25,11.33%,SLC4A10;SLC4A8;SLC4A3;SLC4A4;SLC26A6
prerank,positive regulation of cellular metabolic process (GO:0031325),0.4058072517572836,1.112026870162591,0.28263103802672146,0.8918418416441938,1.0,22/98,15.87%,SFRP4;HPN;ANXA2;VEGFA;LIPT2;TGFBR2;MAPK14;ACLY;PID1;DHRS4;INPP5F;ECE1;AKT1;MAGI2;EGF;CDKN1A;ZC3H12A;KLF4;IL4;GHITM;AHI1;NSF
prerank,histone H4-K16 acetylation (GO:0043984),0.49030404429973823,1.1119162916714294,0.3333333333333333,0.8914512744259866,1.0,8/19,20.13%,MSL2;MSL3;ING4;MSL1;WDR5;KANSL3;OGT;KMT2A
prerank,negative regulation of signal transduction (GO:0009968),0.3817112425565264,1.111824225712165,0.23293172690763053,0.8909808835317872,1.0,37/249,11.65%,SFRP4;DCN;IGFBP5;TNMD;SRMS;EGFR;LRP1;IRS1;GPC3;GRB10;SULF2;DACT3;IRAK3;FGF2;TNS2;TMBIM1;GLIS2;ACVR1;DACT1;PTPRJ;NFATC1;CREB3L1;BEND6;CARD16;NTN1;PID1;SULF1;NDRG4;PALM;SIAH1;INPP5K;CD47;TSKU;KANK1;AKT1;GLI3;SLC2A10
prerank,cell part morphogenesis (GO:0032990),0.5228851861800182,1.111493639100211,0.3483443708609272,0.891380703207178,1.0,7/13,24.98%,WASF1;PID1;MYH14;SUPV3L1;PACSIN2;FIS1;MTM1
prerank,positive regulation of exosomal secretion (GO:1903543),0.5165983277010964,1.1114712543054042,0.34081902245706736,0.8906648952882594,1.0,6/15,26.14%,SMPD3;VPS4B;PDCD6IP;SDCBP;STAM;SDC4
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.4206117436503301,1.1113237749359761,0.3277591973244147,0.8903622543094787,1.0,12/48,17.50%,IRAK3;SLIT3;SLIT2;CARD16;PELI3;GAS6;SAMHD1;PARP14;NLRP2B;IL6;PADI2;YTHDF2
prerank,microtubule polymerization or depolymerization (GO:0031109),0.4605255160627474,1.1110404641012914,0.3413173652694611,0.8905484611284813,1.0,8/24,20.39%,FGF13;KIF2A;MAPT;TPPP3;PIN1;MAP7D3;CKAP5;STMN4
prerank,regulation of myeloid cell differentiation (GO:0045637),-0.2810819506425142,-1.110817984440471,0.23809523809523808,0.7023774166284162,1.0,13/62,8.80%,LYN;H3-3A;MEF2C;CREBBP;KMT2E;THBS1;CDK6;PURB;HSPA9;MEIS1;MYL9;PRKCQ;CTR9
prerank,neural tube development (GO:0021915),0.49738403135585835,1.110609235636355,0.36289222373806274,0.8912911697819526,1.0,5/15,8.02%,PKD1;DACT1;TRIM71;PKD2;ARL13B
prerank,manganese ion transport (GO:0006828),-0.4022476081894495,-1.1105490897018984,0.30036630036630035,0.7008660521688969,1.0,8/14,14.13%,ATP2C1;SLC30A10;SLC39A8;TRPC5;TRPC6;TRPC4;TRPC7;TRPC3
prerank,glucose homeostasis (GO:0042593),0.3993824713628504,1.1104524145235628,0.3357664233576642,0.8910817890609334,1.0,12/83,9.97%,MTNR1B;IRS1;LRRC8D;CRTC2;PIK3R2;FOXK2;TCF7L2;FOXO1;NR1D1;MLXIPL;MCU;INPP5K
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.44343272494602287,1.1102482416086248,0.34414831981460026,0.8909984042558013,1.0,5/37,4.00%,IGFBP5;TGFB3;MMP2;FGF2;MEF2D
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.47018462536403854,1.1100583889112068,0.33915211970074816,0.8908953947041214,1.0,8/23,21.16%,TIMM10B;TIMM9;AGK;BMF;HSP90AA1;TIMM22;TIMM8B;COX18
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.40214137341039013,1.1098712281150436,0.3112033195020747,0.8907504807251798,1.0,30/88,21.51%,AP1G2;AP4B1;LLGL1;ACBD3;AP1M1;DTNBP1;SCAMP3;CLTC;MYO5A;CLVS2;STX4;SCFD1;SNAP23;ARF1;AP4E1;AP1S2;PUM1;NAPA;CORO7;AP4M1;GOPC;SORCS1;VAMP2;RP2;SH3D19;CLVS1;EXOC4;RAB10;AP1S3;ARRB1
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.47892074642380517,1.1096899271874863,0.34886649874055414,0.8906023906057291,1.0,5/19,14.83%,THBS4;C1QBP;MCU;TIRAP;IL4
prerank,positive regulation of T cell activation (GO:0050870),0.4102550422137998,1.1096468326777864,0.3215434083601286,0.8899701327180833,1.0,11/62,16.98%,CD80;ANXA1;ZMIZ1;CD81;ZBTB1;CD47;SIRPA;IL4;IL6;NCK1;FLOT2
prerank,cellular glucose homeostasis (GO:0001678),0.4328245773182543,1.109410334670597,0.3352337514253136,0.8900020313928523,1.0,9/41,12.54%,LRRC8D;PIK3R2;SLC39A14;FOXK2;FOXO1;NR1D1;GAS6;ERN1;ADCY8
prerank,response to growth factor (GO:0070848),0.42783884367952113,1.1089050562738605,0.3262092238470191,0.8910104375153723,1.0,16/41,25.15%,MAPK7;TGFBR2;ACVR1;HDAC6;URI1;AMHR2;AKT1;KLF4;STAT5B;HTRA2;TGFBR1;ACVR2A;BMPR1A;EMD;ACVR1B;LRP2
prerank,interleukin-27-mediated signaling pathway (GO:0070106),-0.4082007564731945,-1.1088379976827432,0.3017543859649123,0.7033464866562213,1.0,11/13,42.46%,OAS2;STAT1;CRLF1;IL27;OASL;CANX;IL27RA;STAT3;JAK1;TYK2;EBI3
prerank,regulation of protein phosphorylation (GO:0001932),0.383641878416335,1.108609354959724,0.23647294589178355,0.8912961911014978,1.0,76/256,22.93%,EPHB2;LRP6;FGF18;NIBAN1;FGF7;EGFR;EFNA5;TMEM119;NPTN;EIF2AK3;PLCE1;CCDC88C;FYN;ITGB3;VEGFA;PDE8A;FGF2;SLIT2;WWTR1;PLPP3;AXIN1;TARDBP;MYADM;PID1;PIP5KL1;GAS6;FLCN;INPP5K;SIRPA;TWF1;MUSK;HDAC3;NPM1;CAMKK2;CEBPB;KRAS;AKT1;GPNMB;PIN1;CCND1;AKAP8;ZC3H12A;FER;WDFY2;HSP90AA1;CHP1;NOP53;PPIL4;HGF;FXR2;PML;PPP2R5B;CHRNA7;PPIA;PLAUR;ILK;IBTK;THPO;CLIP3;BMPER;FKBP8;CORO1C;ACVR2A;PTEN;MOB1B;AKAP8L;ARRB1;NSD1;SESN2;TERF2IP;ATF4;SPTBN4;CCDC88A;STAT2;FBLN1;FLOT1
prerank,mononuclear cell differentiation (GO:1903131),0.46413561787370394,1.107925406505795,0.34739454094292804,0.8929159763635269,1.0,5/24,14.83%,AXL;VEGFA;GAS6;FLT3;IL4
prerank,regulation of lamellipodium assembly (GO:0010591),0.4359645963824237,1.1073871354278308,0.3443396226415094,0.8940480515492872,1.0,9/34,14.21%,PLCE1;SLIT2;AKIRIN1;FSCN1;ACTR3;PIK3CA;TWF1;AVIL;FER
prerank,ceramide biosynthetic process (GO:0046513),-0.3124560981295292,-1.107232396887429,0.26153846153846155,0.7053375769750566,1.0,13/40,14.59%,SGMS1;ST8SIA4;ST6GALNAC3;SPTSSA;SAMD8;ST6GALNAC5;DEGS2;ST8SIA2;CERS1;CERS5;ST8SIA6;SPTLC2;SPTSSB
prerank,cellular potassium ion homeostasis (GO:0030007),0.5209451715989306,1.1071208279138405,0.3404539385847797,0.8942075658414916,1.0,5/13,5.51%,KCNMA1;ATP1A4;ATP1A3;ATP1A1;KCNJ2
prerank,regulation of cell growth (GO:0001558),0.3823123480765393,1.1069388453575963,0.24348697394789579,0.8940625916587185,1.0,37/204,13.17%,EGFR;WT1;HPN;DCBLD2;FHL1;PLCE1;DACT3;SGK3;SGK2;TGFB2;SLIT3;SLIT2;CDKN2AIP;S100A8;S100A9;SMAD4;DDX49;GNG4;PSRC1;MTOR;ITCH;PTPRJ;SOCS2;CAMK2D;EGLN2;MELTF;FLCN;CYP27B1;NRG3;URI1;BCL6;AKT1;DNAJB2;LGI1;TAOK2;ADAM15;CDKN1A
prerank,organic hydroxy compound transport (GO:0015850),-0.3146485328875641,-1.106819531539383,0.2734375,0.7043034433086789,1.0,9/36,12.72%,ABCC4;SLCO2B1;SLCO1C1;RBP4;SLC5A3;STRA6;NCOA1;CEACAM1;OSBP
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.40659367929878204,1.1067605311699076,0.32800851970181044,0.8938591271310968,1.0,17/67,14.60%,AXL;NCF4;FYN;ITGB3;VEGFA;PIK3R2;MAPK14;SRC;SULF1;PRKD2;ABI1;PIK3CA;MAPK11;ITGAV;RHOA;AAMP;HSP90AA1
prerank,regulation of catabolic process (GO:0009894),0.49484555363894217,1.10668013787429,0.36259541984732824,0.893384669013195,1.0,5/18,13.23%,FAP;ZDHHC7;ODC1;TMEM9;ZDHHC2
prerank,regulation of actin filament-based process (GO:0032970),0.4047591960964508,1.106571558494147,0.3149522799575822,0.8929875320326581,1.0,13/70,16.21%,CORO2B;ARHGAP44;LRP1;EFNA5;EPHA3;MTOR;FSCN1;IQGAP1;RHOQ;TAOK2;RHOA;RND3;RAC3
prerank,defense response to bacterium (GO:0042742),0.396115844997631,1.1065329200399419,0.3192584963954686,0.8923652196022105,1.0,11/105,12.32%,SYK;LBP;ANG;S100A8;S100A9;TIRAP;TLR4;CEBPB;DMBT1;SLPI;RNASE6
prerank,actin filament depolymerization (GO:0030042),0.5403323096334316,1.1065229961645677,0.37110481586402266,0.8916269174277249,1.0,3/11,11.23%,GSN;TWF1;MICAL2
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.42429750209227846,1.1064446722924943,0.33370535714285715,0.8911153820732641,1.0,8/47,14.08%,CD34;FYN;ATP2B4;WDTC1;ACADVL;SIRPA;GLA;ZC3H12A
prerank,"base-excision repair, gap-filling (GO:0006287)",0.43863045098086084,1.1062145635346847,0.327313769751693,0.8911704788717787,1.0,3/35,9.95%,MPG;POLB;PARG
prerank,positive regulation of stress fiber assembly (GO:0051496),0.42528157344168305,1.105578905101411,0.3254769921436588,0.8925700517751582,1.0,9/44,10.15%,MYOC;TGFB3;S100A10;SORBS3;LPAR1;PFN2;ARHGEF10L;ARHGEF10;CD47
prerank,hemopoiesis (GO:0030097),0.3999024452738535,1.1047242378003852,0.30546955624355004,0.894739914044479,1.0,11/87,8.93%,CD34;MFAP5;WNT10B;TGFB2;TGFBR2;RUNX1;FLCN;FLT3LG;ZFP36L2;TIRAP;JAG1
prerank,RNA 3'-end processing (GO:0031123),0.40959245344696327,1.1046525097261384,0.3245521601685985,0.8942384304859101,1.0,30/69,28.90%,SRSF2;SRSF6;TENT4A;U2AF1;SRSF3;CPSF4;SRSF11;THOC7;POLDIP3;THOC2;THOC1;ZC3H11A;CPSF2;TENT2;DDX39A;SRRM1;TENT4B;SUPV3L1;U2AF2;CSTF2T;CPSF1;CPSF7;WDR33;PABPN1;ALYREF;UPF3B;CDC40;THOC5;CPSF3;SRSF5
prerank,negative regulation of cation transmembrane transport (GO:1904063),-0.3866141901700878,-1.1044011071265634,0.319047619047619,0.7086975568542225,1.0,2/18,0.55%,ATP1A2;NEDD4L
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.45124744179193116,1.1042859085723695,0.35722819593787336,0.8946915011651587,1.0,5/31,11.79%,CD80;GLMN;RC3H1;CEBPB;GPNMB
prerank,cell-cell junction maintenance (GO:0045217),0.5309949472188094,1.1039306689240918,0.36812411847672777,0.8951286057212264,1.0,4/11,8.24%,CD177;F2R;MYADM;PARD6A
prerank,triglyceride catabolic process (GO:0019433),0.48457941795785514,1.1037929299789175,0.34267515923566877,0.8948201813831551,1.0,4/19,18.64%,FABP12;FABP5;LIPC;LIPH
prerank,positive regulation of cell-cell adhesion (GO:0022409),-0.3112667862749611,-1.103739641765591,0.30612244897959184,0.7082247995605827,1.0,4/41,1.98%,TJP1;GCNT2;PODXL;BMP7
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.47460029982801444,1.1035043445388744,0.3482587064676617,0.8950585999063174,1.0,8/21,22.52%,EFNA5;EPHA3;SLK;SLC9A1;RHOA;ACTG1;CORO1C;LDB1
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.45510015794221303,1.1029957734235434,0.3586698337292161,0.8960939087839702,1.0,14/27,26.43%,MRGBP;ATAT1;MSL3;KAT2B;NAT8;MORF4L1;NAA50;TAF6L;TRRAP;SGF29;KAT6B;KAT5;KAT7;BRD8
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.3520972557835274,-1.102782931346321,0.2947976878612717,0.7085844737658288,1.0,4/23,2.10%,PRKAG2;CEMIP;BMP7;APP
prerank,aorta morphogenesis (GO:0035909),-0.38337025503563316,-1.102571752552549,0.334841628959276,0.7070300614781687,1.0,6/17,9.45%,MYLK;ADAMTS9;ENG;TBX1;PDGFRB;TBX2
prerank,regulation of secretion by cell (GO:1903530),0.4184357842692776,1.1025672166106588,0.3420479302832244,0.8968400376586368,1.0,20/54,27.68%,ANXA1;DISP1;LLGL1;RHBDF1;SCG5;STX4;RAB3D;HCRT;P3H1;NSF;SYT1;VAMP2;RIMS2;RALA;RAB10;STXBP5L;RAB12;RAB3C;VAMP3;RAB8B
prerank,striated muscle contraction (GO:0006941),-0.29735740656980875,-1.102431497894565,0.2911392405063291,0.7052597379997031,1.0,5/53,2.81%,ATP1A2;TPM1;DMD;RCSD1;DTNA
prerank,multivesicular body assembly (GO:0036258),0.45333059666779824,1.10221865809314,0.34360189573459715,0.8972104211666337,1.0,10/30,23.95%,CHMP7;VPS4B;MVB12A;VPS37D;VPS37C;VPS37B;VPS36;PDCD6IP;IST1;STAM
prerank,regulation of cardiac conduction (GO:1903779),-0.27739944956229656,-1.1022118322382,0.2891566265060241,0.7036758888063506,1.0,12/54,12.11%,ATP1A2;ITPR1;ATP1B3;AHCYL1;SLC8A3;ABCC9;ITPR3;NPR1;FXYD1;RYR2;NOS1;ATP2A3
prerank,regulation of protein transport (GO:0051223),0.449562595038351,1.1021894976587763,0.3578088578088578,0.8965609547289283,1.0,8/27,15.25%,DISP1;LLGL1;NDEL1;RHBDF1;SCFD1;NDFIP1;P3H1;CHP1
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.47336803533907,1.1020537413623461,0.35,0.8962210428913367,1.0,5/22,13.25%,GTF2H3;RAD23B;ERCC3;UBA52;DDB1
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.4339733963534298,1.101697404772337,0.34104046242774566,0.8967007016409195,1.0,11/36,17.86%,TAOK3;DACT1;AIDA;ITCH;FOXO1;SIRPA;HDAC3;NCOR1;PER1;PPIA;QARS1
prerank,cellular response to BMP stimulus (GO:0071773),0.4052597564484687,1.101680995199847,0.3329798515376458,0.8959864213845552,1.0,12/66,10.84%,AMH;TMEM100;TGFB3;TGFB2;SMAD4;ACVR1;BMP15;FAM83G;SMAD5;BMP8A;SMAD6;AMHR2
prerank,positive regulation of protein import into nucleus (GO:0042307),0.44681145024513347,1.101547209454486,0.34143377885783716,0.8957030574520976,1.0,12/28,22.69%,ZPR1;PIK3R2;PSEN1;RBM22;HDAC3;JUP;ZC3H12A;DMAP1;IPO5;FLNA;BAG3;TPR
prerank,positive regulation of chondrocyte differentiation (GO:0032332),0.5424498096690422,1.101467657221644,0.36906377204884666,0.8951980071200754,1.0,2/10,9.28%,LOXL2;SOX5
prerank,positive regulation of viral transcription (GO:0050434),0.46075531163625233,1.1011025791725781,0.3389423076923077,0.8956802332255154,1.0,7/25,15.09%,POLR2H;MDFIC;CDK9;POLR2D;POLR2G;CTDP1;GTF2F1
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),-0.36442097865549317,-1.1010641956780227,0.3054187192118227,0.704493269852904,1.0,8/21,10.06%,CNOT2;SAMD4A;CNOT9;PAN3;CNOT7;TUT4;CNOT11;TUT7
prerank,regulation of axon extension (GO:0030516),0.4340491208778253,1.1005133307667725,0.3613636363636364,0.896926230394051,1.0,8/37,11.38%,DBN1;PTPRS;NTN1;TRIM46;ISLR2;SEMA3A;L1CAM;MAPT
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.38789151366472063,1.1004037719720177,0.27401415571284127,0.8965655554608828,1.0,25/142,18.07%,ACKR3;CD55;ESR1;C1QTNF1;LPAR3;NPTN;PLCE1;F2R;DLG4;LPAR1;ATP2B4;ADCYAP1;ABL2;YWHAE;ACKR4;CALCA;SLC35G1;ADCY8;SLC8A2;PDGFRA;CXCR4;CXCR2;BCAP31;IAPP;ATP2B1
prerank,negative regulation of protein modification process (GO:0031400),0.39782925704441113,1.0996546400324632,0.3301787592008412,0.8983821599068648,1.0,28/79,23.52%,EPHB2;LRP6;NIBAN1;SLIT2;WWTR1;PLPP3;ATP2B4;TARDBP;MYADM;PID1;PIP5KL1;INPP5K;SIRPA;MAPT;P3H1;ZC3H12A;CDYL;CHP1;PPIA;TINF2;IBTK;FKBP8;CORO1C;PTEN;TERF2IP;YWHAB;FBLN1;ATG14
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.5314587118171317,1.0991314665472731,0.37398373983739835,0.8994371735946421,1.0,3/12,13.57%,IRS1;IRS2;TWIST1
prerank,regulation of translation (GO:0006417),0.3835893022321522,1.0990750798587157,0.28888888888888886,0.8988459324892432,1.0,59/173,27.22%,IGFBP5;NIBAN1;PKP3;EIF3B;EIF2AK3;RBM4;PAIP2B;CTIF;MTOR;TRIM71;SAMD4B;ATXN2;LARP4;MRPL13;HNRNPD;EIF1;NPM1;IGF2BP1;PASK;EIF6;LARP1;LTN1;RPS27L;BCL3;ZCCHC4;CNOT10;NOLC1;POLDIP3;RBM3;EIF3E;GSPT1;IL6;EIF3D;FXR2;YTHDF1;EPRS1;PAIP2;PCIF1;MTIF2;METAP1;NEMF;EIF2A;YTHDF3;OGFOD1;TRAP1;EIF4G3;EIF4H;CALR;LARP6;GRM5;CYFIP1;UPF3B;EIF2B2;EIF4G1;EIF4E2;UPF1;DDX1;TSC1;PRKDC
prerank,cochlea morphogenesis (GO:0090103),0.5369370166494455,1.0989877017814378,0.3670886075949367,0.8983769183684102,1.0,2/10,7.53%,HPN;MYO3B
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.4197147102600799,1.0989654481361772,0.3482142857142857,0.8976980068914459,1.0,13/43,21.72%,CDC14B;INTS3;TAOK3;RINT1;DTL;TAOK2;CDKN1A;ABRAXAS1;NBN;NOP53;BLM;DONSON;CLSPN
prerank,regulation of T cell differentiation in thymus (GO:0033081),0.5150515461050343,1.098870359384324,0.35570469798657717,0.8972456943553472,1.0,2/13,7.50%,ZC3H8;GLI2
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),-0.3305229211682352,-1.0988524700798739,0.28994082840236685,0.7083776164779017,1.0,6/27,9.21%,SLC7A2;SLC1A3;SLC7A5;SLC6A9;SLC3A2;SLC38A5
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.4162976808509114,1.0988057773703959,0.3551609322974473,0.8966831876172924,1.0,14/50,17.84%,TRIAP1;CD44;VEGFA;CARD16;SRC;GAS6;DPEP1;YWHAE;GPX1;AKT1;SFN;KLF4;HGF;PLAUR
prerank,acute inflammatory response (GO:0002526),0.46473278236470006,1.0986888785984215,0.35432098765432096,0.8963044969206083,1.0,1/23,0.28%,LBP
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.45222805885766953,1.098457422500503,0.3501199040767386,0.8963447610603659,1.0,7/27,16.30%,HAS2;CD44;CD47;SIRPA;IRAK1;RHOA;IL6
prerank,lymphocyte migration (GO:0072676),0.43949486860854814,1.0983452056051852,0.33642691415313225,0.8960033474863528,1.0,4/32,12.91%,CCL8;RET;CCL25;CCL13
prerank,regulation of axon guidance (GO:1902667),0.5381345591701601,1.0981176132016748,0.37285714285714283,0.8960471005519725,1.0,5/10,17.46%,VEGFA;ZSWIM4;MYCBP2;ZSWIM8;YTHDF1
prerank,positive regulation of protein phosphorylation (GO:0001934),0.3781629606847074,1.0977477718350264,0.225,0.8965096704279558,1.0,62/348,13.43%,GHR;LIF;DDR2;CD80;FGF18;NIBAN1;FGF7;EGFR;TGFB3;EFNA5;ANGPT4;TMEM119;NPTN;CAMKK1;CD44;ITGB3;DGKQ;VEGFA;PDE8A;FGF2;TGFB2;MIF;SMAD4;AXIN1;ACVR1;BMP15;ITGA5;MAP2K3;ATP2B4;PTPRJ;DOCK7;MAPRE3;RASSF2;THBS4;INHA;SRC;PFN2;S1PR2;BANK1;HDAC6;ADCYAP1;GAS6;FLCN;PRKD2;CD81;CDK9;IQGAP1;BMP8A;MUSK;HDAC3;CAMKK2;KRAS;AKT1;GPNMB;EGF;XRCC5;CALM2;TAOK2;CDKN1A;PIN1;CCND1;IL5
prerank,positive regulation of protein localization to Cajal body (GO:1904871),0.5339774130602984,1.0975125303419235,0.3798342541436464,0.895828881896107,1.0,5/11,27.82%,MEPCE;CCT7;LARP7;CCT4;CCT6A
prerank,regulation of protein localization to Cajal body (GO:1904869),0.5339774130602984,1.0975125303419235,0.3798342541436464,0.895828881896107,1.0,5/11,27.82%,MEPCE;CCT7;LARP7;CCT4;CCT6A
prerank,neutrophil activation involved in immune response (GO:0002283),0.37608008424027806,1.0965906198615754,0.205,0.8983853439700605,1.0,104/428,21.61%,SYK;TIMP2;GSN;CD55;ARSA;B4GALT1;CD44;CD177;ANXA2;RAB6A;ANPEP;ACTR1B;TMBIM1;MIF;S100A8;S100A9;SPTAN1;MAPK14;AP1M1;ACLY;RAP1B;TMEM63A;PTPRJ;TOM1;PLEKHO2;AP2A2;PRCP;RAB37;IDH1;DOK3;TCN1;ATP11A;COPB1;SURF4;CAPN1;ARHGAP9;DYNC1LI1;PSEN1;IQGAP1;ABCA13;SNAP23;ITGAV;CD47;LPCAT1;SIRPA;CSTB;NRAS;RAB3D;SLPI;GLA;JUP;TMEM30A;XRCC5;NIT2;SNAP25;RHOA;CMTM6;TNFRSF1B;NME2;SLC2A3;UBR4;SLC15A4;HSP90AA1;CD14;DIAPH1;ATP6V0A1;DYNC1H1;GAA;ATP6V1D;PKM;CAP1;IGF2R;CANT1;FABP5;CTSD;PPIA;PADI2;ILF2;RAB5B;RAB5C;SLC44A2;CXCR2;COTL1;TMEM179B;PLAUR;VAMP2;PYGB;PRG2;ALDOA;APAF1;RAB24;DDOST;TOLLIP;ITGAM;ACP3;QSOX1;RAB10;PYCARD;COMMD9;MAPK1;ANXA3;ERP44;CAB39;CPNE1
prerank,protein K11-linked ubiquitination (GO:0070979),0.45491259331528394,1.0964655192905877,0.3578313253012048,0.8980505114401159,1.0,10/27,20.91%,UBE2B;UBE2W;CDC23;ANAPC5;UBE2A;CDC27;CDC26;ANAPC4;UBE2D3;ANAPC10
prerank,negative regulation by host of viral transcription (GO:0043922),0.5262126190578714,1.0963420122545395,0.3767313019390582,0.8977022872771857,1.0,4/12,21.89%,TARDBP;INPP5K;TFAP4;JUN
prerank,protein localization to kinetochore (GO:0034501),0.501131258255409,1.0959946290050473,0.3559322033898305,0.8981799780311174,1.0,3/14,5.96%,CHAMP1;ZW10;CENPT
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.5076466068741716,1.0959262146834206,0.3505291005291005,0.8976584546668971,1.0,3/15,12.04%,PRKCA;CAMK2D;SLC9A1
prerank,chromatin organization (GO:0006325),0.3851613671738223,1.0958718459963155,0.30707070707070705,0.8970919472760412,1.0,53/132,30.40%,ESR1;LOXL2;SMARCD2;MCM3AP;SMARCD1;PHF1;ZBTB1;SETD7;KAT2B;KDM5C;SATB2;HDAC3;NPM1;SMARCC2;SETD2;KDM5B;DR1;DDX11;HDAC4;EZH1;GATAD1;INO80;SETD5;SMARCA4;NUDT5;BAZ2B;CHD1;PADI2;SUPV3L1;TAF6L;EZH2;BAZ2A;SETDB1;KDM4C;SETDB2;BAZ1A;INO80C;TCF7L1;HP1BP3;SAFB;ARID1A;JARID2;HDAC8;SUV39H1;CHRAC1;KDM4B;TADA2A;PBRM1;ZBTB7A;ATRX;SOX9;HCFC2;HCFC1
prerank,regulation of Ras protein signal transduction (GO:0046578),0.39420787460845025,1.095865258303359,0.32322175732217573,0.8963545474896473,1.0,21/85,16.38%,EPHB2;ARHGEF28;ARHGAP44;AKAP13;PLCE1;TGFB2;RASGRF1;RASGEF1A;MYO9B;FLCN;ARFGAP1;KANK1;SQSTM1;IRS2;SHOC2;DENND1A;ARF6;RAPGEF1;MADD;EPS8L2;OGT
prerank,positive regulation of nuclear division (GO:0051785),-0.34294718075885733,-1.09534633774084,0.3076923076923077,0.7154610535313601,1.0,6/25,8.67%,INSR;TGFA;IGF1;RGCC;IGF2;PDGFRB
prerank,regulation of nuclear division (GO:0051783),0.4706856475332257,1.0951835517206017,0.3552795031055901,0.8979870836485389,1.0,5/20,13.95%,CCDC8;KIF20B;FBXO5;PIN1;CUL9
prerank,negative regulation of JNK cascade (GO:0046329),0.44012785569535495,1.0949652002295696,0.36662749706227965,0.8979699029532927,1.0,9/31,16.20%,TAOK3;DACT1;AIDA;ITCH;SIRPA;HDAC3;NCOR1;PDCD4;PER1
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.3820482178021038,1.0948794353529256,0.2708124373119358,0.8975038082728383,1.0,91/241,28.90%,GEMIN6;POLR2H;SRSF2;CD2BP2;HNRNPA1;SRSF6;DHX16;RBM4;ZCRB1;DDX42;LSM4;PRPF4;U2AF1;SRSF3;TFIP11;PRPF3;GPATCH1;USP39;HNRNPD;RBM22;DNAJC8;SNRPB2;CPSF4;HNRNPH1;DHX8;RBM17;PRPF40A;SRSF11;POLR2D;POLR2G;SNU13;HNRNPA3;AQR;SF3B4;GTF2F1;ZCCHC8;BCAS2;SF3A1;CPSF2;PHF5A;DDX5;SNRPA;SNRPG;SNRPD3;PNN;SNIP1;PDCD7;DDX39A;SRRM1;RBM6;PUF60;GCFC2;PRCC;HNRNPUL1;U2AF2;ELAVL2;ZMAT5;NOVA1;LSM7;PTBP1;SF3B2;SF3B1;PRPF38A;GPKOW;RBM5;SNRPA1;CSTF2T;CPSF1;RALY;CPSF7;WDR33;PABPN1;POLR2C;CWC27;ALYREF;UPF3B;PPIH;USP49;RBMX;PRPF19;CRNKL1;PRPF6;LSM5;CDC40;WDR83;CPSF3;RBM15;HNRNPC;SNRPC;WBP11;SRSF5
prerank,histone H2A ubiquitination (GO:0033522),0.48626551142087293,1.0945869407190494,0.37711313394018203,0.8977880094892036,1.0,8/17,22.64%,UBE2B;RNF2;RYBP;UBE2A;DDB1;RING1;KDM2B;UBR2
prerank,carbohydrate derivative transport (GO:1901264),0.4800436539122113,1.0944378270796724,0.355584082156611,0.8975412409885396,1.0,1/18,0.28%,LBP
prerank,cardiac muscle cell membrane repolarization (GO:0099622),0.5355126785092698,1.0943990813715578,0.3712737127371274,0.8969162821262169,1.0,5/11,18.74%,ATP1A1;KCNJ2;YWHAE;KCNJ3;KCNH2
prerank,protein oxidation (GO:0018158),0.5282341592018361,1.0941143152167918,0.36712328767123287,0.8971693471752433,1.0,3/11,18.51%,LOXL2;LOXL1;LOX
prerank,epiboly involved in wound healing (GO:0090505),0.49542819418600087,1.0938957997078502,0.3588082901554404,0.8971318045243213,1.0,5/16,14.53%,TMEFF2;CD44;TOR1A;RHOA;DDR1
prerank,neural crest cell differentiation (GO:0014033),0.4779218228701013,1.0938781349753712,0.37738246505717915,0.8964364767576745,1.0,4/18,16.60%,LRP6;SOX8;NOLC1;SNAI2
prerank,positive regulation of chemokine production (GO:0032722),0.41742514908983014,1.0934570419091456,0.3429844097995546,0.8971810639157421,1.0,10/44,18.61%,SYK;IL33;ADCYAP1;IL17RA;TIRAP;TLR4;TWIST1;IL6;IL18;MBP
prerank,ameboidal-type cell migration (GO:0001667),0.4140421345944581,1.093165178226023,0.3671444321940463,0.8974444124025448,1.0,11/51,13.08%,SEMA3C;GPC3;RADIL;SOX10;SOX8;SEMA3A;PDXDC1;AKT1;PDLIM1;SEMA3D;GDNF
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.4384706784574153,1.0931224624721894,0.3422897196261682,0.8968477808576344,1.0,10/33,20.87%,SCIN;RAB7B;MAPK14;HOXA5;MAPK11;STAT5B;PITHD1;THPO;ABCB10;ACVR2A
prerank,mitochondrial protein processing (GO:0034982),-0.4132182446072574,-1.0927845119548758,0.3449612403100775,0.7202219709491379,1.0,4/11,17.54%,IMMP2L;ATP23;YME1L1;STOML2
prerank,synaptic membrane adhesion (GO:0099560),0.508978655891566,1.0925651602296782,0.36213991769547327,0.8981672953359212,1.0,3/14,6.78%,GPC6;PTPRS;PTPRF
prerank,regulation of acute inflammatory response (GO:0002673),0.48358273146532166,1.092245436064139,0.38522427440633245,0.8984760710877373,1.0,3/18,16.30%,KLKB1;IL4;IL6
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),-0.38385903846313923,-1.0918683374763456,0.3282828282828283,0.7205782174437105,1.0,8/16,14.18%,IGF1;MEF2C;NOTCH1;TGFBR3;FGFR2;TBX2;AKAP6;EDN1
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.4691573248262859,1.0916840693270866,0.3753056234718826,0.8996546529365669,1.0,10/22,28.36%,VPS4B;MVB12A;VPS37D;VPS37C;VPS37B;UBAP1;VPS36;STAM;RNF126;PTPN23
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),-0.33793105217917513,-1.0909771525390006,0.3333333333333333,0.7209668058087916,1.0,4/23,4.23%,INSR;IGF1;APP;PRKAA2
prerank,positive regulation of phosphorylation (GO:0042327),0.3765053940405115,1.090882569724687,0.2682682682682683,0.9016249702858059,1.0,56/240,18.13%,DDR2;AR;EPHB2;FGF18;AXL;NIBAN1;FGF7;EGFR;FGFR1;EFNA5;TMEM119;GLMN;NPTN;EPHA3;ANG;ITGB3;VEGFA;PDE8A;FGF2;MST1R;MIF;AXIN1;RET;MLXIPL;GAS6;FLCN;FZD7;PSEN1;EPHB3;MUSK;DSCAM;HDAC3;CAMKK2;SLC4A4;KRAS;AKT1;EPHA10;GPNMB;EGF;FLT3;PIN1;CCND1;PDGFRA;NBN;WDFY2;DDR1;HSP90AA1;KCTD20;HGF;FXR2;CHRNA7;PPIA;RAD50;PLAUR;ILK;EPHB1
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.4580140022065144,1.0907560736546371,0.3765133171912833,0.9013000249628575,1.0,6/25,14.70%,ITGB3;DLG4;ATXN2;PSEN1;ITGAV;ARF6
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.5340115058776789,1.0902693185232903,0.391008174386921,0.9022121497004548,1.0,3/11,10.38%,CD44;SRC;KANK1
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.41762394682928605,1.0899585040067405,0.36469221835075494,0.9025444730858193,1.0,4/39,5.35%,AREG;EGFR;BTC;PTPRJ
prerank,negative regulation of B cell activation (GO:0050869),0.47639825896703175,1.089902921874129,0.36900369003690037,0.9019644697915523,1.0,4/21,7.02%,PARP3;INHA;BANK1;RC3H1
prerank,modulation by symbiont of host process (GO:0044003),-0.42859675786954865,-1.089706489241262,0.3413793103448276,0.7224292909768962,1.0,4/10,18.89%,B2M;ENO1;PGK1;MRC1
prerank,regulation of necroptotic process (GO:0060544),0.47302400429963676,1.0893441673893038,0.3757725587144623,0.9031053487461898,1.0,10/23,22.93%,SPATA2;STUB1;SLC25A4;HSP90AA1;OGT;FLOT2;PDCD6IP;SDCBP;CYLD;FLOT1
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.47739113654972054,1.089264475942772,0.3669250645994832,0.9026463534332184,1.0,3/18,9.60%,IRS1;MIDN;BMP8A
prerank,negative regulation of cartilage development (GO:0061037),0.5119068107638777,1.0891922369728468,0.3948087431693989,0.902168049406293,1.0,5/13,18.40%,WNT9A;CHADL;SNAI2;EFEMP1;TGFBR1
prerank,nucleosome assembly (GO:0006334),0.4432693204988409,1.0891667117674106,0.3850574712643678,0.9015172869876885,1.0,16/31,32.82%,CHAF1B;SPTY2D1;NPM1;ANP32B;UBN1;GRWD1;NAP1L2;BRD2;KAT6B;NAP1L3;ATRX;HIRA;SOX9;IPO4;RSF1;NASP
prerank,positive regulation of phospholipase activity (GO:0010518),0.4623667608688444,1.089034080398582,0.37995049504950495,0.9011801535205933,1.0,5/22,7.45%,ESR1;FGFR1;FGF2;ARF4;ABL2
prerank,cell-cell junction assembly (GO:0007043),-0.2711885208892162,-1.0890292862747992,0.2898550724637681,0.7222032292101578,1.0,12/63,7.75%,TJP1;PKP4;CDH5;GJB6;CLDN5;PATJ;GJB2;CDH6;ACTB;TLN2;GJA1;CDH7
prerank,establishment of melanosome localization (GO:0032401),-0.3605580229537543,-1.088920818355283,0.3287037037037037,0.7203618462715646,1.0,8/19,17.83%,SHROOM2;BLOC1S5;RAB11A;BBS7;MREG;RAB27A;BLOC1S6;MLPH
prerank,regulation of B cell apoptotic process (GO:0002902),0.5156361601326628,1.0888478276713474,0.3756983240223464,0.9010589804620391,1.0,4/12,12.14%,FOXP1;NOC2L;BCL6;IRS2
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.4257808258258279,1.0877961969713188,0.3659090909090909,0.903859958949317,1.0,16/38,26.48%,OTUD3;PTPRJ;BANK1;FLCN;PHLPP2;INPP5K;AKT1;MAGI2;PLEKHA1;NOP53;PPP2R5B;SFRP5;PTEN;TSC2;DDIT3;MUL1
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.4963914626385317,1.0873791166467321,0.39213197969543145,0.9045522018492623,1.0,5/15,18.74%,ATP1A1;KCNJ2;YWHAE;KCNJ3;KCNH2
prerank,response to axon injury (GO:0048678),0.47596944108271316,1.0871079641862758,0.37247474747474746,0.9047392752986595,1.0,9/18,29.94%,GAP43;FLRT3;MTR;RTN4RL1;SARM1;MORN4;P2RX4;DHFR;MAPK8IP3
prerank,gene expression (GO:0010467),0.3779719393910535,1.0868897701502043,0.241,0.9047145388155673,1.0,79/348,19.51%,NOX4;RPSA;TSPAN17;POLR2H;SRSF2;ADARB1;MRPS11;SRSF6;NXF1;RRBP1;DDX19B;COPS5;RBM4;MRPS18B;NUP93;IGHMBP2;MCM3AP;BICD1;NUP107;PRPF4;STUB1;U2AF1;SRSF3;TFIP11;PPP5C;MRPL13;MRPS17;NUP98;AGO2;DUSP11;HNRNPD;CPSF4;GSPT2;HNRNPH1;RPL10A;DHX8;MRPL10;CELF2;MRPL55;TNIP1;SRSF11;THOC7;POLR2D;POLR2G;MPHOSPH10;DDX17;RPS5;BCL3;MRPL36;POLDIP3;RBM3;DNAJB11;SMG7;TASP1;THOC2;MRPL3;THOC1;GSPT1;ZC3H11A;SMG6;FYTTD1;DDX20;RPL6;NUP37;MRPL51;HARS1;CPSF2;ABCF1;NUFIP1;DDX39A;SRRM1;RBM6;RBM39;NUP50;SLBP;HNRNPUL1;U2AF2;RPL23;RPL17
prerank,regulation of macrophage migration (GO:1905521),0.5309354631649381,1.0867950079498054,0.36681222707423583,0.9042775539341996,1.0,3/10,21.90%,CD81;CD200R1;CSF1
prerank,positive regulation of epithelial cell migration (GO:0010634),0.39652234708985346,1.0864142270744224,0.3374358974358974,0.9048612028444456,1.0,23/92,14.70%,FGF7;PRKCA;ANGPT4;SPARC;ITGB3;VEGFA;FGF2;TGFB2;FOXP1;ADAM9;SMOC2;MTOR;SRC;HDAC6;PRKD2;FOXC2;EMC10;AKT1;EGF;AAMP;ZC3H12A;BCAS3;ARF6
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.3917013473309535,1.0861542169419673,0.34854771784232363,0.9050171543490493,1.0,17/87,14.33%,CDK2AP2;FHL1;PSMC4;ZFP36L1;CDK4;DACT1;PRMT2;PSMC6;PKD2;ZFP36L2;PSMD8;AVEN;BRD7;GPNMB;FBXO5;CDKN1A;KLF4
prerank,UV protection (GO:0009650),0.5435094527821068,1.085574678753056,0.3802228412256267,0.9062507549126108,1.0,3/10,17.52%,SCARA3;GPX1;ERCC5
prerank,translational elongation (GO:0006414),0.3889293422334474,1.0854927927488118,0.34564102564102567,0.9057980465802288,1.0,24/101,16.83%,MRPS11;MRPL38;EEF2K;MRPS18B;GTPBP2;CHCHD1;MRPL13;MRPS17;AURKAIP1;MRPS27;MRPL30;MRPL10;GFM1;DAP3;MRPL55;MRPS10;LTN1;MRPL36;MRPL3;MRPL21;MRPS34;MRPL51;EEF1B2;EEF1G
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.39720094471048684,1.0851297510099576,0.3418803418803419,0.9063015008905011,1.0,13/72,16.86%,SYK;AXL;IRAK3;RUNX1;SPATA2;ABCE1;GAS6;CHUK;SPPL2B;IRAK1;MADD;RBCK1;TAX1BP1
prerank,nucleic acid metabolic process (GO:0090304),0.401923647800788,1.085057569265822,0.36227224008574493,0.9058248919472389,1.0,26/69,28.67%,POLR2H;HNRNPA1;KPNA2;ATXN2;DNASE2;DUSP11;HNRNPD;HNRNPH1;RBFOX2;POLR2D;POLR2G;DNA2;HNRNPA3;DNASE1L2;GTF2F1;RAD50;DDX24;PTBP1;POLR2C;DNASE1L1;RBMX;DDX1;MMS19;LSM1;HNRNPC;PDE12
prerank,regulation of striated muscle contraction (GO:0006942),-0.31583710933756215,-1.0848353360434015,0.2795031055900621,0.729589528268162,1.0,3/27,3.48%,ATP1A2;DMD;SLC8A3
prerank,cellular response to retinoic acid (GO:0071300),0.4262458931086044,1.0847880568724082,0.36914285714285716,0.9059770392027209,1.0,7/42,8.19%,WNT10B;WNT2;EPHA3;WNT9A;RET;ABL2;FZD7
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.3768776495406465,1.084761198101754,0.2782782782782783,0.9053279708852188,1.0,100/264,28.90%,GEMIN6;POLR2H;SRSF2;CD2BP2;HNRNPA1;SRSF6;DHX16;RBM4;ZCRB1;DDX42;LSM4;PRPF4;U2AF1;SRSF3;TFIP11;WDR77;PRPF3;GPATCH1;USP39;HNRNPD;RBM22;DNAJC8;SNRPB2;CPSF4;HNRNPH1;DHX8;RBM17;PRPF40A;SRSF11;TGS1;POLR2D;POLR2G;DDX17;SNU13;HNRNPA3;AQR;SF3B4;GTF2F1;DDX20;ZCCHC8;BCAS2;SF3A1;CPSF2;PHF5A;DDX5;SNRPA;SNRPG;SNRPD3;PNN;SNIP1;PDCD7;DDX39A;SRRM1;RBM6;PUF60;GCFC2;PRCC;STRAP;HNRNPUL1;U2AF2;ELAVL2;ZMAT5;NOVA1;LSM7;PTBP1;SF3B2;SF3B1;SRPK1;PRPF38A;GPKOW;RBM5;SMN1;SNRPA1;COIL;CSTF2T;CPSF1;RALY;CPSF7;WDR33;PABPN1;POLR2C;CWC27;ALYREF;UPF3B;PPIH;USP49;RBMX;PRPF19;CRNKL1;PRPF6;DDX1;LSM5;CDC40;WDR83;CPSF3;RBM15;HNRNPC;SNRPC;WBP11;SRSF5
prerank,response to metal ion (GO:0010038),0.40465594685914585,1.0842779962465685,0.37037037037037035,0.9062188432770886,1.0,11/67,12.63%,LOXL2;KCNMA1;SNCB;ADAM9;CRIP1;SEC31A;MTF1;SLC11A2;PPP5C;MAPT;CALM2
prerank,regulation of metal ion transport (GO:0010959),0.4939978165531295,1.0840132517981862,0.38976377952755903,0.9063734607394524,1.0,3/16,3.40%,IL16;ANK2;SRI
prerank,positive regulation of proteolysis (GO:0045862),0.4096581204666828,1.0839858801342768,0.3569060773480663,0.9057327691404227,1.0,17/55,23.59%,CCBE1;MAPK12;ADAM9;RCN3;STUB1;AURKAIP1;TBC1D10A;TNIP1;BAK1;TNFRSF1B;ZC3H12A;OGT;GPLD1;SH3D19;FBXW11;PACSIN3;IST1
prerank,protein modification process (GO:0036211),0.39588121755816624,1.0837950526397246,0.34345549738219894,0.9056056178595225,1.0,28/76,26.46%,PLOD2;LOXL2;RABGGTA;GGCX;PHKA2;ABL2;FBXO2;FBXL2;CSNK1G3;UBA52;CDC34;FBXO11;ST3GAL1;ADPRH;LOX;STK38;NEDD8;UBE2D3;FBXW2;ICMT;YES1;ATG3;MMP15;RABGGTB;UBA7;FBXO22;PIGH;DUSP12
prerank,glutathione metabolic process (GO:0006749),0.43204080214250096,1.0836891553940355,0.364367816091954,0.905226973234918,1.0,8/38,14.50%,GCLC;DPEP1;HAGH;CNDP2;GPX1;GSTM2;NAT8;GGT7
prerank,regulation of ion transport (GO:0043269),0.3968644215765659,1.083646075419114,0.3720682302771855,0.9046345028797365,1.0,19/76,18.56%,SYT2;ITGB3;ATP1A1;SYT12;SYT11;SYT13;KCNJ2;DTNBP1;TOR1A;CLDN10;KCNA2;PXK;GDNF;KCNJ3;STC1;PER1;SYT1;SNX6;VAMP2
prerank,erythrocyte differentiation (GO:0030218),-0.2901393743518014,-1.0834801399245024,0.30701754385964913,0.7311653585675989,1.0,11/44,13.99%,LYN;KMT2E;KIT;TGFBR3;HSPA9;CASP3;RPS14;INHBA;PTPN2;TAL1;HIPK2
prerank,mRNA 3'-end processing (GO:0031124),0.3990746391238495,1.083398422299575,0.35796045785639957,0.9047078536629953,1.0,33/78,28.07%,SRSF2;SRSF6;SCAF8;U2AF1;SRSF3;CPSF6;CPSF4;SRSF11;THOC7;POLR2D;POLDIP3;THOC2;THOC1;ZC3H11A;CPSF2;PAPOLB;TENT2;DDX39A;SRRM1;TENT4B;SLBP;U2AF2;PAF1;CSTF2T;CPSF1;CPSF7;WDR33;PABPN1;ALYREF;UPF3B;CDC40;THOC5;CPSF3
prerank,inorganic ion transmembrane transport (GO:0098660),0.5190805793775063,1.0822170654994974,0.3956343792633015,0.9080066527146137,1.0,6/12,28.27%,P2RX3;PKD2;ASIC2;ABCC8;KCNJ11;CACNA1H
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.4055394586618441,1.081582763138221,0.38286334056399135,0.9093905533841,1.0,6/53,14.19%,LPAR3;MTNR1B;ANXA1;HTR1F;TSHR;LHCGR
prerank,autophagosome organization (GO:1905037),0.4160015366886993,1.0813318063888568,0.37831858407079644,0.9094991632689075,1.0,20/50,25.67%,RAB23;RAB19;ATG2B;PACS2;WIPI2;STX12;WDR45B;ULK2;RAB43;ATG2A;ATP2A2;ULK1;RAB1B;ATG16L2;ATG13;ATG16L1;ATG3;ATG14;EMC6;RAB1A
prerank,dicarboxylic acid transport (GO:0006835),-0.3212807206290355,-1.0811995882178775,0.3163841807909605,0.7351268779648428,1.0,6/28,7.61%,SLC1A3;SLC13A3;SLC26A7;PDPN;SLC22A6;GJA1
prerank,cilium organization (GO:0044782),0.3759096785614884,1.0811738948861973,0.3,0.9092943041849632,1.0,74/209,27.68%,GSN;NME8;CDC14B;ODF2;ABLIM1;PKD1;RAB23;FHDC1;ARF4;ACTR3;HDAC6;BBS9;PKD2;ATAT1;ARL13B;TMEM138;OCRL;CPLANE1;CNGB1;EHD2;NUDCD3;DZIP1;TTC39C;AVIL;TEKT5;PIBF1;DYNC2I2;KIF3A;RPGR;KIF3B;IFT46;TTLL3;BBS4;TTC8;ATP6V1D;FAM161B;AHI1;CCP110;CEP164;DYNC2H1;CEP89;DYNC2I1;CEP83;CCDC28B;RP2;BBS5;BBIP1;IFT52;EXOC4;CC2D2A;SPAG16;FLNA;PCM1;DNAH5;FBF1;TMEM231;TCTN2;RAB11FIP3;PDE6D;CFAP126;DYNLL1;CEP78;TCTN1;CDC14A;NEK1;CEP126;RAB1A;CFAP70;KIFAP3;GBF1;FUZ;IFT81;PTPDC1;RAB8B
prerank,positive regulation of macrophage chemotaxis (GO:0010759),-0.3839506573628143,-1.0809758111417342,0.34375,0.7335291730108638,1.0,6/14,17.79%,IL34;THBS1;MDK;MAPK3;PTK2;RARRES2
prerank,regulation of DNA replication (GO:0006275),0.4159148442186097,1.080853117745664,0.3606194690265487,0.9096005254238342,1.0,11/49,14.84%,EGFR;CTC1;GTPBP4;RBBP6;GLI2;FBXO5;EGF;TERF1;DNA2;EHMT2;GMNN
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.41111458636415477,1.0808316064909673,0.3698781838316722,0.9089365348763458,1.0,23/52,28.98%,MBNL1;HNRNPA1;SRSF6;RBM4;NSRP1;MBNL2;CELF2;RBFOX2;DDX17;DDX5;FXR2;SAP18;PUF60;NOVA1;PTBP1;THRAP3;RBM5;RBM24;CELF3;RBMX;CELF1;RBM15;ZBTB7A
prerank,inhibitory synapse assembly (GO:1904862),0.5171459357849255,1.0807052189413093,0.3949579831932773,0.9086174826205102,1.0,2/11,2.87%,LGI2;FGF13
prerank,negative regulation of telomere maintenance (GO:0032205),0.4939242125783392,1.0806813809083347,0.3881578947368421,0.9079678798783741,1.0,7/15,22.85%,ERCC4;TERF1;NBN;SMG6;RAD50;TERF2IP;ERCC1
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.4804225821621083,1.0806464014803947,0.36770186335403726,0.9073685927463446,1.0,1/18,0.61%,LAX1
prerank,calcium ion transport (GO:0006816),-0.24737692727055532,-1.0805987212896184,0.1875,0.7323449837565431,1.0,25/113,14.13%,ITPR1;TRPM3;SLC24A3;TRPM6;CALCRL;NALCN;CACNA1E;ATP2C1;SLC8A3;RAMP1;CACNB2;CACNA1D;TRPC5;CAV1;SLC3A2;TRPC6;TRPC4;ORAI2;CACNG8;RYR2;ATP2A3;TRPV4;SLC24A5;TRPC7;TRPC3
prerank,lysosome localization (GO:0032418),0.4289480190756023,1.0801345593849763,0.391705069124424,0.9083682332465662,1.0,12/37,21.28%,NDEL1;HDAC6;FLCN;VPS33A;MAP6;HPS6;BLOC1S2;SNAPIN;PIP4P1;KXD1;VPS33B;PIK3CG
prerank,electron transport chain (GO:0022900),0.48946042158933695,1.0799963711845944,0.3946308724832215,0.9080904853880749,1.0,6/15,17.76%,ETFA;ENOX2;POR;ETFB;ETFDH;CYB561
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.3710617655548213,1.0797843674758576,0.294,0.9080628299144388,1.0,48/248,15.34%,SFRP4;LRP6;COL1A1;DKK2;EGFR;TLE6;CCDC88C;SCEL;GPC3;PSMC4;UBE2B;DACT3;CDK14;AMER3;IGFBP6;WWTR1;SMURF2;RBMS3;KREMEN1;AXIN1;IGFBP4;DACT1;TCF7L2;DAAM2;PSMC6;FZD7;PSMD8;PSEN1;CUL3;GSKIP;TLE2;PLEKHA4;KANK1;TMEM9;CSNK1G1;CSNK1G3;PRDM15;ANKRD6;TPBG;GLI3;JUP;EGF;PIN1;STK3;AMFR;CTNND2;CHD8;FZD4
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.4988136618772062,1.0797710930599127,0.3881401617250674,0.9073804262872419,1.0,5/14,19.99%,SRSF6;C1QBP;SAP18;U2AF2;PTBP1
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.426753434125977,1.0793987239195573,0.36621315192743764,0.9079414466898655,1.0,9/40,15.86%,SFRP4;ANXA2;VEGFA;BICD1;MAGI2;EGF;CBL;IL4;AHI1
prerank,regulation of cytokine production involved in immune response (GO:0002718),-0.3385181163170297,-1.0793413923942055,0.3316582914572864,0.7335651873173689,1.0,10/22,31.71%,WNT5A;SLC7A5;LACC1;SPHK2;NOD2;TRIM6;BTK;CCR2;TNFRSF14;LILRB1
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.4529669176776137,1.0792629472321271,0.38461538461538464,0.9076773852237688,1.0,4/20,6.85%,VEGFA;SMAD4;NFE2L2;SMAD5
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.4878057894018598,1.0787000982179766,0.3801324503311258,0.9087606192014708,1.0,9/15,32.61%,ACTR3;MAGEL2;ARPC5L;ARPC1A;ARPC2;ARPC4;ARPC5;WHAMM;TRIM27
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.4126582038887567,1.078682982793415,0.36983240223463687,0.9080961609873921,1.0,14/46,25.09%,TIMM50;GDAP1;TIMM10B;TIMM9;AKT1;GRPEL2;TIMM22;TIMM8B;BCAP31;TOMM5;RALA;TIMM17A;FIS1;TOMM40
prerank,immunoglobulin mediated immune response (GO:0016064),0.5336548393498433,1.078534991317075,0.4031563845050215,0.9078287279333723,1.0,2/10,12.21%,CD81;CD27
prerank,spliceosomal complex assembly (GO:0000245),0.4148743429566469,1.0785156700671474,0.3661814109742441,0.9071784907389968,1.0,25/46,32.89%,SRSF6;USP39;KHDC4;CELF2;SF3A1;SNRPG;LUC7L3;PUF60;GCFC2;LUC7L2;SF3B1;SRPK1;RBM5;SMN1;CELF3;PRPF19;CRNKL1;PRPF6;DDX1;CELF1;SRSF5;CELF4;SF1;SF3A2;DDX39B
prerank,nucleocytoplasmic transport (GO:0006913),0.4218232567394537,1.0784489807437843,0.3604004449388209,0.9066672703663774,1.0,12/40,22.99%,GEMIN6;HNRNPA1;NUP98;NPM1;BACH2;DDX20;SNRPG;SNRPD3;NXT2;NEMF;HTATIP2;SMN1
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.5033176725862065,1.0783023532869456,0.3997308209959623,0.9064178846287575,1.0,4/13,10.36%,CHST1;NAGK;OGA;LARGE1
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.3911560565107692,1.0779632407277047,0.33089770354906056,0.9068089254422699,1.0,12/88,12.14%,SYK;SMPD3;PRKCA;VEGFA;CDC42EP2;MPP7;GNL3L;VPS4B;PFN2;TIRAP;BMF;BAK1
prerank,regulation of microtubule depolymerization (GO:0031114),0.4572759688481051,1.0778358078619694,0.3754556500607533,0.9064964139856454,1.0,7/25,22.56%,MAP1B;FGF13;CAMSAP1;NAV3;CLASP2;MAP1A;MAP1S
prerank,regulation of actin filament depolymerization (GO:0030834),-0.40663719498358153,-1.0778192315573003,0.34545454545454546,0.735578415584131,1.0,2/12,3.28%,PLEKHH2;SEMA5A
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.43863427057339216,1.0775103237906523,0.38415366146458585,0.9069199944058496,1.0,10/29,19.53%,MRPS11;ABT1;KRI1;NOP9;RRP36;WDR46;DCAF13;PWP2;TBL3;NOL10
prerank,glutamine family amino acid metabolic process (GO:0009064),0.4356710152178062,1.0775026894516744,0.3772032902467685,0.9062249467064147,1.0,11/33,20.59%,GCLC;ALDH18A1;ART4;GLS2;GLS;NIT2;ALDH5A1;GLUD1;PYCR1;DDAH2;GOT1
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.4193020364314667,1.0773745306085234,0.39933259176863184,0.9059259889331941,1.0,5/43,4.00%,IGFBP5;MMP2;FGF2;FOXP1;MEF2D
prerank,peroxisome organization (GO:0007031),0.44986455252682667,1.0769756772340295,0.3711843711843712,0.9064947014177357,1.0,8/25,24.14%,SEC16B;PEX16;PEX12;PEX1;PEX3;ABCD3;PEX2;FIS1
prerank,regulation of mitotic sister chromatid separation (GO:0010965),0.49145918794372534,1.0766866114134614,0.37880794701986753,0.9067166782265244,1.0,6/15,22.69%,HECW2;CDC23;CDC27;CENPE;RIOK2;TPR
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.4343171299042981,1.0765979974554054,0.38588235294117645,0.9062687364098418,1.0,6/31,12.23%,DBN1;ARHGAP44;PPFIA2;SRCIN1;TANC2;NGEF
prerank,regulation of B cell activation (GO:0050864),0.44799635511031466,1.0765695476075037,0.3933415536374846,0.9056530927136905,1.0,5/25,16.30%,ZFP36L1;BANK1;ZFP36L2;IL4;IL6
prerank,regulation of hippo signaling (GO:0035330),-0.37087240617457495,-1.076561585861418,0.36099585062240663,0.736858855725849,1.0,9/17,19.04%,MOB3B;VGLL4;WTIP;WWC1;MARK3;AJUBA;SOX11;NF2;WWC2
prerank,female gonad development (GO:0008585),0.4744458971030737,1.076509027615408,0.39920948616600793,0.9051452318276594,1.0,7/19,14.19%,ANG;VEGFA;INHA;NUP107;COL9A3;CEBPB;LHCGR
prerank,extrinsic apoptotic signaling pathway (GO:0097191),-0.2628565440585086,-1.0764815705873318,0.36585365853658536,0.7349298473126551,1.0,18/70,12.99%,SORT1;BCL2L1;SMAD3;BCL2;DAB2IP;IL6R;CASP8AP2;TNFSF12;DELE1;CASP3;GABARAP;TLR3;INHBA;FAS;RIPK1;TGFB1;CASP9;BCL2L2
prerank,low-density lipoprotein particle remodeling (GO:0034374),-0.4009836328724505,-1.0763482671951254,0.3310104529616725,0.7331613693047287,1.0,2/11,6.36%,ABCG1;AGTR1
prerank,peptidyl-threonine modification (GO:0018210),0.3989664316541679,1.0761354012868896,0.37072649572649574,0.905686974038356,1.0,23/66,24.76%,PRKCA;DYRK4;TGFBR2;GALNT16;ACVR1;CAMK2D;PRKD2;DYRK2;GALNT1;AKT1;STK39;ULK1;HIPK4;TGFBR1;GALNTL6;CIT;OXSR1;HIPK3;MAPK1;CSNK2A2;GALNT4;ACVR1B;MARK2
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.3760843429970195,-1.076091365605228,0.3094170403587444,0.7317439661355166,1.0,9/16,23.56%,SHLD1;HELB;KLHL15;RIF1;SMCHD1;FANCB;MAD2L2;RMI2;PARPBP
prerank,regulation of protein localization to cell periphery (GO:1904375),0.4740202982631949,1.0756087940846562,0.39724310776942356,0.9066843317096106,1.0,4/18,16.15%,AR;ZDHHC7;ZDHHC2;SPTBN1
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.407228383026829,1.0754181594232124,0.37269772481040087,0.9065609138291116,1.0,11/55,14.08%,UCP1;TGFBR2;MAPK14;COQ7;ARF4;PID1;DHRS4;SIRT2;EIF6;CDKN1A;ZC3H12A
prerank,microtubule anchoring (GO:0034453),0.5125204521647951,1.0751010520725437,0.39762219286657857,0.9069079958532813,1.0,4/12,21.34%,SAXO1;BICD1;CLASP2;PCM1
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.49526910333063284,1.0750002400447054,0.39669421487603307,0.906515187995745,1.0,4/13,16.60%,CD44;MIF;TWIST1;SNAI2
prerank,positive regulation of biosynthetic process (GO:0009891),0.4172946031060783,1.0748443827709235,0.3908174692049272,0.9063141899067746,1.0,8/40,11.31%,TGFB3;F2R;RUNX1;MTOR;CREB3L1;MLXIPL;TLR4;AKT1
prerank,ubiquinone metabolic process (GO:0006743),0.486547376627254,1.0746161209064025,0.3787465940054496,0.9063274728796666,1.0,4/15,10.63%,COQ10B;COQ7;AIFM2;COQ3
prerank,regulation of cell-cell adhesion (GO:0022407),0.42109053350813586,1.0742224242638065,0.38838268792710706,0.9068744608885307,1.0,12/39,16.98%,DPP4;EFNA5;GTPBP4;TENM3;SRC;JAG1;CD47;EPHB3;FUT9;ZDHHC2;MDGA1;FLOT2
prerank,chromatin assembly or disassembly (GO:0006333),0.5106233802837996,1.0742048709991439,0.40054127198917455,0.906226562520219,1.0,2/11,7.61%,CHAF1B;NOC2L
prerank,Wnt signaling pathway (GO:0016055),0.38163960867762853,1.0739958112577839,0.36401673640167365,0.9062246359371376,1.0,10/92,5.14%,SFRP4;LRP6;WNT10B;WNT2;CCDC88C;WNT9A;PLPP3;AXIN1;ZRANB1;TCF7L2
prerank,stabilization of membrane potential (GO:0030322),0.4858008188495984,1.0738288577681858,0.3893333333333333,0.9060421759677425,1.0,3/16,9.45%,KCNK5;KCNK13;KCNK9
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.3850366880549575,-1.0737166405948055,0.321285140562249,0.7340170002904953,1.0,2/14,1.57%,ABCG2;SLCO2B1
prerank,heme catabolic process (GO:0042167),-0.3850366880549575,-1.0737166405948055,0.321285140562249,0.7340170002904953,1.0,2/14,1.57%,ABCG2;SLCO2B1
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.41797405449777036,-1.0736652656264078,0.3948339483394834,0.7320548741412141,1.0,1/11,0.50%,LYN
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.3944829286182808,1.0733729699763517,0.3806998939554613,0.9068533150498798,1.0,28/72,28.67%,RNASE4;GTF2H3;EDC4;PNRC2;ERCC3;UBA52;ERCC4;RNASE6;FAN1;DDB1;DNA2;ZC3H12A;DNASE1L2;RFC4;RAD50;ERCC5;POLD1;OGG1;ERCC1;EDC3;DNASE1L1;RNASE1;DCP1A;DCP1B;MEI4;DDX1;RFC3;PDE12
prerank,negative regulation of macrophage activation (GO:0043031),0.49125291493851553,1.0733302321154838,0.40234375,0.906279719288804,1.0,7/16,22.54%,SYT11;NR1D1;ZC3H12A;IL4;LRFN5;IL31RA;LDLR
prerank,response to endoplasmic reticulum stress (GO:0034976),0.38604987449437367,1.072742095364128,0.35507246376811596,0.9074914228724957,1.0,38/107,23.43%,NIBAN1;EIF2AK3;PIK3R2;RASGRF1;SYVN1;TMEM259;CREB3L1;RCN3;THBS4;SCAMP5;ERN1;HERPUD1;SELENOK;CEBPB;BAK1;BBC3;QRICH1;ATP2A2;EIF2S1;UFC1;PDIA3;SELENOS;NCK1;UFL1;BCAP31;UFM1;ATF6;ERP44;TMTC3;JUN;ATF4;DERL1;SEL1L;USP19;TMEM33;FLOT1;ATG10;UBXN6
prerank,negative regulation of axon extension (GO:0030517),0.437263302302055,1.0726445731855385,0.40518256772673733,0.9071080685010252,1.0,5/30,12.28%,SEMA3C;PTPRS;TRIM46;SEMA3A;SEMA3D
prerank,axonal fasciculation (GO:0007413),0.5180629503859815,1.0725608537928761,0.3905579399141631,0.9066919278812585,1.0,3/12,10.29%,EPHB2;EPHA3;EPHB3
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.4048512321143455,1.0724624661049125,0.3868131868131868,0.9063181380815242,1.0,19/51,28.61%,HNRNPA1;CTC1;GNL3L;SRC;ACD;CCT7;XRCC5;TERF1;SMG6;TENT4B;TINF2;NEK7;MAPK1;CCT4;EXOSC10;SMG5;STN1;CCT6A;HNRNPC
prerank,hydrogen peroxide metabolic process (GO:0042743),0.47468391037700053,1.072443616141644,0.39552238805970147,0.9056691691465368,1.0,4/19,17.99%,DUOX1;GPX1;ACOX1;PXDN
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.48352991750244023,1.0722410235353315,0.4018324607329843,0.9056305982349148,1.0,6/16,23.48%,AMPD2;PAICS;GART;ATIC;ADSS2;LHPP
prerank,negative regulation of viral release from host cell (GO:1902187),0.5043896086657387,1.0721532930258382,0.39271255060728744,0.905235062321189,1.0,5/13,23.62%,MID2;TRIM11;PML;TRIM35;TRIM8
prerank,positive regulation of cation channel activity (GO:2001259),0.4242568095118926,1.0721510390633051,0.36486486486486486,0.9045378151046615,1.0,7/40,14.04%,EPHB2;ANK2;PKD2;GSTM2;CALM2;ANTKMT;CASQ1
prerank,digestive tract development (GO:0048565),0.43675321290209107,1.0719620492619266,0.38221709006928406,0.904467740493191,1.0,8/32,15.10%,PCSK5;TGFB2;COBL;PKD1;GLI2;EPHB3;GLI3;CHD8
prerank,DNA packaging (GO:0006323),0.48879918463246813,1.0716713286408344,0.3979591836734694,0.9047018962105882,1.0,2/16,7.61%,CHAF1B;NOC2L
prerank,negative regulation of immune response (GO:0050777),0.3743187041607098,1.0713872104873952,0.35850956696878145,0.9049462445579476,1.0,23/154,14.21%,COL3A1;SYK;VIPR2;FYN;IRAK3;MAPK14;ITCH;GLP2R;C1QBP;SRC;RC3H1;ADCYAP1;DPEP1;CRHR1;GPR20;SIRT2;CALCA;GPR45;TSHR;ADCY8;GNB1;LHCGR;FER
prerank,regulation of cytokine production (GO:0001817),0.3804045468841999,1.0713370704334324,0.3641912512716175,0.9044043433346916,1.0,26/126,18.08%,ANXA1;GLMN;NPTN;FOXP1;MIF;HDAC9;MAPK14;SYT11;IL33;SCAMP5;CD47;SIRPA;BCL6;GPNMB;LRRC19;IGF2BP1;ACKR1;TNFRSF1B;MOG;BTN3A3;TRAF3;PER1;IL6;SNAI2;ATP2B1;VTCN1
prerank,protein processing (GO:0016485),0.3846971705775725,1.0713116009723427,0.35647668393782384,0.9037902536674649,1.0,25/102,19.06%,PCSK6;PCSK5;KLKB1;PRSS12;ADAMTS3;TMEM208;ADAM19;PCSK4;SPCS1;PSEN1;ECE1;SEC11C;XPNPEP3;ECE2;EEF1AKMT4-ECE2;KLK1;KLK6;RCE1;FAM111A;OGT;HTRA2;SPG7;MMP16;METAP2;PCSK7
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.4006596675565693,-1.0711208523547258,0.35842293906810035,0.7370164850892849,1.0,2/12,1.98%,GCNT2;BMP7
prerank,positive regulation of protein binding (GO:0032092),-0.27824211804737126,-1.070739451994895,0.33707865168539325,0.7358040160056837,1.0,18/56,13.99%,RAPGEF2;VTN;CLDN5;APP;APOE;EPB41;CAV1;B2M;DTX3L;MARK3;NMD3;HIP1R;BMP2;TERT;ABL1;BDNF;TRIM21;HIPK2
prerank,regulation of cellular metabolic process (GO:0031323),0.41882667153070996,1.070141966071256,0.39864864864864863,0.9069566797459795,1.0,16/45,24.51%,ACLY;COQ7;ARF4;PID1;STUB1;ARF1;SSH1;EIF6;MBOAT7;NCOR2;MKLN1;RNF41;CYP1B1;FLOT1;PARL;RSPO1
prerank,positive regulation of glucose metabolic process (GO:0010907),0.48800918185827075,1.0699966132250223,0.40185676392572944,0.9067407260491082,1.0,5/14,19.54%,IRS1;AKT1;IRS2;DDB1;GPLD1
prerank,negative regulation of protein transport (GO:0051224),-0.33323808922411413,-1.0698830263837977,0.33540372670807456,0.7359873982910631,1.0,8/25,12.23%,APOE;WWP2;SNX3;HMGCR;RHBDF2;NDFIP2;PKDCC;PPM1F
prerank,myeloid cell development (GO:0061515),0.47325635611729516,1.0693713416239181,0.4087403598971722,0.9080671892834682,1.0,3/18,6.81%,ANXA2;FOXP1;SRC
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.43254721424477754,1.0687739917134602,0.39227166276346603,0.9092955281664877,1.0,14/30,26.43%,UBE2J2;USP36;HPS4;NPEPPS;HTRA2;VPS11;ARIH2;ATG13;UBE2D3;SAE1;CSNK2A2;LEPROT;FBXW7;RNF31
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.4602245788696633,1.0684545524746647,0.4112271540469974,0.9096617466214197,1.0,7/18,23.83%,MAPK7;NFE2L2;AKT1;HTRA2;PPIA;TRAP1;BAG5
prerank,mRNA splice site selection (GO:0006376),0.4381367960815105,1.068264672050322,0.388042203985932,0.9095665213382197,1.0,15/30,31.98%,SRSF6;KHDC4;CELF2;SF3A1;PSIP1;LUC7L3;PUF60;LUC7L2;CELF3;CELF1;SNRPC;SRSF5;CELF4;SF1;SF3A2
prerank,lipoprotein catabolic process (GO:0042159),-0.4238858546610228,-1.0682080621778494,0.3611111111111111,0.738200250433959,1.0,3/11,7.56%,APOE;ABHD17C;NOTUM
prerank,positive regulation of cholesterol transport (GO:0032376),-0.3249627743420294,-1.0680567098432816,0.33714285714285713,0.736499839920236,1.0,10/27,16.89%,PLTP;PTCH1;APOE;NR1H3;CAV1;SIRT1;ABCA3;NFKBIA;EEPD1;ABCA5
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.5267052575647211,1.067993644292032,0.42301943198804187,0.9097994245166832,1.0,4/10,15.83%,GRB10;PID1;INPP5K;SELENOS
prerank,mitochondrion morphogenesis (GO:0070584),0.5117722542068098,1.0679019794658189,0.3962516733601071,0.909402699965967,1.0,6/11,24.98%,WASF1;PID1;MYH14;SUPV3L1;FIS1;MTM1
prerank,mesoderm formation (GO:0001707),0.46582094476639,1.0677834678384965,0.40025252525252525,0.9090738766878791,1.0,2/17,4.48%,ITGB3;ITGA2
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.38413862504961876,1.0676027478709327,0.36420395421436,0.9089816390172495,1.0,17/87,16.21%,CORO2B;ARHGAP44;LRP1;EFNA5;EPHA3;MTOR;FSCN1;ABL2;PIK3CA;IQGAP1;RHOQ;TWF1;TAOK2;RHOA;PDGFRA;RND3;RAC3
prerank,receptor-mediated endocytosis (GO:0006898),0.38070565833682557,1.067493251659855,0.3786802030456853,0.9086663368254752,1.0,16/132,8.35%,ACKR3;SYK;LRP6;CD9;LRP1;DNM1;AP1G2;SPARC;COLEC11;WASF1;AP2A2;PDLIM7;CLTC;SNX1;CD81;INPP5F
prerank,ganglion development (GO:0061548),-0.41754872081408473,-1.0674095468268578,0.3623693379790941,0.7362668675747849,1.0,2/11,6.34%,NRP2;NRP1
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.473488545253074,1.0670420131808054,0.4045226130653266,0.9094778829384504,1.0,5/17,10.71%,AR;ATP1A3;ATP1A1;SRC;URI1
prerank,cellular response to superoxide (GO:0071451),-0.4362853534846488,-1.0668794850958407,0.34050179211469533,0.7356267351757282,1.0,5/10,18.60%,NOS3;PRDX1;SOD1;PRDX2;MT3
prerank,regulation of macroautophagy (GO:0016241),0.3794252361957504,1.0666995415757867,0.38445807770961143,0.9099162455639581,1.0,24/105,16.13%,DCN;UCHL1;GNAI3;USP36;ATP6V0A2;MTOR;PRKAB2;HDAC6;CAPN1;GPSM1;PIK3CA;NRBP2;ERN1;AKT1;ATP6V1E1;SESN3;LARP1;SMCR8;RRAGD;ULK1;IL4;ATP6V0A1;ATP6V1D;ATP6V1B2
prerank,nuclear envelope organization (GO:0006998),0.4620659197502293,1.0663866244272455,0.4057788944723618,0.9102347684086827,1.0,4/20,9.04%,TMEM43;REEP3;NUP93;TOR1A
prerank,diacylglycerol metabolic process (GO:0046339),0.45424915251656145,1.0663102629279066,0.40336134453781514,0.9097840246536035,1.0,6/23,12.98%,PLCE1;ANG;DGKQ;MOGAT1;DAGLA;MOGAT2
prerank,negative regulation of biosynthetic process (GO:0009890),-0.3617064772983497,-1.066212171947604,0.36554621848739494,0.7352563932948268,1.0,8/16,28.20%,SLC30A10;PPARA;CEACAM1;GPER1;CIITA;SLC18A2;PARK7;ASXL3
prerank,cellular response to amino acid stimulus (GO:0071230),0.42551902712851725,1.0657392138407897,0.39231664726426074,0.9109469442218371,1.0,13/33,22.92%,FYN;CAPN2;MTOR;SESN3;NSMF;RRAGD;CPEB1;IPO5;CASTOR2;SESN2;UBR2;KLHL22;SLC38A9
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),0.49652204818903556,1.0651847808502266,0.3934640522875817,0.9120434337589717,1.0,7/14,24.22%,CPSF6;ERN1;CPSF4;CPSF2;CSTF2T;CPSF1;CPSF7
prerank,positive regulation of gene expression (GO:0010628),0.36737578731133397,1.0651697839025727,0.263,0.911397060661018,1.0,71/442,14.83%,CD34;SFRP4;AR;GSN;EPHB2;AMH;FGF18;SEC16B;NIBAN1;FGF7;C1QTNF1;EGFR;POLR2H;WT1;HPN;TMEM119;PKP3;GLMN;EIF2AK3;ANK2;DGKQ;VEGFA;FGF2;CAMK2N1;MIF;ZPR1;NFE2L2;RBMS3;MAPK14;ADAM19;MTOR;HOXA5;DTNBP1;IL33;TENT4A;PID1;SCAMP5;GAS6;POLR1G;LARP4;VDR;PSEN1;AGO2;TLR4;HNRNPD;RBM22;KAT2B;MAPK11;ERN1;MUSK;NPM1;MITF;DDX21;KRAS;AKT1;SLC2A10;PASK;NAT8;EIF6;EGF;NWD1;RPS27L;BCL3;ZCCHC4;TWIST1;POLDIP3;ZC3H12A;RBM3;KLF4;EIF3E;IL4
prerank,positive regulation of lamellipodium organization (GO:1902745),0.42684946025766085,1.065146935659769,0.3919716646989374,0.9107791284685562,1.0,7/32,11.21%,PLCE1;AKIRIN1;SRC;FSCN1;ACTR3;PIK3CA;AVIL
prerank,multivesicular body organization (GO:0036257),0.4336679012054928,1.0650822392472625,0.39740566037735847,0.9102852091459828,1.0,10/31,23.95%,CHMP7;VPS4B;MVB12A;VPS37D;VPS37C;VPS37B;VPS36;PDCD6IP;IST1;STAM
prerank,positive regulation of protein metabolic process (GO:0051247),0.3767856553634296,1.0649952704137895,0.37962962962962965,0.9098727924644523,1.0,25/110,17.74%,CD80;GPC3;MAPK7;STX5;SMURF2;AXIN1;DACT1;KLF2;ITCH;FOXO1;SEC22B;EGLN2;PSEN1;DTL;PAEP;HECW2;AKT1;DDB1;KLF4;NSF;HACE1;IDE;CHRNA7;RAB1B;IL18
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.4929358621420832,1.0645497027634698,0.41450068399452805,0.9106194837544761,1.0,2/13,7.58%,AXL;GAS6
prerank,secondary alcohol metabolic process (GO:1902652),0.41743694605096643,1.064529979046515,0.3843537414965986,0.9099944142536952,1.0,12/42,21.00%,IDH1;ABCA1;LCAT;TSKU;GBA2;IL4;PIP4P1;FDX1;ANGPTL3;IDH3G;IDH3B;SOAT1
prerank,positive regulation of kinase activity (GO:0033674),0.37760483011778473,1.064195124150161,0.3721881390593047,0.9103673614791189,1.0,26/107,14.53%,DDR2;EPHB2;AXL;EGFR;FGFR1;CAMKK1;EPHA3;MST1R;MAP2K3;MAPRE3;RASSF2;RET;ADCYAP1;GAS6;TIGAR;IQGAP1;EPHB3;MUSK;MAPT;EPHA10;XRCC5;FLT3;CDKN1A;PDGFRA;NBN;DDR1
prerank,cytosolic transport (GO:0016482),0.38093758716966497,1.0639127278199572,0.38022426095820594,0.9106031087952796,1.0,52/108,32.02%,DCTN1;BET1L;RAB6A;STX5;HOOK2;HEATR5A;RAB6B;VPS52;CLTC;SNX1;WDR91;MAGEL2;TBC1D17;GGA1;TBC1D10A;TBC1D23;GOSR1;ARFRP1;TMEM87A;EVI5;PHETA2;CORO7;ANKRD27;AP4M1;PREPL;SNX6;DENND2A;STX16;ANKFY1;VTI1A;BAIAP3;SNX16;RAB29;RNF126;GOSR2;GBF1;RBSN;VAMP3;YKT6;LAPTM5;STX8;PTPN23;RHOBTB3;TBC1D5;SPAG9;RAB9B;PIKFYVE;RAB14;AP2A1;TMEM87B;SNX5;ARL1
prerank,regulation of viral life cycle (GO:1903900),0.4593304524187857,1.0638512086246004,0.40954773869346733,0.9101256005477377,1.0,6/21,20.75%,AXL;KPNA2;HS3ST5;TRIM68;PPIA;TYRO3
prerank,positive regulation of catabolic process (GO:0009896),0.3912406113762613,1.0635493680180124,0.39787234042553193,0.9104260667493965,1.0,15/65,16.89%,GPC3;STX5;SMURF2;AXIN1;DACT1;ITCH;FOXO1;SEC22B;EGLN2;DTL;HECW2;DDB1;NSF;HACE1;IDE
prerank,neuromuscular process (GO:0050905),0.4777481085914841,1.063349503894767,0.3958333333333333,0.9104401720046071,1.0,3/16,7.89%,DCTN1;MYCBP2;TPP1
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.4562976990953723,1.0632501146673656,0.41551939924906134,0.9100595951392695,1.0,5/20,17.74%,LBP;TLR4;IRAK1;CD14;IL18
prerank,aminoglycan catabolic process (GO:0006026),0.4422284935271976,1.0632173877806168,0.4126794258373206,0.9094824151499596,1.0,7/28,17.88%,GPC6;GPC3;HSPG2;NAGLU;IDUA;SDC2;OVGP1
prerank,protein O-linked mannosylation (GO:0035269),-0.3615326613268173,-1.062388656543428,0.3235294117647059,0.7435299873413497,1.0,3/18,3.02%,TMTC1;TMTC4;TMTC2
prerank,regulation of protein localization to centrosome (GO:1904779),0.5179288951124775,1.0617407821416482,0.42275280898876405,0.9135782479600315,1.0,2/10,8.24%,BICD1;PARD6A
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.4701606239689784,1.0616912606035578,0.4074074074074074,0.9130433548708401,1.0,3/17,10.95%,CD160;PTPRJ;UBASH3A
prerank,neutrophil degranulation (GO:0043312),0.3641901021109521,1.0616741302446895,0.303,0.912397691797028,1.0,103/425,21.61%,TIMP2;GSN;CD55;ARSA;B4GALT1;CD44;CD177;ANXA2;RAB6A;ANPEP;ACTR1B;TMBIM1;MIF;S100A8;S100A9;SPTAN1;MAPK14;AP1M1;ACLY;RAP1B;TMEM63A;PTPRJ;TOM1;PLEKHO2;AP2A2;PRCP;RAB37;IDH1;DOK3;TCN1;ATP11A;COPB1;SURF4;CAPN1;ARHGAP9;DYNC1LI1;PSEN1;IQGAP1;ABCA13;SNAP23;ITGAV;CD47;LPCAT1;SIRPA;CSTB;NRAS;RAB3D;SLPI;GLA;JUP;TMEM30A;XRCC5;NIT2;SNAP25;RHOA;CMTM6;TNFRSF1B;NME2;SLC2A3;UBR4;SLC15A4;HSP90AA1;CD14;DIAPH1;ATP6V0A1;DYNC1H1;GAA;ATP6V1D;PKM;CAP1;IGF2R;CANT1;FABP5;CTSD;PPIA;PADI2;ILF2;RAB5B;RAB5C;SLC44A2;CXCR2;COTL1;TMEM179B;PLAUR;VAMP2;PYGB;PRG2;ALDOA;APAF1;RAB24;DDOST;TOLLIP;ITGAM;ACP3;QSOX1;RAB10;PYCARD;COMMD9;MAPK1;ANXA3;ERP44;CAB39;CPNE1
prerank,response to ionizing radiation (GO:0010212),0.3946982272574839,1.061565250992945,0.38788522848034007,0.9120317440528706,1.0,17/70,18.58%,ANXA1;FANCD2;INTS3;MAPK14;RFWD3;COP1;IKBIP;INIP;RHNO1;RAD1;CDKN1A;ABRAXAS1;INO80;TNKS1BP1;SPIDR;BLM;SMPD1
prerank,cellular response to tumor necrosis factor (GO:0071356),0.36825742535942857,1.0614727643007094,0.375,0.9116758781018888,1.0,27/175,16.06%,TNFSF9;HAS2;CCL8;PSMC4;NFE2L2;ZFP36L1;NR1D1;TNFRSF11B;PSMC6;PID1;ZFP36L2;TNFRSF18;CHUK;PSMD8;TNFSF13B;CCL25;INPP5K;AKT1;PLVAP;CD27;ZFP36;CCL13;TNFRSF1B;ZC3H12A;EDA;BAG4;TRAF3
prerank,actin cytoskeleton reorganization (GO:0031532),0.3917640320097601,1.0609597994120015,0.40665236051502146,0.9126345011703569,1.0,9/63,10.06%,ANTXR1;GSN;FGF7;ANXA1;DTNBP1;FARP2;S1PR2;MCU;EFS
prerank,nervous system development (GO:0007399),0.3617912911167425,1.0606318156779548,0.292,0.913001064910852,1.0,99/429,19.88%,GSN;EPHB2;NAV2;AXL;NAV1;DCLK1;WNT2;SCIN;EFNA5;NUMBL;MBNL1;PMP22;DCTN1;NEUROD2;VEGFA;FGF13;FGF2;MST1R;GLIS2;APBA1;DLG4;WWTR1;DPF2;LPAR1;PKD1;ACAN;SOX10;DACT1;NAB1;VCAN;TRIM71;MARCKS;ALDH3A2;JRKL;DPF1;TRAK2;MTF1;FARP1;ADAM22;TBX6;SCRG1;PKD2;TPP1;SOX8;SH3GL1;DAGLA;SIAH1;MYLIP;JAG1;GDA;PCDHA1;LSAMP;DSCAM;L1CAM;IRF2BPL;AVIL;GBA2;RBFOX2;IGF2BP1;FLRT3;LGI1;KLK6;MTR;MOBP;GDNF;GJB1;ASIC2;HDAC4;NDUFV2;ARTN;MOG;CNTFR;TMOD2;POU3F2;SH3GL3;DAGLB;ALDH5A1;NR2C2;CDK5RAP2;AHI1;NAGLU;PRPS1;SPG7;CXCR4;BTD;CNTN4;EPHB1;GPM6A;TGFBR1;GMFB;SMPD1;MBP;NAV3;SNTG2;APAF1;COX7B;NBL1;SCD5;WDR62
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.46153635251418834,1.060276163263707,0.42575558475689884,0.9134175361352589,1.0,9/19,28.82%,USP36;HDAC6;CAMKK2;VDAC1;HTRA2;SREBF1;CSNK2A2;FBXW7;SREBF2
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.5148759373528177,1.0601498714195476,0.4228650137741047,0.9131574279515979,1.0,6/11,29.45%,CREB3L1;CEBPB;ATF6;ATF4;DDIT3;TP53
prerank,negative regulation of protein metabolic process (GO:0051248),0.4018585584170784,1.0599501628713957,0.4013452914798206,0.9131145833758503,1.0,20/48,29.03%,EGFR;ITGB3;IRAK3;MDM4;SIRT2;ITGAV;PIN1;FLOT2;PFDN6;IAPP;FLNA;FMN2;AZIN2;LDLR;CRYAB;VBP1;PFDN2;PRKCG;NFKB1;PRNP
prerank,peptidyl-serine modification (GO:0018209),0.3702009282189189,1.0598103111427966,0.3834510595358224,0.9128529056053395,1.0,29/166,14.07%,PRKCA;MAPK12;EIF2AK3;RPS6KA2;DYRK4;DGKQ;SGK3;SGK2;TGFBR2;GALNT16;MAPK14;PKD1;MTOR;CAMK2D;NTMT1;MAST4;GAS6;PRKD2;CHUK;AKT3;DYRK2;CSNK1G1;CSNK1G3;GALNT1;AKT1;STK39;ULK2;ULK1;HIPK4
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.4854954124033969,1.0597693007934241,0.4217506631299735,0.9122737292495804,1.0,4/15,15.94%,DHX33;TLR4;USP50;NLRP2B
prerank,xenobiotic transport (GO:0042908),-0.38144453922478067,-1.0594129442239646,0.35319148936170214,0.7494579219022237,1.0,7/17,18.35%,ABCG2;SLC7A5;SLC22A4;GJA1;ABCA3;SLC22A2;SLC22A18
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.3858981478123665,1.0593583389884111,0.3854166666666667,0.9128458233638821,1.0,19/84,19.66%,IGFBP5;EIF2AK3;BIN1;RBM4;PAIP2B;TRIM71;SAMD4B;MRPL13;ORMDL2;IGF2BP1;LARP1;PIN1;CNOT10;RTN3;FXR2;CHRNA7;EPRS1;PAIP2;PCIF1
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.37332003692368415,1.0591972105367846,0.38634046890927626,0.912683946841309,1.0,17/110,14.19%,ADGRD1;GNAS;LPAR3;GPR12;LPAR1;CXCL10;S1PR2;ABCA1;ADCYAP1;ADGRG2;CRHR1;CALCA;GPR161;TSHR;ADCY8;GNB1;LHCGR
prerank,positive regulation of mRNA processing (GO:0050685),0.4519651685648669,1.058746363842158,0.4015056461731493,0.9134287400414994,1.0,12/21,34.08%,NUP98;RBM3;SF3B4;PAF1;THRAP3;DAZAP1;CELF3;RBMX;CELF4;CIRBP;NCBP2;NCL
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.5221314187133552,1.058531736904669,0.4277699859747546,0.9133960617243205,1.0,4/10,15.90%,ETFA;ACADVL;ETFB;ETFDH
prerank,regulation of protein export from nucleus (GO:0046825),-0.32765974003736675,-1.0583858225983476,0.36180904522613067,0.7501463567781194,1.0,3/23,1.29%,PTPN14;SP100;RAPGEF3
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.5284732398277144,1.058157273203237,0.42896935933147634,0.9139103961555787,1.0,1/10,1.21%,DPP4
prerank,neutrophil mediated immunity (GO:0002446),0.3630723667550122,1.058091460337502,0.313,0.9134201296572905,1.0,105/432,21.61%,TIMP2;GSN;CD55;ARSA;B4GALT1;CD44;CD177;ANXA2;RAB6A;ANPEP;ACTR1B;TMBIM1;MIF;S100A8;S100A9;SPTAN1;MAPK14;AP1M1;ACLY;RAP1B;TMEM63A;PTPRJ;TOM1;PLEKHO2;AP2A2;PRCP;RAB37;IDH1;DOK3;TCN1;ATP11A;COPB1;SURF4;CAPN1;ARHGAP9;DYNC1LI1;PSEN1;IQGAP1;ABCA13;SNAP23;ITGAV;CD47;LPCAT1;SIRPA;CSTB;IRAK4;NRAS;RAB3D;SLPI;GLA;JUP;TMEM30A;XRCC5;NIT2;SNAP25;RHOA;CMTM6;TNFRSF1B;NME2;SLC2A3;UBR4;SLC15A4;HSP90AA1;CD14;DIAPH1;ATP6V0A1;DYNC1H1;GAA;ATP6V1D;PKM;CAP1;IL6;IGF2R;CANT1;FABP5;CTSD;PPIA;PADI2;ILF2;RAB5B;RAB5C;SLC44A2;CXCR2;COTL1;TMEM179B;PLAUR;VAMP2;PYGB;PRG2;ALDOA;APAF1;RAB24;DDOST;TOLLIP;ITGAM;ACP3;QSOX1;RAB10;PYCARD;COMMD9;MAPK1;ANXA3;ERP44;CAB39;CPNE1
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),0.4571667126278156,1.0579285435656374,0.42052565707133915,0.9132497254429595,1.0,7/22,22.98%,TIMP2;ADAM9;TNFRSF1B;GPLD1;SH3D19;PTPN3;PACSIN3
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.5238108022346364,1.0579184593458553,0.4307909604519774,0.9126041393632927,1.0,7/10,27.96%,SIRT2;NCK1;DNAJB1;JUN;BAG3;VHL;IMPACT
prerank,cilium assembly (GO:0060271),0.3651783342661237,1.0576997673933093,0.316,0.9126301356741411,1.0,104/296,27.74%,GSN;NME8;DCTN1;CDC14B;ODF2;ABLIM1;PKD1;RAB23;FHDC1;ARF4;YWHAG;ACTR3;HDAC6;BBS9;SSNA1;ATAT1;ARL13B;TOGARAM1;YWHAE;TMEM138;OCRL;CPLANE1;RSPH1;CNGB1;EHD2;ALMS1;NUDCD3;DZIP1;MAPRE1;TTC39C;HAUS3;AVIL;TEKT5;PIBF1;VANGL2;DYNC2I2;KIF3A;SFI1;RPGR;KIF3B;IFT46;CEP97;TTLL3;BBS4;DNAAF3;HSP90AA1;TUBB4A;TUBA4A;TTC8;DYNC1H1;ATP6V1D;CDK5RAP2;AHI1;DYNC2LI1;CCP110;AKAP9;CEP164;RPGRIP1;DYNC2H1;CEP89;CKAP5;DYNC2I1;CEP83;CCDC28B;RP2;BBS5;PAFAH1B1;BBIP1;IFT52;EXOC4;CC2D2A;SPAG16;FLNA;PCM1;IFT57;DYNLRB1;DNAH5;FBF1;DCTN2;TMEM231;DCX;TCTN2;NEDD1;RAB11FIP3;PDE6D;DYNLL1;CEP78;TCTN1;CDC14A;NEK1;TNPO1;CEP126;RAB1A;CSNK1E;CFAP70;ACTR1A;KIFAP3;CETN2;GBF1;FUZ;IFT81;PTPDC1;RAB8B;E2F4
prerank,regulation of autophagosome assembly (GO:2000785),0.42348665970066046,1.0574967010605696,0.4166666666666667,0.912606160012027,1.0,18/33,33.91%,SEC22B;SCFD1;SMCR8;NUPR1;RAB1B;PIP4K2C;ADPRH;LRSAM1;PIP4K2B;TBC1D12;MTM1;TMEM39A;PIKFYVE;IFT20;CHMP4A;CHMP4B;RAB3GAP1;FEZ1
prerank,coenzyme A biosynthetic process (GO:0015937),0.5179180064401846,1.0571839520288142,0.403899721448468,0.9115531777280923,1.0,7/11,30.74%,SLC25A16;PANK1;PANK3;DCAKD;ACAT1;ACOT7;PANK2
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.5179180064401846,1.0571839520288142,0.403899721448468,0.9115531777280923,1.0,7/11,30.74%,SLC25A16;PANK1;PANK3;DCAKD;ACAT1;ACOT7;PANK2
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.5179180064401846,1.0571839520288142,0.403899721448468,0.9115531777280923,1.0,7/11,30.74%,SLC25A16;PANK1;PANK3;DCAKD;ACAT1;ACOT7;PANK2
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.41903060578191886,-1.0570994613049034,0.36333333333333334,0.7514558110778615,1.0,5/10,31.71%,CEACAM1;ARRB2;PTPRC;FCGR2B;LILRB1
prerank,cellular response to interferon-gamma (GO:0071346),0.3794076767213869,1.057084461771108,0.3915289256198347,0.9112039497741184,1.0,11/88,12.91%,MID1;CCL8;IRF4;CD44;CAMK2D;CCL25;TLR4;CD47;SIRPA;SLC26A6;CCL13
prerank,membrane depolarization (GO:0051899),-0.3073302500546898,-1.0566708278403891,0.3533834586466165,0.7505692474404208,1.0,13/32,27.15%,CACNA1E;YWHAH;SCN3A;CAV1;CACNG4;ABL1;CACNB3;SCN7A;SCN3B;CHRNA4;CACNA1B;CACNB4;SCN5A
prerank,negative regulation of vascular permeability (GO:0043116),0.5067565872199409,1.0565300709424124,0.41825613079019075,0.9122813374747811,1.0,3/12,5.35%,VEGFA;SLIT2;PTPRJ
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.42512119837884504,1.0558163106697203,0.4105011933174224,0.9139305971698788,1.0,17/31,32.26%,DIS3L2;LSM4;EDC4;EXOSC7;POLR2G;EXOSC1;LSM7;EDC3;DCP1A;DCP1B;LSM5;HBS1L;LSM1;PATL1;EXOSC3;CNOT8;LSM6
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.44034791873260826,1.0550955557758237,0.42804878048780487,0.9156328410262418,1.0,13/25,28.94%,SCAF8;EAF2;SETD5;THOC1;EAF1;TCEA2;LDB1;ELL;KAT7;ALYREF;HTATSF1;THOC5;WDR43
prerank,positive regulation of tissue remodeling (GO:0034105),0.5082107498620558,1.0550273713316094,0.4114285714285714,0.9151622067511174,1.0,2/10,17.74%,TMBIM1;IL18
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),-0.3895046540234924,-1.0545816906405847,0.3775933609958506,0.7540846184878127,1.0,2/14,3.31%,ADAM10;WNT5A
prerank,glycoprotein catabolic process (GO:0006516),0.47070516089875447,1.054443057245824,0.4249037227214377,0.9163448859848659,1.0,5/17,8.71%,EDEM1;OGA;FBXO2;EDEM2;FBXO17
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.3144338247407656,-1.054007009501158,0.33962264150943394,0.7534756627252264,1.0,4/28,3.74%,ITPR1;BCL2;DAB2IP;CASP4
prerank,regulation of B cell proliferation (GO:0030888),0.4052125196426376,1.0536195550052516,0.40618101545253865,0.9183102061517268,1.0,9/44,14.83%,EPHB2;MIF;CLCF1;RC3H1;CD81;TIRAP;TNFSF13B;IRS2;IL4
prerank,positive regulation of protein sumoylation (GO:0033235),0.5183539033254915,1.0534401826878093,0.40709219858156026,0.9181989592287261,1.0,5/10,26.48%,PIAS3;UBA2;HDAC4;SAE1;MUL1
prerank,calcium ion import across plasma membrane (GO:0098703),0.4832006541351925,1.0530422687616883,0.39869281045751637,0.9187907780183625,1.0,6/14,26.25%,TRPV3;ATP2B4;SLC8A2;CACNA2D1;TRPV2;SLC24A2
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.47797960228988223,1.0527542998375305,0.404227212681638,0.919035548178571,1.0,4/16,18.93%,EME1;RMI1;ERCC4;TOP2B
prerank,negative regulation of cell death (GO:0060548),0.3810786114740305,1.0526898489390528,0.40229885057471265,0.9185616216078523,1.0,16/88,17.33%,CD34;FYN;KIR3DL2;SRSF6;CCN5;PDE8A;FGF2;VPS4B;TIGAR;AKT1;GPNMB;CD200R1;TNFRSF1B;NCK1;HTRA2;SRGAP2
prerank,negative regulation of MAPK cascade (GO:0043409),0.37568895789658113,1.0522717847479521,0.40894901144641,0.9192005271987558,1.0,21/87,18.58%,EPHB2;UCHL1;IRAK3;CAMK2N1;SMAD4;PIK3R2;PTPRJ;FOXO1;FLCN;TLR4;INPP5K;SIRPA;PRDM15;PPEF2;TNIP1;PIN1;PPIA;QARS1;SYNJ2BP;STK38;SMPD1
prerank,regulation of Golgi organization (GO:1903358),0.4745737398996036,1.052149912569811,0.43523316062176165,0.9189345657550869,1.0,9/17,27.62%,STX5;MYO5A;MAP2K2;RAB33B;AKAP9;ARMH3;MAPK1;RBSN;PDE4DIP
prerank,regulation of mast cell degranulation (GO:0043304),0.48039758365533347,1.0520800909690602,0.4409448818897638,0.9184681927674819,1.0,1/14,0.24%,SYK
prerank,neural crest cell development (GO:0014032),0.4019912678854591,1.0519986390560438,0.4099099099099099,0.9180560624140618,1.0,8/44,13.74%,SEMA3C;RADIL;SOX10;SOX8;SEMA3A;SEMA3D;GDNF;NOLC1
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.40356074421419275,1.0518601745279845,0.4201117318435754,0.9178115096652041,1.0,16/44,27.89%,ZFP36L1;RC3H1;ZFP36L2;AGO2;ZC3HAV1;PUM1;ZFP36;POLR2G;ZC3H12A;YTHDF1;YTHDF2;YTHDF3;TNRC6A;RBM24;UPF1;CELF1
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.5240711404314127,1.0514009697443463,0.43661971830985913,0.9186119010682141,1.0,6/10,28.17%,C1QBP;SEC14L1;TSPAN6;UFD1;RIOK3;NPLOC4
prerank,telomere maintenance (GO:0000723),0.3990324766126779,1.051124867859606,0.40670391061452515,0.9188361263094068,1.0,23/50,28.52%,PARP3;XRCC3;CTC1;ACD;SMC5;ERCC4;XRCC5;TERF1;DNA2;SMC6;NBN;RAD50;BLM;POLD1;TINF2;TEP1;TERF2IP;NSMCE2;LTO1;RAD51D;PRKDC;STN1;XRCC6
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.39084822548864895,1.0504694852468057,0.4165781083953241,0.9202326532590587,1.0,18/70,21.36%,SYK;FYN;WIPF1;PIK3R2;MYO10;SRC;ACTR3;ABI1;PIK3CA;MYH2;HSP90AA1;ACTG1;ARPC1A;NCK1;ARPC2;PLD2;MAPK1;YES1
prerank,negative regulation of organelle assembly (GO:1902116),0.4167208540214491,1.05026158545955,0.42577675489067895,0.920185717953189,1.0,12/35,19.75%,SMAD4;SEC22B;KAT2B;SCFD1;SMCR8;CEP97;NUPR1;CDK5RAP2;EVI5L;CCP110;ODF2L;MDM1
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.41718489206153764,1.0500339762186468,0.4161849710982659,0.9202156325537774,1.0,8/33,17.84%,AREG;BTC;DOK1;AKT1;EGF;CBL;ARAP1;PLAUR
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.3901669663446446,1.0500139868137932,0.41675503711558853,0.9195983151194261,1.0,18/71,21.36%,SYK;FYN;WIPF1;PIK3R2;MYO10;SRC;ACTR3;ABI1;PIK3CA;MYH2;HSP90AA1;ACTG1;ARPC1A;NCK1;ARPC2;PLD2;MAPK1;YES1
prerank,mitotic nuclear membrane organization (GO:0101024),0.4037893485503463,1.0498476895556406,0.42311886586695746,0.9188040746166387,1.0,24/51,32.30%,LMNA;REEP3;NUP93;CHMP7;AHCTF1;NUP107;NUP98;SIRT2;NUP37;PPP2R2A;CC2D1B;ANKLE2;IST1;EMD;NUP133;NUP85;NUP188;KPNB1;SUMO1;CHMP4C;SEC13;CHMP4A;CHMP4B;NUP160
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.4037893485503463,1.0498476895556406,0.42311886586695746,0.9188040746166387,1.0,24/51,32.30%,LMNA;REEP3;NUP93;CHMP7;AHCTF1;NUP107;NUP98;SIRT2;NUP37;PPP2R2A;CC2D1B;ANKLE2;IST1;EMD;NUP133;NUP85;NUP188;KPNB1;SUMO1;CHMP4C;SEC13;CHMP4A;CHMP4B;NUP160
prerank,mitochondrial RNA metabolic process (GO:0000959),-0.38528958320925627,-1.049674820397576,0.39846743295019155,0.7633036546756693,1.0,9/14,25.87%,TFB1M;MTERF2;FASTKD1;TEFM;PNPT1;POLRMT;TWNK;FASTKD5;TFB2M
prerank,cellular response to hexose stimulus (GO:0071331),-0.3392368869756794,-1.0493441038147278,0.38823529411764707,0.7621754201446932,1.0,5/23,4.62%,UNC13B;IGF1R;PRKAA2;KCNB1;TRA2B
prerank,spermatid development (GO:0007286),0.4134755204073995,1.0492452396593206,0.42550655542312277,0.9200357158593713,1.0,5/32,14.65%,TOPAZ1;DPY19L2;RSPH1;BBS4;CDYL
prerank,positive regulation of T cell chemotaxis (GO:0010820),-0.4274831254182611,-1.0491537277899101,0.38408304498269896,0.760638388744204,1.0,2/10,3.31%,ADAM10;WNT5A
prerank,response to interferon-alpha (GO:0035455),0.4712650171628894,1.048925994768724,0.42575558475689884,0.9203914669124149,1.0,2/16,7.58%,AXL;GAS6
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.4422815886816326,1.0488922092524464,0.4220532319391635,0.9198328999068794,1.0,6/24,11.21%,PLCE1;AKIRIN1;FSCN1;ACTR3;PIK3CA;AVIL
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.36468054856629795,1.0488112223028332,0.39317953861584753,0.9194293404658747,1.0,59/184,26.73%,DCTN1;CDC14B;PSMC4;ODF2;PKD1;ZFP36L1;ZW10;PSMC6;YWHAG;SSNA1;ZFP36L2;YWHAE;PSMD8;CUL3;SIRT2;ALMS1;HECW2;CDC23;MAPRE1;HAUS3;ANAPC5;FBXO5;ERCC3;UBA52;SFI1;DDB1;CDC27;INO80;HSP90AA1;TUBB4A;TUBA4A;DYNC1H1;CDK5RAP2;TFAP4;CCP110;CDC26;AKAP9;CEP164;PPP1R9B;ANAPC4;CKAP5;CENPE;PAFAH1B1;RIOK2;ANAPC10;PCM1;DCTN2;ANAPC15;NEDD1;PSMD3;DYNLL1;CEP78;PSMD4;CDC14A;CSNK1E;PSMB3;ANAPC2;ACTR1A;CETN2
prerank,neuron projection morphogenesis (GO:0048812),0.3657613433565206,1.0485117624104177,0.40466531440162273,0.9196702555273286,1.0,50/137,26.09%,DBN1;EPHB2;DCLK1;MAP1B;LLGL1;DLG4;TNN;TAOK3;TRIO;DOCK7;DTNBP1;FARP1;S100A6;IQGAP1;EPHB3;KIF20B;FLRT3;TAOK2;MAP6;DCC;CTNND2;SLC9A6;DIP2A;ANKRD27;SDC2;SRGAP2;SHTN1;CNTN4;EPHB1;GPM6A;NBL1;GAS7;SLITRK4;RAB10;PTEN;MAP1A;ABITRAM;CPNE1;CTTN;SPTBN4;MAP1S;CNTNAP1;NTNG2;ALS2;DVL1;LRP2;PAX2;ATL1;NRCAM;SLITRK5
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.37032983602339925,1.048310543138986,0.41164453524004085,0.9196502038835659,1.0,21/113,12.38%,AREG;FGF7;PRKCA;EGFR;HPN;ANG;ITGB3;SRSF6;VEGFA;FGF2;ECM1;TCF7L2;THBS4;PRKD2;STAT5A;FZD7;AKT3;EMC10;NRAS;AKT1;EGF
prerank,negative regulation of cell differentiation (GO:0045596),0.3592975775490911,1.0481788815627195,0.38755020080321284,0.919381753281116,1.0,39/181,18.57%,COL5A2;COL5A1;WNT10B;EGFR;HPN;LDLRAD4;ITGB3;WNT9A;HDAC7;TNN;WWTR1;SKI;TRIO;HOPX;MEIS2;FOXO1;ABCA1;ZFPM2;ZFP36L2;CHADL;SOX8;JAG1;SIRT2;ITGAV;SMAD6;TSKU;VASN;ANP32B;TWIST1;HOXA9;PDCD4;IL6;NBR1;SNAI2;EFEMP1;YTHDF2;CNTN4;TGFBR1;SDHAF2
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.4536744169474103,1.0481358966457794,0.41967621419676215,0.9188287727595021,1.0,6/22,14.04%,ANK2;PKD2;GSTM2;SLC9A1;CALM2;CASQ1
prerank,chromatin remodeling (GO:0006338),0.3750074495116949,1.0481161928493714,0.4228395061728395,0.9182272644713271,1.0,44/100,30.40%,ESR1;SMARCD2;SMARCD1;ZBTB1;KAT2B;KDM5C;POLE3;SATB2;NPM1;ACTR5;SMARCC2;KDM5B;DR1;HDAC4;EZH1;GATAD1;INO80;SMARCA4;CHD8;SRCAP;BAHD1;NUDT5;BAZ2B;CHD3;TAF6L;BAZ2A;KDM4C;BAZ1A;MBD2;INO80C;ARID1A;JARID2;CHRAC1;KDM4B;ARID1B;HNRNPC;TADA2A;PBRM1;ZBTB7A;ATRX;SOX9;MBD3;HCFC2;HCFC1
prerank,fatty acid oxidation (GO:0019395),0.39228133431983875,1.0479785875340353,0.42036836403033584,0.9179759250222922,1.0,15/57,22.15%,EHHADH;ALDH3A2;AUH;SCP2;ACADVL;SLC25A17;ACOX1;BDH2;ABCD3;MCAT;HSD17B4;ACAT1;CPT2;PEX2;CROT
prerank,negative regulation of intracellular protein transport (GO:0090317),0.45021858438771556,1.0477299267963154,0.4239401496259352,0.9180761032103164,1.0,9/22,18.62%,RAB23;MDFIC;LMAN1;INPP5K;GDI1;CABP1;CHP1;BAG4;UFM1
prerank,dorsal/ventral pattern formation (GO:0009953),0.46170001929698723,1.0475825857408663,0.4140127388535032,0.9178744620992005,1.0,4/20,7.50%,LMX1B;ACVR1;AIDA;GLI2
prerank,positive regulation of protein transport (GO:0051222),-0.26192058962549875,-1.0472450747476385,0.33962264150943394,0.7641097489151211,1.0,11/67,6.02%,BMP6;UNC13B;FRMD4A;IGF1;CD2AP;ATP2C1;MYO18A;CEP290;ABCG1;ACSL3;PRR5L
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.45278882586782293,1.0463993088428036,0.4193954659949622,0.9209631230123295,1.0,6/22,18.61%,CD44;MAPK7;MYADM;KLF4;FLOT2;MBP
prerank,Rap protein signal transduction (GO:0032486),-0.413072075980866,-1.0463098169858294,0.3890784982935154,0.7645989487956598,1.0,2/10,1.29%,RAPGEF2;RAPGEF3
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.4449893110983222,1.0460449762429056,0.4289308176100629,0.9214063952449824,1.0,6/20,14.67%,TMBIM1;CSK;PID1;CLTC;RHOQ;PPFIA1
prerank,potassium ion homeostasis (GO:0055075),0.4527742292594727,1.0459681480726102,0.44636251541307026,0.920975438957244,1.0,7/23,7.79%,KCNMA1;ATP1A4;ATP1A3;ATP1A1;SLC12A8;KCNJ2;SLC12A4
prerank,positive regulation of cell aging (GO:0090343),0.5113142716159487,1.0458697207477026,0.4444444444444444,0.9206264414893458,1.0,4/11,17.26%,LMNA;CGAS;YPEL3;EEF1E1
prerank,serine family amino acid metabolic process (GO:0009069),0.47171612137995306,1.0455377572788618,0.4007936507936508,0.9210031338784973,1.0,1/16,0.79%,GCLC
prerank,regulation of transcription by RNA polymerase I (GO:0006356),0.45856704153863226,1.0455204443064166,0.4156010230179028,0.9203990632774642,1.0,4/18,11.37%,EIF2AK3;MAF1;DHX33;UBTF
prerank,response to organonitrogen compound (GO:0010243),0.4129547444278585,1.0454378676008589,0.4154696132596685,0.9199714768241307,1.0,5/38,6.12%,IRAK3;SYVN1;MTOR;MEAK7;RCN3
prerank,positive regulation of response to wounding (GO:1903036),-0.3324214157322808,-1.0454226700264582,0.3390804597701149,0.765091693538465,1.0,9/24,13.28%,PTN;MYLK;VTN;OCLN;PRKCE;ADRA2A;MDK;CLDN1;PTK2
prerank,negative regulation of cell population proliferation (GO:0008285),0.361443251932943,1.04536331733474,0.367,0.9195445069338156,1.0,42/351,10.15%,NOX4;SFRP4;MN1;IGFBP5;AR;SCIN;TGFB3;WT1;HPN;DIS3L2;GLMN;FAP;RPS6KA2;ADARB1;ANG;OGN;WNT9A;TNS2;TGFB2;CAMK2N1;F2R;IGFBP6;LMNA;TNN;ATF5;SKI;GTPBP4;PTPRJ;ZBTB7C;MDM4;PLPP1;FLCN;PKD2;ABI1;NDRG4;CYP27B1;VDR;SIRT2;KAT2B;ING4;SMAD6;BRD7
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.4800881576562282,1.045177465958155,0.4304291287386216,0.9194681724888296,1.0,5/15,18.58%,ENTPD2;NME2;CMPK2;AK8;ENTPD6
prerank,maturation of SSU-rRNA (GO:0030490),0.41790860312181677,1.0451653148666888,0.4297423887587822,0.9188425116501278,1.0,18/34,32.26%,MRPS11;RIOK1;RRP36;WDR46;SNU13;DCAF13;DDX52;PWP2;SRFBP1;NOL10;RIOK2;TSR3;RIOK3;TSR1;NAT10;RPS28;NOL11;LSM6
prerank,regulation of response to cytokine stimulus (GO:0060759),0.45860721371042384,1.044609204263662,0.43467336683417085,0.9199158016954854,1.0,4/19,14.33%,MAPK7;RUNX1;IRAK1;KLF4
prerank,protein localization to chromatin (GO:0071168),0.4559867646767405,1.044345897773482,0.4338138925294889,0.9200485058655712,1.0,2/18,5.04%,ESR1;CHMP7
prerank,protein prenylation (GO:0018342),0.511226645420802,1.0441627202016013,0.4209039548022599,0.9199601858999183,1.0,6/10,33.61%,RABGGTA;RCE1;RABGGTB;CHML;CHM;FNTB
prerank,peptidyl-serine phosphorylation (GO:0018105),0.3651723187557276,1.043041142335144,0.41051567239635994,0.9227818389250394,1.0,27/153,14.07%,PRKCA;MAPK12;EIF2AK3;RPS6KA2;DYRK4;DGKQ;SGK3;SGK2;TGFBR2;MAPK14;PKD1;MTOR;CAMK2D;MAST4;GAS6;PRKD2;CHUK;AKT3;ERN1;DYRK2;CSNK1G1;CSNK1G3;AKT1;STK39;ULK2;ULK1;HIPK4
prerank,regulation of cellular response to heat (GO:1900034),0.38252675567931577,1.041884154682658,0.4297782470960929,0.9256342254710465,1.0,26/77,26.14%,CD34;NUP93;MTOR;CAMK2D;DNAJC2;NUP107;YWHAE;NUP98;MAPT;HSP90AA1;HSBP1;CHORDC1;NUP37;BAG4;FKBP4;NUP50;MAPK1;DNAJB1;BAG3;TPR;CRYAB;BAG5;NUP133;NUP85;HSPH1;NUP188
prerank,positive regulation of transport (GO:0051050),0.3774371420798681,1.0416599246046414,0.4148148148148148,0.9256616549747988,1.0,21/85,20.96%,SCIN;ANXA1;LRP1;GPC3;ANXA2;SGK2;GAS6;INPP5K;CD47;SIRPA;BAK1;CALY;CHP1;DYNC1H1;SMPD1;CAPN10;CLIP3;GPLD1;KMT2A;NUMA1;PYCARD
prerank,positive regulation of cell differentiation (GO:0045597),0.3630656495359547,1.0415736613433269,0.39039039039039036,0.9252937953296912,1.0,25/237,6.02%,CD34;MEDAG;DDR2;CDON;AR;COL1A1;LOXL2;TMEM100;TGFB3;FGFR1;MAPK12;TMEM119;NEUROD2;TGFB2;TGFBR2;SMAD4;WWTR1;MAPK14;ACVR1;ZFP36L1;RBM4;MTOR;HOXA5;AKIRIN1;BEND6
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.471999810497543,1.0413270900513527,0.41709183673469385,0.9247476328199101,1.0,5/15,21.23%,DTNBP1;AP3D1;BLOC1S2;SNAPIN;AP3B2
prerank,anterograde synaptic vesicle transport (GO:0048490),0.471999810497543,1.0413270900513527,0.41709183673469385,0.9247476328199101,1.0,5/15,21.23%,DTNBP1;AP3D1;BLOC1S2;SNAPIN;AP3B2
prerank,negative regulation of nervous system development (GO:0051961),-0.35312871351286096,-1.0413234029151948,0.3739130434782609,0.7746646208799814,1.0,5/17,10.51%,NOTCH1;ROBO2;B2M;APPL2;SORL1
prerank,cellular response to organonitrogen compound (GO:0071417),0.3753736652686121,1.041172948827583,0.4139004149377593,0.9245981712612679,1.0,25/99,19.27%,IGFBP5;WT1;CAPN2;SLIT2;P2RX3;ZFP36L1;RAP1B;MTOR;PKD2;INPP5K;HCN4;SSH1;SLC26A6;TSHR;JUP;LARP1;NSMF;RRAGD;RAPGEF1;DIAPH1;CPEB1;AKAP9;IPO5;HCN1;GABRG2
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.48004635421311037,1.0411671344427014,0.43983957219251335,0.9239488264724619,1.0,4/15,10.36%,CHST1;NAGK;OGA;LARGE1
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.46040627605586715,1.040998226781666,0.43039591315453385,0.9238222975785809,1.0,7/18,19.86%,LLGL1;RAP1B;KANK1;KIF20B;BCAS3;SHTN1;ARFGEF1
prerank,embryonic digestive tract development (GO:0048566),0.45483481125658864,1.04080375837791,0.44582814445828145,0.9237651158502621,1.0,6/18,18.95%,PCSK5;TGFB2;GLI2;GLI3;PDGFRA;NIPBL
prerank,regulation of viral entry into host cell (GO:0046596),0.42466492742490747,1.0405787862169968,0.4268727705112961,0.9237743683094373,1.0,6/30,15.77%,GSN;MID2;LGALS1;TRIM11;HS3ST5;TRIM68
prerank,mitochondrial fission (GO:0000266),0.47310161300507336,1.0404470663429561,0.4543046357615894,0.9235377250106529,1.0,4/16,16.43%,DNM1;GDAP1;SLC25A46;MTFR1L
prerank,midbody abscission (GO:0061952),0.46517228921720144,1.0403607510437063,0.4538558786346397,0.9231274907384912,1.0,2/17,5.32%,CHMP7;VPS4B
prerank,regulation of organelle assembly (GO:1902115),0.3811832770735606,1.04007124096441,0.44820295983086683,0.9233289132586145,1.0,26/72,24.98%,GSN;CEP295NL;ATXN2;TBC1D2B;TBC1D17;ALMS1;NPM1;TBC1D10A;ATXN2L;EVI5;DYNC2LI1;SENP6;TBC1D13;RAB1B;VPS11;ADPRH;TBC1D22B;TBC1D15;TBC1D19;ATG3;PDCD6IP;CYLD;TRAPPC12;TBC1D12;STAM;CDKL1
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.4027264951675091,1.0399467965092846,0.432967032967033,0.9230400220567262,1.0,11/48,15.01%,JSRP1;ANK2;F2R;SRI;CAMK2D;CXCL10;GSTM2;PDE4D;CALM2;CASQ1;DIAPH1
prerank,regulation of cell aging (GO:0090342),0.513494986020014,1.039752656662022,0.426367461430575,0.9229987914171321,1.0,4/11,17.49%,MIF;LMNA;RSL1D1;NEK4
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.41476719589115435,1.039643548911985,0.4238636363636364,0.9226871447411579,1.0,9/34,17.06%,RAB7B;IRAK3;PTPRS;NR1D1;TLR4;CD14;GRAMD4;NLRP2B;SARM1
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.3107452408064918,-1.0395561707677876,0.36065573770491804,0.7774022672219298,1.0,11/26,16.04%,CNOT2;STRN3;PIAS2;CNOT9;HEYL;CRY1;SFRP1;SIRT1;KANK2;VPS18;DAB2
prerank,negative regulation of establishment of protein localization (GO:1904950),0.5131464569220746,1.0395541045975873,0.44986072423398327,0.9223147310499622,1.0,4/10,13.44%,CORO2B;MAPT;NDFIP1;TERF1
prerank,regulation of centrosome duplication (GO:0010824),0.41964032471001367,1.0394707365956544,0.4128113879003559,0.9219077952301584,1.0,5/29,10.70%,XRCC3;CEP295NL;VPS4B;ALMS1;NPM1
prerank,regulation of cell cycle (GO:0051726),0.35949049731669713,1.039461077027189,0.39,0.9212782361451741,1.0,65/271,19.03%,LRP6;MAPK12;FAP;GADD45G;CDC14B;RPS6KA2;ADARB1;CKS1B;TGFB2;CAMK2N1;TRNP1;MIF;BIN1;PKD1;CDK4;JUND;TCF7L2;TTC28;RASSF1;TARDBP;INHA;MLXIPL;GAS2L1;PKD2;MYBL2;DTL;CDK9;SIRT2;IQGAP1;BEX2;KAT2B;ING4;ERN1;SON;KIF20B;PUM1;MAGI2;FBXO5;LIN9;PCLAF;CDKN1A;FBXL3;CCND1;PLAGL1;CDC123;NBN;UHRF2;GMNN;NUPR1;NOP53;NUDT6;MADD;NLRP2B;PDCD4;HTRA2;E4F1;TFAP4;PML;CDC26;PPP1R9B;TBRG1;TGFBR1;PRCC;SKP2;NEK7
prerank,cellular response to alkaloid (GO:0071312),-0.3522100006693183,-1.039253887164603,0.38596491228070173,0.7761407593718604,1.0,8/17,22.37%,TGM2;CASP3;CASP7;RYR2;CASP6;HTR1B;CASQ2;RAD51
prerank,negative regulation of insulin secretion (GO:0046676),0.4637291934144561,1.0387771718328698,0.41644562334217505,0.9227351796212195,1.0,3/17,9.60%,IRS1;MIDN;BMP8A
prerank,embryonic axis specification (GO:0000578),-0.36063846802491184,-1.0370125211096972,0.4220532319391635,0.7801425857066961,1.0,3/15,3.49%,PTCH1;CXXC4;TBX3
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.3840480715840603,1.03601927798787,0.44139387539598735,0.9305309396226465,1.0,18/73,21.36%,SYK;FYN;WIPF1;PIK3R2;MYO10;SRC;ACTR3;ABI1;PIK3CA;MYH2;HSP90AA1;ACTG1;ARPC1A;NCK1;ARPC2;PLD2;MAPK1;YES1
prerank,response to X-ray (GO:0010165),0.4888295698519896,1.03594950305879,0.4385733157199472,0.930094676406452,1.0,5/14,18.95%,ANXA1;IKBIP;XRCC5;BLM;NIPBL
prerank,regulation of histone deacetylation (GO:0031063),0.4816443912631412,1.0358095530984137,0.45454545454545453,0.929872010940922,1.0,5/13,21.50%,CAMK2D;AKAP8;NIPBL;CTBP1;AKAP8L
prerank,oligosaccharide biosynthetic process (GO:0009312),0.45297603684124044,1.0354679421218196,0.45226130653266333,0.930260095378313,1.0,5/20,11.72%,ST3GAL2;B4GALT1;FUT2;FUT9;ST3GAL4
prerank,protein stabilization (GO:0050821),0.3614754666291942,1.035173861578299,0.44232698094282846,0.9305108599951569,1.0,55/168,26.48%,WNT10B;SAXO1;UBE2B;ANK2;PLPP3;USP36;OTUD3;GTPBP4;SYVN1;RASSF2;MDM4;PFN2;HPS4;USP33;STX12;CCT7;CDKN1A;PIN1;P3H1;IFT46;CCNH;STK3;HSP90AA1;USP7;CHP1;NOP53;BAG4;FLOT2;NAPG;NAA15;TBRG1;RPL23;FLNA;PTEN;USP13;SEL1L;BAG3;USP19;FLOT1;CRYAB;TNIP2;RABL3;PER3;CCT4;BAG5;DVL1;RTN4;TRIM44;CRTAP;CALR;VHL;AFM;FBXW7;STXBP4;MUL1
prerank,negative regulation of growth (GO:0045926),0.36573754064405173,1.0349535165865815,0.43248730964467,0.9305091038330202,1.0,19/121,13.17%,WT1;DCBLD2;FHL1;DACT3;TGFB2;SLIT3;SLIT2;CDKN2AIP;SMAD4;GNG4;PSRC1;PTPRJ;FLCN;CYP27B1;ING4;BCL6;DNAJB2;ADAM15;CDKN1A
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.4123738953014041,1.0348556363879002,0.4290697674418605,0.9301645348098306,1.0,6/35,16.30%,GHR;F2R;IL10RA;EGF;BCL3;IL6
prerank,B cell activation (GO:0042113),0.37793514249110444,1.034768437402032,0.4437299035369775,0.9297842825732922,1.0,10/68,14.83%,EPHB2;LAX1;HDAC9;CLCF1;PTPRJ;BANK1;FLT3;CR2;HDAC4;IL4
prerank,positive regulation of hormone secretion (GO:0046887),-0.3521158990128646,-1.0341275692969882,0.3950617283950617,0.786422227762542,1.0,6/17,15.75%,C1QTNF3;SPP1;EDN1;SOX11;EDN3;HFE
prerank,neuron projection development (GO:0031175),0.36158164317713853,1.0340814598547483,0.421105527638191,0.9312464812974297,1.0,46/168,18.29%,DBN1;MYOC;EPHB2;DCLK1;ZPR1;DLG4;TAOK3;RASGRF1;UNC5A;TRIO;DOCK7;DTNBP1;LRP12;ADCYAP1;TOR1A;TSKU;EPHB3;PLP1;L1CAM;CAMSAP1;MAPT;KIF20B;TBC1D23;FLRT3;LGI1;TAOK2;GDNF;ULK1;ATCAY;BLOC1S2;CTNND2;MANF;MAP4;SLC9A6;SNAPIN;IL6;DIP2A;ANKRD27;RAB35;SRGAP2;PPP1R9B;SHTN1;STX3;CNTN4;EPHB1;GPM6A
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),0.5067254445077486,1.0339517920806909,0.43706777316735823,0.9309818512633842,1.0,5/10,31.14%,CRHR1;GNB5;GPR35;DRD2;CALM1
prerank,positive regulation of macroautophagy (GO:0016239),0.3980280733549911,1.033934262894223,0.45625692137320045,0.9303805073963554,1.0,16/48,22.99%,DCN;GNAI3;GPSM1;SLC25A4;SESN3;LARP1;SMCR8;IL4;VDAC1;PIP4K2C;LRSAM1;VPS13D;PIP4K2B;SESN2;BAG3;MAP3K7
prerank,regulation of SMAD protein signal transduction (GO:0060390),0.44426291126781214,1.0338339631501003,0.44925742574257427,0.9300542502037871,1.0,5/21,6.28%,TGFB3;SMAD4;WWTR1;NUP93;SH2B1
prerank,membrane fusion (GO:0061025),0.4189000987188296,1.0337440490369645,0.4508670520231214,0.929680848794216,1.0,11/33,20.25%,DNM1;STX11;USO1;SNAP23;NAPA;CHP1;NSF;HACE1;NAPG;VAMP2;VPS33B
prerank,gene silencing by miRNA (GO:0035195),0.4146987397350993,1.0335299340588824,0.4432497013142174,0.9296824023217998,1.0,10/32,19.45%,TARBP2;RBM4;TRIM71;AGO2;PUM1;EIF6;ZFP36;AGO4;SNIP1;AGO3
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),0.5171856374976933,1.0334558651682357,0.4667609618104668,0.9292751515423775,1.0,2/10,3.66%,NPTN;DLG4
prerank,DNA duplex unwinding (GO:0032508),0.3902250172339583,1.032873694474503,0.44468784227820374,0.930368851139685,1.0,13/50,18.63%,ANXA1;GTF2H3;RAD23B;ASCC3;ERCC3;UBA52;DDB1;DDX11;NBN;RECQL;RAD50;BLM;SUPV3L1
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.41831536276275133,1.0327897783022082,0.4522144522144522,0.929964402401853,1.0,11/29,24.57%,ESR1;RUNX1;AXIN1;UFL1;VPS11;GPAM;UFM1;KCTD6;CARM1;LATS1;UFSP2
prerank,axon guidance (GO:0007411),0.35653867842329084,1.0326743588370284,0.42570281124497994,0.929681140573248,1.0,44/201,14.33%,SEMA3C;EPHB2;PRKCA;EFNA5;NPTN;GRB10;EPHA3;FYN;MAPK7;GAP43;VEGFA;SLIT3;SLIT2;NTN4;SLIT1;SPTAN1;DOK1;UNC5A;SPTA1;NFIB;PDLIM7;RET;SRC;NTN1;GLI2;SEMA3A;PIK3CA;SIAH1;PLXNA3;DOK4;USP33;EPHB3;DSCAM;UNC5D;L1CAM;EPHA10;IRS2;SEMA3D;LGI1;IGSF9;GDNF;PALLD;ARTN;DCC
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.3595858538276971,1.0325545808074026,0.4275653923541248,0.9293752503622581,1.0,23/161,11.60%,SFRP4;LRP6;DKK2;TLE6;CCDC88C;PSMC4;DACT3;IGFBP6;TNN;WWTR1;RBMS3;KREMEN1;AXIN1;IGFBP4;DACT1;TCF7L2;PSMC6;PSMD8;CUL3;TLE2;ANKRD6;TPBG;GLI3
prerank,nucleoside phosphate catabolic process (GO:1901292),-0.3794883765061235,-1.0324255876355464,0.3944223107569721,0.7889137220948146,1.0,3/13,5.36%,ENPP1;ENTPD1;ENPP3
prerank,calcium ion import (GO:0070509),-0.3074903198483067,-1.0323266662193444,0.3716216216216216,0.7870823062494243,1.0,6/28,12.49%,CACNA1E;CACNB2;CACNA1D;MICU2;TRPC4;TRPV4
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.39103248598849843,1.0323040937085375,0.44933920704845814,0.9295225019806845,1.0,9/51,10.15%,MYOC;TGFB3;S100A10;SORBS3;LPAR1;PFN2;ARHGEF10L;ARHGEF10;CD47
prerank,negative regulation of cellular process (GO:0048523),0.35311377148050066,1.0322925121074977,0.389,0.9289162257829051,1.0,98/521,17.33%,NOX4;CD34;SFRP4;AR;EPHB2;CD9;SCIN;TGFB3;WT1;DIS3L2;GLMN;DCBLD2;FHL1;EIF2AK3;RPS6KA2;TMEM98;ADARB1;DACT3;SRSF6;CCN5;PDE8A;WNT9A;FGF2;TNS2;TGFB2;SLIT3;SLIT2;CAMK2N1;F2R;IGFBP6;CDKN2AIP;MIF;SMAD4;LMNA;ATF5;SKI;SYT11;GNG4;HOPX;GTPBP4;DACT2;PSRC1;MIA3;VPS4B;PTPRJ;ZBTB7C;INHA;MDM4;PLPP1;TGFBI;ADAM22;FLCN;PKD2;ABI1;CYP27B1;VDR;SIRT2;PLXNA3;KAT2B;ING4;SMAD6;BRD7;SIRPA;DSCAM;NPM1;BCL6;MAGI2;GPNMB;FBXO5;DNAJB2;ANP32B;ADAM15;SPOCD1;CDKN1A;P3H1;TMEM127;PDE3B;TNFRSF1B;DNAJA3;NACC2;DDX4;ORC6;KLF4;GMNN;SMARCA4;NUPR1;NUDT6;NLRP2B;PDCD4;IL6;NCK1;HTRA2;CD164;TFAP4;PML;NME1;EEF1E1;SRGAP2
prerank,P-body assembly (GO:0033962),0.489449673475552,1.0320046758580386,0.4400564174894217,0.9291690107281174,1.0,4/12,15.35%,RC3H1;LSM4;ATXN2;DYNC1H1
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),0.4919345335805306,1.0312634666816212,0.46467391304347827,0.9307335324043688,1.0,5/13,17.16%,EPHB2;SQSTM1;ADCY8;ZDHHC2;CHRNA7
prerank,response to prostaglandin E (GO:0034695),-0.4314905135895737,-1.0311494680228162,0.38305084745762713,0.788171544517519,1.0,5/10,25.17%,TGFBR3;SFRP1;GNG2;CCL19;ADCY6
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.3899322948073996,1.031105978416208,0.4322860238353196,0.9305474173584235,1.0,21/56,29.06%,LBP;S100A8;S100A9;TLR5;TLR4;IRAK4;IRAK1;UBA52;CD14;TRAF3;TAB2;MAP3K7;CTSK;HSP90B1;CTSB;CTSL;BCL10;MAPKAPK3;SFTPA1;SFTPA2;MYD88
prerank,regulation of cellular localization (GO:0060341),0.3918040573091911,1.0309916846822236,0.4594894561598224,0.9302442240977331,1.0,14/46,20.65%,GSN;EFNA5;CAMK2D;NR1D1;TRIM46;PARD6A;GOSR1;FER;HSP90AA1;DYNC1H1;REEP5;TTL;TRIM67;NUMA1
prerank,metanephric mesenchyme development (GO:0072075),0.505371238682964,1.0308640515499778,0.47083926031294454,0.9299906456420483,1.0,4/10,13.72%,WT1;SIX4;PKD2;SIX1
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),-0.32098838758102943,-1.0308499941860019,0.4124293785310734,0.7869529516004349,1.0,11/25,28.95%,IGF1;NIBAN2;TGFB1;SOX11;MAD2L2;HEY1;TRIM6;HEY2;RB1;PARK7;SIN3A
prerank,positive regulation of cilium assembly (GO:0045724),0.45641234049022245,1.0307646317390562,0.4453125,0.9296364072241519,1.0,9/18,29.21%,SAXO1;BBS4;CCP110;ENTR1;CROCC;SEPTIN9;CCDC88A;FUZ;KCTD17
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.3771477423291567,1.0306886657612968,0.4387646432374867,0.9292019068179411,1.0,13/72,14.13%,DCN;MYOC;FGFR1;FGF2;TGFB2;F2R;SRC;PIK3CA;IRS2;EGF;FLT3;CBL;PDGFRA
prerank,regulation of NMDA receptor activity (GO:2000310),0.4149855384783697,1.0306122856409834,0.4591121495327103,0.9287875109780469,1.0,6/32,9.39%,EPHB2;DLG4;DLG2;NEFL;CAPN1;GRIA2
prerank,negative regulation of neuron death (GO:1901215),0.3723070639085797,1.030328110545406,0.43212435233160623,0.9289610300188793,1.0,22/93,22.19%,CD34;TGFB3;SIX4;KIR3DL2;F2R;CLCF1;NFATC4;NRBP2;AKT1;GPNMB;GDNF;CD200R1;SIX1;TNFRSF1B;HTRA2;SET;SNX6;RASA1;TYRO3;KDM2B;CSF1;ATF4
prerank,regulation of kinase activity (GO:0043549),0.37183146939364026,1.0303251334040437,0.4607329842931937,0.9283277784400917,1.0,19/89,14.53%,DDR2;EPHB2;AXL;EGFR;FGFR1;PLCE1;EPHA3;MST1R;RET;EPHB3;MUSK;CAMKK2;MAPT;EPHA10;IRS2;FLT3;PDGFRA;NBN;DDR1
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.4472185919056031,1.0299107741688616,0.45828295042321643,0.9289570416486894,1.0,3/22,7.93%,AHNAK;SRI;CRHR1
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),-0.28681707507807636,-1.0297363397750436,0.39090909090909093,0.7879192843462155,1.0,18/42,24.93%,WDR48;SHLD1;ARID2;HELB;MRNIP;KLHL15;RIF1;SMCHD1;PPP4C;FANCB;TIMELESS;MAD2L2;RPA2;RMI2;RAD51;PARPBP;CHEK1;WRAP53
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.4840534464102636,1.0296405409650684,0.44798890429958393,0.9291341071710618,1.0,3/12,11.31%,MIA3;FUT9;AKT1
prerank,positive regulation of cell growth (GO:0030307),0.3690180451985573,1.0296115926072258,0.4380165289256198,0.9285891692387247,1.0,27/96,22.86%,DBN1;EGFR;HPN;SYT2;TGFB2;CDKN2AIP;S100A8;S100A9;DDX49;NTN1;ISLR2;L1CAM;AKT1;MAPT;LGI1;INO80;GOLGA4;SYT1;SHTN1;TGFBR1;SUPV3L1;RIMS2;N6AMT1;SLC25A33;SMURF1;SDCBP;KLHL22
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.3941970974363702,1.0294772082689578,0.4217687074829932,0.9283416583551231,1.0,4/43,5.35%,AREG;EGFR;BTC;PTPRJ
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.3102744515986724,-1.0292129337120839,0.40384615384615385,0.7873538786127593,1.0,8/27,13.28%,FLT1;PRKD1;KIT;EPHA8;PDGFRB;TEK;TGFB1;PTK2
prerank,calcium ion import into cytosol (GO:1902656),0.4663148581006509,1.0291642959095408,0.44559585492227977,0.9286439282988237,1.0,6/15,26.25%,TRPV3;ATP2B4;SLC8A2;CACNA2D1;TRPV2;SLC24A2
prerank,positive regulation of intracellular protein transport (GO:0090316),0.36178469640672645,1.0289640495432273,0.44659206510681587,0.9286394846005648,1.0,54/144,26.43%,SEC16B;FYN;ZPR1;PIK3R2;UBE2J2;USP36;TCF7L2;MIEF2;YWHAG;GAS6;CD81;YWHAE;HPS4;B3GAT3;PSEN1;RBM22;HDAC3;PPP3CC;KIF20B;JUP;TMEM30A;ANP32B;SFN;NPEPPS;BBC3;ZDHHC2;ZC3H12A;DMAP1;BCAS3;CHP1;HTRA2;IPO5;VPS11;ARIH2;VAMP2;ATG13;ITGAM;UBE2D3;FLNA;SAE1;PCM1;ICE1;YWHAB;BAG3;TPR;CSNK2A2;LEPROT;EMD;FIS1;MTCL1;RAB29;FBXW7;OAZ1;RNF31
prerank,positive regulation of GTPase activity (GO:0043547),-0.2340698534122984,-1.0288350744622592,0.0,0.786416760540277,1.0,46/188,11.95%,ARHGAP29;PKP4;TBC1D4;RAPGEF2;RAPGEF3;TBC1D1;ITGA6;RAP1GDS1;NET1;CDKL5;F11R;ARHGAP24;RALGAPA1;DOCK8;TGM2;RASGRP2;SIPA1L1;ARHGEF26;MAP4K4;PIP5K1A;RGS6;DVL3;NTRK3;RANGAP1;TBC1D25;DOCK9;GRTP1;CCDC125;TBC1D16;BCAR3;PLXNB1;ERBB2;CX3CL1;SFRP1;CAV2;MTSS2;ZC3H15;USP6NL;LIMS1;AGRN;TBC1D30;RGP1;RALGAPA2;TBC1D10B;TBC1D8;SCRIB
prerank,postsynaptic membrane organization (GO:0001941),0.45548975142190234,1.02876714113694,0.43586387434554974,0.9286123245137217,1.0,4/17,13.81%,CEL;DLG4;MUSK;DNAJA3
prerank,hexose transmembrane transport (GO:0008645),0.44487691249141215,1.0285591843065682,0.4458128078817734,0.9286025659103079,1.0,5/21,18.06%,SLC5A9;SLC50A1;SLC2A10;SLC2A3;SLC45A1
prerank,protein methylation (GO:0006479),0.40881078803166465,1.028551751186845,0.4391891891891892,0.9279841616785612,1.0,14/40,26.53%,RAB6A;PRMT2;NTMT1;EHMT2;GSPT1;SNRPD3;EEF2KMT;N6AMT1;ICMT;NSD1;CARM1;EZH2;CAMKMT;EEF1AKMT3
prerank,double-strand break repair (GO:0006302),0.36176355954038103,1.0283188452406353,0.4408493427704752,0.9280161982019748,1.0,40/158,19.59%,PARP3;REV3L;XRCC3;EME1;SFR1;RAD51B;RFWD3;KPNA2;TENT4A;CYREN;UBE2N;PPP5C;HELQ;AP5S1;SAMHD1;POLB;SMC5;ACTR5;RMI1;ERCC4;FAN1;XRCC5;ABRAXAS1;SEM1;DNA2;BRIP1;SMC6;NBN;INO80;TNKS1BP1;IFFO1;RECQL;SPIDR;RNF138;RAD50;ERCC5;BLM;MORF4L1;DCLRE1A;SMARCAL1
prerank,signal transduction by p53 class mediator (GO:0072331),0.4191059349406834,1.028172554901445,0.43498273878020716,0.9278389184974813,1.0,9/30,21.95%,TRIAP1;USP10;MDM4;BCL3;FHIT;NBN;DDX5;PYCARD;SESN2
prerank,RNA interference (GO:0016246),0.4668583664934445,1.0277731020569956,0.4630606860158311,0.9283991600346281,1.0,6/17,27.89%,TARBP2;AGO2;AGO4;AGO3;AGO1;CELF1
prerank,positive regulation of lipid kinase activity (GO:0090218),-0.29912555234925725,-1.027773014855518,0.42038216560509556,0.7874068196224043,1.0,9/29,13.28%,FLT1;PRKD1;KIT;DGKZ;EPHA8;PDGFRB;TEK;TGFB1;PTK2
prerank,phospholipid transport (GO:0015914),0.38938317289491603,1.0276611031262761,0.4428726877040261,0.9281053883452327,1.0,11/52,12.71%,ATP8B1;TRIAP1;ATP9A;OSBPL2;ABCA1;PRELID3A;ATP11A;SCP2;ATP9B;TMEM30A;ABCC1
prerank,neuron projection extension (GO:1990138),-0.296759072990034,-1.02763395324865,0.42138364779874216,0.7857319839576966,1.0,4/32,3.28%,ALCAM;AUTS2;NRP2;SEMA5A
prerank,phospholipid metabolic process (GO:0006644),0.3839436638301786,1.0276048981184345,0.4450317124735729,0.9276364330748951,1.0,16/71,20.47%,SMPD3;PLPP3;PLPP1;LCAT;AGPAT3;LPCAT1;PLPPR3;AGPAT5;FADS1;PLA2G4E;PIP4P1;PLPP2;GPAM;SMPD1;ANGPTL3;PIP4K2B
prerank,ventricular cardiac muscle cell action potential (GO:0086005),-0.3550279624772693,-1.027402801628779,0.4474885844748858,0.7842502382517341,1.0,7/17,20.35%,NEDD4L;GPD1L;KCNQ1;RYR2;KCNE4;SNTA1;SCN3B
prerank,cellular response to cadmium ion (GO:0071276),0.4354947788962741,1.027358407623026,0.4635603345280765,0.927755001959389,1.0,8/24,29.97%,EGFR;CHUK;AKT1;MAPK1;JUN;SUMO1;FOS;HSF1
prerank,inorganic anion transport (GO:0015698),-0.26560259269927033,-1.0272475490997517,0.3372093023255814,0.782648618238053,1.0,13/53,17.09%,SLC13A4;SLC26A7;ENPP1;ANO1;ENPP3;CLIC5;SLC5A5;SLC25A11;FXYD1;CLCN2;PACC1;ANO8;CLCN1
prerank,cellular response to insulin stimulus (GO:0032869),0.3594829171352889,1.0271924590605441,0.450920245398773,0.9276376211450182,1.0,38/124,20.86%,IRS1;GRB10;HDAC9;PIK3R2;ATP6V0A2;ZFP36L1;SLC39A14;ZDHHC7;FOXO1;MYO5A;INSIG2;FOXC2;SYAP1;KAT2B;INPP5K;RHOQ;AKT1;ATP6V1E1;IRS2;ATP6AP1;PDE3B;FER;ATP6V0A1;ATP6V1D;PKM;SELENOS;ATP6V1B2;SOS1;IDE;CPEB1;EPRS1;VAMP2;CAPN10;GPLD1;LPIN3;GOT1;RAB10;FOXO4
prerank,intraciliary retrograde transport (GO:0035721),0.4883347333611787,1.026837598730685,0.43543956043956045,0.9280460790539924,1.0,4/12,18.23%,DYNC2I2;DYNC2LI1;DYNC2H1;DYNC2I1
prerank,tRNA processing (GO:0008033),0.3855656889284526,1.026719315892707,0.43683083511777304,0.9277568699657216,1.0,20/61,24.60%,ANKRD16;TSEN54;TRMT6;RPP21;RTRAF;TRMT61A;FTSJ1;CPSF4;TRMT10B;TRMT1;DTWD1;TRPT1;QTRT1;TYW5;PTCD1;TRUB1;METTL1;RPP30;CPSF1;WDR4
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.41587612701186083,1.0265682557047067,0.450887573964497,0.9275575379590795,1.0,12/34,25.16%,MYOC;S100A10;MYADM;C1QBP;TRIOBP;LIMS2;RAC3;ILK;FLNA;DMTN;CALR;RAC1
prerank,hematopoietic stem cell differentiation (GO:0060218),-0.4081680386273381,-1.0264135050958205,0.3942307692307692,0.7829606490086037,1.0,2/10,9.38%,MLLT3;SFRP1
prerank,skeletal muscle tissue development (GO:0007519),0.4095584059772965,1.026053158894551,0.4436781609195402,0.9284878272700937,1.0,7/32,19.02%,SIX4;SKI;SVIL;MYH14;SIX1;KLHL41;SELENON
prerank,protein targeting to lysosome (GO:0006622),-0.348540704964741,-1.025843986839461,0.41621621621621624,0.7825628243216988,1.0,5/20,11.22%,SCARB2;GGA3;RAB7A;SORL1;GCC2
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.4092054688856926,1.0256544020004283,0.4447031431897555,0.929049479490421,1.0,6/33,10.95%,CD160;PTPRJ;RC3H1;PRKD2;CD81;UBASH3A
prerank,organonitrogen compound catabolic process (GO:1901565),0.3845550389235601,1.0254072130761565,0.43539630836047777,0.9292015763118918,1.0,20/57,27.12%,ANPEP;MTOR;NAGK;LNPEP;TPP1;CLPX;SIAH1;PDXDC1;PNPLA8;NPEPPS;IDE;MPST;LIPC;LRSAM1;TXN2;USE1;TRIM24;CTH;PLA2G7;PPT1
prerank,regulation of cell population proliferation (GO:0042127),0.3500999751362282,1.025395040690855,0.372,0.9286032078101218,1.0,115/691,14.33%,NOX4;SFRP4;LIF;AREG;AR;HAS2;AVPR1A;FGF18;FGF7;DPP4;WNT2;EGFR;SCIN;TGFB3;WT1;IRS1;FGFR1;DIS3L2;GLMN;CTF1;RPS6KA2;ADARB1;BTC;SIX4;VEGFA;WNT9A;FGF2;TNS2;SGK3;SGK2;TGFB2;MST1R;CAMK2N1;F2R;TGFBR2;TRNP1;IGFBP6;RUNX1;TIPIN;LMNA;ELN;ATF5;WWTR1;SKI;ZFP36L1;CDK4;GTPBP4;JUND;CLCF1;TCF7L2;TRIM71;PTPRJ;MEIS2;GLP2R;MEAK7;ZBTB7C;CXCL10;INHA;MDM4;MLXIPL;S1PR2;PLPP1;MELTF;ESM1;TBX6;PKD2;FLT3LG;DNAJA2;ABI1;CD81;STAT5A;CAPN1;WDR77;CYP27B1;VDR;CUL3;JAG1;SIRT2;STX4;KAT2B;ING4;ITGAV;SMAD6;BRD7;CD47;NPM1;BCL6;KRAS;AKT1;RBFOX2;KIF20B;MAGI2;GPNMB;FBXO5;TSHR;UBE2A;DNAJB2;JUP;IRS2;EGF;XRCC5;GDNF;FLT3;CDKN1A;P3H1;RHOA;TMEM127;SIX1;DNAJA3;NACC2;HDAC4;CDC123;PDGFRA;FER;KLF4
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.42348719226920384,1.0248883429950115,0.45185185185185184,0.9294364490311331,1.0,7/27,16.59%,EGFR;AGO2;PUM1;ZFP36;MAP2K2;IL6;DDX5
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.3502509828919766,1.0247844285755077,0.387,0.929121266781738,1.0,158/834,16.39%,LMX1A;DCN;LIF;AR;LRP6;ESR1;NFIX;IRF4;WNT2;EGFR;TGFB3;WT1;MEOX2;TRIAP1;HSF2;ELF4;MAPK7;ZMIZ1;VEGFA;FGF2;TGFB2;PBX1;GLIS2;RUNX1;CRTC2;SMAD4;NFE2L2;PIK3R2;ATF5;WWTR1;DPF2;LMX1B;AKNA;MEF2D;SKI;PKD1;COPS5;ACVR1;FOXK2;KLF2;JUND;MAFF;TCF7L2;NR1D2;NFATC1;HOXA5;SMARCD2;MEIS2;FOXO1;IL33;AKIRIN1;NR1D1;NFIB;RTRAF;CXCL10;NCOA3;MUC1;SSBP3;NFIA;RNF111;ZFHX3;DPF1;MEPCE;ARF4;MLXIPL;SMAD5;ACTR3;MTF1;PID1;SMARCD1;ADCYAP1;GLI2;ZFPM2;FLCN;PRKD2;PKD2;CD81;SOX8;CHUK;VDR;MYBL2;FOXC2;AGO2;JAG1;CDK9;SIRT2;TLR4;BEX1;ONECUT1;KAT2B;MED24;ATAD2B;RHOQ;RNF10;SATB2;HELZ2;SQSTM1;HDAC3;NPM1;MZF1;TCERG1;MITF;PRDM15;IRF2BPL;CSRNP3;TOX2;SLC30A9;MICAL2;CEBPB;GLI3;DCAF6;ZNF462;TNIP1;SLC9A1;AKIRIN2;UBA52;KANSL3;JUP;CCNC;DR1;GDNF;ATF1;DDX17;PEG3;PIN1;MED13;TWIST1;SIX1;HDAC4;RFX5;PLAGL1;NME2;ZC3H12A;EAF2;KLF4;HOXA7;BCL9;PTOV1;HOXC4;INO80;BCAS3;PPP3CA;POU3F2;IL4;SMARCA4;GTF2F1;CHD8;MLXIP;NR2C2;E2F3;AHI1;UBP1;PER1;IL6;HGF;NCK1;OGT;STAT5B
prerank,retrograde axonal transport (GO:0008090),0.4607035993705956,1.0247361204617353,0.4367816091954023,0.9286468729181518,1.0,7/16,22.51%,DST;DLG2;NEFL;DYNC1H1;PAFAH1B1;MAP1A;FBXW11
prerank,positive regulation of programmed cell death (GO:0043068),0.35232537632852734,1.0247270671471889,0.45045045045045046,0.9280485309475516,1.0,75/272,24.04%,SFRP4;SYK;WNT10B;KCNMA1;SCIN;TGFB3;AKAP13;GADD45G;RPS6KA2;SLIT2;BIN1;TRIO;ADAMTSL4;MTCH1;HOXA5;FOXO1;PRMT2;RASSF2;C1QBP;ARHGEF3;HDAC6;PIP5KL1;AIFM2;FLCN;SIAH1;PSEN1;PDCD2;RYBP;ING4;TIAM2;SQSTM1;CSRNP3;BCL6;BMF;ERCC3;UBA52;BAK1;NGEF;QRICH1;DIABLO;STK3;MLLT11;MTCH2;CALHM2;DDX20;HRK;NLRP2B;IL6;SOS1;HTRA2;TFAP4;SAP18;CTSD;EEF1E1;IAPP;SMPD1;SUDS3;APAF1;CLIP3;GPLD1;TRIM35;ATF6;TIAM1;PYCARD;JUN;NF1;ATF4;CYP1B1;UBE2Z;RBM5;HTATIP2;VAV2;RRP1B;TFPT;LATS1
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.4713020826522042,1.0247000866788067,0.4283854166666667,0.9275129267841334,1.0,6/15,20.35%,TRIAP1;GPX1;AKT1;GHITM;HGF;PRELID1
prerank,mitochondrial translational elongation (GO:0070125),0.37024768720835244,1.0236834877559517,0.45454545454545453,0.9299313078546833,1.0,19/88,15.59%,MRPS11;MRPL38;MRPS18B;CHCHD1;MRPL13;MRPS17;AURKAIP1;MRPS27;MRPL30;MRPL10;GFM1;DAP3;MRPL55;MRPS10;MRPL36;MRPL3;MRPL21;MRPS34;MRPL51
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.3589978105761157,1.0236738537884718,0.4595959595959596,0.9293273913527571,1.0,49/166,20.69%,NIBAN1;EGFR;IRS1;CTC1;FGF2;SMOC2;KLF2;MTOR;NR1D1;MLXIPL;GLI2;PRKD2;PKD2;LARP4;EPM2AIP1;TLR4;HNRNPD;DYRK2;NPM1;AKT1;ELOVL5;PASK;IRS2;DUOXA1;EIF6;EGF;RPS27L;BCL3;DDB1;ZCCHC4;DNA2;POLDIP3;RBM3;KLF4;HSP90AA1;EIF3E;GIPC1;CHP1;IL6;HGF;EIF3D;FXR2;YTHDF1;SREBF1;GPLD1;PCIF1;DDAH2;ABCB10;OPN3
prerank,B cell receptor signaling pathway (GO:0050853),0.41415388734357744,1.0234831394747608,0.44651162790697674,0.9292574735377221,1.0,2/32,3.34%,SYK;RFTN1
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),-0.3846457842490054,-1.022742912706407,0.4117647058823529,0.788669111006334,1.0,3/13,10.58%,BMP5;APOE;BMP2
prerank,metal ion transport (GO:0030001),-0.24775489391604594,-1.0226227570145043,0.4634146341463415,0.7869257926267816,1.0,20/86,12.56%,ITPR1;CALCRL;SLC41A1;CACNA1E;ATP2C1;SLC8A3;RAMP1;SLC39A8;CACNA1D;TRPC5;CAV1;SLC3A2;SLC30A1;TRPC4;CACNG8;RYR2;NDFIP2;ATP2A3;TRPV4;NIPA2
prerank,negative regulation of myotube differentiation (GO:0010832),0.48946090811851584,1.0225983584681113,0.46132971506105835,0.9312650516496801,1.0,3/12,13.86%,TMEM119;HDAC3;HDAC4
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.3998633886002838,1.021852413888405,0.4697986577181208,0.9327781592457143,1.0,15/40,25.74%,GLMN;DESI1;AXIN1;RAD23B;SGTA;UFL1;PML;RPL23;PTEN;SMURF1;UBE3A;CSNK2A2;LATS1;UBQLN4;FBXW7
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.4873183731916729,1.02140248249019,0.4574175824175824,0.9328097515249482,1.0,4/12,15.25%,ATP2B4;DYRK2;RCAN1;CHP1
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.4873183731916729,1.02140248249019,0.4574175824175824,0.9328097515249482,1.0,4/12,15.25%,ATP2B4;DYRK2;RCAN1;CHP1
prerank,negative regulation of phosphatase activity (GO:0010923),0.41983416931219725,1.0213911712367383,0.4490521327014218,0.9322148562204707,1.0,13/25,30.20%,TGFB2;PPP1R1B;URI1;CHP1;SH2D4A;FKBP1A;TIPRL;PPP1R26;CRY2;PTPA;GPATCH2;FKBP1B;BOD1
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.45426613460085585,1.0212766307935235,0.46153846153846156,0.9319167210317686,1.0,3/17,6.37%,CD55;PRKCA;CARD16
prerank,positive regulation of mitochondrial translation (GO:0070131),0.4620227945846652,1.0210396123454109,0.45528455284552843,0.9319841041829191,1.0,5/14,21.41%,C1QBP;MRPS27;RCC1L;RMND1;MPV17L2
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),0.4862950369449847,1.020761894548101,0.4397834912043302,0.932188713050315,1.0,4/13,23.03%,SLC4A10;SLC8A2;SHISA6;GRIK2
prerank,positive regulation of organelle assembly (GO:1902117),0.3970972702632551,1.0206846229534454,0.45222222222222225,0.9317951413362021,1.0,19/44,27.27%,GPSM2;SAXO1;FSCN1;IL5;BBS4;DYNC1H1;CCP110;PIP4K2C;LRSAM1;ENTR1;PIP4K2B;NUMA1;CROCC;PDCD6IP;CCDC88A;SDCBP;G3BP1;SDC4;FUZ
prerank,positive regulation of secretion by cell (GO:1903532),-0.25513211616809217,-1.020585429204047,0.4375,0.7903980639393038,1.0,12/70,6.55%,BMP6;UNC13B;FRMD4A;IGF1;CD2AP;SLC12A2;SNCA;MYO18A;KCNB1;STXBP5;ABCG1;RGCC
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.49816524339296003,1.020063793487247,0.45557122708039494,0.9329719305985836,1.0,5/10,13.61%,UBE2B;PDE11A;PDE4D;CDC34;PDE3B
prerank,protein localization to lysosome (GO:0061462),-0.3082078238974287,-1.0199817011948884,0.38333333333333336,0.7900262185264144,1.0,7/28,11.22%,SCARB2;GGA3;RAB7A;MFSD1;LAMTOR5;SORL1;GCC2
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.45347173176285976,1.0198583659413145,0.489501312335958,0.9329242227929712,1.0,9/16,31.29%,NUP98;RBM3;SF3B4;THRAP3;DAZAP1;CELF3;RBMX;CELF4;CIRBP
prerank,triglyceride metabolic process (GO:0006641),0.39084573709246767,1.0196391473760889,0.44568868980963045,0.9329672251652945,1.0,12/48,22.45%,GPAT4;FABP12;MOGAT1;GK5;MOGAT2;GPAT3;FABP5;GPAM;LIPC;LIPH;LPIN3;SEL1L
prerank,protein deacetylation (GO:0006476),0.3931525738433905,1.0195217065651672,0.46781609195402296,0.9326791105484622,1.0,13/41,20.33%,HDAC9;HDAC7;HDAC6;SIN3B;MSL3;SIRT2;RCOR3;HDAC3;HDAC4;MORF4L1;SUDS3;MIER1;FLNA
prerank,regulation of glycogen metabolic process (GO:0070873),0.4807185058041986,1.019241385569127,0.4681139755766621,0.9328804744127556,1.0,5/12,24.10%,INPP5K;AKT1;PPP1R3C;PPP1R3D;PPP1R3E
prerank,protein maturation (GO:0051604),0.3657062822972112,1.0190202032074858,0.4657676348547718,0.93292992773011,1.0,26/95,21.66%,PCSK6;TSPAN17;PCSK5;LIPT2;ADAMTS3;ADAM19;PCSK4;STUB1;PSEN1;ECE1;NDUFAB1;XPNPEP3;ECE2;EEF1AKMT4-ECE2;DNAJB11;TASP1;CIAO2B;OGT;NAA15;MMP16;METAP2;NAA50;PCSK7;BACE1;CCS;CPZ
prerank,translational termination (GO:0006415),0.3674812191508552,1.0189850039225719,0.46810699588477367,0.9324199878521076,1.0,21/95,15.59%,MRPS11;MRPL38;MRPS18B;ABCE1;CHCHD1;MRPL13;MRPS17;AURKAIP1;MRPS27;GSPT2;MRPL30;MRPL10;DAP3;MRPL55;MRPS10;MRPL36;MRPL3;GSPT1;MRPL21;MRPS34;MRPL51
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.40646425101902267,1.0189487346860004,0.4396248534583822,0.931908781707152,1.0,8/31,21.64%,TIMM50;PEX16;GRPEL2;PEX12;PEX1;PEX5;PEX2;TIMM17A
prerank,response to interleukin-6 (GO:0070741),-0.4165471876624234,-1.018858345590048,0.42758620689655175,0.7909760739250635,1.0,3/10,11.04%,ST3GAL6;PTGIS;PTPRT
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.3620003061991116,-1.0186383382307678,0.43171806167400884,0.789549738407385,1.0,5/15,21.63%,PRKCH;AGTR1;MAPK9;LPL;MSR1
prerank,fatty acid catabolic process (GO:0009062),0.38019735198450116,1.018593366205501,0.4589114194236926,0.9323465432580543,1.0,19/67,22.15%,EHHADH;CEL;NUDT7;ALDH3A2;AUH;SCP2;ACADVL;SLC25A17;ACOX1;BDH2;NUDT19;ABCD3;MCAT;LPIN3;HSD17B4;ACAT1;CPT2;PEX2;CROT
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),-0.3545874444530264,-1.0185159170979547,0.4214876033057851,0.7879045236943928,1.0,5/16,17.97%,PDK1;SCARB2;SIRT1;PDK3;ADIPOR1
prerank,T cell migration (GO:0072678),-0.3803783463100889,-1.018432197720728,0.43253968253968256,0.7861606358794647,1.0,4/13,10.47%,SLC12A2;S1PR1;PIK3CD;CXCL16
prerank,regulation of cellular component movement (GO:0051270),0.38535783837477783,1.0184296450354844,0.4590347923681257,0.9322047446987757,1.0,16/49,18.40%,CD9;EGFR;BTC;VEGFA;ZSWIM4;HDAC6;ABL2;MYCBP2;INPP5F;EGF;RHOA;DIAPH1;ZSWIM8;ARAP1;YTHDF1;TGFBR1
prerank,regulation of cell motility (GO:2000145),0.36403574965695706,1.0182744362182716,0.4654471544715447,0.9320566494373471,1.0,22/121,13.57%,DUOX1;FGF18;FGF7;EGFR;BTC;FGF2;SGK3;LMNA;MEAK7;NTN1;ABL2;SLK;INPP5F;SRCIN1;KIF2A;PLXNA3;AKT1;CCDC25;EGF;PIN1;RHOA;TWIST1
prerank,positive regulation of protein import (GO:1904591),0.40775371336315475,1.01824220851888,0.4427020506634499,0.931525662217823,1.0,12/30,22.69%,ZPR1;PIK3R2;PSEN1;RBM22;HDAC3;JUP;ZC3H12A;DMAP1;IPO5;FLNA;BAG3;TPR
prerank,regulation of actin filament polymerization (GO:0030833),0.37753374334877166,1.018117232242263,0.47521551724137934,0.9312810524410355,1.0,23/69,24.09%,DBN1;SLIT2;CDC42EP2;BIN1;MYADM;PFN2;TWF1;KANK1;SSH1;GBA2;FCHSD1;FER;ARF6;NCK1;COTL1;ARFGEF1;RASA1;PYCARD;ABITRAM;SSH3;CTTN;LATS1;NCK2
prerank,cellular zinc ion homeostasis (GO:0006882),0.42680439365937234,1.0177374997520345,0.4637336504161712,0.9317973948154079,1.0,5/26,16.58%,SLC39A13;SLC39A14;SLC39A7;SLC30A9;SLC30A5
prerank,somite development (GO:0061053),0.4979924887600253,1.0176790321499687,0.45850914205344584,0.9313459192269449,1.0,1/11,1.62%,MEOX2
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),-0.4106439742959101,-1.0175220325392644,0.42560553633217996,0.7867213004521175,1.0,9/11,46.83%,PRKCQ;MALT1;NFKBID;IL12RB1;CARD9;IL23A;IL23R;IL12B;CLEC6A
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.368223669212218,1.0174636972010473,0.4560496380558428,0.9313378828913093,1.0,14/88,13.60%,IGFBP5;EIF2AK3;CAMK2N1;RBM4;PAIP2B;TRIM71;SAMD4B;HDAC6;MRPL13;CSTB;AKT1;IGF2BP1;LARP1;CNOT10
prerank,digestive tract morphogenesis (GO:0048546),-0.35709900396739763,-1.017441830932976,0.4155844155844156,0.7849488724544632,1.0,6/14,15.57%,RBPMS2;FGFR2;SOX17;STRA6;BBS7;SOX11
prerank,keratan sulfate catabolic process (GO:0042340),0.48800997234947896,1.0172267164949997,0.46802721088435373,0.931422241997635,1.0,2/11,4.27%,OGN;ACAN
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),-0.37794894727289563,-1.017180748654013,0.41155234657039713,0.7837276969444211,1.0,4/12,10.54%,SORBS1;IGF2;SORL1;SIRT1
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.35099722974110664,1.017174764071278,0.472,0.9309712723099042,1.0,103/314,26.29%,UCHL1;PSMC4;UBE2B;SPSB1;SPSB4;NFE2L2;UBE2J2;SMURF2;SYVN1;TRIM71;ITCH;EDEM1;RAD23B;RMND5B;RNF121;COP1;PSMC6;SPSB2;STUB1;UBE2W;ANKZF1;FBXO2;PSMD8;SIAH1;FBXO17;CUL3;SIRT2;FBXL2;ECPAS;UBE2G2;FBXW4;HECW2;FBXL20;HERPUD1;CDC23;ANAPC5;FBXO5;FBXO31;UBE2A;DNAJB2;UBA52;CDC34;LTN1;TMUB2;DDB1;FBXL3;SGTA;CDC27;AMFR;RNF216;SELENOS;RNF187;RBCK1;ZSWIM8;HACE1;PML;CDC26;DMAC2;KCTD2;UBE2G1;FBXL5;ANAPC4;AUP1;SKP2;PCNP;UBE2D3;FBXL19;CUL5;KCTD10;ANAPC10;JKAMP;NEMF;ARRB1;UBXN11;SMURF1;ANAPC15;DERL1;SEL1L;FBXW11;UBR2;USP19;KLHL22;ECRG4;SPSB3;IFI27;FBXO38;PSMD3;DCAF12;RHBDD2;FBXL12;PSMD4;SEC61B;MDM2;AGAP3;KAT5;HSP90B1;UFD1;DDIT3;FBXW7;RNF126;PSMB3;UBE2K;ANAPC2
prerank,cellular response to gamma radiation (GO:0071480),-0.345940044510942,-1.0168427182509698,0.40444444444444444,0.7826815147233995,1.0,8/17,20.32%,MAP3K20;YAP1;ATM;TMEM109;RPL26;WRN;HRAS;TSPYL5
prerank,nuclear export (GO:0051168),0.3732688161082116,1.016700704685015,0.47713097713097713,0.9316996601203599,1.0,29/80,27.45%,SRSF2;DESI1;HNRNPA1;SRSF6;NXF1;PKD1;U2AF1;STRADA;SRSF3;SRSF11;THOC7;POLDIP3;THOC2;THOC1;ZC3H11A;CHP1;DDX39A;SRRM1;U2AF2;NEMF;SMURF1;TPR;XPO7;CALR;ALYREF;UPF3B;NUP188;CDC40;THOC5
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.3847645484557889,1.0164489777070917,0.45788336933045354,0.9318177826107727,1.0,18/52,23.21%,EPHB2;EGFR;LRP1;EPHA3;ATP2B4;STX4;SQSTM1;AKT1;ZDHHC2;ARF6;PLS1;CNST;SPTBN1;STX3;CLIP3;STAC3;ZDHHC8;ZDHHC5
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.49702270792414527,1.016403955867243,0.4754335260115607,0.9313519851277269,1.0,2/11,7.58%,AXL;GAS6
prerank,positive regulation of protein catabolic process (GO:0045732),0.36823607428383925,1.0164014996854687,0.4643605870020964,0.9307425721452824,1.0,22/84,20.46%,GPC3;STX5;ADAM9;SMURF2;AXIN1;DACT1;ITCH;FOXO1;SEC22B;EGLN2;DTL;HECW2;DDB1;TNFRSF1B;HSP90AA1;NSF;HACE1;IDE;VPS11;GPLD1;SH3D19;RNF41
prerank,cellular response to inorganic substance (GO:0071241),0.44878271559685234,1.0162653112135254,0.4675984752223634,0.9305252006820248,1.0,8/21,22.08%,FOXO1;DPEP1;MTR;DDX11;KCNC2;SPIDR;BLM;NSMCE3
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),-0.3983079480720355,-1.016054601030534,0.43956043956043955,0.7827598515277225,1.0,3/11,6.08%,NEDD4L;ACTN2;CAV1
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.4736013790024567,1.0159005677772854,0.46895640686922063,0.9309479504673184,1.0,3/13,17.26%,STX1A;SCAMP5;SYT1
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.361785788154076,1.0158305292274523,0.483971044467425,0.9305385870069077,1.0,33/101,23.59%,NIBAN1;DACT1;MTOR;STUB1;LARP4;AURKAIP1;HNRNPD;NPM1;AKT1;TBC1D10A;PASK;BAK1;EIF6;RPS27L;BCL3;ZCCHC4;POLDIP3;RBM3;KLF4;HSP90AA1;EIF3E;IL6;OGT;EIF3D;FXR2;YTHDF1;VPS11;PCIF1;CSF1;YTHDF3;FBXW11;ATG10;IST1
prerank,positive regulation of fat cell differentiation (GO:0045600),0.38088377472547763,1.015444377875879,0.46354733405875953,0.931023703248538,1.0,10/47,14.40%,MEDAG;ZFP36L1;METRNL;SYAP1;CEBPB;AKT1;ZFP36;SIX1;ZC3H12A;WDFY2
prerank,regulation of cation channel activity (GO:2001257),0.3732952762191568,1.015346276971269,0.4724818276220145,0.9306982617887689,1.0,20/89,19.71%,AHNAK;JSRP1;ANK2;CNIH3;FGF13;DLG4;CAMK2D;DLG2;NEFL;CAPN1;GRIA2;CACNG2;PDE4D;CALM2;CACNB1;FGF14;GRIN2A;VAMP2;SELENON;GRIA3
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.3575930482690972,-1.0153229731306896,0.42913385826771655,0.7827865299668587,1.0,7/15,21.57%,RPS7;DTX3L;ABL1;RPL5;MAD2L2;BAG2;MAD2L1
prerank,organelle disassembly (GO:1903008),0.4127955121754711,1.0151824037610135,0.4828767123287671,0.9305624481758877,1.0,10/33,21.06%,STX5;KLC1;ATG2B;ULK2;ATG2A;ULK1;UFC1;UFL1;UFM1;MTIF2
prerank,regulation of systemic arterial blood pressure (GO:0003073),0.4575800068239355,1.015104761891969,0.4689922480620155,0.9301544217651354,1.0,4/16,12.39%,PRCP;SPX;GPR37L1;KLK1
prerank,inositol phosphate catabolic process (GO:0071545),0.4812650747520696,1.014785548969739,0.4712328767123288,0.9305129721087124,1.0,5/12,27.87%,OCRL;INPP5K;INPP5B;PTEN;SYNJ2
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.3987202887689746,1.0143979691292324,0.46997690531177827,0.9310470702986406,1.0,10/38,22.61%,ESR1;USP10;NR1D1;OTUD7B;TNIP1;ZC3H12A;PER1;PPM1A;PYCARD;RORA
prerank,positive regulation of lymphocyte migration (GO:2000403),-0.3780093994802929,-1.0142604242863644,0.40711462450592883,0.783602926709384,1.0,3/12,4.18%,APP;DOCK8;CXCL12
prerank,membrane repolarization during action potential (GO:0086011),0.4832645238980612,1.0141311385820915,0.45331529093369416,0.9311934727169463,1.0,3/13,8.27%,ATP1A1;KCNJ2;YWHAE
prerank,anterograde trans-synaptic signaling (GO:0098916),0.3497942576502957,1.0140657420939048,0.45145145145145144,0.9307829100489002,1.0,46/224,19.90%,LRP6;LPAR3;SNCB;MTNR1B;APBA3;PMP22;CEL;RPS6KA2;CAMKK1;APBA1;DLG4;SLC1A6;GABRR3;DLG2;SLC18A3;RIT2;HTR1F;SLC12A4;GRIA2;PLP1;CAMKK2;HCRT;SLC12A5;SNAP25;ASIC2;DLGAP1;GABRG3;GAD2;CACNB1;GIPC1;GRIN2A;GRM1;CHRNA7;CHRFAM7A;SYT1;AKAP9;CHRNA5;SYNJ2BP;HTR2C;MBP;PAFAH1B1;PRKAR2A;GABRG2;GRIA3;NOVA1;EXOC4
prerank,ncRNA catabolic process (GO:0034661),0.4117213332471503,1.0136592939132962,0.47878787878787876,0.9313176913202117,1.0,6/28,18.37%,DIS3L2;NUDT16L1;EXOSC7;NUDT16;ZCCHC8;TENT4B
prerank,regulation of activated T cell proliferation (GO:0046006),0.41211375368493003,1.0128741762235258,0.4634146341463415,0.933009172252017,1.0,2/30,7.02%,TNFSF9;RC3H1
prerank,inorganic cation transmembrane transport (GO:0098662),0.3503976081262058,1.012862212743003,0.474,0.9324272490032759,1.0,48/268,16.58%,SCARA5;KCNK5;SCNN1B;UCP1;HPN;KCNV1;SLC4A8;SLC39A13;ATP1A4;ATP1A3;ATP1A1;PKD1;P2RX3;SLC39A14;TRPV3;ATP2B4;KCNJ2;SLC9A9;KCND1;SLC6A8;SLC11A2;ABCB8;GAS6;SLC25A27;PKD2;ATP5PO;KCNK13;KCNK9;ITGAV;HCN4;SLC39A7;KCNA2;SLC4A4;KCNA6;KCNAB3;SLC6A11;SLC6A4;SLC9A1;ATP2A2;ASIC2;SLC8A2;KCNC2;TRPC4AP;SLC9A7;SLC9A6;SCN4B;TMEM165;SLC30A5
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.3839315010204328,1.0127572892845589,0.4507042253521127,0.9321023868677405,1.0,10/56,10.09%,TGFB3;LDLRAD4;TGFB2;PMEPA1;SMAD4;ACVR1;BMP15;INHA;BMP8A;SMAD6
prerank,activation of protein kinase B activity (GO:0032148),-0.30208807035769625,-1.0126390788374866,0.44966442953020136,0.7858862093306481,1.0,8/29,8.98%,INSR;IGF1;WNT5A;OSBPL8;PINK1;NTRK3;FGF1;ADRA2A
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.3770615841304234,1.0125383076228751,0.4758324382384533,0.932131560529515,1.0,19/59,24.76%,PRKCA;DYRK4;TGFBR2;ACVR1;CAMK2D;PRKD2;DYRK2;AKT1;STK39;ULK1;HIPK4;TGFBR1;CIT;OXSR1;HIPK3;MAPK1;CSNK2A2;ACVR1B;MARK2
prerank,positive regulation of rRNA processing (GO:2000234),0.5017765055740873,1.0120839012838385,0.46906474820143884,0.9328572619025256,1.0,2/10,4.77%,DIMT1;RIOK1
prerank,negative regulation of signaling receptor activity (GO:2000272),0.42210394958131103,1.0119945313327103,0.4827586206896552,0.9325060326231638,1.0,2/25,3.88%,EPHB2;CNRIP1
prerank,negative regulation of protein catabolic process (GO:0042177),0.39288263633003234,1.011868024809711,0.4859075535512965,0.9322557329795534,1.0,5/40,9.06%,TIMP2;EGFR;IRAK3;MDM4;SIRT2
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.42551579747385876,1.0114042935314649,0.4666666666666667,0.9330002611266772,1.0,10/26,19.36%,FGFR1;MAPK7;RET;EYA2;AKT1;GDNF;PPP2R1B;SNAI2;HTRA2;MCL1
prerank,regulation of cell development (GO:0060284),0.3986262307709505,1.0110376872502231,0.4826388888888889,0.9334453420587074,1.0,5/36,11.31%,BHLHE40;HDAC9;DOCK7;FOXO1;AKT1
prerank,positive regulation of mitochondrion organization (GO:0010822),0.3794139386084783,1.010906479248414,0.4547413793103448,0.9332329969900275,1.0,14/57,20.96%,DCN;MIEF2;MCU;CAMKK2;BMF;BAK1;BBC3;MLLT11;HRK;HTRA2;PLAUR;DDHD1;RALA;PYCARD
prerank,histone mRNA catabolic process (GO:0071044),-0.35793152237410714,-1.010889664000687,0.4166666666666667,0.7886755865813458,1.0,6/15,16.74%,SSB;TUT1;TUT4;TUT7;ATM;MTPAP
prerank,transferrin transport (GO:0033572),0.4114027185801372,1.0108733972707622,0.4675324675324675,0.9327063584061205,1.0,9/33,16.13%,STEAP3;ATP6V0A2;CLTC;ATP6V1E1;ATP6AP1;REP15;ATP6V0A1;ATP6V1D;ATP6V1B2
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.4645091504765431,1.0105565045068001,0.4782608695652174,0.9330290687869938,1.0,8/15,25.55%,REEP3;LNPK;RTN3;RAB10;TMEM33;RAB18;RTN4;ATL1
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.3035696302523471,-1.0103011137925277,0.44329896907216493,0.7884759167352725,1.0,6/23,12.05%,CBFA2T3;PPARA;CRY1;C1QTNF3;SIK1;EP300
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.46352948853069476,1.0102693738223145,0.48104575163398694,0.9332538158824389,1.0,4/15,14.83%,ADAM9;MAPK14;EHD2;IL4
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),-0.41913604132160803,-1.010212919476931,0.4645161290322581,0.7868030765063924,1.0,3/10,4.66%,NEDD4L;OSR1;PRKCE
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.49600621726215327,1.0100643133184877,0.46174863387978143,0.9325834292544507,1.0,4/10,15.12%,TIGAR;NCOR1;HDAC4;NUPR1
prerank,negative regulation of glycolytic process (GO:0045820),0.49600621726215327,1.0100643133184877,0.46174863387978143,0.9325834292544507,1.0,4/10,15.12%,TIGAR;NCOR1;HDAC4;NUPR1
prerank,purine-containing compound biosynthetic process (GO:0072522),0.41264805112101677,1.0099285208758104,0.4585308056872038,0.9323806945508942,1.0,6/25,16.62%,AMPD2;PAICS;GART;PRPSAP1;PRPS1;PRPS1L1
prerank,ketone body metabolic process (GO:1902224),-0.39743563172730334,-1.0098529277403478,0.43309859154929575,0.7858989630368339,1.0,3/10,9.59%,ACSS3;HMGCS2;AACS
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),0.491675008629937,1.0096499955978213,0.4803921568627451,0.932559161560328,1.0,4/12,11.75%,WT1;JAG1;IQGAP1;MAGI2
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.3656632307226258,1.0093339157848977,0.48290155440414506,0.9328750252513646,1.0,35/94,26.73%,DCTN1;ODF2;YWHAG;SSNA1;YWHAE;ALMS1;MAPRE1;HAUS3;SFI1;CEP97;HSP90AA1;TUBB4A;TUBA4A;DYNC1H1;CDK5RAP2;AHI1;CCP110;AKAP9;CEP164;CEP89;CKAP5;CEP83;PAFAH1B1;CC2D2A;PCM1;FBF1;DCTN2;TCTN2;NEDD1;DYNLL1;CEP78;TCTN1;CSNK1E;ACTR1A;CETN2
prerank,carbohydrate biosynthetic process (GO:0016051),0.43809844774889245,1.0092544432607942,0.48198757763975153,0.9324788055681978,1.0,5/21,11.72%,ST3GAL2;B4GALT1;FUT2;FUT9;ST3GAL4
prerank,negative regulation of mRNA processing (GO:0050686),0.4635826641950408,1.0090717283895143,0.4567243675099867,0.9323731334231888,1.0,5/15,19.99%,SRSF6;C1QBP;SAP18;U2AF2;PTBP1
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.4684113945632503,1.0085786356536437,0.4713541666666667,0.9332089609982243,1.0,5/14,14.83%,SYT11;NR1D1;CD200R1;TNFRSF1B;IL4
prerank,regulation of secretion (GO:0051046),0.4715956709789493,1.0082960339452114,0.45722300140252453,0.9333951263401722,1.0,3/13,12.38%,SCIN;POFUT2;EGF
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.3238650328576158,-1.0082512850180356,0.4461538461538462,0.7863967585076,1.0,4/23,3.17%,TFDP2;BCL2;PPP1R13B;YWHAH
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.3238650328576158,-1.0082512850180356,0.4461538461538462,0.7863967585076,1.0,4/23,3.17%,TFDP2;BCL2;PPP1R13B;YWHAH
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.3436168959677442,-1.007962664040057,0.4476987447698745,0.7852968632916235,1.0,4/17,9.13%,RAPGEF2;ADRA1B;ADRA2A;ADCY9
prerank,negative regulation of platelet activation (GO:0010544),0.4517652599419135,1.0076640473714873,0.4691516709511568,0.9345765671281328,1.0,4/16,14.13%,C1QTNF1;CD9;ADAMTS18;PDGFRA
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.41399607238254205,1.0074649797363102,0.47215777262180975,0.9345106851980621,1.0,11/30,23.83%,UCHL5;RYBP;FHIT;SGTA;USP7;GIPC1;NOP53;OGT;MAP1A;SDCBP;BAG5
prerank,response to UV (GO:0009411),0.3629753252374708,1.0072024269389688,0.4876543209876543,0.9346962734152259,1.0,31/95,24.07%,EGFR;TRIAP1;UBE2B;NOC2L;SCARA3;ZBTB1;RHNO1;DTL;NPM1;GPX1;AKT1;BMF;ERCC3;UBE2A;BAK1;ERCC4;PCLAF;BCL3;CCND1;EIF2S1;INO80;UVSSA;ERCC5;POLD1;SMPD1;NSMCE3;ATF4;SDE2;RELA;REV1;POLH
prerank,response to cadmium ion (GO:0046686),0.42163650666026636,1.0067084930956751,0.4863258026159334,0.9355040235862245,1.0,8/26,29.97%,EGFR;CHUK;AKT1;MAPK1;JUN;SUMO1;FOS;HSF1
prerank,regulation of centriole replication (GO:0046599),0.45265246542404725,1.00634326396726,0.46938775510204084,0.9359805850997729,1.0,6/17,19.75%,CEP295NL;KAT2B;ALMS1;NPM1;CDK5RAP2;MDM1
prerank,positive regulation of inflammatory response (GO:0050729),0.36453623818894765,1.0061900028796584,0.49422875131164745,0.935802316326313,1.0,16/86,19.14%,LBP;IL16;S100A8;S100A9;IL33;IL17RA;CD81;TLR4;CD47;TNIP1;ABCC1;NUPR1;PDCD4;IL6;IL18;IFI35
prerank,negative regulation of cell motility (GO:2000146),0.3583238227615271,1.00528610920602,0.48762886597938143,0.9377849848152324,1.0,21/108,13.18%,IGFBP5;TMEFF2;ADARB1;LDLRAD4;SLIT2;MIF;GTPBP4;MIA3;PTPRJ;SRGAP1;SULF1;PIP5KL1;FLCN;DPEP1;JAG1;KANK1;MITF;MAGI2;RECK;ADAM15;PIN1
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.3781570646575549,1.005178043211862,0.47876857749469215,0.9374642071059874,1.0,27/59,29.87%,CDK4;TCF7L2;MED24;MITF;CEBPB;CCNC;CDKN1A;MED13;CCND1;TWIST1;MED15;IL6;AGO4;MED23;MED6;AGO3;PTEN;JUN;MED7;TNRC6A;RELA;MED26;AGO1;NFKB1;BAX;TP53;SOX9
prerank,negative regulation of autophagosome assembly (GO:1902902),0.4654140253723292,1.0051594179943526,0.48313090418353577,0.9369128394027326,1.0,9/13,33.91%,SEC22B;SCFD1;SMCR8;NUPR1;MTM1;TMEM39A;CHMP4A;CHMP4B;FEZ1
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),-0.33091830648183895,-1.005096786541861,0.43010752688172044,0.791461381237555,1.0,7/19,9.45%,MEF2C;RBP4;VGLL4;NOTCH1;TGFBR3;FGFR2;TBX2
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.47420584659202347,1.0048767934903102,0.48717948717948717,0.9371060496813207,1.0,8/12,31.70%,RFWD3;FBXO31;RPS27L;CCND1;SDE2;PRKDC;TP53;WAC
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),0.4703938974048839,1.0048545470664496,0.4684563758389262,0.9365524977803963,1.0,4/13,6.28%,TGFB3;SMAD4;NUP93;SH2B1
prerank,protein targeting to mitochondrion (GO:0006626),0.37890643689586534,1.0047686682105597,0.48083242059145676,0.9361964767164843,1.0,17/52,28.04%,TIMM50;GDAP1;TIMM10B;TIMM9;AGK;GRPEL2;HSP90AA1;IMMP1L;TIMM22;TIMM8B;BCAP31;TOMM5;TIMM17A;FIS1;TOMM40;NDUFA13;PITRM1
prerank,protein lipidation (GO:0006497),0.3768974485847656,1.0044207116289514,0.48663101604278075,0.936588963462442,1.0,21/59,24.18%,ZDHHC16;ZDHHC7;PIGZ;WIPI2;HHAT;PIGC;WDR45B;SELENOK;MPPE1;ZDHHC2;PIGW;PIGM;ZDHHC21;ZDHHC20;GPLD1;ZDHHC18;ZDHHC8;ZDHHC5;ATG10;PIGL;DPM2
prerank,nuclear pore organization (GO:0006999),0.4607750593132064,1.0042572115616126,0.46765498652291104,0.9364742462699598,1.0,4/14,8.69%,NUP93;AHCTF1;NUP107;NUP98
prerank,positive regulation of RNA metabolic process (GO:0051254),0.3856630755233101,1.0042036638820837,0.48368953880764903,0.9360266678077024,1.0,12/45,19.78%,EGFR;DIMT1;ZPR1;RIOK1;RBM22;ERN1;MAP2K2;IL6;DDX5;SUPV3L1;U2AF2;RIOK2
prerank,zinc ion homeostasis (GO:0055069),0.4157230006611303,1.0040048733722977,0.4900117508813161,0.935978519830175,1.0,5/28,16.58%,SLC39A13;SLC39A14;SLC39A7;SLC30A9;SLC30A5
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.41962556041529664,1.0038508858840092,0.4891566265060241,0.9358046258834295,1.0,2/25,3.89%,CD55;CD160
prerank,negative regulation of gene expression (GO:0010629),0.3464382817443998,1.0036724093331515,0.504,0.9357031548655397,1.0,51/302,14.33%,CD34;IGFBP5;ESR1;DIS3L2;NPTN;EIF2AK3;DGKQ;VEGFA;FGF2;TGFB2;FOXP1;RUNX1;MIF;HDAC9;RBMS3;SYT11;RBM4;PAIP2B;ATP2B4;TRIM71;SAMD4B;CREB3L1;CREBZF;TARDBP;MYADM;FLCN;ZFP36L2;PHF1;VDR;MRPL13;PSEN1;AGO2;NUDT16L1;KAT2B;ERN1;MPHOSPH8;PARP14;MAPT;NUDT16;SLC2A10;GPNMB;IGF2BP1;NDFIP1;LARP1;ZFP36;SMCR8;NCOR2;NCOR1;CNOT10;ZC3H12A;KLF4
prerank,hemidesmosome assembly (GO:0031581),0.48245148257655923,1.0033510592753194,0.4957983193277311,0.9360191840635148,1.0,2/11,5.04%,COL17A1;DST
prerank,positive regulation of cell junction assembly (GO:1901890),0.3783135013423929,1.0032585662361524,0.4884742041712404,0.9356684386827083,1.0,5/56,5.35%,MYOC;EPHB2;VEGFA;S100A10;PTPRJ
prerank,cGMP biosynthetic process (GO:0006182),-0.4165413490097323,-1.0030388896319926,0.4222972972972973,0.7950149464544202,1.0,4/10,21.82%,GUCY1B1;NPR1;GUCY1A1;GUCY2C
prerank,regulation of phagocytosis (GO:0050764),0.3761092349770172,1.0029853856919497,0.4723726977248104,0.9358008267763989,1.0,6/53,10.20%,SYK;SYT11;GAS6;ITGAV;CD47;SIRPA
prerank,copper ion transport (GO:0006825),0.4930647163868215,1.0029719163827535,0.4857916102841678,0.9352395923915751,1.0,2/11,7.16%,STEAP3;SLC11A2
prerank,cardiac atrium morphogenesis (GO:0003209),-0.35592939413250424,-1.0027410000162873,0.4434782608695652,0.7939049703135665,1.0,4/16,10.58%,ENG;NOTCH1;BMPR2;BMP2
prerank,sodium ion homeostasis (GO:0055078),0.43535979876822245,1.0027180378399168,0.49937421777221525,0.9353838734392558,1.0,4/21,3.99%,SCNN1B;ATP1A4;ATP1A3;ATP1A1
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.47814928117337135,1.002565113573772,0.4859154929577465,0.9351900572014527,1.0,6/12,26.39%,STX4;ADCY8;PPP3CB;GPLD1;BAIAP3;CFTR
prerank,positive regulation of cellular process (GO:0048522),0.34191701405379943,1.0024534592541654,0.484,0.9349295689065753,1.0,93/565,14.83%,LBP;LIF;AREG;AR;HAS2;LRP6;AVPR1A;FGF18;FGF7;DPP4;WNT2;PRKCA;EGFR;LRP1;TGFB3;IRS1;HPN;FGFR1;CTF1;BTC;VEGFA;FGF2;TGFB2;MST1R;F2R;TGFBR2;CDKN2AIP;S100A8;S100A9;TIPIN;LMNA;WWTR1;DDX49;P2RX3;ZFP36L1;CDK4;ACLY;CLCF1;PTPRJ;POFUT2;MEIS2;GLP2R;ZFHX3;C1QBP;MLXIPL;S1PR2;ESM1;TBX6;GAS6;FLCN;PRKD2;FLT3LG;DNAJA2;CD81;TNFRSF18;FZD7;CAPN1;WDR77;CUL3;SIRT2;TLR4;STX4;ITGAV;RNF10;CD47;SIRPA;SMC5;NPM1;KRAS;AKT1;MAPT;KIF20B;FBXO5;TSHR;UBE2A;IRS2;LGI1;EGF;ZFP36;GDNF;FLT3;CCND1;SMC6;TNFRSF1B;HDAC4;CDC123;ZC3H12A;PDGFRA;FER;INO80;PPP3CA;POU3F2;IL4
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.44310868011110294,1.0022289917431526,0.48346055979643765,0.9349455905844588,1.0,2/19,4.64%,DBN1;FBXW8
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.46329939020606686,1.0020998847823983,0.47883597883597884,0.934706631204986,1.0,4/13,17.66%,EDEM1;EDEM2;UBE2G2;BCAP31
prerank,regulation of apoptotic process (GO:0042981),0.3404277771403862,1.001752062998263,0.481,0.9350387983672541,1.0,153/676,20.48%,SFRP4;COMP;TNFSF9;FSTL1;AXL;GCLC;WNT10B;ARHGAP10;KCNMA1;EGFR;SCIN;ANXA1;TGFB3;WT1;AKAP13;HPN;RABGGTA;ANGPT4;TRIAP1;GADD45G;RPS6KA2;SIX4;CD44;GAS1;VEGFA;SLIT2;STEAP3;MIF;BIN1;ATF5;USP36;COPS5;TRIO;ITCH;ADAMTSL4;MTCH1;SOCS2;CBX4;HOXA5;DDX42;FOXO1;PRMT2;CXCL10;RASSF2;TARDBP;C1QBP;ARF4;SRC;EGLN2;ARHGEF3;PIP5KL1;AIFM2;HS1BP3;GAS6;FLCN;DPEP1;SLK;SOX8;SIAH1;PSEN1;PDCD2;BEX2;RYBP;AVEN;LGALS1;ING4;TIAM2;SMAD6;SON;SQSTM1;HDAC3;NPM1;ALPK2;CSRNP3;BCL6;AKT1;BMF;IRAK1;ERCC3;NAT8;UBA52;BAK1;CD27;NGEF;ANP32B;QRICH1;DIABLO;GLS2;GDNF;FLT3;BCL3;NSMF;WDR73;DNAJA3;NME2;CBL;STK3;MLLT11;MTCH2;CALHM2;HSP90AA1;IL4;NUPR1;VDAC1;DDX20;RSL1D1;NOP53;BAG4;HRK;AHI1;MADD;NLRP2B;IL6;SOS1;HGF;ANXA4;HTRA2;TFAP4;TAX1BP1;SAP18;NME1;CTSD;PPIA;EEF1E1;ERCC5;FAIM2;FBXO11;TMBIM4;PLAUR;NAA15;IAPP;VTCN1;SMPD1;UFM1;SUPV3L1;PRDM9;SKP2;DSTYK;SUDS3;APAF1;CLIP3;MCL1;GPLD1;IL31RA;HIPK3;STK26;RASA1;TRIM35;ATF6;FLNA;PRELID1;DDAH2;TIAM1
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.4224962090665659,1.0015647242382144,0.468557336621455,0.9349298741786481,1.0,4/22,14.08%,GADD45G;VEGFA;EMC10;ZC3H12A
prerank,positive regulation of immunoglobulin production (GO:0002639),0.4028760022708957,1.0015362531689713,0.4888888888888889,0.9344177607251881,1.0,4/31,9.18%,EPHB2;CLCF1;HMCES;STX4
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.4199742035119886,1.0015282990230399,0.4940047961630695,0.9338464249347619,1.0,7/29,17.52%,GTF2H3;RAD23B;ERCC3;UBA52;DDB1;CCNH;ERCC5
prerank,platelet aggregation (GO:0070527),0.39905312598358217,1.0014491557406409,0.49241540256709454,0.9334639608109953,1.0,10/33,21.28%,GNAS;ITGB3;PDGFRA;ACTG1;PPIA;ILK;FLNA;TYRO3;METAP1;PIK3CG
prerank,pyrimidine nucleoside catabolic process (GO:0046135),-0.3985354069106588,-1.0012944668647867,0.43272727272727274,0.7958187274152707,1.0,3/10,7.93%,DPYD;UPB1;NT5E
prerank,cellular response to UV (GO:0034644),0.3650485630413435,1.0010965002283148,0.4680628272251309,0.9338186717443154,1.0,23/76,22.85%,TRIAP1;MMP2;CRIP1;CARD16;NOC2L;ZBTB1;RHNO1;NPM1;ACTR5;BMF;BAK1;ERCC4;CDKN1A;DDB1;EIF2S1;INO80;POLD1;SMPD1;OPN3;NSMCE3;ATF4;SDE2;ERCC1
prerank,regulation of cholesterol biosynthetic process (GO:0045540),-0.3448500541261268,-1.000861262560133,0.44541484716157204,0.7950341866135934,1.0,7/17,23.61%,APOE;ABCG1;FGF1;SOD1;MBTPS2;ABCA2;ERLIN2
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.34612939013391136,1.0007104050014015,0.503,0.9342591837664515,1.0,114/341,26.29%,UCHL1;PSMC4;UBE2B;SPSB1;SPSB4;NFE2L2;UBA6;SMURF2;ZRANB1;SYVN1;TRIM71;ITCH;VPS4B;RAD23B;RMND5B;RBBP6;MVB12A;VPS37D;COP1;RNF111;PSMC6;SPSB2;RC3H1;STUB1;UBE2W;WDR91;ADRM1;PSMD8;SIAH1;MYLIP;CUL3;DTL;SIRT2;UBE2G2;FBXW4;HECW2;USP33;OTUD7B;HERPUD1;SQSTM1;CDC23;ANAPC5;RNF7;UBE2A;CDC34;NDFIP1;DDB1;VPS37C;CDC27;CBL;UBR4;AMFR;RNF128;RNF216;TRPC4AP;RNF14;RNF187;RBCK1;ZSWIM8;HACE1;KEAP1;PML;CDC26;KCTD2;VPS37B;UBE2G1;FBXO11;ANAPC4;NTAN1;ARIH2;UBAP1;UBE2R2;NEDD8;SKP2;PCNP;RNF19A;UBE3C;TOLLIP;UBE2D3;KCTD6;FBXL19;ARIH1;KCTD10;ANAPC10;KCTD21;ARRB1;RC3H2;UBXN11;SMURF1;ANAPC15;RNF6;FBXW11;KLHL22;RNF114;SPSB3;IFI27;RNF13;PSMD3;UBQLN4;PSMD4;MDM2;AGAP3;KAT5;RNF166;UFD1;FBXO22;RNF20;DDIT3;FBXW7;RNF126;PSMB3;UBE2K;RNF167;ANAPC2
prerank,negative regulation of cellular component movement (GO:0051271),-0.3618182262229787,-1.0001640942237349,0.4312796208530806,0.7947998231792139,1.0,5/15,10.93%,SP100;FRMD5;TGFBR3;CCDC125;ACTN1
prerank,DNA replication (GO:0006260),0.3584728632927335,0.999393743439182,0.49124613800205974,0.9372862789499874,1.0,34/105,25.21%,REV3L;TIPIN;IGHMBP2;NT5M;RHNO1;POLG2;POLB;POLE3;ING4;MCM3;RMI1;RAD1;PCLAF;DNA2;BRIP1;ORC6;DBF4;NBN;FAM111A;RFC4;GRWD1;RAD50;SET;BLM;TBRG1;POLD1;DONSON;KIN;CLSPN;REV1;ORC2;BAZ1A;KAT5;KAT7
prerank,regulation of pH (GO:0006885),0.4910158176096867,0.9993526506482212,0.46835443037974683,0.9367986167824401,1.0,4/11,15.88%,ATP1A4;SLC9A1;ATP6AP1;SLC9A7
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.37002455014242214,0.9990782536227089,0.47807486631016044,0.9369732187084701,1.0,11/67,16.21%,FBLN2;MYOC;VIT;S100A10;MYADM;C1QBP;CCL25;JUP;TRIOBP;LIMS2;RAC3
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),0.43312345721206513,0.9990423799239951,0.4860050890585242,0.9364716244649893,1.0,3/20,12.28%,SEMA3C;SEMA3A;SEMA3D
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.3580156986117442,0.9988509270865804,0.48297213622291024,0.9364392493588415,1.0,22/101,14.00%,FGF18;EGFR;FGFR1;VEGFA;FGF2;MST1R;PKD1;PSRC1;ATP2B4;MAPRE3;ETAA1;SRC;PKD2;SYAP1;AKT1;IRAK1;EGF;CALM2;FLT3;CCND1;RHOA;SLC8A2
prerank,endocardial cushion morphogenesis (GO:0003203),0.44423534063355913,0.9985864961296046,0.47073474470734744,0.9365922661441942,1.0,4/18,6.76%,TGFB2;TGFBR2;ACVR1;MDM4
prerank,protein localization to condensed chromosome (GO:1903083),0.4734081415308532,0.9985008489411256,0.48005502063273725,0.9362347767220321,1.0,2/12,4.97%,CHAMP1;ZW10
prerank,MAPK cascade (GO:0000165),0.3450860645411514,0.9984448802380597,0.51,0.9358244109581486,1.0,54/295,14.35%,AREG;FGF18;FGF7;EGFR;IRS1;FGFR1;MAPK12;PSMC4;BTC;FYN;FGF13;FGF2;DLG4;PIK3R2;TAOK3;SPTAN1;RASGRF1;ZFP36L1;SPTA1;DLG2;RET;NEFL;PSMC6;RASGEF1A;RIT2;FLT3LG;ZFP36L2;CHUK;YWHAE;RGL1;PPP5C;PIK3CA;PSMD8;CUL3;MAPK11;RGL2;ITGAV;CAMKK2;NRAS;KRAS;CSF2RA;UBA52;PLVAP;IRS2;EGF;SHOC2;ZFP36;TAOK2;GDNF;FLT3;IL5;PDGFRA;ARTN;RCE1
prerank,positive regulation of T cell cytokine production (GO:0002726),0.4343296160995238,0.9984000972505738,0.49,0.9353606564787863,1.0,7/20,24.63%,CD55;CD81;IL4;IL6;IL18;MAP3K7;PRKCZ
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.41159227680228117,0.9983498595462702,0.5029585798816568,0.9349152411994078,1.0,6/26,17.07%,PRKCA;SMOC2;MEIS2;CUL3;USP22;TTL
prerank,glucose 6-phosphate metabolic process (GO:0051156),-0.3077881345088111,-0.998314854230158,0.4790697674418605,0.7980371893295565,1.0,8/21,23.13%,HK2;DERA;PGLS;TALDO1;RBKS;RPE;GPI;RPIA
prerank,regulation of lipid storage (GO:0010883),0.4232955792485284,0.9983089476959632,0.5074626865671642,0.9344361266747888,1.0,5/22,16.30%,ITGB3;ALKBH7;ITGAV;ZC3H12A;IL6
prerank,negative regulation of autophagy (GO:0010507),0.3752730176277644,0.9980022196851913,0.49671772428884026,0.9347151692748007,1.0,26/54,30.72%,USP36;FOXK2;MTOR;IL10RA;PIK3CA;SIRT2;NRBP2;AKT1;BMF;SMCR8;NUPR1;HGF;DAP;MCL1;QSOX1;TAB2;KLHL22;EIF4G3;LEPR;EIF4G1;CTSA;TSC1;ZKSCAN3;LZTS1;TLK2;RUBCN
prerank,regulation of sequestering of triglyceride (GO:0010889),-0.35219544293899746,-0.9976762443481586,0.4788135593220339,0.7979470757547037,1.0,6/15,21.15%,OSBPL8;PPARA;PNPLA2;LPL;ABHD5;FITM2
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.36032616363218817,0.9976602784659963,0.5074152542372882,0.9350329666212093,1.0,24/80,23.57%,TGFB3;SAXO1;PLCE1;CDC42EP2;NDEL1;AKIRIN1;FSCN1;ACTR3;PALM;PIK3CA;RHOQ;AVIL;BBS4;BCAS3;EPS8L2;CCP110;ARAP1;ARPC2;GPM6A;ENTR1;RALA;CROCC;CCDC88A;DOCK11
prerank,axonogenesis (GO:0007409),0.3426012073816248,0.997639557034676,0.5090180360721442,0.9344905645439487,1.0,55/237,18.13%,SEMA3C;EPHB2;PRKCA;MAP1B;EFNA5;NPTN;GRB10;EPHA3;FYN;MAPK7;SLIT3;SLIT2;NTN4;LLGL1;SLIT1;SPTAN1;DOK1;UNC5A;SPTA1;DOCK7;PDLIM7;RET;SRC;GLI2;S100A6;SEMA3A;PIK3CA;SIAH1;DOK4;USP33;EPHB3;DSCAM;UNC5D;L1CAM;EPHA10;IRS2;ULK2;SEMA3D;LGI1;TAOK2;IGSF9;GDNF;PALLD;ULK1;ARTN;DCC;HSP90AA1;SLC9A6;SPTBN1;SOS1;NRXN3;CXCR4;SHTN1;CNTN4;EPHB1
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.33939134652029174,0.9975576279924397,0.491,0.9341276538401071,1.0,210/1082,16.87%,LMX1A;DCN;LIF;AR;LRP6;CD80;ESR1;COL1A1;NFIX;FGF7;IRF4;WNT2;EGFR;CREB5;TGFB3;WT1;ZC3H8;MEOX2;TRIAP1;EIF2AK3;HSF2;SIX4;ELF4;MAPK7;ZMIZ1;VEGFA;FGF2;PBX1;F2R;GLIS2;SFR1;RUNX1;ZPR1;CRTC2;SMAD4;NFE2L2;PIK3R2;ATF5;WWTR1;DPF2;LMX1B;AKNA;MEF2D;SKI;PKD1;CXXC1;COPS5;AXIN1;SOX10;ACVR1;FOXK2;KLF2;MAP2K3;JUND;MAFF;PSRC1;TCF7L2;MTOR;NR1D2;NFATC1;HOXA5;SCAF8;SMARCD2;MEIS2;FOXO1;IL33;AKIRIN1;NR1D1;NFIB;RTRAF;MAPRE3;EBF3;PRMT2;CXCL10;NCOA3;SSBP3;NFIA;RNF111;ZFHX3;DPF1;RET;ARF4;TRIP4;MLXIPL;SMAD5;DNAJC2;ACTR3;MTF1;PID1;SMARCD1;ADCYAP1;GLI2;ZFPM2;DHX33;FLCN;MDFIC;PRKD2;PKD2;CD81;SOX8;CHUK;FZD7;VDR;MYBL2;PSEN1;FOXC2;AGO2;JAG1;CDK9;SIRT2;TLR4;HNRNPD;ATXN7L3;BEX1;RYBP;ONECUT1;KAT2B;MED24;ATAD2B;INPP5K;RHOQ;RNF10;SATB2;BRD7;HELZ2;SQSTM1;HDAC3;NPM1;MZF1;TCERG1;MITF;PRDM15;CAMKK2;SMARCC2;IRF2BPL;CSRNP3;TOX2;SLC30A9;CEBPB;AKT1;UBTF;GLI3;DCAF6;ZNF462;TNIP1;SLC9A1;AKIRIN2;UBA52;KANSL3;JUP;EGF;CCNC;QRICH1;DR1;GDNF;ATF1;DDX17;PEG3;PIN1;MED13;BCL3;TWIST1;RAI1;SIX1;HDAC4;RFX5;PLAGL1;NME2;ZC3H12A;EAF2;KLF4;TASP1;HOXA7;MLLT11;BCL9;PTOV1;HOXC4;INO80;BCAS3;THOC1;PPP3CA;POU3F2;IL4;SMARCA4;GTF2F1;CHD8;MLXIP;FZD4;NR2C2;MAP2K2;E2F3;RNF14;CDK5RAP2;AHI1;RNF187;UBP1;USP22;PER1;HIVEP3;IL6;HGF;NCK1;OGT;STAT5B;PHF5A;E4F1;BCLAF3;PITHD1;TFAP4;PML
prerank,regulation of phosphorylation (GO:0042325),0.3490910714374775,0.9973334294346087,0.5,0.934153086301039,1.0,43/120,25.39%,AR;EGFR;GLMN;CCDC88C;ANG;MIF;NUP93;INHA;NUP107;FLCN;FZD7;NUP98;PSEN1;SIRT2;DSCAM;EIF6;EGF;CDKN1A;PIN1;FER;IL4;NOP53;NUP37;KCTD20;OGT;PML;ILK;NUP50;CORO1C;CDKN2C;SESN2;LDB2;LDB1;CCDC88A;STAT2;TPR;SDCBP;ANKLE2;ATG14;DYNLL1;NUP133;NUP85;GRM5
prerank,cell-cell junction organization (GO:0045216),0.3632946155720642,0.9973325473104662,0.4994786235662148,0.9335695949206486,1.0,13/79,8.24%,CADM3;TGFB3;PKP3;ANG;CD177;TGFB2;F2R;NECTIN3;CSK;MYADM;FSCN1;FLCN;PARD6A
prerank,regulation of neural precursor cell proliferation (GO:2000177),-0.3180336042254271,-0.9965821760552657,0.39880952380952384,0.7988606288614598,1.0,6/22,14.71%,SLC16A2;NES;PTPRZ1;APPL2;MDK;TOX
prerank,cardiac cell development (GO:0055006),0.48446804932480325,0.99649862323459,0.48667601683029454,0.9352484936331436,1.0,3/11,10.90%,VEGFA;JAG1;ALPK2
prerank,determination of bilateral symmetry (GO:0009855),-0.2989164889885236,-0.9963677158971967,0.41420118343195267,0.7975587149414941,1.0,13/24,30.03%,NOTCH1;TBX1;CITED2;BBS7;GALNT11;DNAH11;STIL;ZIC3;CFAP53;DLL1;ODAD2;ODAD3;FOXJ1
prerank,arachidonic acid metabolic process (GO:0019369),0.39443211963165886,0.9961344454181652,0.48729792147806006,0.9356785928699107,1.0,7/35,17.78%,MGLL;CYP2S1;DAGLA;GPX1;PNPLA8;DAGLB;EPHX1
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.36004858232526915,-0.9960699325448522,0.42424242424242425,0.7964501867713533,1.0,6/14,21.07%,DMD;WNK4;ATP1B1;GLRX;ACTN4;ANK3
prerank,myeloid leukocyte differentiation (GO:0002573),0.36654218044239045,0.9960253316992352,0.5032119914346895,0.9353702187470023,1.0,8/65,7.43%,VEGFA;FOXP1;TGFBR2;RUNX1;MAPK14;CDK4;FARP2;OSTM1
prerank,positive regulation of filopodium assembly (GO:0051491),0.41838714530590765,0.996022198360755,0.4870530209617756,0.9347941152767009,1.0,11/24,28.16%,TGFB3;FSCN1;PALM;RHOQ;BCAS3;ARAP1;GPM6A;RALA;DOCK11;WASL;NLGN1
prerank,positive regulation of nervous system process (GO:0031646),-0.33298677242808605,-0.9958682197884466,0.4195121951219512,0.7951086966843282,1.0,2/18,0.93%,UNC13B;TENM4
prerank,postreplication repair (GO:0006301),0.3829540317723292,0.9958334753683389,0.49500554938956715,0.9347345792694738,1.0,15/45,24.47%,UBE2B;USP10;UBE2N;ZBTB1;DTL;POLI;UBE2A;UBA52;PCLAF;RFC4;POLD1;FAAP20;REV1;POLH;WDR33
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),-0.36012363783446777,-0.9958148753715035,0.4448818897637795,0.7933873671303286,1.0,6/14,12.56%,VEGFC;FOXC1;KDR;NRP1;PIK3CD;FLT4
prerank,protein K48-linked ubiquitination (GO:0070936),0.3809482716216618,0.9956815488420706,0.5059588299024919,0.9345548899552462,1.0,23/54,26.07%,UBE2B;SYVN1;ITCH;CUL3;UBE2G2;UBE2A;CDC34;AMFR;RNF216;RNF187;HACE1;UBE2G1;ARIH2;UBE2R2;SKP2;UBE2D3;UBE2Q2;UBE3A;RNF6;IFI27;FBXO38;RNF126;UBE2K
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.3591929699115248,0.9955234544132139,0.4936708860759494,0.9344172969049589,1.0,19/80,17.66%,SYK;TRIAP1;CD44;VEGFA;F2R;CARD16;SRC;GAS6;DPEP1;YWHAE;GPX1;AKT1;SFN;KLF4;GRAMD4;HGF;HTRA2;CTSD;BCAP31
prerank,lymphocyte chemotaxis (GO:0048247),0.39402324976402114,0.9954780741709571,0.4868571428571429,0.9339481467316776,1.0,6/34,12.91%,CCL8;CXCL10;GAS6;CCL25;HSD3B7;CCL13
prerank,base-excision repair (GO:0006284),0.38169776866818356,0.9954480592873691,0.48636859323882226,0.9334474611309783,1.0,8/48,20.44%,MPG;POLB;PARG;DNA2;RFC4;ERCC5;POLD1;OGG1
prerank,lipid biosynthetic process (GO:0008610),0.3656856551848016,0.9953239941966118,0.5194123819517313,0.9332290488775234,1.0,19/77,19.73%,GPAT4;ACLY;MVK;SCP2;SRD5A1;GGPS1;NDUFAB1;AGPAT3;LPCAT1;AGPAT5;FADS1;HSD17B8;GPAM;LIPC;LIPH;SREBF1;ABCD3;MCAT;SCD5
prerank,regulation of microtubule nucleation (GO:0010968),0.49962868638432933,0.9952297198179244,0.4884979702300406,0.9329195065400037,1.0,4/10,28.23%,DCTN1;CKAP5;ARHGEF7;RANGRF
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),0.4866328857026217,0.9951361077685354,0.4894217207334274,0.9326055108969371,1.0,5/10,22.29%,JAM3;MUC1;PDE3B;SNAI2;CYP1B1
prerank,response to hydroxyurea (GO:0072710),0.4839752103676651,0.9949657022791356,0.47520661157024796,0.932507735233438,1.0,6/11,29.30%,DDX11;SPIDR;BLM;NSMCE3;KAT7;ATRX
prerank,response to ATP (GO:0033198),0.43908440394165316,0.9949571078108465,0.4791666666666667,0.9319557344020143,1.0,3/18,11.00%,DGKQ;P2RX3;SSH1
prerank,cellular response to arsenic-containing substance (GO:0071243),0.45164489534883784,0.994841078886044,0.5089285714285714,0.931693041525935,1.0,3/15,17.77%,HNRNPA1;ZC3H12A;GSTO2
prerank,serine family amino acid catabolic process (GO:0009071),-0.40486433182385895,-0.9947304906719872,0.46557377049180326,0.7944221365102178,1.0,8/10,37.12%,DLD;CBS;GCSH;THNSL2;SHMT2;SHMT1;AMT;DAO
prerank,regulation of glycolytic process (GO:0006110),-0.24593921117659875,-0.9942364791853486,0.4153846153846154,0.7939011918233377,1.0,11/68,7.79%,PRKAG2;INSR;IGF1;APP;PRKAA2;CBFA2T3;PPARA;NUP35;NDC1;RAE1;PGAM1
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.4658905415080961,0.994181810389793,0.4986111111111111,0.9329434818861959,1.0,3/12,9.97%,ITGB3;ABCA1;ITGAV
prerank,morphogenesis of an epithelium (GO:0002009),0.4191709541713042,0.9939326896468461,0.4940758293838863,0.9330586186112985,1.0,7/25,21.77%,LRP6;SOX10;SOX8;AHI1;ACTG1;KDM2B;LHX1
prerank,protein catabolic process (GO:0030163),0.3735532917139089,0.9936232494162578,0.5172786177105831,0.9333562251198636,1.0,22/59,24.39%,MTOR;NR1D1;OGA;TPP1;FBXO2;CLPX;SIAH1;FBXO17;UBE2G2;DDB1;HSP90AA1;NGLY1;SOCS6;HTRA2;IDE;CTSD;UBE2G1;LRSAM1;RNF41;USE1;TRIM24;RAB12
prerank,protein K48-linked deubiquitination (GO:0071108),0.42429991920137133,0.9935033285448893,0.5036764705882353,0.933089701175888,1.0,5/23,12.26%,OTUD3;USP33;OTUD7B;USP50;USP5
prerank,negative regulation of potassium ion transport (GO:0043267),-0.36777476089800903,-0.9934200792042632,0.41935483870967744,0.7943319372462997,1.0,3/13,6.08%,NEDD4L;ACTN2;CAV1
prerank,histone modification (GO:0016570),0.3521861052602758,0.9931923672630261,0.501532175689479,0.9333520067141158,1.0,33/109,22.80%,UBE2B;HDAC9;USP36;MRGBP;PRMT2;NTMT1;HDAC6;SIN3B;EYA2;UBE2N;MSL3;SIRT2;ATXN7L3;RCOR3;PHC1;UBE2A;HDAC4;EHMT2;USP22;UFL1;PADI2;MORF4L1;NAA50;SUDS3;TAF6L;MIER1;TRRAP;NSD1;SGF29;CARM1;EZH2;KAT6B;BAZ2A
prerank,polarized epithelial cell differentiation (GO:0030859),0.47545534337061846,0.993171375478382,0.4821192052980132,0.9328433868910591,1.0,4/13,20.69%,ZDHHC7;MYO9A;RHOA;RAB10
prerank,protein modification by small protein conjugation (GO:0032446),0.3417876210030465,0.992906635146543,0.533,0.9329967048183322,1.0,133/361,27.84%,TSPAN17;MIB2;UBE2B;NEUROD2;SPSB1;SPSB4;STX1A;NFE2L2;UBA6;UBE2J2;SMURF2;RNF212B;FBXW8;SYVN1;NUP93;ITCH;RFWD3;PIAS3;MSL2;GAN;RNF111;SPSB2;NUP107;STUB1;UBA2;MYCBP2;UBE2N;UBE2W;FBXO2;NUP98;MYLIP;CUL3;FBXL2;UBE2G2;ASB12;HECW2;CDC23;TRIM11;RNF7;UBE2A;UBA52;CDC34;USP5;BSPRY;DDB1;FBXL3;CDC27;PEX12;CUL9;CBL;AMFR;USP7;UHRF2;UFC1;TRPC4AP;KLHL41;NUP37;UVSSA;RNF14;TRIM68;SELENOS;RNF187;ZSWIM8;HACE1;RNF138;KEAP1;UFL1;UBE2G1;FBXL5;FBXO11;PEX5;VPS11;ARIH2;NUP50;UBE2R2;UFM1;NEDD8;PCNP;BRAP;UBE2D3;TRIM35;ARIH1;RNF41;CUL5;KCTD10;SAE1;PEX2;PAF1;ARRB1;ATG3;UBE2Q2;KLHL9;SMURF1;FBXO24;DERL1;RNF6;UBE2Z;FBXW11;SDE2;UBR2;TPR;LZTR1;DTX2;ATG10;TRIM24;RTF1;NSMCE2;RNF157;MKRN2;TRIM44;NUP133;MDM2;BCL11A;NUP85;UBA7;VHL;RNF20;FBXW7;UBE2K;NUP188;MUL1;OTULIN;UBE2F;NUP88;DCUN1D1;CUL7;PRKDC;URM1;BCL10;VCPIP1;DTX3;EIPR1;WWP1
prerank,purine nucleotide metabolic process (GO:0006163),0.41845798673979284,0.992822101509679,0.4946107784431138,0.9326607687083902,1.0,7/24,16.62%,GDA;GPX1;FHIT;GART;PRPSAP1;PRPS1;PRPS1L1
prerank,negative regulation of interleukin-17 production (GO:0032700),0.5010485333338431,0.9928204108181056,0.49645390070921985,0.932089274218065,1.0,5/10,36.36%,TLR4;DDIT3;PRNP;NCKAP1L;VSIR
prerank,methylguanosine-cap decapping (GO:0110156),0.4832533344061157,0.9926382155880672,0.49632892804698975,0.9320087460143988,1.0,7/10,29.69%,EDC4;PNRC2;EDC3;DCP1A;DCP1B;LSM1;PATL1
prerank,negative regulation of response to external stimulus (GO:0032102),0.35698038348836536,0.9925645654994196,0.5345717234262126,0.9316290665623949,1.0,20/105,15.97%,MAPK7;IRAK3;FGF2;PTPRS;METRNL;ITCH;MVK;NR1D1;CARD16;C1QBP;INPP5F;SIRT2;FNDC4;SIRPA;RTN4RL1;KLF4;IL4;LRFN5;SELENOS;ILRUN
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.3437171347202983,0.9922037253121593,0.5055276381909548,0.9320487639322391,1.0,27/186,11.60%,SFRP4;LRP6;DKK2;LRP1;TLE6;CCDC88C;PSMC4;GRB10;DACT3;IGFBP6;WWTR1;RBMS3;KREMEN1;AXIN1;IGFBP4;DACT1;TCF7L2;NFATC1;PSMC6;PSMD8;CUL3;TLE2;TSKU;ALPK2;ANKRD6;TPBG;GLI3
prerank,bile acid metabolic process (GO:0008206),0.4059831818686369,0.9921871326818278,0.4946236559139785,0.9315137991209558,1.0,6/27,11.50%,OSBPL3;OSBPL2;SCP2;HSD3B7;OSBPL6;GBA2
prerank,negative regulation of endothelial cell migration (GO:0010596),0.3908482641279812,0.9918715668972108,0.49257142857142855,0.9318193172950431,1.0,5/36,5.24%,DCN;ANGPT4;FGF2;SLIT2;ATP2B4
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.35140709785886065,0.9917715783199378,0.5234131113423517,0.9315364070076638,1.0,32/102,20.69%,IRS1;HDAC9;PIK3R2;ZFP36L1;SLC39A14;FOXO1;SRC;MYO5A;CRHR1;INSIG2;SYAP1;KAT2B;INPP5K;RHOQ;AKT1;TSHR;IRS2;ADCY8;PDE3B;LHCGR;FER;PKM;SELENOS;CPEB1;EPRS1;VAMP2;CAPN10;PRKAR2A;GPLD1;LPIN3;GOT1;RAB10
prerank,DNA metabolic process (GO:0006259),0.34216710976744097,0.9912995243546742,0.5395395395395396,0.9322893260150191,1.0,59/270,19.01%,MPG;PARP3;INTS3;UBE2B;GTF2H3;XRCC3;CTC1;NUDT1;RAD51B;TCF7L2;KPNA2;IGHMBP2;UBE2N;ACD;INIP;ZBTB1;FANCL;DNASE2;SAMHD1;POLB;POLE3;PARG;MCM3;SMC1A;NPM1;DDX21;POLI;ERCC3;UBE2A;UBA52;CDC34;ERCC4;RAD1;FAN1;XRCC5;DDB1;TERF1;DNA2;ORC6;DBF4;FANCG;NBN;INO80;USP7;UHRF2;GMNN;DNASE1L2;NOP53;RFC4;HMGB3;RECQL;RAD50;ERCC5;BLM;POLD1;SUPV3L1;TINF2;TOP2B;NOC3L
prerank,mitotic metaphase plate congression (GO:0007080),0.37717242408701823,0.9912840574952251,0.4856194690265487,0.9317674811241476,1.0,13/51,22.88%,CHAMP1;ZW10;CHMP7;PSRC1;VPS4B;CUL3;CDC23;PIBF1;CENPC;CENPE;PDCD6IP;DCTN2;RMDN1
prerank,regulation of dephosphorylation (GO:0035303),0.448623172372275,0.9910249973377033,0.49076517150395776,0.9318756393576517,1.0,5/15,15.54%,SRC;INPP5K;SMG7;SMG6;MTMR1
prerank,positive regulation of dendritic spine development (GO:0060999),0.4342901935310477,0.9899993219777694,0.494910941475827,0.9340376735957527,1.0,3/20,13.87%,DBN1;PSEN1;LLPH
prerank,myeloid cell differentiation (GO:0030099),-0.2682685005439501,-0.9899295409747451,0.45132743362831856,0.8017911801735259,1.0,21/47,26.61%,LYN;KMT2E;KIT;HSPA9;CASP3;PRDX3;RPS14;INHBA;PTPN2;TAL1;HIPK2;SNRK;ACIN1;UBA5;SPI1;JAK3;RASGRP4;KAT8;ALAS2;CEBPA;HCLS1
prerank,negative regulation of DNA replication (GO:0008156),0.4591798145193831,0.9897584972465597,0.4879356568364611,0.9340822789116662,1.0,3/13,14.84%,GTPBP4;TERF1;GMNN
prerank,regulation of establishment of protein localization (GO:0070201),0.46660877575779824,0.9897584961223403,0.5125164690382081,0.9335081656486596,1.0,4/13,17.20%,CORO2B;SCFD1;SPIDR;CTSD
prerank,regulation of nucleocytoplasmic transport (GO:0046822),-0.3753944444472215,-0.98975335478666,0.43333333333333335,0.8004479953287399,1.0,4/12,14.87%,PTPN14;KHDRBS1;TGFB1;NUP214
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.4163458208399428,0.989504973555273,0.49515738498789347,0.9336471539702718,1.0,7/26,14.60%,TMEM106A;KLF2;PKD2;TLR4;AKT1;KLF4;HSP90AA1
prerank,defense response to Gram-negative bacterium (GO:0050829),0.3807463096339579,0.9892761367955863,0.5005675368898979,0.933691916869781,1.0,5/42,16.30%,LBP;TLR4;DMBT1;RNASE6;IL6
prerank,regulation of interferon-alpha production (GO:0032647),0.41806973445942713,0.9889193187896049,0.5062344139650873,0.9340364636236381,1.0,4/23,11.81%,PTPRS;CHUK;TLR4;SETD2
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.45962910163877796,0.9885813777441963,0.5060402684563758,0.9343770205592197,1.0,5/13,19.48%,ABT1;KRI1;NOP9;RCL1;TBL3
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.3790996722107404,0.9884421677977556,0.5110375275938189,0.934199621401033,1.0,17/49,24.14%,EIF2AK3;S100A8;S100A9;SRC;NOC2L;SIAH1;HERPUD1;URI1;BMF;BBC3;NUPR1;BCAP31;PLAUR;MCL1;PYCARD;CYLD;FIS1
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.33564788081404145,0.9882015481140165,0.571,0.9342718461285192,1.0,302/1668,16.94%,LMX1A;EBF2;DCN;PRRX1;LIF;AR;LRP6;LHX8;ESR1;HOXA3;PAX9;EBF1;LOXL2;TRPS1;SP9;FOXP2;NFIX;IRF4;WNT2;EGFR;CREB5;TGFB3;WT1;ZFHX4;MEOX2;TRIAP1;TLE6;TBX15;SCRT2;ZNF367;HSF2;TADA1;CCNL2;SIX4;HOXA2;ELF4;HIVEP2;NEUROD2;MAPK7;SKIL;GTF2H3;ZMIZ1;DGKQ;VEGFA;KLF3;TSHZ2;FGF2;PBX1;KLF12;FOXP1;BHLHE40;TLX3;GLIS2;RUNX1;TEF;CRTC2;SMAD4;NFE2L2;HDAC9;ZNF25;PIK3R2;ATF5;WWTR1;DPF2;LMX1B;AKNA;MEF2D;SMURF2;SKI;MAPK14;PKD1;PAX1;COPS5;SOX10;ACVR1;CDK4;IRX5;HOPX;DACT1;RFX1;FOXK2;KLF2;TCF25;JUND;ZBTB12;NFATC4;MED13L;MAFF;TCF7L2;MRGBP;NR1D2;ATP2B4;NFATC1;CBX4;RBAK;HOXA5;CAMK2D;CREB3L1;SMARCD2;MEIS2;FOXO1;IL33;AKIRIN1;NR1D1;PIAS3;NFIB;RTRAF;EBF3;ZBTB7C;CXCL10;NCOA3;CREBZF;MUC1;SSBP3;NFIA;RNF111;ZFHX3;DPF1;C1QBP;ARF4;MDM4;MLXIPL;SMAD5;ACTR3;MYT1;MTF1;HOXA4;SIN3B;PID1;SMARCD1;ADCYAP1;GLI2;ZFPM2;TBX6;NOC2L;BRD9;RNF2;MAMSTR;FLCN;FOXL1;PRKD2;PKD2;ETV3;CD81;STAT5A;SOX8;CHUK;ZBTB1;WDR77;VDR;NR6A1;MYBL2;ZNF260;KDM3B;PSEN1;FOXC2;AGO2;JAG1;CDK9;SIRT2;TLR4;ATXN7L3;SOX5;BEX1;RCOR3;ELP4;ONECUT1;KAT2B;MED24;ATAD2B;RHOQ;SMAD6;RNF10;SATB2;BRD7;HELZ2;ZMYM5;MYPOP;OTUD7B;SQSTM1;ZNF3;CHD2;HDAC3;NPM1;URI1;MZF1;TAF3;TCERG1;MITF;PRDM15;ATF7;SMARCC2;IRF2BPL;CSRNP3;BCL6;ZHX2;TOX2;SLC30A9;CEBPB;GLI3;DCAF6;ZNF462;TNIP1;SLC9A1;AKIRIN2;UBA52;KANSL3;JUP;ZFP36;BACH2;LIN9;CCNC;KDM5B;ZNF691;DR1;ZNF112;NCOR2;GDNF;ATF1;DDX17;PEG3;CDKN1A;PIN1;MED13;NCOR1;IKZF5;PROX2;CCND1;CRYM;TWIST1;BRIP1;RAI1;SIX1;DNAJA3;NACC2;HDAC4;RFX5;PLAGL1;EZH1;NME2;ZC3H12A;CCNH;EHMT2;ZNF569;PLAGL2;DMAP1;EAF2;KLF4;HOXA7;BCL9;CTDP1;PTOV1;HOXC4;INO80;BCAS3;HOXA9;HSBP1;PPP3CA;POU3F2;IL4;ZNF692;SMARCA4;GTF2F1;CHD8;CCNQ;MLXIP;DDX20;NFE2L3;NR2C2;YEATS2;NOP53;SRCAP;E2F3;PPIL4;HMGB3;RNF14;AHI1;ZFP28;ZBTB25;MED15;ZBTB5;PSIP1;UBP1;PER1;HIVEP3;IL6;HGF;BAZ2B;NCK1;OGT;STAT5B;ANXA4;CHD1;DDX5;SNAI2;CHD3;E4F1;BCLAF3;TFAP4;ZEB1;SAP18;AGO4
prerank,homotypic cell-cell adhesion (GO:0034109),0.3866628004588887,0.9879035038334387,0.5028312570781427,0.9345143060081804,1.0,12/39,21.28%,GNAS;ITGB3;PLPP3;DSC2;PDGFRA;ACTG1;PPIA;ILK;FLNA;TYRO3;METAP1;PIK3CG
prerank,peptidyl-threonine dephosphorylation (GO:0035970),-0.31687076223421634,-0.9876789364971282,0.46511627906976744,0.8042023110004765,1.0,7/22,18.25%,PPM1E;PPM1D;DUSP10;PPM1F;DUSP7;DUSP6;PPP2CA
prerank,defense response to tumor cell (GO:0002357),0.4836605765190086,0.9876425283385434,0.5007112375533428,0.9346912284230571,1.0,3/10,14.33%,RBMS3;DLEC1;KLF4
prerank,rRNA pseudouridine synthesis (GO:0031118),0.4894491868713677,0.9875235353545233,0.5064194008559201,0.9344387934274551,1.0,2/10,9.46%,RPUSD1;GAR1
prerank,melanosome organization (GO:0032438),0.40613723895153325,0.987388594682676,0.4964200477326969,0.9342151008086338,1.0,7/26,16.19%,RAB32;AP1M1;DTNBP1;AP3D1;HPS4;BLOC1S2;SNAPIN
prerank,regulation of defense response to virus by host (GO:0050691),0.40434394591500883,0.9873722697955455,0.5036319612590799,0.9336862028031531,1.0,7/30,15.18%,TARBP2;CGAS;TRAF3IP2;ZC3H12A;HSP90AA1;IL4;RNF216
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.44865126676469447,0.9873568561502545,0.48673740053050396,0.9331544002802297,1.0,3/16,12.04%,PRKCA;CAMK2D;SLC9A1
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),-0.3738186227026163,-0.9870428316136443,0.46688741721854304,0.804087119105968,1.0,4/11,10.97%,WTIP;PUM2;XPO5;AJUBA
prerank,tRNA wobble base modification (GO:0002097),-0.3626258608466447,-0.9869869121710618,0.46494464944649444,0.8023768826399554,1.0,2/14,3.45%,ELP3;TRMT9B
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.3513604544710128,-0.9868508366770485,0.46218487394957986,0.8009363353506452,1.0,8/15,26.63%,TNK2;PIK3CB;HIP1R;DAB2;NEU3;SCYL2;AAK1;SMAP1
prerank,negative regulation of developmental growth (GO:0048640),0.4030810835007582,0.9866994191207094,0.5052631578947369,0.9343545453510647,1.0,8/30,14.33%,FGF13;PTPRS;TRIM46;SLC6A4;ULK2;CDKN1A;ULK1;DCC
prerank,insulin receptor signaling pathway (GO:0008286),0.36355564695658665,0.986281901827977,0.5043103448275862,0.9349108864457298,1.0,19/69,16.89%,IRS1;GRB10;PIK3R2;ATP6V0A2;SLC39A14;FOXO1;PIK3CA;FOXC2;RHOQ;AKT1;ATP6V1E1;IRS2;ATP6AP1;FER;ATP6V0A1;ATP6V1D;ATP6V1B2;SOS1;IDE
prerank,cellular response to UV-A (GO:0071492),0.4701774984295982,0.9861354189972615,0.512396694214876,0.9347525502247401,1.0,1/11,2.85%,MMP2
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.38880572206875796,0.9857739054817155,0.5051546391752577,0.9351462540349935,1.0,9/39,11.31%,MAPK7;VEGFA;AKNA;GTPBP4;MIA3;MYADM;FXYD5;JAG1;AKT1
prerank,positive regulation of apoptotic process (GO:0043065),0.3388271081301726,0.9855091430467883,0.5475475475475475,0.935268146968154,1.0,77/293,22.57%,SFRP4;WNT10B;KCNMA1;SCIN;TGFB3;AKAP13;FAP;GADD45G;RPS6KA2;TGFB2;SLIT2;BIN1;TRIO;ADAMTSL4;MTCH1;HOXA5;FOXO1;PRMT2;RASSF2;C1QBP;ARHGEF3;PIP5KL1;AIFM2;FLCN;SIAH1;PSEN1;SIRT2;PDCD2;RYBP;ING4;TIAM2;SQSTM1;CSRNP3;BCL6;BMF;ERCC3;UBA52;BAK1;NGEF;QRICH1;DIABLO;ZC3H12A;STK3;MLLT11;MTCH2;CALHM2;NUPR1;DDX20;HRK;NLRP2B;IL6;SOS1;HTRA2;TFAP4;PTRH2;SAP18;CTSD;EEF1E1;IAPP;TGFBR1;SMPD1;SUDS3;APAF1;CLIP3;GPLD1;TRIM35;BACE1;ATF6;TIAM1;PYCARD;BTG1;JUN;NF1;ATF4;CYP1B1;UBE2Z;RBM5
prerank,regulation of ceramide biosynthetic process (GO:2000303),0.44809087785386403,0.9850772285206703,0.510840108401084,0.9358691498573392,1.0,2/15,9.13%,SMPD3;ORMDL2
prerank,cellular response to organic cyclic compound (GO:0071407),0.3477547382566135,0.9848403014272501,0.5227963525835866,0.9359268288880174,1.0,32/141,19.27%,IGFBP5;AR;ESR1;EGFR;WT1;ATP1A3;ATP1A1;P2RX3;ZFP36L1;RAP1B;NCOA3;PKD2;INPP5K;HCN4;URI1;SSH1;SLC26A6;JUP;LARP1;ADCY8;EPG5;GNB1;ZC3H12A;RAPGEF1;DIAPH1;SPIDR;AKAP9;IL18;BLM;NRIP1;HCN1;GABRG2
prerank,positive regulation of cell population proliferation (GO:0008284),0.3367423175991526,0.9843828189276128,0.566,0.9366038318973088,1.0,67/423,14.21%,LIF;DDR2;AREG;AR;HAS2;AVPR1A;FGF18;FGF7;DPP4;WNT2;EGFR;TGFB3;IRS1;FGFR1;TMEM119;CTF1;BTC;VEGFA;FGF2;TGFB2;MST1R;FOXP1;F2R;TGFBR2;MIF;TIPIN;WWTR1;CDK4;CLCF1;TCF7L2;MEIS2;GLP2R;MLXIPL;S1PR2;PID1;ESM1;ZFPM2;TBX6;GAS6;FLT3LG;S100A6;DNAJA2;CD81;SOX8;CAPN1;WDR77;CUL3;STX4;ITGAV;CD47;NPM1;KRAS;AKT1;KIF20B;FBXO5;TSHR;UBE2A;IRS2;EGF;GDNF;FLT3;CDKN1A;HDAC4;NME2;CDC123;PDGFRA;FER
prerank,negative regulation of cyclase activity (GO:0031280),0.4617908990277142,0.9842195608376798,0.5033288948069241,0.9364850574520102,1.0,3/14,9.26%,GNAI3;PALM;LTB4R2
prerank,positive regulation of endopeptidase activity (GO:0010950),-0.30212139280468076,-0.9840802069154163,0.48502994011976047,0.8067074803549498,1.0,6/26,13.86%,LYN;EPHA4;AIM2;TTBK1;PSME2;PSME1
prerank,positive regulation of interferon-beta production (GO:0032728),-0.2795493329994144,-0.9839387666077085,0.5034013605442177,0.8051898997637298,1.0,7/33,10.03%,TRIM56;POLR3C;MAVS;POLR3B;TLR3;OAS2;RNF135
prerank,negative regulation of DNA binding (GO:0043392),-0.3016271144199224,-0.9835109839695823,0.47023809523809523,0.8044855071929699,1.0,2/28,0.77%,LEF1;SP100
prerank,central nervous system development (GO:0007417),0.3396712816514684,0.983220940234413,0.5245245245245245,0.9386122415042458,1.0,65/250,23.09%,GSN;DCLK1;SCIN;AFF2;VIT;UGP2;PBX1;TGFBR2;GLIS2;ZPR1;PKD1;ACAN;SOX10;VCAN;MARCKS;MEIS2;ALDH3A2;JRKL;NFIB;GRIN2D;ZFHX3;MTF1;ADAM22;TBX6;PKD2;TPP1;SOX8;NDRG4;SH3GL1;EEF1AKMT4-ECE2;GBA2;TBC1D23;HSPG2;KLK6;SLC23A1;ASIC2;MOG;SH3GL3;MDGA1;UFC1;CHD8;ALDH5A1;CDK5RAP2;AHI1;GRIN2A;CXCR4;QARS1;BTD;CNTN4;MBP;UFM1;EML1;NIPBL;SNTG2;COX7B;ITGAM;PITPNM1;PTEN;NF1;DCX;UBE3A;MAP1S;ECRG4;ANKLE2;NPTX1
prerank,regulation of isotype switching (GO:0045191),0.4561127371087527,0.9827054237016303,0.5149456521739131,0.9394327251392941,1.0,4/14,14.83%,PARP3;HMCES;SLC15A4;IL4
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.4649970531510261,0.9825229316929428,0.5041899441340782,0.9393288989055198,1.0,4/12,22.88%,CHAMP1;CENPC;CENPE;RMDN1
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.38252682988193076,0.9824129114298759,0.5145739910313901,0.9390467517157786,1.0,12/40,20.60%,EME1;TIPIN;RFWD3;ETAA1;CDK9;DDX11;THOC1;FAM111A;BLM;POLD1;SMARCAL1;DONSON
prerank,pre-miRNA processing (GO:0031054),0.45794817859573783,0.9823718218916487,0.4993103448275862,0.9385842606397222,1.0,4/14,19.45%,TARBP2;AGO2;AGO4;AGO3
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.4770542084039387,0.9823564558886521,0.5335195530726257,0.9380543196524744,1.0,6/11,27.89%,MPHOSPH8;TPR;SETDB1;SETDB2;TASOR;ATF7IP
prerank,positive regulation of potassium ion transport (GO:0043268),0.39125394417747006,0.9821771466866225,0.5,0.9379949361649156,1.0,4/38,5.51%,KCNMA1;FHL1;ANK2;KCNJ2
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.3409208189882838,0.9818658939065695,0.5541082164328658,0.9382664758011746,1.0,40/234,17.22%,DDR2;AR;LRP6;ESR1;WNT2;RAB7B;NEUROD2;VEGFA;IRAK3;S100A8;S100A9;CRTC2;MID2;PLPP3;COPS5;CARD16;DHX33;UBE2N;PRKD2;CHUK;TIRAP;TLR4;BEX1;NPM1;AKT1;IRAK1;UBA52;JUP;ADCY8;HDAC4;FER;STK3;SMARCA4;EDA;FZD4;TRIM68;RBCK1;IL6;FLOT2;PPIA
prerank,replication fork processing (GO:0031297),0.38695492103537527,0.9817478409785091,0.5284738041002278,0.938031468659925,1.0,11/38,19.59%,EME1;RFWD3;ETAA1;CDK9;SAMHD1;DNA2;DDX11;THOC1;FAM111A;BLM;SMARCAL1
prerank,neuron development (GO:0048666),0.34683042853142365,0.981655997111732,0.5288753799392097,0.9377195419843488,1.0,38/141,18.29%,MYOC;UGDH;TGFB2;PBX1;RUNX1;RASGRF1;UNC5A;TENM3;DOCK7;DTNBP1;LRP12;ADCYAP1;GLI2;TOR1A;PLP1;L1CAM;CAMSAP1;MAPT;GBA2;TBC1D23;UNK;FLRT3;LGI1;GDNF;ULK1;THOC2;ATCAY;BLOC1S2;POU3F2;MANF;MAP4;SNAPIN;IL6;RAB35;PPP1R9B;STX3;CNTN4;GPM6A
prerank,post-translational protein modification (GO:0043687),0.3393616955329725,0.9814937201665033,0.551,0.9375775018015452,1.0,101/332,27.77%,IGFBP5;FSTL1;FBN1;WSB1;RABGGTA;GPC3;PSMC4;PRSS23;SPSB1;SPSB4;COPS5;BMP15;IGFBP4;FBXW8;CALU;VCAN;MIA3;SOCS2;CCDC8;WDTC1;COP1;TULP4;GAN;PSMC6;SPSB2;MELTF;GAS6;FBXO2;PSMD8;FBXO17;CUL3;DTL;SENP8;ASB12;FBXW4;LGALS1;FBXL20;WDR5;RAB2A;RNF7;DCAF6;FBXO31;DDB1;FBXL3;DCAF13;ASB8;CUL9;KLHL41;MXRA8;SOCS6;DCAF10;IL6;SDC2;KEAP1;CHRDL1;RAB1B;FBXL5;FBXO11;COPS4;NEDD8;SKP2;LAMC1;KCTD6;FBXL19;FBXW9;FBXW2;QSOX1;CUL5;PRKCSH;ICMT;CSF1;KLHL9;SUMF2;FBXW11;KLHL22;SPSB3;DCAF5;KLHL11;PSMD3;GPS1;FBXL12;PSMD4;DNAJC3;RABGGTB;SERPINC1;HSP90B1;VHL;FBXO22;RAB1A;FBXW7;FBXO30;PSMB3;UBE2F;MBTPS1;DCUN1D1;CUL7;MEN1;FBXO41;PSMB2;COPS6;CHML
prerank,mitotic spindle organization (GO:0007052),0.3443102603908551,0.9811716735769246,0.5442522889114955,0.9378889460926034,1.0,37/153,20.62%,GPSM2;DYNC1LI2;CLIP1;NDEL1;ZW10;KIFC2;AHCTF1;CENPT;NUP107;TOGARAM1;ZWINT;DYNC1LI1;NUP98;DYNC1I1;KIF2A;ARHGEF10;SMC1A;MAPRE1;PIBF1;SBDS;ABRAXAS1;RHOA;KIF3B;DYNC1H1;NUP37;MAP4;CENPC;PPP1CC;RCC2;CKAP5;CENPE;EML1;PAFAH1B1;WDR62;STAG2;FLNA;CLASP2
prerank,positive regulation of phosphatase activity (GO:0010922),-0.3129206130356496,-0.9811448379208106,0.46875,0.809145136492072,1.0,6/21,13.50%,ITGA1;MEF2C;PDGFRB;PPP1R15B;BMP2;CD300A
prerank,nuclear body organization (GO:0030575),0.46160671915287615,0.9811443223928169,0.49863387978142076,0.9374001888516263,1.0,4/12,16.87%,AFF2;ZPR1;USP50;PML
prerank,glycerolipid catabolic process (GO:0046503),0.42581786300917773,0.9810645450353132,0.4968632371392723,0.9370462164190981,1.0,1/19,0.62%,MGLL
prerank,cholesterol transport (GO:0030301),0.38502765411789214,0.9810244508329177,0.5341409691629956,0.9365952898427055,1.0,7/45,10.41%,CEL;ABCG4;OSBPL2;ABCA1;LCAT;TSKU;STX12
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.36031147417458165,0.9809290300786474,0.5147864184008762,0.9362830199412502,1.0,11/65,14.21%,AREG;EGFR;BTC;DOK1;PTPRJ;RHBDF1;MVB12A;AKT1;EGF;CBL;FER
prerank,isotype switching (GO:0045190),-0.3932336897223243,-0.9806361285286763,0.4950166112956811,0.8086466765692502,1.0,4/10,23.08%,MSH2;BATF;RNF8;LIG4
prerank,determination of left/right symmetry (GO:0007368),-0.2720775007536347,-0.9800105758920186,0.49074074074074076,0.8085365009995397,1.0,21/36,36.24%,NOTCH1;TBX1;CITED2;BBS7;GALNT11;DNAH11;ENKUR;STIL;ZIC3;CFAP53;DLL1;ODAD2;ODAD3;FOXJ1;MEGF8;ODAD4;SHH;OFD1;CCDC40;LEFTY1;DNAAF4
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),0.4344980726634271,0.9799412231386622,0.5329949238578681,0.938222731563796,1.0,10/18,31.31%,DLG4;STX1B;CHRNA7;RIMS2;PTEN;PRKCZ;NLGN1;NLGN3;NRXN1;NLGN2
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.35974309030194007,-0.97979270858851,0.4977973568281938,0.8072922359135274,1.0,2/14,1.20%,ATP1B3;ACTN2
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.357161124192737,0.9797211226249796,0.5368983957219251,0.9382882005232235,1.0,15/75,12.38%,PRKCA;FGFR1;ANG;ITGB3;VEGFA;FGF2;ECM1;THBS4;PRKD2;STAT5A;AKT3;EMC10;NRAS;AKT1;EGF
prerank,regulation of cell adhesion (GO:0030155),0.34683765954842727,0.9795957546610891,0.5497967479674797,0.9380598255336478,1.0,24/129,10.56%,EPHB2;PRKCA;EFNA5;VEGFA;FUT2;DACT2;MIA3;PTPRJ;ZFHX3;MYADM;C1QBP;RET;SRC;TGFBI;ADAM22;ABL2;FLCN;PRKD2;TNFRSF18;STX4;PLXNA3;ITGAV;EPHB3;DSCAM
prerank,maintenance of protein localization in organelle (GO:0072595),0.42875608912927526,0.979417009365477,0.5063613231552163,0.9379962506468028,1.0,6/19,16.87%,TAF8;TAF3;AKT1;BCL3;BBS4;PML
prerank,chemical synaptic transmission (GO:0007268),0.33533149031315346,0.9788899559213797,0.573,0.9388257744370181,1.0,67/284,23.09%,LRP6;LPAR3;SNCB;MTNR1B;APBA3;PMP22;CEL;RPS6KA2;CAMKK1;STX1A;APBA1;DLG4;SLC1A6;GABRR3;DLG2;GRIN2D;SLC18A3;RIT2;HTR1F;ERC2;SLC12A4;GRIA2;PLP1;CAMKK2;NAPA;FCHSD1;HCRT;SLC12A5;SNAP25;NSG1;ASIC2;DLGAP1;GABRG3;GAD2;CACNB1;GIPC1;GRID1;SNAPIN;GRIN2A;GRM1;CHRNA7;CHRFAM7A;SNPH;SYT1;AKAP9;CHRNA5;SYNJ2BP;HTR2C;VAMP2;MBP;PAFAH1B1;PRKAR2A;GABRG2;GRIA3;NOVA1;EXOC4;SLC12A6;STAC3;MAPK1;PTEN;SHISA6;NAPB;SDCBP;HTR2A;GRIK5;GRIK2;NPTX1
prerank,microvillus organization (GO:0032528),-0.37162654052925015,-0.978676950501448,0.4457831325301205,0.8082423541023501,1.0,3/13,5.73%,RAPGEF2;TNIK;MAP4K4
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.3510085937745852,0.9786227721908956,0.5303186022610483,0.9389818904626539,1.0,27/100,21.28%,DCN;MYOC;EGFR;FGFR1;FGF2;TGFB2;F2R;SRC;PIK3CA;FBXL2;PIK3IP1;IRS2;EGF;FLT3;TWIST1;CBL;PDGFRA;NOP53;HGF;PPP2R5B;PIP4K2C;IL18;DIPK2A;PIP4K2B;MAPK1;PTEN;PIK3CG
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.45494031673355256,0.9783936807816912,0.5041095890410959,0.9390490304951137,1.0,1/13,0.51%,TNMD
prerank,microvillus assembly (GO:0030033),-0.36054146310024454,-0.9782972152888731,0.4495798319327731,0.80747067401415,1.0,3/14,5.73%,RAPGEF2;TNIK;MAP4K4
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.3502042101807284,0.9781130492713533,0.5322415557830092,0.9392518041542652,1.0,32/100,25.85%,GLMN;DESI1;RAD23B;COP1;UCHL5;STUB1;SIRT2;RYBP;HERPUD1;DNAJB2;USP5;FHIT;USP7;GIPC1;NOP53;RNF14;ZER1;OGT;KEAP1;UFL1;ARIH2;RNF19A;ARIH1;MAP1A;SDCBP;ZYG11B;BAG5;UBQLN4;DVL1;MDM2;FBXO22;CSNK1E
prerank,regulation of gene expression (GO:0010468),0.3330908253243616,0.9778639202309963,0.613,0.9393911560167648,1.0,156/903,16.98%,CD34;SFRP4;AHNAK2;AR;GSN;EPHB2;AMH;ESR1;AHNAK;FGF18;SEC16B;AFF3;FGF7;C1QTNF1;BNC2;C1D;WT1;HPN;AFF2;MBNL1;TMEM119;PKP3;GLMN;SCRT2;EIF2AK3;PRDM8;ANK2;DGKQ;VEGFA;FGF2;TGFB2;MLF2;FOXP1;CAMK2N1;BHLHE40;RUNX1;MIF;ZPR1;NFE2L2;ATF5;WWTR1;CRIP1;LMX1B;RBMS3;MAPK14;USP36;CXXC1;ZFP36L1;CDK4;ADAM19;FOXK2;NAB1;MTOR;COQ7;CLK1;NR1D2;ATP2B4;TRIM71;SPIN4;RBAK;HOXA5;CREB3L1;DTNBP1;IL33;IGSF1;NFIA;TARDBP;ZFHX3;MYADM;TRIP4;MLXIPL;RC3H1;HDAC6;MYT1;NUP107;STX1B;PID1;GAS6;FLCN;PHF1;MSL3;SPTY2D1;FZD7;LARP4;VDR;MYBL2;PSEN1;AGO2;TLR4;HNRNPD;TDRD7;RYBP;ONECUT1;MAPK11;TSKU;SIRPA;MBNL2;SON;MUSK;CPSF4;HNRNPH1;MZF1;TRIM11;MITF;ALPK2;ACTR5;ATF7;GPX1;PARP14;BCL6;CEBPB;KRAS;AKT1;MAPT;SLC2A10;PUM1;LRRC19;ZNF462;IGF2BP1;NAT8;EGF;NDFIP1;LARP1;SMCR8;NWD1;GDNF;PEG3;PIN1;TWIST1;SIX1;HDAC4;SLC8A2;ZC3H12A;FADS1;KLF4;MOG;IL4;BTN3A3;NR2C2;RPL6;MAP2K2;RNF14;TRIM68;ACTG1;RNF187;TRAF3;PER1;IL6;DIP2A;SNAI2;CHD3;EFEMP1;PML;PTRH2;AGO4;FLOT2
prerank,regulation of focal adhesion assembly (GO:0051893),0.3679126031180496,0.9770758645186718,0.5215469613259669,0.9409385739207163,1.0,16/54,21.11%,MYOC;EFNA5;EPHA3;VEGFA;S100A10;PTPRJ;SRC;SLK;SLC9A1;RHOA;BCAS3;ACTG1;RCC2;CLASP2;CORO1C;PTEN
prerank,cell cycle G1/S phase transition (GO:0044843),0.36045644495213613,0.9768838997184633,0.5152173913043478,0.940858493745546,1.0,14/61,15.63%,ACVR1;CDK4;TRIM71;USP29;BCAT1;CUL3;USP26;CDC34;CDKN1A;CCND1;CCNH;DBF4;GSPT1;E2F3
prerank,vesicle transport along actin filament (GO:0030050),-0.3245452998397676,-0.9767175855316859,0.5042735042735043,0.8098247335086434,1.0,5/19,13.52%,MYO1B;FNBP1L;MYO1D;MYO5B;MYO19
prerank,long-chain fatty acid metabolic process (GO:0001676),0.36268020227797193,0.9766115554258327,0.5220667384284177,0.9410440818985301,1.0,17/64,22.29%,MGLL;DAGLA;SCP2;SLC27A3;GPX1;GSTM2;PNPLA8;ELOVL5;ACOT1;FADS1;DAGLB;ACAD9;ACOX1;EPHX1;HSD17B4;CPT2;CYP1B1
prerank,entry into host (GO:0044409),0.45707575089592667,0.9763758446725048,0.5205479452054794,0.9411016565969431,1.0,5/13,17.22%,SRC;ITGAV;CBL;CXCR4;PPIA
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.36314657144185286,0.9762416711635755,0.5303514376996805,0.9408956401410149,1.0,17/72,18.45%,POLR2H;GTF2H3;COPS5;ERCC3;UBA52;ERCC4;POLR2D;POLR2G;DDB1;AQR;CCNH;USP7;UVSSA;RFC4;ERCC5;POLD1;COPS4
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.421268944058916,0.9762049094636721,0.5063451776649747,0.9404305464022443,1.0,6/19,21.08%,PAPSS2;BPNT2;SULT4A1;SLC26A1;ABHD14B;TPST2
prerank,protein acylation (GO:0043543),0.37996356946382465,0.9761004971223535,0.5351473922902494,0.9401264713690909,1.0,13/38,23.21%,ZDHHC16;ZDHHC7;FOXO1;KAT2B;ING4;HHAT;SELENOK;ZDHHC2;ZDHHC21;ZDHHC20;ZDHHC18;ZDHHC8;ZDHHC5
prerank,regulation of response to external stimulus (GO:0032101),0.3471890583978446,0.9759640133878049,0.5507692307692308,0.9399444774604131,1.0,21/121,17.00%,EPHB2;CD55;MGLL;ANXA1;FOXP1;F2R;AKNA;SPATA2;NR1D2;TIRAP;CNGB1;SAMHD1;BCL6;SAG;LRRC19;PDGFRA;STK24;DAGLB;TRAF3;UFL1;CXCR4
prerank,central nervous system neuron development (GO:0021954),0.44875794982740447,0.9758994343586843,0.5142083897158322,0.9395395844027329,1.0,4/15,14.60%,LHX8;MAPT;GBA2;HSP90AA1
prerank,activation of protein kinase activity (GO:0032147),0.35002894977891724,0.9758644323176751,0.5454545454545454,0.9390804350771987,1.0,20/106,14.83%,GHR;ANG;ITGB3;VEGFA;TGFB2;TGFBR2;TAOK3;AXIN1;MTOR;GAS6;STRADA;TIRAP;CALCA;AKT1;IRAK1;PIBF1;ADCY8;TAOK2;STK3;IL4
prerank,regulation of membrane depolarization (GO:0003254),0.42865493912044256,0.9757674640526899,0.49873417721518987,0.9387698222636957,1.0,3/18,10.05%,FHL1;CAMK2D;HCN4
prerank,ureteric bud development (GO:0001657),0.43628818945064585,0.9756280233418976,0.5203145478374837,0.9385741025336375,1.0,4/17,7.86%,WT1;GPC3;SLIT2;PKD2
prerank,regulation of neuroblast proliferation (GO:1902692),-0.34811317794181895,-0.9755990407874092,0.48863636363636365,0.8110128744218331,1.0,5/15,16.62%,PTN;CX3CL1;SMARCD3;CTNNB1;DISC1
prerank,motor neuron axon guidance (GO:0008045),0.4476969124088453,0.9750839830141501,0.503968253968254,0.9394110238984744,1.0,4/15,8.25%,SLIT2;SLIT1;NTN1;SEMA3A
prerank,regulation of cell size (GO:0008361),0.4149507760458251,0.9750170011044185,0.532043530834341,0.9390317894178833,1.0,8/23,25.84%,RAP1GAP2;MTOR;DEPTOR;RHOA;PTEN;VAV2;RAC1;RARG
prerank,phagosome-lysosome fusion (GO:0090385),0.4928453776608575,0.9750092221375192,0.5246376811594203,0.9384978955560537,1.0,1/10,2.11%,RAB7B
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.4109027127147495,0.9749393984690422,0.5296343001261034,0.9381374490058865,1.0,5/20,14.67%,TMBIM1;PID1;CLTC;RHOQ;PPFIA1
prerank,cellular response to DNA damage stimulus (GO:0006974),0.33860498545433493,0.9746865201871996,0.585,0.9382519590179643,1.0,73/336,17.49%,PARP3;MAPK12;INTS3;ZDHHC16;UBE2B;GTF2H3;XRCC3;FOXP1;CDKN2AIP;CRIP1;UBA6;TAOK3;MAPK14;NUDT1;RAD51B;RFWD3;USP10;FOXO1;RBBP6;ETAA1;ALKBH7;IGHMBP2;CGAS;PHF1;HMCES;INIP;ZBTB1;TIGAR;FANCL;PSEN1;SETD7;DTL;SAMHD1;POLB;POLE3;SMC5;DYRK2;SMC1A;NPM1;BCL6;POLI;FBXO31;ERCC3;UBE2A;BAK1;ERCC4;RAD1;FAN1;XRCC5;SFN;PCLAF;TAOK2;CDKN1A;BCL3;DDB1;CCND1;SMC6;TNFRSF1B;DDX11;ZC3H12A;FANCG;NBN;INO80;FAM111A;NOP53;RFC4;RECQL;HTRA2;SPIDR;UFL1;PML;RAD50;NEK4
prerank,V(D)J recombination (GO:0033151),-0.38616033604821265,-0.9745041824187848,0.47896440129449835,0.8119306530428753,1.0,1/11,2.72%,HMGB1
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),-0.3263452352179813,-0.9741884658039953,0.4698275862068966,0.811044664541718,1.0,4/20,4.66%,NEDD4L;ACTN2;OSR1;PRKCE
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.3453776326173039,0.9740507907832151,0.5480283114256825,0.9394599171051687,1.0,27/138,15.63%,AR;ESR1;POLR2H;GTF2H3;HDAC9;HDAC7;WWTR1;TAF8;NR1D2;NR1D1;VDR;NR6A1;CDK9;KAT2B;HDAC3;TAF3;ERCC3;POLR2D;DR1;POLR2G;NCOR2;NCOR1;GTF2A2;CCNH;GTF2F1;NR2C2;E2F3
prerank,regulation of sodium ion transport (GO:0002028),-0.27538904007855575,-0.9739975311000761,0.4896551724137931,0.8097656046088684,1.0,10/34,12.41%,WNK4;YWHAH;AHCYL1;DLG1;GPD1L;SIK1;NKAIN4;NKAIN3;NOS1;NKAIN1
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.4182773777948508,0.9739947494841468,0.5135135135135135,0.939046814162116,1.0,7/20,22.52%,ZFP36L1;HOXA5;MEIS2;ZFP36;HOXA9;PAF1;LDB1
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.34261121594829497,0.9737103014390982,0.558282208588957,0.9392058337564669,1.0,35/125,24.90%,GPSM2;DYNC1LI2;CLIP1;NDEL1;ZW10;AHCTF1;CENPT;NUP107;ZWINT;DYNC1LI1;NUP98;DYNC1I1;KIF2A;MAPRE1;SETD2;SBDS;KIF3B;DYNC1H1;NUP37;MAP4;CENPC;PPP1CC;RCC2;CKAP5;CENPE;EML1;PAFAH1B1;WDR62;CLASP2;DCTN2;RMDN1;TUBG2;DYNLL1;NUP133;NUP85
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.33943640614863,-0.973665237022299,0.4661016949152542,0.8088628460886003,1.0,7/16,17.54%,ATP5F1C;ATP5F1D;ATP5F1E;ATP5PD;ATP5MG;ATP5MC2;STOML2
prerank,negative regulation of TORC1 signaling (GO:1904262),-0.357302626770361,-0.9734975167374358,0.4798387096774194,0.8075178395105944,1.0,4/13,15.50%,RNF152;ATM;SPAAR;SESN1
prerank,lipid transport (GO:0006869),0.3513282815513683,0.9733012174061751,0.5419689119170984,0.9397298835779492,1.0,12/97,9.70%,LBP;SLCO2A1;ATP8B1;TRIAP1;SLC51A;ABCG4;OSBPL2;ABCA1;PRELID3A;SCP2;SLC27A3;ABCA13
prerank,regulation of myoblast fusion (GO:1901739),0.4810643555222666,0.9732284255254393,0.5202231520223152,0.9393631208573274,1.0,4/11,22.93%,MAPK14;EHD2;IL4;FLOT1
prerank,vacuolar acidification (GO:0007035),0.41638104901788664,0.9730239486373142,0.515802781289507,0.9393564320277672,1.0,8/21,27.12%,ATP6V0A2;TMEM9;DMXL2;CCDC115;ATP6V0A1;TMEM199;DMXL1;PPT1
prerank,positive regulation of peptidase activity (GO:0010952),0.4270983108026075,0.9729528940629223,0.5037406483790524,0.938992035911177,1.0,2/20,6.12%,MAPK12;RCN3
prerank,monocyte chemotaxis (GO:0002548),0.38999578359619397,0.9727528379045385,0.5309218203033839,0.9389558766429085,1.0,6/32,16.30%,CCL8;ANXA1;CCL25;CALCA;CCL13;IL6
prerank,fluid transport (GO:0042044),-0.3704270544176197,-0.9726728614232745,0.5083333333333333,0.8078784987375253,1.0,2/12,8.86%,PDPN;AQP11
prerank,negative regulation of receptor binding (GO:1900121),0.4834567016201351,0.9725167459912278,0.5365168539325843,0.9390207839852825,1.0,3/10,13.34%,PTPRF;ADAM15;ATP2A2
prerank,cellular protein metabolic process (GO:0044267),0.33577077031844504,0.9721649273924294,0.59,0.9394158890599796,1.0,85/396,21.36%,PLOD2;IGFBP5;FSTL1;RPSA;FBN1;LOXL2;RABGGTA;PCSK5;GPC3;PRSS23;MRPS11;MMP2;IGFBP6;RRBP1;TMEM208;COPS5;BMP15;IGFBP4;MRPS18B;GGCX;CALU;MSRB1;VCAN;MIA3;PHKA2;SPCS1;IGHMBP2;MELTF;ABL2;GAS6;FBXO2;MRPL13;MRPS17;PSEN1;AGO2;SEC11C;FBXL2;UBE2G2;LGALS1;GSPT2;RPL10A;CSNK1G3;MRPL10;CSF2RA;DMBT1;MRPL55;NAPSA;TNIP1;UBA52;CDC34;RPS5;ZDHHC2;MRPL36;MRPL3;GSPT1;MXRA8;RPL6;MRPL51;HARS1;IL6;HTRA2;SDC2;IDE;SPG7;ABCF1;CHRDL1;UBE2G1;FBXO11;ST3GAL1;ADPRH;FDX1;LOX;STK38;NEDD8;RPL23;RPL17;UBE2D3;LAMC1;FBXW2;QSOX1;D2HGDH;PRKCSH;RPS25;ICMT;YES1
prerank,acidic amino acid transport (GO:0015800),-0.3242622338550519,-0.9719360963183532,0.4743083003952569,0.8080268380783427,1.0,3/17,3.01%,SLC6A13;SLC1A3;SLC6A1
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),0.4503213811782307,0.9718614536687922,0.5105820105820106,0.9396206908626661,1.0,2/14,8.91%,AVPR1A;ECE1
prerank,negative regulation of adenylate cyclase activity (GO:0007194),0.46583839661680726,0.9715130136650449,0.5253077975376197,0.9399437602720048,1.0,3/13,9.26%,GNAI3;PALM;LTB4R2
prerank,release of cytochrome c from mitochondria (GO:0001836),0.44092637368074084,0.9713501410910438,0.535064935064935,0.9398211663899967,1.0,4/17,12.73%,TIMM50;BAK1;SFN;BBC3
prerank,protein polyubiquitination (GO:0000209),0.33664180528035853,0.9712439507734709,0.601,0.9395484786015164,1.0,103/297,26.48%,WSB1;MIB2;PSMC4;UBE2B;SPSB1;HECTD2;UBE2J2;SMURF2;FBXW8;SYVN1;TRIM71;ITCH;RBBP6;PSMC6;RC3H1;PELI3;LNPEP;STUB1;ANKRD39;UBE2N;UBE2W;FBXO2;PSMD8;MAGEL2;SIAH1;FBXO17;MYLIP;CUL3;DTL;UBE2G2;FBXW4;HECW2;FBXL20;CDC23;ANAPC5;FBXO31;UBE2A;UBA52;CDC34;THOP1;UNKL;NPEPPS;FBXO28;FBXL3;TRAF3IP2;CDC27;AMFR;RNF216;RNF14;TRIM68;RNF187;TRAF3;RBCK1;HACE1;CDC26;UBE2G1;FBXL5;FBXO11;ANAPC4;ARIH2;UBE2R2;SKP2;RNF19A;UBE3C;LRSAM1;UBE2D3;FBXL19;TPP2;FBXW9;FBXW2;ARIH1;RNF41;ANAPC10;RC3H2;UBE2Q2;SMURF1;UBE3A;RNF6;FBXW11;UBR2;RNF114;TRIM36;IFI27;TRAF5;FBXO38;PSMD3;FBXL12;PSMD4;MDM2;RNF166;FBXO22;RNF20;FBXW7;FBXO30;ZNRF2;RNF126;PSMB3;UBE2K;RNF167;ANAPC2;PRPF19;RNF31;MUL1
prerank,regulation of JNK cascade (GO:0046328),0.34817002050971274,0.9708964931027287,0.5551020408163265,0.9399028718456341,1.0,19/101,13.21%,SH3RF3;EGFR;GADD45G;TAOK3;COPS5;AXIN1;DACT1;AIDA;ITCH;RASSF2;FZD7;SEMA3A;TIRAP;SIRPA;HDAC3;ANKRD6;CD27;TAOK2;NCOR1
prerank,cell cycle checkpoint signaling (GO:0000075),0.4641066999398256,0.9706833474205381,0.5156462585034014,0.9398970426706307,1.0,3/12,18.48%,ZW10;ZWINT;PRCC
prerank,embryonic organ development (GO:0048568),0.36906302783629696,0.9701963186981788,0.5528281750266809,0.9406155254051554,1.0,14/61,13.08%,PCSK5;TGFB2;PBX1;TGFBR2;COBL;GLI2;FLT3LG;NDRG4;COL2A1;GLI3;ERCC3;TBC1D23;ALDH1A3;GDNF
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.3358985586619639,-0.9701833876632999,0.504424778761062,0.8107381037773785,1.0,7/17,17.54%,ATP5F1C;ATP5F1D;ATP5F1E;ATP5PD;ATP5MG;ATP5MC2;STOML2
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.3950752859064515,0.9701429465043581,0.5403128760529483,0.9402005059449122,1.0,8/29,19.45%,TARBP2;TRIM71;DGCR8;AGO2;PUM1;AGO4;SNIP1;AGO3
prerank,snRNA processing (GO:0016180),0.4429462830226043,0.9695430513171882,0.49416342412451364,0.9411869262330609,1.0,5/16,18.59%,INTS3;INTS10;INTS6;INTS2;INTS12
prerank,regulation of vasoconstriction (GO:0019229),0.40233357755521554,0.9689558342664051,0.5299760191846523,0.9421733269848295,1.0,3/27,8.91%,AVPR1A;F2R;ECE1
prerank,tricarboxylic acid metabolic process (GO:0072350),0.46146628296492337,0.9688221395687202,0.5294943820224719,0.9419717911285651,1.0,6/12,20.84%,ACLY;IDH1;ACO2;GLUD1;IDH3G;IDH3B
prerank,Golgi to endosome transport (GO:0006895),-0.3357067053269782,-0.9688189587438889,0.4908256880733945,0.8125148279481038,1.0,4/16,13.38%,SORT1;VPS13A;DOP1B;EPS15
prerank,cellular response to leucine starvation (GO:1990253),0.47792341380586045,0.9682658957470753,0.5123367198838897,0.9428591562869182,1.0,5/10,27.96%,MTOR;SESN3;RRAGD;SESN2;IMPACT
prerank,nuclear membrane reassembly (GO:0031468),0.3694637316295046,0.9680447204352428,0.5471289274106176,0.9428793636777442,1.0,24/54,32.30%,LMNA;REEP3;NUP93;CHMP7;AHCTF1;NUP107;NUP98;SIRT2;NUP37;PPP2R2A;CC2D1B;ANKLE2;IST1;EMD;NUP133;NUP85;NUP188;KPNB1;SUMO1;CHMP4C;SEC13;CHMP4A;CHMP4B;NUP160
prerank,negative regulation of TOR signaling (GO:0032007),-0.27605978068537973,-0.968039398035423,0.5035971223021583,0.8128840012042262,1.0,9/36,16.50%,RNF152;UBR1;EPM2A;PRKAA2;SIRT1;ATM;SPAAR;SESN1;TNFAIP8L1
prerank,response to exogenous dsRNA (GO:0043330),0.43097820848991053,0.967483027275171,0.5039164490861618,0.9437634666115257,1.0,3/18,6.70%,IRAK3;RFTN1;CGAS
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.45356325358320293,0.9673975128437894,0.5089163237311386,0.9434461253910651,1.0,2/13,5.95%,NFATC4;NFIB
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.48602320284488176,0.9671001828431491,0.5276967930029155,0.9436676971552379,1.0,3/10,11.89%,INPP5F;PARP14;PIBF1
prerank,negative regulation of response to wounding (GO:1903035),0.4223430100680444,0.9669093727310235,0.5214646464646465,0.9436032352646173,1.0,4/19,13.45%,FGF2;PTPRS;INPP5F;RTN4RL1
prerank,calcium import into the mitochondrion (GO:0036444),0.4859534901237167,0.9667355603079003,0.5169014084507042,0.9434914350284689,1.0,2/10,11.50%,MCU;MCUB
prerank,positive regulation of reproductive process (GO:2000243),0.3904628750218972,0.9662203081134979,0.5476477683956574,0.9442501970045442,1.0,5/31,9.06%,VEGFA;SMURF2;C1QBP;AGO2;SIRT2
prerank,regulation of response to biotic stimulus (GO:0002831),0.40266773944046147,0.9660561826548161,0.5275498241500586,0.9441077060345782,1.0,4/28,9.65%,CD55;FOXP1;TIRAP;SAMHD1
prerank,positive regulation of protein dephosphorylation (GO:0035307),-0.2759303561233056,-0.9657068331695273,0.45222929936305734,0.8172577913789582,1.0,8/32,13.50%,CDH5;ITGA1;PPP1R16B;PDGFRB;PPP1R15B;PPP2R5A;TGFB1;CD300A
prerank,positive regulation of vasculature development (GO:1904018),0.34792192122351323,0.9654774314501253,0.5701030927835051,0.9450083472916536,1.0,9/94,3.87%,CD34;FGF18;PRKCA;ANGPT4;VEGFA;FGF2;ECM1;RUNX1;SMOC2
prerank,T-helper cell differentiation (GO:0042093),0.4416490856189384,0.9654219828130679,0.510752688172043,0.9446054136526785,1.0,4/14,16.30%,TMEM98;FOXP1;IL4;IL6
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.4208876352843624,0.965119534978944,0.5183312262958281,0.9448293520600157,1.0,2/20,2.91%,HAS2;TGFB2
prerank,positive regulation of cellular respiration (GO:1901857),-0.38409159700979356,-0.9646751091609774,0.45149253731343286,0.81817991102765,1.0,4/11,13.06%,IFNAR1;IL10RB;PINK1;ISCU
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.38527880347287224,0.9643910899106992,0.5389016018306636,0.9461335560542528,1.0,14/37,23.83%,UCHL5;RYBP;FHIT;SGTA;USP7;GIPC1;NOP53;OGT;PML;RPL23;MAP1A;SDCBP;CSNK2A2;BAG5
prerank,metanephros development (GO:0001656),0.4008912377206389,0.9639515075279598,0.536969696969697,0.9467279331331545,1.0,6/26,13.72%,WT1;SIX4;PKD1;PKD2;GDNF;SIX1
prerank,protein complex oligomerization (GO:0051259),0.35194543369067405,0.9639231600198309,0.5550935550935551,0.9462502137640718,1.0,27/85,26.22%,UGDH;LRRC8D;ZNHIT6;MPP2;PKD2;ZBTB1;MCU;CPSF6;VSTM5;MAT2A;SLC9A1;ADCY8;TMEM120A;NACC2;ZC3H12A;KCNC2;BLM;CARD11;PYCARD;PDCD6IP;KCNC1;CPSF7;ALS2;ATL1;GLRA3;RBMX;HGSNAT
prerank,mitochondrial translational termination (GO:0070126),0.3491952057427102,0.9638832080931228,0.5590062111801242,0.9457943847671396,1.0,18/88,15.59%,MRPS11;MRPL38;MRPS18B;CHCHD1;MRPL13;MRPS17;AURKAIP1;MRPS27;MRPL30;MRPL10;DAP3;MRPL55;MRPS10;MRPL36;MRPL3;MRPL21;MRPS34;MRPL51
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.3270101406665986,0.963520525062681,0.738,0.9462111549506763,1.0,291/1646,16.90%,LMX1A;EBF2;PRRX1;AR;LRP6;CD80;LHX8;ESR1;HOXA3;PAX9;COL1A1;EBF1;GCLC;ATP8B1;LOXL2;TRPS1;SP9;FOXP2;NFIX;FGF7;BNC2;IRF4;EGFR;CREB5;TGFB3;WT1;ZFHX4;ZC3H8;MEOX2;TBX15;SCRT2;ZNF367;HSF2;PRDM8;TADA1;CCNL2;SIX4;HOXA2;ELF4;HIVEP2;NEUROD2;ZMIZ1;DGKQ;VEGFA;KLF3;TSHZ2;FGF2;PBX1;KLF12;MLF2;CDK14;FOXP1;F2R;BHLHE40;TLX3;GLIS2;SFR1;RUNX1;TEF;SMAD4;NFE2L2;HDAC9;ZNF25;ATF5;WWTR1;DPF2;LMX1B;MEF2D;SMURF2;MAPK14;PAX1;CXXC1;AXIN1;SOX10;ACVR1;TSC22D4;IRX5;HOPX;RFX1;FOXK2;KLF2;MAP2K3;JUND;ZBTB12;NAB1;NFATC4;MED13L;MAFF;PSRC1;TCF7L2;MRGBP;NR1D2;ATP2B4;SPIN4;NFATC1;CBX4;RBAK;HOXA5;CAMK2D;CREB3L1;SMARCD2;MEIS2;FOXO1;NR1D1;PIAS3;NFIB;MAPRE3;EBF3;PRMT2;ZBTB7C;IGSF1;CREBZF;NFIA;RNF111;ZFHX3;DPF1;RET;MDM4;TRIP4;MLXIPL;SMAD5;DNAJC2;HDAC6;MYT1;MTF1;HOXA4;NUP107;SMARCD1;GLI2;ZFPM2;TBX6;GAS6;BRD9;MAMSTR;FOXL1;MDFIC;BRF2;PHF1;MSL3;ETV3;STAT5A;SOX8;SPTY2D1;CHUK;FZD7;ZBTB1;WDR77;VDR;NR6A1;MYBL2;ZNF260;MAGEL2;KDM3B;PSEN1;FOXC2;SIRT2;HNRNPD;ATXN7L3;SOX5;RCOR3;RYBP;ELP4;ONECUT1;CIPC;MED24;KDM5C;ING4;INPP5K;SMAD6;TLE2;RNF10;SATB2;BRD7;CALCA;MYPOP;PHC3;ZNF3;PHC1;CHD2;HDAC3;NPM1;URI1;SAMD1;MZF1;MPHOSPH8;MITF;PRDM15;ACTR5;ATF7;CAMKK2;SMARCC2;IRF2BPL;CSRNP3;BCL6;ZHX2;TOX2;CEBPB;AKT1;RBFOX2;GLI3;FBXO5;EGF;XRCC5;BACH2;LIN9;CCNC;KDM5B;QRICH1;ZNF691;ZNF112;NCOR2;ATF1;DDX17;PEG3;CDKN1A;MED13;NCOR1;BCL3;IKZF5;PROX2;CBFA2T2;TWIST1;BRIP1;RAI1;SIX1;NACC2;HDAC4;RFX5;PLAGL1;NME2;CCNH;ZNF569;FADS1;PLAGL2;DMAP1;KLF4;TASP1;HOXA7;MLLT11;HOXC4;HOXA9;SETD5;THOC1;POU3F2;IL4;GMNN;ZNF692;SMARCA4;CHD8;CCNQ;MLXIP;FZD4;NFE2L3;NR2C2;RPL6;YEATS2;SRCAP;MAP2K2;E2F3;HMGB3;RNF14;CDK5RAP2;BAHD1;ZFP28;ZBTB25;RNF187;ZBTB5;PSIP1;UBP1;USP22;PDCD4;PER1;HIVEP3;IL6;BAZ2B;OGT;STAT5B;ANXA4;CHD1;PHF5A;DDX5;SNAI2;CHD3;EFEMP1;E4F1;PITHD1;TFAP4;ZEB1;DKK3;PML;SAP18
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.3520699800304825,0.9635088854084071,0.5390374331550802,0.9456992295580202,1.0,10/70,9.97%,NCF4;PSMC4;ITGB5;SEC22B;PSMC6;LNPEP;CHUK;PSMD8;SNAP23;ITGAV
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.4445393215688016,0.9634766003850193,0.5160857908847185,0.9452271330778592,1.0,2/15,1.29%,SRMS;EGFR
prerank,negative regulation of protein kinase activity (GO:0006469),0.3442931046218061,0.9634637145621443,0.5698151950718686,0.944714687016577,1.0,21/88,17.86%,LRP6;TARBP2;ADARB1;CAMK2N1;WWTR1;DTNBP1;RTRAF;YWHAG;SRCIN1;GSKIP;INPP5K;NPM1;AKT1;SFN;DEPTOR;SMCR8;CDKN1A;CHP1;CEP85;PPIA;QARS1
prerank,bile acid biosynthetic process (GO:0006699),0.40118755755907126,0.963162307730204,0.5245098039215687,0.9449670724592407,1.0,5/24,9.72%,OSBPL3;OSBPL2;SCP2;HSD3B7;OSBPL6
prerank,sodium-independent organic anion transport (GO:0043252),0.48121431797790265,0.9630671301974348,0.5536723163841808,0.9446685600442831,1.0,1/10,0.43%,SLCO2A1
prerank,inorganic cation import across plasma membrane (GO:0098659),0.3564668268883855,0.9630223650245119,0.5724867724867725,0.9442255495923324,1.0,18/75,15.89%,ATP1A4;ATP1A3;ATP1A1;SLC12A8;SLC39A14;TRPV3;ATP2B4;KCNJ2;SLC9A9;SLC12A4;KCNK9;HCN4;SLC9A1;SLC12A5;KCNJ3;SLC8A2;SLC9A7;SLC9A6
prerank,quinone biosynthetic process (GO:1901663),0.44145928039380755,0.9628799138062328,0.5399449035812672,0.9440300900308282,1.0,6/14,25.83%,COQ10B;COQ7;COQ3;COQ5;COQ2;COQ10A
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.3840924575815033,0.9627035628021788,0.5507584597432905,0.9439588632013614,1.0,8/34,10.24%,ANXA1;GAS1;VEGFA;MAPK14;MAP2K3;PRKD2;PIK3CA;ERN1
prerank,positive regulation of cell death (GO:0010942),-0.2469426026543241,-0.9621395100968839,0.5857142857142857,0.8228561988610259,1.0,7/59,5.44%,SLC6A13;EFNB2;ACER2;SNCA;WNT5A;PRODH;AXIN2
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.4084484990050418,0.9621215931758936,0.5458996328029376,0.9449071211832787,1.0,3/23,8.29%,INTS3;ZW10;ZWINT
prerank,negative regulation of defense response (GO:0031348),0.35439398935167093,0.9621089692189692,0.5643979057591623,0.9443958072859533,1.0,15/77,15.97%,MAPK7;IRAK3;METRNL;ITCH;MVK;NR1D1;C1QBP;SIRT2;FNDC4;SIRPA;KLF4;IL4;LRFN5;SELENOS;ILRUN
prerank,brain morphogenesis (GO:0048854),0.45586474537873084,0.9620960081631289,0.5219858156028369,0.9438867543304593,1.0,7/12,28.55%,SLC6A4;BBS4;PAFAH1B1;PTEN;FBXW11;PAX2;SPEF2
prerank,negative regulation of cell cycle (GO:0045786),-0.23386256642091324,-0.9616621744095845,0.5535714285714286,0.8222620689755283,1.0,14/73,12.16%,PTPRK;NR2F2;BMP7;SMAD3;PPP1R13B;FOXC1;CDK6;TAF6;BRINP3;INHBA;BMP2;CDKN1C;SCRIB;TGFB1
prerank,regulation of lipid kinase activity (GO:0043550),0.4672269130793421,0.961198602659833,0.5289957567185289,0.9456264687349448,1.0,2/11,8.17%,PIK3R2;WDR91
prerank,pore complex assembly (GO:0046931),0.41780422643813775,0.9606244526908037,0.5508155583437893,0.9464685473809217,1.0,4/19,8.69%,NUP93;AHCTF1;NUP107;NUP98
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.3371133290061197,0.9604552652621555,0.5840080971659919,0.9463911560586171,1.0,30/145,17.83%,DCTN1;FHL1;PSMC4;ODF2;CDK4;RAD51B;VPS4B;PSMC6;YWHAG;SSNA1;YWHAE;PSMD8;DTL;AVEN;ALMS1;MAPRE1;HAUS3;FBXO5;SFI1;CCND1;HSP90AA1;TUBB4A;TUBA4A;DYNC1H1;CDK5RAP2;CCP110;RCC2;AKAP9;CEP164;CKAP5
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.33442788948641033,0.96015375757426,0.6086519114688129,0.9466025987817976,1.0,27/214,13.18%,ACKR3;SYK;EPHB2;CCL8;PRKCA;EGFR;CD44;PDE8A;FGF2;CAMK2N1;F2R;MIF;SMAD4;ADCYAP1;GAS6;FLCN;PRKD2;NDRG4;TIRAP;CCL25;TLR4;SIRPA;GPNMB;TNIP1;ATP6AP1;CCL13;PIN1
prerank,lung epithelium development (GO:0060428),0.4737538006197777,0.9599913900663908,0.5283842794759825,0.946463499993551,1.0,2/10,6.12%,PKD1;RCN3
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),0.43612547662976575,0.9597830838557576,0.5468956406869221,0.9464834941388299,1.0,3/14,16.78%,PKD1;PKD2;KEAP1
prerank,regulation of T cell differentiation (GO:0045580),0.38297039629768487,0.9593532605115662,0.5661680092059839,0.9470210919270354,1.0,4/33,8.30%,ZMIZ1;RUNX1;TNFRSF18;ZBTB1
prerank,mitotic spindle assembly (GO:0090307),0.37502682376086166,0.9593291443526017,0.5522222222222222,0.9465428413985024,1.0,12/42,20.62%,KIFC2;TOGARAM1;KIF2A;ARHGEF10;SMC1A;PIBF1;ABRAXAS1;RHOA;KIF3B;STAG2;FLNA;CLASP2
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.42340757315547445,0.9587331299607067,0.5334190231362468,0.9475097274514251,1.0,5/18,16.91%,SLC25A31;ALKBH7;SLC25A4;BAK1;SPG7
prerank,ER-associated misfolded protein catabolic process (GO:0071712),0.4659997767988659,0.958593232170166,0.5255172413793103,0.9473261524085228,1.0,6/11,27.32%,TOR1A;AUP1;UGGT1;DERL1;UFD1;UGGT2
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.3510213489154279,0.9578722184379141,0.5555555555555556,0.9486167565242936,1.0,23/86,21.98%,DCTN1;CDC42EP2;BIN1;CLIP1;PSRC1;PFN2;TOGARAM1;PSEN1;MAPRE1;COLGALT1;GPX1;MAPT;FCHSD1;SLAIN2;FER;ARF6;CDK5RAP2;NCK1;AKAP9;NAV3;NUMA1;PYCARD;CTTN
prerank,cellular protein catabolic process (GO:0044257),0.35468063551874607,0.9575638229615164,0.5435501653803748,0.9488436839942557,1.0,21/59,27.81%,FAP;CAPN2;AP2A2;CLTC;CLPX;MYLIP;UBE2G2;RSPRY1;CLPP;HTRA2;IDE;UBE2G1;AFG1L;RNF123;AP2M1;RAB12;CTSK;MDM2;CTSB;CTSL;CASP8
prerank,mesonephric tubule development (GO:0072164),0.4390861926660265,0.9574796143493651,0.5317139001349528,0.948512986718197,1.0,4/15,7.86%,WT1;SLIT2;PKD1;PKD2
prerank,nucleotide-excision repair (GO:0006289),0.34534724320993615,0.9570196039063074,0.5721596724667349,0.9491330222752647,1.0,23/101,18.45%,POLR2H;GTF2H3;COPS5;RAD23B;RNF111;POLB;SLC30A9;ERCC3;UBA52;ERCC4;FAN1;POLR2D;POLR2G;DDB1;BRIP1;AQR;CCNH;USP7;UVSSA;RFC4;ERCC5;POLD1;COPS4
prerank,cellular lipid catabolic process (GO:0044242),0.3898177835967771,0.956544990920898,0.5357142857142857,0.9497589851579229,1.0,7/27,22.29%,CEL;SIRT2;ACOX1;NUDT19;ANGPTL3;LPIN3;CYP1B1
prerank,cellular response to light stimulus (GO:0071482),0.35681396209194627,0.9564960688610642,0.5591397849462365,0.9493487651401369,1.0,19/66,22.62%,TRIAP1;NOC2L;ZBTB1;RHNO1;CNGB1;NPM1;BMF;SAG;BAK1;ERCC4;EIF2S1;GNB1;INO80;POLD1;SMPD1;OPN3;NSMCE3;ATF4;SDE2
prerank,negative regulation of cytoskeleton organization (GO:0051494),0.387820583399287,0.9564930833827496,0.5447058823529412,0.9488158649513135,1.0,8/29,11.00%,SLIT2;SMAD4;MYADM;PFN2;PIK3CA;TWF1;KANK1;SSH1
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.40207877565278627,0.9564240801020774,0.5353658536585366,0.9484601845342803,1.0,12/25,31.93%,PRPF4;PRPF3;MPHOSPH10;SF3B4;BCAS2;SRRM1;SF3B1;PRPF6;WDR83;LSM1;PRPF8;GEMIN2
prerank,proteasomal protein catabolic process (GO:0010498),0.3346168495417233,0.9563421323814035,0.6204819277108434,0.9481319372675976,1.0,63/201,26.34%,UCHL1;PSMC4;UBE2B;SPSB1;SPSB4;NFE2L2;SMURF2;SYVN1;TRIM71;ITCH;RAD23B;RMND5B;NR1D1;RCN3;COP1;PSMC6;SPSB2;STUB1;UBE2W;PSMD8;SIAH1;CUL3;SIRT2;HECW2;UBE2A;CDC34;DDB1;RNF216;RNF187;SOCS6;RBCK1;ZSWIM8;HACE1;PML;KCTD2;UBE2G1;SKP2;PCNP;UBE2D3;FBXL19;RNF41;KCTD10;ARRB1;UBXN11;SMURF1;DERL1;SEL1L;FBXW11;KLHL22;SPSB3;IFI27;UBXN6;PSMD3;PSMD4;MDM2;AGAP3;KAT5;DDIT3;FBXW7;RNF126;PSMB3;UBE2K;PRPF19
prerank,regulation of cell division (GO:0051302),0.3547911626667119,0.9563235535728019,0.5675105485232067,0.9476403305009669,1.0,15/72,14.17%,CDK2AP2;TLE6;AHCTF1;NCOA3;FSD1;FLCN;SIRT2;PRDM15;SETD2;PRPF40A;SFN;CALM2;PIN1;BBS4;ORC6
prerank,cellular response to calcium ion (GO:0071277),0.3547469208971363,0.9562782907217124,0.562634989200864,0.9472258679573548,1.0,10/67,9.19%,SYT2;NEUROD2;CPNE8;SYT12;SYT11;SYT13;CAMK2D;PKD2;DPEP1;IQGAP1
prerank,regulation of transport (GO:0051049),-0.27119690331985175,-0.9559028237205639,0.5234375,0.8355751611254316,1.0,9/36,11.64%,EPB41;SNCA;ICA1;ACTB;WWC1;NRP1;PINK1;RAB11A;CDK5
prerank,sphingolipid metabolic process (GO:0006665),0.34040143308213405,0.9557493148156879,0.5746887966804979,0.9479550515009824,1.0,20/108,13.64%,SMPD3;CERS6;ARSA;B3GALNT1;PLPP3;ALDH3A2;TECR;PLPP1;PRKD2;ORMDL2;AGK;SGMS2;PDXDC1;FA2H;GBA2;ELOVL5;GLA;CERK;PRKD3;GLTP
prerank,regulation of establishment of endothelial barrier (GO:1903140),-0.33866420083142756,-0.9557377246847448,0.5196850393700787,0.834231627918554,1.0,3/17,3.21%,CDH5;CLDN5;F11R
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.3072294471951531,-0.9555856640997052,0.5112359550561798,0.8328367977056427,1.0,7/23,12.16%,ENG;SMAD3;LTBP4;ITGA3;TGFBR3;TRIM33;TGFB1
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),-0.29759048338348215,-0.9555842878722179,0.5392156862745098,0.8310390773616902,1.0,9/22,20.72%,PSMA5;PSMA2;PSMA3;PSMB10;PSMA1;PSMB8;PSMB9;PSMB4;PSMA8
prerank,cellular iron ion homeostasis (GO:0006879),0.36307350886880135,0.9552793148327544,0.5733041575492341,0.9486168150186355,1.0,5/55,7.16%,SCARA5;SMAD4;ATP6V0A2;SLC39A14;SLC11A2
prerank,regulation of angiogenesis (GO:0045765),0.33436899900720357,0.9552790396212263,0.6234939759036144,0.9480787453561178,1.0,32/192,14.33%,CD34;DCN;TNMD;FGF18;PRKCA;ANGPT4;ISM1;SPARC;VEGFA;FGF2;TGFB2;ECM1;RUNX1;SMOC2;CD160;ATP2B4;HOXA5;CXCL10;THBS4;SULF1;PRKD2;SERPINF1;AGO2;RHOJ;EMC10;GPNMB;JUP;HSPG2;TWIST1;PDE3B;ZC3H12A;KLF4
prerank,regulation of proteolysis (GO:0030162),0.3651825270206406,0.9551340240215055,0.5488888888888889,0.9479249945055459,1.0,16/48,23.67%,CAMK2N1;ITCH;HDAC6;STUB1;AURKAIP1;CSTB;AKT1;TBC1D10A;BAK1;TRAF3;OGT;PLAUR;NEDD8;FBXW11;IST1;PARL
prerank,cellular macromolecule catabolic process (GO:0044265),0.363816033229282,0.9549546988688683,0.5613259668508287,0.9478208651865311,1.0,18/49,24.96%,OGA;FBXO2;FBXO17;HNRNPD;UBE2G2;EXOSC7;SIDT2;RNASE6;DNASE1L2;NGLY1;HTRA2;IDE;UBE2G1;SUPV3L1;RAB12;DFFB;RNASEH2C;DNASE1L1
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.4264613975046823,0.9549168949353829,0.5371794871794872,0.9473802533826762,1.0,8/16,31.64%,CHMP7;TMEM50A;VPS36;LEPROT;STAM;CHMP4C;CHMP4A;CHMP4B
prerank,cation transport (GO:0006812),0.3350833692433029,0.9548142151304952,0.60261569416499,0.947104229304863,1.0,24/167,14.00%,KCNK5;SCNN1B;SLC5A9;PIEZO2;KCNMA1;KCNV1;FGF13;SLC7A6;ATP1A4;SLC47A1;KCNJ2;SLC11A2;KCNK9;CNGB1;HCN4;KCNA2;SLC4A4;KCNA6;KCNAB3;NDFIP1;SLC23A1;KCNJ3;CATSPER3;SLC8A2
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.3646043024857104,0.9546410479634292,0.5542168674698795,0.9470007409095801,1.0,13/49,20.13%,SCIN;RAB7B;RUNX1;DPY30;KAT2B;WDR5;EIF6;PITHD1;AGO4;THPO;AGO3;KMT2C;KMT2A
prerank,cholesterol metabolic process (GO:0008203),0.35548606825041007,0.9543206242671509,0.5555555555555556,0.9472799937363082,1.0,14/68,18.77%,CEL;ACLY;MVK;ABCA1;INSIG2;LCAT;GGPS1;TSKU;GBA2;IL4;PMVK;PIP4P1;FDX1;ANGPTL3
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.3873724030029432,0.9536515054192544,0.5441008018327605,0.9483664803966741,1.0,12/32,26.30%,GPAT4;CHKB;SLC44A1;LCAT;LPCAT1;CEPT1;SLC44A2;LPIN3;PCTP;CSNK2A2;SLC27A1;LPCAT3
prerank,cortical actin cytoskeleton organization (GO:0030866),0.41203186907904066,0.9534680850622584,0.5380774032459426,0.9482766909555753,1.0,6/20,14.70%,LLGL1;FMNL1;RHOQ;FMNL3;FHOD3;ARF6
prerank,endodermal cell fate commitment (GO:0001711),-0.3880197915068878,-0.9534491976424423,0.5154320987654321,0.8348504695041999,1.0,2/10,8.80%,SOX17;CTR9
prerank,negative regulation of cell development (GO:0010721),0.39907600311439245,0.95318376861323,0.5367647058823529,0.9484283375394311,1.0,1/25,0.36%,FBN1
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.42253105452938156,0.953165760183685,0.5394736842105263,0.9479420862406577,1.0,4/17,16.60%,CD44;MIF;TWIST1;SNAI2
prerank,regulation of melanin biosynthetic process (GO:0048021),-0.37581854816201843,-0.9529574738802057,0.5171339563862928,0.8342406402826456,1.0,2/10,8.88%,RAPGEF2;CTNS
prerank,regulation of gene silencing by RNA (GO:0060966),0.3634946848070415,0.9528366850620109,0.5734649122807017,0.9476688770021945,1.0,20/50,27.67%,POLR2H;NUP93;TRIM71;NUP107;NUP98;AGO2;PUM1;POLR2D;POLR2G;NUP37;NUP50;TPR;TNRC6A;POLR2C;NUP133;NUP85;NUP188;EIF4G1;NUP88;AGO1
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.3634946848070415,0.9528366850620109,0.5734649122807017,0.9476688770021945,1.0,20/50,27.67%,POLR2H;NUP93;TRIM71;NUP107;NUP98;AGO2;PUM1;POLR2D;POLR2G;NUP37;NUP50;TPR;TNRC6A;POLR2C;NUP133;NUP85;NUP188;EIF4G1;NUP88;AGO1
prerank,positive regulation of type 2 immune response (GO:0002830),0.43993112436318477,0.952833882568025,0.5449664429530201,0.9471412857896462,1.0,6/14,24.85%,CD81;IL4;IL6;IL18;PRKCZ;RARA
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.3782623605805414,0.9524763376218056,0.5568181818181818,0.947503240812061,1.0,11/39,22.85%,GTF2H3;ERCC3;UBA52;ERCC4;FAN1;DDB1;RFC4;ERCC5;POLD1;OGG1;ERCC1
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.4095837092405403,0.9523797421597677,0.5374233128834356,0.9472119479267362,1.0,4/22,12.04%,PRKCA;SMAD4;CAMK2D;SLC9A1
prerank,organophosphate biosynthetic process (GO:0090407),0.3844148304602745,0.9517587014917634,0.5560640732265446,0.9482172086438121,1.0,10/37,20.20%,FGF2;GK5;AGPAT3;LPCAT1;AGPAT5;NFS1;FADS1;IPPK;GPAM;IP6K1
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.4175642918571948,0.9512925440396672,0.5415117719950434,0.9488699537529293,1.0,6/18,22.45%,SYVN1;EDEM2;UBA52;AMFR;UGGT1;SEL1L
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.34664506443592624,0.95121463372366,0.560796645702306,0.94850161264378,1.0,20/77,20.35%,AR;TRIAP1;ACVR1;TCF7L2;SRC;PELI3;NOC2L;ITGAV;HERPUD1;URI1;GPX1;AKT1;IL4;GHITM;HGF;PLAUR;QARS1;TGFBR1;MCL1;PRELID1
prerank,regulation of endopeptidase activity (GO:0052548),0.3549341755631835,0.9510000163233233,0.5744908896034298,0.9485010018620436,1.0,7/59,12.90%,TIMP2;SERPINB8;SERPINE3;SERPINF1;SERPINH1;AKT1;SERPING1
prerank,regulation of neuron projection development (GO:0010975),0.3307470311011358,0.9506436379066237,0.6121212121212121,0.9488506427716206,1.0,34/163,13.45%,DBN1;ARHGAP44;NPTN;EPHA3;PTPRS;S100A9;LPAR1;PPFIA2;NDEL1;TENM3;RET;RIT2;STX1B;ABL2;FRMD7;NDRG4;SEMA3A;RTN4IP1;PSEN1;MYLIP;SRCIN1;TSKU;TWF1;EPHB3;KANK1;FUT9;AVIL;AKT1;MAGI2;TANC2;KIDINS220;P3H1;CBFA2T2;RTN4RL1
prerank,regulation of tube diameter (GO:0035296),0.4549751546034574,0.9504571586206372,0.5647382920110193,0.9482498179043655,1.0,1/13,0.79%,GCLC
prerank,vascular process in circulatory system (GO:0003018),0.4549751546034574,0.9504571586206372,0.5647382920110193,0.9482498179043655,1.0,1/13,0.79%,GCLC
prerank,positive regulation of phospholipid transport (GO:2001140),0.47480315361196423,0.9502793500321857,0.5406562054208274,0.9481765935740867,1.0,4/10,23.76%,TRIAP1;TMEM30A;PRELID1;ABCB4
prerank,O-glycan processing (GO:0016266),0.35511936378836173,0.9501032204023513,0.5575027382256298,0.9480714348086346,1.0,7/54,11.72%,ST3GAL2;C1GALT1;GALNT10;MUC1;B3GNT8;GALNT1;ST3GAL4
prerank,negative regulation of interferon-beta production (GO:0032688),0.4635513120791445,0.9500187594983479,0.5509325681492109,0.9477462007322818,1.0,2/10,10.20%,PTPRS;SIRPA
prerank,negative regulation of lipid metabolic process (GO:0045833),-0.3070244922174078,-0.9499892083632488,0.5221674876847291,0.8397351727194658,1.0,5/22,14.88%,APOD;ADRA2A;PPP2R5A;CEACAM1;GPER1
prerank,positive regulation of ATPase activity (GO:0032781),-0.26481657983940976,-0.9498904200557322,0.5508474576271186,0.8381813310170201,1.0,12/41,18.87%,TPM1;ATP1B3;PLSCR1;SSBP1;MSH3;RYR2;PFN1;MSH2;ATP1B1;SETMAR;DYNLL2;TNNT3
prerank,neuron migration (GO:0001764),0.3553499823438096,0.9498778984151539,0.5620842572062085,0.9475454583208979,1.0,8/48,8.25%,NAV1;MAP1B;FGFR1;VEGFA;FGF13;POMGNT2;LRP12;SEMA3A
prerank,DNA repair (GO:0006281),0.3288884051990012,0.9497042156205192,0.656,0.9474381196828944,1.0,50/284,15.70%,MPG;PARP3;FANCD2;INTS3;UBE2B;GTF2H3;XRCC3;EME1;NUDT1;RAD51B;RFWD3;RAD23B;KPNA2;TENT4A;IGHMBP2;UBE2N;INIP;ZBTB1;RHNO1;PPP5C;FANCL;FAAP100;POLB;FANCE;SMC1A;EXO5;NPM1;ACTR5;ASCC3;SLC30A9;POLI;SETD2;ERCC3;UBE2A;UBA52;ERCC4;RAD1;FAN1;XRCC5;DDB1;ABRAXAS1;DNA2;BRIP1;FANCG;NBN;INO80;FAM111A;TNKS1BP1;NOP53;RFC4
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.4523797535125697,0.9494870534099528,0.5405405405405406,0.9474305256272496,1.0,6/13,24.22%,CPSF6;CPSF4;CPSF2;CSTF2T;CPSF1;CPSF7
prerank,contractile actin filament bundle assembly (GO:0030038),0.43564422058554964,0.9494590829411951,0.5665349143610013,0.9464375337239455,1.0,6/15,13.49%,ITGB5;FHDC1;SRC;CUL3;PDLIM1;RHOA
prerank,stress fiber assembly (GO:0043149),0.43564422058554964,0.9494590829411951,0.5665349143610013,0.9464375337239455,1.0,6/15,13.49%,ITGB5;FHDC1;SRC;CUL3;PDLIM1;RHOA
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.2957249219954337,-0.9490094936884192,0.5052631578947369,0.8387132862619706,1.0,4/23,8.41%,CADM1;AP1G1;NECTIN2;PIK3R6
prerank,response to amino acid (GO:0043200),0.3826383681284223,0.948904260788924,0.5530660377358491,0.947220769745847,1.0,9/31,22.92%,CAPN2;MTOR;MEAK7;NSMF;RRAGD;CPEB1;IPO5;SESN2;SLC38A9
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.28387506734236456,-0.9487398120389665,0.5348837209302325,0.8375695075326643,1.0,10/29,14.88%,THBS1;CAV1;TNFSF12;SFRP1;INHBA;WWOX;RIPK1;TNFSF10;DEDD2;GPER1
prerank,mitochondrial transcription (GO:0006390),-0.39034692549304106,-0.9479928356927912,0.49295774647887325,0.8376976738906804,1.0,6/10,25.87%,TFB1M;MTERF2;TEFM;POLRMT;TWNK;TFB2M
prerank,translation (GO:0006412),0.32968928791428415,0.9475226504423012,0.6352705410821643,0.9500565554285845,1.0,78/208,31.08%,RPSA;MRPS11;RRBP1;COPS5;EEF2K;MRPS18B;MARS2;ABCE1;IGHMBP2;GTPBP2;FTSJ1;MRPL13;MRPS17;AGO2;GSPT2;RPL10A;MRPL10;TARS1;SARS2;MRPL55;TNIP1;UBA52;RPS5;MRPL36;VARS1;MRPL3;GSPT1;MRPS34;RPL6;MRPL51;EEF1B2;HARS1;GARS1;EEF1G;ABCF1;EEF1E1;EPRS1;QARS1;AIMP1;RPL22L1;RPL23;RPL17;N6AMT1;RWDD1;QRSL1;RPS25;RSL24D1;NOA1;AIMP2;RPL22;NARS1;APEH;EIF4EBP2;EIF4G1;MRPL34;PPA1;EEF1D;RPL34;ASMT;YARS1;RPS29;HBS1L;TMA7;SARS1;RPS26;PPA2;IGF2BP3;DARS1;RPS15;RPS20;WARS2;RPL31;RPLP2;RPS28;MRPL23;AARS1;LARS2;RPS6
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.46057115340223137,0.9475075617329572,0.5596590909090909,0.94956428604052,1.0,4/11,14.38%,STK25;GSKIP;DIABLO;STK24
prerank,pulmonary valve morphogenesis (GO:0003184),0.4256023789277944,0.9474307927657883,0.5428937259923176,0.9492144874518351,1.0,5/17,10.09%,TGFB2;SLIT2;NFATC1;JAG1;SMAD6
prerank,negative regulation of phagocytosis (GO:0050765),-0.31853319545292624,-0.9474035604166396,0.519650655021834,0.837372167437891,1.0,4/17,4.53%,HMGB1;PLSCR1;SNX3;DYSF
prerank,nitric oxide metabolic process (GO:0046209),-0.34177926657525937,-0.9474027117295817,0.5245901639344263,0.8355943072097851,1.0,4/14,12.22%,NOS3;GCH1;NOS1;SPR
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.32568238352041046,0.9470915779822835,0.704,0.949524140133549,1.0,110/497,19.66%,IGFBP5;PAX9;GCLC;ATP8B1;LOXL2;FOXP2;WT1;ZC3H8;EIF2AK3;SIX4;FOXP1;BHLHE40;GLIS2;SMAD4;HDAC9;ATF5;DPF2;SMURF2;TSC22D4;RBM4;PAIP2B;GTPBP4;FOXK2;NAB1;TCF7L2;NR1D2;TRIM71;CBX4;RBAK;SAMD4B;CREB3L1;FOXO1;NR1D1;PRMT2;CREBZF;DPF1;MLXIPL;HDAC6;ZFPM2;GAS6;MDFIC;SOX8;VDR;MAGEL2;MRPL13;SIRT2;RCOR3;CIPC;KDM5C;ING4;INPP5K;TLE2;BRD7;CALCA;PHC3;PHC1;HDAC3;SAMD1;MPHOSPH8;SMARCC2;BCL6;ZHX2;RBFOX2;GLI3;IGF2BP1;PASK;XRCC5;LARP1;NCOR2;CDKN1A;NCOR1;BCL3;CBFA2T2;TERF1;TWIST1;CNOT10;NACC2;HDAC4;DMAP1;KLF4;HOXA7;IL4;GMNN;SMARCA4;CHD8;YEATS2;SELENOS;BAHD1;PDCD4;PER1;FXR2;TFAP4;ZEB1;DKK3;PML;SAP18;SET;EPRS1;QARS1;SNX6;DAP;GCFC2;CTCF;NIPBL;PAIP2;BTAF1;SUDS3;RING1;PCGF6;PCIF1
prerank,negative regulation of cell activation (GO:0050866),0.43346329820602353,0.9468890063925368,0.5554089709762533,0.9494917029416781,1.0,3/14,14.13%,C1QTNF1;NR1D1;PDGFRA
prerank,negative regulation of anoikis (GO:2000811),0.4365145082689377,0.9466841551047455,0.5519053876478318,0.9494496046242982,1.0,6/14,19.36%,ITGA5;SRC;PIK3CA;SNAI2;PTRH2;MCL1
prerank,cardiac muscle cell development (GO:0055013),-0.3072159566347007,-0.9466488829448735,0.5299539170506913,0.8357137144666354,1.0,5/20,8.78%,SORBS2;PDLIM5;CXADR;PDGFRB;MYH11
prerank,regulation of gene expression by genetic imprinting (GO:0006349),-0.3801775569015729,-0.9465764185756872,0.4901315789473684,0.8341453766998634,1.0,3/10,12.14%,PCGF5;IGF2;ZFP57
prerank,nitric oxide biosynthetic process (GO:0006809),-0.34725066799633064,-0.9463200814736846,0.48412698412698413,0.833047453617258,1.0,4/13,12.22%,NOS3;GCH1;NOS1;SPR
prerank,regulation of cell cycle phase transition (GO:1901987),0.34004678391132065,0.9460749008951205,0.5875647668393782,0.950421421193814,1.0,16/91,17.68%,MN1;PSMC4;ATP2B4;PSMC6;PSMD8;CDC23;ANAPC5;FBXO5;ERCC3;CDKN1A;DDB1;CDC27;DBF4;TFAP4;CDC26;ANAPC4
prerank,cardiac left ventricle morphogenesis (GO:0003214),0.43923912700832807,0.9455874645699411,0.5453367875647669,0.9510644358247771,1.0,2/13,3.68%,TGFBR2;SMAD4
prerank,protein ubiquitination (GO:0016567),0.32502412035753886,0.9453259786042203,0.714,0.9511737426008219,1.0,168/471,28.26%,WSB1;SH3RF3;TSPAN17;MIB2;PSMC4;UBE2B;NEUROD2;SPSB1;SPSB4;HECTD2;NFE2L2;UBA6;UBE2J2;SMURF2;FBXW8;SYVN1;TRIM71;ITCH;RFWD3;RBBP6;MSL2;GAN;RNF111;PSMC6;SPSB2;RC3H1;PELI3;LNPEP;STUB1;MYCBP2;UBE2N;UBE2W;FBXO2;PSMD8;FANCL;SIAH1;FBXO17;MYLIP;CUL3;DTL;FBXL2;UBE2G2;ASB12;FBXW4;HECW2;FBXL20;RNF10;PHC1;CDC23;TRIM11;RNF7;FBXO31;RNF141;UBE2A;UBA52;CDC34;USP5;THOP1;UNKL;NPEPPS;BSPRY;FBXO28;DDB1;FBXL3;CDC27;PEX12;CUL9;CBL;AMFR;USP7;UHRF2;TRPC4AP;KLHL41;UVSSA;RNF14;TRIM68;SELENOS;RNF187;USP22;RBCK1;ZSWIM8;HACE1;RNF138;KEAP1;UBE2G1;FBXL5;FBXO11;PEX5;VPS11;ARIH2;UBE2R2;NEDD8;SKP2;PCNP;RNF19A;UBE3C;LRSAM1;BRAP;UBE2D3;FBXL19;TRIM35;TPP2;FBXW9;FBXW2;ARIH1;RNF41;CUL5;KCTD10;PEX2;PAF1;ARRB1;RC3H2;ATG3;UBE2Q2;KLHL9;SMURF1;FBXO24;DERL1;UBE3A;RNF6;UBE2Z;FBXW11;SDE2;UBR2;LZTR1;DTX2;KLHL22;RNF114;TRIM36;RNF13;TRIM24;RTF1;PSMD3;RNF157;MKRN2;FBXL12;PSMD4;TRIM44;MDM2;RNF166;VHL;FBXO22;RNF20;FBXW7;FBXO30;ZNRF2;RNF126;PSMB3;UBE2K;RNF167;PRPF19;RNF31;MUL1;KLHL12;OTULIN;CUL7;PRKDC;BCL10;VCPIP1;FBXO41;PSMB2;DTX3;EIPR1;WWP1;UBE3B;TOPORS;CRBN;PSMD5
prerank,sterol metabolic process (GO:0016125),-0.2364350247032659,-0.9453012342123632,0.6111111111111112,0.8339500681119124,1.0,6/60,6.08%,PRKAG2;CYP7B1;APOE;CYP26B1;ABCG1;HMGCR
prerank,positive regulation of histone modification (GO:0031058),0.3783733187445118,0.94525948489728,0.5516431924882629,0.9508039827591409,1.0,10/33,21.51%,UBE2N;CDK9;BRD7;AKAP8;NIPBL;GLYR1;CTBP1;PAF1;AKAP8L;ARRB1
prerank,negative regulation of fibroblast proliferation (GO:0048147),-0.31569700595066424,-0.9451630889960186,0.5463414634146342,0.8325348366998536,1.0,6/18,14.56%,DAB2IP;FTH1;SFRP1;PARP10;CD300A;TRIM32
prerank,regulation of cellular component organization (GO:0051128),0.33472101697113177,0.945141846586416,0.6154628687690743,0.9505571231520734,1.0,27/135,15.75%,STON2;PLCE1;CD177;IRAK3;SGK3;SGK2;ATF5;RAP1B;MTOR;ITCH;SOCS2;CAMK2D;EGLN2;RIT2;MELTF;ABL2;ARFGAP1;HJURP;NRG3;URI1;SLC2A10;RUFY1;TAOK2;HSP90AA1;SETD5;RAPGEF1;RAB33B
prerank,mitotic nuclear division (GO:0140014),0.34643385829513995,0.9450184748844912,0.5805084745762712,0.9503346992980305,1.0,15/71,14.55%,NDEL1;ZW10;CHMP7;KIFC2;TOGARAM1;ZWINT;KIF2A;ARHGEF10;SMC1A;PIBF1;ABRAXAS1;RHOA;KIF3B;CTDP1;INO80
prerank,regulation of developmental growth (GO:0048638),0.3862691679578027,0.9446051537403184,0.5586854460093896,0.9507500553374437,1.0,7/29,18.95%,GHR;SIX4;STAT5A;MUSK;SIX1;STAT5B;NIPBL
prerank,positive regulation of cyclase activity (GO:0031281),-0.3397283204927024,-0.9443640089197504,0.5224489795918368,0.83278662844814,1.0,5/14,12.96%,NOS3;CACNA1D;NOS1;MAPK8;MAPK3
prerank,positive regulation of MAP kinase activity (GO:0043406),0.35145509095612804,0.9443025365751663,0.591728525980912,0.9509547036047692,1.0,7/66,4.01%,FGF18;EGFR;FGFR1;VEGFA;FGF2;MST1R;TAOK3
prerank,regulation of acrosome reaction (GO:0060046),-0.3857160409998295,-0.944092424023676,0.5198675496688742,0.8317007355759574,1.0,1/10,4.85%,PLCB1
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.4158480162328564,0.9436552999116398,0.5570719602977667,0.9520098389256442,1.0,7/20,13.34%,ANK2;TNNI3;CAMK2D;GSTM2;SLC9A1;CALM2;ATP2A2
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.44663857867910456,0.9436505422649123,0.5621546961325967,0.951492974475197,1.0,3/12,11.89%,WDTC1;ACADVL;PIBF1
prerank,macrophage differentiation (GO:0030225),0.4432441749209224,0.9435799425498422,0.5628415300546448,0.9511480277870682,1.0,4/13,27.81%,VEGFA;IL31RA;CSF1;CASP8
prerank,protein deneddylation (GO:0000338),0.4717291914402002,0.9433938551332646,0.5624142661179699,0.9510967315602129,1.0,7/10,31.27%,COPS5;TOR1A;COPS4;GPS1;COPS6;COPS3;COPS7B
prerank,metal ion homeostasis (GO:0055065),0.36584748822824303,0.943358430939894,0.5735461801596351,0.9506502240611518,1.0,10/40,20.50%,SCNN1B;SLC12A8;SLC12A4;CYP27B1;COX11;SLC12A5;CNNM4;KCNH2;SELENON;SLC12A6
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.38688563824885663,0.9430313502394834,0.5740514075887393,0.9509146572936846,1.0,6/27,18.42%,F2R;LPAR1;GPR20;CALCA;GRM1;HTR2C
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.322675969645867,0.9427934545569983,0.705,0.9509827186864166,1.0,91/476,16.87%,AR;LRP6;CD80;ESR1;COL1A1;FGF7;IRF4;EGFR;CREB5;TGFB3;WT1;SIX4;ELF4;ZMIZ1;FGF2;F2R;GLIS2;SFR1;RUNX1;SMAD4;ATF5;CXXC1;AXIN1;SOX10;ACVR1;FOXK2;KLF2;MAP2K3;PSRC1;NR1D2;NFATC1;FOXO1;NR1D1;NFIB;MAPRE3;EBF3;PRMT2;RNF111;ZFHX3;RET;TRIP4;MLXIPL;SMAD5;DNAJC2;GLI2;MDFIC;SOX8;CHUK;FZD7;PSEN1;FOXC2;HNRNPD;ATXN7L3;RYBP;MED24;INPP5K;RNF10;BRD7;NPM1;MITF;CAMKK2;SMARCC2;CEBPB;AKT1;GLI3;EGF;QRICH1;MED13;BCL3;RAI1;SIX1;HDAC4;NME2;KLF4;TASP1;MLLT11;IL4;SMARCA4;CHD8;FZD4;MAP2K2;RNF14;CDK5RAP2;RNF187;USP22;HIVEP3;IL6;PHF5A;PITHD1;TFAP4;PML
prerank,regulation of myelination (GO:0031641),0.39017217947342314,0.9423725108038483,0.5639464068209501,0.951446921960331,1.0,6/25,13.72%,EIF2AK3;TMEM98;ZPR1;SIRT2;RNF10;TNFRSF1B
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.41597314033335453,0.9423556988583798,0.5675,0.9509665147668183,1.0,7/20,12.58%,KCNMA1;ATP1A4;ATP1A3;ATP1A1;KCNJ2;SLC9A1;ATP6AP1
prerank,apoptotic cell clearance (GO:0043277),0.38378790869200896,0.9423072645048639,0.5518867924528302,0.9505501103784212,1.0,5/30,9.97%,ANXA1;LRP1;ITGB3;GAS6;ITGAV
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.3626120311099042,0.941924491130225,0.5646794150731158,0.9509658065038963,1.0,8/46,13.18%,EPHB2;CAMK2N1;SMAD4;FLCN;TLR4;SIRPA;TNIP1;PIN1
prerank,regulation of oxidoreductase activity (GO:0051341),0.44380382010588393,0.9418122776926761,0.5379310344827586,0.9507352784467246,1.0,2/13,7.45%,HDAC6;ABL2
prerank,eye photoreceptor cell differentiation (GO:0001754),-0.3446317524252217,-0.9412957224798378,0.5074074074074074,0.8370853962783047,1.0,4/12,8.15%,PROM1;NKD1;CEP290;SDK2
prerank,regulation of protein acetylation (GO:1901983),-0.3550120009666651,-0.9411324770750875,0.5288135593220339,0.8357469889901535,1.0,3/12,15.13%,RAPGEF3;SIRT1;TAOK1
prerank,cellular response to interleukin-1 (GO:0071347),0.3300388437490903,0.9409457479679918,0.6199186991869918,0.9522223766167763,1.0,21/143,12.91%,HAS2;CCL8;PSMC4;IRAK3;USP10;NR1D1;PSMC6;RC3H1;PELI3;UBE2N;CHUK;PSMD8;CCL25;MAPK11;CD47;SIRPA;SQSTM1;IRAK4;IRAK1;UBA52;CCL13
prerank,vitamin D metabolic process (GO:0042359),0.44751288991746857,0.9409325217997364,0.5580110497237569,0.9517231697877142,1.0,5/13,27.49%,CYP27B1;VDR;GC;LRP2;CYP2R1
prerank,apoptotic DNA fragmentation (GO:0006309),-0.3284117007313474,-0.9408670715051664,0.5062761506276151,0.8346450510499377,1.0,3/16,7.78%,CECR2;HMGB1;CASP3
prerank,regulation of endothelial cell migration (GO:0010594),0.34342262397171275,0.940863760616629,0.5917525773195876,0.9513633455521798,1.0,21/85,15.37%,DCN;PRKCA;ANGPT4;SPARC;ITGB3;VEGFA;FGF2;SLIT2;FOXP1;SMOC2;PRCP;PRKD2;FOXC2;RHOJ;EMC10;AKT1;EGF;AAMP;ZC3H12A;BCAS3;STC1
prerank,cellular transition metal ion homeostasis (GO:0046916),0.34335209266538286,0.9408426114869843,0.6119711042311662,0.9508981189199857,1.0,16/91,17.49%,SCARA5;SLC39A13;SMAD4;ATP6V0A2;SLC39A14;COX19;SLC11A2;ARF1;SLC39A7;SLC30A9;NDFIP1;ATP6AP1;CCDC115;SLC30A5;FLVCR1;FBXL5
prerank,heterochromatin organization (GO:0070828),0.4321064206233638,0.940705938240819,0.5591836734693878,0.9506900449515182,1.0,8/14,26.27%,LOXL2;SETD7;POLE3;EZH1;BAHD1;SETDB1;SETDB2;HP1BP3
prerank,intracellular protein transmembrane transport (GO:0065002),0.36555034045440776,0.940276298231509,0.5699774266365688,0.9511906337450805,1.0,12/42,25.09%,TIMM50;PEX16;GRPEL2;PEX12;PEX1;SEC63;SEC61A1;PEX5;PEX2;TIMM17A;SEC61B;TOMM40
prerank,negative regulation of protein binding (GO:0032091),0.3495358362715952,0.9398497437629015,0.5914893617021276,0.9517007591776115,1.0,15/71,15.09%,DACT1;GNL3L;CARD16;PTPRF;TFIP11;USP33;AKT1;SLPI;DNAJB2;ADAM15;CDKN1A;PIN1;ATP2A2;DDX11;GTF2F1
prerank,sympathetic nervous system development (GO:0048485),-0.3265121659824348,-0.9394007167503493,0.524904214559387,0.8365004536280416,1.0,4/15,15.57%,NRP2;NRP1;CTNNB1;SOX11
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.3884372533861711,0.9391487352648661,0.5593824228028503,0.9528187865712398,1.0,12/27,28.73%,CCDC88C;CHUK;MAPK11;UBA52;TAOK2;MAPK1;FBXW11;MAP3K7;TNIP2;KAT7;NFKB1;CUL1
prerank,apoptotic nuclear changes (GO:0030262),-0.2893484797342999,-0.938979807813589,0.49206349206349204,0.835937274022395,1.0,9/24,23.64%,CECR2;HMGB1;CASP3;DEDD2;GPER1;BLCAP;ACIN1;TOP2A;FOXL2
prerank,response to nitric oxide (GO:0071731),0.44509770197401477,0.9385181308008068,0.568988173455979,0.9538253119829574,1.0,4/13,14.62%,FOXO1;DPEP1;MTR;KCNC2
prerank,B cell differentiation (GO:0030183),0.35605854483787014,0.9385043674685315,0.5858585858585859,0.9533369497547509,1.0,8/46,14.83%,HDAC9;SYVN1;CLCF1;PTPRJ;FLT3;CR2;HDAC4;IL4
prerank,protein phosphorylation (GO:0006468),0.32135406144979695,0.9383985157768487,0.729,0.9530959194210701,1.0,80/478,14.53%,SYK;DDR2;EPHB2;SRMS;DCLK1;PRKCA;EGFR;TNK1;FGFR1;MAPK12;STK25;EIF2AK3;RPS6KA2;CDKL2;EPHA3;DYRK4;FYN;GTF2H3;DGKQ;IRAK3;SGK3;SGK2;TGFB2;LMTK3;CDK14;TGFBR2;TAOK3;MAPK14;PKD1;ACVR1;CDK4;EEF2K;MTOR;CAMK2D;CSK;RET;MAST4;TBCK;SRC;ABL2;GAS6;STRADA;PRKD2;SLK;ABI1;TNNI3K;CHUK;TESK2;CDK9;TLR4;CDK20;AKT3;BMP2K;NRBP2;ERN1;EPHB3;DYRK2;MUSK;CSNK1G1;AMHR2;CSNK1G3;CAMKK2;STK16;AKT1;MAP3K6;IRAK1;PASK;STK39;ULK2;PXK;TAOK2;FLT3;ULK1;HIPK4;PDGFRA;CCNH;FER;STK24;STK3;DDR1
prerank,protein destabilization (GO:0031648),0.37134839644058343,0.9383656713446176,0.5647058823529412,0.9526534807928085,1.0,4/32,8.86%,GSN;CCDC88C;NR1D1;CUL3
prerank,positive regulation of leukocyte migration (GO:0002687),0.3903115160960948,0.9382552036312719,0.5652173913043478,0.9523818733971061,1.0,7/27,16.30%,VEGFA;MIA3;JAM3;TNFRSF18;PLVAP;IL4;IL6
prerank,regulation of chromatin organization (GO:1902275),-0.3469080335391783,-0.9381647284915205,0.5319148936170213,0.8363156049971853,1.0,3/14,8.12%,MLLT3;SSRP1;IGF2
prerank,positive regulation of chromatin organization (GO:1905269),0.44021927294331015,0.9381426740930576,0.573187414500684,0.9521195508424111,1.0,6/12,22.09%,UBE2N;ACD;TERF1;TINF2;MIER1;TERF2IP
prerank,regulation of mesenchymal cell proliferation (GO:0010464),-0.36179477278563466,-0.93796530412268,0.5072463768115942,0.8351200673900877,1.0,4/11,10.42%,WNT5A;FGFR2;TBX1;STAT1
prerank,potassium ion transmembrane transport (GO:0071805),0.3327334530320135,0.937928908004315,0.6508097165991903,0.95208633562776,1.0,26/135,15.89%,KCNK5;KCNT2;HPN;KCNV1;ATP1A4;ATP1A3;ATP1A1;SLC12A8;KCNJ2;SLC9A9;KCND1;ABCB8;SLC12A4;PKD2;KCNK13;KCNK9;HCN4;KCNA2;KCNA6;KCNAB3;SLC9A1;SLC12A5;KCNJ3;KCNC2;SLC9A7;SLC9A6
prerank,protein autophosphorylation (GO:0046777),0.3263297281339807,0.937796255850072,0.6311557788944724,0.9518698822547876,1.0,31/157,14.53%,DDR2;SRMS;EGFR;TNK1;FGFR1;STK25;EIF2AK3;TAOK3;EEF2K;MTOR;CAMK2D;SRC;PRKD2;SLK;ERN1;EPHB3;MUSK;CAMKK2;STK16;AKT1;IRAK1;PASK;STK39;ULK2;TAOK2;FLT3;ULK1;PDGFRA;FER;STK24;DDR1
prerank,positive regulation of lymphocyte activation (GO:0051251),0.3811812940487231,0.9377281051256435,0.5608591885441527,0.951503218567174,1.0,11/28,30.49%,CD47;SIRPA;IL6;PYCARD;TNIP2;TICAM1;CCDC88B;FGF10;PRKDC;XRCC6;SH3KBP1
prerank,autonomic nervous system development (GO:0048483),0.4252175118589244,0.9374261183721204,0.5789473684210527,0.9517125582684949,1.0,4/17,13.08%,SOX10;SOX8;SEMA3A;GDNF
prerank,prostaglandin metabolic process (GO:0006693),0.3909013344509873,0.9372767047203675,0.5639464068209501,0.9515541376611336,1.0,6/26,15.84%,CYP2S1;MIF;PTGR1;PNPLA8;DAGLB;ACOX1
prerank,positive regulation of synapse assembly (GO:0051965),0.39020662729902234,0.9364267814919033,0.5829268292682926,0.9530412454920841,1.0,13/27,31.31%,EPHB2;EPHB3;VSTM5;SYNDIG1;EPHB1;CLSTN3;IL1RAPL1;GRID2;NLGN1;NLGN3;LRRC4B;NRXN1;NLGN2
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.38992856167090023,0.9361038536893432,0.5625,0.9532552027042619,1.0,2/26,2.27%,AREG;BTC
prerank,regulation of cell-substrate adhesion (GO:0010810),0.3673154210095755,0.936083964214392,0.5837155963302753,0.9527850720304255,1.0,5/42,8.19%,FBLN2;CORO2B;VIT;MYADM;FZD7
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.45210116062708905,0.9356259524370983,0.5881561238223418,0.9533546216120831,1.0,2/12,10.59%,B3GALNT1;B3GNT8
prerank,negative regulation of lyase activity (GO:0051350),0.42644625364913513,0.9350959898840819,0.5727391874180865,0.9540713248210975,1.0,3/16,9.26%,GNAI3;PALM;LTB4R2
prerank,regulation of cell cycle process (GO:0010564),0.3355246378711049,0.9346730866866791,0.6138917262512769,0.9545533628103345,1.0,28/104,23.67%,TIPIN;ATF5;CCDC8;AHCTF1;FSD1;FLCN;NUDT16;KIF20B;FBXO5;SETD2;PRPF40A;CALM2;PIN1;CUL9;BBS4;DBF4;DYNC1H1;CEP85;E4F1;CCP110;TTL;YTHDF2;ENTR1;NUMA1;KLHL9;USP19;CSNK2A2;RAB11FIP3
prerank,cholesterol homeostasis (GO:0042632),-0.23642491815481398,-0.934399107441399,0.6666666666666666,0.8426488792765483,1.0,10/64,8.48%,CYP7B1;GRAMD1B;APOE;SCARB1;TTC39B;NR1H3;ABCG1;CAV1;LDLRAP1;EPHX2
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.443853171963656,0.9343045788032023,0.5481682496607869,0.9548772864545175,1.0,6/12,28.82%,DGKQ;SREBF1;LPCAT3;KPNB1;MBTPS1;SREBF2
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.33505513602267484,0.9341285075756633,0.636085626911315,0.9547572152721268,1.0,40/119,25.18%,TTC7A;FGF2;PIK3C2B;PIK3R2;SOCS2;PIGZ;PI4K2B;FIG4;OCRL;INPP5F;PIK3CA;ARF1;INPP5K;PIGC;PLEKHA4;MPPE1;MBOAT7;RUFY1;INPP4A;PLEKHA1;PIGW;PI4KB;PIGM;MTMR6;PI4KA;MTMR1;SOCS6;PIP4K2C;CDIPT;PITPNM1;IP6K1;PIP4K2B;PTEN;PIK3CG;PI4K2A;TTC7B;PIGL;DPM2;MTM1;SLC27A1
prerank,phagolysosome assembly (GO:0001845),0.4489817375614479,0.9339373454825799,0.5567715458276333,0.9547175590220469,1.0,1/12,2.11%,RAB7B
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.44564960167600265,0.9337794616942803,0.5527777777777778,0.9545709569142634,1.0,2/11,9.18%,CD177;STX4
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.35963276282902745,0.933721059077789,0.5900900900900901,0.954195974660693,1.0,6/42,12.09%,MYOC;VEGFA;S100A10;PTPRJ;CCL25;JUP
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),-0.2620218976323635,-0.9335525852636984,0.5901639344262295,0.8431239522903771,1.0,6/39,4.66%,NEDD4L;DMD;OSR1;WNK4;YWHAH;PRKCE
prerank,regulation of lamellipodium organization (GO:1902743),0.4313881948745457,0.9334865496210527,0.5832223701731025,0.954246794628274,1.0,5/14,25.16%,CD44;TWF1;FER;DMTN;RAC1
prerank,negative regulation of cellular senescence (GO:2000773),-0.3419870121360636,-0.9334392257713973,0.5182186234817814,0.8416590260208834,1.0,8/13,23.58%,SLC30A10;CDK6;MAP3K3;SIRT1;TERT;RBL1;TERF2;HMGA2
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.3411446079845912,0.9326531701950551,0.576017130620985,0.9557264780887303,1.0,9/67,9.97%,NCF4;PSMC4;ITGB5;SEC22B;PSMC6;CHUK;PSMD8;SNAP23;ITGAV
prerank,negative regulation of mononuclear cell migration (GO:0071676),0.43737157224939105,0.9325847174079106,0.5843454790823212,0.9553739822048137,1.0,7/12,27.25%,SLIT2;MIA3;AKT1;NBL1;CCN3;DUSP1;WASL
prerank,regulation of execution phase of apoptosis (GO:1900117),0.44812499728643984,0.9325818860155349,0.5576923076923077,0.9548649544906794,1.0,3/11,14.08%,FAP;SIRT2;ZC3H12A
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.380882455143223,0.9321843759086093,0.5757575757575758,0.955282803336246,1.0,4/29,13.08%,PKP3;TENT5B;LARP1;GDNF
prerank,regulation of endocytic recycling (GO:2001135),0.45036779859064985,0.9321491974376247,0.5720221606648199,0.9548506548624452,1.0,4/11,15.34%,ATP9A;INPP5F;EHD2;PLA2G4E
prerank,pyrimidine nucleobase metabolic process (GO:0006206),-0.3493958388763191,-0.9320926314229822,0.5176056338028169,0.8433704986059223,1.0,3/12,8.77%,DPYD;CTPS1;CTPS2
prerank,positive regulation of cellular amide metabolic process (GO:0034250),0.33973826433373405,0.9319289122283727,0.6251319957761352,0.954833072692796,1.0,29/80,27.70%,NIBAN1;SMPD3;MTOR;LARP4;HNRNPD;NPM1;PASK;EIF6;RPS27L;BCL3;ZCCHC4;POLDIP3;RBM3;EIF3E;IL6;EIF3D;FXR2;CHRNA7;YTHDF1;PCIF1;NSMAF;YTHDF3;LRRTM3;RELA;LARP6;UPF3B;SLC2A13;PRKDC;IFNGR1
prerank,cellular response to glucose stimulus (GO:0071333),0.37565719959566124,0.9317114817962348,0.5866188769414575,0.954835342190695,1.0,6/30,12.54%,RAB11FIP5;SLC39A14;MLXIPL;GAS6;ERN1;ADCY8
prerank,cellular response to ATP (GO:0071318),0.43231583392317463,0.9315156454448884,0.5683646112600537,0.9547932703991496,1.0,2/14,11.00%,P2RX3;SSH1
prerank,negative regulation of receptor internalization (GO:0002091),0.444447207586463,0.9307460445446382,0.5695006747638327,0.9561130180271618,1.0,2/12,7.92%,DLG4;ATXN2
prerank,sulfate transport (GO:0008272),-0.3354295467910549,-0.9306739883869943,0.5217391304347826,0.8452221997971188,1.0,2/14,1.69%,SLC13A4;SLC26A7
prerank,sphingoid metabolic process (GO:0046519),0.4421333364625853,0.9301455080554754,0.5547945205479452,0.95696550815376,1.0,4/12,24.28%,PLPP3;PLPP1;PLPP2;SGPP1
prerank,peptide hormone secretion (GO:0030072),0.3890867259797665,0.9297392915234407,0.5716019417475728,0.9573744085053517,1.0,5/26,18.84%,ANXA1;ADCYAP1;CRHR1;IL6;RIMS2
prerank,mesenchyme development (GO:0060485),-0.3415741883772544,-0.9297003244962101,0.5210727969348659,0.8459726624529018,1.0,4/15,10.58%,BMP7;FGFR2;BMPR2;BMP2
prerank,positive regulation of pseudopodium assembly (GO:0031274),0.45687348903120995,0.9295163437836863,0.5782122905027933,0.9568486885835145,1.0,1/10,3.21%,CDC42EP2
prerank,regulation of pseudopodium assembly (GO:0031272),0.45687348903120995,0.9295163437836863,0.5782122905027933,0.9568486885835145,1.0,1/10,3.21%,CDC42EP2
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.33290437580527177,-0.9293396028952857,0.5582329317269076,0.8451142826063015,1.0,2/14,2.54%,AUTS2;KMT2E
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.3465882214156024,0.9292303861804269,0.6150537634408603,0.9570188542850049,1.0,12/60,16.31%,HNRNPA1;FGF2;SMOC2;PRKD2;ACD;POLG2;CCT7;XRCC5;KLF4;HSP90AA1;RFC4;HGF
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.3820768331471917,0.9289714394841871,0.5757575757575758,0.9570812645283779,1.0,12/27,30.09%,BHLHE40;RBM4;FBXL3;PER1;PPP1CC;PML;PER3;FBXL12;CRY2;CRTC1;TP53;FBXL8
prerank,positive regulation of exocytosis (GO:0045921),0.372676784686408,0.9287270569439166,0.6038592508513053,0.9571165992023785,1.0,12/35,26.39%,SMPD3;VPS4B;RAB3D;ATP6AP1;RAB27B;RAB2B;CLASP2;PDCD6IP;SDCBP;STAM;SDC4;CFTR
prerank,positive regulation of locomotion (GO:0040017),0.3790060492849069,0.9285860119211251,0.5897129186602871,0.9569110242348363,1.0,5/27,13.57%,DUOX1;NTN1;STX4;CCDC25;TWIST1
prerank,long-term memory (GO:0007616),0.4089411008063446,0.9285707190400215,0.5641677255400254,0.9564280884991649,1.0,2/19,5.07%,RASGRF1;NFATC4
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.4174552256299042,0.9279830937089731,0.5827067669172933,0.9572275621285216,1.0,5/17,24.49%,ANK2;SCN4B;AKAP9;KCNH2;CACNA2D1
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.3216279043936498,0.9276359660245042,0.7074148296593187,0.9575042652355119,1.0,90/259,27.68%,GSN;NME8;PMP22;CDC14B;EMP3;ABLIM1;EMP1;PKD1;RAB23;FHDC1;RAP1B;ARF4;FSCN1;NTN1;S1PR2;ACTR3;HDAC6;BBS9;ATAT1;ARL13B;FXYD5;TMEM138;OCRL;CPLANE1;CNGB1;EHD2;INPP5K;NUDCD3;DZIP1;TTC39C;AVIL;TEKT5;VSTM5;PIBF1;DYNC2I2;KIF3A;RPGR;KIF3B;IFT46;TTLL3;BBS4;ARF6;TTC8;ATP6V1D;AHI1;SRGAP2;CEP164;PPP1R9B;DYNC2H1;CEP89;SHTN1;DYNC2I1;CEP83;CCDC28B;RP2;BBS5;BBIP1;IFT52;EXOC4;STK26;CC2D2A;SPAG16;FLNA;PCM1;DNAH5;FBF1;TMEM231;CCDC88A;SDCBP;TCTN2;RAB11FIP3;PDE6D;DYNLL1;DMTN;TCTN1;RAC1;CDC14A;NEK1;CYFIP1;CEP126;RAB1A;CFAP70;SPATA13;RAP1A;GBF1;ARHGEF7;FUZ;IFT81;PTPDC1;RAB8B
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.35562379158290014,0.9274734875314374,0.6065217391304348,0.957378178134627,1.0,7/53,7.06%,GLMN;DESI1;PKD1;RHBDF1;RAD23B;PSMC6;UCHL5
prerank,cellular protein modification process (GO:0006464),0.3162954455450587,0.9274133359269211,0.839,0.9570063017916877,1.0,270/982,25.75%,PLOD2;COL3A1;IGFBP5;FSTL1;SYK;FBN1;LOXL2;LORICRIN;PARP3;WSB1;DCLK1;ST3GAL2;PRKCA;TNK1;ANXA1;TIMM50;FGFR1;RABGGTA;STK25;CEL;EIF2AK3;CDC14B;GPC3;PSMC4;PRSS23;B3GALNT1;CDKL2;FYN;IRAK3;SGK3;SGK2;TGFB2;SPSB1;LMTK3;SPSB4;CDK14;TGFBR2;PIGT;PTPRS;FUT2;TAOK3;GPAA1;ART4;COPS5;ACVR1;CDK4;BMP15;IGFBP4;KRT10;FBXW8;GGCX;CALU;MGAT1;VCAN;MTOR;MIA3;PTPRJ;SOCS2;CCDC8;WDTC1;CAMK2D;PHKA2;CSK;COP1;TULP4;GAN;ILKAP;RET;ARF4;PSMC6;TBCK;PTPRF;SPSB2;MELTF;PARP6;ABL2;GAS6;STRADA;OGA;PRKD2;TNNI3K;FBXO2;CHUK;PPP5C;TESK2;PSMD8;FBXO17;CTDSP2;CUL3;DTL;DUSP11;CDK9;PPM1G;SENP8;SIRT2;CDK20;FBXL2;ASB12;FBXW4;AKT3;BMP2K;NRBP2;LGALS1;WIPI2;FBXL20;LOXL1;ERN1;DYRK2;ALG1;LARGE1;WDR5;WDR45B;FUT9;B3GNT8;RAB2A;ZC3HAV1;AMHR2;CSNK1G3;PPP3CC;CAMKK2;SSH1;PARP14;AKT1;MAP3K6;RNF7;DCAF6;HS3ST5;ST3GAL4;IRAK1;PPEF2;FBXO31;PASK;STK39;UBA52;CDC34;PXK;PIGS;TAOK2;DDB1;FBXL3;P3H1;DCAF13;ASB8;CUL9;ULK1;FER;RCE1;TRIOBP;STK24;STK3;PIGK;CTDP1;PPP3CA;PPP2R1B;MTMR6;EVPL;KLHL41;MXRA8;NGLY1;SOCS6;DCAF10;B3GALNT2;IL6;PPP1CC;SDC2;KEAP1;UFL1;PPP2R5B;CHRDL1;RAB1B;FBXL5;NEK4;PDP2;FBXO11;PTPN5;ST3GAL1;ILK;ST3GAL3;ADPRH;METAP2;TGFBR1;COPS4;GMFB;LOX;STK38;SDHAF2;NEDD8;SKP2;NEK7;PPP3CB;PPP2R2A;DDOST;UBE2D3;LAMC1;KCTD6;CTBP1;OXSR1;HIPK3;STK26;FBXL19;PTPN3;FBXW9;FBXW2;QSOX1;PPM1A;CUL5;PRKCSH;ACVR2A;BMPR1A;MAPK1;SRPK1;PTEN;METAP1;PPP6C;ICMT;YES1;ATG3;METAP1D;CSF1;KLHL9;BRD2;CDKL4;SUMF2;OGFOD1;FBXW11;JMJD7;CDC25B;KLHL22;CSNK1G2;SPSB3;ATG10;FUT10;CTDSP1;PTPN18;LHPP;DCAF5;UST;PICK1;KLHL11;PSMD3;VRK2;FAM20B;LATS1;BCR;WNK2;GPS1;STK10;FBXL12;PSMD4;PRKCZ;MMP15;ACVR1B;MARK2;RARA;CDKL1;MTM1;DNAJC3;RABGGTB;SERPINC1;UBA7;NRBP1;NEK1;HSP90B1;CTH;VHL;FBXO22;PARP16;RAB1A;FBXW7;FBXO30
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.4188921106526229,0.9273576063933485,0.5810983397190294,0.9566286128300109,1.0,2/17,5.71%,IGFBP5;DOCK7
prerank,"phototransduction, visible light (GO:0007603)",0.4254759372949457,0.9272268304361936,0.5727272727272728,0.9564354436108302,1.0,3/14,13.76%,CNGB1;SAG;GNB1
prerank,second-messenger-mediated signaling (GO:0019932),0.3373073038869265,0.9271995355037562,0.6233090530697191,0.9559809256158958,1.0,8/82,10.97%,ACKR3;EIF2AK3;PLCE1;RCAN3;MCU;ACKR4;RCAN1;CAMKK2
prerank,regulation of phosphatase activity (GO:0010921),0.38884074180420675,0.9270868546120932,0.5675675675675675,0.9557464601656572,1.0,10/24,28.88%,PPP6R2;URI1;CHP1;SH2D4A;TIPRL;HSP90B1;PPP1R26;TSC1;PTPA;GPATCH2
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.3567611958160933,0.9268780325878092,0.574468085106383,0.955696583526303,1.0,14/41,26.25%,FGF2;F2R;TRPV3;ATP2B4;GRIN2D;PKD2;SLC8A2;GRIN2A;HTR2C;IBTK;HTR2A;CACNA2D1;TRPV2;SLC24A2
prerank,dendrite morphogenesis (GO:0048813),0.36667052005961503,0.9266424756777375,0.5877502944640753,0.9557422350081253,1.0,13/35,21.43%,EPHB2;DLG4;FARP1;EPHB3;TAOK2;MAP6;CTNND2;DIP2A;SDC2;CHRNA7;EPHB1;PTEN;ABITRAM
prerank,sterol homeostasis (GO:0055092),-0.23528089399659285,-0.9266240555574764,0.6481481481481481,0.8500192197398105,1.0,10/65,8.48%,CYP7B1;GRAMD1B;APOE;SCARB1;TTC39B;NR1H3;ABCG1;CAV1;LDLRAP1;EPHX2
prerank,Golgi to lysosome transport (GO:0090160),-0.36518521961649825,-0.9263884125372989,0.5587188612099644,0.8488246765090709,1.0,5/11,23.77%,SORT1;AP1G1;CLN3;EHD3;CCDC91
prerank,regulation of monocyte chemotaxis (GO:0090025),-0.27773507300418143,-0.9263551087323476,0.5449101796407185,0.8472116569072164,1.0,3/24,4.18%,LYN;HMGB1;CXCL12
prerank,cellular response to hydroxyurea (GO:0072711),0.4603929005548244,0.9262460861230418,0.5673758865248227,0.956110732947812,1.0,5/10,29.30%,DDX11;SPIDR;BLM;NSMCE3;ATRX
prerank,ATP transport (GO:0015867),0.4627274810978955,0.9262179488784806,0.5832167832167832,0.9556565646962432,1.0,3/10,14.88%,SLC25A4;CD47;SLC25A17
prerank,regulation of sequestering of calcium ion (GO:0051282),0.44604431263516126,0.9254746114373207,0.5866302864938608,0.9568568591917062,1.0,3/12,15.01%,ANK2;CASQ1;DIAPH1
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.3687714833771051,0.9253904985224192,0.5962877030162413,0.9565315233252067,1.0,20/37,32.66%,DYNC2I2;KIF3A;KIF3B;IFT46;DYNC2LI1;DYNC2H1;DYNC2I1;IFT52;PCM1;IFT57;DYNLRB1;DYNLL1;TNPO1;KIFAP3;IFT81;IFT20;KIF3C;IFT172;TRAF3IP1;KIF17
prerank,regulation of ion transmembrane transport (GO:0034765),-0.2558505946471894,-0.9253759447230702,0.5923566878980892,0.8476850697618586,1.0,6/33,12.81%,NEDD4L;AHCYL1;WWP2;KCNQ1;KCNJ12;AKAP6
prerank,sprouting angiogenesis (GO:0002040),0.3512277633038998,0.925135356396287,0.589010989010989,0.9566291110620655,1.0,7/51,7.54%,CCBE1;LOXL2;VEGFA;FGF2;SLIT2;MIA3;ESM1
prerank,response to sterol (GO:0036314),0.4549980759163621,0.9251158052781597,0.5712270803949224,0.9561761459996614,1.0,4/11,22.61%,TGFBR2;PMVK;TGFBR1;RORA
prerank,regulation of MAPK cascade (GO:0043408),0.322428431953291,0.925048003021219,0.6680203045685279,0.9558300936008676,1.0,27/157,16.45%,SYK;LIF;MYOC;EGFR;FGFR1;FGF2;F2R;PIK3R2;LPAR1;TAOK3;TMEM106A;PTPRJ;RET;RIT2;DHX33;IQGAP1;PRDM15;GPR37L1;PPEF2;EGF;TAOK2;FLT3;GPR37;STK3;MAP2K2;IL6;NBR1
prerank,regulation of cell death (GO:0010941),0.3342165867938267,0.9246866322507938,0.6504653567735263,0.9561586360050914,1.0,28/94,27.96%,SNCB;LRP1;SRSF6;CCN5;PDE8A;FGF2;VPS4B;TNFRSF1B;ZC3H12A;DCC;CHP1;NCK1;SARM1;CHRNA7;SRGAP2;EPHB1;RRAS2;DUS2;CRYAB;CCN3;NOA1;RAB29;PARP16;EIF4G1;ADNP2;TSC1;CELF1;IMPACT
prerank,purine-containing compound salvage (GO:0043101),0.4313790720781022,0.9244702493483267,0.5933609958506224,0.956131404558862,1.0,1/12,2.31%,AMPD2
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.32716013945994465,0.9244024486524989,0.648870636550308,0.9557725783458126,1.0,17/117,14.19%,SYK;VIPR2;FYN;MAPK14;GLP2R;SRC;ADCYAP1;DPEP1;CRHR1;CD81;GPR20;CALCA;GPR45;TSHR;ADCY8;GNB1;LHCGR
prerank,sister chromatid segregation (GO:0000819),0.3692709830606521,0.9239819994209496,0.5813397129186603,0.9562155590701968,1.0,9/31,24.04%,CHAMP1;ZW10;ZWINT;SMC1A;INO80;TOP2B;KLHL22;TUBG2;LATS1
prerank,DNA double-strand break processing (GO:0000729),0.40651788468579486,0.923749500164436,0.5593008739076155,0.9562401341582284,1.0,6/18,18.32%,UBE2N;DNA2;NBN;RNF138;RAD50;BLM
prerank,glucose import (GO:0046323),-0.33858659006013436,-0.9235431421079863,0.5578512396694215,0.8504028037213187,1.0,2/13,1.84%,SORT1;SLC2A1
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),0.45409706034825836,0.9234880459822212,0.5881523272214386,0.9563400259493622,1.0,2/10,11.61%,MLXIPL;ELOVL5
prerank,regulation of DNA damage checkpoint (GO:2000001),0.45894650109320734,0.9229144695907636,0.5900709219858156,0.9571062683064749,1.0,3/10,14.71%,RFWD3;ETAA1;THOC1
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.340414033117905,0.9225276235959633,0.6374085684430512,0.9574549384012199,1.0,18/74,19.36%,AR;SCRT2;MAPK7;TMBIM1;ACVR1;TCF7L2;SRC;PELI3;EYA2;ITGAV;GPX1;AKT1;GDNF;IL4;SNAI2;FAIM2;TGFBR1;MCL1
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.4060147954453923,0.9223754767295483,0.5805194805194805,0.9573002159683243,1.0,5/18,16.30%,SMAD4;SRC;CBL;FER;IL6
prerank,phosphatidylinositol metabolic process (GO:0046488),0.3309173802161724,0.9223341530509236,0.6519959058341863,0.956889418317354,1.0,30/109,21.28%,MTMR11;FGF2;PIK3C2B;PIK3R2;PI4K2B;FIG4;OCRL;INPP5F;PIK3CA;ARF1;INPP5K;PLEKHA4;MBOAT7;RUFY1;INPP4A;PLEKHA1;PIGW;PI4KB;MTMR6;PLA2G4E;PI4KA;MTMR1;PIP4P1;PIP4K2C;CDIPT;INPP5B;PITPNM1;PIP4K2B;PTEN;PIK3CG
prerank,negative regulation of protein polymerization (GO:0032272),0.379859324678288,0.9222262726967526,0.5842424242424242,0.956633942622284,1.0,11/27,21.54%,SLIT2;MYADM;PFN2;TWF1;KANK1;MAPRE1;SSH1;TUBB4A;CLIP3;ARFGEF1;SSH3
prerank,response to calcium ion (GO:0051592),0.3291227470147468,0.9219908044956845,0.6287487073422957,0.9566760886664522,1.0,13/102,9.19%,KCNMA1;SYT2;NEUROD2;CPNE8;ADAM9;SYT12;SYT11;SEC31A;SYT13;CAMK2D;PKD2;DPEP1;IQGAP1
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.36465092722118464,0.921723817357774,0.5747126436781609,0.9568233833913324,1.0,12/37,25.36%,MAPK14;IL17RA;TLR4;SIRPA;ZC3H12A;PDCD4;PER1;IL6;PYCARD;CUEDC2;CHID1;TICAM1
prerank,dendritic cell migration (GO:0036336),-0.3163494484815851,-0.9215845148017515,0.5481171548117155,0.8536177453101694,1.0,2/16,2.72%,EPS8;HMGB1
prerank,epithelial tube morphogenesis (GO:0060562),0.3778408194606893,0.9214920580010652,0.594626168224299,0.9568352731106731,1.0,6/32,7.86%,SLIT2;PKD1;ACVR1;GLI2;PRKD2;PKD2
prerank,aortic valve morphogenesis (GO:0003180),0.3773330397617818,0.921440430096453,0.5961768219832736,0.9564574272563765,1.0,8/30,16.60%,SLIT3;SLIT2;ELN;NFATC1;JAG1;SMAD6;TWIST1;SNAI2
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.35414024514461445,0.9213901901856983,0.6138165345413363,0.9560641736599805,1.0,5/43,5.95%,WT1;FGF2;TGFB2;NFATC4;NFIB
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.3350588510942257,0.9207905499775527,0.6271008403361344,0.9569101043853436,1.0,11/75,12.39%,MGLL;PLCE1;DGKQ;GNG4;SLC39A14;ZDHHC7;ADCYAP1;CNGB1;USP33;SAG;KLK6
prerank,negative regulation of cilium assembly (GO:1902018),0.4319910861615167,0.9206906138631263,0.5829903978052127,0.9566346755704112,1.0,5/12,18.49%,CEP97;MAP4;EVI5L;CCP110;ODF2L
prerank,mitochondrial membrane organization (GO:0007006),0.3714315695969436,0.9202746183317327,0.5892018779342723,0.9571068031590075,1.0,10/32,21.87%,TIMM50;SLC25A31;SLC25A4;BAK1;GHITM;SPG7;RCC1L;MICOS10;APOOL;IMMT
prerank,thymus development (GO:0048538),0.4287251439085974,0.920231639462087,0.5887978142076503,0.9566977534999761,1.0,6/13,27.08%,ZBTB1;EPHB3;SIX1;TGFBR1;FGF10;HES1
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.31431684094007495,0.9201711097428823,0.782,0.9563237110951567,1.0,76/509,14.13%,DCN;LIF;AREG;MYOC;CD80;ESR1;FGF18;AXL;FGF7;EGFR;AKAP13;IRS1;FGFR1;MIB2;BTC;FYN;NEUROD2;VEGFA;FGF2;TGFB2;ECM1;MST1R;F2R;MIF;S100A8;S100A9;PIK3R2;LPAR1;MID2;TMEM106A;P2RX3;TCF7L2;PTPRJ;CARD16;C1QBP;RET;CGAS;SRC;RIT2;GAS6;DHX33;FLCN;UBE2N;TFG;PRKD2;FLT3LG;CHUK;PPP5C;PIK3CA;SIAH1;TIRAP;TLR4;IQGAP1;LGALS1;ITGAV;HDAC3;IRAK4;DDX21;BMF;GPR37L1;PUM1;IRAK1;LRRC19;IRS2;CD27;EGF;NDFIP1;BBC3;SMCR8;FLT3;TRAF3IP2;RHOA;RRAGD;GPR37;CBL;PDGFRA
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.35954244728392876,0.9200090776532555,0.6065388951521984,0.9561945228881779,1.0,10/40,19.36%,RFWD3;ETAA1;UBE2N;CDK9;PARG;MAPT;FBXO5;FXR2;NEK4;MCL1
prerank,organic anion transport (GO:0015711),0.3369773937635752,0.9199208066271727,0.6136125654450262,0.9558836164013618,1.0,11/76,13.02%,SLCO2A1;SLC4A10;LRRC8D;SLC4A8;SLC4A3;SLC35B1;SLC25A4;SLC4A4;SLC26A6;SLC2A10;SLC23A1
prerank,icosanoid secretion (GO:0032309),0.4282323928249572,0.9197987230841635,0.5795918367346938,0.9556674686140579,1.0,2/12,11.43%,ANXA1;PNPLA8
prerank,male meiosis I (GO:0007141),0.4154782310755607,0.9197524637717663,0.5901201602136181,0.9552744506923224,1.0,3/16,18.65%,SLC25A31;DDX4;FOXJ2
prerank,plasma membrane invagination (GO:0099024),0.37426606975201643,0.9196879116568544,0.5838218053927315,0.954927996710976,1.0,1/29,0.45%,GSN
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),-0.268430030652588,-0.9196089883619162,0.5977653631284916,0.8568702822970521,1.0,9/27,16.89%,PRKCH;PPARA;NR1H3;ABCG1;AGTR1;NFKBIA;MAPK9;LPL;ABCA5
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.32373087269059986,0.9194191891267723,0.6787878787878788,0.9550360952942949,1.0,15/151,9.03%,ACKR3;CCL8;PRKCA;EGFR;CD44;PDE8A;FGF2;F2R;MIF;ADCYAP1;GAS6;PRKD2;NDRG4;TIRAP;CCL25
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.36290475761202184,0.9193107846584239,0.6054732041049031,0.9547848703010045,1.0,9/37,17.66%,S100A8;S100A9;SIAH1;BMF;BBC3;NACC2;NUPR1;NCK1;BCAP31
prerank,reverse cholesterol transport (GO:0043691),-0.34960246123429817,-0.9192458752477985,0.5387755102040817,0.8560931512414933,1.0,3/13,5.81%,APOE;SCARB1;ABCG1
prerank,regulation of programmed cell death (GO:0043067),0.3204260183422802,0.9192050221449627,0.6827794561933535,0.9545227673353662,1.0,28/161,15.91%,TNFSF9;RABGGTA;TRIAP1;GAS1;STEAP3;USP36;DDX42;CXCL10;TARDBP;AIFM2;HS1BP3;SLK;TIGAR;BEX2;LGALS1;ALPK2;BCL6;AKT1;ANP32B;GLS2;FLT3;BCL3;DNAJA3;NME2;HSP90AA1;RSL1D1;NOP53;MADD
prerank,regulation of mRNA catabolic process (GO:0061013),0.32654373379277585,0.9187872889500117,0.65439672801636,0.9549710175600247,1.0,47/121,31.73%,PRKCA;PKP3;PSMC4;ZFP36L1;SAMD4B;PSMC6;RC3H1;CARHSP1;ZFP36L2;PSMD8;HNRNPD;EXOSC7;ZC3HAV1;AKT1;PUM1;IGF2BP1;UBA52;ZFP36;ZC3H12A;EXOSC1;FXR2;YTHDF1;YTHDF2;SET;RC3H2;YWHAB;YTHDF3;PSMD3;PSMD4;RBM24;TNPO1;PSMB3;DCP1A;EIF4G1;UPF1;PSMB2;PSMD5;IGF2BP3;SERBP1;HSPA8;EXOSC3;PSMD14;PSMC3;PSMC5;CNOT8;FXR1;PSME4
prerank,neuromuscular junction development (GO:0007528),-0.2904341390228066,-0.9185555039544654,0.5846153846153846,0.8560481740195612,1.0,5/24,5.48%,UNC13B;PDZRN3;UNC13C;CACNB2;PPFIBP2
prerank,negative regulation of transport (GO:0051051),0.3481365139128176,0.9181185142065728,0.6131868131868132,0.9559565199150453,1.0,10/51,12.49%,EPHA3;ITGB3;SYT11;SCAMP5;ITGAV;SIRPA;YRDC;EGF;NDFIP1;PXK
prerank,histone exchange (GO:0043486),0.36311989708981934,0.9179804245471224,0.5929304446978335,0.9557655038689216,1.0,9/37,22.38%,CENPT;SPTY2D1;HJURP;NPM1;DMAP1;SRCAP;CENPC;ZNHIT1;VPS72
prerank,positive regulation of establishment of protein localization (GO:1904951),0.40550828090967983,0.9167117976342012,0.5922693266832918,0.958079577781754,1.0,3/18,15.25%,CORO2B;CCT7;CHP1
prerank,regulation of cell-matrix adhesion (GO:0001952),0.33813077793020835,0.9164550839983899,0.6257928118393234,0.9581169525421126,1.0,17/64,22.52%,MYOC;EFNA5;EPHA3;SLK;JAG1;CCL25;SLC9A1;JUP;ADAM15;RHOA;HOXA7;ACTG1;RASA1;CORO1C;CSF1;NF1;LDB1
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),-0.2949560709796285,-0.9163816585217734,0.5775862068965517,0.8596573382177911,1.0,1/20,0.16%,NR2F2
prerank,regulation of cellular respiration (GO:0043457),-0.3119581132764317,-0.9156996831627197,0.6055045871559633,0.8595098476612187,1.0,4/17,7.69%,IFNAR1;CBFA2T3;IL10RB;PRDM16
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.3409605231993408,0.9156734125448275,0.6062906724511931,0.9593718608217903,1.0,16/59,21.82%,OSBPL3;ACLY;OSBPL2;SCP2;HSD3B7;OSBPL6;NDUFAB1;GAMT;ALDH1A3;HSD17B8;LIPC;LIPH;ABCD3;MCAT;HSD17B4;SRR
prerank,regulation of protein polymerization (GO:0032271),0.36787716218649463,0.9156661667715907,0.6018518518518519,0.9588863303793488,1.0,13/35,21.98%,DBN1;MAPRE3;PFN2;CAMSAP1;MAPT;GBA2;FCHSD1;TPPP3;HSP90AA1;COTL1;RASA1;ABITRAM;CTTN
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),0.3993269050586077,0.915563348103818,0.5912596401028277,0.9586030140472592,1.0,4/17,5.30%,VEGFA;FGF2;SLIT2;MIA3
prerank,histone deubiquitination (GO:0016578),0.401279506599734,0.915537781684289,0.597911227154047,0.9581577007612407,1.0,5/18,20.88%,USP36;ATXN7L3;USP7;USP22;TRRAP
prerank,regulation of brown fat cell differentiation (GO:0090335),-0.31720036712085986,-0.9151328768847902,0.591304347826087,0.859081236183095,1.0,5/16,10.54%,BMP7;SOX13;NAPEPLD;PTGS2;SIRT1
prerank,photoperiodism (GO:0009648),0.3752993021105241,0.9151327227972794,0.5900846432889963,0.9585415171222916,1.0,12/28,30.09%,BHLHE40;RBM4;FBXL3;PER1;PPP1CC;PML;PER3;FBXL12;CRY2;CRTC1;TP53;FBXL8
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),-0.29462664015774853,-0.9148746337525857,0.6185567010309279,0.8562807863210018,1.0,3/21,2.46%,EYA1;BCL2L1;BCL2
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.29462664015774853,-0.9148746337525857,0.6185567010309279,0.8562807863210018,1.0,3/21,2.46%,EYA1;BCL2L1;BCL2
prerank,tRNA methylation (GO:0030488),0.36755498975117123,0.9146971555640618,0.5872291904218928,0.9590326812182883,1.0,7/34,15.07%,PRORP;TYW3;TRMT61A;FTSJ1;DALRD3;THADA;TRMT1
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),-0.3624763416030051,-0.9146636982746936,0.564748201438849,0.8551180724626826,1.0,3/11,6.64%,NOVA2;PCBP3;IGF2BP2
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.33161542163286767,0.9143459711243078,0.6358811040339702,0.9593119805840408,1.0,22/76,22.77%,IRAK3;ITCH;PRMT2;CHUK;IRAK1;NWD1;COMMD6;ZC3H12A;KLF4;USP7;CHP1;NLRP2B;TRAF3;RBCK1;ANXA4;UFL1;TAX1BP1;DAP;PYCARD;ARRB1;CYP1B1;CYLD
prerank,apical protein localization (GO:0045176),0.45054225601825204,0.9141914704079057,0.5899705014749262,0.9591493868757927,1.0,5/10,20.67%,ATP8B1;JAM3;VANGL2;GOPC;SHROOM3
prerank,positive regulation of positive chemotaxis (GO:0050927),0.4092774609027511,0.9141800139398307,0.5822281167108754,0.9586737769382635,1.0,2/15,2.76%,IL16;VEGFA
prerank,cellular response to glucose starvation (GO:0042149),-0.2583339588983932,-0.9140974979157902,0.5982142857142857,0.8548615105485289,1.0,5/41,4.59%,PRKAG2;SIK2;NUAK1;PRKAA2;NIM1K
prerank,organelle organization (GO:0006996),0.31461156239431864,0.9139607616245601,0.755,0.9586805035391617,1.0,115/388,25.95%,SEC16B;ATP8B1;ARHGAP21;ARHGAP10;EIF2AK3;PLCE1;RAB32;ODF2;DIAPH3;PEX16;TMED1;BIN1;SEC31A;FBXW8;TOR1AIP2;ZRANB1;CLUH;ZW10;CHMP7;DST;MIA3;VPS4B;PLEKHF1;CENPT;LYSMD3;RAB30;PI4K2B;MAST4;SYNE1;MIEF2;PKD2;SURF4;LARP4;LMAN1;TOR1A;STX4;POLG2;RAB2A;SEC23IP;CAMSAP1;MICAL2;PRPF40A;LNPK;STX17;KIF3A;RAB43;CCL13;HPS6;PALLD;WDR73;FMNL3;DNAJA3;PEX12;FANCG;PTCD2;BCAS3;PEX1;GEM;DIAPH1;SEC61A1;FAM161B;ANK1;PEX3;BLZF1;HACE1;REEP5;PPIA;YTHDF1;YTHDF2;DYNC2H1;BCS1L;AUP1;VPS11;MICAL1;RANBP10;SLC25A36;ABCD3;SH3D19;ARFGEF1;TMED2;PLD2;VPS13D;CLASP2;NUMA1;PEX2;SLC25A33;ATP8B2;ZMYM3;TJAP1;PDCD6IP;GABPA;PI4K2A;YTHDF3;AFG1L;GOLPH3L;PACSIN2;PACSIN3;TRAPPC12;CNTNAP1;SYNE3;BNIP1;ESRRA;CFAP126;BAG5;RAB18;DMTN;CEP78;STX7;ATP5F1B;RAB29;ATL1;RHOT2;RAB1A;STRIP1;ZMYM6
prerank,regulation of chemotaxis (GO:0050920),-0.2705284359803829,-0.9139233241225648,0.6272189349112426,0.8535779317348079,1.0,9/30,14.70%,EFNB2;ZSWIM6;THBS1;USP14;PDGFRB;PTPN2;TGFB1;PPM1F;ADGRA2
prerank,defense response to protozoan (GO:0042832),0.43210948217562717,0.9139031097382022,0.5934065934065934,0.9583065679447481,1.0,1/12,1.14%,IRF4
prerank,organic substance transport (GO:0071702),0.32218943784937754,0.913382884469186,0.6707317073170732,0.9589408823354617,1.0,20/121,13.57%,SLCO2A1;DISP1;SLC50A1;ARRDC2;SLC47A1;MIA3;TOM1;SCAMP3;RCN3;ABCG4;ABCA1;SCAMP5;TCN1;ABCA13;SLC6A4;LRP1B;RUFY1;KIF3A;SLC23A1;CMTM6
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.3367005993879526,0.9132527874906332,0.6237837837837837,0.9587312430927468,1.0,10/61,12.44%,COL3A1;AKAP13;F2R;LPAR1;RASGRF1;RASGEF1A;ARHGEF3;GPR20;IRS2;SHOC2
prerank,histone deacetylation (GO:0016575),0.3493895447101107,0.9131743666125763,0.6143344709897611,0.9584095059914098,1.0,12/43,20.08%,HDAC9;HDAC6;SIN3B;MSL3;SIRT2;RCOR3;HDAC3;HDAC4;PER1;MORF4L1;SUDS3;MIER1
prerank,regulation of nervous system development (GO:0051960),-0.25547714613034117,-0.9129261562510257,0.583941605839416,0.8543738560643054,1.0,6/37,9.29%,PTN;TENM4;PTPRZ1;HEYL;CX3CL1;YAP1
prerank,cranial nerve development (GO:0021545),-0.36405507263034664,-0.9129127687519455,0.5220588235294118,0.8527444649342308,1.0,2/11,6.44%,CHD7;SALL1
prerank,pulmonary valve development (GO:0003177),0.4051325026255528,0.912846652946298,0.6015424164524421,0.9586403638560704,1.0,6/18,13.72%,TGFB2;SLIT2;NFATC1;JAG1;SMAD6;TNFRSF1B
prerank,striated muscle cell development (GO:0055002),-0.32618735102588703,-0.9125628022535959,0.5730337078651685,0.8519332252970995,1.0,2/14,6.57%,PGM5;TMOD3
prerank,regulation of protein secretion (GO:0050708),0.324294501671598,0.9125471816252767,0.6646216768916156,0.9587898395831149,1.0,12/119,5.42%,DPP4;PRKCA;MTNR1B;TGFB3;DISP1;ANG;CACNA2D2;TGFB2;STX1A;ADAM9;LLGL1;RHBDF1
prerank,alcohol catabolic process (GO:0046164),0.45569871694384084,0.9125080138490319,0.5903271692745377,0.9583774562135549,1.0,1/10,1.78%,CEL
prerank,monocyte differentiation (GO:0030224),0.45367243542511215,0.912473023656389,0.5907738095238095,0.9579604947221714,1.0,1/10,2.76%,VEGFA
prerank,regulation of cholesterol transport (GO:0032374),0.39259596277769765,0.9123377192244877,0.5871446229913473,0.9577530100211975,1.0,3/20,9.72%,LRP1;ABCA13;OSBPL6
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.41232434143753327,0.9123331585888044,0.570855614973262,0.957271319397681,1.0,5/14,22.09%,ACD;TPP1;XRCC5;TINF2;TERF2IP
prerank,histone lysine methylation (GO:0034968),0.3688762185458952,0.9122922854852649,0.6053240740740741,0.9568725585186224,1.0,15/33,28.36%,CXXC1;DPY30;WDR5;EHMT2;PRDM9;SETD1B;KMT2A;N6AMT1;EZH2;SETDB1;SETDB2;WDR5B;MEN1;SUV39H1;PRDM5
prerank,response to leucine (GO:0043201),0.4444075550553139,0.9119697053864113,0.6140602582496413,0.9566032989235749,1.0,6/10,22.86%,MTOR;SESN3;RRAGD;SESN2;UBR2;KLHL22
prerank,cellular response to leucine (GO:0071233),0.4444075550553139,0.9119697053864113,0.6140602582496413,0.9566032989235749,1.0,6/10,22.86%,MTOR;SESN3;RRAGD;SESN2;UBR2;KLHL22
prerank,regulation of inflammatory response (GO:0050727),0.3195099826391665,0.9112249513439308,0.6995967741935484,0.9577458700512848,1.0,38/190,19.14%,MGLL;ANXA1;IL16;MAPK7;FOXP1;S100A8;S100A9;AKNA;METRNL;SPATA2;NR1D2;MVK;IL33;NR1D1;IL17RA;DAGLA;TLR4;FNDC4;CD47;SIRPA;BCL6;LRRC19;TNIP1;ABCC1;CD200R1;TNFRSF1B;KLF4;IL4;LRFN5;DAGLB;SELENOS;PDCD4;IL6;UFL1;IL18;SNX6;VAMP2;IFI35
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.3202569401533041,0.9111715058295585,0.6971544715447154,0.957368625158633,1.0,24/140,10.45%,TRIP10;ARHGAP21;ARHGAP10;ARHGAP44;AKAP13;PLCE1;SLIT2;PIK3R2;RASGRF1;TRIO;SRGAP1;SRC;ARHGEF3;MYO9B;FLCN;MYO9A;OCRL;ARHGAP9;TAGAP;RHOJ;ITGAV;TIAM2;RHOQ;SQSTM1
prerank,rRNA modification (GO:0000154),0.3969342070727658,0.9108880405124447,0.6076433121019108,0.957505030149635,1.0,11/21,35.54%,DIMT1;GAR1;ZCCHC4;TSR3;FTSJ3;NHP2;NAT10;FBL;NSUN3;BUD23;THUMPD1
prerank,zinc ion transport (GO:0006829),0.3901441783465905,0.9108103967404104,0.5907960199004975,0.9571825846653894,1.0,6/21,19.98%,SLC39A13;SLC39A14;SLC39A7;SLC30A9;SLC30A5;SLC39A3
prerank,lipid droplet formation (GO:0140042),-0.36550487991060965,-0.9103905757264315,0.5704225352112676,0.855651578763411,1.0,4/10,21.70%,ZFYVE1;PLA2G4C;FITM2;CDS2
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.3455477384638061,-0.9096121775965075,0.5399239543726235,0.8557734424596661,1.0,3/12,3.43%,F3;SNCA;APOD
prerank,T cell differentiation (GO:0030217),-0.24645656742270936,-0.909211823725714,0.6341463414634146,0.8550321925743399,1.0,10/40,13.69%,CHD7;SOX13;KIT;TCF7;JAG2;PIK3CD;RHOH;PTPN2;GPR89B;GPR89A
prerank,regulation of receptor-mediated endocytosis (GO:0048259),-0.2522044267790277,-0.9091118996370214,0.6666666666666666,0.8536103664964413,1.0,11/35,15.76%,VTN;TNK2;PIK3CB;B2M;LDLRAP1;HIP1R;HNRNPK;SGIP1;HIP1;HFE;SERPINE1
prerank,organelle fusion (GO:0048284),0.3876354199605837,0.9090667490497203,0.6019536019536019,0.9605063660186681,1.0,9/22,30.71%,GDAP1;MIEF2;STX4;SPG7;VPS11;FIS1;CHCHD3;BAX;MFN2
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.4467764467228367,0.9090307596767573,0.6143250688705234,0.9596003004907748,1.0,1/10,9.45%,CNGB1
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.4467764467228367,0.9090307596767573,0.6143250688705234,0.9596003004907748,1.0,1/10,9.45%,CNGB1
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.43745040395178403,0.9088538123880586,0.6137931034482759,0.9594916645411786,1.0,4/12,27.82%,GNL3L;CCT7;CCT4;CCT6A
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),-0.33480306851767677,-0.9088337682667273,0.5502183406113537,0.8526170482280542,1.0,4/13,7.43%,IGF1;RAMP1;PLCB1;ALG10B
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.39321474408095347,0.9087164345091208,0.5774111675126904,0.9592971967707253,1.0,10/19,29.17%,PARD3B;DLG2;FSCN1;SYNJ2BP;MARK2;MTCL1;CRB1;LRRC7;PRKCI;PARD3
prerank,positive regulation of neuron migration (GO:2001224),-0.35237323179475805,-0.9085707631202645,0.583941605839416,0.851572304576543,1.0,4/11,10.67%,RAPGEF2;DAB2IP;SEMA6A;MDK
prerank,fatty acid metabolic process (GO:0006631),0.32266448050707375,0.9083999816887727,0.676200204290092,0.9594594343326605,1.0,27/115,22.15%,CEL;ACLY;ACOT6;CPT1C;ALKBH7;CRAT;SLC27A3;PON3;NDUFAB1;GPX1;FA2H;PNPLA8;ACOT1;HSD17B8;ACAD9;ACOX1;GPAM;LIPC;LIPH;NUDT19;ANGPTL3;ABCD3;MCAT;LPIN3;CPT2;PEX2;CROT
prerank,negative regulation of heart contraction (GO:0045822),-0.3617501941679129,-0.9082058958990795,0.599290780141844,0.8508492746068699,1.0,1/11,0.02%,ATP1A2
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.3731021558840123,-0.9078764136689448,0.5909090909090909,0.8500431505667106,1.0,4/10,28.61%,CAV1;KCNE4;ANK3;KCNAB1
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.4149921145971624,0.907697843885555,0.5959731543624162,0.9604865089999576,1.0,5/15,24.72%,NYNRIN;NUDT16;ZC3H12A;RPP30;KHNYN
prerank,response to retinoic acid (GO:0032526),0.3405451746912249,0.9076893734052008,0.6199782844733985,0.9600051319281755,1.0,7/59,8.19%,WNT10B;WNT2;EPHA3;WNT9A;RET;ABL2;FZD7
prerank,fatty acid transport (GO:0015908),-0.3143560863253039,-0.9075880981519491,0.5714285714285714,0.849123643186611,1.0,2/17,2.45%,ACSL1;APOE
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.3981686368236709,0.9074286489180625,0.6170212765957447,0.9600671099291762,1.0,7/21,14.04%,ANK2;SRI;CAMK2D;GSTM2;PDE4D;CALM2;CASQ1
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.3304072787938731,0.9074235620662093,0.6513089005235602,0.9595864391186177,1.0,22/72,23.19%,FGF13;SLIT2;SMAD4;MYADM;PFN2;CHADL;PIK3CA;TWF1;KANK1;MAPRE1;SSH1;CAMSAP1;TUBB4A;PFDN6;IAPP;NAV3;CLIP3;ARFGEF1;CLASP2;SSH3;LDLR;CRYAB
prerank,negative regulation of interleukin-1 production (GO:0032692),0.38530661383360254,0.9073142604589676,0.608058608058608,0.9593212015982409,1.0,4/23,15.94%,CARD16;GAS6;ZC3H12A;NLRP2B
prerank,regulation of carbohydrate catabolic process (GO:0043470),-0.244044690667551,-0.9071598419698352,0.6141732283464567,0.8485564230082895,1.0,13/41,20.22%,PRKAG2;SCARB2;NUP35;NDC1;RAE1;PGAM1;NUP153;EP300;NUP214;POM121;NUP155;HIF1A;NUP205
prerank,peptidyl-lysine dimethylation (GO:0018027),0.40748239331555364,0.9071518639904034,0.606516290726817,0.9591839464052421,1.0,6/18,20.13%,SETD7;SETD2;EHMT2;PRDM9;SETD1B;KMT2A
prerank,sensory perception of smell (GO:0007608),0.44394804623303274,0.9067435684354166,0.6070422535211267,0.9595885862523479,1.0,4/11,36.34%,BBS4;SLC24A4;DRD2;ADCY3
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.318784164869646,0.9067178327247738,0.6795523906408952,0.9591561175283947,1.0,33/124,25.16%,SFRP4;CCDC88C;PSMC4;SMURF2;TCF7L2;NFATC1;AP2A2;PSMC6;CLTC;FZD7;PARD6A;PSMD8;AGO2;VANGL2;RHOA;GNB1;PPP3CA;FZD4;AGO4;DAAM1;SFRP5;PPP3CB;AGO3;TIAM1;GNAO1;SMURF1;MAP3K7;AP2M1;TNRC6A;PSMD3;DVL1;PSMD4;RAC1
prerank,aortic valve development (GO:0003176),0.36543266275851116,0.9066372584996977,0.6282660332541568,0.9588486404158791,1.0,9/34,16.60%,SLIT3;SLIT2;ELN;NFATC1;JAG1;SMAD6;TWIST1;TNFRSF1B;SNAI2
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.452286934324967,0.9063933959113734,0.6,0.9589025885961407,1.0,2/10,13.49%,MYO9A;RHOA
prerank,regulation of DNA binding (GO:0051101),-0.24763851087622077,-0.9060573947615832,0.6037735849056604,0.8493224611003968,1.0,5/44,3.59%,LEF1;SP100;IGF1;HMGB1;FOXC1
prerank,potassium ion import across plasma membrane (GO:1990573),0.3587439848396853,0.9060012372754432,0.6306818181818182,0.9592408794002432,1.0,10/41,13.35%,ATP1A4;ATP1A3;ATP1A1;SLC12A8;KCNJ2;SLC12A4;KCNK9;HCN4;SLC12A5;KCNJ3
prerank,positive regulation of viral genome replication (GO:0045070),0.371741509340506,0.9057725330662252,0.6014669926650367,0.9592462105981592,1.0,8/29,21.09%,TARBP2;ADARB1;LARP1;DDB1;HACD3;PPIA;TOP2B;SRPK1
prerank,negative regulation of apoptotic process (GO:0043066),0.3095295058536411,0.905633598003505,0.808,0.9590784079109094,1.0,91/444,20.75%,COMP;FSTL1;AXL;GCLC;ARHGAP10;PRKCA;EGFR;ANXA1;TGFB3;WT1;HPN;ANGPT4;TRIAP1;SIX4;CD44;VEGFA;F2R;MIF;ATF5;COPS5;ITGA5;CLCF1;NFATC4;ITCH;SOCS2;CBX4;FOXO1;CARD16;ARF4;SRC;GAS6;DPEP1;SOX8;YWHAE;PIK3CA;PSEN1;AVEN;NRBP2;SMAD6;SON;SQSTM1;HDAC3;NPM1;GPX1;AKT1;IRAK1;NAT8;UBA52;CD27;SFN;GDNF;BCL3;WDR73;SIX1;NME2;CBL;ZC3H12A;KLF4;IL4;NUPR1;VDAC1;BAG4;AHI1;IL6;HGF;ANXA4;SNAI2;TAX1BP1;PTRH2;ERCC5;FAIM2;SET;TMBIM4;PLAUR;QARS1;SNX6;NAA15;VTCN1;UFM1;SUPV3L1;PRDM9;DSTYK;MCL1;IL31RA;HIPK3;RASA1;FLNA;PRELID1;DDAH2;OPN3;TYRO3
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.3765013279078954,0.9053531329536001,0.5960591133004927,0.95920114855454,1.0,9/24,19.04%,UBE2B;PDE11A;CGAS;PDE4D;CDC34;PDE3B;PEX5L;TCP11;PRKAR2A
prerank,RNA modification (GO:0009451),0.34882925206977305,0.9052438660906964,0.6265060240963856,0.9589438602123392,1.0,18/54,28.44%,ADARB1;ANKRD16;TRMT6;MEPCE;TRMT61A;FTSJ1;TRMT1;DTWD1;QTRT1;TYW5;TRUB1;METTL1;NOP2;TSR3;WDR4;FTSJ3;URM1;RBM15
prerank,regulation of synapse assembly (GO:0051963),0.3475541420073346,0.9047140268794251,0.6248612652608213,0.9596590123523779,1.0,9/46,15.06%,EPHB2;GPC6;SLIT1;EPHB3;MUSK;SYNDIG1;SETD5;LRFN5;MDGA1
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.43895555434668637,0.9044502398678764,0.6095505617977528,0.9597596127115223,1.0,2/11,14.83%,TMEM106A;IL4
prerank,regulation of cellular response to stress (GO:0080135),0.32318972632392107,0.9043041175815751,0.6820512820512821,0.9595806594040832,1.0,39/115,26.19%,CORO2B;NUP93;MTOR;CAMK2D;DNAJC2;NUP107;AIFM2;YWHAE;NUP98;NPM1;CEBPB;MAPT;ADCY8;HSP90AA1;AMFR;HSBP1;NUPR1;CHORDC1;MANF;RSL1D1;NUP37;BAG4;NEK4;FKBP4;NUP50;MCL1;MAPK1;DNAJB1;ATF4;BAG3;USP19;TPR;CRYAB;BAG5;NUP133;NUP85;HSPH1;NUP188;EIF4G1
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.34279960046295443,0.9037772711011507,0.6466739367502726,0.9601950686305115,1.0,23/52,29.45%,UBE2J2;USP36;YWHAG;YWHAE;HPS4;PPP3CC;SFN;NPEPPS;BBC3;HTRA2;VPS11;ARIH2;ATG13;UBE2D3;SAE1;YWHAB;CSNK2A2;LEPROT;FBXW7;RNF31;CASP8;SREBF2;TP53
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.42175183502522473,0.9037599030561179,0.6080536912751678,0.9597467375776313,1.0,2/15,7.50%,LRP6;GLI2
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.43264417086831725,0.9033242963280543,0.6069444444444444,0.9601747497407791,1.0,3/12,12.09%,BIN1;DSC2;JUP
prerank,cellular response to topologically incorrect protein (GO:0035967),0.3686193349507306,0.9032595484394704,0.6293302540415704,0.9598334290682901,1.0,7/31,15.32%,HDAC6;STUB1;HSPA13;UBE2W;ERN1;BAK1;HSPA14
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.318107700455436,0.9030746330950323,0.7255297679112008,0.9597476424629386,1.0,24/163,16.35%,SYK;LAX1;PRAM1;PSMC4;FYN;RFTN1;PIK3R2;PTPRJ;CSK;PSMC6;RC3H1;UBE2N;PRKD2;CHUK;PIK3CA;PSMD8;FYB2;PDE4D;PLEKHA1;ZC3H12A;MOG;BTN3A3;RBCK1;NCK1
prerank,mitochondrion localization (GO:0051646),0.39243857257352965,0.9030678961163315,0.5972906403940886,0.9592764103644829,1.0,6/19,26.48%,TLE6;TRAK2;ATCAY;MARK2;MTM1;MUL1
prerank,positive regulation of monooxygenase activity (GO:0032770),-0.27441430881282713,-0.9026931097685882,0.6470588235294118,0.8555330629854695,1.0,7/26,12.38%,APOE;SCARB1;PIK3CB;NPR3;GCH1;TERT;S100A1
prerank,negative regulation of RNA splicing (GO:0033119),0.399152103112753,0.9023105951719991,0.5913705583756346,0.9604082855976358,1.0,8/19,28.31%,SRSF6;C1QBP;SAP18;U2AF2;PTBP1;PTBP2;RBMX;RPS26
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.3992758499656273,0.9019439960783541,0.5949044585987261,0.9607089512239239,1.0,4/18,12.54%,VEGFA;CRTC2;PRKD2;ADCY8
prerank,regulation of calcium-mediated signaling (GO:0050848),0.37592272225680634,0.9019279864063346,0.6040428061831153,0.9602497017456368,1.0,6/25,17.71%,NEUROD2;P2RX3;RIT2;MAPT;SLC8A2;TMBIM4
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.395691956023778,0.9017167361920335,0.6090686274509803,0.9597161742202335,1.0,5/21,17.52%,GTF2H3;ERCC3;ERCC4;DDB1;ERCC5
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.395691956023778,0.9017167361920335,0.6090686274509803,0.9597161742202335,1.0,5/21,17.52%,GTF2H3;ERCC3;ERCC4;DDB1;ERCC5
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.4166575989633059,0.9015355418390859,0.6007802340702211,0.9596302605570919,1.0,6/15,29.44%,CUL3;NPM1;PAF1;EZH2;STXBP4;GLI1
prerank,regulation of viral release from host cell (GO:1902186),0.3888526437102554,0.9010066410405598,0.6029776674937966,0.9602331083022686,1.0,7/21,23.62%,MID2;TRIM11;DDB1;PML;VPS37B;TRIM35;TRIM8
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.4214362635184131,0.9009895622428693,0.625169147496617,0.9597928421443401,1.0,3/13,9.49%,FGFR1;FGF2;AKT3
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.417381304698396,0.9008244791381,0.6198675496688741,0.9596616099623255,1.0,1/15,1.09%,SRM
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.40451744265190576,0.9007832095581765,0.61003861003861,0.9592767339901976,1.0,4/18,13.86%,TMEM119;FZD7;HDAC3;HDAC4
prerank,cellular response to copper ion (GO:0071280),-0.3132429743443216,-0.9007149073666263,0.6147186147186147,0.8587364641415999,1.0,1/16,3.22%,SNCA
prerank,negative regulation of programmed cell death (GO:0043069),0.30912193610478533,0.9006058787230042,0.792,0.9591712582669606,1.0,72/355,20.69%,COMP;FSTL1;AXL;GCLC;ARHGAP10;EGFR;ANXA1;WT1;HPN;ANGPT4;TRIAP1;SIX4;CD44;VEGFA;MIF;ATF5;COPS5;ITCH;SOCS2;CBX4;FOXO1;ARF4;SRC;AIFM2;GAS6;DPEP1;SOX8;TIGAR;PSEN1;AVEN;SMAD6;SON;SQSTM1;HDAC3;NPM1;AKT1;IRAK1;NAT8;UBA52;CD27;GDNF;BCL3;WDR73;NME2;CBL;IL4;NUPR1;VDAC1;BAG4;AHI1;IL6;HGF;ANXA4;TAX1BP1;ERCC5;FAIM2;TMBIM4;PLAUR;NAA15;VTCN1;UFM1;SUPV3L1;PRDM9;DSTYK;MCL1;IL31RA;HIPK3;RASA1;FLNA;PRELID1;DDAH2;OPN3
prerank,positive regulation of cell cycle process (GO:0090068),0.3258930182282408,0.9005531496491207,0.6825232678386763,0.9588177308391707,1.0,18/91,15.35%,GPSM2;CDC14B;BTC;XRCC3;SVIL;RHNO1;DYNC1LI1;CUL3;SIRT2;NUDT16;KIF20B;EGF;RHOA;DDX11;DBF4;INO80;GIPC1;DYNC1H1
prerank,positive regulation of cellular catabolic process (GO:0031331),0.31797238085785257,0.9004307525191554,0.698880976602238,0.9586019758533643,1.0,29/132,20.30%,DCN;IRS1;ADAM9;MID2;DACT1;ITCH;FOXO1;PLEKHF1;MLXIPL;RC3H1;FLCN;PSEN1;ZC3HAV1;SLC4A4;IRS2;TWIST1;TNFRSF1B;ULK1;ZC3H12A;HSP90AA1;DAGLB;TRIM68;ZSWIM8;UFL1;VPS11;SUPV3L1;GPLD1;SH3D19;ATF6
prerank,synapse assembly (GO:0007416),-0.2194688571263632,-0.9002469702772354,0.696969696969697,0.858233647077634,1.0,16/67,13.24%,SPOCK2;CDH1;WNT5A;SHANK3;PLXND1;DNM3;RYK;SDK2;PLXNB1;LRRC4;GABRB3;SDK1;CDK5;BDNF;PCDHB14;SLITRK1
prerank,response to amyloid-beta (GO:1904645),0.3488613071328887,0.9002247020435148,0.6225165562913907,0.9585500864203268,1.0,11/44,18.00%,LRP1;FYN;MMP2;ATP1A3;PSEN1;TLR4;ABCC1;CACNB1;GRIN2A;CHRNA7;SNX6
prerank,positive regulation of BMP signaling pathway (GO:0030513),-0.28670185418187977,-0.8986531183664984,0.6073619631901841,0.8602921486608992,1.0,4/25,7.95%,CDH5;ENG;NOTCH1;BMPR2
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.3187982737975796,0.8984054503571075,0.6938144329896907,0.9618718116429982,1.0,21/116,19.04%,SYK;VIPR2;FYN;MAPK14;GLP2R;SRC;ADCYAP1;DPEP1;CRHR1;GPR20;CALCA;GPR45;TSHR;ADCY8;GNB1;LHCGR;SELENOS;IL6;RXFP1;IAPP;PRKAR2A
prerank,regulation of microglial cell activation (GO:1903978),0.41036146336270896,0.8980905166728503,0.6059817945383615,0.9620392324544648,1.0,4/15,22.54%,SYT11;NR1D1;IL6;LDLR
prerank,glycoprotein metabolic process (GO:0009100),0.3399714786638726,0.8978006669588389,0.646733111849391,0.9621777926210278,1.0,10/53,15.68%,PCSK6;ST3GAL2;OGA;FBXO2;FBXO17;LARGE1;ST3GAL4;TNIP1;MGAT4B;NGLY1
prerank,primary alcohol metabolic process (GO:0034308),0.3719752547283208,0.8975773513655055,0.6180469715698393,0.9621699057489902,1.0,2/25,5.80%,DHRS9;ALDH3A2
prerank,hexose biosynthetic process (GO:0019319),0.3501544423863366,0.8975438750261031,0.6333333333333333,0.9617621886882669,1.0,3/42,4.59%,AKR1B1;CRTC2;SLC39A14
prerank,organophosphate ester transport (GO:0015748),0.37942502934379874,0.8972009924465411,0.6158536585365854,0.9619929409094591,1.0,9/24,22.54%,TRIAP1;OSBPL2;PRELID3A;SCP2;EPG5;PITPNM1;PRELID1;PCTP;LDLR
prerank,receptor catabolic process (GO:0032801),0.38165105881319894,0.8971883223373405,0.6309963099630996,0.9615337887705815,1.0,4/24,8.76%,AP2A2;MVB12A;CLTC;MYLIP
prerank,cellular response to decreased oxygen levels (GO:0036294),0.3374307184481468,0.8970794856196884,0.6570820021299254,0.9612827191953519,1.0,11/65,9.06%,ANGPT4;VEGFA;LMNA;ZFP36L1;MTOR;CARD16;MDM4;EGLN2;STUB1;TIGAR;SIRT2
prerank,regulated exocytosis (GO:0045055),0.3166519107811906,0.8970315074375771,0.7414486921529175,0.9608980797874015,1.0,35/173,20.69%,RAB11FIP5;CD9;SCIN;TGFB3;SYT2;CLEC3B;SPARC;ITGB3;VEGFA;TGFB2;ECM1;STX1A;SYT12;SYT11;SYT13;GTPBP2;GAS6;EGF;SERPING1;SNAP25;TUBA4A;RAB27B;MANF;LGALS3BP;SNAPIN;HGF;SYT1;VAMP2;RIMS2;ALDOA;PPP3CB;APOOL;QSOX1;FLNA;RAB10
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.38372118721625986,0.8969666489315908,0.6317073170731707,0.9605603479658645,1.0,6/23,15.07%,FYN;ANK2;CAMK2D;CASQ1;DIAPH1;CACNB1
prerank,mitotic sister chromatid cohesion (GO:0007064),-0.3097220282104737,-0.8968941216664389,0.5822784810126582,0.862813430294524,1.0,1/16,0.39%,PDS5B
prerank,positive regulation of protein localization to membrane (GO:1905477),0.3229907726360917,0.8961238098904942,0.6947040498442367,0.9618092782829231,1.0,20/98,16.15%,EPHB2;EGFR;LRP1;EPHA3;FYN;ATP2B4;MIEF2;YWHAG;CD81;YWHAE;STX4;SQSTM1;PPP3CC;AKT1;SFN;BBC3;ARF6;CHP1;PLS1;SPTBN1
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.4188089482564521,0.8960661251384388,0.6108108108108108,0.9614457697668939,1.0,3/13,12.96%,AGO2;ZFP36;POLR2G
prerank,mitotic sister chromatid segregation (GO:0000070),0.32048222575230034,0.8959248251844629,0.6839378238341969,0.9612606957600907,1.0,24/98,23.11%,DIS3L2;ZW10;CHMP7;PSRC1;VPS4B;TENT4A;ZWINT;CUL3;SMC1A;CDC23;PIBF1;NCAPG;INO80;SMC2;SET;NAA50;CENPE;NIPBL;AKAP8L;PDCD6IP;DCTN2;KLHL22;CSNK2A2;TUBG2
prerank,Ras protein signal transduction (GO:0007265),0.3181939130677302,0.8958387559093071,0.7147208121827411,0.9609592469040787,1.0,29/137,16.50%,COL1A2;GPSM2;PLCE1;FGF2;CDC42EP2;MAPK14;RAP1B;RASSF1;WASF1;FARP2;NTN1;RIT2;ARHGEF3;MYO9B;MAPK11;RGL2;GDI1;NRAS;KRAS;USP50;SHOC2;CDKN1A;RHOA;GNB1;RAPGEF1;HACD3;EPS8L2;SOS1;HACE1
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.31709768898261204,0.8955997433255249,0.7283702213279678,0.9609689300147056,1.0,49/166,25.25%,AR;ESR1;POLR2H;GTF2H3;HDAC9;HDAC7;WWTR1;TAF8;NR1D2;NR1D1;POLR1G;BRF2;VDR;NR6A1;CDK9;KAT2B;HDAC3;TAF3;UBTF;ERCC3;POLR2D;POLR2G;NCOR2;NCOR1;GTF2A2;CCNH;BRF1;GTF2F1;NR2C2;E2F3;POLR3H;MED23;NR2C2AP;GTF2E2;POLR1C;RRN3;RORA;MED7;TBP;TAF13;NR3C1;ESRRA;NCOA6;POLR1B;POLR2C;RARA;GTF2E1;MED26;NRBP1
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.3336251327699618,0.895000012808684,0.6421621621621622,0.9617139840400161,1.0,14/62,15.56%,POLR2H;GTF2H3;ADRM1;CDK9;ELP4;SETD2;ERCC3;POLR2D;POLR2G;CCNH;EAF2;CTDP1;GTF2F1;EAF1
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.41912937546696993,0.8948476398964786,0.6310013717421125,0.9615523256121731,1.0,4/12,15.05%,FOXP1;NCOR2;NCOR1;SMARCA4
prerank,protein-containing complex assembly (GO:0065003),0.3081311975998762,0.8946889783535745,0.78,0.9613802090209769,1.0,79/259,27.81%,AREG;SEC16B;SEC24D;CNIH3;WIPF1;STX5;LLGL1;DLG4;GPAA1;AXIN1;SEC31A;ZW10;TCF7L2;PREB;ZNHIT6;SEC24A;WASF1;FARP2;SEC22B;MDM4;TFG;SEC23A;USO1;MCU;LMAN1;CUL3;SCFD1;TLE2;MITF;SEC23IP;NAPA;SLC9A1;ADCY8;CNIH1;TRAPPC2L;CDC123;ZC3H12A;BCL9;SMARCA4;NSF;TFAP4;PML;SPG7;NAPG;SEC24B;RAB1B;EPRS1;BLM;PYGO2;VAMP2;TMED2;LAMC1;KMT2A;TIAM1;TRRAP;PPP6C;TRAPPC6B;AP2M1;PYGO1;DMTN;NDUFAF1;MDM2;KAT5;TRAPPC4;RAB1A;PPIH;TCF7L1;HGSNAT;GOSR2;KIFAP3;KLHL12;TRAPPC2;HES1;GORASP1;VAMP3;WASL;MEN1;PDE4DIP;CASP8
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.389827310167018,0.8943774093347479,0.6252983293556086,0.961524265892839,1.0,4/21,13.57%,MED24;MITF;MED13;TWIST1
prerank,positive regulation of RNA splicing (GO:0033120),0.3622725501804286,0.8942243727393824,0.621654501216545,0.9613484767802282,1.0,14/29,31.29%,ZPR1;NUP98;RBM22;ERN1;RBM3;SF3B4;U2AF2;THRAP3;DAZAP1;CELF3;RBMX;HABP4;CELF4;CIRBP
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.3379801611220879,0.8941883500488573,0.6609442060085837,0.9609458561668165,1.0,25/60,29.87%,CDK4;TCF7L2;MED24;CEBPB;CCNC;CDKN1A;MED13;CCND1;MED15;IL6;AGO4;MED23;MED6;AGO3;PTEN;MED7;TNRC6A;RELA;MED26;AGO1;ATF7IP;NFKB1;BAX;TP53;SOX9
prerank,neuron projection fasciculation (GO:0106030),0.44651878350310903,0.8939862677612681,0.620384047267356,0.9609092664544754,1.0,2/10,10.29%,EPHB2;EPHB3
prerank,phosphate-containing compound metabolic process (GO:0006796),0.3108649366394177,0.8936753432781368,0.7402206619859579,0.9610542340256651,1.0,45/198,21.28%,GFPT2;EPHB2;PFKP;PLCE1;GFPT1;PLPP3;PLCB4;ACP2;MTOR;PLPP1;GK5;TIGAR;OCRL;PIK3CA;LCAT;AGK;INPP5K;AKT1;PGM2L1;CERK;PLPPR3;INPP4A;PPP3CA;PLA2G4E;PI4KA;NUDT5;G6PC3;SLC20A1;IPPK;PIP4P1;PLCD4;PLPP2;ANGPTL3;ALDOA;PPP3CB;PANK3;TOLLIP;INPP5B;ACYP1;ACP3;IP6K1;PPM1A;PIP4K2B;PTEN;PIK3CG
prerank,carbohydrate derivative catabolic process (GO:1901136),0.3945147560975466,0.8935315796531397,0.6018518518518519,0.9608790271405073,1.0,5/18,15.68%,OGA;FBXO2;FBXO17;SAMHD1;NGLY1
prerank,sensory perception of mechanical stimulus (GO:0050954),0.3219904250988299,0.8934227069765005,0.6694473409801877,0.9606116401018652,1.0,11/85,10.14%,COL1A1;PIEZO2;COL11A1;SLC26A5;PDZD7;TSPEAR;MYO1A;MYO3B;TIMM9;MYH14;COL2A1
prerank,retina homeostasis (GO:0001895),-0.2904011120802487,-0.8930524146099108,0.6288659793814433,0.8699787689154831,1.0,7/23,16.99%,ACTB;POTEF;B2M;WHRN;PRDX1;HSPB1;SOD1
prerank,negative regulation of protein processing (GO:0010955),0.42022874341360505,0.8927879338742792,0.6111869031377899,0.9614685626217977,1.0,1/12,2.62%,GAS1
prerank,regulation of lymphocyte differentiation (GO:0045619),0.38979675727417934,0.8924302410251215,0.6232073011734028,0.9617119555994832,1.0,2/18,7.90%,ZFP36L1;ZFP36L2
prerank,positive regulation of protein acetylation (GO:1901985),-0.3367879552617368,-0.8923813988725438,0.6075085324232082,0.8699078930564985,1.0,2/12,4.23%,RAPGEF3;PRKAA2
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.26046035510237847,-0.8923375057704881,0.6351351351351351,0.8683731512074097,1.0,8/30,12.44%,BMP5;BCL2L1;NOS3;FAS;ICAM1;CFLAR;RIPK1;TNFSF10
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.3575795270461677,0.8922370800222561,0.6479713603818615,0.9616198611918779,1.0,10/29,22.09%,ACD;GAR1;TERF1;HSP90AA1;TNKS1BP1;PPIA;RAD50;TINF2;PPP6C;TERF2IP
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.3921675917081885,0.8922254656790606,0.6291989664082688,0.961171655105957,1.0,8/17,33.73%,ALG1;DHDDS;SRD5A3;MVD;MPDU1;NUS1;ALG8;DOLPP1
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.30871550004459586,0.8921291423916009,0.798,0.9608865516265737,1.0,59/306,18.38%,RPSA;ST3GAL2;POLR2H;MRPS11;RRBP1;TIPIN;EXT1;COPS5;EEF2K;MRPS18B;IGHMBP2;INHA;NT5M;GTPBP2;RHNO1;PPP5C;MRPL13;MRPS17;AGO2;POLE3;ING4;MCM3;LARGE1;FUT9;GSPT2;RPL10A;RMI1;MRPL10;MRPL55;ST3GAL4;TNIP1;RAD1;PCLAF;POLR2D;POLR2G;RPS5;BCL3;DNA2;BRIP1;MRPL36;ORC6;DBF4;NBN;MRPL3;FAM111A;GSPT1;RPL6;MRPL51;RFC4;EEF1B2;GRWD1;HARS1;EEF1G;ABCF1;RAD50;SET;BLM;TBRG1;POLD1
prerank,iron ion homeostasis (GO:0055072),0.33703702835502475,0.891929770671724,0.6778741865509761,0.9608031549790138,1.0,12/58,19.70%,SCARA5;SMAD4;ATP6V0A2;SLC11A2;NDFIP1;ATP6AP1;CCDC115;BDH2;FLVCR1;FBXL5;NEDD8;TMEM199
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.35341806586573654,0.8915127452522112,0.6208092485549133,0.961147417290823,1.0,3/34,9.18%,EPHB2;CLCF1;STX4
prerank,DNA unwinding involved in DNA replication (GO:0006268),-0.30801894426592386,-0.8908585133649908,0.6088888888888889,0.8701715645383716,1.0,6/16,22.37%,SSBP1;PURA;WRN;MCMDC2;TWNK;RAD51
prerank,protein localization to plasma membrane (GO:0072659),0.3162013153249255,0.8899543330618739,0.7271805273833671,0.9638490349751232,1.0,22/129,13.75%,LRP6;TTC7A;TSPAN17;PKP3;PRAM1;ANK2;FGF13;S100A10;NECTIN3;PLEKHF1;MYADM;MYO5A;GAS6;PACS2;CD81;EHD2;INPP5K;FYB2;RAB3D;JUP;ZDHHC2;PIGW
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.37614718382382434,0.8892122642571763,0.6186961869618696,0.9648532548433317,1.0,3/22,10.95%,CD160;PTPRJ;UBASH3A
prerank,regulation of glycogen biosynthetic process (GO:0005979),0.37005818605527824,0.8887237009896242,0.6280193236714976,0.9654084800149406,1.0,9/24,15.83%,IRS1;EPM2AIP1;INPP5K;DYRK2;AKT1;PASK;IRS2;PPP1R3C;SELENOS
prerank,positive regulation of endocytosis (GO:0045807),0.34239296542652825,0.8885414828240209,0.6568848758465011,0.9652905270380195,1.0,9/45,14.83%,AXL;LRP1;GPC3;BICD1;TOR1A;ABCA13;CALY;CBL;IL4
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.3598803608311794,0.8882294746638996,0.6319526627218935,0.9654237265091699,1.0,13/31,29.17%,PARD3B;DLG2;MYO9A;RHOA;ANK1;SYNJ2BP;PDCD6IP;MARK2;MTCL1;CRB1;LRRC7;PRKCI;PARD3
prerank,negative regulation of neuron projection development (GO:0010977),0.33076490251482255,0.8880137128183918,0.6612729234088457,0.9653876080380667,1.0,20/56,25.53%,PTPRS;LPAR1;STX1B;SEMA3A;MYLIP;TSKU;GDI1;KANK1;NGEF;CBFA2T2;RTN4RL1;RHOA;DCC;FKBP4;CRMP1;PTEN;BAG5;RTN4;BCL11A;RAB29
prerank,RNA methylation (GO:0001510),0.33283670074874744,0.8877900747211444,0.6641630901287554,0.9653577351599809,1.0,9/60,13.28%,DIMT1;TRMT6;TYW3;MEPCE;TRMT61A;FTSJ1;TGS1;THADA;ZCCHC4
prerank,negative regulation of DNA recombination (GO:0045910),0.34460988555721145,0.8875973806674948,0.6533333333333333,0.9653083159312011,1.0,14/43,26.85%,PARP3;POLR2H;CGAS;ACD;POLR2D;POLR2G;TERF1;BLM;TINF2;TERF2IP;UBQLN4;POLR2C;H1-0;MSH6
prerank,morphogenesis of an epithelial sheet (GO:0002011),0.44267294219706865,0.8875829781268952,0.6350574712643678,0.9648652365521906,1.0,1/10,0.47%,LRP6
prerank,regulation of small molecule metabolic process (GO:0062012),-0.2661319208333793,-0.8875637214199401,0.64375,0.8762575144050476,1.0,7/28,10.54%,PDK1;APOE;TTC39B;PPARA;ACADL;EPHX2;SIRT1
prerank,rRNA transcription (GO:0009303),0.4000480805994592,0.8875421514551242,0.622568093385214,0.9644669529480473,1.0,6/17,23.55%,ANG;POLR1G;GTF3C2;BRF1;SPIN1;GTF3C5
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.31436880484166,0.8872222412550286,0.7223910840932117,0.9646368744260203,1.0,32/124,18.29%,MYOC;ODF2;RASGRF1;UNC5A;DOCK7;DTNBP1;LRP12;ADCYAP1;PKD2;TOR1A;PLP1;L1CAM;CAMSAP1;MAPT;TBC1D23;FLRT3;LGI1;GDNF;PLEKHA1;ULK1;ATCAY;BLOC1S2;MANF;MAP4;FAM161B;SNAPIN;IL6;RAB35;PPP1R9B;STX3;CNTN4;GPM6A
prerank,outer dynein arm assembly (GO:0036158),0.4089323056583134,0.887108371207605,0.6306666666666667,0.9644011110192522,1.0,4/14,22.57%,DNAH8;DNAAF5;DNAH5;DNAL1
prerank,mitotic cell cycle phase transition (GO:0044772),0.307153262426884,0.886742011283183,0.7386934673366834,0.9646537715452942,1.0,56/203,24.70%,DCTN1;ODF2;CDK14;ACVR1;CDK4;CHMP7;TRIM71;USP29;YWHAG;BCAT1;SSNA1;YWHAE;CUL3;PPP1R12B;ALMS1;USP26;CDC23;MAPRE1;HAUS3;CDC34;SFI1;CDKN1A;FBXL3;CCND1;CDC27;CCNH;DBF4;CTDP1;HSP90AA1;TUBB4A;TUBA4A;GSPT1;DYNC1H1;E2F3;CDK5RAP2;CCP110;AKAP9;CEP164;CKAP5;SKP2;PAFAH1B1;PPP2R2A;CUL5;CLASP2;PPP6C;PCM1;CDKN2C;DCTN2;FBXW11;CDC25B;NEDD1;LATS1;DYNLL1;CEP78;FBXL12;ACVR1B
prerank,glycolipid biosynthetic process (GO:0009247),0.3570735827391432,0.8866498114512845,0.6318181818181818,0.9643725303909054,1.0,8/38,14.92%,ST3GAL2;PIGZ;PIGC;LARGE1;ST3GAL4;MPPE1;PIGW;PIGM
prerank,phagosome maturation (GO:0090382),0.35576628376750447,0.8863244285515451,0.6435185185185185,0.9645835608424277,1.0,7/35,16.13%,RAB32;ATP6V0A2;ATP6V1E1;RAB43;ATP6V0A1;ATP6V1D;ATP6V1B2
prerank,rRNA 3'-end processing (GO:0031125),0.43191111808833244,0.8858428367273133,0.6078431372549019,0.9650483463934996,1.0,2/10,9.54%,ERI3;EXOSC7
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.4338458148509461,0.8858187491716296,0.6161473087818697,0.9646213925561894,1.0,4/10,22.09%,ACD;TFIP11;DCLRE1A;TERF2IP
prerank,aspartate family amino acid metabolic process (GO:0009066),-0.2904128417699068,-0.885498839917305,0.616822429906542,0.8794324416289107,1.0,7/18,20.57%,MSRA;ASPG;ASS1;ADI1;ASNS;NAT8L;FOLH1
prerank,positive regulation of transferase activity (GO:0051347),0.31039767469474183,0.8851691834617654,0.7204843592330978,0.9654681744459408,1.0,25/142,14.60%,DDR2;EPHB2;AXL;EGFR;FGFR1;EPHA3;MST1R;AXIN1;RET;UBE2N;ACD;EPM2AIP1;HNRNPD;POLG2;EPHB3;MUSK;EPHA10;XRCC5;FLT3;PIN1;PDGFRA;NBN;KLF4;DDR1;HSP90AA1
prerank,negative regulation of leukocyte migration (GO:0002686),0.4317308237300029,0.885010824926267,0.607898448519041,0.9653173417999248,1.0,3/10,14.43%,SLIT2;CD200R1;HOXA7
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.30212302204659386,0.8848972949650313,0.877,0.9650707768461575,1.0,157/572,25.90%,AR;ESR1;LOXL2;TRPS1;FOXP2;NFIX;WT1;TLE6;SCRT2;SKIL;VEGFA;KLF12;FOXP1;BHLHE40;GLIS2;RUNX1;SMAD4;HDAC9;ZNF25;DPF2;SMURF2;SKI;SOX10;DACT1;KLF2;TCF25;NFATC4;TCF7L2;NR1D2;CBX4;MEIS2;IL33;NR1D1;NFIB;ZFHX3;C1QBP;MDM4;SIN3B;GLI2;ZFPM2;TBX6;NOC2L;RNF2;FLCN;SOX8;ZBTB1;VDR;NR6A1;PSEN1;FOXC2;SIRT2;ZMYM5;MYPOP;OTUD7B;ZNF3;HDAC3;URI1;MZF1;TAF3;TCERG1;MITF;IRF2BPL;BCL6;ZHX2;CEBPB;GLI3;UBA52;ZFP36;DR1;NCOR2;PEG3;NCOR1;IKZF5;CCND1;CRYM;TWIST1;DNAJA3;NACC2;HDAC4;EZH1;EHMT2;DMAP1;KLF4;HOXA7;HSBP1;IL4;ZNF692;SMARCA4;CHD8;DDX20;NR2C2;YEATS2;NOP53;ZBTB5;PER1;DDX5;SNAI2;CHD3;E4F1;ZEB1;HIVEP1;NRIP1;CTCF;UXT;NIPBL;SUDS3;RPL23;KDM1B;UBE2D3;CTBP1;MIER1;PPM1A;DNAJB1;HSF4;PEX2;PAF1;KDM2B;NSD1;PHF21A;JUN;LARP7;EZH2;ATF4;VPS72;LDB2;LDB1;BAG3;TPR;SDCBP;ZNF431;GATAD2A;IFI27;NR3C1;PER3;SKOR2;RTF1;RELA;ZEB2;ORC2;LCOR;HEXIM1;MDM2;BCL11A;CALR;RARA;E2F7;KAT5;PHF12;PHF6;VHL;MBD2;MAFK;MYT1L;DDIT3;H1-0;RARG;CRY2
prerank,DNA recombination (GO:0006310),0.3475463466961755,0.8847345717683619,0.6469221835075494,0.9649217094706607,1.0,9/37,18.63%,XRCC3;RAD51B;IGHMBP2;RHNO1;HMGB3;RECQL;RAD50;BLM;SUPV3L1
prerank,Golgi ribbon formation (GO:0090161),-0.32918818346980916,-0.8846824012729625,0.6299212598425197,0.8796270622696548,1.0,6/13,18.05%,STX6;MYO18A;OPTN;GCC2;GOLGA2;TRIP11
prerank,regulation of cellular protein catabolic process (GO:1903362),-0.30330397074427723,-0.8846612028232868,0.589041095890411,0.8780415080198883,1.0,6/18,13.64%,VGLL4;DAB2IP;NELL1;ATRAID;RGP1;RIC1
prerank,regulation of JUN kinase activity (GO:0043506),-0.23801762696754364,-0.8846307765731417,0.6544117647058824,0.8764725200745883,1.0,10/33,20.40%,SASH1;DAB2IP;DUSP10;DVL3;TNFRSF11A;EDN1;MAP3K5;ARHGEF5;DUSP19;MAP3K10
prerank,amyloid-beta metabolic process (GO:0050435),-0.31762859934927967,-0.8845557853463444,0.6498054474708171,0.8750519576602865,1.0,3/16,3.36%,BACE2;MGAT3;DYRK1A
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.3047550984100443,0.8841621155256274,0.861,0.965601196217651,1.0,90/417,19.33%,PAX9;GCLC;ATP8B1;LOXL2;FOXP2;WT1;ZC3H8;SIX4;FOXP1;BHLHE40;GLIS2;SMAD4;HDAC9;ATF5;DPF2;SMURF2;TSC22D4;FOXK2;NAB1;TCF7L2;NR1D2;CBX4;RBAK;CREB3L1;FOXO1;NR1D1;PRMT2;CREBZF;DPF1;MLXIPL;HDAC6;ZFPM2;GAS6;MDFIC;SOX8;VDR;MAGEL2;SIRT2;RCOR3;CIPC;KDM5C;ING4;INPP5K;TLE2;BRD7;CALCA;PHC3;PHC1;HDAC3;SAMD1;MPHOSPH8;SMARCC2;BCL6;ZHX2;RBFOX2;GLI3;XRCC5;NCOR2;NCOR1;BCL3;CBFA2T2;TWIST1;NACC2;HDAC4;DMAP1;KLF4;HOXA7;IL4;GMNN;SMARCA4;CHD8;YEATS2;BAHD1;PDCD4;PER1;TFAP4;ZEB1;DKK3;PML;SAP18;SET;QARS1;SNX6;DAP;GCFC2;CTCF;NIPBL;BTAF1;SUDS3;RING1
prerank,regulation of insulin secretion (GO:0050796),0.3183329518297608,0.8840300286436866,0.7033985581874357,0.9654031977067677,1.0,18/101,16.30%,DPP4;PRKCA;MTNR1B;IRS1;EFNA5;CACNA2D2;STX1A;MIDN;TCF7L2;NR1D1;MCU;BMP8A;IRS2;TRH;SNAP25;KCNC2;GLUD1;IL6
prerank,neutral amino acid transport (GO:0015804),0.3641660455637273,0.8838498013243957,0.6393244873341375,0.9652911370154742,1.0,2/28,5.23%,SLC1A5;SLC43A2
prerank,interleukin-35-mediated signaling pathway (GO:0070757),-0.347495412312714,-0.8837190360751468,0.6056338028169014,0.8753318602661482,1.0,9/11,42.46%,STAT1;IL12RB2;STAT4;CANX;IL27RA;STAT3;IL12A;JAK1;EBI3
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),-0.3312013839197529,-0.883519237071987,0.6213991769547325,0.8741497917763188,1.0,6/14,14.28%,STARD13;THBS1;NOTCH1;PDCD10;TBXA2R;HDAC5
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.4204070466770502,0.8832179930889847,0.6426666666666667,0.9661072349280191,1.0,5/12,23.48%,PAICS;GART;ATIC;ADSS2;LHPP
prerank,bile acid and bile salt transport (GO:0015721),0.3655113651017452,0.8831130942447183,0.6205250596658711,0.9658591134246477,1.0,2/24,3.12%,ATP8B1;SLC51A
prerank,mesoderm development (GO:0007498),0.38324400676450954,0.8830708090197484,0.6269633507853403,0.965463647842162,1.0,3/18,8.77%,VEGFA;TBX6;FOXC2
prerank,cholesterol efflux (GO:0033344),0.38689400765798176,0.8830234448198248,0.6419753086419753,0.9650865343635915,1.0,4/20,10.41%,ABCG4;ABCA1;TSKU;STX12
prerank,negative regulation of catalytic activity (GO:0043086),0.3666195472162417,0.8827370424571093,0.6376988984088128,0.9651856679254919,1.0,3/24,7.11%,APBA3;TMBIM1;HDAC6
prerank,mesenchymal cell development (GO:0014031),-0.3005790950475068,-0.8826849659765397,0.6255707762557078,0.874481122009292,1.0,6/18,17.28%,NOTCH1;FOXC1;HEYL;TAPT1;SOX11;CDH2
prerank,innate immune response (GO:0045087),0.30570280314380865,0.8826830237721,0.7805611222444889,0.9648213381004236,1.0,33/217,18.94%,SYK;LBP;SRMS;TNK1;FYN;ANG;MID2;MSRB1;COLEC11;CXCL10;SRC;CHUK;CYP27B1;TLR4;MASP2;IRAK4;TRIM11;DMBT1;SLPI;IRAK1;SETD2;RNASE6;ADAM15;CR2;FER;IL4;TRIM68;RNF187;PML;AKAP1;SMPD1;MBL2;SKP2
prerank,cellular response to interleukin-12 (GO:0071349),0.33417585005127726,0.8821896278985683,0.6696132596685083,0.965338322779103,1.0,11/48,23.29%,ANXA2;MIF;RAP1B;ARF1;CD47;SIRPA;PDCD4;PPIA;RALA;SNRPA1;MTAP
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.41314264590713945,0.8819746015318413,0.6511936339522546,0.9652776931156709,1.0,2/13,3.19%,VEGFA;TGFBR2
prerank,heme biosynthetic process (GO:0006783),-0.28047364977080047,-0.8817211125291857,0.6633663366336634,0.8749358697775459,1.0,3/22,6.55%,ABCG2;PGRMC1;FECH
prerank,negative regulation of hydrolase activity (GO:0051346),0.33389537457727625,0.8815262885039219,0.6883408071748879,0.9656821713846636,1.0,12/49,19.94%,MAPK7;ECM1;SLC39A14;GPSM1;CSTB;URI1;BCAS3;CHP1;SH2D4A;RCC2;ARFGEF1;TMED2
prerank,dicarboxylic acid metabolic process (GO:0043648),0.33426057217482213,0.8811546741992694,0.6601092896174864,0.9659476580827134,1.0,13/52,25.28%,GCLC;ALDH18A1;ACLY;IDH1;NIT2;ALDH5A1;MDH2;GOT1;D2HGDH;MTHFD2L;MTHFD2;MTRR;ME3
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.327617577545022,-0.8811064165274461,0.6092436974789915,0.8747310423924413,1.0,5/13,9.45%,MEF2C;NOTCH1;TGFBR3;FGFR2;TBX2
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.34465323179983526,0.8810893175053328,0.6486175115207373,0.9656102300036283,1.0,10/33,22.09%,CTC1;ACD;GAR1;TERF1;HSP90AA1;TNKS1BP1;RAD50;TINF2;PPP6C;TERF2IP
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.35742793887933866,0.8810325653203221,0.6122699386503068,0.9652462846856943,1.0,6/27,17.26%,CD44;MIF;TWIST1;DDX5;SNAI2;EEF1E1
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.36391317954196395,0.8808486869041877,0.638196915776987,0.9651519538500349,1.0,7/26,12.78%,SRI;PKD2;CRHR1;YWHAE;GSTM2;CALM2;THADA
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.4262749305541898,0.8807146692996409,0.6396148555708391,0.9649499682551301,1.0,1/11,3.49%,RUNX1
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.4214877625405465,0.8805772940210506,0.6388140161725068,0.964773103395145,1.0,2/12,5.71%,IGFBP5;DOCK7
prerank,regulation of cytoplasmic translation (GO:2000765),0.4073345384797864,0.8805436986422965,0.6283783783783784,0.9643660846596875,1.0,5/14,28.81%,UNK;PKM;CPEB1;RBM24;CNBP
prerank,ncRNA transcription (GO:0098781),0.42112412420006035,0.880369239379282,0.6064690026954178,0.964222091923958,1.0,4/13,21.73%,ANG;POLR1G;BRF1;SPIN1
prerank,substrate-dependent cell migration (GO:0006929),0.40792086003312045,0.8801908838721096,0.6344370860927152,0.9641073536288273,1.0,3/14,6.86%,ITGA11;ITGA2;NTN1
prerank,nuclear transport (GO:0051169),0.3981734698545819,0.8800819368229704,0.6360052562417872,0.9638462832288559,1.0,4/16,18.50%,NUP98;NPM1;PSIP1;NXT2
prerank,positive regulation of sprouting angiogenesis (GO:1903672),0.406918974369619,0.880000936331811,0.6477572559366754,0.9635502797807721,1.0,5/15,15.67%,VEGFA;FGF2;ITGA5;KLF4;PKM
prerank,glycerolipid metabolic process (GO:0046486),-0.3399354532047894,-0.8796347714263961,0.6,0.8765180883289907,1.0,7/11,24.63%,DGKB;DGKZ;PIP5K1A;PLA2G15;PNPLA3;GAL3ST1;DGKG
prerank,protein monoubiquitination (GO:0006513),0.34903226839759405,0.8793395841874948,0.6631330977620731,0.9643640160230156,1.0,15/36,28.12%,UBE2B;UBE2W;FANCL;CUL3;DTL;ATXN7L3;PEX12;UBE2R2;UBE2D3;PAF1;KLHL22;RNF20;RNF126;KLHL12;TOPORS
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",-0.3041087777871959,-0.8789952512413814,0.6206896551724138,0.8763741369406067,1.0,6/16,18.03%,DCPS;CWC15;SNRNP200;SRSF12;SRSF1;WBP4
prerank,regulation of interferon-gamma production (GO:0032649),0.32220099500970745,0.8789150269523085,0.670926517571885,0.964726087247461,1.0,10/71,14.88%,AXL;C1QBP;INHA;GAS6;TLR4;CD47;SIRPA;PDE4D;ZC3H12A;CD14
prerank,telomere organization (GO:0032200),0.33824837320235407,0.8787719616543088,0.6681514476614699,0.9645368971375993,1.0,12/43,18.66%,PARP3;CTC1;ACD;ERCC4;XRCC5;TERF1;DNA2;NBN;RAD50;BLM;POLD1;TINF2
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.305076529784137,0.8787437432681933,0.7951807228915663,0.9641306282441382,1.0,57/208,23.90%,ESR1;AKAP13;MIB2;ECM1;F2R;LPAR1;MID2;TMEM106A;USP10;NR1D1;CARD16;UBE2N;TFG;CHUK;PPP5C;TIRAP;LGALS1;OTUD7B;SQSTM1;IRAK4;DDX21;IRAK1;TNIP1;NDFIP1;TRAF3IP2;RHOA;ZC3H12A;TRIM68;TRAF3;PER1;RBCK1;SLC20A1;UFL1;MAP3K14;CANT1;SLC44A2;CARD11;LURAP1;MIER1;UNC5CL;FLNA;PPM1A;GOLT1B;TSPAN6;PYCARD;TAB2;CPNE1;TRAF4;TERF2IP;RORA;ROR1;MAP3K7;FKBP1A;TRAF5;TNIP2;TRIM8;RELA
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.33551592994003115,0.8783732771172678,0.6839266450916937,0.9644019619464929,1.0,9/54,13.76%,KCNMA1;FHL1;BIN1;KCNJ2;YWHAE;KCNAB3;STK39;KCNJ3;GNB1
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.3100717933051559,0.878032124525569,0.7605633802816901,0.9646510480118381,1.0,50/172,23.23%,GPAT4;DGKQ;FGF2;PIK3C2B;PIK3R2;PI4K2B;FAR1;CHKB;FIG4;OCRL;INPP5F;PIK3CA;SLC44A1;LCAT;AGK;ARF1;INPP5K;AGPAT3;LPCAT1;PLEKHA4;MBOAT7;RUFY1;INPP4A;PLEKHA1;PI4KB;AGPAT5;GPAT3;MTMR6;CEPT1;PI4KA;MTMR1;PIP4K2C;SLC44A2;GPAM;CDIPT;LIPH;DDHD1;PLD2;PITPNM1;LPIN3;PIP4K2B;TAMM41;PTEN;PIK3CG;CPNE1;PCTP;PI4K2A;CSNK2A2;PTDSS1;ACP6
prerank,purine ribonucleotide catabolic process (GO:0009154),-0.27428637080448226,-0.8779084913017816,0.6288659793814433,0.8772289174516382,1.0,9/21,21.15%,NUDT4;NT5E;HPRT1;PDE2A;NUDT3;NT5C2;NT5C1A;AMPD3;FITM2
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.37711283225442477,0.877898274466033,0.6422360248447205,0.9644360756770051,1.0,9/21,24.32%,RASSF2;MLXIPL;INPP5K;PDE4D;NLRP2B;NCK1;PTEN;NCK2;DMTN
prerank,histone H3-K4 methylation (GO:0051568),0.36626027057123733,0.877819140605308,0.6595238095238095,0.9641334518762484,1.0,8/26,20.13%,CXXC1;DPY30;WDR5;OGT;PRDM9;KMT2C;SETD1B;KMT2A
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.3585115817307232,0.8778079756336256,0.6526442307692307,0.9636881845025198,1.0,9/27,26.75%,NDEL1;FRMD7;PSEN1;AKT1;NCS1;PTEN;CCDC88A;NTNG2;IL1RAPL1
prerank,modulation by host of symbiont process (GO:0051851),0.3532974165712882,0.8768722350579852,0.6383981154299175,0.9650137674888496,1.0,8/31,16.80%,HPN;TARDBP;INPP5K;LRRC19;CTDP1;SMARCA4;CHD1;TFAP4
prerank,apoptotic mitochondrial changes (GO:0008637),0.3549755309287949,0.8761956610059309,0.662020905923345,0.9659269483751001,1.0,6/32,12.73%,TIMM50;AIFM2;NDUFS1;BAK1;SFN;BBC3
prerank,positive regulation of isotype switching (GO:0045830),-0.3101264176067213,-0.8760712855354731,0.6235294117647059,0.8796986430723999,1.0,9/15,21.65%,KMT5B;SHLD1;KMT5C;TFRC;RIF1;TGFB1;CD40;MAD2L2;TNFSF13
prerank,negative regulation of ATPase activity (GO:0032780),0.3930037930335327,0.875868013728616,0.6216931216931217,0.9661027511927063,1.0,3/16,12.78%,TNNI3;PXK;THADA
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.4040276240507758,0.875837096529665,0.6671087533156499,0.9656984197989339,1.0,6/14,27.46%,PRKD2;CD81;CARD11;RELA;RAB29;BCL10
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.3499561442286714,0.8756190996016068,0.6494845360824743,0.9656654017846422,1.0,8/37,18.38%,GTF2H3;ERCC3;UBA52;ERCC4;DDB1;RFC4;ERCC5;POLD1
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.3581354089560792,0.8748897969327396,0.6479041916167665,0.9665835016874196,1.0,4/28,9.40%,PARP3;CYREN;TFIP11;NUDT16L1
prerank,negative regulation of cell adhesion (GO:0007162),0.32228387595139846,0.8747689622941047,0.6975505857294995,0.9663648061475321,1.0,18/72,16.80%,EPHB2;CORO2B;GTPBP4;DACT2;MIA3;JAM3;MUC1;TGFBI;ADAM22;FZD7;JAG1;PLXNA3;DSCAM;RHOA;PDE3B;FZD4;SNAI2;CD164
prerank,melanosome localization (GO:0032400),-0.2848636183684332,-0.8746607360797578,0.6532663316582915,0.8811689724034789,1.0,8/21,17.83%,SHROOM2;BLOC1S5;RAB11A;BBS7;MREG;RAB27A;BLOC1S6;MLPH
prerank,positive regulation of angiogenesis (GO:0045766),0.31321253424894063,0.8745581124461268,0.7346938775510204,0.9663194177080618,1.0,10/108,4.65%,CD34;FGF18;PRKCA;ANGPT4;VEGFA;FGF2;ECM1;RUNX1;SMOC2;ITGA5
prerank,regulation of neutrophil migration (GO:1902622),0.43734863107963134,0.87443205909712,0.6380027739251041,0.9661019887909207,1.0,2/10,11.70%,JAM3;MPP1
prerank,mitotic cytokinetic process (GO:1902410),0.3820175298061799,0.8741797070989242,0.6565656565656566,0.966111624398845,1.0,3/20,13.49%,CHMP7;VPS4B;RHOA
prerank,regulation of ATP metabolic process (GO:1903578),-0.22137938285943115,-0.8738534933209046,0.7708333333333334,0.8812595289419723,1.0,16/54,20.22%,PRKAG2;NUP35;NDC1;RAE1;PINK1;PGAM1;UQCC2;NUP153;EP300;NUP214;AK4;POM121;NUP155;SPHK2;HIF1A;NUP205
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.42356451859635563,0.873743709699305,0.638095238095238,0.9665162000688654,1.0,4/11,27.82%,CCT7;TERF1;CCT4;CCT6A
prerank,positive regulation of calcium ion import (GO:0090280),-0.32676324822226877,-0.8736533795489164,0.6159420289855072,0.8801235659176322,1.0,2/12,8.67%,CXCL12;PDGFRB
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.30464221854831347,0.8727164436655888,0.7734138972809668,0.9680080685171237,1.0,32/182,16.98%,CD34;ESR1;DGKQ;VEGFA;FGF2;TGFB2;FOXP1;RUNX1;MIF;DLG4;RBMS3;ATP2B4;CREB3L1;TARDBP;MYADM;FLCN;ATXN2;VDR;PSEN1;AGO2;PARP14;MAPT;SLC2A10;NDFIP1;SMCR8;ZC3H12A;KLF4;MAP2K2;DIP2A;PTRH2;AGO4;FLOT2
prerank,potassium ion transport (GO:0006813),0.31101011505185433,0.8724868595790698,0.7551020408163265,0.9680088864275058,1.0,22/120,15.89%,KCNK5;KCNMA1;HPN;KCNV1;ATP1A4;KCNJ2;SLC9A9;KCND1;ABCB8;PKD2;KCNK13;KCNK9;HCN4;KCNA2;KCNA6;KCNAB3;SLC9A1;KCNJ3;KCNC2;CHP1;SLC9A7;SLC9A6
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.3519148198923081,0.8724312813473868,0.6459554513481829,0.9676686787885818,1.0,7/33,14.33%,ANGPT4;MEOX2;FGF2;ATP2B4;JUP;RHOA;KLF4
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.3510451255853152,0.8724194237054553,0.6650602409638554,0.967228161199873,1.0,11/32,21.11%,MYOC;SRC;JAG1;ADAM15;HOXA7;BCAS3;RCC2;RASA1;CLASP2;CORO1C;PTEN
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.28381844361651515,-0.8721274187369917,0.6885245901639344,0.8818074687966967,1.0,6/20,12.99%,BCL2L1;BCL2;CASP3;FAS;CASP9;BCL2L2
prerank,regulation of sodium ion transmembrane transport (GO:1902305),-0.26656867149276836,-0.8720762400839823,0.6666666666666666,0.8803282251318268,1.0,10/27,20.35%,NEDD4L;YWHAH;DLG1;GPD1L;FXYD1;NOS1;UTRN;SNTA1;SLMAP;SCN3B
prerank,histone H3-K9 demethylation (GO:0033169),-0.34313766000900725,-0.8719136737566154,0.5910931174089069,0.8790717363029581,1.0,2/11,2.52%,KDM7A;KDM4A
prerank,positive regulation of monocyte chemotaxis (GO:0090026),-0.28649412732976354,-0.8719043869537845,0.6666666666666666,0.8774952981453696,1.0,2/17,4.18%,HMGB1;CXCL12
prerank,glial cell development (GO:0021782),0.3655951993502685,0.8718555874372838,0.6642066420664207,0.967888034970945,1.0,3/25,4.37%,PRDM8;S100A9;SOX10
prerank,rRNA methylation (GO:0031167),0.37686349121698026,0.871561571718118,0.6580565805658056,0.9679695253442032,1.0,4/22,14.19%,DIMT1;FDXACB1;ZCCHC4;MRM3
prerank,positive regulation of neuron projection development (GO:0010976),0.31682006499230886,0.8714944940638858,0.7238493723849372,0.9676295232807115,1.0,17/85,13.39%,DBN1;NPTN;EPHA3;COBL;S100A9;TENM3;RET;RIT2;ABL2;NDRG4;TWF1;FUT9;AVIL;MAGI2;KIDINS220;P3H1;CBFA2T2
prerank,positive regulation of keratinocyte differentiation (GO:0045618),0.4308366885566775,0.8714411939995342,0.6306179775280899,0.9672583705106147,1.0,5/10,20.65%,NCOA3;CYP27B1;VDR;NME2;NUMA1
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.3469921162281511,0.8713668868427478,0.666270783847981,0.96694170207138,1.0,3/33,2.91%,WT1;FGF2;TGFB2
prerank,regulation of MAP kinase activity (GO:0043405),0.3137394255003367,0.8711751120438582,0.7236024844720497,0.9668399033879544,1.0,9/92,5.35%,FGF18;EGFR;FGFR1;UCHL1;VEGFA;IRAK3;FGF2;MST1R;PTPRJ
prerank,activation of adenylate cyclase activity (GO:0007190),-0.2499222913714257,-0.8710498459574049,0.76,0.8778906389144899,1.0,6/35,9.13%,ADCY5;ADCY1;EDNRA;CAP2;ADCY4;ADCY9
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.4070545107385457,0.870159790460478,0.6363636363636364,0.968291689723574,1.0,3/13,14.57%,BMF;VDAC2;BLOC1S2
prerank,aromatic amino acid family catabolic process (GO:0009074),-0.30656705173279764,-0.870152204024118,0.6434782608695652,0.8782804388916358,1.0,15/15,69.38%,QDPR;KYNU;FAH;HGD;IL4I1;HAAO;AADAT;IDO2;TDO2;IDO1;ACMSD;TAT;KYAT1;GSTZ1;KMO
prerank,regulation of protein kinase A signaling (GO:0010738),-0.2898752382927511,-0.8699483115745855,0.6855670103092784,0.8770839298253361,1.0,7/20,17.69%,ADGRV1;AKAP7;PRKAR1B;AKAP6;PRKAR2B;TCIM;ADRB2
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.277848377780162,-0.8699222439929719,0.6728971962616822,0.8755757059034158,1.0,2/23,1.98%,UACA;BMP7
prerank,mitochondrial translation (GO:0032543),0.31073789903068016,0.8698910166579533,0.7430626927029804,0.9683685969395469,1.0,20/104,15.98%,MRPS11;MRPL38;MRPS18B;CHCHD1;MRPL13;MRPS17;AURKAIP1;MRPS27;MRPL30;MRPL10;GFM1;DAP3;MRPL55;MRPS10;MRPL36;MRPL3;MRPL21;MRPS34;MRPL51;HARS1
prerank,cellular component assembly (GO:0022607),0.30114689283731877,0.869776634860308,0.8144433299899699,0.968145742278426,1.0,50/253,20.33%,HAS2;GSN;HAS1;SCIN;STK25;WIPF1;LLGL1;DLG4;CHAF1B;GPAA1;ZW10;TLCD2;WASF1;MDM4;FSCN1;GAS6;NOC2L;ACD;MYO9A;TOGARAM1;SYCP2;RSPH1;RHOJ;RHOQ;MITF;RHOA;RTN3;TTLL3;SPAG17;LIMS2;PLS1;ACTG1;SPTBN1;RAC3;TFAP4;PML;SPG7;NAPG;YTHDF1;YTHDF2;EPRS1;ILK;MICAL1;VAMP2;TINF2;LAMC1;KMT2A;SPAG16;QSOX1;FLNA
prerank,regulation of cell migration (GO:0030334),0.29815393830745224,0.8697689351385826,0.859,0.9677015557283642,1.0,54/382,12.88%,IGFBP5;SEMA3C;HAS2;MYOC;EPHB2;FGF18;COL1A1;FGF7;PRKCA;EGFR;ANXA1;IGSF10;TMEFF2;ADARB1;LDLRAD4;VEGFA;FGF2;SGK3;SLIT2;F2R;MIF;ADAM9;LMNA;ACVR1;GTPBP4;MIA3;PTPRJ;MEAK7;SRGAP1;MYADM;RET;SRC;SULF1;PIP5KL1;FLCN;DPEP1;SLK;SEMA3A;SRCIN1;JAG1;KIF2A;STX4;PLXNA3;KANK1;MAPRE1;MITF;AKT1;MAGI2;GPNMB;SEMA3D;EGF;RECK;ADAM15;MGAT5
prerank,negative regulation of lymphocyte migration (GO:2000402),0.43219042850145384,0.8696990266519322,0.6546242774566474,0.9673648204835488,1.0,4/10,17.22%,MIA3;AKT1;CD200R1;PADI2
prerank,positive regulation of autophagy (GO:0010508),0.3170239723317785,0.8696946177327974,0.7223382045929019,0.9669149721461969,1.0,15/81,16.85%,DCN;GNAI3;MID2;FOXO1;PLEKHF1;FLCN;GPSM1;CAMKK2;SESN3;LARP1;ULK1;ZC3H12A;IL4;TRIM68;UFL1
prerank,protein localization to centrosome (GO:0071539),0.3871217924401096,0.8696360282889115,0.6491228070175439,0.9665840006549878,1.0,7/17,23.47%,NUDCD3;PIBF1;BBS4;CEP83;PCM1;DCTN2;NEDD1
prerank,regulation of calcium ion import (GO:0090279),0.37738896551112805,0.8690160806876693,0.6593673965936739,0.9673207229871521,1.0,4/21,15.37%,FYN;PKD2;EGF;STC1
prerank,artery morphogenesis (GO:0048844),0.35170734444258905,0.8689222663817149,0.6710059171597633,0.9670326953913319,1.0,5/30,8.93%,LRP1;VEGFA;TGFB2;PKD2;JAG1
prerank,regulation of triglyceride biosynthetic process (GO:0010866),-0.30451106979399156,-0.8687227157110602,0.640495867768595,0.8766434939575083,1.0,6/15,22.06%,SCARB1;NR1H3;SIK1;CTDNEP1;FITM2;C3
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.33630733847869987,0.8686890546641785,0.6850393700787402,0.9670100369767054,1.0,18/48,27.38%,MYOC;S100A10;FBXW8;MYADM;C1QBP;TRIOBP;LIMS2;RAC3;ILK;FLNA;DMTN;CALR;RAC1;IL1RAPL1;ARHGEF7;CUL7;PRKDC;CAPRIN2
prerank,protein import into mitochondrial matrix (GO:0030150),0.3774876969096173,0.8684597930783826,0.6323155216284987,0.9669551988414897,1.0,2/18,11.47%,TIMM50;GRPEL2
prerank,transcription by RNA polymerase II (GO:0006366),0.3029913618726332,0.8684227395028478,0.838,0.9665652190344585,1.0,83/305,25.25%,PRRX1;AR;ESR1;NFIX;POLR2H;ZC3H8;INTS3;GTF2H3;ABT1;HDAC9;HDAC7;WWTR1;PAX1;TAF8;NR1D2;SCAF8;NR1D1;INTS10;ZBTB1;VDR;NR6A1;ADRM1;CDK9;SOX5;ELP4;KAT2B;INTS6;CPSF4;HDAC3;TAF3;DDX21;SETD2;ERCC3;POLR2D;POLR2G;NCOR2;NCOR1;GTF2A2;CCNH;EAF2;CTDP1;GTF2F1;BTF3;NFE2L3;NR2C2;EAF1;E2F3;CPSF2;DDX5;SNRPG;INTS2;SNRPD3;MED23;INTS12;SLBP;NR2C2AP;GTF2E2;MBD1;PAF1;ICE1;LHX1;TFCP2;ATF4;RORA;RNMT;ELL;MED7;TBP;TAF13;NR3C1;CSTF2T;ESRRA;TRIM24;RTF1;CPSF1;CPSF7;WDR33;PABPN1;POLR2C;RARA;GTF2E1;MED26;NRBP1
prerank,mesenchymal cell differentiation (GO:0048762),0.3309165529283241,0.8683106752087278,0.6893523600439078,0.9663217557510789,1.0,5/51,3.94%,LRP6;LOXL2;FGFR1;TGFB2;AKNA
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",-0.26749913785255,-0.8682580911843917,0.6945812807881774,0.8761249157409715,1.0,4/23,9.89%,CECR2;HMGB1;CASP3;REXO4
prerank,defense response to symbiont (GO:0140546),-0.21276432220889038,-0.8680298601668521,0.813953488372093,0.875079568026904,1.0,14/92,10.42%,BCL2L1;SERINC3;BCL2;TRIM56;PLSCR1;IFITM3;ABCC9;MAVS;CNOT7;IFIT1;IFIT2;TLR3;OAS2;STAT1
prerank,negative regulation of lipid storage (GO:0010888),-0.29109268676720124,-0.86802271532025,0.6604651162790698,0.8735489726962465,1.0,7/19,12.68%,TTC39B;OSBPL8;PPARA;NR1H3;ABCG1;PTPN2;NFKBIA
prerank,regulation of sprouting angiogenesis (GO:1903670),0.35907373270936094,0.8676383750059847,0.6740914419695193,0.9671511372720976,1.0,6/33,5.67%,FGF18;VEGFA;FGF2;ITGA5;KLF2;CREB3L1
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.3001191424739251,0.8674626928779979,0.7801204819277109,0.9670141490260552,1.0,55/190,22.77%,ESR1;UBE2B;SLIT2;HDAC7;PIK3R2;MAPK14;OTUD3;MAP2K3;ATP2B4;PTPRJ;PDE11A;USP10;NR1D1;MYADM;SRC;PDE10A;BANK1;NOC2L;FLCN;PHLPP2;INPP5K;OTUD7B;HERPUD1;URI1;PRDM15;AKT1;MAGI2;PPEF2;PDE4D;PIK3IP1;TNIP1;CDC34;DEPTOR;PLEKHA1;TMEM127;TWIST1;PDE3B;ZC3H12A;NOP53;PER1;PPP2R5B;PLAUR;SFRP5;IFI35;MCL1;CIT;PPM1A;TSPAN6;PYCARD;PTEN;CPNE1;NF1;RORA;UBR2;CYLD
prerank,substantia nigra development (GO:0021762),0.34263583311597023,0.8673755049768103,0.6647264260768335,0.9667396117840356,1.0,14/37,25.80%,YWHAE;SIRT2;PLP1;RAD1;CALM2;RHOA;GLUD1;PADI2;MBP;NDRG2;SUDS3;DYNLL1;FGF9;MAPKAP1
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.29547454180366656,0.8671273090379512,0.949,0.9667598272313094,1.0,221/807,25.90%,AR;ESR1;PAX9;GCLC;ATP8B1;LOXL2;TRPS1;FOXP2;NFIX;WT1;ZC3H8;TLE6;SCRT2;SIX4;SKIL;VEGFA;KLF12;FOXP1;BHLHE40;GLIS2;RUNX1;SMAD4;HDAC9;ZNF25;ATF5;DPF2;SMURF2;SKI;SOX10;TSC22D4;DACT1;FOXK2;KLF2;TCF25;NAB1;TCF7L2;NR1D2;CBX4;RBAK;MAF1;CREB3L1;MEIS2;FOXO1;IL33;NR1D1;PRMT2;CREBZF;MUC1;ZFHX3;DPF1;C1QBP;MDM4;MLXIPL;HDAC6;SIN3B;GLI2;ZFPM2;TBX6;GAS6;NOC2L;RNF2;FLCN;MDFIC;SOX8;ZBTB1;VDR;NR6A1;MAGEL2;PSEN1;FOXC2;SIRT2;RCOR3;CIPC;KDM5C;ING4;INPP5K;TLE2;BRD7;CALCA;ZMYM5;MYPOP;OTUD7B;PHC3;ZNF3;PHC1;HDAC3;URI1;SAMD1;MZF1;MPHOSPH8;TAF3;TCERG1;MITF;SMARCC2;IRF2BPL;BCL6;ZHX2;CEBPB;RBFOX2;GLI3;UBA52;XRCC5;ZFP36;DR1;NCOR2;PEG3;NCOR1;BCL3;IKZF5;CBFA2T2;CCND1;CRYM;TWIST1;DNAJA3;NACC2;HDAC4;EZH1;EHMT2;DMAP1;KLF4;HOXA7;HSBP1;IL4;GMNN;ZNF692;SMARCA4;CHD8;DDX20;NR2C2;YEATS2;NOP53;BAHD1;ZBTB5;PDCD4;PER1;DDX5;SNAI2;CHD3;E4F1;TFAP4;ZEB1;DKK3;PML;SAP18;SET;QARS1;HIVEP1;SNX6;DAP;GCFC2;NRIP1;CTCF;UXT;NIPBL;BTAF1;SUDS3;RING1;RPL23;PCGF6;KDM1B;UBE2D3;CTBP1;MIER1;FLNA;PPM1A;DNAJB1;MBD1;HSF4;PEX2;PAF1;KDM2B;NSD1;PHF21A;LHX1;JUN;LARP7;EZH2;ATF4;KAT6B;VPS72;FBXW11;LDB2;LDB1;TPR;SDCBP;ZNF431;GATAD2A;CRYAB;IFI27;NR3C1;PER3;SKOR2;RTF1;RELA;ZEB2;ORC2;LCOR;SCMH1;L3MBTL3;SCML2;HEXIM1;MDM2;BCL11A;SETDB2;CALR;RARA;E2F7;KAT5;PHF12;KAT7;PAX2;DPF3;PHF6;VHL;MBD2;MAFK;MYT1L;DDIT3;H1-0;RARG;CRY2
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.32030788331322946,0.8669634764313419,0.6909090909090909,0.9665892896898602,1.0,23/67,25.16%,ATP8B1;GAP43;MYO10;FSCN1;TBC1D2B;TBC1D17;TWF1;TBC1D10A;FER;ARF6;EVI5;DYNC2LI1;FXR2;TBC1D13;TBC1D22B;TBC1D15;TBC1D19;ABITRAM;ATG3;CYLD;DMTN;CDKL1;RAC1
prerank,neurotransmitter transport (GO:0006836),0.3156552097608448,0.8668278407774389,0.7145899893503728,0.9663785848549099,1.0,17/73,18.56%,SLC1A7;STX1A;APBA1;PPFIA2;SLC1A6;SLC18A3;SLC6A4;GLS2;GLS;SNAP25;PPFIA1;GAD2;SNAPIN;SLC38A1;SNPH;SYT1;VAMP2
prerank,regulation of autophagosome maturation (GO:1901096),-0.3230130756553644,-0.8667710595221257,0.6222222222222222,0.8746127742156868,1.0,6/13,25.08%,UVRAG;TBC1D25;CLN3;ADRB2;IRGM;PHF23
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.4325576275232013,0.8663789772618229,0.6577086280056577,0.9667328691934057,1.0,3/10,12.14%,IRS1;AKT1;IRS2
prerank,positive regulation of TOR signaling (GO:0032008),0.3385546660774854,0.8662351274532636,0.6838487972508591,0.9665355730524979,1.0,10/40,22.92%,GAS6;FLCN;PIK3CA;HDAC3;SMCR8;RRAGD;PIP4P1;GPR137B;KLHL22;SLC38A9
prerank,acyl-CoA biosynthetic process (GO:0071616),0.38960899790404,0.8661755205377926,0.6511936339522546,0.9661833267637097,1.0,5/16,21.01%,ACLY;HSD17B8;DIP2A;SCD5;ACAT1
prerank,sulfation (GO:0051923),0.41667389545126476,0.8660990974293883,0.6105563480741797,0.965874867068078,1.0,3/11,23.53%,HS3ST5;SULT4A1;UST
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",-0.27155466123634764,-0.8660355330511196,0.6666666666666666,0.8746272808877243,1.0,6/24,11.03%,H3-3A;PPM1D;EED;SUZ12;EPC1;BMI1
prerank,regulation of intracellular protein transport (GO:0033157),-0.24154540341892294,-0.8660060457050623,0.6912751677852349,0.8731400644295053,1.0,8/32,13.91%,PTPN14;CEP290;PRR5L;PTPN1;GCC2;TGFB1;PDCD10;RIPOR1
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),-0.33501012440558275,-0.8656671734597062,0.637065637065637,0.872325682308477,1.0,4/12,17.01%,HUS1;TOPBP1;SETMAR;ORC1
prerank,sodium ion export across plasma membrane (GO:0036376),0.4090830667762817,0.8656419701356586,0.6483221476510067,0.9662812985065327,1.0,5/13,12.04%,ATP1A4;ATP1A3;ATP1A1;SLC4A4;SLC9A1
prerank,positive regulation of cellular protein catabolic process (GO:1903364),0.37821112024287423,0.865376406852779,0.6370757180156658,0.9663167341424249,1.0,5/18,17.98%,DACT1;CD81;HSP90AA1;RNF128;VPS11
prerank,maturation of 5.8S rRNA (GO:0000460),0.3832665273642812,0.8649631343009494,0.657258064516129,0.9666618245310301,1.0,7/17,27.22%,C1D;URB1;EIF6;MAK16;EXOSC10;FTSJ3;PRKDC
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.32909761727447073,-0.8648560341631698,0.6367041198501873,0.8725218530353176,1.0,2/12,1.62%,UNC13B;UNC13C
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.32064276896971106,0.8647573740380535,0.6870967741935484,0.9665824530648479,1.0,14/64,15.56%,POLR2H;GTF2H3;ADRM1;CDK9;ELP4;SETD2;ERCC3;POLR2D;POLR2G;CCNH;EAF2;CTDP1;GTF2F1;EAF1
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.32590380660157403,-0.8645310272600617,0.6303501945525292,0.8716348247847892,1.0,4/13,12.22%,NOS3;GCH1;QDPR;SPR
prerank,regulation of adenylate cyclase activity (GO:0045761),0.37349002134361725,0.8644625432802167,0.6625463535228677,0.9666738264374841,1.0,7/22,21.97%,GNAI3;CRHR1;PALM;LTB4R2;CAP1;STIM1;NF1
prerank,negative regulation of type I interferon production (GO:0032480),0.33197369792081954,0.8643823646823195,0.6577480490523969,0.9663897249384809,1.0,16/40,32.40%,PTPRS;ITCH;SIRPA;PIN1;RNF216;ILRUN;TAX1BP1;PYCARD;CYLD;UBA7;UFD1;HAVCR2;NPLOC4;CACTIN;TRAF3IP1;TBK1
prerank,cellular response to metal ion (GO:0071248),0.308542716367582,0.8639350788633208,0.7487179487179487,0.9667596628973325,1.0,15/123,9.19%,EGFR;SYT2;NEUROD2;CPNE8;DLG4;SYT12;SYT11;SYT13;CAMK2D;DLG2;PKD2;DPEP1;CHUK;TIGAR;IQGAP1
prerank,membrane protein proteolysis (GO:0033619),0.3356782834241444,0.8637520692418302,0.6562860438292965,0.9666644453614054,1.0,17/37,30.77%,ADAM9;ADAM19;RET;PSEN1;SPPL2B;NAPSA;CLPP;BACE1;PARL;RELA;RBMX;MBTPS1;NFKB1;HM13;ADAM17;TRAF6;PSENEN
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.3334098709285375,0.8632867737661198,0.6883977900552486,0.9670680677518717,1.0,7/45,9.60%,TGFB3;TGFB2;SMAD4;ACVR1;BMP15;INHA;BMP8A
prerank,cellular component maintenance (GO:0043954),-0.3158992483144327,-0.862881730318897,0.6681034482758621,0.8737029602882251,1.0,3/12,4.00%,INSR;IGF1R;ITGA3
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.35034061770693614,0.862472268257316,0.641395908543923,0.9681451049059581,1.0,15/29,32.26%,LSM4;EDC4;EXOSC7;EXOSC1;LSM7;EDC3;DCP1A;DCP1B;LSM5;HBS1L;LSM1;PATL1;EXOSC3;CNOT8;LSM6
prerank,peptidyl-lysine acetylation (GO:0018394),-0.3578706218562214,-0.8621068069382347,0.6275862068965518,0.8737470332155124,1.0,3/10,12.05%,CREBBP;SIRT1;EP300
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.3216612550699175,0.8620159161980309,0.7136706135629709,0.9685449233525364,1.0,13/63,18.40%,AR;FGFR1;ACVR1;TCF7L2;SRC;PELI3;STX4;ITGAV;DEPTOR;IL4;MADD;PML;TGFBR1
prerank,mitochondrial calcium ion homeostasis (GO:0051560),-0.28240830026947583,-0.8611492883391108,0.6947368421052632,0.874192002349639,1.0,4/21,8.17%,RAP1GDS1;SLC8A3;TGM2;MICU2
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.40915479337283517,0.8611174498424565,0.664796633941094,0.9697717188207089,1.0,5/12,20.82%,SCP2;ELOVL5;FADS1;ACOX1;HSD17B4
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),-0.3046941701922878,-0.8610169395620684,0.6510638297872341,0.8729299270311487,1.0,3/16,7.52%,CADM1;AP1G1;NECTIN2
prerank,regulation of histone H3-K9 methylation (GO:0051570),-0.34325536381706334,-0.8609302240482768,0.6203389830508474,0.8715743424282725,1.0,4/10,23.18%,SIRT1;RIF1;DNMT1;BRCA1
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),-0.3251698197683367,-0.8606121596102771,0.6334661354581673,0.8707620696845452,1.0,7/13,19.32%,ELOVL7;HACD1;HACD4;HACD2;ELOVL1;ELOVL4;TECRL
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.3383721730754891,0.8605928921928088,0.6910569105691057,0.970292239480282,1.0,7/34,14.13%,IRS1;FGF2;PIK3R2;WDR91;PIK3IP1;FLT3;PDGFRA
prerank,signal transduction in response to DNA damage (GO:0042770),0.3313087348292501,0.8602502723819113,0.6974416017797553,0.9705055437375354,1.0,18/49,29.45%,TRIAP1;MAPK14;USP10;MDM4;RHNO1;RAD1;BCL3;BRIP1;NBN;DONSON;CLSPN;SESN2;TIPRL;E2F7;PRPF19;RAD17;ATRX;TP53
prerank,gland development (GO:0048732),0.3194421777671162,0.8600409386827124,0.6993534482758621,0.9704329564714569,1.0,8/59,10.29%,ANXA1;TGFB3;WT1;COBL;GLI2;PKD2;ZBTB1;EPHB3
prerank,positive regulation of DNA binding (GO:0043388),-0.2499780519058989,-0.8592146590458469,0.6845637583892618,0.8721490297816271,1.0,4/31,3.59%,IGF1;NIBAN2;HMGB1;FOXC1
prerank,regulation of smooth muscle contraction (GO:0006940),0.37029639084262045,0.8587888167936597,0.6501240694789082,0.972315760089989,1.0,6/20,22.46%,PLCE1;F2R;ZDHHC21;ATP2B1;CTTN;NMU
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),0.3914897201916395,0.858782498376113,0.6742323097463284,0.9718693908138509,1.0,5/15,23.38%,EDEM1;SPCS1;SEC61A1;RAB10;SRPRB
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.3087262961066,0.8587329649732228,0.7228661749209695,0.9715019054127194,1.0,16/83,15.63%,CDK14;ACVR1;CDK4;TRIM71;USP29;BCAT1;CUL3;USP26;FBXO5;CDC34;CDKN1A;CCND1;CCNH;DBF4;GSPT1;E2F3
prerank,cellular response to osmotic stress (GO:0071470),0.3702280049377034,0.8584675936164563,0.6662468513853904,0.9715622731219942,1.0,4/21,12.02%,LRRC8D;ZFP36L1;PKD2;STK39
prerank,axon extension (GO:0048675),0.36398864770168865,0.8583341396751183,0.6806411837237978,0.9713742644397411,1.0,9/23,15.89%,MAP1B;SLIT3;SLIT2;SLIT1;SEMA3A;ULK2;ULK1;HSP90AA1;SLC9A6
prerank,inner mitochondrial membrane organization (GO:0007007),0.328993878496638,0.8583077867907843,0.6968680089485458,0.970964497159891,1.0,21/47,29.81%,TIMM10B;TIMM9;ATP5PO;AGK;ATP5ME;TIMM22;GHITM;SPG7;TIMM8B;UQCC3;MICOS10;APOOL;IMMT;ATP5MC3;DNAJC11;ATP5F1B;NDUFA13;LETM1;CHCHD3;ATP5F1A;CHCHD6
prerank,sensory perception of sound (GO:0007605),0.30898157291868367,0.8582342314599726,0.7293625914315569,0.9706592370563806,1.0,11/88,10.14%,COL1A1;HPN;COL11A1;SLC26A5;PDZD7;TSPEAR;MYO1A;MYO3B;TIMM9;MYH14;COL2A1
prerank,autophagy of mitochondrion (GO:0000422),0.33990989294349777,0.8581185186685336,0.6696629213483146,0.9704135399046762,1.0,14/38,24.76%,ATG2B;WIPI2;SQSTM1;WDR45B;ULK2;ATG2A;ULK1;CISD2;ATG13;ATG3;ATG14;FIS1;CTSK;MARK2
prerank,regulation of purine nucleotide metabolic process (GO:1900542),-0.23459101027692714,-0.8580277196636568,0.7333333333333333,0.8731236655780964,1.0,13/41,20.22%,PRKAG2;LACC1;NUP35;NDC1;RAE1;PGAM1;NUP153;EP300;NUP214;POM121;NUP155;HIF1A;NUP205
prerank,regulation of dendritic cell apoptotic process (GO:2000668),0.420809233868202,0.8579758695909656,0.6657142857142857,0.9702332021730741,1.0,2/10,7.58%,AXL;GAS6
prerank,cobalamin metabolic process (GO:0009235),0.3840364047392623,0.8579624253731646,0.6597671410090556,0.9698043872851295,1.0,6/17,24.87%,TCN1;MTR;ABCC1;MMADHC;MMAB;MTRR
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.37740767490422433,0.8579357067562144,0.6447876447876448,0.9693967581367972,1.0,2/17,4.97%,CHAMP1;ZW10
prerank,beta-catenin-TCF complex assembly (GO:1904837),-0.2486312381158014,-0.8579350809309417,0.6712328767123288,0.8718009554858999,1.0,8/29,15.91%,LEF1;CREBBP;TCF7;AXIN2;TERT;EP300;CTNNB1;TLE4
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.3874199193649067,0.8574132932202759,0.657516339869281,0.9699276091046837,1.0,3/16,13.21%,WDTC1;ACADVL;NCOR1
prerank,genitalia development (GO:0048806),0.4070033770161824,0.8571891519723341,0.6432432432432432,0.9698787542035683,1.0,2/12,4.15%,WT1;PKD1
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.3365695891682778,0.8571861354565566,0.6851015801354402,0.9694369139504951,1.0,12/40,20.96%,TRIAP1;GPX1;AKT1;BMF;BBC3;MLLT11;HRK;GHITM;HGF;PLAUR;PRELID1;PYCARD
prerank,negative regulation of viral transcription (GO:0032897),0.4073763169559683,0.8571502235444933,0.6487935656836461,0.9690545697746402,1.0,6/13,24.78%,MID2;TRIM11;ZFP36;UBP1;LARP7;HEXIM1
prerank,membrane lipid biosynthetic process (GO:0046467),0.31947527740202636,0.8565040568592285,0.7094668117519043,0.9697942245743386,1.0,11/58,12.43%,CERS6;ST3GAL2;PLPP3;ALDH3A2;PLPP1;PRKD2;SGMS2;FA2H;ELOVL5;ST3GAL4;PRKD3
prerank,linoleic acid metabolic process (GO:0043651),0.3820453446582265,0.856361834274167,0.6573705179282868,0.9696175487002101,1.0,4/17,14.28%,GSTM2;PNPLA8;ELOVL5;FADS1
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.2956275501103174,-0.8562736819519559,0.6666666666666666,0.8737969814076266,1.0,4/16,14.48%,AUTS2;CTR9;CTNNB1;BCOR
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.27256832684873733,-0.8560994814325505,0.6649746192893401,0.8726378586310406,1.0,4/21,6.44%,SLC30A10;PPARA;SIRT5;PINK1
prerank,pyrimidine-containing compound catabolic process (GO:0072529),-0.2988724759321725,-0.8559769928504989,0.6173913043478261,0.8714077156274906,1.0,3/16,7.93%,DPYD;UPB1;NT5E
prerank,lymphocyte differentiation (GO:0030098),0.31275279534163675,0.855765152190997,0.7265877287405813,0.9702481583106295,1.0,10/68,16.01%,AXL;PBX1;HDAC9;CLCF1;PTPRJ;FLT3;CR2;HDAC4;IL4;LMBR1L
prerank,Notch signaling involved in heart development (GO:0061314),-0.3291440873769723,-0.8555162304610407,0.6145454545454545,0.8708893025215908,1.0,6/11,23.85%,NOTCH1;HEYL;GALNT11;HEY1;HEY2;DLL4
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.40949855600569823,0.8554408672554271,0.6372549019607843,0.9703510058712012,1.0,2/11,8.08%,RFTN1;SCARA3
prerank,negative regulation of histone methylation (GO:0031061),0.4256106975512066,0.8549818258184668,0.6652542372881356,0.9707363482726057,1.0,2/10,10.42%,PHF1;WDR5
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.3468752895460797,0.8548751570172096,0.664327485380117,0.9704857999697835,1.0,12/30,22.56%,GGA1;ARFRP1;GGA2;GOLGA4;NSF;SPTBN1;BLZF1;PREPL;VAMP2;RAB10;VAMP4;GOLPH3L
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.327509720535064,0.8545183904397095,0.6915254237288135,0.9706998870079254,1.0,11/42,24.07%,USP10;ZBTB1;DTL;POLI;UBA52;PCLAF;RFC4;POLD1;FAAP20;REV1;POLH
prerank,regulation of gluconeogenesis (GO:0006111),0.35331249493131694,0.854418907130077,0.6785276073619632,0.97043970190753,1.0,6/27,16.38%,DGKQ;DDB1;USP7;ZNF692;SELENOS;OGT
prerank,lipid phosphorylation (GO:0046834),-0.34267451335750126,-0.8542090491191372,0.6185185185185185,0.8720409861807102,1.0,3/10,4.74%,DGKB;DGKE;DGKZ
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.3688467187255534,0.8540033674808889,0.6683354192740926,0.9707955436450285,1.0,5/20,18.40%,ZMIZ1;ITCH;DNAJB2;HSP90AA1;TGFBR1
prerank,protein deacylation (GO:0035601),0.3657540996130024,0.853965902907984,0.6687116564417178,0.9704103000996895,1.0,5/23,13.86%,HDAC7;HDAC6;SIRT2;HDAC3;HDAC4
prerank,triglyceride homeostasis (GO:0070328),-0.2631675263023121,-0.8537148703603313,0.6685393258426966,0.8715645088261902,1.0,9/26,21.15%,APOE;SCARB1;NR1H3;C1QTNF3;SIRT1;LPL;NR1H4;MTLN;FITM2
prerank,regulation of autophagy (GO:0010506),0.2974436598985208,0.8536777936406661,0.820281124497992,0.9704745969926102,1.0,70/216,27.00%,DCN;UCHL1;PIK3R2;MID2;USP36;ATP6V0A2;FOXK2;MTOR;USP10;PRKAB2;FOXO1;PLEKHF1;HDAC6;ABL2;FLCN;IL10RA;CAPN1;SIRT2;FBXL2;USP33;ERN1;AKT1;MAPT;BMF;ATP6V1E1;SMCR8;DRAM1;RRAGD;ULK1;ZC3H12A;CISD2;NUPR1;VDAC1;ATP6V0A1;ATP6V1D;TRIM68;ATP6V1B2;HGF;HTRA2;KEAP1;UFL1;PIP4K2C;GPR137B;SNX6;DAP;ATG13;SREBF1;MCL1;EXOC4;ATF6;PIP4K2B;TAB2;USP13;KLHL22;CSNK2A2;SLC38A9;ATP6V0B;TRIM8;EIF4G3;LEPR;DCAF12;RAB39B;KAT5;TICAM1;DDIT3;FBXW7;EIF4G1;CAPNS1;CTSA;TPCN1
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),-0.2984231974834375,-0.8534531756697955,0.6787330316742082,0.8705779426212619,1.0,3/17,7.52%,CADM1;AP1G1;NECTIN2
prerank,positive regulation of glycogen metabolic process (GO:0070875),0.3964774138900171,0.8533953198376234,0.6684350132625995,0.9705316579647545,1.0,5/13,12.14%,IRS1;EPM2AIP1;DYRK2;AKT1;IRS2
prerank,cellular calcium ion homeostasis (GO:0006874),0.30271387150354895,0.8533737463233276,0.7682186234817814,0.9701242064052996,1.0,28/133,19.16%,CCL8;NPTN;ANK2;TNNI3;ATP2B4;CAMK2D;PACS2;YWHAE;MCU;PSEN1;CALCA;HERPUD1;SELENOK;ATP13A1;SLC35G1;MCUB;BAK1;ADCY8;CCL13;ATP2A2;SLC8A2;STC1;TMEM165;PML;CHRNA7;ATP2B1;HTR2C;STIM1
prerank,cellular response to lectin (GO:1990858),0.30440115140513035,0.8533604199955868,0.745398773006135,0.9692557879395048,1.0,10/104,11.27%,SYK;PSMC4;FYN;MUC1;PSMC6;SRC;CHUK;PSMD8;NRAS;KRAS
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.30440115140513035,0.8533604199955868,0.745398773006135,0.9692557879395048,1.0,10/104,11.27%,SYK;PSMC4;FYN;MUC1;PSMC6;SRC;CHUK;PSMD8;NRAS;KRAS
prerank,negative regulation of inflammatory response (GO:0050728),0.2980284182025916,0.8533213247779751,0.7995971802618328,0.9688857534050045,1.0,29/182,16.30%,SYK;VIPR2;FYN;MAPK7;MAPK14;METRNL;MVK;NR1D1;GLP2R;SRC;ADCYAP1;DPEP1;CRHR1;GPR20;FNDC4;CALCA;SIRPA;GPR45;TSHR;ADCY8;CD200R1;TNFRSF1B;GNB1;LHCGR;KLF4;IL4;LRFN5;SELENOS;IL6
prerank,positive regulation of nervous system development (GO:0051962),0.33201764815193674,0.8525282563288487,0.7088465845464725,0.9698312414368648,1.0,7/42,19.42%,EPHB2;NUMBL;SERPINF1;EPHB3;SYNDIG1;EPHB1;CLSTN3
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.3568978371223442,0.8524321258415962,0.691358024691358,0.9695480563729055,1.0,11/26,28.54%,EFNA5;NR1D1;STX4;ADCY8;PPP3CB;GPLD1;EPHA5;BAIAP3;STXBP4;CFTR;LRP5
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.3036837586677683,0.8522171554294452,0.7436159346271706,0.9694859899865307,1.0,10/105,11.27%,SYK;PSMC4;FYN;MUC1;PSMC6;SRC;CHUK;PSMD8;NRAS;KRAS
prerank,Golgi to plasma membrane transport (GO:0006893),0.32575361758616783,0.8521700011281477,0.7013129102844639,0.969135300169445,1.0,15/47,22.56%,LLGL1;GGA1;ARFRP1;GGA2;GOLGA4;NSF;SPTBN1;BLZF1;GOPC;PREPL;VAMP2;EXOC4;RAB10;VAMP4;GOLPH3L
prerank,fatty acid elongation (GO:0030497),-0.3187042072850057,-0.8521278632022645,0.6538461538461539,0.8717947139510064,1.0,6/13,17.04%,ELOVL7;HACD1;HACD4;HACD2;ELOVL1;ELOVL4
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.37603956752619483,0.8519840528441373,0.6743295019157088,0.9690136275432791,1.0,7/18,29.35%,TMEM259;ERN1;BAK1;NCK1;USP13;DDIT3;BAX
prerank,morphogenesis of a polarized epithelium (GO:0001738),0.41199356125842357,0.8518051936479445,0.660377358490566,0.9689059072939247,1.0,5/12,20.69%,ZDHHC7;VANGL2;AHI1;ACTG1;RAB10
prerank,regulation of protein metabolic process (GO:0051246),0.33128427223743195,0.8517136330836899,0.6990077177508269,0.9686380798891133,1.0,15/44,24.79%,MAPK7;KLF2;ODC1;TMEM9;SSH1;ZDHHC2;KLF4;TRAF3;CHRNA7;PLAUR;NEDD8;LDLR;FKBP1A;PARL;MDM2
prerank,regulation of interleukin-1 beta production (GO:0032651),0.3167407074047587,0.8516510788663361,0.7252631578947368,0.9682906555976865,1.0,10/66,16.30%,FOXP1;F2R;TMEM106A;CARD16;TLR4;SIRPA;USP50;ZC3H12A;NLRP2B;IL6
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.3596126180911439,0.8515783053115986,0.6767554479418886,0.9679752058961896,1.0,3/22,11.15%,RUNX1;TNFRSF18;BCL6
prerank,hexose metabolic process (GO:0019318),0.3348141190241181,0.8509327997008354,0.6790123456790124,0.9687015111525453,1.0,9/39,23.16%,CHST1;GALK1;IRS2;GAA;ALDOA;GALM;SLC37A4;SLC35A2;KCNJ11
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.34042883872594265,0.8507931279026659,0.6985040276179517,0.9685126666793015,1.0,13/36,22.56%,NECTIN3;GGA1;ARFRP1;GGA2;GOLGA4;NSF;SPTBN1;BLZF1;PREPL;VAMP2;RAB10;VAMP4;GOLPH3L
prerank,histone H3 acetylation (GO:0043966),0.3371650594689143,0.8507400353497718,0.6902356902356902,0.9681694998919343,1.0,14/40,22.99%,TADA1;KAT2B;POLE3;ING4;WDR5;DR1;KAT14;YEATS2;PER1;TAF6L;SGF29;KAT6B;LDB1;MAP3K7
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.422752313342145,0.8502265357918319,0.6499261447562777,0.9686183534410403,1.0,1/10,2.76%,VEGFA
prerank,cellular response to ketone (GO:1901655),0.34230695139821465,0.8498879309438415,0.6995359628770301,0.9687923386870739,1.0,6/35,13.76%,AR;SRC;LARP1;ADCY8;ADAM15;GNB1
prerank,cellular response to exogenous dsRNA (GO:0071360),-0.32566837795016024,-0.8497527258947706,0.6758620689655173,0.8749847034547045,1.0,3/12,7.21%,MAVS;CAV1;IFIT1
prerank,clathrin-dependent endocytosis (GO:0072583),-0.2627637269420951,-0.849750289643842,0.6864864864864865,0.8734980003803346,1.0,4/26,7.11%,DNAJC6;FNBP1L;GPR107;FCHSD2
prerank,extracellular transport (GO:0006858),-0.31457659665884496,-0.8497299067235106,0.6678966789667896,0.8720494578432867,1.0,9/12,36.24%,WWP2;ARRDC1;CABYR;ROPN1L;ADCY10;SPA17;DNAAF2;CCDC40;DNAAF4
prerank,negative regulation of myoblast differentiation (GO:0045662),-0.31652026003189293,-0.8496910330130886,0.6704980842911877,0.8706505453083943,1.0,3/13,12.16%,NOTCH1;TBX3;TGFB1
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.39404619360383114,0.8492667506060073,0.6772068511198946,0.9694685852268458,1.0,6/15,27.01%,ADAM9;TNFRSF1B;GPLD1;SH3D19;PACSIN3;SNX33
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.35615110286777013,0.8492660640570868,0.6759708737864077,0.9690242824838455,1.0,11/24,29.35%,TGFB2;NUPR1;MCL1;ITGAM;BACE1;NF1;ATF4;DDIT3;FBXW7;PRNP;BAX
prerank,proteasome assembly (GO:0043248),0.41428335945443084,0.8490690655203318,0.6689944134078212,0.9689135464462805,1.0,2/11,8.49%,PSMG2;ADRM1
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.33520001265821836,0.848241546774281,0.7002262443438914,0.9699346919553363,1.0,6/36,14.60%,CYGB;EGFR;ATP2B4;AKT1;GLA;HSP90AA1
prerank,sodium ion transmembrane transport (GO:0035725),0.3112538366008484,0.8480304049959473,0.7599164926931107,0.9698706840784274,1.0,18/84,16.02%,SCNN1B;SLC4A8;ATP1A4;ATP1A3;ATP1A1;SLC9A9;SLC6A8;PKD2;HCN4;SLC4A4;SLC6A11;SLC6A4;SLC9A1;ASIC2;SLC8A2;SLC9A7;SLC9A6;SCN4B
prerank,ubiquinone biosynthetic process (GO:0006744),0.38459794445120576,0.8474321467041556,0.6666666666666666,0.9704659291782548,1.0,6/15,25.83%,COQ10B;COQ7;COQ3;COQ5;COQ2;COQ10A
prerank,homeostasis of number of cells (GO:0048872),0.4011633915402117,0.8469849238686228,0.6586345381526104,0.9707897122827923,1.0,3/12,11.93%,F2R;UBAP2L;LRRC19
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.33885400963904966,0.8469655632577435,0.6816608996539792,0.970383252725715,1.0,7/33,15.12%,MAPK7;NFE2L2;TCF7L2;GAS6;CAST;IL4;NUPR1
prerank,regulation of organelle organization (GO:0033043),0.3074224009910136,0.8466461918693512,0.7326315789473684,0.9704839511425141,1.0,28/80,27.62%,CAPN2;S100A8;S100A9;STX5;SYT11;PREB;MIEF2;MYO5A;SURF4;LMAN1;SQSTM1;MAPT;DIAPH1;RAB33B;AKAP9;ARMH3;VPS11;MAPK1;TMEM33;PARL;ZEB2;FIS1;MARK2;MTM1;RHOT2;MUL1;RBSN;PDE4DIP
prerank,sodium ion transport (GO:0006814),0.30806210254396393,0.8466365367558353,0.7484407484407485,0.970064718608156,1.0,15/85,14.00%,SCNN1B;SLC5A9;SLC4A8;FGF13;ATP1A4;SLC6A8;PKD2;HCN4;SLC4A4;SLC6A11;SLC6A4;SLC23A1;ASIC2;CATSPER3;SLC8A2
prerank,phosphatidylcholine metabolic process (GO:0046470),0.31432457068745223,0.8465723865183546,0.7198731501057083,0.9697343869417714,1.0,19/70,26.89%,GPAT4;PLAAT1;CHKB;SLC44A1;LCAT;LPCAT1;PNPLA8;MBOAT7;CEPT1;PLA2G4E;SLC44A2;LIPC;GPLD1;LPIN3;PCTP;CSNK2A2;SLC27A1;LPCAT3;PLA2G7
prerank,regulation of DNA recombination (GO:0000018),0.33984022333908914,0.8465179564614785,0.7061556329849012,0.9693941817259419,1.0,12/32,26.85%,KPNA2;SETD2;THOC1;IL4;SPIDR;RAD50;BLM;KPNA1;TERF2IP;ALYREF;H1-0;MSH6
prerank,regulation of protein localization (GO:0032880),0.3214401008072122,0.8464368650536387,0.7372972972972973,0.9690940836290954,1.0,18/58,25.85%,RABGAP1L;ITGB3;ZDHHC7;TRIM46;ADCYAP1;ATCAY;HSP90AA1;RSL1D1;TRIM68;UFL1;CTSD;TRIM67;TMEM231;TPR;FKBP1A;DVL1;FBXW7;CSNK1E
prerank,acylglycerol metabolic process (GO:0006639),0.3352852909195667,0.8462054677606121,0.6902857142857143,0.9690510528017081,1.0,3/37,7.63%,MGLL;DGKQ;GK5
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.38843534337864144,0.8460231805222448,0.6631158455392809,0.9689470949398601,1.0,7/15,31.85%,IL17RA;TLR4;IL6;TICAM1;MYD88;IL17D;APPL1
prerank,granulocyte differentiation (GO:0030851),-0.2857114703020413,-0.8459123149181753,0.6448598130841121,0.8767299217797636,1.0,5/18,13.71%,LEF1;CBFA2T3;CDK2;EP300;TAL1
prerank,protein polyglutamylation (GO:0018095),-0.3386308595374831,-0.8458886324243567,0.6515679442508711,0.8752910132593162,1.0,4/11,17.93%,TTLL5;CFAP20;TTLL1;CEP41
prerank,transcription preinitiation complex assembly (GO:0070897),0.4069215881265738,0.8454833966633726,0.6717241379310345,0.9694658640539611,1.0,5/12,23.46%,DR1;GTF2A2;TAF7L;TBP;BDP1
prerank,carboxylic acid catabolic process (GO:0046395),0.4004714338759182,0.8454065968390198,0.6652949245541838,0.9691574520638022,1.0,2/12,9.36%,NAGK;PON3
prerank,water-soluble vitamin metabolic process (GO:0006767),-0.20590216143586926,-0.8451078599031864,0.864406779661017,0.8753926576788705,1.0,12/68,12.88%,PCCA;SLC2A1;ENPP1;PDXK;MTHFS;TCN2;RFK;CUBN;ALDH1L1;MMAA;MCCC2;SLC19A3
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.3573323397208364,0.8446622818618281,0.6752136752136753,0.9700555106087377,1.0,6/25,14.60%,KLF2;PKD2;TLR4;AKT1;KLF4;HSP90AA1
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.2883056932163764,0.8444518125785334,0.89,0.9700130223736759,1.0,107/366,26.27%,ESR1;BNC2;WT1;PKP3;SCRT2;PRDM8;MLF2;BHLHE40;ATF5;WWTR1;LMX1B;CXXC1;FOXK2;NAB1;NR1D2;SPIN4;RBAK;RBBP6;IGSF1;NFIA;ZFHX3;TRIP4;MLXIPL;MYT1;NUP107;ATXN2;PHF1;MSL3;SPTY2D1;FZD7;MYBL2;HNRNPD;RYBP;ONECUT1;MZF1;MITF;ACTR5;ATF7;CEBPB;FBXO5;SIX1;NOLC1;RBM3;EHMT2;FADS1;GMNN;NR2C2;RPL6;RNF14;SNAI2;CHD3;EFEMP1;PML;GON4L;MED23;GCFC2;TGFBR1;ZSCAN26;PCIF1;ELAVL2;JMJD1C;TAF6L;ASCC1;OGG1;FOXO4;TRRAP;METAP1;NSD1;USP13;SPIN1;BTG1;EIF2A;CARM1;TERF2IP;EZH2;ATF4;KAT6B;RNF6;LDB1;CCDC88A;RORA;BAZ2A;NCOA2;ZNF431;NFXL1;NR3C1;RABL3;ESRRA;TGFBRAP1;SAP30L;SKOR2;RELA;SERTAD3;DVL1;ACVR1B;CALR;PHF12;APBB2;KAT7;GRM5;VHL;CYFIP1;RNF20;DDIT3;TCF7L1;ZNF2;HP1BP3
prerank,hyaluronan catabolic process (GO:0030214),0.3777533085478981,0.8444423349799256,0.684346701164295,0.9695892977956192,1.0,4/18,15.25%,CD44;FGF2;SLC9A1;CHP1
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.38949885483671653,0.8441876527789126,0.6765847347994826,0.9695994890128957,1.0,3/15,7.85%,FGF2;SMOC2;PRKD2
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.20482003543080432,-0.8440309960295136,0.8947368421052632,0.876136935338381,1.0,32/87,20.76%,RPL13;SEC61A2;RPS7;RPL37;RPS27;RPS13;RPL19;RPL36;RPL30;RPL36A;SRP14;RPS14;RPL18A;RPS18;RPS21;RPL5;RPL7A;RPS24;RPS11;RPL39;RPL29;SRP72;RPL26;RPS23;RPL35;RPL14;SRP68;RPL37A;RPL24;RPL18;ZFAND2B;RPL9
prerank,protein mannosylation (GO:0035268),-0.2797209818130412,-0.8438455314352509,0.7528735632183908,0.8750474790161947,1.0,6/22,13.39%,TMTC1;TMTC4;TMTC2;DPY19L4;FKRP;POMT2
prerank,regulation of Notch signaling pathway (GO:0008593),0.3100329380628892,0.8434747836805994,0.7677824267782427,0.9704375853083648,1.0,14/76,12.38%,EGFR;ZMIZ1;TGFB2;LLGL1;TSPEAR;BEND6;SRC;JAG1;RFNG;KAT2B;BMP2K;ENHO;AKT1;EGF
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),-0.2719902945703733,-0.8434542543451043,0.7114427860696517,0.8743330878987237,1.0,8/21,20.76%,EPHA7;AIM2;DELE1;TTBK1;BEX3;MT3;PSMB9;BIRC2
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.3273429293805137,0.8434349610001666,0.7242937853107345,0.9700701478976158,1.0,17/45,25.60%,PKP3;TRIM71;RC3H1;ATXN2;LARP4;TDRD7;PUM1;LARP1;NOLC1;RBM3;PER1;PCIF1;METAP1;EIF2A;ATG14;GRM5;CYFIP1
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.3139239642734644,0.8431946974407043,0.7298474945533769,0.9700347890957755,1.0,11/57,17.66%,SYK;FYN;F2R;TBC1D10A;USP50;BAK1;GRAMD4;HTRA2;GRIN2A;CTSD;BCAP31
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),-0.33071805171980917,-0.8431785831459577,0.6640316205533597,0.8734904565514684,1.0,11/11,66.96%,PKD1L3;LPO;RTP3;TAS1R2;GNAT3;GNAT2;PIGR;TAS1R3;RTP4;RTP2;PKD2L1
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.32922870995769266,0.8429662577023814,0.7052868391451068,0.9700038601734979,1.0,7/41,20.33%,KCNMA1;ANK2;KCNJ2;KCNJ3;GNB1;KCNH2;FLNA
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.3166276716660124,0.8429267154090365,0.7145993413830956,0.9696388773883612,1.0,6/55,9.41%,FHL1;PSMC4;ATF5;PSMC6;PSMD8;AVEN
prerank,ERK1 and ERK2 cascade (GO:0070371),0.35661329532487374,0.8417964277796279,0.6658476658476659,0.9711798262847224,1.0,5/21,15.61%,ZFP36L1;ZFP36L2;ITGAV;EGF;MAP2K2
prerank,cell cycle G2/M phase transition (GO:0044839),0.29852949875271506,0.8417576885388635,0.781947261663286,0.970815519873148,1.0,37/129,24.46%,DCTN1;ODF2;CDK14;YWHAG;SSNA1;YWHAE;PPP1R12B;ALMS1;MAPRE1;HAUS3;SFI1;CDKN1A;FBXL3;AKAP8;CCNH;HSP90AA1;TUBB4A;TUBA4A;DYNC1H1;CDK5RAP2;CCP110;AKAP9;CEP164;CKAP5;SKP2;PAFAH1B1;PPP2R2A;PCM1;AKAP8L;DCTN2;FBXW11;CDC25B;NEDD1;LATS1;DYNLL1;CEP78;FBXL12
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.4188565215487914,0.841540121692881,0.6662068965517242,0.9707399560934228,1.0,3/10,15.82%,PDZD7;TSKU;PLS1
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.4034233399142909,0.8412245380537356,0.6771545827633378,0.9708645470354834,1.0,2/12,7.02%,RUNX1;RC3H1
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.39889667961600034,0.8411429063089714,0.676510067114094,0.9705684199851541,1.0,5/13,26.30%,EIF2AK3;NUPR1;MANF;USP19;LPCAT3
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.31446179384495915,0.8410631803211035,0.7426160337552743,0.9702729990698991,1.0,20/69,25.11%,POLR2H;ZC3H8;INTS3;TAF8;INTS10;CDK9;INTS6;POLR2D;POLR2G;GTF2A2;GTF2F1;INTS2;INTS12;GTF2E2;ICE1;ELL;TBP;TAF13;POLR2C;GTF2E1
prerank,defense response to virus (GO:0051607),-0.19739749862704906,-0.8407797583890558,0.8780487804878049,0.8766993813108622,1.0,27/100,21.80%,BCL2L1;SERINC3;BCL2;TRIM56;PLSCR1;IFITM3;ABCC9;MAVS;CNOT7;IFIT1;IFIT2;TLR3;OAS2;RNF135;STAT1;IFIT3;RNASEL;CLPB;PHB2;CD40;RSAD2;OPRK1;ZDHHC1;MLKL;BNIP3;TRIM5;IRF3
prerank,regulation of mRNA stability (GO:0043488),0.29418573542371873,0.8407231418719381,0.790273556231003,0.9704396984556083,1.0,51/145,31.73%,PRKCA;PSMC4;TENT5B;ZFP36L1;SAMD4B;PSMC6;RC3H1;CARHSP1;ZFP36L2;PSMD8;HNRNPD;EXOSC7;NPM1;AKT1;PUM1;IGF2BP1;UBA52;LARP1;ZFP36;GDNF;EXOSC1;FXR2;YTHDF1;YTHDF2;SET;THRAP3;RC3H2;YWHAB;YTHDF3;PSMD3;PSMD4;RBM24;TNPO1;PSMB3;DCP1A;EIF4G1;PSMB2;CELF1;PSMD5;PDE12;IGF2BP3;TBRG4;SERBP1;HSPA8;EXOSC3;PSMD14;PSMC3;PSMC5;CIRBP;FXR1;PSME4
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.34853883281566067,0.8403585108912184,0.6793611793611793,0.9706303368742041,1.0,11/25,31.64%,CHMP7;VPS4B;MVB12A;TMEM50A;LYST;UBXN6;LEPROT;CHMP4C;LAPTM4B;CHMP4A;CHMP4B
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.28709963191978893,0.8401745063066065,0.8847695390781564,0.9705020881495566,1.0,94/327,26.27%,ESR1;BNC2;WT1;SCRT2;PRDM8;ZMIZ1;MLF2;BHLHE40;ATF5;WWTR1;LMX1B;CXXC1;FOXK2;NAB1;NR1D2;SPIN4;RBAK;IGSF1;NFIA;ZFHX3;TRIP4;MLXIPL;MYT1;NUP107;PHF1;MSL3;SPTY2D1;FZD7;MYBL2;HNRNPD;RYBP;ONECUT1;MZF1;MITF;ACTR5;ATF7;CEBPB;SIX1;FADS1;NR2C2;RPL6;RNF14;SNAI2;CHD3;EFEMP1;PML;GON4L;MED23;GCFC2;TGFBR1;ZSCAN26;ELAVL2;JMJD1C;TAF6L;ASCC1;OGG1;FOXO4;TRRAP;NSD1;USP13;SPIN1;BTG1;CARM1;TERF2IP;EZH2;ATF4;KAT6B;RNF6;LDB1;RORA;BAZ2A;NCOA2;ZNF431;NFXL1;NR3C1;ESRRA;TGFBRAP1;SAP30L;SKOR2;RELA;SERTAD3;RALY;DVL1;ACVR1B;CALR;PHF12;APBB2;KAT7;VHL;RNF20;DDIT3;TCF7L1;ZNF2;HP1BP3
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.29960549011716764,-0.839484092639833,0.6875,0.8778545732791124,1.0,5/16,12.12%,PDGFD;NRP1;PTPN1;PDGFRB;ABL1
prerank,histone methylation (GO:0016571),0.3498602778677091,0.8392575651152044,0.6792452830188679,0.9716714325943362,1.0,11/26,31.65%,PRMT2;NTMT1;EHMT2;N6AMT1;NSD1;CARM1;EZH2;SUV39H1;PRMT8;SIRT7;PRMT7
prerank,nitrogen compound transport (GO:0071705),0.2949560121149024,0.8389927389466284,0.8130081300813008,0.9716906713034671,1.0,28/141,17.47%,SLC1A5;LRRC8D;SLC7A6;ARRDC2;SLC43A2;MIA3;TOM1;SCAMP3;RCN3;SLC6A8;SCAMP5;TCN1;SLC44A1;SLC16A10;SLC6A4;TMEM30A;SLC7A3;LRP1B;RUFY1;KIF3A;ABCC1;SLC23A1;CMTM6;SLC15A4;SEC14L1;SLC38A1;FLVCR1;SLC44A2
prerank,positive regulation of innate immune response (GO:0045089),0.3429204269973294,0.8386893173529735,0.6771084337349398,0.9717850916140902,1.0,4/30,14.59%,LBP;POLR3D;AKIRIN2;SLC15A4
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.4176710264607694,0.8381065249783992,0.6937321937321937,0.9723505194704468,1.0,5/10,35.91%,TSKU;LAPTM4B;CDH3;HSP90AB1;FN1
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.3576979651932334,0.8381048343637091,0.6905615292712067,0.9719138341689059,1.0,10/23,31.27%,COPS5;RAD23B;UBA52;DDB1;COPS4;GPS1;CETN2;COPS6;COPS3;COPS7B
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.34436359657741034,-0.8377244020916771,0.652014652014652,0.879864179849321,1.0,3/10,12.96%,LYN;FAS;MAPK3
prerank,mitochondrion organization (GO:0007005),0.29416655711109735,0.8374043533913799,0.8353413654618473,0.9727349865164073,1.0,45/165,25.60%,TIMM50;DNM1;RAB32;CLUH;GDAP1;WASF1;TIMM10B;TRAK2;MIEF2;PID1;AIFM2;TIMM9;SLC25A4;TMEM70;MYH14;AKT3;POLG2;NDUFS1;DNAJA3;FANCG;ATCAY;PTCD2;TIMM22;MTFR1L;SPG7;TIMM8B;BCAP31;BCS1L;SUPV3L1;SLC25A36;VPS13D;TOMM5;TIMM17A;SLC25A33;GABPA;MGME1;AFG1L;ESRRA;FIS1;RAB5IF;MTM1;TOMM40;ATP5F1B;RAB29;RHOT2
prerank,protein localization to cell periphery (GO:1990778),0.29660638915161425,0.8369118766511073,0.8135764944275583,0.9731360038335974,1.0,25/133,16.98%,LRP6;TTC7A;TSPAN17;PKP3;PRAM1;ANK2;FGF13;S100A10;PLEKHF1;MYADM;MYO5A;GAS6;PACS2;CD81;EHD2;INPP5K;FYB2;RAB3D;JUP;ZDHHC2;PIGW;ANK1;SPTBN1;AP4M1;FLOT2
prerank,positive regulation of JNK cascade (GO:0046330),0.30576835108635425,0.8367887612564633,0.7361256544502618,0.9729006518485412,1.0,11/70,12.81%,SH3RF3;GADD45G;TAOK3;AXIN1;RASSF2;FZD7;SEMA3A;TIRAP;ANKRD6;CD27;TAOK2
prerank,termination of RNA polymerase I transcription (GO:0006363),0.3480280706803323,0.8367660071352188,0.6994152046783626,0.9724980784145555,1.0,6/30,14.14%,POLR2H;GTF2H3;POLR1G;UBTF;ERCC3;CCNH
prerank,prostanoid biosynthetic process (GO:0046457),-0.30732286834306244,-0.8364436593787148,0.7325102880658436,0.8808098716184813,1.0,6/15,15.79%,PTGDS;PTGS2;PTGIS;PTGES3;EDN1;CD74
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),0.3978449026167572,0.8363577626999258,0.6880984952120383,0.9727718356424462,1.0,5/12,12.14%,IRS1;EPM2AIP1;DYRK2;AKT1;IRS2
prerank,RNA biosynthetic process (GO:0032774),-0.24792648669768175,-0.8361371756216561,0.7246376811594203,0.8799120345960545,1.0,8/31,16.43%,PRIM2;TAF6;POLR2A;HELB;TERT;TAF7;TAF5;GTF2B
prerank,snRNA transcription (GO:0009301),0.31185260308692075,0.836077621461674,0.7449947312961012,0.9728205608294377,1.0,20/70,25.11%,POLR2H;ZC3H8;INTS3;TAF8;INTS10;CDK9;INTS6;POLR2D;POLR2G;GTF2A2;GTF2F1;INTS2;INTS12;GTF2E2;ICE1;ELL;TBP;TAF13;POLR2C;GTF2E1
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.35522939781510965,0.8359137612416657,0.6927710843373494,0.9726793920225832,1.0,8/24,22.99%,ITCH;UBE2N;IRAK1;UBA52;AAMP;TAB2;CYLD;MAP3K7
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.33284643307104705,-0.8356458272622243,0.6704119850187266,0.8793138912287998,1.0,4/11,12.22%,NOS3;GCH1;QDPR;SPR
prerank,nucleotide metabolic process (GO:0009117),0.3563209626926743,0.8355243171892707,0.7011070110701108,0.972905258001025,1.0,6/23,17.56%,REXO2;FHIT;NME2;NUDT5;CMPK2;AK8
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.3877811088029227,0.8353997893616014,0.711436170212766,0.972670643053987,1.0,11/14,38.30%,NME2;CMPK2;AK8;AK5;AK3;ME1;NMNAT2;AK1;CMPK1;AK7;PNP
prerank,chemical homeostasis (GO:0048878),0.31362725524845364,0.8352857887009508,0.7415254237288136,0.9724366733744727,1.0,16/61,24.17%,SLC4A10;SLC4A8;SLC4A3;NR1D2;TLCD2;SLC4A4;PNPLA8;IRS2;THADA;ACOX1;TENT4B;ANGPTL3;EIF5A2;SLC4A2;ABCB4;WNK2
prerank,positive regulation of sodium ion transport (GO:0010765),-0.32069860187901733,-0.8350921182041414,0.6875,0.8789645807118074,1.0,5/12,21.07%,AHCYL1;GPD1L;NOS1;SCN3B;ANK3
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.3905391324042524,0.8349634605188553,0.6804979253112033,0.9725497686221823,1.0,6/13,26.59%,KPNA2;IPO5;KPNA1;CBLB;KPNA6;KPNB1
prerank,striated muscle cell differentiation (GO:0051146),0.37484764789367814,0.8344639035360548,0.6842800528401585,0.9729842635809809,1.0,2/16,4.06%,AKAP13;SKI
prerank,regulation of mitotic spindle assembly (GO:1901673),0.3658512330778301,0.8341070701290811,0.7063291139240506,0.9731495585322186,1.0,5/19,22.69%,VPS4B;CCSAP;CEP97;PDCD6IP;TPR
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.3585470471165409,0.8334120992440492,0.7077114427860697,0.9738985322431444,1.0,7/22,16.75%,WASF1;AKT1;MAPT;MAGI2;KIDINS220;RAPGEF1;RAB35
prerank,glucan catabolic process (GO:0009251),-0.3009426127825324,-0.8333914986348296,0.6952789699570815,0.8808249107938207,1.0,3/15,5.34%,PHKB;PYGM;AGL
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.32412518878500735,0.8332115666993938,0.7197309417040358,0.9738285423692219,1.0,18/42,30.14%,SMARCD2;SPTY2D1;ACTR5;SMARCC2;DMAP1;INO80;SMARCA4;CHD8;SRCAP;CHD3;ZNHIT1;VPS72;MBD2;ARID1A;ARID1B;HNRNPC;PBRM1;MBD3
prerank,endothelial cell development (GO:0001885),0.3496401200710246,0.8330155031064659,0.7021531100478469,0.9737399667002931,1.0,7/25,15.37%,TNMD;RAP1B;MYADM;COL15A1;PDE4D;RAPGEF1;STC1
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.3373000985486216,0.8330087650099418,0.7051129607609988,0.9733150821377982,1.0,2/29,2.30%,HPN;LDLRAD4
prerank,erythrocyte development (GO:0048821),0.4143738519511838,0.8327897964614673,0.6838340486409156,0.9732402472323868,1.0,5/10,36.16%,ABCB10;DMTN;ZBTB7A;NCKAP1L;MED1
prerank,positive regulation of neuron differentiation (GO:0045666),-0.22977743114227311,-0.8322302338647949,0.8260869565217391,0.8816627857719401,1.0,10/40,16.88%,TCF4;MEF2C;HEYL;BRINP3;VWC2;BMP2;MMD2;TRIM32;SOX11;HOXD3
prerank,regulation of neurotransmitter receptor activity (GO:0099601),0.3114030869542865,0.8317127896130065,0.7480832420591457,0.9746380279558493,1.0,12/57,17.31%,CNIH3;DLG4;DLGAP4;DLG2;NEFL;CAPN1;GRIA2;DLGAP3;CACNG2;DLGAP1;GRIN2A;AKAP9
prerank,positive regulation of TORC1 signaling (GO:1904263),0.37325231444798207,0.8315795306945394,0.6974358974358974,0.9744531432304006,1.0,5/16,22.86%,FLCN;RRAGD;PIP4P1;GPR137B;KLHL22
prerank,excitatory postsynaptic potential (GO:0060079),0.36471365051443944,0.8315729015800062,0.7037037037037037,0.9740299969596369,1.0,9/19,32.92%,MPP2;GRIN2D;AKT1;GRIN2A;GRID2;NPAS4;DRD2;GSK3A;RAB3GAP1
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.32542609026252417,0.8313459828646292,0.708803611738149,0.9739865508779011,1.0,9/39,18.98%,TCF7L2;GRP;ADCYAP1;MCU;IRS2;TRH;GLUD1;CAPN10;AIMP1
prerank,DNA replication-independent nucleosome organization (GO:0034724),-0.3223280344342733,-0.8311692534959044,0.6755725190839694,0.8821899170996907,1.0,1/11,1.76%,H3-3A
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.40319659070266434,0.8311533323882634,0.6815020862308763,0.9738847789557362,1.0,2/11,8.90%,NECAB3;AGO2
prerank,regulation of receptor recycling (GO:0001919),0.38097486252483503,0.8311198749891623,0.6998706338939198,0.9735104189393994,1.0,4/16,15.87%,ANXA2;INPP5F;ECE1;NSF
prerank,negative regulation of endocytosis (GO:0045806),0.3477864352488524,0.8309412166377481,0.6957575757575758,0.9733938316906718,1.0,8/24,27.01%,EPHA3;SYT11;SCAMP5;ARF6;LRSAM1;PACSIN3;RAC1;SNX33
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.3597585998550341,0.8303424958215709,0.7107231920199502,0.9739336124442247,1.0,3/21,8.09%,FOXP1;RUNX1;CD81
prerank,cell chemotaxis (GO:0060326),0.3090585630289549,0.8302206739285515,0.75,0.9736995561448223,1.0,11/60,18.13%,ACKR3;VEGFA;LPAR1;CCL25;ACKR4;ABCC1;PDGFRA;HGF;CXCR4;CXCR2;EPHB1
prerank,positive regulation of protein localization to cell surface (GO:2000010),0.38775365124625405,0.8301841607770555,0.7097661623108665,0.9733207682204236,1.0,6/13,28.93%,STX4;STX3;MAP1A;SNX33;RANGRF;TM9SF4
prerank,carnitine metabolic process (GO:0009437),0.39875034740446286,0.8298567553274232,0.7077131258457375,0.9734433446187684,1.0,5/12,22.34%,CPT1C;CRAT;CPT2;CROT;ALDH9A1
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.36207558970006265,0.8296252262217595,0.7032967032967034,0.973362818034609,1.0,6/21,24.49%,ANK2;SCN4B;AKAP9;KCNH2;FLNA;CACNA2D1
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.3005071506284745,-0.8293798505166106,0.7003610108303249,0.8841847589213255,1.0,7/13,26.59%,ATM;SPRED3;SPRED2;RPL26;PLA2R1;MSX1;ATR
prerank,cellular respiration (GO:0045333),0.3241163086292832,0.8293597910362787,0.7207207207207207,0.9733482744383279,1.0,14/41,27.03%,COQ10B;ETFA;NDUFS1;SURF1;MDH2;ETFB;ETFDH;MTFR1L;UQCRH;UQCR10;ME3;SDHC;COQ10A;COX15
prerank,histone monoubiquitination (GO:0010390),0.34583167744951065,0.8293351962188511,0.6966707768187423,0.9729543830130953,1.0,7/24,21.49%,RNF2;ATXN7L3;RYBP;DDB1;RING1;PAF1;KDM2B
prerank,telomere maintenance via telomerase (GO:0007004),0.3348226344278065,0.8292051817855,0.698450536352801,0.97274634852233,1.0,9/28,22.09%,ACD;GAR1;TERF1;HSP90AA1;TNKS1BP1;RAD50;TINF2;PPP6C;TERF2IP
prerank,positive regulation of histone methylation (GO:0031062),-0.2562708386629482,-0.8290769621693286,0.7425742574257426,0.8833048905956961,1.0,6/24,14.28%,AUTS2;TET1;CTR9;SIRT1;RIF1;CTNNB1
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.40188826704125874,0.828844604142412,0.7037037037037037,0.9728964419594668,1.0,6/11,37.63%,TENT4B;LARP7;EXOSC10;EXOSC3;FBL;PARN
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.3188402809019575,0.8287336618745182,0.7422907488986784,0.9726589456322878,1.0,16/48,26.82%,POLR2H;ZMIZ1;SMARCD1;POLR1G;KAT2B;ATAD2B;DDX21;PADI2;POLR1C;SF3B1;TBP;POLR1B;H1-0;ELOF1;SERTAD2;ARID1A
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.34502650195632223,0.8285829211075354,0.711217183770883,0.9725067679646604,1.0,2/26,1.34%,EGFR;ANXA1
prerank,tetrapyrrole metabolic process (GO:0033013),0.36710316275925714,0.8284515746051601,0.7097186700767263,0.9723096120531645,1.0,6/18,24.87%,TCN1;MTR;ABCC1;MMADHC;MMAB;MTRR
prerank,negative regulation of JUN kinase activity (GO:0043508),0.40953561168085184,0.8282070622903949,0.698005698005698,0.972283984604229,1.0,3/10,20.08%,AIDA;PDCD4;HIPK3
prerank,blood vessel diameter maintenance (GO:0097746),0.33232195052677505,0.8281174786770357,0.7202797202797203,0.9719935214143899,1.0,3/34,8.91%,GCLC;KLF2;ECE1
prerank,adrenergic receptor signaling pathway (GO:0071875),-0.2681387456507663,-0.8279930509802825,0.7174887892376681,0.8838342493434668,1.0,4/20,9.13%,RAPGEF2;ADRA1B;ADRA2A;ADCY9
prerank,positive regulation of axonogenesis (GO:0050772),0.3207093071000531,0.8275313486692574,0.7142857142857143,0.9725760602865963,1.0,10/43,13.49%,DBN1;SLIT2;NTN1;ISLR2;PLXNA3;TIAM2;L1CAM;MAPT;MAP6;RHOA
prerank,regulation of calcium ion transport (GO:0051924),0.3153728499178236,0.8274452633525716,0.7431991294885746,0.9722861537386769,1.0,11/54,19.16%,IL16;ANK2;F2R;SRI;PKD2;INPP5K;EGF;CASQ1;STC1;ATP2B1;STIM1
prerank,carbohydrate homeostasis (GO:0033500),0.3049575405306797,0.8273835817742347,0.7593984962406015,0.9719656372048591,1.0,8/67,12.54%,MTNR1B;IRS1;CRTC2;TCF7L2;MLXIPL;MCU;INPP5K;ADCY8
prerank,eye photoreceptor cell development (GO:0042462),0.38086614071057295,0.8272261304586909,0.6946666666666667,0.9718095230231286,1.0,3/15,17.45%,VEGFA;BBS4;RPGRIP1
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),-0.25707899431215214,-0.8266879242026206,0.7225130890052356,0.8847691919474026,1.0,3/24,6.55%,ABCG2;PGRMC1;FECH
prerank,pyruvate metabolic process (GO:0006090),-0.2147975295649205,-0.8263994805379711,0.8045977011494253,0.8838477118154813,1.0,17/52,21.72%,BSG;ENO1;HK2;PGAM1;PGAM4;PGK1;PFKM;ALDOC;GAPDH;PFKL;DLD;TPI1;GAPDHS;ENO3;GPI;LDHB;NR4A3
prerank,synaptic vesicle cycle (GO:0099504),0.3383693071024271,0.826040400935068,0.7083825265643447,0.9733792483932537,1.0,6/30,20.02%,STX1A;SNAP25;SYNDIG1;SNAPIN;VAMP2;PLD2
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),0.40832438419709294,0.825879866167588,0.6849507735583685,0.9732282136526084,1.0,3/10,8.27%,SESTD1;BIN1;YWHAE
prerank,activin receptor signaling pathway (GO:0032924),0.3805572165456073,0.8250632175305042,0.7091633466135459,0.9741715600367175,1.0,7/15,32.25%,ACVR1;AMHR2;TGFBR1;ACVR2A;ACVR1B;ACVR1C;INHBB
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.32306386959609146,0.824693096121457,0.7296678121420389,0.9743338521980134,1.0,8/39,14.77%,PPFIA2;NDEL1;MYO1A;TRAK2;MYO5A;DYNC1I1;TANC2;CCDC186
prerank,chromosome organization (GO:0051276),0.2946959562708805,0.8241741064644003,0.7944501541623844,0.974747836838209,1.0,31/99,28.06%,COPS5;TCF7L2;RFWD3;RAD23B;CENPT;PHF1;SETD7;POLE3;HDAC3;UBA52;DDB1;EZH1;GATAD1;GEM;SMARCA4;BAHD1;PADI2;COPS4;TOP2B;EZH2;LDB1;LATS1;GPS1;NUP133;TCF7L1;SAFB;CETN2;MSH6;COPS6;HDAC8;SUV39H1
prerank,response to unfolded protein (GO:0006986),0.3205113230688108,0.8240411522182047,0.7317073170731707,0.9745332135040812,1.0,24/48,34.60%,HSPA13;ERN1;HERPUD1;SERPINH1;DNAJB2;BAK1;HSP90AA1;HSPA14;DNAJB1;ERP44;DERL1;BAG3;TM7SF3;HSPH1;DDIT3;DNAJA1;BAX;HSPA8;HSF1;DNAJB5;HSPB8;HSPA5;HSP90AB1;HSPA4
prerank,zymogen activation (GO:0031638),0.3214393284194963,0.8239568612944379,0.7160493827160493,0.9742384679277539,1.0,6/39,16.79%,KLKB1;PRSS12;TBC1D10A;BAK1;KLK1;GRIN2A
prerank,response to zinc ion (GO:0010043),0.3527296937057964,0.8236511840859375,0.7310924369747899,0.974304796806973,1.0,7/25,31.87%,CRIP1;SLC30A5;D2HGDH;PAM;P2RX4;GLRA2;SLC30A4
prerank,cellular amide metabolic process (GO:0043603),0.29444161425916077,0.8222278840018719,0.7901740020470829,0.9762622709176921,1.0,24/102,22.19%,SMPD3;GPAT4;PLPP3;PLAAT1;ACOT6;PLPP1;ORMDL2;ACOT9;THOP1;CERK;ACOT1;PLA2G4E;ABCB9;PLPP2;ST3GAL1;BTD;DNPEP;SMPD1;GNE;NIT1;MTHFD2L;NSMAF;CPZ;ATF4
prerank,filopodium assembly (GO:0046847),-0.2886471479031354,-0.82219232012267,0.7017543859649122,0.8901472294689965,1.0,3/16,4.29%,FGD4;FGD5;DNM3
prerank,embryonic heart tube morphogenesis (GO:0003143),0.3203068889017568,0.8221345704935527,0.7480662983425415,0.9759918978653186,1.0,9/43,15.86%,TGFBR2;ACVR1;TBX6;PKD2;NDRG4;MICAL2;VANGL2;BBS4;AHI1
prerank,sodium ion import across plasma membrane (GO:0098719),0.36994329107133983,0.8221244942030118,0.6840764331210191,0.9755853029164839,1.0,5/17,15.89%,SLC9A9;HCN4;SLC9A1;SLC9A7;SLC9A6
prerank,mRNA methylation (GO:0080009),0.3731387008287255,0.8220148283744771,0.6993464052287581,0.9753295313430798,1.0,2/15,8.10%,TRMT6;TRMT61A
prerank,regulation of innate immune response (GO:0045088),-0.2096003472996096,-0.821758359753505,0.8194444444444444,0.8894777474446028,1.0,17/57,17.35%,XIAP;PLSCR1;POLR3C;ERAP1;USP18;PTPN1;POLR3B;APPL2;RNF135;GBP5;RNASEL;TRIM21;N4BP1;NMI;LRP8;DHX58;PARP9
prerank,programmed necrotic cell death (GO:0097300),0.36209975825533375,0.8216923807702231,0.7066326530612245,0.9754233552105619,1.0,6/18,25.36%,ALKBH7;TLR4;PGAM5;CD14;CYLD;TICAM1
prerank,protein-containing complex disassembly (GO:0032984),0.31454382292287314,0.8216387081572785,0.7485970819304153,0.9750767422320744,1.0,7/54,13.15%,LRP6;AXIN1;LIX1L;WIPI2;VPS33A;STX17;EPG5
prerank,cellular response to purine-containing compound (GO:0071415),-0.3302840988640554,-0.8214463690372871,0.7256317689530686,0.8885997214981758,1.0,4/10,20.91%,RYR2;P2RY1;P2RY6;CASQ2
prerank,positive regulation of cell migration (GO:0030335),0.283105252305129,0.819973799380948,0.889,0.9773624608948661,1.0,37/253,14.83%,SEMA3C;DDR2;HAS2;MYOC;EPHB2;COL1A1;PRKCA;EGFR;VEGFA;TGFB2;F2R;ADAM9;SMURF2;ACVR1;MTOR;MIA3;MYADM;C1QBP;RET;SRC;HDAC6;TNFRSF18;SEMA3A;AGO2;STX4;MAPRE1;KIF20B;GPNMB;FBXO5;SEMA3D;EGF;MGAT5;NSMF;PDGFRA;FER;PPP3CA;IL4
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.34561734830397334,0.8194888937029262,0.7362637362637363,0.9777382273657901,1.0,6/26,15.25%,ATP2B4;STIMATE;DYRK2;RCAN1;SLC9A1;CHP1
prerank,amyloid precursor protein metabolic process (GO:0042982),0.3566551914465145,0.8194026135860962,0.7114624505928854,0.9774612320274454,1.0,5/18,13.64%,ADAM19;TMCC2;PSEN1;KLK6;NSG1
prerank,mitochondrion disassembly (GO:0061726),0.32966971049688243,0.8193536367663393,0.72480181200453,0.9771126329500381,1.0,12/34,24.76%,ATG2B;WIPI2;SQSTM1;WDR45B;ULK2;ATG2A;ULK1;CISD2;ATG3;FIS1;CTSK;MARK2
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),-0.2690903872573409,-0.8193380866632647,0.7474747474747475,0.8908765573985,1.0,7/21,16.62%,NES;CX3CL1;MDK;SMARCD3;CTNNB1;TOX;DISC1
prerank,alanine transport (GO:0032328),-0.335100958988493,-0.8193020113091829,0.6996587030716723,0.889506538596541,1.0,2/10,12.51%,SLC6A17;SLC6A6
prerank,Rac protein signal transduction (GO:0016601),0.35889476564278583,0.8191641624517272,0.6916354556803995,0.9769861588975389,1.0,7/18,25.60%,WASF1;FARP2;HACD3;HACE1;TIAM1;RAC1;CYFIP1
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.4008599602763947,0.8183797486621601,0.7138849929873773,0.9778541481405821,1.0,1/11,2.47%,FYN
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.3861257598641186,0.8182337975034534,0.7080394922425952,0.9776578307854787,1.0,1/12,2.03%,CDC14B
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.35421636486298347,0.8182080580249758,0.7130541871921182,0.9772656200067532,1.0,4/21,20.62%,FGF13;CAMSAP1;NAV3;CLASP2
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.402943081156626,0.8179774501880004,0.7061281337047354,0.9772118381948482,1.0,7/10,29.45%,MUC1;ING4;RPS27L;TFAP4;KAT5;FOXM1;TP53
prerank,cellular response to radiation (GO:0071478),0.32482482801682194,0.8175607663270145,0.7410404624277457,0.9774544881823548,1.0,10/40,22.08%,MAPK14;RHNO1;RAD1;CDKN1A;INO80;TNKS1BP1;SPIDR;BLM;OPN3;NSMCE3
prerank,cellular response to peptide (GO:1901653),0.30927234597700987,0.8174469652250207,0.7589967284623773,0.9772269016743368,1.0,13/56,19.50%,LRP1;FYN;ATP1A3;ZFP36L1;SRC;PSEN1;TLR4;ABCC1;DDX11;CACNB1;GRIN2A;SNX6;RPL23
prerank,peptide metabolic process (GO:0006518),0.29978309418765714,0.8171512427354531,0.7921940928270043,0.9772935216107179,1.0,13/75,12.53%,PCSK5;ANPEP;SPCS1;LNPEP;DPEP1;TPP1;PSEN1;SEC11C;GPX1;GSTM2;NAT8;THOP1;NPEPPS
prerank,very long-chain fatty acid metabolic process (GO:0000038),-0.24480222400207485,-0.817043678943283,0.7142857142857143,0.8920937138937314,1.0,10/30,19.61%,ACSL1;ELOVL7;HACD1;HACD4;HACD2;ACSL6;ELOVL1;ELOVL4;TECRL;SLC27A2
prerank,positive regulation of cellular component movement (GO:0051272),0.3433727459760422,0.8170265208551157,0.7220216606498195,0.9770873770126355,1.0,5/24,13.57%,DUOX1;VEGFA;NTN1;CCDC25;TWIST1
prerank,zinc ion transmembrane transport (GO:0071577),0.34799603559449993,0.8169591433040344,0.71712158808933,0.9767726314113172,1.0,5/22,19.98%,SLC39A13;SLC39A14;SLC39A7;SLC30A5;SLC39A3
prerank,"DNA-templated transcription, termination (GO:0006353)",0.30932607431239917,0.8165559749377046,0.7837552742616034,0.9770047895822648,1.0,21/68,24.64%,POLR2H;GTF2H3;SCAF8;POLR1G;CPSF4;UBTF;ERCC3;CCNH;CPSF2;SNRPG;SNRPD3;SLBP;POLR1C;SMN1;TBP;CSTF2T;POLR1B;CPSF1;CPSF7;WDR33;PABPN1
prerank,negative regulation of GTPase activity (GO:0034260),-0.25157792689176667,-0.8164542742529399,0.7574257425742574,0.8917118222144287,1.0,5/22,10.29%,F11R;DAB2IP;LRCH1;CPEB2;ARL2
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.3447050535531456,0.8160878496767194,0.6955974842767295,0.9773145594206291,1.0,12/20,33.76%,ADAM9;PSEN1;SPPL2B;RELA;MBTPS1;NFKB1;HM13;ADAM17;TRAF6;PSENEN;SPPL2A;NCSTN
prerank,regulation of aerobic respiration (GO:1903715),-0.2886295514189836,-0.8160817328746351,0.6820083682008368,0.8909686121199372,1.0,4/15,15.35%,CBFA2T3;PINK1;UQCC2;AK4
prerank,peptide biosynthetic process (GO:0043043),0.2879744006983157,0.8159933874252878,0.8477822580645161,0.9770563479837728,1.0,23/153,15.98%,RPSA;PCSK5;MRPS11;RRBP1;COPS5;MRPS18B;IGHMBP2;MRPL13;MRPS17;AGO2;GSPT2;RPL10A;MRPL10;MRPL55;TNIP1;RPS5;MRPL36;GGT7;MRPL3;GSPT1;RPL6;MRPL51;HARS1
prerank,neuropeptide signaling pathway (GO:0007218),-0.21924340443811502,-0.8159003227761367,0.8888888888888888,0.88983259000711,1.0,3/58,1.64%,RAPGEF2;SORT1;CPE
prerank,negative regulation of cell projection organization (GO:0031345),0.3113501893873155,0.8155476021986577,0.7601760176017601,0.97738526199179,1.0,11/48,14.33%,FYN;PTPRS;LPAR1;STX1B;SEMA3A;MYLIP;TSKU;KANK1;CBFA2T2;RTN4RL1;DCC
prerank,regulation of TOR signaling (GO:0032006),0.3008770734429077,0.8155311917790811,0.7815845824411135,0.9769861796263966,1.0,11/67,15.12%,DGKQ;TBCK;GAS6;FLCN;PIK3CA;HDAC3;DEPTOR;SMCR8;TMEM127;RRAGD;GPAT3
prerank,regulation of T cell chemotaxis (GO:0010819),-0.31843915070223666,-0.8155060875796055,0.7025089605734767,0.8891021748401473,1.0,2/11,3.31%,ADAM10;WNT5A
prerank,lamellipodium assembly (GO:0030032),-0.2540070388588326,-0.815494614906021,0.776536312849162,0.8877003626474734,1.0,6/26,12.39%,PARVB;KIT;S1PR1;PTPRO;CDH13;ARHGEF4
prerank,small GTPase mediated signal transduction (GO:0007264),0.29228356564614577,0.8154834579849397,0.8069815195071869,0.976632616568728,1.0,36/103,25.61%,PLCE1;CCDC88C;FGF2;MAPK14;RASSF1;NTN1;RIT2;RGL1;MAPK11;RGL2;TIAM2;NRAS;KRAS;USP50;RRAD;SHOC2;CDKN1A;GNB1;CHP1;HACD3;SOS1;SHTN1;RRAS2;BRAP;PLD2;TIAM1;RALA;JUN;NF1;CCDC88A;SETDB1;BCR;RAB18;G3BP1;RAC1;RGS19
prerank,positive regulation of transporter activity (GO:0032411),0.3846735681644928,0.8151469682160208,0.710455764075067,0.9767355247298448,1.0,3/13,20.13%,SGK2;STK39;KMT2A
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),0.38097310574301746,0.8150075361059381,0.7259552042160737,0.9765354914403588,1.0,5/14,24.32%,CD177;SLC2A10;LIMS2;FLNA;DMTN
prerank,regulation of macromolecule metabolic process (GO:0060255),0.28604566988877145,0.8148733975485114,0.8514056224899599,0.9763402698683058,1.0,33/170,20.32%,AFF3;C1D;AFF2;FOXP1;CRIP1;ZFP36L1;CDK4;COQ7;TARDBP;STX1B;PSEN1;HNRNPD;ARF1;TSKU;SIRPA;TRIM11;ALPK2;ZNF462;IGF2BP1;GDNF;PEG3;PIN1;SLC8A2;ZC3H12A;MTMR1;TRIM68;RNF187;CTCF;PRDM9;MKLN1;NOVA1;RASA1;CIAO3
prerank,lysine metabolic process (GO:0006553),0.38998704907912674,0.8144053856401976,0.7066848567530696,0.976242682809189,1.0,1/12,0.85%,SLC25A21
prerank,lysine catabolic process (GO:0006554),0.38998704907912674,0.8144053856401976,0.7066848567530696,0.976242682809189,1.0,1/12,0.85%,SLC25A21
prerank,regulation of nervous system process (GO:0031644),0.35344657050888856,0.8141948311877695,0.7060333761232349,0.9761640571025026,1.0,9/18,25.88%,DLGAP4;DLGAP3;SLC8A2;DLGAP1;CHRNA7;AKAP9;HTR2C;NPTX1;BEGAIN
prerank,cardiac muscle cell action potential (GO:0086001),0.3361620842381534,0.8139429523923802,0.719441210710128,0.9761242209731937,1.0,6/30,10.05%,ANK2;ATP1A1;SLC4A3;KCNJ2;YWHAE;HCN4
prerank,positive regulation of cellular senescence (GO:2000774),0.40478721599891176,0.8137770495548149,0.7231884057971014,0.9759624160083533,1.0,3/10,17.26%,CGAS;YPEL3;EEF1E1
prerank,mismatch repair (GO:0006298),-0.24048718084290144,-0.8132457106767547,0.7953216374269005,0.8903004402123397,1.0,12/27,25.84%,MCM9;MSH3;XPC;PCNA;ABL1;TDG;MSH2;POLD2;RPA2;MLH3;MUTYH;POLD4
prerank,myeloid dendritic cell activation (GO:0001773),0.3850025277470555,0.8131669297774798,0.7193460490463215,0.9765782909036003,1.0,3/12,20.96%,TGFBR2;IL4;PYCARD
prerank,regulation of amyloid-beta clearance (GO:1900221),0.3668742038861992,0.8129496043631078,0.7214854111405835,0.9765034390785272,1.0,1/16,1.37%,LRP1
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.28865138798956985,0.8127682188050649,0.8264462809917356,0.9763736118713644,1.0,16/114,17.94%,TNFSF9;PSMC4;TNFRSF11B;PSMC6;TNFRSF18;CHUK;PSMD8;TNFSF13B;PLVAP;CD27;TNFRSF1B;EDA;BAG4;TRAF3;MAP3K14;ILK
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.29969612765277065,0.8125730632538157,0.7689839572192514,0.9762602760479452,1.0,14/63,16.87%,TRIAP1;RFWD3;MUC1;MDM4;FBXO31;SFN;RPS27L;CDKN1A;CCND1;CNOT3;CNOT10;PLAGL1;TNKS1BP1;PML
prerank,termination of RNA polymerase II transcription (GO:0006369),0.3362141442402397,0.8125365839663133,0.7465116279069768,0.9758981024229875,1.0,11/33,24.64%,SCAF8;CPSF4;CPSF2;SNRPG;SNRPD3;SLBP;CSTF2T;CPSF1;CPSF7;WDR33;PABPN1
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.35995462721254756,0.812527253000343,0.7219387755102041,0.9754875675743114,1.0,6/18,21.16%,COX19;SURF1;BCS1L;COX16;COX14;COX18
prerank,protein tetramerization (GO:0051262),0.29856898988387215,0.8124624671955365,0.7773019271948608,0.9751738562147606,1.0,12/67,15.11%,PKD1;KRT10;TK1;KCNJ2;OSBPL2;PKD2;CPSF6;SAMHD1;ALDH1A3;GLS;CRYZ;HSD17B8
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.28648434897938013,0.8124201805345572,0.8504016064257028,0.974812202790419,1.0,22/159,13.94%,CDH26;CADM3;GPC6;NPTN;CD177;TGFB2;TGFBR2;NECTIN3;PTPRS;PKD1;ACVR1;TENM3;PTPRF;CDH22;CLDN10;DSCAM;UNC5D;L1CAM;FLRT3;IGSF9;PALLD;CLDN12
prerank,regulation of gene silencing by miRNA (GO:0060964),0.3007931655083951,0.8123288493391543,0.7812166488794023,0.9745376084241123,1.0,21/62,27.67%,POLR2H;NUP93;TRIM71;NUP107;NUP98;AGO2;PUM1;ZFP36;POLR2D;POLR2G;NUP37;NUP50;TPR;TNRC6A;POLR2C;NUP133;NUP85;NUP188;EIF4G1;NUP88;AGO1
prerank,regulation of DNA biosynthetic process (GO:2000278),0.34187374787415353,0.8116360133452605,0.7147971360381862,0.9751898229097298,1.0,6/27,16.31%,FGF2;SMOC2;PRKD2;CDKN1A;SMG6;HGF
prerank,negative regulation of reproductive process (GO:2000242),0.3574468451166683,0.8114757682718963,0.735330836454432,0.975017884914763,1.0,9/17,33.45%,SULF1;WDR77;PAEP;CALR;DUSP1;NPPC;ACVR1C;ARHGDIB;TIMP1
prerank,ion transport (GO:0006811),0.28748962778860754,0.8114658899656206,0.7948979591836735,0.9746113041993196,1.0,22/111,17.16%,PIEZO2;SLC1A7;ATP1A4;SLC26A11;SLC1A6;SLC9A9;SLC12A4;SLC17A5;CNGB1;HCN4;SLC26A6;VDAC2;SLC9A1;SLC12A5;SLC8A2;SLC15A4;VDAC1;SLC9A7;SLC9A6;SLC20A1;SLC26A1;CHRNA7
prerank,regulation of AMPA receptor activity (GO:2000311),-0.25050997399175495,-0.8114507079224197,0.7880434782608695,0.8920848128236145,1.0,8/25,17.69%,MEF2C;SHANK3;CACNG4;CACNG8;GSG1L;SHISA9;MINK1;ADRB2
prerank,protein sumoylation (GO:0016925),0.31135455510202714,0.8113948784634547,0.762472885032538,0.9743033846495397,1.0,19/49,29.16%,STX1A;RNF212B;NUP93;PIAS3;NUP107;UBA2;NUP98;NUP37;NUP50;SAE1;TPR;NSMCE2;NUP133;BCL11A;NUP85;NUP188;NUP88;TOPORS;SUMO1
prerank,prostaglandin biosynthetic process (GO:0001516),-0.2758788036426955,-0.8113169621988245,0.7534883720930232,0.8908956369982547,1.0,9/18,23.95%,PTGDS;PTGS2;PTGIS;PTGES3;EDN1;CD74;TBXAS1;CBR1;PTGS1
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.338608467869014,0.8109902241722484,0.7305825242718447,0.9745209415953745,1.0,6/26,12.35%,WDTC1;PRKAB2;MLXIPL;ACADVL;ELOVL5;EIF6
prerank,ceramide metabolic process (GO:0006672),0.30713549374909177,0.8109231053237449,0.7541528239202658,0.9742099825922483,1.0,8/49,12.38%,CERS6;PLPP3;PLPP1;ORMDL2;AGK;SGMS2;FA2H;CERK
prerank,regulation of interleukin-13 production (GO:0032656),0.37646432661295137,0.8108344480904144,0.7047872340425532,0.973932715641113,1.0,5/13,24.85%,IRF4;IL4;IL18;PRKCZ;RARA
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.30771213636258704,0.8105818892810276,0.7463359639233371,0.9739233827674544,1.0,9/43,17.38%,IRS1;GRB10;TNS2;PID1;INPP5K;KANK1;NCK1;OGT;PIP4K2C
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.31197145749042016,0.8105369419079543,0.7464008859357697,0.9735738430788381,1.0,7/45,11.15%,GAS1;ZFP36L1;ZW10;ZFP36L2;ZWINT;AURKAIP1;BCL6
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.3688092127425021,0.8104772049503712,0.741222366710013,0.9732437982468525,1.0,2/16,2.88%,VEGFA;FGF2
prerank,regulation of defense response (GO:0031347),0.299828190590507,0.8100046012514842,0.8006329113924051,0.9735534247117146,1.0,13/76,16.85%,MGLL;ANXA1;FOXP1;AKNA;SPATA2;NR1D2;TIRAP;SAMHD1;BCL6;LRRC19;DAGLB;TRAF3;UFL1
prerank,negative regulation of cellular metabolic process (GO:0031324),0.3192861429561471,0.8099183248009404,0.7384960718294051,0.9732691148868274,1.0,6/37,13.21%,ITGB3;DLG4;ATXN2;SIRT2;ITGAV;NCOR1
prerank,cellular polysaccharide catabolic process (GO:0044247),-0.28834506561769685,-0.8094506002217141,0.7489177489177489,0.8927520080634956,1.0,3/16,5.34%,PHKB;PYGM;AGL
prerank,establishment of apical/basal cell polarity (GO:0035089),0.3777156264924397,0.80880201279339,0.72,0.9745956875718781,1.0,3/14,13.49%,FSCN1;MYO9A;RHOA
prerank,negative regulation of ion transport (GO:0043271),-0.25261370364884556,-0.808745957374915,0.7687861271676301,0.8925790775703516,1.0,9/24,21.36%,ACTN2;WNK4;SNCA;ADRA2A;NOS1;GPM6B;HTR1B;CASQ2;PLN
prerank,response to UV-B (GO:0010224),0.38144373433718093,0.8086578044863296,0.7210242587601078,0.9744086458142948,1.0,2/12,13.17%,CRIP1;CDKN1A
prerank,protein autoubiquitination (GO:0051865),0.3026506808913978,0.8081730763192387,0.7903225806451613,0.9747638733590638,1.0,20/61,24.79%,SH3RF3;UBE2B;TRIM71;ITCH;STUB1;CUL3;RNF10;RNF141;UBE2A;AMFR;UHRF2;TRIM68;RNF187;LRSAM1;UBE2D3;RNF41;UBE3A;RNF13;RNF157;MDM2
prerank,"synaptic transmission, glutamatergic (GO:0035249)",-0.28629731767347444,-0.8080774112771102,0.7142857142857143,0.8923246516759261,1.0,2/18,1.62%,UNC13B;UNC13C
prerank,vitamin transport (GO:0051180),-0.24053886877720865,-0.8077596627595597,0.7986577181208053,0.8914466551259489,1.0,5/29,9.01%,ABCG2;PDPN;SLC35F3;TCN2;CUBN
prerank,regulation of cytokinesis (GO:0032465),0.29845367443840604,0.8076533079011794,0.797071129707113,0.9751445996073845,1.0,22/78,25.22%,CDC14B;SVIL;AHCTF1;FSD1;FLCN;CUL3;KIF20B;SETD2;PRPF40A;CALM2;PIN1;RHOA;BBS4;GIPC1;CCP110;CIT;ENTR1;KLHL9;CDC25B;RAB11FIP3;E2F7;CDC14A
prerank,negative regulation of protein depolymerization (GO:1901880),0.34049933425121726,0.8075292362438469,0.7370325693606755,0.9749367626456278,1.0,5/24,20.62%,FGF13;PIK3CA;CAMSAP1;NAV3;CLASP2
prerank,neuromuscular synaptic transmission (GO:0007274),-0.26798211343176587,-0.8074392714942596,0.7286432160804021,0.8906150648913607,1.0,4/18,13.17%,DTNA;TBC1D24;FCHSD2;SLC5A7
prerank,fat-soluble vitamin metabolic process (GO:0006775),-0.25500566430632,-0.8073523630431827,0.7951219512195122,0.8893433531463417,1.0,3/22,9.01%,ALDH1A2;RBP1;CUBN
prerank,photoreceptor cell development (GO:0042461),0.37247478509489657,0.8071525682788239,0.7081081081081081,0.9751041830261803,1.0,6/14,31.51%,VEGFA;AHI1;DCX;TOPORS;TULP1;RORB
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.2983865384565887,0.8071389936457393,0.7684887459807074,0.9747061728323407,1.0,6/65,9.41%,FHL1;PSMC4;INTS3;PSMC6;PSMD8;AVEN
prerank,negative regulation of cellular catabolic process (GO:0031330),0.3030082623951884,0.8068640419771236,0.8051668460710442,0.974721069530922,1.0,17/63,23.85%,TIMP2;FOXK2;MTOR;IL10RA;SIRT2;AKT1;BMF;NUPR1;HGF;DAP;MCL1;GPLD1;PTPN3;TAB2;KLHL22;EIF4G3;LEPR
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.2832060741981778,0.806482752640207,0.8607467204843592,0.9748833836295786,1.0,43/158,23.90%,AKAP13;MIB2;ECM1;F2R;LPAR1;MID2;TMEM106A;CARD16;UBE2N;TFG;CHUK;PPP5C;TIRAP;LGALS1;IRAK4;DDX21;IRAK1;NDFIP1;TRAF3IP2;RHOA;TRIM68;RBCK1;SLC20A1;MAP3K14;CANT1;SLC44A2;CARD11;LURAP1;MIER1;UNC5CL;FLNA;PPM1A;GOLT1B;TSPAN6;TAB2;TERF2IP;ROR1;MAP3K7;FKBP1A;TRAF5;TNIP2;TRIM8;RELA
prerank,histone mRNA metabolic process (GO:0008334),-0.23582501052928206,-0.8063661763767348,0.8226950354609929,0.889613805822081,1.0,11/27,21.24%,SSB;TUT1;TUT4;TUT7;SNRPB;ATM;MTPAP;LSM11;SNRPE;SNRPF;LSM10
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.3146099543210713,-0.8062997950342443,0.6810631229235881,0.8883350319708391,1.0,4/11,27.45%,PINK1;HIF1A;NR4A3;PARK7
prerank,negative regulation of synaptic transmission (GO:0050805),0.3418039211326389,0.806276043641588,0.7335811648079306,0.9747703352328463,1.0,8/23,31.20%,SYT11;ARF1;ATAD1;PTEN;PICK1;SLC24A2;DRD2;CBLN1
prerank,cardiac muscle contraction (GO:0060048),0.3253409164434312,0.8060359438087836,0.7407407407407407,0.9747221143497593,1.0,4/34,8.49%,GSN;TNNI3;CAMK2D;PIK3CA
prerank,negative regulation of mitochondrion organization (GO:0010823),0.32427975840801554,0.8058639580143196,0.7430555555555556,0.9745665110119204,1.0,9/33,20.35%,TRIAP1;FLCN;GPX1;AKT1;MAPT;GHITM;HGF;IAPP;PRELID1
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.2850051464639343,-0.8055994856961562,0.7375565610859729,0.8880590060940312,1.0,2/16,3.32%,ETS1;NFAT5
prerank,positive regulation of protein modification process (GO:0031401),0.2799395602752877,0.8051024871585095,0.880641925777332,0.9753372258772367,1.0,37/203,19.33%,FGF18;NIBAN1;FGF7;EGFR;EFNA5;TMEM119;NPTN;ITGB3;VEGFA;PDE8A;FGF2;AXIN1;GAS6;FLCN;UBE2N;MUSK;HDAC3;CAMKK2;KRAS;AKT1;GPNMB;CALM2;PIN1;CCND1;NSMF;WDFY2;HSP90AA1;CHP1;HGF;FXR2;CHRNA7;PPIA;PLAUR;ILK;SMPD1;THPO;CLIP3
prerank,nucleotide catabolic process (GO:0009166),0.3637673037231166,0.8050417885186705,0.7377260981912145,0.9750256749420582,1.0,3/16,10.96%,SAMHD1;GDA;GPX1
prerank,cellular response to alcohol (GO:0097306),0.3132612404321768,0.8049856454226545,0.7438202247191011,0.9746998920623923,1.0,10/42,19.54%,LRP6;GRAMD1A;JUP;LARP1;ADCY8;ADAM15;GNB1;SPIDR;BLM;GPLD1
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.34503712264361175,0.8048047000559747,0.7260981912144703,0.9745569856229895,1.0,4/21,11.09%,ADAM9;ADAM19;PSEN1;SPPL2B
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.32873192221253583,0.8046592330537561,0.7285223367697594,0.9743781937637966,1.0,10/32,23.85%,POLR2H;GTF2H3;POLR1G;UBTF;ERCC3;CCNH;POLR1C;RRN3;TBP;POLR1B
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.2819064302600982,0.8037612358258287,0.8723618090452261,0.9753802589856072,1.0,45/149,29.06%,AR;RAB7B;IRAK3;S100A8;S100A9;MID2;CARD16;DHX33;UBE2N;PRKD2;CHUK;TIRAP;TLR4;NPM1;IRAK1;UBA52;FER;EDA;TRIM68;RBCK1;IL6;FLOT2;PPIA;IL18;CARD11;PYCARD;TAB2;TERF2IP;ROR1;FLOT1;MAP3K7;TRAF5;TRIM8;RELA;PRKCZ;TICAM1;RNF31;RHEBL1;BCL10;NFKB1;EDA2R;PRKCI;RPS6KA5;ZBTB7A;MYD88
prerank,steroid metabolic process (GO:0008202),0.2965910417297022,0.8036366883414223,0.8143009605122732,0.9751553672366524,1.0,7/72,11.50%,DHRS9;DHRS4;CYP27B1;VDR;SCP2;SRD5A1;GBA2
prerank,regulation of ATP biosynthetic process (GO:2001169),0.35865904923350794,0.8034419149240396,0.7207207207207207,0.9750538452042891,1.0,4/16,14.83%,PID1;FLCN;ANTKMT;IL4
prerank,establishment of vesicle localization (GO:0051650),0.34735557914865045,0.8031973713751783,0.7251908396946565,0.9750234754146155,1.0,4/18,16.19%,SYT11;TOR1A;CCDC186;SNAPIN
prerank,positive regulation of blood coagulation (GO:0030194),-0.27891286751024225,-0.8030516724408372,0.75,0.8909862416121778,1.0,5/17,15.76%,F3;THBS1;ENPP4;USF1;SERPINE1
prerank,secondary alcohol biosynthetic process (GO:1902653),0.3283955457814577,0.8028764468899287,0.7532013969732246,0.9750732528890566,1.0,4/30,9.30%,ACLY;MVK;INSIG2;GGPS1
prerank,regulation of telomere capping (GO:1904353),0.34426447928047843,0.8026935488016972,0.7362637362637363,0.9749483646708678,1.0,7/23,21.04%,HNRNPD;NBN;USP7;SMG6;RAD50;NEK7;MAPK1
prerank,positive regulation of coagulation (GO:0050820),0.3849434057553772,0.8021559596655834,0.7204450625869263,0.9749736119011813,1.0,2/10,11.72%,F2R;ST3GAL4
prerank,positive regulation of hemostasis (GO:1900048),0.3849434057553772,0.8021559596655834,0.7204450625869263,0.9749736119011813,1.0,2/10,11.72%,F2R;ST3GAL4
prerank,cellular response to zinc ion (GO:0071294),-0.2737317930688097,-0.8018627983828529,0.7370892018779343,0.8915278581385466,1.0,15/15,72.66%,MT3;HVCN1;MT2A;MT1G;MT1A;MT1B;MT1F;MT1H;MT1E;MT1X;MT1M;ATP13A2;GLRA1;GLRA2;P2RX4
prerank,ncRNA processing (GO:0034470),0.2780275598621733,0.8016633149010142,0.8912386706948641,0.9753358451577485,1.0,48/200,23.68%,C1D;TARBP2;INTS3;DDX49;RPP21;DGCR8;FCF1;INTS10;AGO2;ESF1;HELQ;EXOSC7;INTS6;RRP36;RPL10A;WDR46;UBA52;SBDS;MPHOSPH10;RCL1;SNU13;NOLC1;DCAF13;RRP7A;EXOSC1;ZCCHC8;RPL6;NOP53;DDX52;POP4;INTS2;AGO4;PWP2;TRPT1;EBNA1BP2;INTS12;AGO3;TBL3;RPL23;RPL17;PDCD11;KRR1;RPS25;RPP30;WDR18;NOC4L;TEX10;RRP1B
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.2849886279674076,0.8015582905484184,0.849746192893401,0.9750894824555092,1.0,45/128,30.09%,DCTN1;ODF2;CDK14;YWHAG;SSNA1;YWHAE;PPP1R12B;ALMS1;MAPRE1;HAUS3;SFI1;CDKN1A;FBXL3;CCNH;HSP90AA1;TUBB4A;TUBA4A;DYNC1H1;CDK5RAP2;CCP110;AKAP9;CEP164;CKAP5;SKP2;PAFAH1B1;PPP2R2A;PCM1;DCTN2;FBXW11;CDC25B;NEDD1;LATS1;DYNLL1;CEP78;FBXL12;CSNK1E;ACTR1A;CETN2;WEE1;CEP152;CUL1;FOXM1;PLK4;SDCCAG8;FBXL8
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.32666251448337036,0.8009783497817884,0.7251995438996579,0.9755547567275573,1.0,4/31,7.56%,TGFB2;TNNI3;SMAD4;ZFPM2
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.3828143080550137,0.8009360714743894,0.7116154873164219,0.9752072150485629,1.0,4/12,27.33%,GAS2L1;BRD8;CTSB;CTSL
prerank,regulation of adaptive immune response (GO:0002819),-0.26798348338800243,-0.8004140944390724,0.75,0.8925872479670962,1.0,8/18,35.10%,AHR;SIRT1;FCGR2B;IRF7;SKAP1;FADD;IL4I1;SASH3
prerank,maintenance of protein location in nucleus (GO:0051457),0.34677601157997384,0.8003649327144388,0.7456575682382134,0.9756526994372271,1.0,6/20,16.87%,TAF8;SYNE1;TAF3;BCL3;BBS4;PML
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.35625578735836616,0.8001128763380093,0.716358839050132,0.9756263186210355,1.0,6/16,23.08%,SIRPA;ZC3H12A;PDCD4;PYCARD;CUEDC2;CHID1
prerank,kinetochore organization (GO:0051383),0.3739668835551492,0.8000980433062777,0.7567934782608695,0.9752331292722417,1.0,3/13,18.82%,CENPT;CENPC;CENPE
prerank,actin filament organization (GO:0007015),0.28182194619086254,0.8000253810774118,0.8624873609706775,0.9749323531984618,1.0,32/151,20.71%,DBN1;GSN;SCIN;TLE6;CDC42EP2;COBL;SVIL;SPTA1;MARCKS;MYO1A;GAS2L1;MYO5A;ABI1;MCU;EFS;AVIL;RHOA;FHOD3;TRIOBP;TMOD2;RND3;PLS1;RAC3;CORO7;PPP1R9B;TPM4;ALDOA;RFLNA;FLNA;SAMD14;SHROOM3;CORO1C
prerank,protein kinase A signaling (GO:0010737),-0.2976222377990194,-0.7996295173313105,0.728,0.8925754882305402,1.0,4/12,26.25%,MYOM1;PRKACB;LCP1;TTN
prerank,stem cell differentiation (GO:0048863),0.3101013537273133,0.7994568322617417,0.7462514417531718,0.9753800752740239,1.0,8/39,18.29%,LRP6;TGFB2;EEF1AKMT4-ECE2;PUM1;SETD2;LMBR1L;UFL1;GPM6A
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.28734114504054975,0.7994224065185951,0.8445807770961146,0.9750133653671793,1.0,20/107,19.16%,CCL8;NPTN;ANK2;TNNI3;SLC39A13;SLC39A14;ATP2B4;SLC39A7;ATP13A1;SLC30A9;CCL13;ATP2A2;SLC8A2;STC1;TMEM165;SLC30A5;CHRNA7;ATP2B1;HTR2C;STIM1
prerank,T cell receptor signaling pathway (GO:0050852),0.2836284129676601,0.7993991423382765,0.8580121703853956,0.9746317756561564,1.0,40/138,28.73%,PRAM1;PSMC4;FYN;RFTN1;PIK3R2;PTPRJ;CSK;PSMC6;RC3H1;UBE2N;PRKD2;CHUK;PIK3CA;PSMD8;FYB2;PDE4D;ZC3H12A;MOG;BTN3A3;RBCK1;NCK1;VTCN1;CARD11;EIF2B1;TAB2;RC3H2;FBXW11;MAP3K7;RELA;PSMD3;PSMD4;EIF2B2;PSMB3;RNF31;PAK3;BCL10;PSMB2;NFKB1;PSMD5;CUL1
prerank,response to muramyl dipeptide (GO:0032495),-0.30882269774285853,-0.7989795974037195,0.7404580152671756,0.8922018093088728,1.0,4/12,24.86%,NOD1;NOD2;ERBIN;RIPK2
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.3569518949465356,0.7988410104498799,0.7168597168597168,0.9750642830092117,1.0,5/17,25.60%,WASF1;ARF1;GMFB;PICK1;CYFIP1
prerank,mesenchyme morphogenesis (GO:0072132),0.35982689910570614,0.7983723521148008,0.7235668789808917,0.9753807475875638,1.0,3/17,6.76%,TGFB2;ACVR1;MDM4
prerank,regulation of heart contraction (GO:0008016),0.2913563755632661,0.7983187652220107,0.8326403326403327,0.9750495100212665,1.0,17/90,14.04%,ANK2;TGFB2;SRI;ATP1A4;ATP1A3;ATP1A1;ATP2B4;CAMK2D;TNNI3K;HCN4;CELF2;PDE4D;CALM2;TMEM65;ATP2A2;SLC8A2;CASQ1
prerank,response to amino acid starvation (GO:1990928),0.29311532579236255,0.7977618983839898,0.8237791932059448,0.975450553296692,1.0,19/72,23.21%,EIF2AK3;MTOR;FLCN;CEBPB;ATP6V1E1;SESN3;LARP1;CDKN1A;RRAGD;EIF2S1;ATP6V1D;ATP6V1B2;DAP;CASTOR2;MAPK1;SESN2;ATF4;SLC38A9;ATP6V0B
prerank,central nervous system myelination (GO:0022010),0.38716315835307713,0.7974811990304351,0.7171145685997171,0.9754632891003637,1.0,6/11,28.08%,SOX10;PLP1;PTEN;CNTNAP1;B4GALT5;MYRF
prerank,positive regulation of insulin secretion (GO:0032024),0.3161385406134671,0.7972419351774783,0.7592165898617511,0.9754088547149857,1.0,13/36,26.39%,TCF7L2;MCU;STX4;IRS2;ADCY8;TRH;GLUD1;CAPN10;PPP3CB;GPLD1;TM7SF3;BAIAP3;CFTR
prerank,lipoxygenase pathway (GO:0019372),0.3686529538200999,0.7972126545302248,0.7297297297297297,0.9750458270368931,1.0,2/14,10.96%,PON3;GPX1
prerank,regulation of TORC1 signaling (GO:1903432),0.32028104014202075,0.7971982556449986,0.7569767441860465,0.9746520093113004,1.0,10/33,22.86%,DGKQ;FLCN;SESN3;SMCR8;RRAGD;PIP4P1;GPR137B;CASTOR2;SESN2;KLHL22
prerank,lipid catabolic process (GO:0016042),0.3489883942217773,0.7970050988675981,0.727735368956743,0.9745251856443183,1.0,4/18,18.64%,CEL;SIRT2;LIPC;LIPH
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.3492728457389875,0.7966912956154265,0.72875,0.9745791665394592,1.0,3/19,15.94%,CARD16;ZC3H12A;NLRP2B
prerank,lymphocyte proliferation (GO:0046651),0.34030963677506054,0.7966607472644035,0.7452471482889734,0.9742138312614599,1.0,6/22,21.28%,ELF4;FLT3;CR2;LMBR1L;PPP3CB;PIK3CG
prerank,embryonic heart tube development (GO:0035050),0.367373276039499,0.7966022744806455,0.7314814814814815,0.9738900596125969,1.0,2/14,8.17%,ACVR1;NDRG4
prerank,amyloid fibril formation (GO:1990000),0.2995051428893785,0.7962352863307129,0.7813186813186813,0.9740312080180072,1.0,10/51,14.78%,GSN;TGFBI;SIAH1;GGA1;CALCA;MAPT;NAT8;UBA52;HSPG2;GGA2
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.31198927602636006,-0.7958747732895443,0.6824817518248175,0.8958904678799967,1.0,2/11,5.24%,SCARB1;NR1H3
prerank,cellular response to amyloid-beta (GO:1904646),0.316911477049079,0.7958320994599992,0.7644394110985278,0.9742224375914462,1.0,9/35,18.00%,LRP1;FYN;ATP1A3;PSEN1;TLR4;ABCC1;CACNB1;GRIN2A;SNX6
prerank,nuclear migration (GO:0007097),0.37700501852959956,0.7955418839398071,0.746938775510204,0.9742768402620436,1.0,8/13,23.25%,DCTN1;DOCK7;DYNC1H1;PAFAH1B1;PCM1;TMEM201;FBXW11;SYNE3
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.3131618965240053,-0.7953207806968211,0.701195219123506,0.8953752404784686,1.0,4/11,17.69%,GRK3;GTF2H2;ADM;ADRB2
prerank,protein localization to membrane (GO:0072657),0.27865836757339296,0.7951663677122056,0.8845381526104418,0.9743997053369531,1.0,50/187,24.39%,LRP6;TTC7A;TSPAN17;PKP3;PRAM1;RAB32;ANK2;FGF13;S100A10;RFTN1;DLG4;PLEKHF1;DLG2;MYADM;AP3D1;MYO5A;GAS6;PACS2;CD81;EHD2;INPP5K;FYB2;RAB3D;MAGI2;JUP;ZDHHC2;HPS6;PIGW;FRMPD1;ANK1;SPTBN1;AP4M1;FLOT2;SYNJ2BP;RAB40C;TMED2;FLNA;CLASP2;RAB10;ABHD17A;SMURF1;SPTBN4;KCNIP4;FLOT1;SYNE3;PICK1;TTC7B;DVL1;RAB12;MRAP2
prerank,tryptophan metabolic process (GO:0006568),-0.30649008285212154,-0.794986692016032,0.7375886524822695,0.8945191884196848,1.0,11/11,69.38%,KYNU;IL4I1;HAAO;AADAT;IDO2;TDO2;IDO1;ACMSD;ATP7A;KYAT1;KMO
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.2788792933702903,0.7943526703652151,0.8247950819672131,0.9751832114431732,1.0,20/118,13.55%,PHLDB1;ARHGAP44;EFNA5;SPARC;FGF2;PPFIA2;ZRANB1;RC3H1;PID1;LARP4;SRCIN1;HECW2;EPHB3;CAMSAP1;BCL6;MAPT;GPNMB;TANC2;GDNF;NSMF
prerank,cellular response to nutrient levels (GO:0031669),0.29630674812093905,0.7940586602944537,0.8075268817204301,0.9752404014043602,1.0,12/62,14.38%,MTOR;FOXO1;GAS2L1;FLCN;WIPI2;USP33;WDR45B;RRAGD;ULK1;EHMT2;FADS1;STK24
prerank,regulation of myoblast differentiation (GO:0045661),0.32339817510804686,0.7938745267914664,0.7485380116959064,0.9751061250820208,1.0,6/32,8.13%,MAPK14;ZFP36L1;AKIRIN1;TRIP4;BOC;SOX8
prerank,regulation of protein autophosphorylation (GO:0031952),0.31745112281798527,0.7936947117678304,0.7790563866513234,0.9749520135099596,1.0,10/36,17.41%,VEGFA;RASSF2;GPNMB;CALM2;TAOK2;NBN;TNKS1BP1;CHP1;PPP2R5B;RAD50
prerank,heterocycle biosynthetic process (GO:0018130),0.36884069901688066,0.7934153868001812,0.75,0.9749648730093627,1.0,8/14,35.06%,NFS1;PYCR1;MOCS1;NOXRED1;PYCR3;MOCS2;LIAS;MOCS3
prerank,regulation of transferase activity (GO:0051338),-0.2807459949412181,-0.7933670226089546,0.7873303167420814,0.8958026563980331,1.0,6/17,21.31%,EMP2;FEM1A;ATM;SPTSSB;PARP4;HMBOX1
prerank,positive regulation of cytokinesis (GO:0032467),0.32112366990675606,0.7932529534895517,0.7451205510907003,0.9747983404045981,1.0,6/32,15.08%,CDC14B;SVIL;CUL3;KIF20B;RHOA;GIPC1
prerank,sensory organ development (GO:0007423),0.30267501887173914,0.793193485456861,0.8046103183315039,0.9744762235547614,1.0,7/51,9.84%,SIX4;ZDHHC16;TGFB2;PBX1;MEIS2;ECE1;ADAMTS18
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.38002829071092437,0.7927213591775635,0.7387755102040816,0.9747875781325397,1.0,7/12,34.10%,SGTA;SEC63;SEC61A1;SEC61B;CHMP4A;CHMP4B;HSPA5
prerank,oligosaccharide metabolic process (GO:0009311),0.3072222292195331,0.7919484926774978,0.7857142857142857,0.9755158896959063,1.0,7/46,12.07%,ST3GAL2;B4GALT1;FUT2;GAL3ST3;FUT9;ST3GAL4;GLA
prerank,histone H2A monoubiquitination (GO:0035518),0.35450768980238506,0.79167185341986,0.7360208062418726,0.9755280800619902,1.0,7/17,24.89%,RNF2;RYBP;DDB1;RING1;PCGF6;KDM2B;PCGF3
prerank,regulation of G0 to G1 transition (GO:0070316),0.3141035053366458,0.791660731509066,0.7803468208092486,0.9751359748243469,1.0,12/38,22.15%,RNF2;RHNO1;RYBP;PHC3;PHC1;EHMT2;UXT;APAF1;RING1;PCGF6;FOXO4;EZH2
prerank,regulation of phospholipid metabolic process (GO:1903725),-0.3068520485592262,-0.7915729789504244,0.7216494845360825,0.8973577206046611,1.0,3/10,16.20%,ABCA3;PHB2;MTMR3
prerank,positive regulation of cell motility (GO:2000147),0.2740753467439086,0.7915343917139402,0.9008016032064128,0.9748878293843459,1.0,28/205,14.83%,SEMA3C;HAS2;MYOC;EPHB2;DUOX1;COL1A1;PRKCA;EGFR;VEGFA;F2R;ADAM9;ACVR1;MYADM;RET;NTN1;SEMA3A;STX4;MAPRE1;GPNMB;SEMA3D;CCDC25;EGF;MGAT5;TWIST1;PDGFRA;FER;PPP3CA;IL4
prerank,amyloid precursor protein catabolic process (GO:0042987),-0.2883639385494019,-0.7913349635799605,0.7352941176470589,0.8963552355627251,1.0,3/14,5.81%,ADAM10;DYRK1A;ABCG1
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),0.3118643553128398,0.7912429963887935,0.7611241217798594,0.9749221678851483,1.0,4/34,6.78%,TNS2;PTPRS;PTPRJ;PTPRF
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.2876331169988039,0.7912267073546612,0.8120380147835269,0.9745340509256641,1.0,11/76,18.42%,ESR1;PLCE1;F2R;LPAR1;GPR20;CALCA;LHCGR;GRM1;CXCR2;TRHR;HTR2C
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.29155688983229866,0.7910259569949443,0.8040468583599574,0.9744258674159915,1.0,6/69,5.07%,TGFB3;SIX4;F2R;ZPR1;CLCF1;NFATC4
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.364823783698533,0.7909191057007018,0.7398160315374507,0.9741727623500934,1.0,4/16,13.23%,INPP5F;PARP14;PIBF1;BCL3
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.2563237112534005,-0.7902203530179487,0.7793427230046949,0.896871294571736,1.0,10/18,37.75%,PLCB1;AGRN;OPRM1;RGS10;CDK5R1;CHRM1;GNA15;GNA11;HRH3;CHRM5
prerank,phosphorylation (GO:0016310),0.271972254033031,0.7900791705282474,0.958,0.9750377758531885,1.0,52/384,12.81%,SYK;EPHB2;DCLK1;PRKCA;TNK1;FGFR1;STK25;EIF2AK3;CDKL2;FYN;DGKQ;IRAK3;SGK3;SGK2;TGFB2;LMTK3;CDK14;TGFBR2;TAOK3;ACVR1;CDK4;MTOR;CAMK2D;CSK;RET;TBCK;GAS6;GK5;STRADA;PRKD2;TNNI3K;CHUK;PIK3CA;TESK2;CDK9;CDK20;AGK;AKT3;BMP2K;NRBP2;ERN1;DYRK2;AMHR2;CAMKK2;AKT1;MAP3K6;IRAK1;PASK;STK39;CERK;PXK;TAOK2
prerank,transcription by RNA polymerase I (GO:0006360),0.31977362086104627,0.7894514778008992,0.7585812356979404,0.9755402448062493,1.0,10/34,23.85%,POLR2H;GTF2H3;POLR1G;UBTF;ERCC3;CCNH;POLR1C;RRN3;TBP;POLR1B
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.21105671328806072,-0.789323919845489,0.9285714285714286,0.8969026287675119,1.0,14/50,18.16%,NR3C2;SASH1;APP;NFAT5;TLR3;LIMS1;EP300;SPHK1;NOD1;CD86;NMI;PHB2;TCIM;ACTN4
prerank,regulation of protein targeting to membrane (GO:0090313),0.32430139562996674,0.7889045722849015,0.7553956834532374,0.975924973760952,1.0,12/28,30.42%,FYN;MIEF2;INPP5K;GDI1;CHP1;ITGAM;FIS1;DMTN;MTCL1;PRNP;MYO1C;AKT2
prerank,cellular metal ion homeostasis (GO:0006875),0.2848029063133897,0.788002534245818,0.86302780638517,0.9768371050566906,1.0,10/102,5.51%,CCL8;KCNMA1;NPTN;ANK2;TNNI3;ATP1A4;ATP1A3;ATP1A1;ATP2B4;KCNJ2
prerank,ear morphogenesis (GO:0042471),0.33896958512226477,0.7879255076711914,0.7667087011349306,0.9765515892653686,1.0,1/20,0.46%,EPHB2
prerank,SNARE complex assembly (GO:0035493),-0.31401905400286373,-0.7878550235992737,0.7508090614886731,0.8977926158026561,1.0,2/10,3.47%,SNCA;UVRAG
prerank,ncRNA export from nucleus (GO:0097064),0.3112036599498666,0.7873655352141143,0.7819634703196348,0.9769855179439906,1.0,19/36,34.13%,NUP93;NUP107;NUP98;NPM1;NUP37;NUP50;XPOT;TPR;NUP133;NUP85;NUP188;NUP88;TSC1;SEC13;AAAS;NUP160;NCBP2;NUP54;RANBP2
prerank,negative regulation of viral process (GO:0048525),0.29435535761383547,0.787091416043044,0.8135964912280702,0.9769760284389629,1.0,17/57,24.78%,MID2;TRIM11;ZC3HAV1;SLPI;TNIP1;ZFP36;FAM111A;UBP1;PML;PPIA;MBL2;TRIM35;BTBD17;SRPK1;LARP7;TRIM8;HEXIM1
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.36166423787326474,0.7869885230652042,0.7663185378590078,0.9767118044426132,1.0,3/15,12.14%,IRS1;AKT1;IRS2
prerank,positive regulation of calcium ion transport (GO:0051928),0.310274480618271,0.7869280788731727,0.7709049255441008,0.9763804084786731,1.0,3/36,4.28%,ANK2;F2R;P2RX3
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.29045176903930037,-0.7865028170763132,0.7791666666666667,0.8986339896506429,1.0,3/13,9.43%,PTPN1;DNAJB9;PPP1R15B
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.28401233007924864,0.7863836309833085,0.81875,0.9767535832805314,1.0,9/86,8.57%,PSMC4;MAPK7;VEGFA;NFE2L2;KLF2;MUC1;PSMC6;EGLN2;PSMD8
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.334657143404618,0.7861298674947416,0.7475609756097561,0.9767216263153866,1.0,7/22,27.45%,SCAF8;TCERG1;THOC1;ELL;KAT7;ALYREF;THOC5
prerank,lipid homeostasis (GO:0055088),0.29519520383141173,0.7861192020098688,0.7922497308934338,0.9763301833288047,1.0,12/57,18.77%,NR1D2;TLCD2;RCN3;MLXIPL;ABCA1;ORMDL2;PNPLA8;IRS2;THADA;ACOX1;POLD1;ANGPTL3
prerank,negative regulation of stem cell differentiation (GO:2000737),0.3742286924797721,0.7861134341512854,0.7428571428571429,0.9759318138717921,1.0,3/12,17.50%,ZFP36L2;JAG1;YTHDF2
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.3097397859707047,0.7857090902849186,0.771889400921659,0.9761164912501852,1.0,11/40,21.66%,PID1;PIP5KL1;AKT1;MAPT;NDUFS1;BAK1;TUSC2;SLC25A36;PYCR1;PRELID1;SLC25A33
prerank,chloride transport (GO:0006821),0.2870224521728776,0.7855671939571435,0.8217299578059072,0.9759222260159809,1.0,12/74,17.36%,SLC4A10;ANO3;SLC4A8;SLC12A8;GABRR3;SLC12A4;SLC26A6;SLC12A5;GABRG3;TTYH3;SLC26A1;ANO5
prerank,plasma membrane tubulation (GO:0097320),-0.29202233934316035,-0.7849868060275614,0.7628458498023716,0.8996013668963058,1.0,2/13,3.88%,FNBP1L;CAVIN2
prerank,glycerophospholipid metabolic process (GO:0006650),-0.19968621122519548,-0.7849033159554452,0.9038461538461539,0.8983355736451389,1.0,23/75,21.53%,GPCPD1;PLCG1;PLA1A;HDHD5;PIGN;PLCB1;PIGG;PIP5K1A;PIGP;PDGFRB;ABCA3;PIGB;PNPLA6;PLA2G15;CLN3;CPNE3;PNPLA3;DGKH;PLA2G4C;PIGF;CPNE7;PIGA;ABHD3
prerank,response to hexose (GO:0009746),0.3274577350803335,0.7847175534064046,0.7633136094674556,0.9767465257012431,1.0,6/25,19.83%,TCF7L2;IRS2;SELENOS;VAMP2;GPLD1;EIF2B1
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.2341679384977831,-0.7839862218084913,0.8023255813953488,0.8983591533190566,1.0,7/29,13.17%,WNT5A;MAVS;CNOT7;USP18;PTPN1;PTPN2;RNASEL
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.328314075928952,0.7829037405343988,0.7947178871548619,0.9789846972138859,1.0,3/25,6.21%,ANK2;F2R;CXCL10
prerank,intracellular sterol transport (GO:0032366),0.3760411996261036,0.7828174696842624,0.7496671105193076,0.9787062625088253,1.0,2/13,7.01%,OSBPL2;ABCA1
prerank,regulation of T cell mediated immunity (GO:0002709),0.3823713085699538,0.7822437278522756,0.7414965986394558,0.9791052125865163,1.0,2/10,13.72%,ZBTB1;TNFRSF1B
prerank,negative regulation of transmembrane transport (GO:0034763),0.382919324950576,0.7816776230651211,0.7244318181818182,0.979539583908888,1.0,3/10,12.14%,INPP5K;AKT1;IRS2
prerank,protein kinase B signaling (GO:0043491),0.33330902487363234,0.7812361437157838,0.7657992565055762,0.9797808567837931,1.0,8/23,25.33%,ZFP36L1;GAS6;SIRT2;AKT1;TYRO3;PTEN;TSC2;PAX2
prerank,regulation of type I interferon production (GO:0032479),0.2846614087363375,0.7811240013080217,0.8352331606217617,0.9795318537414526,1.0,28/84,29.06%,POLR2H;ITCH;CGAS;DHX33;POLR3E;TIRAP;POLR3D;IRAK1;XRCC5;PIN1;CD14;RNF216;ILRUN;TRAF3;TAX1BP1;POLR3H;POLR1C;POLR3A;CYLD;RELA;G3BP1;UBA7;UFD1;PRKDC;NPLOC4;NFKB1;XRCC6;MYD88
prerank,smoothened signaling pathway (GO:0007224),0.30888956210074586,0.7810799832743026,0.7733644859813084,0.9791935876398269,1.0,5/32,11.60%,DISP2;GLI2;ARL13B;DYRK2;GLI3
prerank,membrane lipid metabolic process (GO:0006643),0.3275905741910452,0.7808802050210104,0.7490864799025578,0.9790805852237007,1.0,4/22,12.38%,FUT2;TECR;AGK;CERK
prerank,neuromuscular process controlling balance (GO:0050885),0.374356527923512,0.7808588707874832,0.7503355704697987,0.978699891720507,1.0,5/12,33.82%,TPP1;PAFAH1B1;NRXN1;PCDH15;SHANK1
prerank,DNA conformation change (GO:0071103),-0.270156704674661,-0.78076915945938,0.7478260869565218,0.9020350861176798,1.0,7/17,25.52%,HMGB1;ABL1;HHEX;TOP1MT;NAA10;TOP2A;TOP3B
prerank,positive regulation of myelination (GO:0031643),-0.30795387167469446,-0.7804405309706377,0.7286821705426356,0.9011582967317846,1.0,2/11,7.91%,TENM4;TPPP
prerank,DNA methylation (GO:0006306),0.3295106875502001,0.7797078332332108,0.7524390243902439,0.9799307652299486,1.0,11/23,29.85%,SPOCD1;EHMT2;DMAP1;N6AMT1;BAZ2A;GATAD2A;PICK1;MTRR;ATF7IP;ATRX;FOS
prerank,regulation of anoikis (GO:2000209),0.34291163971911004,0.7793256713607338,0.7721518987341772,0.9800735458746609,1.0,6/19,19.36%,ITGA5;SRC;PIK3CA;SNAI2;PTRH2;MCL1
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.3595549015295926,0.7785852724539972,0.7568627450980392,0.980737501399792,1.0,6/14,27.78%,PPP5C;PPP3CA;NCK1;PPP2R2A;DUSP1;PPP2R2D
prerank,cholesterol biosynthetic process (GO:0006695),0.3173244198100043,0.7781875733586143,0.779837775202781,0.9808874352923471,1.0,4/31,9.30%,ACLY;MVK;INSIG2;GGPS1
prerank,respiratory chain complex IV assembly (GO:0008535),0.33297876223328005,0.7781827210060848,0.7589616810877626,0.9804899796260961,1.0,8/21,27.03%,COX19;SURF1;BCS1L;COX16;COX14;COX18;SCO1;COX15
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.274518183767243,0.777839067322158,0.9059656218402427,0.9805719117940437,1.0,28/151,17.79%,CERS6;ST3GAL2;PCSK5;GPAT4;PLPP3;ALDH3A2;INHA;PLPP1;CHKB;PRKD2;SLC44A1;LCAT;SGMS2;LPCAT1;LARGE1;GSTM2;FA2H;ELOVL5;ST3GAL4;TNIP1;PRKD3;NFS1;CEPT1;HACD3;SLC44A2;SLC25A15;GSTO2;PLPP2
prerank,adherens junction organization (GO:0034332),0.30189926117322935,0.7776764551930557,0.799552071668533,0.9803947589351498,1.0,7/48,12.09%,CADM3;ANG;NECTIN3;CSK;JAM3;CDH22;JUP
prerank,purine ribonucleotide transport (GO:0015868),0.3511876567862767,0.7776308001924922,0.7313054499366286,0.9800547341763504,1.0,3/16,14.88%,LRRC8D;SLC25A4;SLC25A17
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.3346949732027904,0.7775610975998594,0.7602996254681648,0.9797561265789587,1.0,6/20,23.48%,AMPD2;PAICS;GART;ATIC;ADSS2;LHPP
prerank,response to ethanol (GO:0045471),0.36463256560532564,0.777387802323895,0.7629139072847683,0.9795974934790358,1.0,4/14,30.13%,GRIN3A;GRIN2A;GOT2;GLRA2
prerank,ribosomal large subunit biogenesis (GO:0042273),0.2963943326109781,0.7773779684339047,0.8108108108108109,0.9792083340512321,1.0,16/54,24.19%,SDAD1;NOC2L;NPM1;RPL10A;EIF6;SNU13;RSL1D1;RPL6;NOP53;RPF2;EBNA1BP2;MAK16;NOP2;RSL24D1;BRIX1;LTO1
prerank,regulation of inclusion body assembly (GO:0090083),-0.3072990676436219,-0.7771693794230278,0.6956521739130435,0.9048082432626083,1.0,1/11,0.83%,SNCAIP
prerank,protein K63-linked ubiquitination (GO:0070534),0.30147694694638827,0.7767304327650031,0.7766666666666666,0.9797365571712582,1.0,10/41,18.12%,UBE2B;ITCH;PELI3;STUB1;UBE2N;MAGEL2;TRAF3IP2;TRAF3;UBE2G1;ARIH2
prerank,piRNA metabolic process (GO:0034587),-0.26387457213169785,-0.7763541366571278,0.7549019607843137,0.9046420334144337,1.0,17/19,50.42%,TDRKH;EXD1;MYBL1;PIWIL2;TDRD9;TDRD12;PIWIL4;FKBP6;MAEL;MOV10L1;HENMT1;ASZ1;GPAT2;BTBD18;TDRD1;PIWIL1;PLD6
prerank,type I interferon signaling pathway (GO:0060337),-0.21826192432275054,-0.7762170384743945,0.872,0.9020942155778802,1.0,12/41,18.30%,SP100;IFNAR1;IFITM3;IFIT1;IFIT2;OAS2;STAT1;IFIT3;RNASEL;ADAR;RSAD2;PSMB8
prerank,cellular response to type I interferon (GO:0071357),-0.21826192432275054,-0.7762170384743945,0.872,0.9020942155778802,1.0,12/41,18.30%,SP100;IFNAR1;IFITM3;IFIT1;IFIT2;OAS2;STAT1;IFIT3;RNASEL;ADAR;RSAD2;PSMB8
prerank,regulation of cellular component size (GO:0032535),-0.22244825618851283,-0.7757017759374447,0.9133333333333333,0.9015558475923353,1.0,5/30,8.03%,EPS8;RAB22A;RPTOR;RIN3;LAMTOR5
prerank,positive regulation of interferon-alpha production (GO:0032727),0.33812765845937287,0.7756711594268775,0.7637292464878672,0.980811007728197,1.0,3/19,11.81%,CHUK;TLR4;SETD2
prerank,"phagocytosis, engulfment (GO:0006911)",0.3096796483897084,0.775420891713069,0.783256880733945,0.980766192393451,1.0,1/36,0.45%,GSN
prerank,regulation of mitotic cell cycle (GO:0007346),0.26989559578482275,0.7751645396302937,0.8909090909090909,0.9807074697237643,1.0,53/171,30.16%,PRKCA;PSMC4;GAS1;CKS1B;SMOC2;CCDC8;TTC28;MEIS2;PSMC6;PSMD8;CDK9;IQGAP1;CDC23;ANAPC5;KIF20B;FBXO5;ERCC3;PIN1;DDB1;CDC27;CUL9;USP22;TFAP4;TTL;CDC26;ANAPC4;NEK7;TRIM35;PTPN3;ANAPC10;BTG1;ANAPC15;SDCBP;CYLD;CDC25B;PSMD3;PSMD4;MDM2;BTG3;CKS2;RNF20;PSMB3;ANAPC2;GBF1;CUL7;PSMB2;PSMD5;THAP1;CUL1;BRINP2;SRA1;HSF1;PSMD14
prerank,fatty acid biosynthetic process (GO:0006633),0.28892053875524565,0.7750296038382648,0.8329741379310345,0.980487905947418,1.0,13/63,19.73%,ACLY;TECR;NDUFAB1;ELOVL5;FADS1;HSD17B8;HACD3;FADS3;LIPC;LIPH;ABCD3;MCAT;SCD5
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.28133687784079525,0.77494928518922,0.8459937565036421,0.9802012473467999,1.0,12/86,9.60%,TGFB3;TGFB2;SMAD4;ACVR1;BMP15;NUP93;SH2B1;RNF111;INHA;SULF1;FLCN;BMP8A
prerank,positive regulation of chromosome organization (GO:2001252),0.3591965896375831,0.7746841350724492,0.7647058823529411,0.980170284859388,1.0,4/15,17.41%,DDX11;NBN;PML;RAD50
prerank,negative regulation of amyloid-beta formation (GO:1902430),-0.27021013959780527,-0.7743926784479416,0.762114537444934,0.9021259437780672,1.0,5/17,12.26%,IGF1;APOE;GGA3;SORL1;NTRK2
prerank,cognition (GO:0050890),0.29964163770604413,0.7739432569284062,0.7964601769911505,0.9807928524932416,1.0,11/42,18.95%,DGCR2;GPR155;ST3GAL4;SLC8A2;BBS4;LHCGR;SETD5;TTC8;TUSC3;CHRNA7;NIPBL
prerank,ruffle organization (GO:0031529),-0.27293928745890605,-0.7737941496362238,0.7788018433179723,0.9016653745540382,1.0,2/16,5.86%,TPM1;PIP5K1A
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.2740703763031856,0.7737292581439528,0.8655030800821355,0.9806674445223877,1.0,18/108,18.05%,SYK;GSN;EIF2AK3;F2R;S100A8;S100A9;MTCH1;PDCD2;MAPT;ANP32B;BBC3;DIABLO;RPS27L;GRAMD4;HTRA2;CTSD;BCAP31;DAP
prerank,pharyngeal system development (GO:0060037),0.35416267554089537,0.7729854728842528,0.7794316644113667,0.9813298354377031,1.0,2/15,2.91%,SIX4;TGFB2
prerank,sarcomere organization (GO:0045214),0.319186664369833,0.7727890179257988,0.7728365384615384,0.981183652606327,1.0,4/27,14.04%,SIX4;CSRP2;FHOD3;CASQ1
prerank,protein localization to mitochondrion (GO:0070585),0.3750289510290278,0.7727448158810968,0.75177304964539,0.9808406282068688,1.0,5/11,27.79%,AKT1;MTCH2;RALA;COX18;DNAJA1
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.33024391237317086,0.7726874405944463,0.7866831072749692,0.9805220977764979,1.0,3/21,8.09%,FOXP1;PRKD2;CD81
prerank,negative regulation of chemotaxis (GO:0050922),0.31036733332359184,0.7726757515465204,0.7857142857142857,0.9801367731322899,1.0,4/31,12.28%,SEMA3C;SLIT2;SEMA3A;SEMA3D
prerank,lipid modification (GO:0030258),0.30251966226457755,0.7725369004610207,0.7698412698412699,0.9799286526966882,1.0,6/37,12.78%,DGKQ;PLPP3;PLPP5;PLPP1;MBOAT7;PLPPR3
prerank,visual system development (GO:0150063),0.30900635750050354,0.7719529805710829,0.784,0.9803288567226818,1.0,5/37,9.84%,ZDHHC16;TGFB2;PBX1;MEIS2;ADAMTS18
prerank,macrophage chemotaxis (GO:0048246),-0.31414274425326283,-0.771328140279303,0.7418181818181818,0.9038594129096758,1.0,5/10,35.45%,EDNRB;TAFA4;CCL2;CXCL17;CCL5
prerank,detection of calcium ion (GO:0005513),0.36127998664529587,0.7712880175712493,0.761049723756906,0.9808349388292121,1.0,7/13,31.14%,CALM2;SYT1;STIM1;KCNIP2;KCNMB2;KCNMB3;CALM1
prerank,myotube cell development (GO:0014904),0.385482547258417,0.7705704083884026,0.7461212976022567,0.9814051760236371,1.0,4/10,23.89%,SKI;SIX1;SELENON;MYORG
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.3716173467602454,0.7700659105755501,0.7640603566529492,0.9816653034096776,1.0,7/11,29.45%,MUC1;ING4;RPS27L;TFAP4;KAT5;FOXM1;TP53
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),0.38757505303083645,0.7698475026998911,0.756393001345895,0.9815658295699167,1.0,1/10,3.40%,SRI
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.33927523855979774,0.7697491077863717,0.787765293383271,0.9813156975870878,1.0,9/19,29.03%,PTPRJ;STIMATE;BCAP31;FIS1;DMTN;GRM5;PTGFR;FKBP1B;PRNP
prerank,regulation of chemokine production (GO:0032642),0.29895110323225493,0.7691418191703923,0.7873831775700935,0.9817701193061074,1.0,8/36,20.96%,FOXP1;IL33;TLR4;ACKR1;IL6;SNAI2;IL18;PYCARD
prerank,UV-damage excision repair (GO:0070914),0.3687782186361939,0.7687706507723435,0.7656903765690377,0.9818948700750121,1.0,4/12,22.85%,ACTR5;DDB1;INO80;ERCC1
prerank,positive regulation of cell division (GO:0051781),0.3037419941569829,0.7685923406086149,0.7975391498881432,0.9817318444596528,1.0,7/38,15.08%,CDC14B;SVIL;CUL3;SIRT2;KIF20B;RHOA;GIPC1
prerank,mitochondrial fusion (GO:0008053),0.34073851827775803,0.7679430269013038,0.7676767676767676,0.982229385991225,1.0,7/18,30.71%,GDAP1;MIEF2;SPG7;FIS1;CHCHD3;BAX;MFN2
prerank,axoneme assembly (GO:0035082),0.3112397584006356,0.7677199876017381,0.792654028436019,0.9821378222060745,1.0,7/30,22.28%,TOGARAM1;RSPH1;TTLL3;DNAAF3;SPAG17;SPAG16;DCX
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.3097721828483162,0.7674706535694674,0.8105625717566016,0.9820771176105325,1.0,2/33,1.34%,EGFR;ANXA1
prerank,neuron maturation (GO:0042551),-0.26395413853689853,-0.767462560776595,0.8284313725490197,0.9082418466807476,1.0,9/18,23.13%,APP;EPHA8;ANKS1A;CX3CL1;C1QA;C3;CLN5;SCARF1;ACTL6B
prerank,regulation of monocyte differentiation (GO:0045655),0.35364368913978395,0.7673567678897507,0.7615894039735099,0.9818188106353546,1.0,2/14,4.40%,FOXP1;ZFP36L1
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.31139348584135307,0.7672195824591075,0.7736289381563594,0.9816021209296755,1.0,3/30,5.51%,ANK2;ATP1A1;KCNJ2
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),-0.20231923909478208,-0.7670294021020323,0.9726027397260274,0.9075189369350307,1.0,14/55,14.88%,BCL2L1;BCL2;DAB2IP;TPD52L1;CAV1;ING5;TNFSF12;FAS;WWOX;BCL2L11;RIPK1;TNFSF10;DEDD2;GPER1
prerank,protein localization to synapse (GO:0035418),0.36867426915860596,0.7665863612691417,0.7547425474254743,0.982074263917145,1.0,7/12,33.82%,DLG4;NLGN1;ZDHHC15;NRXN1;NLGN2;NRXN2;SHANK1
prerank,AMP metabolic process (GO:0046033),0.35973900053966734,0.7663581030340558,0.7648725212464589,0.9819987105376556,1.0,1/13,2.31%,AMPD2
prerank,lipid oxidation (GO:0034440),-0.28931236543610456,-0.7659196991587688,0.7818181818181819,0.9077193662846277,1.0,4/12,23.67%,ADIPOR2;ALOX12;ADIPOR1;PPARGC1A
prerank,heart looping (GO:0001947),0.30318948847519106,0.7658519618993456,0.7991021324354658,0.9822694333853738,1.0,9/39,18.90%,TGFBR2;TBX6;PKD2;NDRG4;MICAL2;VANGL2;BBS4;AHI1;BBS5
prerank,indolalkylamine catabolic process (GO:0046218),-0.3064708466704324,-0.7654210783914092,0.7385159010600707,0.9070492692753698,1.0,10/10,69.38%,KYNU;IL4I1;HAAO;AADAT;IDO2;TDO2;IDO1;ACMSD;KYAT1;KMO
prerank,synaptic vesicle localization (GO:0097479),0.356201456111335,0.7651212388134806,0.7841530054644809,0.9828391587639956,1.0,3/13,16.19%,TOR1A;SYNDIG1;SNAPIN
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.27792681013300974,0.7651194497266576,0.8380651945320715,0.9824422470045201,1.0,16/72,16.87%,TRIAP1;USP10;MUC1;MDM4;ING4;SFN;RPS27L;CDKN1A;BCL3;CNOT3;CNOT10;PLAGL1;NBN;TNKS1BP1;TFAP4;PML
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.27830834850576674,0.7650143441369003,0.8479408658922915,0.9821931801049872,1.0,18/78,24.78%,EGFR;PKD1;GTPBP4;PSRC1;MAPRE3;PKD2;AKT1;CDKN1A;CCND1;CCNH;TFAP4;IPO5;BLM;PTEN;CDKN2C;LATS1;CCNYL1;HEXIM1
prerank,regulation of cellular catabolic process (GO:0031329),0.2862161913860222,0.7649284087617568,0.8230184581976113,0.9819136429023325,1.0,16/62,17.44%,PIK3R2;USP10;HDAC6;ABL2;WDR91;FBXL2;USP33;MAPT;SMCR8;DRAM1;RRAGD;CISD2;NUPR1;KEAP1;PIP4K2C;GPR137B
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.3814742198677559,0.7635204698074496,0.7673410404624278,0.9834196801828469,1.0,5/10,33.73%,CPEB1;PAF1;HSF1;CPEB3;NCBP2
prerank,diol metabolic process (GO:0034311),0.33301188046836294,0.7633844618076068,0.7921419518377694,0.9832180628320174,1.0,5/19,17.79%,PLPP3;PLPP1;AKT1;HSP90AA1;PLPP2
prerank,mucosal immune response (GO:0002385),0.3459529783867552,0.7630004473947504,0.7782204515272244,0.9833300287732007,1.0,2/15,14.83%,OTUD7B;IL4
prerank,regulation of neuron projection arborization (GO:0150011),0.3449019998184164,0.7626740465236136,0.7580645161290323,0.9833818365830367,1.0,6/15,26.64%,DLG4;MYO9A;FZD4;NTNG2;DVL1;GRIP1
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.32767230289160304,0.762586936102592,0.786346396965866,0.9830933578772735,1.0,4/20,17.82%,HOPX;PSMG2;HSP90AA1;PFDN6
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.31971260859783285,0.7624927496148729,0.7910447761194029,0.9828141350133904,1.0,4/23,11.60%,GPC3;GLIS2;GPR161;GLI3
prerank,regulation of granulocyte chemotaxis (GO:0071622),-0.24738912989064613,-0.7622566477845173,0.8374384236453202,0.910180107597106,1.0,5/19,13.28%,IL34;THBS1;MDK;MAPK3;PTK2
prerank,actin filament network formation (GO:0051639),0.3663942340817896,0.7622336542710977,0.7530864197530864,0.9827672739458051,1.0,3/11,15.82%,COBL;FHOD3;PLS1
prerank,phospholipid biosynthetic process (GO:0008654),0.3015178059327728,0.7619754248707703,0.8048498845265589,0.9827137873885349,1.0,13/36,27.23%,FAR1;AGK;SGMS2;AGPAT3;LPCAT1;DHDDS;AGPAT5;FADS1;GPAM;CPNE1;SRD5A3;MVD;NUS1
prerank,macroautophagy (GO:0016236),0.2720630036062266,0.7612081963802251,0.8902564102564102,0.9833401252428399,1.0,35/118,25.13%,VPS4B;PRKAB2;MVB12A;VPS37D;SRC;LIX1L;WIPI2;SQSTM1;TMEM74;VPS33A;PGAM5;STX17;EPG5;VPS37C;ULK1;VDAC1;ILRUN;NBR1;VPS37B;ATG13;VPS33B;TOMM5;PIP4K2B;VPS36;ATG16L1;ATG3;VPS39;CSNK2A2;ATG10;UBXN6;ATG14;STAM;DYNLL1;TOMM40;TECPR1
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.3090394825699077,0.7610192581622139,0.7901524032825322,0.9831936303123361,1.0,6/32,14.04%,F2R;CXCL10;PKD2;GSTM2;CALM2;CASQ1
prerank,epithelial to mesenchymal transition (GO:0001837),0.2930029271130005,0.7601736063526816,0.8184855233853007,0.9839461109549975,1.0,4/47,3.94%,LOXL2;FGFR1;TGFB2;AKNA
prerank,acyl-CoA metabolic process (GO:0006637),0.30743754411108765,0.7600807836504532,0.8006833712984055,0.9836613500902491,1.0,4/35,14.26%,GPAT4;ACOT6;ACOT9;ACOT1
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.313148121642703,0.7598600745763594,0.783816425120773,0.9835583230144411,1.0,1/26,0.56%,UCP1
prerank,negative regulation of neuron differentiation (GO:0045665),-0.24521854347368577,-0.7596407263480999,0.8238095238095238,0.9125782342072276,1.0,2/22,6.86%,BMP7;B2M
prerank,regulation of synapse maturation (GO:0090128),0.3782611311926852,0.7593711209286114,0.7851002865329513,0.9837994720416414,1.0,1/10,2.53%,NEUROD2
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.3700283354097871,0.7592026463875958,0.7602179836512262,0.9836233820526623,1.0,1/10,3.19%,TGFBR2
prerank,cellular response to amino acid starvation (GO:0034198),0.27938649810561966,0.7590663156933433,0.8678038379530917,0.9834060197879165,1.0,18/71,23.21%,EIF2AK3;MTOR;FLCN;CEBPB;ATP6V1E1;SESN3;CDKN1A;RRAGD;EIF2S1;ATP6V1D;ATP6V1B2;DAP;CASTOR2;MAPK1;SESN2;ATF4;SLC38A9;ATP6V0B
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.37242182957286485,0.7584950260112364,0.7551581843191196,0.9837738650608756,1.0,2/10,9.08%,IL33;TLR4
prerank,Rho protein signal transduction (GO:0007266),0.28838656282521324,0.7582982040522993,0.8313253012048193,0.9836448442663184,1.0,6/53,9.73%,COL1A2;CDC42EP2;NTN1;ARHGEF3;MYO9B;RHOJ
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.28623060410979745,-0.7582704527371759,0.8052434456928839,0.9131156274792293,1.0,9/13,46.21%,NECTIN2;CYRIB;FADD;IL12A;IL12RB1;IL23A;IL23R;IL12B;XCL1
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.31507115667126684,0.7581512303421104,0.8104265402843602,0.98344763740416,1.0,8/26,22.99%,ITCH;UBE2N;IRAK1;UBA52;AAMP;TAB2;CYLD;MAP3K7
prerank,intracellular pH reduction (GO:0051452),0.30427151647764983,0.7572963059465279,0.7872832369942196,0.9841949512596228,1.0,7/33,16.13%,ATP6V0A2;TMEM9;DMXL2;ATP6V1E1;ATP6V0A1;ATP6V1D;ATP6V1B2
prerank,negative regulation of cell aging (GO:0090344),0.33722609729550773,0.756777030166505,0.7723785166240409,0.9844733771519331,1.0,4/16,13.57%,MIF;AKT3;FBXO5;TWIST1
prerank,negative regulation of amyloid fibril formation (GO:1905907),-0.289595521323124,-0.7560078864824743,0.8152173913043478,0.9148784457997555,1.0,2/12,3.96%,APOE;PFDN5
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.31476627178809186,0.7559120360894442,0.8092269326683291,0.9852321502382668,1.0,11/25,33.72%,TCERG1;EAF2;EAF1;LARP7;LDB1;ELL;HEXIM1;NELFA;WDR43;NELFB;HNRNPU
prerank,regulation of double-strand break repair (GO:2000779),-0.20029501841023717,-0.7556963279443197,0.9217391304347826,0.9138886938217469,1.0,6/39,9.46%,TRIP12;SPIRE1;UBR5;SLF2;MGMT;MRNIP
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.2978762142025247,0.7553189442576475,0.8088578088578089,0.9856236991602122,1.0,12/36,23.78%,TCF7L2;NFATC1;AGO2;GNB1;PPP3CA;FZD4;AGO4;PPP3CB;AGO3;GNAO1;MAP3K7;TNRC6A
prerank,synapse organization (GO:0050808),0.26416115102503723,0.7552197704305886,0.8888888888888888,0.9853591091293341,1.0,21/125,15.07%,SNCB;GPC6;DCTN1;F2R;PTPRS;PPFIA2;PTPRF;FARP1;CAST;PSEN1;MUSK;DSCAM;L1CAM;MAPT;FLRT3;PIN1;SLC8A2;CTNND2;PPFIA1;LRFN5;CACNB1
prerank,regulation of protein kinase C signaling (GO:0090036),0.3411258290761132,0.7551066717389502,0.7592105263157894,0.985109524483453,1.0,2/14,6.59%,VEGFA;MYADM
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),0.3127713605604092,0.7547369141520365,0.8134777376654633,0.9851877892021926,1.0,7/26,25.79%,IRAK3;TLR5;NLRP2B;FLOT2;TYRO3;FLOT1;OTUD4
prerank,neuron projection regeneration (GO:0031102),0.36910488403443187,0.7542931438778979,0.7603748326639893,0.9854013547136932,1.0,3/10,13.45%,GAP43;MTR;RTN4RL1
prerank,positive regulation of transmembrane transport (GO:0034764),-0.2800636697633959,-0.7541736339252375,0.8095238095238095,0.914546120303205,1.0,1/13,0.82%,ACSL1
prerank,pyrimidine nucleoside metabolic process (GO:0006213),0.3521867793260991,0.7541498875743293,0.7957839262187089,0.985191324154968,1.0,2/14,7.15%,UMPS;NT5M
prerank,histone H4-K5 acetylation (GO:0043981),0.34833454582447054,0.7538815581018018,0.7797927461139896,0.9847329170900108,1.0,4/15,16.38%,ING4;WDR5;KANSL3;OGT
prerank,histone H4-K8 acetylation (GO:0043982),0.34833454582447054,0.7538815581018018,0.7797927461139896,0.9847329170900108,1.0,4/15,16.38%,ING4;WDR5;KANSL3;OGT
prerank,cellular senescence (GO:0090398),0.31173991860594985,0.7533255956188022,0.8173913043478261,0.9850791392758229,1.0,8/27,24.81%,MAPK14;SMC5;CDKN1A;SMC6;PML;ECRG4;NSMCE2;CALR
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.27429585906029985,0.7532695492781178,0.8722513089005236,0.9847604906024718,1.0,24/87,21.66%,NDUFS5;COX19;TMEM126A;NDUFAF8;NDUFAB1;NDUFAF6;SDHAF1;NDUFS1;NDUFB7;NDUFV2;SURF1;TTC19;NDUFA2;ACAD9;DMAC2;BCS1L;UQCC3;COX16;COX14;SDHAF2;NDUFB2;DMAC1;COX18;SLC25A33
prerank,microtubule depolymerization (GO:0007019),0.3381058001945141,0.7530671556875228,0.7911802853437094,0.9846295211829753,1.0,4/17,20.39%,KIF2A;CCSAP;CKAP5;STMN4
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.30873812524111116,0.7529571188285963,0.8002322880371661,0.9843756964635715,1.0,11/28,27.81%,ITCH;UBE2N;IRAK1;UBA52;AAMP;TAB2;CYLD;MAP3K7;RELA;OTULIN;CASP8
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.24771370070498502,-0.7525948310523124,0.8340080971659919,0.91532919329584,1.0,5/17,21.25%,COX4I1;COX6C;NDUFA4;CYCS;COX5A
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.31745687608559203,0.7524167176656191,0.8077858880778589,0.9846769186147188,1.0,4/24,15.83%,SYVN1;CREB3L1;HERPUD1;SELENOS
prerank,positive regulation of immune response (GO:0050778),0.2741214372360868,0.7524029500531003,0.8406417112299466,0.984303904252449,1.0,10/64,20.96%,CD177;TGFB2;CD81;STX4;POLR3D;AKIRIN2;SLC15A4;IFI35;ITGAM;PYCARD
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.30575883959145844,0.7522877298077434,0.8152046783625732,0.9840578748618791,1.0,8/30,24.18%,MGAT1;LMAN1;MGAT5;MGAT2;TUSC3;DDOST;UGGT1;DPM2
prerank,regulation of smoothened signaling pathway (GO:0008589),0.2830736674809583,0.7520304626797895,0.8355555555555556,0.9840126463102601,1.0,7/50,12.43%,GPC3;GAS1;GLIS2;TEDC1;UCHL5;GLI3;TUBD1
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.2860566833712071,0.7515132518097951,0.8388888888888889,0.984318564859983,1.0,9/46,23.29%,ANXA2;MIF;RAP1B;ARF1;PDCD4;PPIA;RALA;SNRPA1;MTAP
prerank,oligodendrocyte differentiation (GO:0048709),0.3269657889193232,0.7514620855317486,0.7909319899244333,0.983994658636826,1.0,3/19,8.13%,PRDM8;SOX10;SOX8
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.3644185568976518,0.7507316351597083,0.7752161383285303,0.9845567911121993,1.0,2/10,17.29%,SIRT2;RCC2
prerank,megakaryocyte differentiation (GO:0030219),-0.29453059417876326,-0.7501134496101088,0.7942238267148014,0.9173279909526744,1.0,3/11,20.79%,KIT;TAL1;UBA5
prerank,determination of heart left/right asymmetry (GO:0061371),0.29577356334901805,0.7497737593668163,0.8163493840985442,0.9854169686491998,1.0,9/42,18.90%,TGFBR2;TBX6;PKD2;NDRG4;MICAL2;VANGL2;BBS4;AHI1;BBS5
prerank,regulation of embryonic development (GO:0045995),0.30041312708635554,0.74974508897194,0.8224513172966781,0.9850597733388032,1.0,2/34,1.66%,PHLDB1;TLE6
prerank,adenine nucleotide transport (GO:0051503),0.33609363961462513,0.7494879617153531,0.7911392405063291,0.9849972547229482,1.0,3/17,14.88%,LRRC8D;SLC25A4;SLC25A17
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.28048479415310135,0.7493659753441987,0.8283499446290143,0.9847579120514491,1.0,22/52,29.92%,SAMD4B;RC3H1;LSM4;EDC4;EXOSC7;ZFP36;POLR2D;CNOT3;CNOT10;EXOSC1;TNKS1BP1;LSM7;RC3H2;EDC3;DCP1A;DCP1B;LSM5;HBS1L;LSM1;PDE12;PATL1;EXOSC3
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.33607058884110635,0.7493652426727905,0.8056628056628057,0.9843670486907797,1.0,4/16,18.66%,ERCC4;TERF1;SMG6;TINF2
prerank,cellular response to heat (GO:0034605),0.3009708730242934,0.7493009433961705,0.8167053364269141,0.9840536724225825,1.0,9/35,22.69%,STUB1;YWHAE;MAPT;POLR2D;HSP90AA1;HSBP1;HTRA2;BAG3;TPR
prerank,copper ion homeostasis (GO:0055070),-0.25142458931310724,-0.7489311588450159,0.8296703296703297,0.9175414523640236,1.0,3/17,9.41%,APP;XIAP;CUTC
prerank,regulation of actin filament bundle assembly (GO:0032231),0.3128027148012422,0.7487572634733948,0.8043478260869565,0.984371594183989,1.0,5/26,15.99%,ASAP3;PFN2;ALMS1;SLC9A1;ACTG1
prerank,mammary gland epithelium development (GO:0061180),0.3503206005048066,0.7486067653280682,0.7757009345794392,0.984169510405587,1.0,2/14,11.31%,WNT2;AKT1
prerank,ribosome biogenesis (GO:0042254),0.2603038792953619,0.7484932902174023,0.935678391959799,0.9839302015275333,1.0,65/187,31.08%,C1D;SDAD1;DDX49;RIOK1;ABCE1;FCF1;NOC2L;ESF1;HELQ;EXOSC7;RRP36;NPM1;RPL10A;WDR46;UBA52;EIF6;SBDS;MPHOSPH10;RCL1;SNU13;MRPL36;NOLC1;DCAF13;RRP7A;EXOSC1;RPL6;NOP53;DDX52;POP4;PWP2;DDX31;RPF2;EBNA1BP2;TBL3;RPL23;RPL17;PDCD11;RIOK2;KRR1;RPS25;EIF2A;RBIS;WDR18;NOC4L;TEX10;RRP1B;LTO1;RPL22;EXOSC10;NOP16;DHX29;TSC1;RPL34;NOP56;WDR43;UTP18;NOP58;RPS15;EXOSC3;NIP7;RPL31;RPLP2;DDX27;RPS28;RPS6
prerank,protein autoprocessing (GO:0016540),0.3373055131935604,0.7482829417073437,0.7968545216251638,0.9838282378052255,1.0,6/17,30.31%,KLK6;FAM111A;HTRA2;CTSL;MYRF;SPRTN
prerank,activation of GTPase activity (GO:0090630),0.27262480339530326,0.7473454019324589,0.8630705394190872,0.9846406153591736,1.0,27/89,24.05%,SGSM2;RABGAP1L;RAP1GAP2;RASGRF1;ARHGAP42;DOCK7;TBCK;TBC1D2B;TBC1D17;ARHGEF10;TIAM2;TBC1D10A;NGEF;BCAS3;EVI5;SGSM1;EVI5L;TBC1D13;ADPRH;TBC1D22B;TBC1D15;TIAM1;CORO1C;RUNDC1;TBC1D8B;TBC1D12;BCR
prerank,monocarboxylic acid catabolic process (GO:0072329),0.31771502635406423,0.7472407054734321,0.8034188034188035,0.984391395479895,1.0,4/21,20.28%,CEL;ACOX1;NUDT19;LPIN3
prerank,glucose catabolic process to pyruvate (GO:0061718),0.3125324576079127,0.7471780189873983,0.7889688249400479,0.9836904507274822,1.0,2/24,4.84%,PFKP;FOXK2
prerank,canonical glycolysis (GO:0061621),0.3125324576079127,0.7471780189873983,0.7889688249400479,0.9836904507274822,1.0,2/24,4.84%,PFKP;FOXK2
prerank,protein export from nucleus (GO:0006611),0.3111924274144253,0.7471388788265794,0.8021978021978022,0.9833411642555167,1.0,8/27,24.81%,DESI1;PKD1;STRADA;CHP1;SMURF1;TPR;XPO7;CALR
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.30794555275020163,0.747124811653465,0.8056537102473498,0.9829687092759262,1.0,4/29,14.83%,CXCL10;C1QBP;GAS6;IL4
prerank,phospholipid catabolic process (GO:0009395),-0.2308896101881459,-0.7470221970353839,0.8473684210526315,0.9186841707985486,1.0,1/24,0.63%,GPCPD1
prerank,positive regulation of binding (GO:0051099),0.2708446292357551,0.7469099841917769,0.8604407135362014,0.9828658724837193,1.0,18/84,17.84%,LRP1;SKI;PKD1;DACT1;TCF7L2;GPSM1;PSEN1;SIRT2;USP33;EGF;PIN1;DDX11;STK3;AMFR;GMNN;IDE;NME1;PLAUR
prerank,CENP-A containing nucleosome assembly (GO:0034080),0.30754514864919325,0.7464927810708156,0.8118343195266272,0.9825974845226987,1.0,4/29,15.93%,CENPT;HJURP;NPM1;CENPC
prerank,CENP-A containing chromatin organization (GO:0061641),0.30754514864919325,0.7464927810708156,0.8118343195266272,0.9825974845226987,1.0,4/29,15.93%,CENPT;HJURP;NPM1;CENPC
prerank,positive regulation of mRNA metabolic process (GO:1903313),0.34839197020481527,0.7462405495395379,0.7912087912087912,0.9825390470790119,1.0,3/13,14.08%,RC3H1;ZC3HAV1;ZC3H12A
prerank,protein localization to microtubule organizing center (GO:1905508),0.3398812027907069,0.7454110048335135,0.7950481430536451,0.983206025427658,1.0,6/15,23.47%,PIBF1;BBS4;CEP83;PCM1;DCTN2;NEDD1
prerank,endocardial cushion development (GO:0003197),0.323410718468105,0.7452527187159611,0.7777777777777778,0.9830108893658317,1.0,3/21,6.76%,TGFB2;ACVR1;MDM4
prerank,mitochondrial gene expression (GO:0140053),0.29407345235784565,0.7451886545533196,0.8282138794084186,0.982702071255461,1.0,16/42,34.40%,MRPS11;MRPS18B;MRPS17;MRPS34;MRPL51;HARS1;QRSL1;SLC25A33;NOA1;MRPL12;MRPL23;LARS2;FOXO3;IARS2;MRPL16;GFM2
prerank,regulation of response to interferon-gamma (GO:0060330),-0.27723020905267126,-0.744911319545674,0.8360655737704918,0.9200856624533095,1.0,14/14,72.31%,STAT1;PTPN2;PIAS1;PARP9;SOCS1;IFNGR2;JAK1;IFNG;HSP90AB1;CDC37;SUMO1;SOCS3;JAK2;IFNGR1
prerank,positive regulation of intracellular transport (GO:0032388),0.29480683711986017,0.7443416002412319,0.832026875699888,0.9834076576085158,1.0,15/38,27.71%,B3GAT3;EHD2;KIF20B;BCAS3;PLA2G4E;DYNC1H1;VAMP2;CAPN10;NUMA1;PCM1;ICE1;TPR;RAB29;OAZ1;EIPR1
prerank,iron-sulfur cluster assembly (GO:0016226),-0.23705829644077575,-0.7443069944410369,0.8540540540540541,0.9195780651607511,1.0,7/24,16.28%,NUBPL;HSPA9;CIAO1;NFU1;ISCU;GLRX3;NDOR1
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.3490326519123535,0.744082627462654,0.8042609853528628,0.9833589731853258,1.0,5/13,28.28%,EGF;MGAT5;IL6;HES1;JAK2
prerank,regulation of histone H3-K9 acetylation (GO:2000615),-0.29257400244005916,-0.7440614378044844,0.7534722222222222,0.91854415031657,1.0,6/10,24.42%,RAPGEF3;SMARCB1;HDAC5;SPHK2;BRCA1;CHEK1
prerank,regulation of neurotransmitter secretion (GO:0046928),0.29687247781302667,0.7439518809072051,0.8297872340425532,0.9831139337326494,1.0,7/32,18.84%,SYT11;DTNBP1;STX1B;HCRT;SNAPIN;PREPL;RIMS2
prerank,response to interferon-beta (GO:0035456),-0.2334093304997898,-0.7436222303984691,0.8571428571428571,0.9178332027012861,1.0,4/22,10.42%,AIM2;PLSCR1;IFITM3;STAT1
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.2733931207483992,0.7434167717440892,0.8640674394099052,0.9833906835136949,1.0,10/73,10.96%,POLR2H;GLMN;CREBZF;HDAC6;POLR1G;PHF1;KAT2B;MPHOSPH8;DDX21;GPX1
prerank,organophosphate catabolic process (GO:0046434),0.3572056239015817,0.7433147222324867,0.8033240997229917,0.9831274633776963,1.0,11/11,64.30%,ANGPTL3;ENPP2;PNLIPRP2;APOA2;LIPG;PLBD2;PON1;PDXP;ABHD12;NUDT15;PLBD1
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.28946426588232976,0.7423921772811302,0.8497237569060774,0.9838827298221057,1.0,10/46,20.02%,GPAT4;DGKQ;AGPAT3;LPCAT1;AGPAT5;GPAT3;GPAM;LIPH;DDHD1;PLD2
prerank,regulation of cilium assembly (GO:1902017),0.27621776311906804,0.7423843304113594,0.8493003229278795,0.9835021787330874,1.0,29/62,31.26%,SAXO1;TBC1D2B;TBC1D17;TBC1D10A;CEP97;BBS4;EVI5;DYNC2LI1;EVI5L;CCP110;TBC1D13;ODF2L;TBC1D22B;TBC1D15;TBC1D19;ENTR1;ATG3;CROCC;CCDC88A;CYLD;CDKL1;FUZ;KCTD17;TBC1D5;TCHP;SDCCAG8;RABGAP1;TBC1D9B;IFT20
prerank,protein localization to Golgi apparatus (GO:0034067),-0.22228909525159546,-0.7418500886732252,0.8806818181818182,0.9186997680564015,1.0,7/27,13.91%,OPTN;PAQR3;VPS13A;GBP5;SORL1;GCC2;RIPOR1
prerank,regulation of viral genome replication (GO:0045069),0.2791133633037469,0.7418331358662056,0.8469162995594713,0.9838043207483093,1.0,12/56,21.09%,TARBP2;ADARB1;ZC3HAV1;SLPI;TNIP1;LARP1;DDB1;FAM111A;HACD3;PPIA;BTBD17;SRPK1
prerank,histone acetylation (GO:0016573),0.2756891427374738,0.7418266801474541,0.8592592592592593,0.9834241003057076,1.0,21/69,25.21%,TADA1;MRGBP;MSL3;KAT2B;POLE3;ING4;WDR5;DR1;KAT14;DMAP1;YEATS2;PER1;MORF4L1;NAA50;TAF6L;TRRAP;SGF29;KAT6B;MAP3K7;KAT5;KAT7
prerank,regulation of protein modification process (GO:0031399),0.280925784251186,0.7417218969607196,0.8425720620842572,0.9831797105180109,1.0,16/50,23.64%,CCDC88C;FLCN;CDK9;KAT2B;PARG;PIN1;FER;NOP53;PML;CORO1C;SESN2;CCDC88A;STAT2;ATG10;ATG14;RABL3
prerank,actin crosslink formation (GO:0051764),-0.28794785579692284,-0.7409421181196927,0.8233082706766918,0.9184960214628627,1.0,4/12,16.75%,EPS8;GAS2L3;LCP1;BAIAP2L1
prerank,histone H2B ubiquitination (GO:0033523),-0.30093820837279633,-0.7405635095151116,0.782051282051282,0.9176239772597593,1.0,2/10,8.80%,DTX3L;CTR9
prerank,cell junction organization (GO:0034330),0.27223602767860033,0.7405408436384145,0.8884165781083954,0.9842838047215358,1.0,17/71,17.94%,SNCB;TGFB3;TGFB2;PPFIA2;MYO9A;PSEN1;L1CAM;MAPT;PIN1;RHOA;SLC8A2;CTNND2;PPFIA1;LIMS2;ACTG1;CHRNA7;ILK
prerank,pancreas development (GO:0031016),0.35731409738640024,0.7396847031407322,0.8082191780821918,0.9849387937750639,1.0,1/12,5.14%,TCF7L2
prerank,estrogen metabolic process (GO:0008210),0.332270780919359,0.7393897768121813,0.7970822281167109,0.9849175547747486,1.0,4/15,22.29%,HSD17B8;HSD17B4;HSD17B11;CYP1B1
prerank,peptidyl-asparagine modification (GO:0018196),0.2982655596163745,0.7386898247097929,0.8315911730545877,0.9853972002869583,1.0,8/31,24.18%,MGAT1;LMAN1;MGAT5;MGAT2;TUSC3;DDOST;UGGT1;DPM2
prerank,purine-containing compound catabolic process (GO:0072523),-0.27109964066389297,-0.7386257857114424,0.8145161290322581,0.9186243137846988,1.0,4/13,17.94%,DPYD;NT5E;NT5C2;NT5C1A
prerank,chloride transmembrane transport (GO:1902476),0.28182171016569646,0.7385254369252368,0.8436123348017621,0.9852165280834473,1.0,10/48,20.50%,ANO3;SLC4A8;SLC12A8;GABRR3;SLC12A4;SLC12A5;GABRG3;ANO5;GABRG2;SLC12A6
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.3168494411659726,0.7383901141559676,0.786346396965866,0.9849910541422211,1.0,1/20,1.05%,PSTPIP1
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.2703731831229407,0.7377422064628057,0.8650371944739639,0.9853829189098762,1.0,11/76,16.35%,GPSM2;CDC42EP2;BIN1;SORBS3;PFN2;FCHSD1;FER;BCAS3;ARF6;DYNC1H1;NCK1
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.29218739261063253,0.737556481925411,0.8301886792452831,0.9852317696587207,1.0,15/34,33.00%,MPP2;GRIN2D;AKT1;GABRG3;GRIN2A;GABRG2;GABRA3;GRID2;NPAS4;NLGN3;GABRA1;DRD2;GSK3A;RAB3GAP1;GABRA5
prerank,response to cytokine (GO:0034097),0.25581192981470097,0.7373424553335307,0.9058704453441295,0.985104325677423,1.0,17/141,14.50%,COL3A1;TIMP2;AFF3;PRKCA;ANXA1;IRAK3;ADAM9;SRC;PID1;CYP27B1;CDK9;IRAK1;SETD2;FLT3;RHOA;HDAC4;GGT7
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.304125332469423,0.7369149460010791,0.8102815177478581,0.985257248787717,1.0,10/25,32.92%,MPP2;GRIN2D;AKT1;GRIN2A;GRID2;NPAS4;NLGN3;DRD2;GSK3A;RAB3GAP1
prerank,sphingosine metabolic process (GO:0006670),0.3258244679674743,0.7359919071871068,0.8080939947780679,0.9860030578955554,1.0,2/17,7.05%,PLPP3;PLPP1
prerank,platelet degranulation (GO:0002576),0.2638606938526771,0.7359470911781686,0.9175152749490835,0.9856733105318867,1.0,8/118,3.05%,CD9;TGFB3;CLEC3B;SPARC;ITGB3;VEGFA;TGFB2;ECM1
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.26557302742087746,0.7358131874821097,0.8829676071055381,0.985450554896669,1.0,21/78,25.85%,NFE2L2;COP1;STUB1;SIRT2;HERPUD1;DNAJB2;USP5;SGTA;NOP53;RNF14;ZER1;KEAP1;BCAP31;ARIH2;RNF19A;ARIH1;ZYG11B;DVL1;MDM2;FBXO22;CSNK1E
prerank,transcription by RNA polymerase III (GO:0006383),0.3034513210172575,0.7357678756251794,0.8137603795966786,0.9851307742185165,1.0,8/27,23.55%,ZC3H8;GTF3C2;BRF1;POLR3H;ICE1;ELL;TBP;GTF3C5
prerank,cortical cytoskeleton organization (GO:0030865),0.286412119020336,0.7349383375295828,0.8365276211950394,0.9857672972141809,1.0,9/41,16.21%,LLGL1;FMNL1;RHOQ;RHOA;FMNL3;FHOD3;ARF6;RND3;RAC3
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.277334574072256,0.734757418983907,0.8706896551724138,0.985605468398037,1.0,9/59,13.54%,CADM3;NPTN;NECTIN3;PKD1;TENM3;DSCAM;L1CAM;IGSF9;PALLD
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.3024965328252872,0.7346302280985499,0.8056872037914692,0.9853561617186894,1.0,9/28,24.04%,DBN1;PFN2;GBA2;FCHSD1;COTL1;RASA1;ABITRAM;CTTN;LATS1
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.29829058293129074,0.7342621492733397,0.8195754716981132,0.9854213170189429,1.0,4/28,12.38%,EGFR;BEND6;AKT1;EGF
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.3338606675247579,0.733922460688074,0.8089591567852438,0.9854473902054873,1.0,1/16,0.89%,PARP3
prerank,regulation of ERAD pathway (GO:1904292),0.35472879531270524,0.7338143930148134,0.7926657263751763,0.9851942706803252,1.0,4/11,22.66%,TMEM259;HERPUD1;USP13;USP19
prerank,regulation of astrocyte differentiation (GO:0048710),0.3485932664604324,0.7335500488221014,0.7906647807637907,0.985139002911405,1.0,2/12,5.01%,BIN1;CLCF1
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.2639632667504083,0.7322084711097941,0.8950159066808059,0.9863536453720035,1.0,25/75,27.00%,MAP1B;LLGL1;DOCK7;FARP1;S100A6;UNK;TAOK2;MAP6;DCC;SDC2;SHTN1;CNTN4;SLITRK4;RAB10;MAP1A;ABITRAM;SPTBN4;MAP1S;NTNG2;DVL1;PAX2;ATL1;NRCAM;SLITRK5;PAK3
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.3380632405021674,0.732158322948011,0.8158236057068742,0.9860297166715122,1.0,7/16,26.19%,PIGZ;PIGC;PIGW;PIGM;PIGL;DPM2;PIGH
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.27394789236227673,0.7313961130683532,0.8702702702702703,0.9865422510927793,1.0,7/57,13.71%,GNAI3;LPAR1;HTR1F;AKAP12;GPR37L1;ADCY8;GPR37
prerank,myelin maintenance (GO:0043217),0.3581923637401663,0.7311129723764702,0.7840909090909091,0.9864831414683087,1.0,7/10,37.96%,CXCR4;PTEN;MYRF;EPB41L3;DEGS1;CLU;ABCD1
prerank,L-glutamate transmembrane transport (GO:0015813),0.35968799595539436,0.7306484712170557,0.7982708933717579,0.986648556368052,1.0,2/10,9.93%,SLC1A6;PRAF2
prerank,inorganic anion transmembrane transport (GO:0098661),0.2699366792334412,0.7304756751809706,0.8778135048231511,0.9864606343263499,1.0,14/63,21.28%,ANO3;SLC4A8;SLC12A8;GABRR3;SLC37A3;SLC12A4;SLC12A5;GABRG3;SLC25A3;SLC20A1;ANO5;GABRG2;SLC12A6;SLC37A4
prerank,apoptotic process (GO:0006915),0.2543971514846801,0.7300864960125045,0.9509018036072144,0.9865428537459587,1.0,42/203,19.41%,EFNA5;FAP;MAGI3;TGFBR2;DPF2;KREMEN1;MTOR;FOXO1;DPF1;AIFM2;PIK3CA;SIAH1;PAEP;ING4;AKT1;BMF;ERCC3;NDUFS1;BAK1;BBC3;TAOK2;ADAM15;DIABLO;NSG1;PLAGL1;DCC;STK3;ATCAY;THOC1;CD14;VDAC1;PDCD4;PRUNE2;OGT;CXCR4;PPIA;IAPP;DAP;AKAP1;SFRP5;APAF1;CIT
prerank,regulation of neuron apoptotic process (GO:0043523),0.2646029825629757,0.7292509624914459,0.903125,0.9871704511992528,1.0,21/96,22.19%,TGFB3;SIX4;TGFB2;F2R;CLCF1;NFATC4;EGLN2;NRBP2;GDNF;NSMF;SIX1;NUPR1;FAIM2;SET;SNX6;RASA1;BACE1;TYRO3;KDM2B;NF1;ATF4
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.28919135712714394,0.7291355463508628,0.8451834862385321,0.9869293430948846,1.0,11/36,22.15%,RNF2;RYBP;PHC3;PHC1;EHMT2;UXT;APAF1;RING1;PCGF6;FOXO4;EZH2
prerank,regulation of protein ubiquitination (GO:0031396),0.2601592386541192,0.729081315465639,0.9076923076923077,0.9866028038466417,1.0,36/108,30.46%,AXIN1;GTPBP4;GNL3L;USP4;STUB1;MYCBP2;UBE2N;CUL3;SQSTM1;HDAC3;AKT1;DNAJB2;NDFIP1;HSP90AA1;CHP1;OGT;UFL1;TGFBR1;U2AF2;ARRB1;NSMCE3;DERL1;UBE3A;FKBP1A;BAG5;FBXW7;PRKCG;DCUN1D1;BCL10;DNAJA1;HDAC8;LAPTM5;SENP2;SPRTN;SIRT7;TRAF6
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.3155154333412179,0.728746199814044,0.8148148148148148,0.986606418243962,1.0,11/20,34.79%,AGO2;EIF6;AGO4;AGO3;TNRC6A;AGO1;CELF1;CNOT8;LIMD1;TNRC6C;NRDE2
prerank,cardiolipin metabolic process (GO:0032048),0.33430739619151645,0.7286291911664716,0.8018867924528302,0.9863548809026922,1.0,8/13,35.64%,PNPLA8;TAMM41;SLC27A1;PGS1;PLSCR3;CRLS1;PTPMT1;HADHB
prerank,cellular response to hypoxia (GO:0071456),0.25892148869627707,0.7282726397866547,0.9067882472137792,0.9864162293119378,1.0,14/126,9.06%,ANGPT4;PSMC4;VEGFA;LMNA;ZFP36L1;MTOR;CARD16;PSMC6;MDM4;EGLN2;STUB1;TIGAR;PSMD8;SIRT2
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.28851554206567037,0.7281830171590951,0.8535469107551488,0.9861344574899948,1.0,9/37,14.96%,DGKQ;AXIN1;S1PR2;SIRT2;INPP5K;PPEF2;EGF;CALM2;TNKS1BP1
prerank,purine nucleotide catabolic process (GO:0006195),0.34442339055435917,0.7281599114657704,0.8158940397350993,0.9857810038579328,1.0,2/13,10.96%,GDA;GPX1
prerank,DNA methylation or demethylation (GO:0044728),0.3182516467339762,0.7281279717287046,0.8062111801242235,0.9850531024720709,1.0,9/19,29.85%,SPOCD1;EHMT2;DMAP1;BAZ2A;GATAD2A;MTRR;ATF7IP;ATRX;FOS
prerank,DNA alkylation (GO:0006305),0.3182516467339762,0.7281279717287046,0.8062111801242235,0.9850531024720709,1.0,9/19,29.85%,SPOCD1;EHMT2;DMAP1;BAZ2A;GATAD2A;MTRR;ATF7IP;ATRX;FOS
prerank,negative regulation of hippo signaling (GO:0035331),0.3485690207740202,0.7273909147513091,0.8116343490304709,0.9854930976513006,1.0,2/12,4.92%,MAPK14;MAP2K3
prerank,mRNA modification (GO:0016556),0.30957767095489036,0.727044922215504,0.8382716049382716,0.9855200583698218,1.0,4/22,20.10%,TRMT6;TRMT61A;PCIF1;TRUB1
prerank,negative regulation of centrosome duplication (GO:0010826),0.35466738859697333,0.7268790394486463,0.826027397260274,0.9853294600487961,1.0,4/11,19.75%,KAT2B;NPM1;CDK5RAP2;MDM1
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.3075569305165161,0.726632252386453,0.821078431372549,0.9852505530723032,1.0,3/24,7.58%,MAPK7;NFE2L2;GAS6
prerank,positive regulation by host of viral transcription (GO:0043923),0.33313902606523765,0.7265993729827833,0.8119205298013245,0.9849081604985483,1.0,7/15,23.68%,HPN;CTDP1;SMARCA4;CHD1;TFAP4;JUN;RRP1B
prerank,regulation of epithelial cell differentiation (GO:0030856),-0.2548859752243419,-0.7263493715048628,0.8127659574468085,0.9323404163826579,1.0,7/17,25.85%,OSR1;CAV1;CEACAM1;APOLD1;MAFG;DSPP;DLL1
prerank,sphingolipid biosynthetic process (GO:0030148),0.2658087121955608,0.7261111470854437,0.8873538788522848,0.9850899201210173,1.0,11/71,12.43%,CERS6;PLPP3;ALDH3A2;PLPP1;PRKD2;AGK;SGMS2;LARGE1;FA2H;ELOVL5;PRKD3
prerank,regulation of stem cell population maintenance (GO:2000036),0.3198009317477216,0.7259886837402074,0.8253557567917206,0.9848393868466147,1.0,2/18,6.23%,LOXL2;NCOA3
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.3359349481317956,0.7257220899773132,0.7917771883289124,0.9847806657499839,1.0,5/14,23.48%,PAICS;GART;ATIC;ADSS2;LHPP
prerank,regulation of response to oxidative stress (GO:1902882),0.3534644625882989,0.7257170601375648,0.8191632928475033,0.9844067477888511,1.0,3/11,19.02%,AIFM2;GGT7;SELENON
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.3014759258740076,0.7255960121249466,0.8171021377672208,0.9841803748402614,1.0,2/25,4.84%,PFKP;FOXK2
prerank,regulation of establishment of planar polarity (GO:0090175),0.25956061957739907,0.7255909446591848,0.9025906735751296,0.9838073521450673,1.0,21/88,25.96%,PSMC4;SMURF2;DACT1;AP2A2;PSMC6;CLTC;FZD7;PARD6A;PSMD8;VANGL2;RHOA;FZD4;DAAM1;TIAM1;SMURF1;AP2M1;PSMD3;DVL1;PSMD4;RAC1;PSMB3
prerank,endocrine system development (GO:0035270),0.31275540495352966,0.7245003817948112,0.8115577889447236,0.9846952491865835,1.0,6/21,21.97%,WT1;GLI2;SIX1;DKK3;TGFBR1;NF1
prerank,cytosolic calcium ion transport (GO:0060401),0.2996811960212259,0.7238835318277488,0.8370720188902007,0.985030047957686,1.0,8/28,24.49%,MCU;SLC35G1;MCUB;ATP2A2;SLC8A2;ATP2B1;JPH4;CACNA2D1
prerank,C-terminal protein amino acid modification (GO:0018410),0.34753361973964697,0.7237302067740372,0.7905405405405406,0.9848404475502186,1.0,4/11,25.32%,TTL;GPLD1;ICMT;AGBL1
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),0.252379186666257,0.7229320820302767,0.9354187689202825,0.9853918374822974,1.0,31/168,19.51%,RPSA;DIS3L2;ZFP36L1;CTIF;SAMD4B;RC3H1;EXOSC7;HELZ2;PNRC2;GSPT2;RPL10A;UBA52;ZFP36;POLR2D;POLR2G;RPS5;CNOT3;CNOT10;ZC3H12A;SMG7;EIF3E;GSPT1;TNKS1BP1;SMG6;RPL6;DDX5;TENT2;TENT4B;PPP2R2A;RPL23;RPL17
prerank,phosphatidic acid metabolic process (GO:0046473),0.28134783285332793,0.7224167879000326,0.8669623059866962,0.9855955136215254,1.0,10/48,20.02%,GPAT4;DGKQ;AGPAT3;LPCAT1;AGPAT5;GPAT3;GPAM;LIPH;DDHD1;PLD2
prerank,positive regulation of type I interferon production (GO:0032481),0.2668598903282155,0.7223610878141731,0.8941176470588236,0.9852825979269936,1.0,12/73,14.88%,POLR2H;CGAS;DHX33;POLR3E;CHUK;TLR4;POLR3D;IRAK1;SETD2;XRCC5;HSP90AA1;CD14
prerank,I-kappaB phosphorylation (GO:0007252),0.35761009287830187,0.7223429021478217,0.823953823953824,0.984925845276668,1.0,2/10,9.08%,CHUK;TLR4
prerank,positive regulation of defense response to virus by host (GO:0002230),0.30687454447506646,0.7215938842520697,0.8488664987405542,0.9854524555302,1.0,5/24,14.83%,CGAS;TRAF3IP2;ZC3H12A;HSP90AA1;IL4
prerank,mitotic chromosome condensation (GO:0007076),0.29967667026732003,0.7214854062435097,0.8391777509068924,0.98520191657724,1.0,7/26,26.78%,TENT4A;NCAPG;SMC2;SET;AKAP8L;CSNK2A2;KMT5A
prerank,positive regulation of dendrite extension (GO:1903861),0.3220318061580836,0.7212720419718882,0.8184110970996217,0.9850646231929401,1.0,5/17,24.12%,SYT2;SYT1;RIMS2;SMURF1;RNF157
prerank,sulfur amino acid catabolic process (GO:0000098),0.3473938216835646,0.7210461695328624,0.8107714701601164,0.9849557809835248,1.0,4/10,25.43%,MPST;TXN2;MTRR;CTH
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.3068015410947614,0.7210099684804782,0.8264058679706602,0.9846169897125252,1.0,12/22,37.16%,PPP1R1B;MGAT5;FKBP1A;TIPRL;CRY2;PTPA;FKBP1B;BOD1;PPP4R4;NCKAP1L;ROCK2;GSK3B
prerank,phosphatidylcholine catabolic process (GO:0034638),0.35806422141435085,0.7204899319608867,0.807909604519774,0.9848449343912437,1.0,3/10,26.89%,PNPLA8;LIPC;PLA2G7
prerank,T cell activation (GO:0042110),0.2646752853201075,0.7204470938430908,0.8725910064239829,0.984515014389107,1.0,15/69,25.67%,IRF4;DPP4;CD44;PPP3CA;IL4;LMBR1L;NCK1;PPP3CB;DDOST;PIK3CG;FKBP1A;LEPR;NCK2;RAB29;KIF13B
prerank,regulation of dendrite extension (GO:1903859),0.3179914115421272,0.7202955102006492,0.8306351183063512,0.9843175480208328,1.0,5/18,24.12%,SYT2;SYT1;RIMS2;SMURF1;RNF157
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.288525575249996,0.7197363124436571,0.847877358490566,0.984579964584082,1.0,10/31,28.12%,CDC14B;AXIN1;UBE2N;PIN1;PTEN;RAB1A;FBXW7;GORASP1;DCUN1D1;TOPORS
prerank,positive regulation of triglyceride metabolic process (GO:0090208),-0.24938703692294933,-0.719605844716983,0.8504273504273504,0.9389779553156797,1.0,5/16,20.57%,SCARB1;NR1H3;CTDNEP1;PNPLA2;ABHD5
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.3565440011224634,0.7190258729909949,0.8152327221438646,0.9850129778950332,1.0,4/10,32.41%,RC3H1;PRNP;LGALS9;CD274
prerank,tRNA modification (GO:0006400),0.2681030785823726,0.7185226047884709,0.8898305084745762,0.9852068565158023,1.0,13/62,20.76%,ANKRD16;TRMT6;TYW3;TRMT61A;FTSJ1;THADA;TRMT1;DTWD1;QTRT1;TYW5;DUS2;TRUB1;METTL1
prerank,peptidyl-lysine methylation (GO:0018022),0.2996460624690559,0.7179957770610597,0.8433451118963486,0.9854228958895459,1.0,9/26,28.06%,SETD7;SETD2;ANTKMT;EHMT2;EEF2KMT;N6AMT1;EEF1AKMT3;KMT5A;SUV39H1
prerank,microglial cell activation (GO:0001774),-0.236919252096076,-0.717897589227181,0.903954802259887,0.9395528408257959,1.0,3/21,9.16%,APP;SNCA;CX3CL1
prerank,amide biosynthetic process (GO:0043604),0.2733091694619247,0.7178775067563081,0.8608597285067874,0.9851763980334006,1.0,5/47,11.28%,CERS6;PCSK5;AGK;SGMS2;FA2H
prerank,regulation of protein binding (GO:0043393),0.2571830163224168,0.7176844985494417,0.9215086646279307,0.9850140568692629,1.0,21/114,16.89%,LRP1;PKD1;DACT1;GNL3L;TCF7L2;CARD16;TFIP11;PSEN1;USP33;AKT1;SLPI;DNAJB2;CDKN1A;PIN1;DDX11;HDAC4;STK3;AMFR;GTF2F1;SNAPIN;IDE
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.2806142167286556,0.7176289654369616,0.8585746102449888,0.9847032813922205,1.0,8/44,20.33%,KCNMA1;ANK2;KCNJ2;KCNJ3;GNB1;AKAP9;KCNH2;FLNA
prerank,regulation of RNA export from nucleus (GO:0046831),0.3514552278349118,0.7171085904986105,0.8067700987306065,0.9849191827175829,1.0,4/11,22.69%,CPSF6;SETD2;AKAP8L;TPR
prerank,rRNA processing (GO:0006364),0.24974520197481492,0.7169537332463521,0.9555555555555556,0.9847174173489655,1.0,60/172,31.08%,C1D;DDX49;RIOK1;FCF1;ESF1;HELQ;EXOSC7;RRP36;RPL10A;WDR46;UBA52;EIF6;SBDS;MPHOSPH10;RCL1;SNU13;NOLC1;DCAF13;RRP7A;EXOSC1;RSL1D1;RPL6;NOP53;DDX52;POP4;PWP2;EBNA1BP2;SRFBP1;TBL3;RPL23;RPL17;PDCD11;RIOK2;KRR1;RPS25;MAK16;NOP2;WDR18;NOC4L;TSR3;TEX10;RRP1B;RPL22;EXOSC10;RIOK3;PRKDC;RPL34;NOP56;NHP2;WDR43;UTP18;NOP58;RPS15;EXOSC3;NAT10;RPL31;RPLP2;DDX27;RPS28;RPS6
prerank,retinoic acid metabolic process (GO:0042573),0.3305962897573087,0.7168760539257154,0.843501326259947,0.9844338218899603,1.0,3/14,19.32%,CYP2S1;ALDH1A3;SCPEP1
prerank,regulation of Rac protein signal transduction (GO:0035020),0.322123249528558,0.7166659479012677,0.8172323759791122,0.9842943248110854,1.0,7/16,24.31%,ARHGAP44;RASGRF1;ARF6;OGT;PIK3CG;ARHGAP17;ALS2
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.29346287000728677,0.7157413542044724,0.8470873786407767,0.9849611781834134,1.0,7/29,15.00%,RASGRF1;RASGEF1A;SRC;ITGAV;IRS2;SHOC2;RAPGEF1
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.26802984384714296,0.7153286442269258,0.8634361233480177,0.985051694745424,1.0,22/58,30.16%,CYREN;UBE2N;POLB;SMC5;ERCC4;XRCC5;ABRAXAS1;NBN;IFFO1;RAD50;DCLRE1A;SMARCAL1;ERCC1;NSMCE2;KAT5;PRPF19;PRKDC;XRCC6;KDM2A;ZBTB7A;SUMO1;PSMD14
prerank,dephosphorylation (GO:0016311),0.2508882792934224,0.7146073201810063,0.9343434343434344,0.985464763713101,1.0,41/147,23.48%,TIMM50;CDC14B;PTPRS;PLPP3;ACP2;PTPRJ;PLPP5;ILKAP;PTPRF;PLPP1;PPP5C;CTDSP2;DUSP11;PPM1G;INPP5K;PPP3CC;SSH1;PPEF2;PLPPR3;CTDP1;PPP3CA;PPP2R1B;MTMR6;PPP1CC;PPP2R5B;PDP2;PTPN5;PLPP2;SDHAF2;PPP3CB;PPP2R2A;ACP3;PTPN3;PPM1A;PTEN;PPP6C;FBXW11;ACP6;CTDSP1;PTPN18;LHPP
prerank,regulation of DNA repair (GO:0006282),0.2758704385713627,0.7136857384895833,0.8644444444444445,0.9861070798001801,1.0,7/44,13.31%,EGFR;EYA2;UBE2N;TIGAR;CDK9;PARG;ABRAXAS1
prerank,brain development (GO:0007420),0.25246504347949905,0.7134912600852448,0.9395161290322581,0.9859501847289587,1.0,36/136,24.29%,AFF2;UGP2;PBX1;TGFBR2;MEIS2;NFIB;GRIN2D;ZFHX3;NDRG4;EEF1AKMT4-ECE2;SLC6A4;TBC1D23;HSPG2;SLC23A1;BBS4;MDGA1;UFC1;CHD8;CDK5RAP2;GRIN2A;CXCR4;QARS1;CNTN4;UFM1;EML1;NIPBL;PAFAH1B1;PITPNM1;PTEN;NF1;UBE3A;FBXW11;MAP1S;NCOA6;NKX2-2;RAB18
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.3044361672870964,0.71316191415314,0.8480697384806973,0.9859414012424242,1.0,1/19,2.31%,AMPD2
prerank,cytoskeleton organization (GO:0007010),0.2527778526042739,0.7124744632325207,0.9378185524974516,0.9863176263883436,1.0,35/114,26.31%,ARHGAP10;PLCE1;DIAPH3;BIN1;ZRANB1;DST;MAST4;LARP4;CAMSAP1;MICAL2;PRPF40A;CCL13;RHOA;PALLD;FMNL3;DIAPH1;RND3;ANK1;RAC3;MICAL1;RANBP10;SH3D19;PLD2;ZMYM3;PACSIN2;PACSIN3;CNTNAP1;SYNE3;DMTN;RAC1;RHOBTB2;STRIP1;ZMYM6;MAST2;RND2
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.29406298443214396,0.7124651107105924,0.8624401913875598,0.9859497331899617,1.0,9/29,28.30%,CHUK;TLR4;UBA52;CD14;TRAF3;UBE2D3;TICAM1;CASP8;CD300LF
prerank,regulation of intracellular signal transduction (GO:1902531),0.24648354885753523,0.7123139780926309,0.992,0.9857432471029814,1.0,80/420,18.32%,MYOC;TRIP10;ARHGAP21;ARHGAP10;EGFR;ARHGAP44;AKAP13;VEGFA;PIK3R2;TAOK3;MAPK14;TRIO;MTOR;PRKAB2;RCN3;SRGAP1;RASSF2;TBCK;MDM4;RIT2;ARHGEF3;MYO9B;NOC2L;FLCN;PRKD2;MYO9A;RHNO1;OCRL;ARHGAP9;FBXL2;TAGAP;RHOJ;MAPK11;ITGAV;TIAM2;RHOQ;BRD7;DYRK2;SQSTM1;AKAP12;TAF3;RMI1;AKT1;MAPT;NGEF;RAD1;TAOK2;PIN1;BCL3;RHOA;DNA2;TMEM127;BRIP1;EHMT2;NBN;STK3;SLC15A4;USP7;GPAT3;NOP53;RFC4;TRAF3;RAC3;SOS1;PEX5L;CHD3;UFL1;PML;PIP4P1;PPP2R5B;SRGAP2;SRGAP3;PIP4K2C;ARAP1;RAD50;TCP11;TMBIM4;RPF2;DIPK2A;BLM
prerank,regulation of cellular senescence (GO:2000772),0.2959588018154404,0.71224778351515,0.8365384615384616,0.985440870210102,1.0,8/28,17.49%,CGAS;YPEL3;AKT3;FBXO5;TWIST1;RSL1D1;EEF1E1;NEK4
prerank,aerobic respiration (GO:0009060),0.3084881906303426,0.7119494581470782,0.8431618569636136,0.9854071866845298,1.0,7/20,25.53%,SURF1;MDH2;MTFR1L;UQCRH;UQCR10;ME3;SDHC
prerank,positive regulation of catalytic activity (GO:0043085),0.2833787380107587,0.7118785137019854,0.8577981651376146,0.9851125506168771,1.0,7/37,14.56%,MAPK14;ABL2;B3GAT3;PSEN1;STX4;XRCC5;BCAS3
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.24216890065451013,-0.7113523771862215,0.8366336633663366,0.9455697950360883,1.0,7/18,28.98%,SHANK3;CACNG4;CACNG8;CACNG3;TSHZ3;CCR2;CCL2
prerank,regulation of cellular amide metabolic process (GO:0034248),0.28680432465136574,0.7109099693480813,0.8524970963995354,0.9857952353443262,1.0,11/32,27.20%,PKP3;ATXN2;TIGAR;NOLC1;RBM3;PCIF1;METAP1;EIF2A;GRM5;CYFIP1;TSC1
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),-0.2528065753109784,-0.7108739185962322,0.8623481781376519,0.9447740693418852,1.0,2/14,4.55%,CHKA;ETNK2
prerank,calcium ion homeostasis (GO:0055074),0.25697332732018724,0.7103399216410363,0.9212435233160622,0.986016333451925,1.0,27/95,27.55%,CCL8;NPTN;ANK2;TNNI3;ATP2B4;CYP27B1;ATP13A1;CCL13;ATP2A2;SLC8A2;STC1;TMEM165;CHRNA7;ATP2B1;HTR2C;SELENON;STIM1;SLC8B1;HTR2A;RMDN3;CALR;TMCO1;SLC24A4;SLC24A2;TMEM203;SLC10A7;FAM20A
prerank,GPI anchor metabolic process (GO:0006505),0.3005514704412467,0.7101289791976603,0.845223700120919,0.985882929685428,1.0,9/26,26.19%,PIGZ;PIGC;MPPE1;PIGW;PIGM;GPLD1;PIGL;DPM2;PIGH
prerank,lamellipodium organization (GO:0097581),0.29001577437821713,0.7093886399778951,0.8440797186400938,0.986343767690509,1.0,10/29,26.99%,ABLIM1;WASF1;SNX1;CTTN;CCDC88A;DMTN;RAC1;CYFIP1;SPATA13;ARHGEF7
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.2853869368247397,0.7091613637745056,0.8633754305396096,0.986218077990746,1.0,10/36,23.83%,UCHL5;RYBP;FHIT;USP7;GIPC1;NOP53;OGT;MAP1A;SDCBP;BAG5
prerank,regulation of cellular protein metabolic process (GO:0032268),0.27192087955322836,0.7090788354005109,0.8815060908084164,0.9859219638910701,1.0,17/47,28.23%,PKP3;ATXN2;WDR91;SSH1;AKT1;NOLC1;RBM3;KLF4;PCIF1;METAP1;EIF2A;CSF1;GRM5;CYFIP1;EIF4G1;TSC1;NFKB1
prerank,regulation of chromosome segregation (GO:0051983),0.32170909431865147,0.7087184368382398,0.823146944083225,0.9859478409111392,1.0,5/16,22.89%,SMC5;PUM1;SMC6;NUMA1;CSNK2A2
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.33627681007323873,0.7084602041998915,0.8417462482946794,0.9858507816404058,1.0,6/13,22.69%,RAB23;MDFIC;CABP1;CHP1;UFM1;TPR
prerank,regulation of mitochondrial translation (GO:0070129),0.3041092381139971,0.7081478816463485,0.8263090676883781,0.9858336247364474,1.0,5/21,21.41%,C1QBP;MRPS27;RCC1L;RMND1;MPV17L2
prerank,protein homotetramerization (GO:0051289),0.2708833051910065,0.7069939856269163,0.887260428410372,0.9867211084675818,1.0,10/49,19.06%,TK1;KCNJ2;OSBPL2;PKD2;SAMHD1;ALDH1A3;GLS;CRYZ;ALDOA;HCN1
prerank,retinoic acid receptor signaling pathway (GO:0048384),-0.28131925005477154,-0.7069821941501861,0.8371335504885994,0.9476230757258656,1.0,5/10,29.91%,TBX1;ACTN4;RXRG;RXRB;RXRA
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.31364182744647123,0.7068992071207937,0.8354922279792746,0.9864521993936461,1.0,4/18,17.60%,ABL2;POR;GDNF;PDP2
prerank,epithelial cell development (GO:0002064),0.3094720394579655,0.7068361026783754,0.8596938775510204,0.9861522603462609,1.0,2/20,5.33%,DACT2;PDZD7
prerank,tRNA wobble uridine modification (GO:0002098),0.3287148024295611,0.70673358622629,0.8172043010752689,0.9858856070487214,1.0,3/14,13.77%,ELP4;TRMU;ELP1
prerank,steroid biosynthetic process (GO:0006694),0.267160500474325,0.7066481622028695,0.883695652173913,0.9856037342153606,1.0,7/56,9.72%,OSBPL3;OSBPL2;INSIG2;SCP2;SRD5A1;HSD3B7;OSBPL6
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.296990554351606,0.7062183090762355,0.8406524466750314,0.9856938851313775,1.0,5/21,22.86%,ZW10;ZWINT;FBXO5;TPR;KLHL22
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.22678155057757626,-0.7058317059371213,0.9070796460176991,0.947511030093624,1.0,5/22,13.91%,RPS7;RPL37;ATM;SPRED3;SPRED2
prerank,respiratory electron transport chain (GO:0022904),0.33017895758461296,0.7057888863987094,0.8436213991769548,0.9857982769285204,1.0,3/14,15.90%,ETFA;ETFB;ETFDH
prerank,stem cell development (GO:0048864),0.31509289132563434,0.7055715019676031,0.8247694334650857,0.9856762980837597,1.0,3/16,16.60%,SOX8;NOLC1;SNAI2
prerank,presynapse assembly (GO:0099054),0.31906351912481307,0.7053136005589744,0.8226857887874837,0.9855720093556295,1.0,8/16,31.31%,CEL;PTEN;LRRTM3;DVL1;IL1RAPL1;NLGN1;NLGN3;NLGN2
prerank,regulation of interferon-beta production (GO:0032648),0.27169113364792385,0.7052619141514005,0.8630751964085297,0.9852482755345878,1.0,11/46,22.93%,PTPRS;TIRAP;TLR4;SIRPA;POLR3D;HSP90AA1;RNF216;TRAF3;PYCARD;POLR3A;FLOT1
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.3199196434176656,0.7051933853413187,0.8314028314028314,0.984950796852253,1.0,14/14,68.04%,ATP6AP1;CSF1;TRAF6;IFNG;POU4F2;IL12B;IL23R;TNF;IL23A;OCSTAMP;TNFSF11;CCR1;POU4F1;TYROBP
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.28786589742623514,0.7049033227536221,0.8620283018867925,0.9849065920315226,1.0,9/30,28.30%,CHUK;TLR4;UBA52;CD14;TRAF3;UBE2D3;TICAM1;CASP8;CD300LF
prerank,oxoacid metabolic process (GO:0043436),0.2915895449043697,0.7048310230499436,0.8621523579201935,0.9846101990699255,1.0,6/27,21.08%,LIPT2;MIF;BPNT2;SULT4A1;ABHD14B;TPST2
prerank,positive regulation of dephosphorylation (GO:0035306),0.2863039723433912,0.7046214390388649,0.8733572281959379,0.9844666229546913,1.0,8/27,22.96%,SRC;CALM2;PIN1;NSMF;PPIA;SMPD1;PTBP1;ANKLE2
prerank,positive regulation of hydrolase activity (GO:0051345),0.2474476988185614,0.7043327544702993,0.9479591836734694,0.9844098480488777,1.0,22/137,17.39%,CCL8;SGSM2;MAPK12;S100A10;F2R;RASGRF1;NDEL1;RCN3;ASAP3;ADCYAP1;FLCN;CCL25;CALM2;CCL13;PIN1;RHOA;BCAS3;RAPGEF1;EVI5;EVI5L;SRGAP2;ARAP1
prerank,cellular biogenic amine catabolic process (GO:0042402),-0.2753900590216094,-0.7040055877876145,0.8144329896907216,0.9481521619442914,1.0,2/10,9.08%,ALDH7A1;SARDH
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.2895746103392184,0.7035792941886791,0.8550898203592814,0.9848533318054219,1.0,7/26,22.79%,FGF2;F2R;PKD2;HTR2C;IBTK;SLC8B1;HTR2A
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.2545603318508872,0.7023105290447258,0.9196704428424305,0.9858264809307111,1.0,37/94,29.98%,CRIP1;C1QBP;CUL3;GSKIP;ERN1;SELENOK;CEBPB;BAK1;SFN;BBC3;QRICH1;DIABLO;CDKN1A;FHIT;TNFRSF1B;STK24;MLLT11;DDX5;HTRA2;PML;APAF1;MCL1;CUL5;PYCARD;ATF4;CYP1B1;DDIT3;SCN2A;LGALS12;MSH6;PRKDC;HIC1;TOPORS;CUL1;BAX;TP53;AIFM1
prerank,myofibril assembly (GO:0030239),0.2716328016031118,0.7018841030280382,0.8926940639269406,0.985920159475141,1.0,7/42,15.36%,SIX4;CSRP2;FHOD3;CASQ1;PDGFRA;TMOD2;KLHL41
prerank,positive regulation of neuron death (GO:1901216),0.27172889479281653,0.701551236239342,0.8919213973799127,0.9858888547944187,1.0,11/46,22.19%,FYN;TGFB2;TLR4;MAPT;EIF2S1;NUPR1;SARM1;ITGAM;BACE1;NF1;ATF4
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.29441855735982947,0.701391588696206,0.8594327990135635,0.9856830538918369,1.0,3/24,7.86%,FGF2;F2R;PKD2
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.3367478613125887,0.7008611650174901,0.8512960436562074,0.9858726669033783,1.0,4/11,21.20%,UQCRQ;UQCC3;UQCRH;UQCR10
prerank,toll-like receptor 9 signaling pathway (GO:0034162),0.33310875924079525,0.7006540092592524,0.8317107093184979,0.9857166437504676,1.0,7/13,32.05%,IRAK4;IRAK1;EPG5;TNIP2;MYD88;TRAF6;PIK3R4
prerank,cellular response to interleukin-6 (GO:0071354),0.29012189900898355,0.7004679635311377,0.8731707317073171,0.9855421386477476,1.0,6/26,16.30%,SMAD4;SRC;PID1;CBL;FER;IL6
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.25203399462009923,0.699358378116903,0.9246861924686193,0.9863374814351773,1.0,29/85,31.73%,PSMC4;SMURF2;AP2A2;PSMC6;CLTC;FZD7;PARD6A;PSMD8;MAGI2;VANGL2;RHOA;FZD4;DAAM1;TIAM1;SMURF1;AP2M1;PSMD3;DVL1;PSMD4;RAC1;PSMB3;PSMB2;PSMD5;PSMD14;WNT11;PSMC3;PSMC5;AP2A1;PSME4
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.21788589378494178,-0.6986383231185282,0.9158415841584159,0.9524577546960439,1.0,8/23,27.13%,NR1H3;STAT1;PTPN2;PIAS1;PARP9;IRGM;TXK;SOCS1
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.3263782223262803,0.6985279027221485,0.8324396782841823,0.9868064366237908,1.0,3/13,15.83%,IL33;TLR4;SELENOS
prerank,negative regulation of bone mineralization (GO:0030502),0.3257491711827633,0.6980304791302128,0.8467532467532467,0.986969407512002,1.0,1/13,3.05%,ECM1
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.2873000514500188,0.6977081448114018,0.8567990373044525,0.9869407160204932,1.0,4/29,15.34%,LPCAT1;PNPLA8;MBOAT7;PLA2G4E
prerank,regulation of cellular biosynthetic process (GO:0031326),0.29009843771587424,0.6966271989811381,0.8723150357995226,0.9877023069247948,1.0,7/28,13.72%,PRKAB2;CD47;SIRPA;MITF;AVIL;EIF6;TNFRSF1B
prerank,rRNA catabolic process (GO:0016075),-0.2409847307798216,-0.6966251726524805,0.885593220338983,0.9530635133785548,1.0,6/16,24.22%,EXOSC9;DIS3L;DEDD2;DIS3;PELO;EXOSC4
prerank,cilium movement (GO:0003341),0.26702622063153153,0.6965366369409487,0.8803986710963455,0.9874255656855333,1.0,1/47,0.51%,CFAP251
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.3378717306391109,0.6964721010395201,0.8539007092198582,0.9871093849729027,1.0,1/11,2.47%,FYN
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.27796336275613576,0.696234638322493,0.875,0.986989057255039,1.0,3/32,6.21%,F2R;P2RX3;CXCL10
prerank,carboxylic acid transmembrane transport (GO:1905039),0.27461003757163704,0.6961374856301206,0.8806818181818182,0.9867343387885296,1.0,5/40,13.02%,SLC25A21;SLC7A6;ABCC1;SLC23A1;SLC23A2
prerank,nucleoside triphosphate metabolic process (GO:0009141),-0.25806929074830964,-0.6957695445889183,0.8571428571428571,0.9525142920650599,1.0,2/14,5.36%,ENPP1;ENPP3
prerank,regulation of amyloid fibril formation (GO:1905906),0.31435324998282,0.695727679397975,0.8473895582329317,0.9867868215338321,1.0,8/15,26.38%,PSEN1;CHRNA7;PFDN6;IAPP;LDLR;CRYAB;VBP1;PFDN2
prerank,tRNA export from nucleus (GO:0006409),0.279779013562217,0.6952731763157941,0.8795749704840614,0.9865297044973957,1.0,16/32,34.13%,NUP93;NUP107;NUP98;NUP37;NUP50;XPOT;TPR;NUP133;NUP85;NUP188;NUP88;SEC13;AAAS;NUP160;NUP54;RANBP2
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.279779013562217,0.6952731763157941,0.8795749704840614,0.9865297044973957,1.0,16/32,34.13%,NUP93;NUP107;NUP98;NUP37;NUP50;XPOT;TPR;NUP133;NUP85;NUP188;NUP88;SEC13;AAAS;NUP160;NUP54;RANBP2
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.29784515818044655,0.6948607264849257,0.8549618320610687,0.9865724061182993,1.0,5/20,20.82%,ACLY;FAR1;HSD17B8;SCD5;HSD17B4
prerank,regulation of receptor binding (GO:1900120),0.3475961448008492,0.694809372011547,0.843441466854725,0.9862573725903135,1.0,3/10,13.34%,PTPRF;ADAM15;ATP2A2
prerank,aspartate family amino acid catabolic process (GO:0009068),0.3039198489210792,0.6947552019275489,0.8438709677419355,0.9859393108711932,1.0,1/19,0.85%,SLC25A21
prerank,protein alkylation (GO:0008213),0.2973359514381846,0.694508865175914,0.8459657701711492,0.9858205054446237,1.0,9/22,35.24%,PRMT2;GSPT1;SNRPD3;EEF2KMT;CAMKMT;PRMT8;ETF1;EEF1AKMT1;FAM98A
prerank,cellular copper ion homeostasis (GO:0006878),0.3286042935421004,0.6944077203233308,0.8596938775510204,0.985557563385355,1.0,2/14,9.95%,COX19;ARF1
prerank,clathrin coat assembly (GO:0048268),0.3136828529069517,0.6936872946863027,0.8298701298701299,0.985938880626436,1.0,3/15,13.64%,CLTC;CALY;NSG1
prerank,regulation of sister chromatid cohesion (GO:0007063),-0.2584218134081083,-0.6934878539508506,0.8419117647058824,0.9534488967599638,1.0,3/12,14.28%,AXIN2;WAPL;CTNNB1
prerank,peptidyl-lysine monomethylation (GO:0018026),0.3435955862363005,0.6931795977788398,0.8474341192787794,0.9860917870590908,1.0,2/10,11.81%,SETD7;SETD2
prerank,microtubule nucleation (GO:0007020),0.3068747899193686,0.6928954557019519,0.8500635324015248,0.9860089370999217,1.0,6/19,23.11%,NDEL1;SLAIN2;AKAP9;CLASP2;TUBGCP5;TUBG2
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.2524806476262249,0.6927337091890382,0.9208860759493671,0.9858096382332502,1.0,26/76,31.83%,AXIN1;PIAS3;STUB1;UBA2;MYCBP2;CUL3;HDAC3;TNIP1;NDFIP1;HDAC4;ZC3H12A;SAE1;NSMCE3;DERL1;UBE3A;FKBP1A;FBXW7;MUL1;DCUN1D1;BCL10;LAPTM5;SENP2;SPRTN;TRAF6;GSK3A;CDK5RAP3
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.2795865989741885,0.6922542311965261,0.8885017421602788,0.9859338475025757,1.0,8/32,20.62%,FGF13;MAPRE1;CAMSAP1;TUBB4A;FKBP4;NAV3;CLIP3;CLASP2
prerank,cristae formation (GO:0042407),0.28803989383906187,0.6921731506752649,0.8634146341463415,0.9856446956281443,1.0,13/27,29.81%,ATP5PO;ATP5ME;SPG7;UQCC3;APOOL;IMMT;ATP5MC3;DNAJC11;ATP5F1B;LETM1;CHCHD3;ATP5F1A;CHCHD6
prerank,negative regulation of cholesterol transport (GO:0032375),-0.28236992405698863,-0.6921302699722967,0.8351254480286738,0.9534592347795781,1.0,10/10,71.79%,ABCA2;APOC1;SHH;ABCG5;APOA2;PLA2G10;ABCG8;APOC3;SREBF2;NFKB1
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.2803537357377977,0.692114195998982,0.8775029446407538,0.9853369649375432,1.0,7/32,23.74%,HNRNPA1;ACD;CCT7;XRCC5;NEK7;MAPK1;CCT4
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.26174810676474064,0.692111639193183,0.902330743618202,0.9849727401866224,1.0,12/48,23.66%,PAPSS2;AMPD2;SLC25A16;ADCY8;PANK1;SLC26A1;PANK3;DCAKD;ACAT1;NPR2;ADSS2;ADCY2
prerank,ganglioside biosynthetic process (GO:0001574),0.3172299717781138,0.6917334144837648,0.8299866131191432,0.9849887278753067,1.0,1/15,1.20%,ST3GAL2
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.26197576243278753,0.6913782362628941,0.8961038961038961,0.984612137859436,1.0,19/56,28.00%,NDUFS5;TMEM126A;NDUFAF8;NDUFAB1;NDUFAF6;NDUFS1;NDUFB7;NDUFV2;NDUFA2;ACAD9;DMAC2;BCS1L;NDUFB2;DMAC1;NDUFB3;NDUFAF1;NDUFB9;NDUFA13;TIMMDC1
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.26197576243278753,0.6913782362628941,0.8961038961038961,0.984612137859436,1.0,19/56,28.00%,NDUFS5;TMEM126A;NDUFAF8;NDUFAB1;NDUFAF6;NDUFS1;NDUFB7;NDUFV2;NDUFA2;ACAD9;DMAC2;BCS1L;NDUFB2;DMAC1;NDUFB3;NDUFAF1;NDUFB9;NDUFA13;TIMMDC1
prerank,negative regulation of MAP kinase activity (GO:0043407),0.26574089336489215,0.691287000599837,0.9124579124579124,0.9843313382746458,1.0,4/44,5.35%,UCHL1;IRAK3;AIDA;PTPRJ
prerank,regulation of RIG-I signaling pathway (GO:0039535),0.3047366299028747,0.6904545033779445,0.8578616352201258,0.9847640608909517,1.0,4/18,16.43%,C1QBP;PUM1;NOP53;SEC14L1
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.32083642676210405,0.690450920196514,0.8559892328398385,0.9844033849390404,1.0,5/13,17.32%,FUT9;IRAK1;RHOA;IL6;ZDHHC21
prerank,folic acid-containing compound metabolic process (GO:0006760),-0.23154560513009442,-0.6903992303606244,0.9090909090909091,0.9538255100394746,1.0,9/19,32.19%,MTHFS;ALDH1L1;SLC19A1;SHMT2;MTHFR;FPGS;SHMT1;ALDH1L2;MTHFD1L
prerank,phosphate ion transmembrane transport (GO:0035435),0.3274811797530922,0.6897874777101615,0.847457627118644,0.9847463910078336,1.0,4/12,21.28%,SLC37A3;SLC25A3;SLC20A1;SLC37A4
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.2977085763267848,0.6893975753232714,0.8557336621454994,0.9847707063039005,1.0,5/19,20.96%,DYRK2;RPS27L;BCL3;PML;PYCARD
prerank,modulation of chemical synaptic transmission (GO:0050804),0.24554752217675058,0.6881540157097294,0.9421487603305785,0.9856685767589375,1.0,33/107,26.07%,CEL;SLC4A8;DLG4;DLGAP4;STX1B;NRG3;DLGAP3;HCRT;LGI1;PXK;BTBD9;SLC8A2;DLGAP1;CNTNAP4;GRID1;GRM1;CHRNA7;SYT1;AKAP9;RIMS2;CLSTN3;PTEN;NMU;GRIK5;GRIK2;NPTX1;DGKI;BCR;GRIK4;BAIAP3;GRM5;BEGAIN;EIF4EBP2
prerank,stress-activated MAPK cascade (GO:0051403),0.2552177865497404,0.6869962828761504,0.8995726495726496,0.9864804714920542,1.0,17/61,24.27%,MAPK14;ZFP36L1;MAP2K3;UBE2N;CHUK;MAPK11;IRAK1;UBA52;ZFP36;TAOK2;MAP2K4;MAPK1;TAB2;FBXW11;MAP3K7;TNIP2;GPS1
prerank,regulation of primary metabolic process (GO:0080090),0.24288033487225041,0.6865646088011551,0.940755873340143,0.9865534117080618,1.0,21/126,16.33%,PSMC4;NR1D2;MVK;PRKAB2;NR1D1;PSMC6;PLPP1;SIN3B;CHD9;PSMD8;GGPS1;ODC1;HELZ2;HDAC3;IRS2;TGS1;NCOR2;NCOR1;BBS4;PMVK;OPA3
prerank,cellular protein-containing complex assembly (GO:0034622),0.24209645015628278,0.6865611463371835,0.967741935483871,0.9861899972440688,1.0,40/159,25.43%,BIN1;SMAD4;AXIN1;HOPX;NUP93;PSMG2;AHCTF1;CENPT;VAMP1;SRC;SRP19;NUP107;CLTC;ADRM1;NUP98;MAPT;TBCEL;CALY;NSG1;CASQ1;DNAAF3;HSP90AA1;CENPC;NCK1;PFDN6;VAMP2;CENPE;TIAM1;VAMP4;TPR;FKBP1A;AP2M1;NCK2;EIF4H;RAB5IF;RTN4;PSMD4;NDUFAF1;VBP1;FCHO2
prerank,DNA integrity checkpoint signaling (GO:0031570),0.2737677867732291,0.6865405663713403,0.8727064220183486,0.9858419535363335,1.0,9/36,23.62%,TIPIN;RHNO1;RAD1;DNA2;BRIP1;NBN;DONSON;CLSPN;TIPRL
prerank,atrial cardiac muscle cell action potential (GO:0086014),0.3255082479580521,0.6858389355645493,0.8655913978494624,0.9862209162114963,1.0,2/13,13.35%,ANK2;KCNJ3
prerank,acylglycerol homeostasis (GO:0055090),0.2969944354751003,0.6851734961890301,0.8707653701380176,0.9865198362675245,1.0,6/20,22.61%,MLXIPL;PNPLA8;IL18;LIPC;ANGPTL3;RORA
prerank,negative regulation of dephosphorylation (GO:0035305),0.2966550969840201,0.6847892946673739,0.8535353535353535,0.9865279790506245,1.0,8/18,28.88%,INPP5K;URI1;CHP1;SH2D4A;YWHAB;PPP1R26;PTPA;GPATCH2
prerank,positive regulation of ion transport (GO:0043270),0.26205012794491095,0.68433645513016,0.898360655737705,0.9866197677802792,1.0,3/48,3.19%,FHL1;ANK2;F2R
prerank,regulation of protein localization to cell surface (GO:2000008),0.27611042149964143,0.6841399650964726,0.8990498812351544,0.9864473466445112,1.0,12/33,28.93%,RAB11FIP5;TOR1A;STX4;EGF;GOPC;STX3;MAP1A;LEPROT;GBF1;SNX33;RANGRF;TM9SF4
prerank,positive regulation of phagocytosis (GO:0050766),0.25853755802947226,0.6838520518359682,0.8893805309734514,0.9863564906324507,1.0,5/47,10.21%,PTPRJ;GAS6;CD47;SIRPA;C4B
prerank,cellular amino acid catabolic process (GO:0009063),0.24797212649573697,0.6836720944308915,0.9279749478079332,0.9861434113670682,1.0,11/87,15.42%,AMDHD1;SLC25A21;HAL;BCAT1;AUH;HIBADH;GLS2;GLS;CRYM;ALDH5A1;GLUD1
prerank,sensory perception of taste (GO:0050909),0.3403586497211163,0.6834389907162862,0.8495702005730659,0.9860097160371907,1.0,2/10,20.32%,ASIC2;ASIC1
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.2486128190837816,0.6825198878842066,0.9307450157397692,0.9865405152089792,1.0,21/76,25.85%,AXIN1;COP1;STUB1;SIRT2;DNAJB2;USP5;NOP53;RNF14;ZER1;KEAP1;ARIH2;RNF19A;ARIH1;PTEN;SMURF1;ZYG11B;DVL1;MDM2;FBXO22;FBXW7;CSNK1E
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.2854013773733106,0.6819144136996208,0.8623188405797102,0.9867481609526179,1.0,4/24,10.96%,PKD1;RHBDF1;UCHL5;GPX1
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.24254513988307896,0.6816508650727087,0.9362795477903392,0.9866519902121611,1.0,14/104,15.61%,LRP6;GTPBP4;ETAA1;SRC;SYAP1;AKT1;PPEF2;CALM2;CDKN1A;CCND1;RHOA;SLC8A2;CCNH;MAP2K2
prerank,response to interferon-gamma (GO:0034341),0.24954190036592683,0.6815420050938,0.9287234042553192,0.9863862169001261,1.0,8/67,12.91%,CCL8;CYP27B1;CCL25;TLR4;CD47;SIRPA;SLC26A6;CCL13
prerank,regulation of potassium ion transport (GO:0043266),0.27791212843347674,0.6813489872215207,0.8740068104426788,0.9862126017926052,1.0,2/31,2.71%,FHL1;ANK2
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.245512921224912,0.681258724920953,0.9260823653643083,0.985941821171383,1.0,5/75,5.35%,LRP6;UCHL1;HEG1;IRAK3;PTPRJ
prerank,cardiac conduction system development (GO:0003161),0.2910529046087649,0.6811879058592499,0.8696711327649208,0.9856479985062182,1.0,3/24,10.05%,SMAD4;SMAD5;HCN4
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.3068208988717543,0.6808410792623943,0.8699080157687253,0.9856235397584361,1.0,2/16,13.94%,CLDN10;CLDN12
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.2477081649165894,0.6807869891595943,0.9113924050632911,0.9853182599363791,1.0,11/73,12.87%,EIF2AK3;F2R;S100A8;S100A9;MTCH1;PDCD2;MAPT;ANP32B;BBC3;DIABLO;RPS27L
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.2895119651286942,0.6792814865545255,0.871571072319202,0.9860411995771364,1.0,5/23,15.08%,SMAD4;RNF111;FLCN;SLC2A10;GIPC1
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.2895119651286942,0.6792814865545255,0.871571072319202,0.9860411995771364,1.0,5/23,15.08%,SMAD4;RNF111;FLCN;SLC2A10;GIPC1
prerank,metallo-sulfur cluster assembly (GO:0031163),-0.21909496536989045,-0.6785262630030384,0.9230769230769231,0.9636848954148413,1.0,6/22,16.28%,NUBPL;HSPA9;CIAO1;NFU1;ISCU;NDOR1
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.27077230107843914,0.6782919057973208,0.8809801633605601,0.9866351521823498,1.0,6/34,13.54%,BTC;CUL3;CDC23;ANAPC5;EGF;CDC27
prerank,phosphate ion transport (GO:0006817),0.3051269667836738,0.6782766020786352,0.8689189189189189,0.9862889202220603,1.0,4/16,21.28%,SLC37A3;SLC25A3;SLC20A1;SLC37A4
prerank,regulation of lipid metabolic process (GO:0019216),0.24595393827251372,0.6781934273226061,0.9394572025052192,0.9860057123883549,1.0,17/88,16.33%,NR1D2;MVK;NR1D1;PLPP1;SIN3B;CHD9;GGPS1;HELZ2;HDAC3;IRS2;MBOAT7;TGS1;NCOR2;NCOR1;BBS4;PMVK;OPA3
prerank,response to glucose (GO:0009749),0.259047157632525,0.6780965114979662,0.9134720700985761,0.9857480252532459,1.0,10/46,19.83%,SLC39A14;TCF7L2;GAS6;ERN1;IRS2;ADCY8;SELENOS;VAMP2;GPLD1;EIF2B1
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.24546819973029535,0.677460816328267,0.9365244536940687,0.9860083512438674,1.0,23/85,25.85%,TMEM259;COP1;PSMC6;STUB1;SIRT2;DNAJB2;USP5;NUPR1;NOP53;RNF14;ZER1;KEAP1;ARIH2;RNF19A;ARIH1;TMTC3;USP13;ZYG11B;DVL1;MDM2;FBXO22;FBXW7;CSNK1E
prerank,calcium ion transmembrane transport (GO:0070588),0.2455349242380755,0.67678516227098,0.927159209157128,0.986311592394922,1.0,26/86,26.25%,PKD1;TRPV3;ATP2B4;GRIN2D;GAS6;PKD2;MCU;ITGAV;SLC35G1;MCUB;ATP2A2;SLC8A2;TRPC4AP;TMEM165;GRIN2A;SPG7;ATP2B1;SLC8B1;FKBP1A;PARL;TRPC1;CACNA2D1;TRPV2;TMCO1;SLC24A4;SLC24A2
prerank,cellular response to catecholamine stimulus (GO:0071870),0.2859886568372911,0.676783732976124,0.8754578754578755,0.9859508018236176,1.0,7/23,22.19%,ATP2B4;SIRT2;SLC9A1;GNB1;MAPK1;GABPA;ATF4
prerank,inner dynein arm assembly (GO:0036159),0.33000690391012366,0.6747132701233156,0.876750700280112,0.9875902278117671,1.0,10/10,67.02%,DNAAF5;CCDC39;CFAP73;ZMYND10;DNAI3;DNAAF1;DNAH1;DNAAF4;CCDC40;CFAP100
prerank,positive regulation of defense response (GO:0031349),0.24484677407285957,0.674496892188012,0.9453044375644994,0.9874299374808702,1.0,16/89,19.46%,IL16;S100A8;S100A9;IL33;IL17RA;TLR4;CD47;POLR3D;TNIP1;AKIRIN2;ABCC1;SLC15A4;PDCD4;IL18;IFI35;LRSAM1
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.25366593532503406,0.6743250943142458,0.9130434782608695,0.9872288559401718,1.0,9/53,17.26%,EGFR;EYA2;UBE2N;TIGAR;ABRAXAS1;NACC2;DDX5;FXR2;EEF1E1
prerank,regulation of p38MAPK cascade (GO:1900744),0.26345464286628195,0.6741574072307821,0.8942528735632184,0.9870442793978284,1.0,5/35,16.20%,GADD45G;VEGFA;EMC10;ZC3H12A;PER1
prerank,peptidyl-lysine trimethylation (GO:0018023),0.284681248929916,0.6722150016570629,0.8700834326579261,0.988500322960521,1.0,8/26,20.13%,SETD2;ANTKMT;SETD5;OGT;EEF2KMT;PRDM9;SETD1B;KMT2A
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),0.3340962454500728,0.6721737220269763,0.8688981868898187,0.988180387439214,1.0,3/10,27.82%,CCT7;CCT4;CCT6A
prerank,regulation of transposition (GO:0010528),0.314655577657639,0.6721216177261002,0.8584905660377359,0.9878706321150404,1.0,3/13,22.64%,SPOCD1;DDX4;UBR2
prerank,"transcription, DNA-templated (GO:0006351)",0.23598783131620826,0.671907753082529,0.9839195979899498,0.9877017143292184,1.0,48/207,23.87%,NFIX;POLR2H;GTF2H3;ABT1;PAX1;BRF2;PPP5C;CDK9;SOX5;TAF3;DDX21;UBTF;ERCC3;GTF3C2;POLR2D;POLR2G;BCL3;GTF2A2;CCNH;EAF2;CTDP1;BRF1;GTF2F1;BTF3;NFE2L3;EAF1;DDX5;POLR3H;TCEA2;HIPK3;GTF2E2;POLR1C;MBD1;PAF1;SLC25A33;LHX1;ATF4;RNMT;POLR3A;BAZ2A;SMN1;ELL;TBP;TAF13;GTF3C5;NCOA6;TRIM24;RTF1
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.2416756790294717,0.6707629753193352,0.93521421107628,0.9883833745114678,1.0,22/84,28.26%,PSMC4;PSMC6;PSMD8;CUL3;CDC23;ANAPC5;FBXO5;FBXO31;UBA52;CDC27;CDC26;ANAPC4;SKP2;ANAPC10;ANAPC15;ECRG4;PSMD3;PSMD4;PSMB3;ANAPC2;PSMB2;PSMD5
prerank,histone H3-K4 trimethylation (GO:0080182),0.3280577637745138,0.6705424971136366,0.858887381275441,0.9882349721522125,1.0,6/11,31.07%,OGT;PRDM9;SETD1B;KMT2A;SETD1A;TET3
prerank,regulation of cation transmembrane transport (GO:1904062),-0.20266081750647075,-0.6700718531405493,0.968,0.9697408845252274,1.0,3/29,4.69%,KCNIP3;DLG1;CACNA1D
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.2665158794711323,0.6688153487672016,0.9030023094688222,0.9894571923492886,1.0,7/35,23.74%,HNRNPA1;ACD;CCT7;XRCC5;NEK7;MAPK1;CCT4
prerank,liver development (GO:0001889),0.2667475895007691,0.667151508580388,0.8822143698468787,0.9906185984476912,1.0,4/32,11.24%,ANXA1;COBL;PKD2;CEBPB
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),-0.2629345448350086,-0.6667947555481767,0.8796992481203008,0.97115386325266,1.0,4/11,17.97%,CAV1;PTPRT;NF2;ADIPOR1
prerank,sterol transport (GO:0015918),0.29640080706217187,0.6664174257744839,0.8796068796068796,0.9909352610390953,1.0,2/19,8.69%,OSBPL2;LCAT
prerank,negative regulation of binding (GO:0051100),0.24224927329629264,0.6656668876360812,0.9356540084388185,0.9912555895268583,1.0,15/81,16.80%,DACT1;GTPBP4;GNL3L;CARD16;TFIP11;USP33;AKT1;SLPI;DNAJB2;CDKN1A;PIN1;DDX11;GTF2F1;ILRUN;TFAP4
prerank,negative regulation of DNA metabolic process (GO:0051053),0.28031807602742825,0.6654847691077898,0.8819875776397516,0.9910632004478869,1.0,10/24,27.51%,ERCC4;XRCC5;CDKN1A;BLM;KMT2A;TERF2IP;ERCC1;H1-0;MSH6;DFFA
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.2492564821571659,0.6653542488882863,0.9135667396061269,0.9908100568996309,1.0,10/54,16.87%,TRIAP1;MUC1;MDM4;SFN;CDKN1A;CNOT3;CNOT10;PLAGL1;TNKS1BP1;PML
prerank,folic acid metabolic process (GO:0046655),-0.22338965226697577,-0.6644658302643511,0.9344978165938864,0.9717228239624982,1.0,9/18,32.19%,MTHFS;ALDH1L1;SLC19A1;SHMT2;MTHFR;FPGS;SHMT1;ALDH1L2;MTHFD1L
prerank,cilium-dependent cell motility (GO:0060285),-0.22270436270663466,-0.6642708783168642,0.9387755102040817,0.9705409066114494,1.0,12/22,34.87%,CFAP44;EFHC2;DNAH2;GAS8;RSPH9;DNAH3;DRC1;CCDC65;DNAAF2;TEKT2;DNAH17;CFAP54
prerank,response to light stimulus (GO:0009416),0.2520197495417131,0.6639808927440116,0.9263736263736264,0.9917122642788951,1.0,19/55,31.29%,UBE2B;DTL;ERCC3;UBE2A;ERCC4;PCLAF;UVSSA;ERCC5;TYR;POLD1;OPN3;REV1;CRY2;MSH6;MEN1;SPRTN;DRD2;COPS3;CIRBP
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.23584217296622229,0.663561635586438,0.9571428571428572,0.9917438632163473,1.0,37/109,31.14%,SYK;PSMC4;PIK3R2;NFATC1;PSMC6;CHUK;PIK3CA;PSMD8;FER;PPP3CA;SOS1;MAP2K4;CARD11;PPP3CB;MAPK1;GAB2;TAB2;JUN;FBXW11;MAP3K7;VAV2;RELA;PSMD3;PSMD4;RAC1;PSMB3;BCL10;PSMB2;NFKB1;PSMD5;CUL1;FOS;PSMD14;TRAF6;PSMC3;PSMC5;CALM1
prerank,monocarboxylic acid metabolic process (GO:0032787),0.23516963987741857,0.6627821926673206,0.9662231320368475,0.9921142387346645,1.0,22/117,20.07%,CYP2S1;ACOT6;CPT1C;ALKBH7;SLC6A8;SCP2;HAGH;PTGR1;PDHX;FA2H;PNPLA8;GBA2;GAMT;ALDH1A3;ACOT1;VDAC1;PDHA1;BTD;GPAM;ANGPTL3;SCPEP1;LDHA
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.32970901903730737,0.662461654978755,0.8705547652916074,0.9920374897036802,1.0,6/10,33.35%,DBF4;INO80;E2F7;ATRX;WIZ;CDC7
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.3146431156868283,0.6622135097654217,0.8653061224489796,0.9919099076900666,1.0,1/12,8.30%,ZBTB1
prerank,modulation of excitatory postsynaptic potential (GO:0098815),0.27613341407553516,0.6605903461586683,0.9093078758949881,0.9929962425026332,1.0,12/26,31.31%,DLG4;STX1B;SLC8A2;CHRNA7;RIMS2;PTEN;PRKCZ;NLGN1;NLGN3;NRXN1;CBLN1;NLGN2
prerank,organic cation transport (GO:0015695),0.2873204426267302,0.6600224149656941,0.8781725888324873,0.9931258417975987,1.0,4/20,17.47%,SLC47A1;SLC44A1;SEC14L1;SLC44A2
prerank,2-oxoglutarate metabolic process (GO:0006103),-0.2460829405077594,-0.6589959362396964,0.9007936507936508,0.9733519542638216,1.0,5/13,19.98%,PHYH;OGDH;ADHFE1;DLST;IDH2
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.2530622231811303,0.6588282423961392,0.9084895259095921,0.9938095714144423,1.0,8/44,15.72%,OSBPL3;OSBPL2;INSIG2;SCP2;HSD3B7;OSBPL6;PSAT1;PMVK
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.23868897490676474,0.6583241177173713,0.9610526315789474,0.9939031394457559,1.0,30/88,31.73%,PSMC4;PSMC6;FBXO2;PSMD8;FBXO17;FBXL2;FBXW4;FBXL20;FBXO31;FBXL3;DMAC2;FBXL5;SKP2;CUL5;FBXW11;FBXO38;PSMD3;FBXL12;PSMD4;FBXW7;PSMB3;PSMB2;PSMD5;CUL1;FBXL8;PSMD14;PSMC3;PSMC5;FBXL13;PSME4
prerank,phagosome acidification (GO:0090383),0.2783328974951663,0.6581024592922767,0.8941034897713598,0.9937373662990802,1.0,5/26,16.13%,ATP6V0A2;ATP6V1E1;ATP6V0A1;ATP6V1D;ATP6V1B2
prerank,protein acetylation (GO:0006473),0.2686512847369131,0.6580582691982552,0.8985507246376812,0.9934098591846432,1.0,6/30,18.80%,FOXO1;KAT2B;ING4;MAPT;NAA15;NAA50
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.27608102006015856,0.6580446171445664,0.8938053097345132,0.993060382918327,1.0,6/22,24.14%,INHA;INPP5K;CDKN1A;CDKN2C;ANKLE2;DYNLL1
prerank,rRNA metabolic process (GO:0016072),0.22919553820222435,0.6579578944224375,0.973816717019134,0.9927742345004282,1.0,35/160,23.68%,C1D;DDX49;FCF1;ESF1;HELQ;EXOSC7;RRP36;RPL10A;WDR46;MAPT;UBA52;SBDS;MPHOSPH10;RCL1;SNU13;NOLC1;DCAF13;RRP7A;EXOSC1;RPL6;NOP53;DDX52;POP4;PWP2;EBNA1BP2;TBL3;RPL23;RPL17;PDCD11;KRR1;RPS25;WDR18;NOC4L;TEX10;RRP1B
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.2658322038369605,0.6579223875797443,0.8929804372842347,0.9924544789249697,1.0,6/31,12.73%,YWHAG;YWHAE;PPP3CC;BAK1;SFN;BBC3
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.3066259528524922,0.657228593595019,0.8703208556149733,0.9927064334759297,1.0,3/13,26.16%,ALG1;SRD5A3;MPDU1
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.3086963845570531,0.6570963140136121,0.8743169398907104,0.9924633152262253,1.0,4/13,21.08%,BPNT2;SULT4A1;ABHD14B;TPST2
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",0.29928504458656746,0.6566830951243662,0.8837516512549538,0.992475469411897,1.0,7/15,33.06%,CNTNAP4;BAIAP3;NPAS4;NLGN1;DRD2;NLGN2;ZDHHC3
prerank,negative regulation of histone modification (GO:0031057),0.3046481708520892,0.6565124009450415,0.8817204301075269,0.9922642669046885,1.0,4/14,20.03%,NOC2L;TWIST1;SET;CTBP1
prerank,glycogen catabolic process (GO:0005980),0.29777164904982034,0.6558665682059596,0.8900523560209425,0.9924846324813923,1.0,8/15,31.14%,PHKA2;PGM2L1;GAA;PYGB;PHKA1;RB1CC1;PHKG1;CALM1
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.29168017788661976,0.6558273692943679,0.8973042362002568,0.9921593507135353,1.0,10/18,38.07%,CCT7;CCT4;EXOSC10;CCT6A;NHP2;RUVBL1;RUVBL2;TCP1;PARN;CCT8
prerank,macrophage migration (GO:1905517),-0.24934729960252885,-0.6554829519809536,0.8976377952755905,0.974810262060395,1.0,6/13,35.45%,EDNRB;TAFA4;CCR2;CCL2;CXCL17;CCL5
prerank,positive regulation of protein ubiquitination (GO:0031398),0.23741708784015916,0.6554562936080124,0.9425287356321839,0.9921192467694814,1.0,9/80,13.18%,SPSB4;AXIN1;STUB1;MYCBP2;UBE2N;CUL3;HDAC3;NDFIP1;PIN1
prerank,negative regulation of secretion (GO:0051048),0.3216841899801818,0.6548097875950114,0.861812778603269,0.9923194059254885,1.0,2/10,12.38%,SPX;EGF
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.2885162857168615,0.6540658106551555,0.8876262626262627,0.9925819145569905,1.0,5/19,17.16%,BIN1;PIN1;RTN3;FLOT2;CHRNA7
prerank,cellular response to unfolded protein (GO:0034620),0.2753280503815955,0.6538999745237031,0.9071680376028202,0.992379555325315,1.0,10/26,29.97%,HSPA13;ERN1;BAK1;HSPA14;ABCB10;BAG3;TM7SF3;BAX;HSPA8;HSF1
prerank,meiosis I (GO:0007127),0.2751809426882149,0.6537753969315558,0.9031862745098039,0.9921313827191641,1.0,3/23,18.65%,SLC25A31;DDX4;FOXJ2
prerank,regulation of mitotic nuclear division (GO:0007088),0.24615232839649898,0.6535046746817834,0.9331896551724138,0.9920096456830685,1.0,9/55,15.78%,BTC;CCDC8;AURKAIP1;KIF20B;FBXO5;EGF;PIN1;CUL9;CDK5RAP2
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.320301727330058,0.6533231727433421,0.8893557422969187,0.9918024540567145,1.0,2/10,17.23%,ZNHIT6;NUFIP1
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.24412370554339224,-0.653038918895595,0.8740458015267175,0.9752799986795309,1.0,4/13,14.83%,YAE1;CIAO1;NFU1;GLRX3
prerank,steroid catabolic process (GO:0006706),-0.2619627270296358,-0.6519090306831337,0.8719723183391004,0.9746957196224186,1.0,2/10,10.30%,YWHAH;SPP1
prerank,negative regulation of chemokine production (GO:0032682),0.30037028674413413,0.6509388730798399,0.8803301237964236,0.9934647539995703,1.0,3/14,16.30%,SIRPA;KLF4;IL6
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.31854591721586895,0.65041100431698,0.8756983240223464,0.993556369209372,1.0,2/11,15.12%,SLC25A4;NUPR1
prerank,negative regulation of blood pressure (GO:0045776),0.30552344221871164,0.6502907987113052,0.8657105606258149,0.9932970131851212,1.0,3/13,19.32%,PRCP;GPR37L1;SCPEP1
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.2591788595689591,0.6499793710644322,0.9299655568312285,0.9932174345509729,1.0,5/39,12.02%,FHL1;ANK2;FXYD5;YWHAE;STK39
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.27859459384366964,0.6499462949610642,0.9108040201005025,0.9928943468391225,1.0,5/23,25.00%,CNGB1;SAG;METAP2;METAP1;CAMKMT
prerank,negative regulation of lipid catabolic process (GO:0050995),0.28576540650447413,0.6497692819359127,0.8875816993464052,0.992690432954021,1.0,3/17,19.54%,AKT1;PDE3B;GPLD1
prerank,negative regulation of cell cycle process (GO:0010948),0.24480108693740152,0.6496028887364279,0.9351063829787234,0.9924705799633797,1.0,15/61,22.15%,RNF2;AURKAIP1;RYBP;PHC3;PHC1;FBXO5;TERF1;EHMT2;CCP110;UXT;APAF1;RING1;PCGF6;FOXO4;EZH2
prerank,tRNA transport (GO:0051031),0.2565818554363227,0.6488493542494936,0.9252873563218391,0.9927371421178209,1.0,11/35,27.02%,NUP93;NUP107;NUP98;NUP37;NUP50;XPOT;TPR;NUP133;NUP85;NUP188;NUP88
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),0.31886899489908105,0.648744426004539,0.8771676300578035,0.9924723520261601,1.0,3/10,16.54%,FLCN;SETD5;DIP2A
prerank,negative regulation of protein ubiquitination (GO:0031397),0.2462583839188876,0.6486149158806613,0.9435396308360477,0.9922234721761897,1.0,16/50,29.17%,GTPBP4;GNL3L;USP4;SQSTM1;AKT1;FBXO5;CHP1;OGT;UFL1;U2AF2;ARRB1;BAG5;PRKCG;DNAJA1;HDAC8;SENP2
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.24558327655106066,0.6485884094469428,0.9405405405405406,0.9918899169951629,1.0,10/54,19.22%,GTPBP4;GNL3L;PIAS3;USP4;SQSTM1;AKT1;CHP1;OGT;UFL1;U2AF2
prerank,inositol phosphate biosynthetic process (GO:0032958),0.31592829898740504,0.6483297168397336,0.8837209302325582,0.9917513830595092,1.0,3/11,20.20%,FGF2;IPPK;IP6K1
prerank,regulation of telomerase activity (GO:0051972),0.251142519830985,0.6482095305579717,0.9217002237136466,0.9914960524268293,1.0,10/45,21.04%,SRC;ACD;ERCC4;XRCC5;TERF1;KLF4;HSP90AA1;SMG6;NEK7;MAPK1
prerank,Fc receptor signaling pathway (GO:0038093),0.23053314908207362,0.6481153626639568,0.963265306122449,0.9912238133566613,1.0,37/110,31.14%,SYK;PSMC4;PIK3R2;NFATC1;PSMC6;CHUK;PIK3CA;PSMD8;FER;PPP3CA;SOS1;MAP2K4;CARD11;PPP3CB;MAPK1;GAB2;TAB2;JUN;FBXW11;MAP3K7;VAV2;RELA;PSMD3;PSMD4;RAC1;PSMB3;BCL10;PSMB2;NFKB1;PSMD5;CUL1;FOS;PSMD14;TRAF6;PSMC3;PSMC5;CALM1
prerank,protein targeting to ER (GO:0045047),0.23198452107349482,0.6478888650258385,0.9628865979381444,0.9910507990316206,1.0,12/99,15.51%,RPSA;EDEM1;SPCS1;SRP19;SRP9;RPL10A;UBA52;RPS5;SGTA;SEC63;SEC61A1;RPL6
prerank,peptidyl-arginine modification (GO:0018195),0.29205296737120295,0.6471761952017366,0.8928571428571429,0.9912927052248343,1.0,5/15,31.65%,ART4;PADI2;KRTCAP2;PRMT8;PRMT7
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.2698679118982485,0.6465565042406689,0.9138755980861244,0.9914574316841647,1.0,11/28,31.83%,AXIN1;PSMC6;NUPR1;PTEN;TMTC3;SMURF1;FBXW7;LAPTM5;PSMC3;PSMC5;CDK5RAP3
prerank,phosphatidylglycerol metabolic process (GO:0046471),0.27188381732002964,0.6458745544546726,0.905683192261185,0.9916613997140034,1.0,5/24,25.86%,LPCAT1;PNPLA8;GPAM;SLC27A1;PGS1
prerank,polyol biosynthetic process (GO:0046173),0.2873327411462468,0.645857206198622,0.8922686945500634,0.9913175141428011,1.0,4/16,20.20%,FGF2;CYP27B1;IPPK;IP6K1
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.2858101887111487,0.6457040015341262,0.8887434554973822,0.991080384162494,1.0,3/17,12.63%,MTOR;MAGI2;CALM2
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.25923058560470863,0.6453578876027054,0.9118993135011442,0.9910215710827297,1.0,7/32,20.96%,DYRK2;RPS27L;BCL3;FHIT;DDX5;PML;PYCARD
prerank,histone H4 acetylation (GO:0043967),0.24914688250352385,0.6448259376952306,0.932967032967033,0.9911109706762968,1.0,12/47,20.88%,MSL2;MSL3;ING4;MSL1;WDR5;KANSL3;DMAP1;PER1;OGT;MORF4L1;KMT2A;TRRAP
prerank,protein-DNA complex assembly (GO:0065004),0.23082422508162415,0.6446983032892735,0.9681069958847737,0.9908588713160478,1.0,19/116,17.52%,PSMC4;GTF2H3;CHAF1B;RAD23B;PSMC6;SPTY2D1;PSMD8;MCM3;NPM1;ERCC3;UBA52;ANP32B;DDB1;CCNH;ORC6;GMNN;GRWD1;NAP1L2;ERCC5
prerank,membrane lipid catabolic process (GO:0046466),0.3160638447486576,0.644544727306313,0.8836565096952909,0.9906274592257038,1.0,3/10,27.12%,PDXDC1;CYP1B1;PPT1
prerank,chromatin remodeling at centromere (GO:0031055),0.26411546447363304,0.6445058162504638,0.914792899408284,0.9903079621431068,1.0,4/31,15.93%,CENPT;HJURP;NPM1;CENPC
prerank,negative regulation of nuclear division (GO:0051784),0.31463141735702593,0.6441692766393747,0.8638814016172507,0.9902147990701791,1.0,2/11,11.80%,AURKAIP1;FBXO5
prerank,ceramide catabolic process (GO:0046514),-0.2357138557668979,-0.6435799671501686,0.88,0.9796213791441605,1.0,1/14,2.35%,ACER2
prerank,regulation of feeding behavior (GO:0060259),-0.2577511353871081,-0.6433970818024907,0.9054545454545454,0.9783818002556387,1.0,3/11,21.72%,SGIP1;CFAP20;NR4A3
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.2281953561426211,0.6430663545871674,0.9808080808080808,0.9907483903615593,1.0,37/148,24.95%,MAPK14;MTOR;PRKAB2;MDM4;NOC2L;RHNO1;MAPK11;BRD7;DYRK2;TAF3;RMI1;AKT1;RAD1;PIN1;DNA2;BRIP1;EHMT2;NBN;USP7;NOP53;RFC4;CHD3;PML;PIP4P1;RAD50;RPF2;BLM;TTC5;RPL23;PIP4K2B;NOP2;CSNK2A2;TBP;TAF13;HEXIM1;MDM2;KAT5
prerank,receptor clustering (GO:0043113),0.2673751896133874,0.6429102555042278,0.9081015719467956,0.9905235963920512,1.0,11/27,28.16%,DLG4;DLG2;MUSK;MAGI2;DNAJA3;SYNJ2BP;FLNA;PICK1;DVL1;LRRC7;NLGN1
prerank,mature B cell differentiation involved in immune response (GO:0002313),-0.24598197523102316,-0.6427037243687818,0.8901098901098901,0.9775311425140591,1.0,5/12,25.85%,MFNG;GPR183;DOCK10;FCGR2B;DLL1
prerank,nucleic acid-templated transcription (GO:0097659),0.2537975524468752,0.6424110393920933,0.9217877094972067,0.9905845006044035,1.0,5/42,13.23%,POLR2H;PPP5C;POLR2D;POLR2G;BCL3
prerank,cellular response to mechanical stimulus (GO:0071260),0.24317486542075437,0.6423921205026171,0.9301552106430155,0.9902461681533404,1.0,5/46,12.14%,PIEZO2;TLR5;TLR4;SLC9A1;BAK1
prerank,regulation of histone acetylation (GO:0035065),0.2584385108540755,0.6423737787817406,0.9148936170212766,0.989910504519469,1.0,9/33,21.51%,NOC2L;FLCN;BRD7;SETD5;SET;GLYR1;CTBP1;KMT2A;ARRB1
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.2552729579851973,0.6417382923049207,0.9304245283018868,0.9900550871092023,1.0,12/36,30.33%,AXL;GAS6;PARP14;CXCR4;CPNE1;CSF1;TRIM44;UBE2K;LAPTM5;CD300LF;AGPAT2;ADAM17
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.2683555966614076,0.6415026465548435,0.9146341463414634,0.9898894926368643,1.0,5/27,15.34%,PLAAT1;CHKB;PNPLA8;CEPT1;PLA2G4E
prerank,regulation of neurogenesis (GO:0050767),0.24338798714185095,0.6413175628584583,0.9369469026548672,0.9896942322910192,1.0,4/55,8.12%,NUMBL;BHLHE40;DOCK7;SERPINF1
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.24244564131655638,0.6412420810887813,0.9268817204301075,0.9893983660779302,1.0,19/56,29.89%,SON;RHOA;BBS4;TTC19;SPTBN1;RAB35;CIT;RASA1;PDCD6IP;SEPTIN9;TRIM36;IST1;BIN3;SNX18;SNX33;CUL7;MYH10;INCENP;CKAP2
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.23484117563402487,0.6412147262953433,0.9543039319872476,0.9890629118255285,1.0,7/74,9.06%,PSMC4;VEGFA;NFE2L2;PSMC6;EGLN2;PSMD8;SIRT2
prerank,negative regulation of innate immune response (GO:0045824),0.256677764904238,0.6409663483135949,0.919047619047619,0.9889062105938513,1.0,7/34,22.59%,IRAK3;SAMHD1;SERPING1;YTHDF2;TYRO3;YTHDF3;STAT2
prerank,action potential (GO:0001508),0.2491663221023069,0.6403949198382188,0.9292929292929293,0.9890183336365647,1.0,5/44,10.51%,SRI;SLC4A3;KCNJ2;MYH14;KCNA2
prerank,leukotriene metabolic process (GO:0006691),0.28173598869415395,0.6398003344222395,0.8883116883116883,0.989127956763817,1.0,3/19,12.71%,DPEP1;PTGR1;ABCC1
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.23745601763870094,0.6390520635872348,0.9401069518716577,0.9893494718936126,1.0,13/57,22.20%,SDAD1;RIOK1;NOC2L;RRP36;NPM1;TGS1;MRPL36;DDX31;RPF2;EBNA1BP2;RIOK2;RPS25;RBIS
prerank,necroptotic process (GO:0070266),0.2874306722704909,0.6381538457492734,0.8872870249017037,0.9896962325260018,1.0,5/16,25.36%,TLR4;PGAM5;CD14;CYLD;TICAM1
prerank,embryonic hemopoiesis (GO:0035162),0.305029493016858,0.6376656060777859,0.8804780876494024,0.9897274501195297,1.0,2/12,7.87%,TGFBR2;FLT3LG
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.3023685668231837,0.6374256649044835,0.8952380952380953,0.9895649783237654,1.0,2/12,12.26%,TLR4;DUOXA1
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.25641580835881084,-0.6370907842498611,0.9081272084805654,0.9801951753581957,1.0,2/10,9.97%,ERLEC1;SVIP
prerank,chromosome condensation (GO:0030261),0.25260654395717486,0.6370859371125934,0.9275862068965517,0.9894726764320236,1.0,11/36,29.98%,TENT4A;NCAPG;SMC2;SET;AKAP8L;CSNK2A2;DFFB;H1-0;KMT5A;INCENP;AIFM1
prerank,regulation of chromosome organization (GO:0033044),0.27295235257151695,0.6368976404824213,0.9077306733167082,0.9892707390719403,1.0,8/22,27.95%,HNRNPD;MAPT;XRCC5;SMG6;TERF2IP;UPF1;SMG5;HDAC8
prerank,cellular response to dsRNA (GO:0071359),0.2929441468789033,0.6365170925839323,0.8931909212283045,0.9892358524762382,1.0,6/15,28.67%,CGAS;NPM1;FLOT1;RIOK3;MUL1;PDE12
prerank,mitotic cytokinesis (GO:0000281),0.24564406510701828,0.6364243084435584,0.9377777777777778,0.9889503742504004,1.0,15/47,29.89%,SON;BBS4;TTC19;SPTBN1;RAB35;CIT;RASA1;PDCD6IP;TRIM36;SNX18;SNX33;CUL7;MYH10;INCENP;CKAP2
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.27196370819827353,0.6356081591342623,0.9118773946360154,0.9892357637516435,1.0,3/21,12.43%,TEDC1;UCHL5;TUBD1
prerank,regulation of blood circulation (GO:1903522),0.2572139691533565,0.6355193937629027,0.9259259259259259,0.9889497994198766,1.0,4/34,11.25%,SRI;CAMK2D;ECE1;CELF2
prerank,regulation of mRNA processing (GO:0050684),0.2548850780995033,0.6347449833311798,0.9305882352941176,0.9892205233299014,1.0,10/32,26.61%,ZFP36L1;SRSF3;SON;CPSF4;PTCD2;RBM39;SRPK1;LARP7;PABPN1;SAFB
prerank,regulation of erythrocyte differentiation (GO:0045646),0.24842418895292911,0.6346964819179041,0.9265212399540758,0.9889092938701688,1.0,10/35,24.70%,MAPK14;ZFP36L1;HOXA5;MAPK11;ZFP36;STAT5B;ABCB10;ACVR2A;LDB1;ACVR1B
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.26219710878020414,0.6345953723819713,0.9105199516324063,0.9886275350907061,1.0,9/24,34.64%,POLB;UBA52;RFC4;POLD1;XRCC1;RFC3;RPA3;LIG1;POLD3
prerank,regulation of steroid metabolic process (GO:0019218),0.27086308384642765,0.6339890687979981,0.9238451935081149,0.9887769996250926,1.0,3/23,9.90%,DGKQ;STUB1;ACADVL
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.30988359550049743,0.6338128046089869,0.9105113636363636,0.9885587598816342,1.0,1/11,4.40%,ZFP36L1
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.3062730859596829,0.6336980461573947,0.8952654232424677,0.9882860187297539,1.0,1/10,7.11%,HDAC6
prerank,DNA damage checkpoint signaling (GO:0000077),0.26295150435154907,0.6336843531104375,0.9242788461538461,0.9879454326377635,1.0,13/28,33.83%,RHNO1;RAD1;BRIP1;NBN;DONSON;CLSPN;TIPRL;PRPF19;RAD17;RAD9A;USP28;CHEK2;E2F1
prerank,regulation of histone methylation (GO:0031060),-0.23239214349403642,-0.6333420680741061,0.9368029739776952,0.9813931372454423,1.0,2/13,8.80%,TET1;CTR9
prerank,negative regulation of double-strand break repair (GO:2000780),0.26064804811984665,0.6324834376612004,0.9241706161137441,0.9885119429737255,1.0,5/30,13.57%,CGAS;CYREN;TFIP11;NUDT16L1;TWIST1
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),-0.1944456855450543,-0.6313101165870265,0.9515151515151515,0.981418651044571,1.0,10/25,29.30%,HSPA9;ERO1A;PTGES3;DNAJC18;HSPE1;HSPA1A;ST13;HSPA1B;HSPA2;SDF2L1
prerank,early endosome to late endosome transport (GO:0045022),0.27719338698417645,0.6307859575723463,0.9134993446920052,0.98947260042316,1.0,6/20,28.36%,HOOK2;WDR91;ANKRD27;SNX16;STX8;PTPN23
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.24062875204333584,0.6303064886633608,0.9306608884073673,0.9894875759808993,1.0,17/48,29.45%,CRIP1;DYRK2;BAK1;SFN;RPS27L;BCL3;TNFRSF1B;HTRA2;PML;MCL1;PYCARD;MSH6;PRKDC;HIC1;TOPORS;BAX;TP53
prerank,axonemal dynein complex assembly (GO:0070286),0.2589765905671873,0.6297622584945669,0.9204819277108434,0.9895186685708397,1.0,5/27,22.57%,DNAH8;DNAAF3;DNAAF5;DNAH5;DNAL1
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),0.29014435936140726,0.6297151392902588,0.8849206349206349,0.9891984869942131,1.0,3/13,16.79%,TBC1D10A;BAK1;GRIN2A
prerank,magnesium ion transport (GO:0015693),0.2965010825458957,0.629713822054589,0.9060402684563759,0.9888490425916986,1.0,3/12,16.09%,NIPAL2;CNNM4;TUSC3
prerank,heterochromatin assembly (GO:0031507),0.2712851655491608,0.6287140431812127,0.9275730622617535,0.9892676661493853,1.0,7/20,28.06%,SIRT2;POLE3;EZH1;BAHD1;BAZ2A;MBD2;SUV39H1
prerank,neurotransmitter secretion (GO:0007269),0.24380378573164702,0.6285288428300517,0.9509476031215162,0.9890606465289279,1.0,8/44,18.84%,STX1A;SNAP25;GAD2;SNAPIN;SNPH;SYT1;VAMP2;RIMS2
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.24894807310305211,0.6277966287283873,0.9301014656144306,0.9892329594438503,1.0,5/38,15.93%,CENPT;HJURP;NPM1;UBN1;CENPC
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.28416346473028115,0.6273782423996648,0.9181446111869032,0.9891890873824324,1.0,6/15,30.18%,SAMHD1;YTHDF2;YTHDF3;STAT2;MUL1;CACTIN
prerank,phasic smooth muscle contraction (GO:0014821),-0.26271381598601085,-0.6259416848747342,0.9206896551724137,0.9836186300517232,1.0,3/10,15.59%,EDNRB;EDN1;EDN3
prerank,RNA destabilization (GO:0050779),0.27202700391297185,0.6258709826048507,0.9050632911392406,0.9899284131733003,1.0,6/18,27.89%,PUM1;YTHDF1;YTHDF2;YTHDF3;RBM24;CELF1
prerank,regulation of protein dephosphorylation (GO:0035304),0.2463658089822201,0.6258630010695503,0.9448275862068966,0.9895856101400644,1.0,13/37,28.87%,PPP6R2;CALM2;PIN1;NSMF;PPIA;SMPD1;PTBP1;YWHAB;ANKLE2;TIPRL;HSP90B1;TSC1;PTPA
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.27717936930008835,0.6253449724688662,0.8948069241011984,0.9896169114951598,1.0,5/16,23.22%,KAT2B;NAA15;NAA50;NAA20;NAA30
prerank,covalent chromatin modification (GO:0016569),0.28899304982249846,0.6250790969154711,0.9168900804289544,0.9894642318282776,1.0,5/14,30.38%,SETD5;CHD1;UFL1;MBD2;SIRT7
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.2689772571144587,0.625012356505169,0.9184713375796179,0.9891561359712051,1.0,6/21,27.10%,CDC14B;FBXO5;RPL23;PTEN;RAB1A;GORASP1
prerank,synaptic vesicle transport (GO:0048489),0.3013120277515827,0.6246712502544237,0.9112676056338028,0.989038236966716,1.0,2/11,16.19%,TOR1A;SNAPIN
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.23246925714240227,0.624173312865403,0.9541984732824428,0.9890498759759576,1.0,17/59,27.46%,CHUK;TLR4;AKT1;UBA52;NKIRAS1;BCL3;CD14;RBCK1;MAP3K14;CARD11;TAB2;AZI2;MAP3K7;RELA;TICAM1;RNF31;BCL10
prerank,autophagosome maturation (GO:0097352),0.25386134808775546,0.623579425427892,0.9292565947242206,0.9891175045126794,1.0,6/32,13.34%,LIX1L;WIPI2;VPS33A;STX17;EPG5;ATP2A2
prerank,cellular response to ionizing radiation (GO:0071479),0.2412254777038544,0.6235206615450861,0.9392935982339956,0.9888164497424519,1.0,18/47,30.65%,MAPK14;RHNO1;RAD1;XRCC5;CDKN1A;INO80;TNKS1BP1;SPIDR;BLM;NIPBL;CRYAB;MDM2;EEF1D;XRCC6;TP53;HSF1;TLK2;RAD9A
prerank,regulation of lipid catabolic process (GO:0050994),-0.2095817008813175,-0.6235185645693482,0.9557522123893806,0.9838843723660478,1.0,2/19,8.98%,LONP2;ADRA2A
prerank,cellular response to interferon-beta (GO:0035458),0.28813367411695195,0.6235172636607644,0.9123505976095617,0.988470567212669,1.0,5/14,27.23%,UBE2G2;CDC34;HTRA2;UBE2K;NDUFA13
prerank,regulation of ruffle assembly (GO:1900027),0.264877364639941,0.6232420032550636,0.9170792079207921,0.988315596885147,1.0,4/23,16.27%,NDEL1;PFN2;KANK1;EPS8L2
prerank,positive regulation of cell development (GO:0010720),0.25424036096560965,0.6229186413191843,0.9284064665127021,0.9882040386390016,1.0,3/31,12.58%,NUMBL;SERPINF1;ATP6AP1
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),0.29901320578487917,0.6227257327165198,0.9116022099447514,0.9879913265304837,1.0,4/12,25.01%,KLF2;EZH2;CALR;ASXL1
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.2840557810146971,0.6219607357218789,0.9048843187660668,0.9882166015485521,1.0,2/15,11.61%,MLXIPL;ELOVL5
prerank,regulation of neuron differentiation (GO:0045664),0.22560857539391718,0.6215581577090833,0.9658484525080042,0.9881525404183372,1.0,27/76,31.83%,FGFR1;NEUROD2;BIN1;BEND6;ZFHX3;YWHAG;RHOA;SIX1;CDK5RAP2;ZEB1;CNTN4;NBL1;KCTD11;TIAM1;CPNE1;PCP4;CALR;NRCAM;HES1;IMPACT;NLGN1;BRINP2;MMD;DISP3;ALK;NGF;CDK5RAP3
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.27328826432322495,0.6212235363156429,0.8940568475452196,0.9880323433574745,1.0,3/18,15.70%,POLE3;MCM3;RFC4
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),-0.21227227606616578,-0.6205983246017276,0.9563318777292577,0.9842453220537789,1.0,9/17,40.01%,AKAP6;KCNE4;ANK3;NOS1AP;KCNAB1;KCNS2;RNF207;KCNG1;KCNE5
prerank,N-acetylneuraminate metabolic process (GO:0006054),0.304982722204976,0.620578057151969,0.8987341772151899,0.9881307487904004,1.0,3/10,18.68%,NAGK;ST3GAL1;GNE
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.29364034746116574,0.6201826688383688,0.8972972972972973,0.9880671254681969,1.0,5/13,31.00%,NT5M;OGG1;DUT;SMUG1;UPP2
prerank,branched-chain amino acid metabolic process (GO:0009081),0.27011768875571496,0.6201333816804997,0.9265822784810127,0.987412992737117,1.0,5/20,21.01%,BCAT1;AUH;HIBADH;BCKDHA;ACAT1
prerank,branched-chain amino acid catabolic process (GO:0009083),0.27011768875571496,0.6201333816804997,0.9265822784810127,0.987412992737117,1.0,5/20,21.01%,BCAT1;AUH;HIBADH;BCKDHA;ACAT1
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.2622426212570942,0.6191175368840456,0.9104665825977302,0.9877708161715328,1.0,8/22,27.44%,CAMK2N1;CDKN1A;TFAP4;IPO5;PTEN;LATS1;HEXIM1;MEN1
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.2780987065176438,0.6189498164063487,0.9043927648578811,0.9875382003887901,1.0,17/17,72.22%,LPCAT1;CRLS1;PLA2G12A;LPGAT1;PLA2G4D;PLA2G1B;PLA2G2F;PLA2G2E;PLA2G10;PLA2G2D;PLA2G3;SERAC1;LPCAT4;PLA2G5;PLA2G4B;PLA2G4A;PLA2G4F
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.2214156887583751,0.6188464985570874,0.9636552440290758,0.987265668200771,1.0,11/94,12.07%,PSMC4;IRAK3;PSMC6;PELI3;UBE2N;CHUK;PSMD8;SQSTM1;IRAK4;IRAK1;UBA52
prerank,regulation of vacuole organization (GO:0044088),0.27013642660306963,0.6187138479377232,0.9195402298850575,0.9870086060110448,1.0,8/20,31.26%,ANXA2;RAB1B;ADPRH;TBC1D12;MTM1;PIKFYVE;LAPTM4B;IFT20
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.26243604968701373,0.6180081264884112,0.9170918367346939,0.9864725328583605,1.0,2/20,8.29%,ZW10;ZWINT
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.26243604968701373,0.6180081264884112,0.9170918367346939,0.9864725328583605,1.0,2/20,8.29%,ZW10;ZWINT
prerank,spindle assembly checkpoint signaling (GO:0071173),0.26243604968701373,0.6180081264884112,0.9170918367346939,0.9864725328583605,1.0,2/20,8.29%,ZW10;ZWINT
prerank,sensory perception (GO:0007600),0.23667270682767455,0.6177857839486929,0.954954954954955,0.9862710355241576,1.0,5/45,17.16%,GNAS;KCNA2;BBS4;TTC8;CHRNA7
prerank,acetylcholine receptor signaling pathway (GO:0095500),-0.20033570830887718,-0.6174189436891687,0.9565217391304348,0.9848575799783201,1.0,11/20,37.75%,PLCB1;AGRN;LYPD1;RGS10;CDK5R1;CHRM1;LY6H;LY6G6D;CHRNB2;GNA11;CHRM5
prerank,DNA-dependent DNA replication (GO:0006261),0.2170857539545814,0.6172578631786835,0.9785056294779939,0.9862764344400368,1.0,20/128,19.01%,REV3L;PSMC4;PSMC6;PSMD8;POLG2;POLB;POLE3;MCM3;DDX21;UBA52;CDC34;DNA2;ORC6;DBF4;GMNN;RFC4;RECQL;BLM;POLD1;NOC3L
prerank,protein localization to cilium (GO:0061512),0.24993161658648044,0.6162989408350444,0.9441860465116279,0.9866016802291544,1.0,10/32,32.00%,BBS9;BBS4;ATP6V1D;TCTN2;TCTN1;RAB29;TULP1;ZNF423;IFT20;ARL6
prerank,nerve growth factor signaling pathway (GO:0038180),0.30399146100187546,0.6155966086732083,0.9117221418234442,0.9867346522316802,1.0,3/10,15.00%,MAGI2;KIDINS220;RAPGEF1
prerank,regulation of microtubule-based movement (GO:0060632),0.2945816423714495,0.615495752921922,0.8942857142857142,0.9864578396214949,1.0,1/11,7.11%,HDAC6
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.22263735422898442,0.6148763253037833,0.9714285714285714,0.986522398055635,1.0,22/76,24.58%,EGFR;HDAC7;RASSF2;TLR4;IRAK1;LRRC19;CD27;BCL3;RHOA;ZC3H12A;CD14;PDCD4;ILK;IFI35;PPM1A;TSPAN6;CPNE1;TERF2IP;CYLD;CCN3;RELA;TRIM44
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.29346587089035603,0.6143965402159509,0.9157754010695187,0.9865111206021518,1.0,4/12,22.84%,ERN1;BAK1;ATF6;TMEM33
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.24548532935978618,0.6143152518858085,0.9295774647887324,0.9862208080217694,1.0,2/32,3.64%,CDK14;ZPR1
prerank,tyrosine metabolic process (GO:0006570),0.30360281195079075,0.6141962012221134,0.921875,0.985941855718831,1.0,11/11,69.66%,TYR;GSTZ1;THAP4;PAH;TH;TAT;IYD;DCT;IL4I1;HGD;FAH
prerank,mRNA polyadenylation (GO:0006378),0.25872580198294287,0.6138554341215364,0.9351740696278511,0.9854757619904143,1.0,8/26,24.47%,SCAF8;CPSF2;PAPOLB;TENT2;TENT4B;PAF1;CPSF1;WDR33
prerank,RNA polyadenylation (GO:0043631),0.25872580198294287,0.6138554341215364,0.9351740696278511,0.9854757619904143,1.0,8/26,24.47%,SCAF8;CPSF2;PAPOLB;TENT2;TENT4B;PAF1;CPSF1;WDR33
prerank,pseudouridine synthesis (GO:0001522),0.29148299658923615,0.6129743314363936,0.927694406548431,0.9857219061389261,1.0,4/13,29.72%,GAR1;TRUB1;NHP2;PUS10
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.2480726146034069,0.6129078329099433,0.9307875894988067,0.9854188679701149,1.0,4/30,11.89%,INPP5F;SRCIN1;PARP14;PIBF1
prerank,DNA biosynthetic process (GO:0071897),-0.2123810243863765,-0.6123535416866607,0.9206349206349206,0.9865477488747479,1.0,7/16,29.02%,SIRT1;TERT;WRN;POLD2;POLE;POLD4;POLL
prerank,L-serine metabolic process (GO:0006563),-0.24990130586064085,-0.6121155473435861,0.941747572815534,0.9853364793205128,1.0,1/10,2.06%,SERINC3
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.24414920597281697,0.6118173017310891,0.9501160092807425,0.9857998715961922,1.0,15/35,32.28%,PPP1R1B;MTOR;PPP6R2;MAGI2;CALM2;FKBP1A;TIPRL;HSP90B1;CRY2;TSC1;PTPA;FKBP1B;BOD1;CALM1;PPP4R4
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.26809388125439504,0.6116019203238321,0.9317010309278351,0.9856033013696641,1.0,4/18,21.04%,SRC;MAP2K2;VPS11;MAPK1
prerank,regulation of macrophage chemotaxis (GO:0010758),0.26381805555652454,0.6115643621851229,0.9396984924623115,0.9852810576883813,1.0,2/21,5.86%,MIF;AKIRIN1
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.25395808998104424,0.6115576133499292,0.9459134615384616,0.9849448767284698,1.0,7/25,24.48%,DOK1;AKT1;CBL;ARAP1;PLAUR;CCDC88A;RTN4
prerank,regulation of interleukin-17 production (GO:0032660),0.2507531488678387,0.6112481414839324,0.9390386869871044,0.9848044232757661,1.0,4/31,17.74%,RFTN1;TLR4;IL6;IL18
prerank,sterol biosynthetic process (GO:0016126),0.24611556236372029,0.6112360163768784,0.9314285714285714,0.9844696523736663,1.0,4/33,9.30%,ACLY;MVK;INSIG2;GGPS1
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.29042510300314917,0.6110024089231226,0.9315642458100558,0.9842802852340914,1.0,6/12,33.72%,TCERG1;LARP7;HEXIM1;NELFA;NELFB;HNRNPU
prerank,RNA stabilization (GO:0043489),0.24602970490587361,0.6104609849031601,0.9339735894357744,0.9842590664831444,1.0,7/33,24.84%,TENT5B;LARP1;GDNF;TENT2;ZCCHC17;THRAP3;RBM24
prerank,positive regulation of protein deacetylation (GO:0090312),0.2798928907462775,0.6095799996568627,0.9246031746031746,0.9844579925251109,1.0,6/14,29.83%,AKAP8;NIPBL;CTBP1;AKAP8L;NNMT;BRMS1
prerank,retinal metabolic process (GO:0042574),0.2903187377547325,0.609541854924247,0.9122562674094707,0.9841436584025649,1.0,3/12,22.29%,ALDH1A3;RDH13;CYP1B1
prerank,sphingolipid catabolic process (GO:0030149),0.2764535250319919,0.6094203835712575,0.9295212765957447,0.9838884047822123,1.0,3/15,18.58%,PDXDC1;GLA;SMPD1
prerank,regulation of chromatin binding (GO:0035561),0.3017076613089559,0.609217672427783,0.9080622347949081,0.9836719957963331,1.0,3/10,19.09%,DDX11;GMNN;BTAF1
prerank,regulation of cholesterol metabolic process (GO:0090181),0.26472032131052303,0.6083709163804498,0.9372647427854455,0.9838846305906511,1.0,9/20,28.82%,DGKQ;ACADVL;SREBF1;FMO5;ARV1;LPCAT3;KPNB1;MBTPS1;SREBF2
prerank,exit from mitosis (GO:0010458),0.2910003454962238,0.608348801082052,0.9140518417462483,0.9835601785764069,1.0,6/12,31.64%,CHMP7;CTDP1;CLASP2;PPP2R2D;SIRT7;CHMP4B
prerank,pigment granule transport (GO:0051904),0.268725765939627,0.607811050174064,0.9177377892030848,0.9832352994364604,1.0,4/18,18.90%,MYO5A;BBS4;RAB27B;BBS5
prerank,melanosome transport (GO:0032402),0.268725765939627,0.607811050174064,0.9177377892030848,0.9832352994364604,1.0,4/18,18.90%,MYO5A;BBS4;RAB27B;BBS5
prerank,DNA catabolic process (GO:0006308),0.2917306611082183,0.6070358201058458,0.9113233287858117,0.9833726035350783,1.0,3/11,24.96%,DNASE1L2;DFFB;DNASE1L1
prerank,DNA replication checkpoint signaling (GO:0000076),0.2760163887601913,0.6069944899215404,0.9336870026525199,0.9830554886034565,1.0,2/16,13.52%,TIPIN;DNA2
prerank,cellular response to starvation (GO:0009267),0.21239418548034641,0.6069388531382567,0.9898887765419616,0.9827533517984098,1.0,32/147,23.55%,EIF2AK3;HNRNPA1;MTOR;FOXO1;GAS2L1;FLCN;WIPI2;USP33;WDR45B;CEBPB;ATP6V1E1;SESN3;CDKN1A;RRAGD;EIF2S1;ZC3H12A;EHMT2;FADS1;STK24;ATP6V1D;ATP6V1B2;DAP;SREBF1;CASTOR2;STK26;MAPK1;SESN2;ATF4;SLC38A9;ATP6V0B;ATG14;PICK1
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),-0.20798182609186003,-0.6052115595892231,0.9519230769230769,0.987840280791609,1.0,8/18,28.19%,MPV17L;HIP1R;SLC35F6;CHCHD10;HSPA1A;ZNF205;BOK;BID
prerank,lipoprotein biosynthetic process (GO:0042158),0.29026954715878095,0.6051702877625136,0.9160935350756534,0.9835492290648541,1.0,2/11,10.46%,WIPI2;WDR45B
prerank,microtubule-based transport (GO:0099111),0.2883234942798677,0.605133449551441,0.9265927977839336,0.9832266836236052,1.0,2/12,14.29%,DYNC1I1;SPAG17
prerank,interleukin-15-mediated signaling pathway (GO:0035723),-0.22747952976493865,-0.6045336741784096,0.953125,0.9855035208015344,1.0,2/13,5.54%,PLCB1;SHC1
prerank,cellular response to interleukin-15 (GO:0071350),-0.22747952976493865,-0.6045336741784096,0.953125,0.9855035208015344,1.0,2/13,5.54%,PLCB1;SHC1
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.2711740158349259,0.6038624072514994,0.9240837696335078,0.983669679991462,1.0,2/16,7.11%,IRAK3;HDAC6
prerank,regulation of tau-protein kinase activity (GO:1902947),-0.2440256476009665,-0.6024916123701367,0.8996655518394648,0.9853012815750488,1.0,4/10,28.33%,SORL1;NAB2;RB1;EGR1
prerank,calcium ion transport into cytosol (GO:0060402),0.26003111840545007,0.6021570300342971,0.9330808080808081,0.984379000534509,1.0,2/21,6.15%,ATP2B4;GRIN2D
prerank,neurotransmitter biosynthetic process (GO:0042136),0.277433410978829,0.601036504013571,0.9328859060402684,0.9847174905206424,1.0,4/14,22.34%,DAGLA;SLC6A4;DAGLB;ALDH9A1
prerank,glial cell differentiation (GO:0010001),0.2471368732429015,0.6006152025509586,0.9486858573216521,0.9846259517869496,1.0,3/28,8.13%,SOX10;NFIB;SOX8
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.289087425162199,0.6004818552356852,0.9253731343283582,0.9843758683222631,1.0,5/12,27.89%,MPHOSPH8;SETDB1;SETDB2;TASOR;ATF7IP
prerank,natural killer cell mediated immunity (GO:0002228),-0.21107483676544453,-0.5992532484846996,0.9637096774193549,0.9856641932659403,1.0,15/15,78.92%,ULBP1;RAET1E;KIF5B;TUBB4B;SLAMF7;KLRD1;KLRK1;TUBB;KLRC2;KIR3DL1;GZMB;CEBPG;ARL8B;PLEKHM2;LYST
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.2769849680601829,0.5973671479391827,0.9257362355953905,0.9859677166358481,1.0,4/14,22.84%,COPS5;BAK1;UFL1;TMEM33
prerank,histone H2A acetylation (GO:0043968),0.26973747724186303,0.5958842219694219,0.9246753246753247,0.9865369207549074,1.0,8/16,32.79%,MSL3;DMAP1;MORF4L1;TRRAP;BRD8;YEATS4;RUVBL1;RUVBL2
prerank,regulation of presynapse assembly (GO:1905606),0.265623179173047,0.5958608569965687,0.9331585845347313,0.9858690489282669,1.0,3/18,15.06%,GPC6;LRFN5;MDGA1
prerank,regulation of presynapse organization (GO:0099174),0.265623179173047,0.5958608569965687,0.9331585845347313,0.9858690489282669,1.0,3/18,15.06%,GPC6;LRFN5;MDGA1
prerank,protein localization to vacuole (GO:0072665),0.2808229892057069,0.5957833184518256,0.9185082872928176,0.9855752088100046,1.0,2/13,14.69%,CD81;RNF128
prerank,receptor recycling (GO:0001881),0.2915886700781219,0.5942487017067581,0.9151343705799151,0.9861240625182629,1.0,3/10,16.30%,NSG1;REP15;PHETA2
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.23242177652009438,0.5941229836274368,0.9522184300341296,0.9858560402489717,1.0,11/38,27.23%,NDUFS5;NDUFAB1;NDUFS1;NDUFB7;NDUFV2;NDUFA2;NDUFB2;NDUFB3;NDUFAF1;NDUFB9;NDUFA13
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.25294746383258704,0.5937701836460352,0.9351285189718482,0.98571734227458,1.0,10/21,32.28%,PPP1R1B;YWHAE;YWHAB;FKBP1A;TIPRL;CRY2;PTPA;FKBP1B;BOD1;PPP4R4
prerank,histone lysine demethylation (GO:0070076),0.2521287496428291,0.5935165513238347,0.9471153846153846,0.9855310378021614,1.0,10/25,28.65%,KDM3B;KDM5C;KDM5B;KDM1B;JMJD1C;KDM2B;KDM4C;KDM3A;KDM4B;KDM2A
prerank,detection of visible light (GO:0009584),-0.20754413792123777,-0.5918318448519516,0.958904109589041,0.9880934199788385,1.0,2/16,10.27%,ABCA4;RP1
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.24335127710473753,0.5918080851630068,0.954171562867215,0.9861711881269146,1.0,10/31,35.06%,SCP2;SRD5A1;NFS1;PYCR1;MOCS1;NOXRED1;PYCR3;MOCS2;LIAS;MOCS3
prerank,motile cilium assembly (GO:0044458),-0.21834990383485897,-0.589944545829743,0.9407665505226481,0.9877386213522446,1.0,2/12,8.50%,BBOF1;SPATA6
prerank,protein neddylation (GO:0045116),0.2728293479743904,0.589484491349098,0.9318181818181818,0.9871359150984789,1.0,5/13,29.05%,RNF7;NEDD8;UBE2F;DCUN1D1;UBE2M
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),-0.1840862666567235,-0.5887567079717163,0.9894179894179894,0.9868619104787729,1.0,13/23,39.71%,ABHD4;PLAAT3;PLA2G4C;PLA2G6;PLA2G4F;PLA2G4A;PLA2G4B;PLA2G5;LPCAT4;MBOAT2;PLBD1;MBOAT1;PLA2G3
prerank,synaptonemal complex assembly (GO:0007130),0.27386348915999315,0.5884730328460812,0.9379217273954116,0.9870150165003934,1.0,1/15,8.81%,SYCP2
prerank,synaptonemal complex organization (GO:0070193),0.27386348915999315,0.5884730328460812,0.9379217273954116,0.9870150165003934,1.0,1/15,8.81%,SYCP2
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.2476714231659484,0.5882835761170968,0.9526123936816525,0.9867766371809765,1.0,10/24,32.22%,FYN;MIEF2;CHP1;ITGAM;FIS1;MTCL1;PRNP;MYO1C;AKT2;TCAF1
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.20974799376110478,0.5877695440487042,0.9835897435897436,0.9867291690933387,1.0,13/110,15.51%,RPSA;CTIF;HELZ2;PNRC2;GSPT2;RPL10A;UBA52;RPS5;SMG7;EIF3E;GSPT1;SMG6;RPL6
prerank,nucleotide biosynthetic process (GO:0009165),0.25990852392933117,0.5858015684049288,0.946360153256705,0.9874504520265007,1.0,4/18,16.62%,GART;PRPSAP1;PRPS1;PRPS1L1
prerank,pinocytosis (GO:0006907),0.28755200152774474,0.5839311266588204,0.9343794579172611,0.9881173484524375,1.0,5/10,31.86%,PYCARD;SNX33;PPT1;MAPKAPK3;SNX5
prerank,aerobic electron transport chain (GO:0019646),0.2134468111940285,0.5833949860552258,0.9798087141339001,0.9880694694227529,1.0,20/68,27.23%,NDUFS5;NDUFAB1;NDUFS1;NDUFB7;NDUFV2;NDUFA2;UQCRQ;UQCC3;UQCRH;SDHAF2;COX7B;NDUFB2;UQCR10;AFG1L;NDUFB3;NDUFAF1;SDHC;NDUFB9;COX15;NDUFA13
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.25814322713086824,0.5829508338728205,0.932741116751269,0.9879724226484438,1.0,4/17,21.01%,ACVR1;JAG1;SNAI2;BMPR1A
prerank,DNA strand elongation (GO:0022616),0.25817011690911496,0.5821582443859689,0.9449423815620999,0.9880452591224956,1.0,4/18,17.41%,MCM3;NBN;RFC4;RAD50
prerank,negative regulation of leukocyte activation (GO:0002695),0.26804675615796286,0.580997764933861,0.9431216931216931,0.9883093978016302,1.0,6/15,28.30%,ZC3H12A;IL4;LRFN5;IL31RA;HAVCR2;CD300LF
prerank,glutamate receptor signaling pathway (GO:0007215),0.22932225676235887,0.5808483075276009,0.9680365296803652,0.988050638420189,1.0,11/37,27.39%,GRIN3A;DAGLA;GRIA2;DAGLB;GRIN2A;GRM1;GRIA3;GRIK2;GRIK4;GRM5;GRID2
prerank,icosanoid biosynthetic process (GO:0046456),-0.24122208384117116,-0.5806655615040983,0.9290780141843972,0.9892716174192115,1.0,6/10,33.13%,MGST3;PLA2G4A;PLA2G5;ALOX5AP;MGST2;ALOX5
prerank,regulation of mRNA polyadenylation (GO:1900363),0.2571678540475107,0.5802341453403476,0.9398692810457516,0.9880370582345855,1.0,9/17,33.73%,CPSF6;CDK9;CPEB1;CPSF7;RNF20;HSF1;VIRMA;CPEB3;NCBP2
prerank,centromere complex assembly (GO:0034508),0.22951577263414263,0.5792745681126334,0.9621559633027523,0.9881625398048605,1.0,5/36,18.82%,CENPT;HJURP;NPM1;CENPC;CENPE
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.21200542547213275,0.5779252157965544,0.9861554845580405,0.9885141916847056,1.0,6/73,9.30%,PSMC4;RUNX1;ITCH;PSMC6;PSMD8;PDCD2
prerank,protein-containing complex subunit organization (GO:0043933),0.20688140612902078,0.5767923512975309,0.9917098445595854,0.9887584831704098,1.0,27/109,27.25%,WIPF1;LLGL1;DLG4;GPAA1;ZW10;WASF1;MDM4;NUP98;MITF;TFAP4;PML;SPG7;NAPG;EPRS1;VAMP2;LAMC1;KMT2A;TPR;DMTN;NDUFAF1;NUP133;MDM2;PPIH;KIFAP3;HES1;VAMP3;WASL
prerank,signal release from synapse (GO:0099643),0.22349093380649143,0.5753654532092438,0.9731843575418995,0.9891554415990312,1.0,7/43,18.56%,STX1A;SNAP25;GAD2;SNAPIN;SNPH;SYT1;VAMP2
prerank,cytoplasmic translation (GO:0002181),0.2068012789943186,0.574286852100105,0.9885654885654885,0.9893774736404486,1.0,14/91,20.91%,RPSA;EIF4A1;FTSJ1;GSPT2;RPL10A;UBA52;RPS5;GSPT1;RPL6;RPL22L1;RPL23;RPL17;RWDD1;RPS25
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.20925500872229502,-0.5739025593744522,0.9883268482490273,0.990828136307013,1.0,6/13,28.95%,SOX11;MAD2L2;TAF1;HEY1;HEY2;SIN3A
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.23389814999664632,0.5735263159151677,0.9602888086642599,0.9894184638734724,1.0,4/29,13.18%,AXIN1;UBE2N;FBXO5;PIN1
prerank,ribosomal large subunit assembly (GO:0000027),0.2438021443570182,0.5731607668898439,0.9655172413793104,0.9892587265482486,1.0,6/24,24.03%,RPL6;NOP53;RPF2;NOP2;RSL24D1;BRIX1
prerank,cell differentiation in hindbrain (GO:0021533),-0.2194269110685073,-0.5726285117156962,0.9776119402985075,0.9900056933741698,1.0,2/11,9.17%,OPHN1;KNDC1
prerank,regulation of membrane repolarization (GO:0060306),0.26991188417133727,0.5721713409210004,0.9431216931216931,0.9894218957579765,1.0,4/13,18.74%,KCNJ2;YWHAE;AKAP9;KCNH2
prerank,ncRNA 3'-end processing (GO:0043628),0.266732024676953,0.5716938022912105,0.9324675324675324,0.9893066151147762,1.0,4/14,19.29%,INTS6;INTS2;INTS12;PTCD1
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.2468694228585015,0.5714929366477957,0.9471649484536082,0.9890554344389754,1.0,9/20,32.79%,BRD7;DIP2A;GLYR1;ARRB1;RPS6KA5;TADA2A;PRKAA1;TADA2B;RUVBL2
prerank,positive regulation of interleukin-1 production (GO:0032732),0.21749705981760553,0.5708418866073725,0.9772234273318872,0.9890372629399817,1.0,4/51,11.69%,IL16;TMEM106A;TLR4;USP50
prerank,neuron fate commitment (GO:0048663),0.2661809866529045,0.570061145674028,0.9337837837837838,0.9890756403314905,1.0,3/14,25.69%,POU3F2;TGFBR1;MYT1L
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.2522854436045329,0.5699047429852234,0.9557522123893806,0.9888162019471161,1.0,7/20,30.80%,MCU;MCUB;SPG7;SLC8B1;PARL;LETM1;MICU1
prerank,positive regulation of interferon-gamma production (GO:0032729),-0.15240348901041254,-0.5692866447788698,1.0,0.9899733729912094,1.0,16/48,31.74%,IL1R1;SLC7A5;TLR3;SCRIB;CYRIB;TXK;SLC11A1;IL27;CD276;FZD5;CCR2;IL12RB2;TLR7;RASGRP1;LILRB1;FADD
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.20809583702025072,0.5686764161318338,0.9861702127659574,0.9890829331833859,1.0,20/69,27.23%,NDUFS5;NDUFAB1;NDUFS1;NDUFB7;NDUFV2;NDUFA2;UQCRQ;UQCC3;UQCRH;SDHAF2;COX7B;NDUFB2;UQCR10;AFG1L;NDUFB3;NDUFAF1;SDHC;NDUFB9;COX15;NDUFA13
prerank,regulation of mitochondrial fusion (GO:0010635),0.28009133552181936,0.5668817684689927,0.9481268011527377,0.9895909210385329,1.0,3/11,27.42%,PID1;MUL1;VAT1
prerank,ether lipid biosynthetic process (GO:0008611),0.2774384408676236,0.5650571637491865,0.9324894514767933,0.9901167224591793,1.0,2/10,20.92%,FAR1;PEDS1
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.26305073807809043,0.5638708821559961,0.9618528610354223,0.9903441216443369,1.0,6/13,33.72%,TCERG1;LARP7;HEXIM1;NELFA;NELFB;HNRNPU
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.2734536269755942,0.5631090525983934,0.9394366197183098,0.9903536005132808,1.0,3/10,20.03%,NOC2L;SET;CTBP1
prerank,glucose metabolic process (GO:0006006),0.21204904915808304,0.5630938514742244,0.985945945945946,0.9900223527524314,1.0,12/58,23.16%,CRTC2;SLC39A14;IRS2;GAA;MDH2;G6PC3;ALDOA;GALM;GOT1;SLC37A4;ATF4;KCNJ11
prerank,cotranslational protein targeting to membrane (GO:0006613),0.2017077062664137,0.5629870699459747,0.9958592132505176,0.9897299078978957,1.0,10/91,15.51%,RPSA;SRP19;SRP9;RPL10A;UBA52;RPS5;TRAM1;SEC63;SEC61A1;RPL6
prerank,endothelial tube morphogenesis (GO:0061154),0.2771097053922914,0.5629221544281621,0.9446749654218534,0.9894257958404742,1.0,2/10,13.49%,PRKD2;RHOA
prerank,negative regulation of cellular protein localization (GO:1903828),0.22218510427537314,0.5611490235983084,0.9707602339181286,0.9898876470165276,1.0,10/34,27.79%,FLCN;OTUD7B;MAPT;ILRUN;GOPC;MAP1A;LEPROT;LATS1;SNX33;DNAJA1
prerank,positive regulation of interleukin-1 beta production (GO:0032731),-0.15329946539803863,-0.5603457237914898,1.0,0.9920543843430768,1.0,19/45,32.25%,APP;WNT5A;AIM2;GBP5;HSPB1;LPL;CCL19;NOD2;GSDMD;RIPK2;CASP1;FZD5;AGER;EGR1;MALT1;NLRC4;TYROBP;CD36;TLR6
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.20559167330052405,0.5600101326128244,0.9829605963791267,0.9900682169312999,1.0,5/70,8.57%,PSMC4;RUNX1;ITCH;PSMC6;PSMD8
prerank,negative regulation of viral genome replication (GO:0045071),0.2146911136615809,0.5573567499538595,0.9740406320541761,0.9909082032728401,1.0,9/40,23.06%,INPP5K;MPHOSPH8;ZC3HAV1;SLPI;TNIP1;FAM111A;BTBD17;SRPK1;SETDB1
prerank,autophagy of peroxisome (GO:0030242),0.26870537867004834,0.5572801699568178,0.9510204081632653,0.9906100291153352,1.0,3/12,17.80%,SQSTM1;NBR1;PEX5
prerank,positive regulation of interleukin-17 production (GO:0032740),0.23899860211989382,0.5572529428469055,0.9635678391959799,0.9902877074565579,1.0,3/22,17.74%,RFTN1;IL6;IL18
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.23391714373213301,0.5555451921998181,0.9695493300852619,0.9906609847502316,1.0,5/23,26.31%,GSTM2;FADS1;GSTM1;ELOVL6;ACOT7
prerank,positive regulation of ruffle assembly (GO:1900029),0.259573921522932,0.5550749079397924,0.9478021978021978,0.9905285987353845,1.0,2/13,16.27%,NDEL1;EPS8L2
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.23339215303964014,0.554700402402253,0.9693251533742331,0.9903499533034809,1.0,6/25,20.96%,BMF;BBC3;MLLT11;HRK;PLAUR;PYCARD
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.2569584702816563,0.5528302828264017,0.9472990777338604,0.9907737639784436,1.0,2/14,11.74%,TIRAP;IRAK1
prerank,endocytic recycling (GO:0032456),0.21162568189391812,0.5518113907160261,0.9782135076252724,0.9908260883819007,1.0,17/50,31.07%,VPS52;EHD2;CMTM6;DENND1A;ARF6;ANKRD27;RAB35;ENTR1;VPS39;RAB11FIP3;MICALL1;EIPR1;PTPN23;ACAP2;SNX27;CCDC93;RAB14
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.25282640771120785,0.5511436013645024,0.9539052496798975,0.9907470239190763,1.0,8/15,38.07%,CCT7;CCT4;CCT6A;NHP2;RUVBL1;RUVBL2;TCP1;CCT8
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.25231410089770046,0.5510399429253761,0.9500674763832658,0.9904536511064642,1.0,2/14,11.71%,TLR5;PUM1
prerank,serine family amino acid biosynthetic process (GO:0009070),-0.2116182620374551,-0.5502378209580399,0.9646643109540636,0.9943421595362387,1.0,1/12,2.06%,SERINC3
prerank,establishment of epithelial cell polarity (GO:0090162),0.2441226466290341,0.5501152389811464,0.9443742098609356,0.990508984169756,1.0,8/19,35.19%,MYO9A;RHOA;FBF1;SIPA1L3;PARD3;GOLPH3;CYTH1;CLASP1
prerank,snRNA 3'-end processing (GO:0034472),0.2424995667281925,0.5497747162299607,0.9518518518518518,0.9903031517573923,1.0,4/19,18.59%,EXOSC7;INTS6;INTS2;INTS12
prerank,regulation of store-operated calcium entry (GO:2001256),0.28032691981604363,0.5494015046486753,0.9507246376811594,0.9901148393480855,1.0,3/10,21.65%,CASQ1;STIM1;SLC8B1
prerank,presynapse organization (GO:0099172),0.2715711817722483,0.5493722827164628,0.9471428571428572,0.9897932280661329,1.0,5/10,31.31%,LRRTM3;DVL1;NLGN1;NLGN3;NLGN2
prerank,negative regulation of cell division (GO:0051782),0.26329994682302216,0.548379797434795,0.946866485013624,0.9898575578990212,1.0,4/11,29.74%,ORC6;BLM;E2F7;CHMP4C
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.2275724005627758,0.5463853689228848,0.956949569495695,0.9903303701793473,1.0,7/25,27.22%,MAPK14;MAPK11;STAT5B;ABCB10;ACVR2A;ACVR1B;PRKDC
prerank,endoderm development (GO:0007492),-0.19974890144381668,-0.5456245793365057,0.9822695035460993,0.9945146557935503,1.0,13/13,80.05%,SOX17;SOX7;DUSP4;TBX20;DUSP5;DUSP2;GATA4;KIF16B;EOMES;APELA;DUSP1;LHX1;LAMC1
prerank,regulation of oxidative phosphorylation (GO:0002082),0.24418943864565523,0.5427607432663861,0.9571619812583668,0.9913985789549021,1.0,3/16,21.66%,MLXIPL;NUPR1;SLC25A33
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.26146873711662577,0.5422303894920565,0.9486823855755895,0.9909254311774435,1.0,3/12,19.99%,STIMATE;SLC9A1;PTBP1
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),0.26146873711662577,0.5422303894920565,0.9486823855755895,0.9909254311774435,1.0,3/12,19.99%,STIMATE;SLC9A1;PTBP1
prerank,regulation of water loss via skin (GO:0033561),0.24410120375957506,0.5418288935215383,0.9626288659793815,0.9904153104396238,1.0,2/15,12.49%,FA2H;SFN
prerank,establishment of skin barrier (GO:0061436),0.24410120375957506,0.5418288935215383,0.9626288659793815,0.9904153104396238,1.0,2/15,12.49%,FA2H;SFN
prerank,glycerophospholipid catabolic process (GO:0046475),0.22377718007456365,0.541493639437181,0.9685990338164251,0.9901964719238058,1.0,5/27,20.38%,INPP5F;PNPLA8;PLA2G4E;LIPC;GDPD3
prerank,NIK/NF-kappaB signaling (GO:0038061),0.19889639408278495,0.5411338822147561,0.9925213675213675,0.9899970641330795,1.0,22/72,31.73%,PSMC4;PSMC6;CHUK;PSMD8;TIRAP;AKT1;IRAK1;MAP3K14;FBXW11;MAP3K7;RELA;PSMD3;PSMD4;PSMB3;PSMB2;PSMD5;CUL1;PSMD14;TRAF6;PSMC3;PSMC5;PSME4
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.2554442556000043,0.5406699123380798,0.9548472775564409,0.9898317700049695,1.0,2/12,18.71%,TLR4;STRAP
prerank,regulation of cell projection organization (GO:0031344),0.24954022992887565,0.5376516297347974,0.9448275862068966,0.9905758803344472,1.0,1/13,8.01%,MYO9A
prerank,negative regulation of histone acetylation (GO:0035067),0.2602755939272813,0.5369577461392386,0.9617563739376771,0.9905006177136256,1.0,3/11,20.03%,NOC2L;SET;CTBP1
prerank,very-low-density lipoprotein particle assembly (GO:0034379),-0.21009352834097042,-0.5362254722190318,0.9769230769230769,0.9961603825810591,1.0,12/12,79.01%,ACSL3;APOC1;MTTP;P4HB;APOC4;DGAT1;APOB;APOC3;MFSD2A;SOAT2;LPCAT3;SOAT1
prerank,regulation of cellular amine metabolic process (GO:0033238),0.20506161052374858,0.5357349111231665,0.9887005649717514,0.9905889291700769,1.0,4/50,9.78%,PSMC4;PSMC6;PSMD8;ODC1
prerank,hydrogen peroxide catabolic process (GO:0042744),0.2637358020710113,0.5355937703238444,0.9555256064690026,0.9903003229306566,1.0,2/11,17.99%,GPX1;PXDN
prerank,positive regulation of DNA repair (GO:0045739),0.20578462826108168,0.5352694169351737,0.9911111111111112,0.9900719269442491,1.0,7/46,16.66%,EGFR;EYA2;UBE2N;TIGAR;ABRAXAS1;DDX11;SPIDR
prerank,primary miRNA processing (GO:0031053),0.2672573562687554,0.5349708752297756,0.9613180515759312,0.9898440106177797,1.0,1/10,6.56%,DGCR8
prerank,lipid droplet organization (GO:0034389),-0.1723509829784561,-0.5346526233521138,0.994413407821229,0.995219165812534,1.0,22/22,82.79%,ZFYVE1;PNPLA3;PLA2G4C;FITM2;CDS2;HILPDA;PPID;PLIN5;CIDEA;SMIM22;FAF2;HSD17B13;TSPO2;SQLE;CIDEC;FITM1;BSCL2;CDS1;RAB3GAP1;RAB18;AUP1;PPIA
prerank,tRNA metabolic process (GO:0006399),0.23764707913018823,0.5343491861900715,0.9659685863874345,0.9897251165450505,1.0,5/17,31.04%,RPP21;TRPT1;RPP30;SARS1;AARS1
prerank,gluconeogenesis (GO:0006094),0.21043532504729934,0.5323589607068104,0.981460023174971,0.990061182915211,1.0,8/39,22.19%,CRTC2;SLC39A14;MDH2;G6PC3;ALDOA;GOT1;SLC37A4;ATF4
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.20271876244334242,0.5319329792668096,0.9911602209944751,0.9898618389248034,1.0,5/50,14.14%,CAMK2N1;GTPBP4;CDKN1A;CCND1;CCNH
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.2342229199372055,0.5317344667786997,0.9586466165413534,0.9895948984326677,1.0,18/18,76.60%,SPAG17;SPEF2;NPHP3;CCDC39;NEK10;RFX3;DNAAF1;DNAAF4;CCDC40;OFD1;AQP4;ODAD4;DNAAF2;SPA17;ADCY10;ROPN1L;CFAP53;CABYR
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.24232031852414054,0.5310089736794817,0.9747675962815405,0.9894908959138909,1.0,3/15,16.84%,DAGLA;DAGLB;GRM1
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.24058251818324108,0.5298323726796741,0.972,0.9895333969228073,1.0,6/16,32.89%,VAMP2;LYST;VAMP7;PLEKHM2;ARL8B;CEBPG
prerank,response to histamine (GO:0034776),0.2589354669873754,0.5282549615228987,0.9512893982808023,0.9897150974414307,1.0,2/10,19.27%,DIAPH1;GABRG2
prerank,ether lipid metabolic process (GO:0046485),-0.19880815742956703,-0.5270866990100732,0.9835390946502057,0.9958651699684754,1.0,5/14,18.90%,AGPS;LIPE;PLAAT3;DHRS7B;TMEM86B
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.21850995751877764,0.5257349802100758,0.9783653846153846,0.9901665838239395,1.0,10/27,31.86%,AK2;NME2;NME1;AK8;AK9;DUT;RRM2B;AK5;AK6;GSR
prerank,positive regulation of telomere maintenance (GO:0032206),0.21340839338470835,0.5251791296194525,0.9741176470588235,0.9900153923697302,1.0,7/31,22.85%,HNRNPD;NBN;PML;RAD50;NEK7;MAPK1;ERCC1
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.19755063535054074,0.5221442801734612,0.9833147942157954,0.9905831404887045,1.0,14/48,27.02%,NUP93;NUP107;TIGAR;NUP98;EIF6;NUP37;OGT;NUP50;TPR;NOA1;NUP133;NUP85;NUP188;NUP88
prerank,DNA replication initiation (GO:0006270),0.20341083704422627,0.5216253438058421,0.9829931972789115,0.9904088454973862,1.0,6/37,14.84%,POLE3;MCM3;CDC34;ORC6;DBF4;GMNN
prerank,pre-replicative complex assembly (GO:0036388),0.19302884411681825,0.5205757598093399,0.993485342019544,0.9903924978932307,1.0,7/64,14.84%,PSMC4;PSMC6;PSMD8;MCM3;UBA52;ORC6;GMNN
prerank,tetrahydrofolate metabolic process (GO:0046653),-0.21150296002798513,-0.5194824453317938,0.9789473684210527,0.9963853042595174,1.0,1/10,4.21%,MTHFS
prerank,regulation of mRNA metabolic process (GO:1903311),0.24830199560477068,0.5162306295799738,0.96398891966759,0.9913218541369753,1.0,4/11,29.70%,PTCD2;SRPK1;SAFB;SLTM
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.19529882385197658,0.5155451011899805,0.9933259176863182,0.9911900012664195,1.0,4/53,9.78%,PSMC4;PSMC6;PSMD8;ODC1
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),-0.1975870420014992,-0.5144682304115314,0.9823943661971831,0.9961913113618049,1.0,1/12,2.45%,APOE
prerank,regulation of stem cell proliferation (GO:0072091),0.22672247742416268,0.5139464200577533,0.9721166032953105,0.9912824166909139,1.0,1/17,4.40%,ZFP36L1
prerank,response to gamma radiation (GO:0010332),0.2171715850755404,0.5123540941961499,0.9781021897810219,0.991383526938017,1.0,10/24,30.05%,FANCD2;XRCC5;CRYAB;MDM2;MEN1;XRCC6;TP53;HSF1;PRKAA1;TLK2
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),0.22556983265763325,0.5053713304409246,0.9768637532133676,0.9928520938048754,1.0,2/17,15.34%,MBOAT7;PLA2G4E
prerank,regulation of stem cell differentiation (GO:2000736),0.18283032647905362,0.5045828686114134,0.9968586387434555,0.9927224985898279,1.0,7/89,8.93%,PSMC4;RUNX1;ITCH;PSMC6;ZFP36L2;PSMD8;JAG1
prerank,neuronal action potential (GO:0019228),0.21500891498830593,0.5038100462040951,0.9786967418546366,0.9925835941220621,1.0,11/22,35.53%,MYH14;KCNA2;SCN9A;SCN2A;CACNA1H;KCNMB2;KCNMB3;CACNA1I;CACNA1G;SCN8A;SCN1A
prerank,peptidyl-glutamic acid modification (GO:0018200),0.21135826271985308,0.5021180432945136,0.9876998769987699,0.9926430010835275,1.0,5/24,25.85%,GGCX;TTLL3;TTLL11;VKORC1;TPGS1
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.1980659905207333,0.5020385100564095,0.9919816723940436,0.9923271090633989,1.0,11/35,28.61%,ACLY;FAR1;GGT7;HSD17B8;BDH2;SCD5;ACAT1;BDH1;PPT1;PAM;HMGCL
prerank,glycine metabolic process (GO:0006544),-0.19383591739376058,-0.4963837551363867,1.0,0.9982507064531497,1.0,12/12,80.64%,DLD;GCSH;SHMT2;SHMT1;AMT;GLYAT;RIDA;BAAT;SDS;SDSL;GCAT;GLDC
prerank,B cell mediated immunity (GO:0019724),0.24592754221395244,0.48987011874910324,0.9784172661870504,0.9946972453550555,1.0,1/10,12.21%,CD27
prerank,mitotic DNA replication (GO:1902969),0.23728373471840775,0.48045878158825717,0.9796215429403202,0.9961934755903977,1.0,1/10,10.21%,MCM3
prerank,tryptophan catabolic process (GO:0006569),0.2330529751443636,0.4777638517360621,0.9741144414168937,0.9963521935522613,1.0,11/11,76.71%,AFMID;KMO;KYAT1;ACMSD;IDO1;TDO2;IDO2;AADAT;HAAO;IL4I1;KYNU
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.22721322302485172,0.47196444942158194,0.9919028340080972,0.9970084362022488,1.0,6/12,33.72%,CDYL;LRIF1;PCGF3;RBM15;RLIM;HNRNPU
prerank,fibrinolysis (GO:0042730),-0.17846829880728185,-0.4707158804773595,0.9963235294117647,1.0,1.0,13/13,82.17%,SERPINE1;PLAT;HRG;PLG;SERPINB2;CPB2;GP1BA;F2;KRT1;FGG;SERPINF2;PLAU;PLAUR
prerank,positive regulation of telomerase activity (GO:0051973),0.18456859292101008,0.4653805728657199,0.9919632606199771,0.9977075553689906,1.0,7/33,23.74%,ACD;XRCC5;KLF4;HSP90AA1;NEK7;MAPK1;CCT4
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.2020561871976737,0.4624194584131098,0.9857328145265889,0.9978216642996667,1.0,3/19,17.91%,CHRNA7;CHRFAM7A;CHRNA5
prerank,positive regulation of stem cell proliferation (GO:2000648),-0.16260274583112602,-0.4615480524337247,0.9916666666666667,0.9997603923741009,1.0,6/17,27.11%,GJA1;TERT;SOX11;HMGA2;PTPRC;N4BP2L2
prerank,aromatic amino acid family metabolic process (GO:0009072),-0.18452268875917904,-0.46144206739295324,0.9965034965034965,0.9984271482325455,1.0,10/10,81.57%,QDPR;KYNU;IL4I1;PCBD1;IYD;PAH;ATP7A;KYAT1;THAP4;ASRGL1
prerank,"synaptic transmission, GABAergic (GO:0051932)",0.22169949515338075,0.45112630397578024,0.9871060171919771,0.999007489332057,1.0,5/10,33.00%,GABRG3;GABRG2;GABRA3;GABRA1;GABRA5
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.18311098991197164,0.450239414978935,0.9963636363636363,0.9987849338540933,1.0,1/29,3.89%,CD160
prerank,positive regulation of cytoplasmic transport (GO:1903651),0.21418544737404002,0.44818057048653953,0.9903047091412742,0.9986913271336512,1.0,3/11,28.36%,VPS11;EIPR1;PTPN23
prerank,innate immune response in mucosa (GO:0002227),0.21584786254286867,0.43957853172607947,0.9883040935672515,0.9992986894147332,1.0,1/10,14.83%,IL4
prerank,'de novo' posttranslational protein folding (GO:0051084),0.1788913392528865,0.4385976268772587,0.9917840375586855,0.9990601294897257,1.0,5/30,21.23%,HSPA13;HSPA14;SELENOF;UGGT1;DNAJB1
prerank,positive regulation of acute inflammatory response (GO:0002675),-0.16309875070625904,-0.4371129897503787,0.996,0.9986333878131435,1.0,14/14,83.71%,PTGS2;ADAM8;PARK7;TNF;CREB3L3;OSM;FFAR2;IL1B;C2CD4B;C2CD4A;IL6ST;PTGER3;OSMR;IL6
prerank,negative regulation of transposition (GO:0010529),0.19646272041808796,0.43436812662901764,0.9960159362549801,0.9991406673098591,1.0,3/16,22.64%,SPOCD1;DDX4;UBR2
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.20084784094421734,0.43351241169564453,0.9911392405063291,0.998892969538488,1.0,5/13,32.96%,CBL;SNX6;CBLB;SOCS4;TSG101
prerank,double-strand break repair via break-induced replication (GO:0000727),0.20520913782820321,0.4282477704405164,0.9906291834002677,0.9990170161112161,1.0,1/12,10.21%,MCM3
prerank,sensory perception of pain (GO:0019233),0.18301720889335515,0.42634931983902835,0.9921976592977894,0.9988458771108367,1.0,21/21,81.72%,KCNA2;SCN9A;P2RX4;RETREG1;TRPA1;PTGES;NIPSNAP1;MME;P2RX7;MRGPRX2;PRDM12;PROK2;ALOXE3;CHRNB2;OPRL1;KCNK4;CCL2;CCR2;CHRNA4;OPRM1;OPRK1
prerank,negative regulation of inclusion body assembly (GO:0090084),0.21198966216688228,0.42170284237984434,0.9929873772791024,0.9988822571480028,1.0,2/10,21.23%,DNAJB2;DNAJB1
prerank,glutathione derivative biosynthetic process (GO:1901687),0.18334894110051944,0.4200896681801249,0.9962025316455696,0.9983566363413237,1.0,8/20,33.91%,GSTM2;GSTO2;GSTM1;ESD;GSTM5;GSTT1;GSTZ1;HPGDS
prerank,glutathione derivative metabolic process (GO:1901685),0.18334894110051944,0.4200896681801249,0.9962025316455696,0.9983566363413237,1.0,8/20,33.91%,GSTM2;GSTO2;GSTM1;ESD;GSTM5;GSTT1;GSTZ1;HPGDS
prerank,positive regulation of telomere capping (GO:1904355),0.1856046353884671,0.41733560962804145,0.9948320413436692,0.9982203694779334,1.0,3/17,21.04%,HNRNPD;NEK7;MAPK1
prerank,dendritic cell chemotaxis (GO:0002407),0.19066964428664218,0.4172071091136922,0.9890560875512996,0.9978976471775314,1.0,3/14,21.28%,CXCR4;CXCR2;PIK3CG
prerank,positive regulation of lipid storage (GO:0010884),0.16664822824980496,0.3837236400802513,0.9975609756097561,0.9992862901401108,1.0,2/21,14.08%,PLIN2;ZC3H12A
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.16169573197175743,0.3822261772808466,1.0,0.9990071412546468,1.0,4/23,23.60%,SRCIN1;CBL;SNX6;CBLB
